<SEC-DOCUMENT>0001554795-24-000238.txt : 20240923
<SEC-HEADER>0001554795-24-000238.hdr.sgml : 20240923
<ACCEPTANCE-DATETIME>20240923161925
ACCESSION NUMBER:		0001554795-24-000238
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20240731
FILED AS OF DATE:		20240923
DATE AS OF CHANGE:		20240923

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Red Cat Holdings, Inc.
		CENTRAL INDEX KEY:			0000748268
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				880490034
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40202
		FILM NUMBER:		241316460

	BUSINESS ADDRESS:	
		STREET 1:		15 AVE. MUNOZ RIVERA
		STREET 2:		STE 2200
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-2510
		BUSINESS PHONE:		833-373-3228

	MAIL ADDRESS:	
		STREET 1:		15 AVE. MUNOZ RIVERA
		STREET 2:		STE 2200
		CITY:			SAN JUAN
		STATE:			PR
		ZIP:			00901-2510

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TimefireVR Inc.
		DATE OF NAME CHANGE:	20161121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EnergyTEK Corp.
		DATE OF NAME CHANGE:	20140723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROADLEAF CAPITAL PARTNERS INC
		DATE OF NAME CHANGE:	20040928
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rcat0923form10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:RCAT="http://RCAT/20240731">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_RCAT_RCAT_20240731 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20240501_20240731 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000748268 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_072_XDX_C%2D%2D\Users\zackz\Documents\XBRL accounts\RCAT\2024\10%2DQ 0923\rcat0923template.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityCentralIndexKey" id="ixv-10427">0000748268</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:AmendmentFlag" id="ixv-10428">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0011" name="dei:DocumentQuarterlyReport">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0012" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0013" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0014" name="dei:CurrentFiscalYearEndDate">--04-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0035" name="dei:EntitySmallBusiness">true</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-07-31" id="xdx2ixbrl0067" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" contextRef="AsOf2024-07-31" id="xdx2ixbrl0070" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-07-31" id="xdx2ixbrl0142" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0173" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0185" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0188" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0190" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0217" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0229" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0230" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0250" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0271" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0278" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0279" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0285" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0289" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0320" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0342" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:IncomeLossFromDiscontinuedOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesGainLoss" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2024-07-31" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-05-012023-07-31" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:ConversionOfPreferredStockIntoCommonStock" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0576" decimals="0" sign="-" unitRef="USD">4621</ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0601" decimals="0" sign="-" unitRef="USD">12416376</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0602" decimals="0" sign="-" unitRef="USD">2348412</ix:nonFraction>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0619" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0625" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0631" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0637" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0640" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0643" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0652" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0655" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2024-07-31" id="xdx2ixbrl0690" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" id="xdx2ixbrl0709" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" id="xdx2ixbrl0712" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0722" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0725" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0729" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" id="xdx2ixbrl0732" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" id="xdx2ixbrl0780" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueLongTerm" contextRef="AsOf2024-07-31" id="xdx2ixbrl0858" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0929" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0932" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0933" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0937" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0938" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member" id="xdx2ixbrl0939" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" id="xdx2ixbrl0963" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" id="xdx2ixbrl0964" unitRef="Pure" xs:nil="true"/>
  <ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl1020" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl1021" unitRef="USDPShares" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rcat-20240731.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-05-01to2024-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_SeriesBPreferredStock1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012020-04-30_custom_BusinessAcquisition1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-012021-04-30_custom_BusinessAcquisition2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_BusinessAcquisition3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_BusinessAcquisition4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_RestatementImpactChangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_RestatementImpactChangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_CustomerConcentrationRisk2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-012022-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2022-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-08-31_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012023-04-30_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-012023-04-30_custom_DebtObligation1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012023-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012023-04-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_custom_DebtObligation8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012024-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_SeriesAPreferredStock2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RCAT:SeriesAPreferredStock2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012021-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_WarrantsOutstanding1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-01</xbrli:startDate>
        <xbrli:endDate>2025-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-07-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000748268</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>FORM
<span id="xdx_909_edei--DocumentType_c20240501__20240731_zQSpZlX3aaLb"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:DocumentType" id="ixv-11407">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">(Mark One)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_902_edei--DocumentQuarterlyReport_dxL_c20240501__20240731_zr7JXumWUzZf" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0011">&#9745;</span></span>
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
the <span id="xdx_90C_edei--DocumentFiscalPeriodFocus_dxL_c20240501__20240731_z9Y2x1fpF9f9" title="::XDX::Q1"><span style="-sec-ix-hidden: xdx2ixbrl0012">quarterly</span></span> <span id="xdx_907_edei--DocumentFiscalYearFocus_dxL_c20240501__20240731_zoUF80sNrlG2" title="::XDX::2025"><span style="-sec-ix-hidden: xdx2ixbrl0013">period</span></span> <span id="xdx_908_edei--CurrentFiscalYearEndDate_dxL_c20240501__20240731_zGEfZWvhoMF5" title="::XDX::--04-30"><span style="-sec-ix-hidden: xdx2ixbrl0014">ended</span></span> <span id="xdx_90E_edei--DocumentPeriodEndDate_c20240501__20240731_zvLYeUH6MSS7"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-11408">July 31, 2024</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--DocumentTransitionReport_c20240501__20240731_zxaR7DV4Guvg"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport" id="ixv-11409">&#9744;</ix:nonNumeric></span>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
the transition period from <b>________</b> to <b>_________</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Commission
File Number:&#160;&#160;<span id="xdx_901_edei--EntityFileNumber_c20240501__20240731_zNyp4Edtp7r2"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityFileNumber" id="ixv-11410">001-40202</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityRegistrantName_c20240501__20240731_z9DGvYM3efj6"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityRegistrantName" id="ixv-11411">Red
Cat Holdings, Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20240501__20240731_zYT35K4Cqfck"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-11412">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20240501__20240731_zRWUC4nOnNTd"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityTaxIdentificationNumber" id="ixv-11413">88-0490034</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of incorporation or organization)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; text-align: center; vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20240501__20240731_zxFasfdymlE1"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityAddressAddressLine1" id="ixv-11414">15
    Ave. Munoz Rivera</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20240501__20240731_zwYiD6DabdIc"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityAddressAddressLine2" id="ixv-11415">Ste 2200</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20240501__20240731_zIVDuw1sWvW7"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityAddressCityOrTown" id="ixv-11416">San
    Juan</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCountry_c20240501__20240731_z24CVcZmoJy8"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityAddressCountry" id="ixv-11417">PR</ix:nonNumeric></span></b></span></p></td>
    <td style="vertical-align: top; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; vertical-align: top; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20240501__20240731_zMfA9w85pHah"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityAddressPostalZipCode" id="ixv-11418">00901</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--CityAreaCode_c20240501__20240731_zwHheANLlQwd"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:CityAreaCode" id="ixv-11419">(833)</ix:nonNumeric></span>
<span id="xdx_906_edei--LocalPhoneNumber_c20240501__20240731_zK2g5M2fX9kf"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:LocalPhoneNumber" id="ixv-11420">373-3228</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_905_edei--EntityInformationFormerLegalOrRegisteredName_c20240501__20240731_zQRYAU10CxSe"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityInformationFormerLegalOrRegisteredName" id="ixv-11421">Not
applicable</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif">(Former
name, former address and former fiscal year, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20240501__20240731_zOJG68gOKUdj"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:Security12bTitle" id="ixv-11422">Common
    stock, par value $0.001</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20240501__20240731_zkb7bpTqSaA2"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:TradingSymbol" id="ixv-11423">RCAT</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_909_edei--SecurityExchangeName_c20240501__20240731_zZ7kZFilAqRh"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-11424">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90A_edei--EntityCurrentReportingStatus_c20240501__20240731_zblVCW8XCNQ2"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityCurrentReportingStatus" id="ixv-11425">Yes</ix:nonNumeric></span> <b>&#9745;</b> No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;&#8201;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span id="xdx_909_edei--EntityInteractiveDataCurrent_c20240501__20240731_zxgJtkx76xQ9"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" name="dei:EntityInteractiveDataCurrent" id="ixv-11426">Yes</ix:nonNumeric></span> <b>&#9745;</b> No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityFilerCategory_c20240501__20240731_zkETfewxnEmh"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-11427">Non-accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9745;</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntitySmallBusiness_dxL_c20240501__20240731_z21D6PnhEpfg" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0035">&#9745;</span></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20240501__20240731_zK3v8m31nS1h"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-11428">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></p>

<p style="font: 10pt Segoe UI Symbol,sans-serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;Yes&#160;&#9744; <span id="xdx_90B_edei--EntityShellCompany_c20240501__20240731_zreIpxxAvRQ9"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="ixv-11429">No</ix:nonNumeric></span>&#160;<b>&#9745;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">As of September 19, 2024</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">,
there were <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20240919_zfmCQPLjepD"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-09-19" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11430">75,409,038</ix:nonFraction></span> shares </span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">of the registrant&#8217;s
common stock outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: transparent">
    <td colspan="2" style="padding-right: 1.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART I
    - FINANCIAL INFORMATION</b></span></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529"><b>Page</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left; width: 9%; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM
    1.</span></td>
    <td style="width: 82%; padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements</span></td>
    <td style="vertical-align: top; width: 9%; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"/>
    <td style="padding-left: 0pt; text-indent: -0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
    Consolidated Balance Sheets as of July 31, 2024 (Unaudited) and April 30, 2024</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated
    Statements of Operations and Comprehensive Income </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    the Three Months Ended July 31, 2024 and 2023 (Unaudited)</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
    Consolidated Statements Stockholders' Equity for the Three Months Ended July 31, 2024 and 2023 (Unaudited)</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated
    Statements of Cash Flows for the Three Months Ended July 31, 2024 and 2023 (Unaudited)</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Unaudited Condensed
    Consolidated Financial Statements</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 2.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
    Discussion and Analysis of Financial Condition and Results of Operations</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 3.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative
    and Qualitative Disclosures About Market Risk</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">25</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 4.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls
    and Procedures</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">25</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="2" style="padding-right: 1.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART II
    - OTHER INFORMATION</b></span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 1.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    Proceedings</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 1A.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">26</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 2.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unregistered
    Sales of Equity Securities and Use of Proceeds</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">26</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 3.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defaults
    Upon Senior Securities</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">26</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 4.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Safety Disclosures</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">27</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 5.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Information</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">27</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">ITEM 6.</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">27</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-right: 0.8pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-left: 8.1pt; text-indent: -8.1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-right: 1.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></td>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">28</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">This
Quarterly Report on Form 10-Q contains certain forward-looking statements which are made pursuant to the safe harbor provisions of Section
27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;). Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans,
objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements
are often, but not always, made through the use of words or phrases such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221;
&#8220;will,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221;
&#8220;continues,&#8221; &#8220;intends,&#8221; &#8220;plans&#8221; and &#8220;would&#8221; or the negative of these terms or other comparable
terminology. For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities,
and plans are all forward-looking statements. Our forward-looking statements are based on a series of expectations, assumptions, estimates
and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty.
They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or
achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking
statement. We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Our business
and our forward-looking statements involve substantial known and unknown risks and uncertainties, including the risks and uncertainties
inherent in our statements regarding:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            market and sales success of our existing and any new products;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to raise capital when needed and on acceptable terms;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to make acquisitions and integrate acquired businesses into our company; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to attract and retain management; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            intensity of competition;</span></td></tr></table>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->
<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the political and regulatory environment and in business and economic conditions in the
                                            United States and globally; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/150% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">geopolitical
                                            conflicts throughout the world, including those in Ukraine and Israel. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">All
of our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results may differ
materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will
prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties
referred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reports or other
documents or filings filed with or furnished to the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) could materially
and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake
or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or
projections or other circumstances affecting such forward-looking statements occurring after the date of this Quarterly Report on Form
10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public
statements or disclosures by us following this Quarterly Report on Form 10-Q that modify or impact any of the forward-looking statements
contained in this Quarterly Report on Form 10-Q will be deemed to modify or supersede such statements in this Quarterly Report on Form
10-Q.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">This
Quarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain from internal company
surveys, market research, consultant surveys, publicly available information, reports of governmental agencies and industry publications,
articles and surveys. Industry surveys, publications, consultant surveys and forecasts generally state that the information contained
therein has been obtained from sources believed to be reliable, but the accuracy and completeness of such information is not guaranteed.
While we believe that such studies and publications are reliable, we have not independently verified market and industry data from third-party
sources. Given these uncertainties, readers of this Quarterly Report on Form 10-Q are cautioned not to place undue reliance on such forward-looking
statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking
statements contained herein to reflect future events or developments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">All
references in this Quarterly Report on Form 10-Q to the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;,
are to Red Cat Holdings, Inc., a Nevada corporation, including its wholly owned consolidated subsidiaries Skypersonic, Inc. (&#8220;Skypersonic&#8221;),
Teal Drones, Inc. (&#8220;Teal&#8221;), and Red Cat Propware, Inc. (&#8220;Propware&#8221;), as well as Rotor Riot LLC (&#8220;Rotor
Riot&#8221;), Fat Shark Holdings, Ltd. (&#8220;Fat Shark&#8221;), which were wholly owned subsidiaries until February 16, 2024.<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white"><b></b></span></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white"><b>PART
I - FINANCIAL INFORMATION</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
1. FINANCIAL STATEMENTS</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;<b>RED
CAT HOLDINGS, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Condensed
Consolidated Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zUQEQdBRqIfc" summary="xdx: Statement - Condensed Consolidated Balance Sheets (Unaudited)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20240731_zQBwNSK6U6Qb" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_492_20240430_zi0y8umc4167" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July 31,</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsAbstract_iB_zXlTjt4Xp5Yk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">ASSETS</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_i01B_zA6vuI4XOot4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Current assets</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--Cash_i02I_maCzJdA_z44hUS2p7rr8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Cash</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11431">7,732,763</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11432">6,067,169</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzJdA_zqQA6sCgfIbd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Accounts receivable,
    net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11433">681,775</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11434">4,361,090</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryNet_i02I_maCzJdA_zeaMTiupg5Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Inventory</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11435">10,462,934</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11436">8,007,237</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OtherAssetsCurrent_i02I_maCzJdA_z1dc9LFb0wnb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Other</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11437">2,592,679</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11438">3,962,053</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrent_i02I_mtCzJdA_maCz3dl_zxIIzL8w7QTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt"><span style="font-size: 10pt">Total current
    assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11439">21,470,151</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11440">22,397,549</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--Goodwill_i01I_maCzHBW_zDBXR5PZTnb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Goodwill</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11441">8,995,500</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11442">9,088,550</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzHBW_zjqQi9qwWe6c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Intangible assets,
    net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11443">3,617,060</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11444">3,794,389</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--EquityMethodInvestments_i01I_maCzHBW_zOEY3bz75Mvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Equity method
    investee</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0067">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11445">5,142,500</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermAccountsNotesAndLoansReceivableNetNoncurrent_i01I_maCzHBW_z2FkVRHEa4ia" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Note receivable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0070">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11446">4,000,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzHBW_zKh9gejfL9pg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Property and
    equipment, net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11447">2,143,919</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11448">2,340,684</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsNoncurrent_i02I_maCzHBW_zoivdQVRsCAi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Other</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11449">293,126</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11450">293,126</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzHBW_z3rVxFxI7hw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Operating
    lease right-of-use assets</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11451">1,435,475</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11452">1,480,814</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsNoncurrent_i01I_mtCzHBW_maCz3dl_zhYYET31wHyb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt"><span style="font-size: 10pt">Total long-term
    assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11453">16,485,080</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11454">26,140,063</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Assets_i01TI_mtCz3dl_zpvy7lgL2dXc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">TOTAL
    ASSETS</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11455">37,955,231</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11456">48,537,612</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zHj0ELDV1V4h" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">LIABILITIES
    AND STOCKHOLDERS' EQUITY</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrentAbstract_i01B_zEjAYiSbNlb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Current liabilities</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_i02I_maCzew9_z1fCWSKxVK7b" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Accounts payable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11457">2,081,568</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11458">1,580,422</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzew9_zvBFDR61UQVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Accrued expenses</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11459">1,296,931</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11460">1,069,561</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ShortTermBorrowings_i02I_maCzew9_zaHIF02YZDF2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Debt obligations
    - short term</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11461">599,570</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11462">751,570</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maCzew9_zMnLaq4wOItc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Customer deposits</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11463">50,039</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11464">53,939</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzew9_zszz92nTIj8a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Operating
    lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11465">202,404</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11466">195,638</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrent_i02I_mtCzew9_maCzWen_zzRMSSKLCKK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt"><span style="font-size: 10pt">Total current
    liabilities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11467">4,230,512</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11468">3,651,130</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCzOfO_zA3J7UaDSHih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Operating
    lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11469">1,269,185</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11470">1,321,952</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesNoncurrent_i01I_mtCzOfO_maCzWen_zxkj5KkUPzv4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 40pt"><span style="font-size: 10pt">Total long-term
    liabilities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11471">1,269,185</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11472">1,321,952</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i01I_zCh9Rb3cGqh1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Commitments and
    contingencies (Note 17)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquityAbstract_i01B_zD52g5hIdse3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Stockholders'
    equity</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--PreferredStockValueSeriesB_i02I_maCzBt7_z9i7dvWY6jJl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Series B preferred stock - shares authorized </span><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20230731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdJeZ9XrNtte"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11473">4,300,000</ix:nonFraction></span>; issued and outstanding <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20240731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoWCJtHxIXJf"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11474">4,676</ix:nonFraction></span> and <span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20230731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zjm3xmNYQixk"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11475">4,676</ix:nonFraction></span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:PreferredStockValueSeriesB" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11476">47</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:PreferredStockValueSeriesB" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11477">47</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i02I_maCzBt7_zFO0ZLu00xja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Common stock - shares authorized </span><span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20230731_zWcDj1oIdzY5"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11478">500,000,000</ix:nonFraction></span>; issued and outstanding <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20240731_z1y5OeaULNvc"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11479">74,890,248</ix:nonFraction> </span> and <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20230731_z5ZiGVLrR6S6"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11480">74,289,351</ix:nonFraction></span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11481">74,890</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11482">74,289</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_i02I_maCzBt7_zM6JpTvAJFm" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Additional paid-in
    capital</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11483">125,927,705</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11484">124,616,305</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzBt7_zTC9qGzNosJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Accumulated deficit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11485">93,547,108</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11486">81,130,732</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzBt7_zn0AHoAoMBP9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Accumulated
    other comprehensive income (loss)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0142">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11487">4,621</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquity_i02I_mtCzBt7_maCzWen_zpu6dx86j4q1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Total
    stockholders' equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11488">32,455,534</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11489">43,564,530</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzWen_zVBu5vHNJPtl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">TOTAL
    LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11490">37,955,231</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11491">48,537,612</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RED
CAT HOLDINGS, INC.</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Statements of Operations and Comprehensive Income</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zKylbbuE2Shj" summary="xdx: Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_499_20240501__20240731_zb35IZI0odo6" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_494_20230501__20230731_zo8PfUCd2MTl" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>July
                                            31,</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_maCzuzA_z5ZPaNleutF9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11492">2,776,535</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11493">1,748,129</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostOfGoodsAndServicesSold_msCzuzA_z96dMgKxQ0qd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Cost
    of goods sold</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11494">3,259,926</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11495">1,573,464</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_mtCzuzA_maCzifv_zKnqWmReMfC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Gross (loss)
    profit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11496">483,391</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11497">174,665</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingExpensesAbstract_iB_z9SUL6k26S1g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating Expenses</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzYpK_zqOK5H6gYNUg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Research and
    development</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11498">1,626,440</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11499">1,353,551</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--MarketingAndAdvertisingExpense_i01_maCzYpK_zN2hYAc5WOqe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11500">2,041,511</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11501">1,288,760</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzYpK_zvgUNeM2K2l1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">General and administrative</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11502">3,483,095</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11503">2,863,758</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_i01_maCzYpK_zjqLcJkkqS8k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Impairment
    loss</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11504">93,050</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0173">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpenses_i01T_mtCzYpK_msCzifv_zhtb1qKVke9i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Total
    operating expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11505">7,244,096</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11506">5,506,069</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_iT_mtCzifv_maCzpLY_z3QLWaHAtYJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11507">7,727,487</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11508">5,331,404</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zC63PzXG857j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Other (income)
    expense</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_i01N_di_maCz7bh_zzWCr4jVMF05" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Loss on sale
    of equity method investment</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11509">4,008,357</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0185">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_i01N_di_maCz7bh_zAhCnTOQ8Fdc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Equity method
    loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11510">734,143</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0188">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--InvestmentIncomeNet_i01N_di_maCz7bh_zJ4AtD7iBN9j" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Investment loss,
    net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0190">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11511">239,490</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InterestExpense_i01_msCz7bh_zb8T7oHTQX73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Interest (income)
    expense, net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11512">24,554</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11513">21,857</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherNonrecurringIncomeExpense_i01_msCz7bh_zQREuwV5pYA7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Other,
    net</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherNonrecurringIncomeExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11514">29,057</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonrecurringIncomeExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11515">1,544</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_i01NT_di_mtCz7bh_maCzpLY_zUHbvFt4tPrj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Other expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11516">4,688,889</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11517">262,891</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_mtCzpLY_maCzyR4_zUheRBPo5yv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Net loss from
    continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11518">12,416,376</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11519">5,594,295</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_maCzyR4_zJCRQOfydHP" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Loss
    from discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0205">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11520">242,573</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_mtCzyR4_maOCILBzNNu_zdDIrOfr6c14" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -3.5pt; padding-left: 3.5pt"><span style="font-size: 10pt">Net
    loss</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11521">12,416,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11522">5,836,868</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_iB_zm2TQhRScvWl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -3.5pt; padding-left: 3.5pt"><span style="font-size: 10pt">Other comprehensive
    income (loss)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_i01_maOCILBzNNu_zGMJAMc1EFwc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: 5.25pt; padding-left: 3.5pt"><span style="font-size: 10pt">Change in foreign
    currency translation adjustments</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11523">4,621</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11524">1,646</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_i01_maOCILBzNNu_zlyLg7YWotve" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 5.25pt; padding-left: 3.5pt"><span style="font-size: 10pt">Unrealized
    gain on marketable securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0217">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11525">289,389</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossBeforeTax_i01_mtOCILBzNNu_zT1VgwbLGWp" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -3.5pt; padding-left: 3.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    comprehensive loss&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11526">12,420,997</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11527">5,545,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--EarningsPerShareBasicAndDilutedRCATAbstract_iB_zt7djkjd86q8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Loss per share
    - basic and diluted</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_i01_zdMWz3PvD9Vl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-11528">0.17</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares" id="ixv-11529">0.11</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_ecustom--EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_i01_zDHPyPmF4ID9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Discontinued
    operations</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0229">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0230">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--EarningsPerShareBasicAndDilutedRCATAbstract_iB_zoEn5mjmd237" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Loss
    per share - basic and diluted</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(0.17</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(0.11</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_zuojwA8HM8Xd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Weighted
    average shares outstanding - basic and diluted</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11530">74,500,480</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11531">54,935,339</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RED
CAT HOLDINGS, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Condensed
Consolidated Statements of Shareholders&#8217; Equity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_114_z3ZYcTbhp4n1" summary="xdx: Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_custom--SeriesBPreferredStock1Member_zAnjseKWJpEc" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zLSNwomm1a0i" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zYcxUtKruto" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zwRJK8qA6o1d" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zPOL5edi92nd" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td id="xdx_4BE_zou1UEhAT4Vb" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Series B</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated Other</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="7" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Paid-in</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Comprehensive</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Capital</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Income
    (Loss)</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Equity</span></td></tr>
  <tr id="xdx_43E_c20230501__20230731_eus-gaap--StockholdersEquity_iS_zE9y4NSTSxE8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">Balances, April 30, 2023, as restated</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zr07zPj9H9nj" style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11532">986,676</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11533">9,867</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcox2i2UXONj" style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11534">54,568,065</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11535">54,568</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11536">112,642,726</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11537">57,078,103</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11538">861,117</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 5%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11539">54,767,941</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43A_c20230501__20230731_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_z3x6ggh4xJl2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Stock based compensation</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0247">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0248">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11540">911,606</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0250">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0251">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11541">911,606</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43F_c20230501__20230731_eus-gaap--RestrictedStockValueSharesIssuedNetOfTaxWithholdings_zYLNNodAXfGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Vesting of restricted stock units</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEoaKeDM7Gt7" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11542">155,476</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11543">155</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11544">8,675</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0257">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0258">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11545">8,520</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43E_c20230501__20230731_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zwS8mQSHUWrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Conversion of preferred stock</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_iN_di_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zXjGV7Ml7kL" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11546">982,000</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11547">9,820</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_iN_di_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLrM8M6zQgDd" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares" id="ixv-11548">818,334</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11549">818</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11550">9,002</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0265">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0266">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_438_c20230501__20230731_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_zIYJV30szrn2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Unrealized gain on marketable securities</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0271">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0274">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11551">289,389</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11552">289,389</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43B_c20230501__20230731_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_zo1b2a3e8ZN2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Currency translation adjustments</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0278">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0279">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0281">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11553">1,646</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11554">1,646</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_439_c20230501__20230731_eus-gaap--NetIncomeLoss_zSarGcKRoIw6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Net loss</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0285">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0286">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0287">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11555">5,836,868</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0289">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11556">5,836,868</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20230501__20230731_eus-gaap--StockholdersEquity_iE_zmLXhNb6Cd16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balances, July 31, 2023</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zRHxGOunNqB5" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11557">4,676</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11558">47</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr3oXVOpw7Ij" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11559">55,541,875</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11560">55,541</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11561">113,554,659</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11562">62,914,971</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11563">570,082</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11564">50,125,194</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_438_c20240501__20240731_eus-gaap--StockholdersEquity_iS_zKnNLXoaJH0d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">Balances, April 30, 2024</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_zdwa8XBSc164" style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11565">4,676</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11566">47</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9GH50UoRgu6" style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11567">74,289,351</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11568">74,289</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11569">124,616,305</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11570">81,130,732</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11571">4,621</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11572">43,564,530</ix:nonFraction></span></td><td style="font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20240501__20240731_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zMDttEzeYJwg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Stock based compensation</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0310">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0311">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11573">1,446,038</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0313">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0314">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11574">1,446,038</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_430_c20240501__20240731_eus-gaap--RestrictedStockValueSharesIssuedNetOfTaxWithholdings_zzA2c45cKmVa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Vesting of restricted stock units</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0317">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_988_eus-gaap--RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQiSDUu4zhJe" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11575">293,302</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11576">293</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11577">134,330</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0320">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0321">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11578">134,037</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43D_c20240501__20240731_ecustom--StockIssuedDuringPeriodValueStockWarrantsExercised_zTgubnKXK4G5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt"><span style="font-size: 8pt">Exercise of warrants</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0325">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHsXInncGXV1" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11579">307,595</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11580">308</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11581">308</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_430_c20240501__20240731_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_zy5J4HtVRtzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Currency translation adjustments</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0334">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0335">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11582">4,621</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11583">4,621</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_435_c20240501__20240731_eus-gaap--NetIncomeLoss_z4XMpJltkSu6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">Net loss</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0340">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8212;&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0341">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0342">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11584">12,416,376</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0344">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11585">12,416,376</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_435_c20240501__20240731_eus-gaap--StockholdersEquity_iE_zagSGeMhiKU7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balances, July 31, 2024</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredStock1Member_z2kR4FfYkwae" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11586">4,676</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31_custom_SeriesBPreferredStock1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11587">47</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20240501__20240731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTZtixVL4zge" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11588">74,890,248</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11589">74,890</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11590">125,927,705</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11591">93,547,108</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 8pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11592">32,455,534</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RED
CAT HOLDINGS, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Condensed
Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Unaudited)</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_112_zTUKR2yuq3Oi" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20240501__20240731_zhKmYAmryMSf" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20230501__20230731_zrSr8xmviXAe" style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three
    months ended&#160;July 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zpvThYQMYTgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Cash Flows from Operating Activities</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_i01_maCzRNF_z17Z0DUyeSf2" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Net
    loss</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11593">12,416,376</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11594">5,836,868</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_ecustom--IncomeLossFromDiscontinuedOperations_i01N_di_maCzRNF_z6D5Jw6RA3Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Net
    loss from discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:IncomeLossFromDiscontinuedOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11595">242,573</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperations_i01_mtCzRNF_msCzem6_zOYu1TmNY9Aj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Net loss from
    continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11596">12,416,376</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11597">5,594,295</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zwnfiHOG9Tjd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Adjustments to
    reconcile net loss to net cash from operations:</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_i02_msCzem6_zkuxScaFGmB5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Stock based compensation
    - options</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11598">357,258</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11599">629,426</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_i02_msCzem6_z1K529vedsP7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Stock based compensation
    - restricted units</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11600">1,088,780</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11601">282,180</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AmortizationOfIntangibleAssets_i02_maCzem6_zdGJRJpkoAhk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Amortization
    of intangible assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11602">177,329</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11603">217,368</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--MarketableSecuritiesGainLoss_i02_msCzem6_zDOuvNP5A6Ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Realized loss
    from sale of marketable securities</span></td><td style="font-size: 8pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:MarketableSecuritiesGainLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11604">292,636</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--Depreciation_i02_maCzem6_zF21maNV6zeb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Depreciation</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11605">296,722</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11606">101,001</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_i02N_di_msCzem6_zxirU3ZdTYKd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Loss on sale
    of equity method investment and note receivable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11607">4,008,357</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0387">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_i02N_di_msCzem6_zNXhr0IHywEl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Equity method
    loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11608">734,143</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0390">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_i02_maCzem6_zEfZzg5i8HKl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Impairment on
    goodwill and intangible assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11609">93,050</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_i01B_zKpyGrfu69O7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Changes in operating
    assets and liabilities</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02_msCzem6_zr2OkwbspzVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Accounts receivable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11610">3,679,315</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11611">780</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInInventories_i02_msCzem6_zOIv7YFYtI9b" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Inventory</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11612">2,455,697</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11613">455,871</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherCurrentAssets_i02_msCzem6_zl5rgpHFfxEd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Other</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11614">1,369,374</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11615">1,756,973</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_i02_msCzem6_zT4WDw0YLag9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Operating lease
    right-of-use assets and liabilities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11616">662</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11617">458</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i02_maCzem6_zF8mkCbbqDj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Customer deposits</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11618">3,900</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11619">110,863</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_maCzem6_zupq4dMDJAg1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Accounts payable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11620">501,146</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11621">569,876</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maCzem6_zdpRBYgF56Oc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 40pt"><span style="font-size: 10pt">Accrued
    expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11622">222,749</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11623">40,436</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_i01_mtCzem6_maCzrHc_zaOvGKdV81D6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Net cash used
    in operating activities of continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11624">2,348,412</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11625">6,926,069</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalCashFlowElementsFinancingActivitiesAbstract_iB_zataGPIfFqtk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash Flows from
    Investing Activities</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquireProductiveAssets_i01N_di_msCzyW0_z68kLLkW2L6a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Purchases of
    property and equipment</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11626">99,957</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11627">5,054</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_i01_maCzyW0_z3AVLObeNV88" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Proceeds from
    sale of marketable securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11628">4,888,399</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromSaleOfEquityMethodInvestments_i01_maCzyW0_zHPjy70SFzm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Proceeds
    from sale of equity method investment and note receivable</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11629">4,400,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_i01T_mtCzyW0_maCzrHc_zUu9yVuQR8Cc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Net cash provided
    by investing activities of continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11630">4,300,043</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11631">4,883,345</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z9WFRA2y76e6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash Flows from
    Financing Activities</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--RepaymentsOfDebt_i01N_di_msCzpdL_zq5ALbJotkb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Payments under
    debt obligations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11632">152,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11633">137,989</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_ecustom--PaymentsOfTaxesRelatedToEquityTransactions_i01N_di_msCzpdL_z4f6UWoSittd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Payments
    of taxes related to equity transactions</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:PaymentsOfTaxesRelatedToEquityTransactions" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11634">134,037</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:PaymentsOfTaxesRelatedToEquityTransactions" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11635">8,520</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_i01_mtCzpdL_zEo2Hon6Uqs" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Net cash used
    in financing activities of continuing operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11636">286,037</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11637">146,509</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DiscontinuedOperationAdditionalDisclosuresAbstract_iB_zIuw4XAbZiOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Discontinued
    operations</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_i01_maCzPVB_zNXm7NknrKWi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -11pt; padding-left: 20pt"><span style="font-size: 10pt">Operating activities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11638">356,109</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_i01_maCzPVB_zIU66XDEP994" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -11pt; padding-left: 20pt"><span style="font-size: 10pt">Investing activities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_i01_maCzPVB_zs7yijBx4QOd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -11pt; padding-left: 20pt"><span style="font-size: 10pt">Financing
    activities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11639">237,814</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInDiscontinuedOperations_i01T_mtCzPVB_maCzrHc_z7cQ4Cbwldg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Net cash used
    in discontinued operations</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11640">118,295</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzrHc_zKLPq01ud1Mc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Net increase
    (decrease) in Cash</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11641">1,665,594</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11642">2,307,528</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_iS_maCz4TQ_zQEpy9NS3esj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash, beginning
    of period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11643">6,067,169</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11644">3,260,305</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_iE_maCz4TQ_zlz8qX6Tnhyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash, end of period</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11645">7,732,763</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11646">952,777</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCash_iNE_di_maCz4TQ_zsokqjWZ0wnl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Less:
    Cash of discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11647">15,021</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_mtCz4TQ_zOyN3HdTFYR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash of
    continuing operations, end of period</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11648">7,732,763</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11649">937,756</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_zIswHmktH0Ol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash
    paid for interest</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11650">6,295</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11651">22,590</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxesPaidNet_zFefsTgiuc6e" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Cash
    paid for income taxes</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0482">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0483">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_z7zCuI7LHvyb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -20pt; padding-left: 20pt"><span style="font-size: 10pt">Non-cash
    transactions</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_i01_zubFjgCG3jm2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Unrealized
    gain on marketable securities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11652">289,389</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ConversionOfPreferredStockIntoCommonStock_i01_zr2WUnTtz8w9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -20pt; padding-left: 30pt"><span style="font-size: 10pt">Conversion
    of preferred stock into common stock</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:ConversionOfPreferredStockIntoCommonStock" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11653">9,820</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RED
CAT HOLDINGS, INC.</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;<b>(Unaudited)&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="ixv-5381"><p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z49jg8M1uPti" style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zPmSPEF9Nopd">Note
1 &#8211; The Business</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company was originally incorporated in February 1984. Since April 2016, the Company&#8217;s primary business has been to provide products,
services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January
2020, the Company expanded the scope of its drone products and services through four acquisitions, including:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the Company
    acquired Rotor Riot, a provider of First Person View (&#8220;FPV&#8221;) drones and equipment, primarily to consumers. The purchase
    price was $<span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zxTjophP5vu4"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2019-05-012020-04-30_custom_BusinessAcquisition1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11654">1,995,114</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2020, the Company
    acquired Fat Shark Holdings, Ltd. (&#8220;Fat Shark&#8221;), a provider of FPV video goggles to the&#160;drone industry. The purchase
    price was $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_ztcvHIVe3Tyh"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2020-05-012021-04-30_custom_BusinessAcquisition2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11655">8,354,076</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the Company
    acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations
    where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles
    away. The purchase price was $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zAcRxVPVp1q8"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11656">2,791,012</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2021, the Company
    acquired Teal Drones, Inc. (&#8220;Teal&#8221;), a leader in commercial and government Unmanned Aerial Vehicles (&#8220;UAV&#8221;)
    technology.&#160;The purchase price was $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_zcYUcSso4WFf"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11657">10,011,279</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#8220;Enterprise&#8221;) and the Consumer segment (&#8220;Consumer&#8221;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 16, 2024, we closed the sale of our Consumer
segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and
capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 3 and Note 7.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of <span id="xdx_90F_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zmV21Zv8E8q1"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingShares" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11658">18,400,000</ix:nonFraction></span> shares of common stock which generated
gross proceeds of $<span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_zrbrQy2q6oV8"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11659">9,200,000</ix:nonFraction></span> and net proceeds of approximately $<span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_z7Q27q2Zfn69"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11660">8,400,000</ix:nonFraction></span>.</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 8pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_814_zYrbjbAk0Efc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="ixv-5454"><p id="xdx_807_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zjz85o8K0POe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_825_zTm0e4LXiCv8" style="font-family: Times New Roman, Times, Serif; color: Black"><b>Note
2 &#8211; Summary of Significant Accounting Policies</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-5460"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zutEcgLYyih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_865_zlvklUGo8XD6" style="font-family: Times New Roman, Times, Serif; color: Black"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; color: Black">&#8211; The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(&#8220;GAAP&#8221;) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management,
all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial
statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the
results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes
thereto for the year ended April 30, 2024, included in the Company&#8217;s Annual Report on Form 10-K.</span></p>

</ix:nonNumeric><p id="xdx_85F_zNIqqKUGDSVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" id="ixv-5467"><p id="xdx_844_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zWM3U6GsyAFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zWCqQu6BvACa">Restatement
of Previously Issued Consolidated Financial Statements</span> </b>&#8211; The Company&#8217;s Condensed Consolidated Statement of Operations
and Stockholders&#8217; Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) on September 19, 2023, have been restated. The Company revised its financial statements to&#160;remove
derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having
a derivative component.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 8; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
impacts of these restatements are detailed in the tables below:</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" id="ixv-5487"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of derivative liability</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11661">26,520</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities" contextRef="From2023-05-012023-07-31_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11662">26,520</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11663">5,810,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11664">5,836,868</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11665">26,520</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Shareholders&#8217; Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Additional paid-in capital</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11666">110,905,033</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11667">113,554,659</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11668">2,649,626</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Accumulated deficit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11669">60,397,141</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11670">62,914,971</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11671">2,517,830</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Total equity</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11672">49,993,398</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11673">50,125,194</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockholdersEquityRestatement" contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11674">131,796</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_ze2JTgurI8fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

</ix:nonNumeric><p id="xdx_850_zxjGS8BOnYif" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-5729"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zYX7MX8oMCjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_868_zGp4trD4Rf52">Principles
of Consolidation</span></b> &#8211; <span style="background-color: white">Our condensed consolidated financial statements include the accounts
of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February
16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for
using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions
and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>

</ix:nonNumeric><p id="xdx_853_zyQNzovpfQHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:UseOfEstimates" id="ixv-5741"><p id="xdx_84D_eus-gaap--UseOfEstimates_zvLQBk4nnqlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zWcAXfWWrOb9">Use
of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The preparation of financial statements in accordance with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those
used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></span></p>

</ix:nonNumeric><p id="xdx_85F_z1lrZVjHW9M" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white">&#160;</span></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-5750"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_ze4wFxTi7qq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_863_zbteLT7yvvYf">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade
receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs
ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer
from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable,
net as of July&#160;31, 2024 and April 30, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="ixv-5758"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" summary="xdx: Disclosure - Customer concentration risk (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>July 31, 2024</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>April 30, 2024</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11675">38</ix:nonFraction></td><td style="text-align: left; width: 1%">%</td>
    <td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11676">53</ix:nonFraction></td><td style="text-align: left; width: 1%">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-05-012024-07-31_custom_CustomerConcentrationRisk2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11677">25</ix:nonFraction></td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11678">24</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_z5nsI50jYiG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of July 31,
2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July
31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.</span></p>

</ix:nonNumeric><p id="xdx_85C_z6cWOblx5s61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 9; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:EquityMethodInvestmentsPolicy" id="ixv-5808"><p id="xdx_84C_eus-gaap--EquityMethodInvestmentsPolicy_zKxQuQLqZaOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_867_zceAwNcrS64l">Equity
Method Investment</span> &#8211; </b><span style="background-color: white">The equity method of accounting is applied to investments in which
the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period
for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily
be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an
earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its
investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $<span id="xdx_908_eus-gaap--AssetImpairmentCharges_c20230501__20240430_zkbYsHH966n9"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11679">11,353,875</ix:nonFraction></span> for the year ended April&#160;30,
2024. See Note 7 for additional information.</span></span></p>

</ix:nonNumeric><p id="xdx_854_z3fpt2Dvy0Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-5820"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKT6sOtOpMdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zBVjhFLEIcQc">Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
guidance establishes three levels of the fair value hierarchy as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The
carrying amounts of these instruments approximates fair value due to their short-term nature.</span></p>

</ix:nonNumeric><p id="xdx_852_zMrN4PunMWv" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-5850"><p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zDrocIb8lYd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span><b><span id="xdx_86D_zC2BYsAH4G68">Revenue Recognition</span> </b>&#8211;
The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting
Standards Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue
recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price,
(iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as
each obligation is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are
fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue
upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240731_zv3ruEUYdIei"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11680">50,039</ix:nonFraction> </span> and $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zta0vf4KVPY1"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11681">53,939</ix:nonFraction> </span> at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the
capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_90E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240731_zeehHTInjCH9"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11682">0</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zUia9GjcIxwd"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11683">1,477,859</ix:nonFraction></span> at July 31, 2024 and
April 30, 2024, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table presents the Company&#8217;s revenue disaggregated by revenue type:</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" id="ixv-5863"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three
    Months Ended&#160;July 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11684">886,440</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11685">310,881</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Product related</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueNotFromContractWithCustomer" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11686">1,890,095</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueNotFromContractWithCustomer" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11687">1,437,248</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11688">2,776,535</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11689">1,748,129</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zyVi65qXkNFl" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_85A_zP3l9Kcd8sYg" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 10; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="ixv-5967"><p id="xdx_848_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zzZ20WTYGaPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zB5Fs2RckWq1">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales
data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses.&#160;Warranty
liability was approximately $<span id="xdx_90E_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240731_z2g90xAOwkf2"><ix:nonFraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11690">541,000</ix:nonFraction> </span>
and $<span id="xdx_900_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zjhY2VPYHCm1"><ix:nonFraction name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11691">372,000</ix:nonFraction> </span> as of July 31, 2024 and April 30, 2024 respectively.</span></p>

</ix:nonNumeric><p id="xdx_85B_zxDUjUvqiFUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-5976"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIslxQr6OUV8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zBCv0DVYabr4">Recent
Accounting Pronouncements</span> </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;
<span style="background-color: white">Management does not believe that recently issued, but not yet effective accounting pronouncements,
if adopted, would have a material effect on the accompanying consolidated financial statements.</span></span></p>

</ix:nonNumeric><p id="xdx_854_zKiSTpicZ0Ej" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="ixv-5988"><p id="xdx_844_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9ddSQBeNkBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_869_zGDhiRI4SNhb">Comprehensive
Loss</span> </b>&#8211; Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses
that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of
foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended
July 31, 2024 and July 31, 2023, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20240501__20240731_zk6oWTfRMTJ6"><ix:nonFraction name="RCAT:DifferenceBetweenComprehensiveLossAndNetLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11692">4,621</ix:nonFraction></span>
higher and $<span id="xdx_90E_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20230731_z5YREAIgqlQ9"><ix:nonFraction name="RCAT:DifferenceBetweenComprehensiveLossAndNetLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11693">291,035</ix:nonFraction></span>
lower than net loss, respectively, related to unrealized
gains on available-for-sale securities totaling $<span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20240501__20240731_z3grDvAbQi4h"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11694">0</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20230731_zDFVPqPEWUza"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11695">289,389</ix:nonFraction></span>,  respectively, and foreign currency translation adjustments of $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dxL_c20240501__20240731_zFJ3HWWXeObe" title="::XDX::-4621"><span style="-sec-ix-hidden: xdx2ixbrl0576">4,621 </span></span>
and $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20230731_zNRVZcQe7bY1"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11696">1,646</ix:nonFraction></span>.</span></p>

</ix:nonNumeric><p id="xdx_85C_zTbyWqSdIc61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-6002"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zVUoEFBtUfU" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_860_zSU7UfLWc966">Basic and
Diluted Net Loss per Share</span></b> &#8211; Basic and diluted net loss per share has been calculated by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of
diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents
would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted
net loss per share because their effect would have been anti-dilutive include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-6009"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2023</span></td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Series B Preferred Stock, as converted</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11697">3,896</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11698">3,896</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Stock options</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11699">7,319,988</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11700">6,884,017</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11701">1,821,291</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11702">1,539,999</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Restricted stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11703">2,202,599</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11704">842,701</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11705">11,347,774</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11706">9,270,613</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zKTk0JjIkx29" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

</ix:nonNumeric><p id="xdx_854_zik18tQXDauk" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:RelatedPartiesPolicyTextBlock" id="ixv-6128"><p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zV2baH1iPfPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zPoAEykNX2k8">Related
Parties</span></b> &#8211; Parties are considered to be related to us if they have control or significant influence, directly or indirectly,
over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel
of members of the Board of Directors. Related Party transactions are disclosed in Note 16.</span></p>

</ix:nonNumeric><p id="xdx_857_z8Wi28svccf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" id="ixv-6135"><p id="xdx_84A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAP8XuCbTS1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_86B_zRGfjLqTkQrd">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as
well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a
net loss </span><span style="font-family: Times New Roman, Times, Serif">of approximately $<span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20240501__20240731_zF35Z25bd401" title="::XDX::-12416376"><span style="-sec-ix-hidden: xdx2ixbrl0601">12,000,000 </span></span>&#160;and
used cash in operating activities of approximately $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20240501__20240731_zju8eqwXnN28" title="::XDX::-2348412"><span style="-sec-ix-hidden: xdx2ixbrl0602">2,300,000</span></span>.
As of July 31, 2024, working capital totaled approximately $<span id="xdx_903_eus-gaap--Capital_iI_c20240731_zjp5xsHPQbSj"><ix:nonFraction name="us-gaap:Capital" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11707">17,200,000</ix:nonFraction></span>.
These financial results and our financial position <span style="background-color: white">at&#160;July 31, 2024&#160;raise
substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen
its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of <span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zkFL43bk1sl8"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingShares" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11708">18,400,000</ix:nonFraction></span>
shares of common stock which generated net proceeds of approximately $<span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zz34gyeJ4D2a"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11709">8,400,000</ix:nonFraction></span>
as further described in Note 1 and Note 12. In addition, the Company&#8217;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The
Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the
Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold
its equity method investment for $<span id="xdx_90C_ecustom--ProceedsFromPurchaseAgreement_c20240501__20240731_zNUW7sJPnTrg"><ix:nonFraction name="RCAT:ProceedsFromPurchaseAgreement" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11710">4,400,000</ix:nonFraction></span>
in July 2024.<span style="background-color: white"> As described in Note 18, the Company closed a financing with proceeds of $8
million to be received in late September 2024.</span> Management has concluded that these recent positive developments alleviate any
substantial doubt about the Company&#8217;s ability to&#160;continue its operations, and meet its financial obligations, for twelve
months from the date these consolidated financial statements&#160;are&#160;issued.</span></span></p>

</ix:nonNumeric><p id="xdx_855_zqov4ebKsuLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_813_zMmyi7MtzNI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="ixv-6155"><p id="xdx_80C_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zWAXtnQmdw4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zIqIy55O0bZ1">Note
3 &#8211; Divestiture of Consumer Segment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 16, 2024,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">the
Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement
dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#8220;SPA&#8221;). The transaction
closed concurrently with UMAC&#8217;s initial public offering and listing on the NYSE American exchange (&#8220;IPO&#8221;) under the
symbol &#8220;UMAC.&#8221; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
total consideration received by the Company was valued at $<span id="xdx_909_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_c20230501__20240430_zzAEC1rPEGPb"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11711">20</ix:nonFraction></span> million and consisted of i) $<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_zILcqNPyLqqf"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-11712">1</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif">million in cash, ii) $<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zrPqjzZqNz2g"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-11713">2</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif">million in a secured promissory note (&#8220;Promissory Note&#8221;),
iii) $<span id="xdx_905_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zN7QpLusj8Ha"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-11714">17</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif">million in securities of Unusual Machines, and iv) a post-closing
adjustment for excess working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 11; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Secured
Promissory Note</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
Promissory Note from Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires
monthly payments of interest due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one
or more related debt or equity financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#8217;s completed
IPO), the Company may require payment of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified
Financing. During the occurrence and continuance of any event of default under the Note, the Company may, at its option, convert the
amounts due under the Note to common stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount
to the average daily volume weighted average price for UMAC&#8217;s common stock over the 10 days preceding the conversion price. Conversions
under the Note will be limited such that no conversion may be made to the extent that, after giving effect to the conversion, the Company,
together with its affiliates, would beneficially own in excess of 4.99% of UMAC&#8217;s common stock. This limit may be increased by
the Company upon 61 days written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Unusual
Machines Securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i></i>The $<span id="xdx_90F_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20240501__20240731_ze2DW3e3BvMj"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-11715">17</ix:nonFraction></span> million worth of UMAC common stock was valued at the IPO price for UMAC&#8217;s common stock of $4.00
per share, resulting in
<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20240501__20240731_zmcAOx6QeDkh"><ix:nonFraction name="RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11716">4,250,000</ix:nonFraction></span> shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#8217;s
issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of
the IPO).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Working
Capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
purchase price was adjusted for working capital as of the closing date. </span><span style="font-family: Times New Roman, Times, Serif">Actual
working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. <span style="background-color: white">Working
capital as of closing was finalized at $<span id="xdx_90F_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zDm9R5ivZsn3"><ix:nonFraction name="RCAT:WorkingCapitalAtClosingOfDisposalGroup" contextRef="AsOf2024-02-16" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD" id="ixv-11717">2</ix:nonFraction></span> million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory
Notes due November 30, 2025 (the &#8220;New Notes&#8221;) reflecting (i) satisfaction and settlement of working capital adjustments and
(ii) a maturity date extension to November 30, 2025.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards.
Set forth below are the results of operations for the Consumer segment for:</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="ixv-6229"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zuKaIeWZu0c8" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20240501__20240731_z4VdeuOt2Nki" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230501__20230731_zzSlhuvBqTD4" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>July
                                            31</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zj8g3sgk8Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0619">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11718">1,869,219</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zqzFk1peqQib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Cost
    of goods sold</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11719">1,385,116</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zXptTyvGvpFg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Gross Profit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11720">484,103</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zracsPLzZwCg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating Expenses</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_ziPibjoMV2if" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Research and
    development</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11721">46,249</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zV7ogu7xH47c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0634">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11722">404,104</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_z7Ru2o5k3OS2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">General
    and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11723">253,586</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zRJj7W3xza0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Total
    operating expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0640">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11724">703,939</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_zvBQO3lP0N1i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11725">219,836</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zaK2fMK0e4f6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Other expense
    (income)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zqIZoq6f2Xvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Interest expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11726">22,856</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zxpSTIawrCB8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Other,
    net</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0652">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11727">119</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i02_z5dvtLssGI42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><span style="font-size: 10pt">Other expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11728">22,737</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zsogtd9BqCLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Net
    loss from discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0658">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11729">242,573</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zk2MRCfa1ush" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

</ix:nonNumeric><p id="xdx_816_zgk1SIJ2HnWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock" id="ixv-6652"><p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zzHqLTa6gtZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_828_zPEmyRPf3Feg">Note
4 &#8211; Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Inventories
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="ixv-6663"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zRCtWQmDFBv7" summary="xdx: Disclosure - Inventories (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_490_20240731_zvHIzK3CIl6a" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240430_zeCzF8CvuTd8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_zhWQPFnWYQk8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Raw materials</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11730">6,863,187</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11731">5,750,324</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_zw199aAvrVv4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Work-in-process</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11732">1,622,121</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11733">1,289,997</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_znaANYaOFAM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Finished goods</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11734">1,977,626</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11735">966,916</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryNet_iI_zvmDK7Y3Mez4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11736">10,462,934</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11737">8,007,237</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zK70IRaoFp74" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

</ix:nonNumeric><p id="xdx_812_zBwDBpcsgcy7" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock" id="ixv-6755"><p id="xdx_809_eus-gaap--OtherCurrentAssetsTextBlock_zOA03Ci8w8p" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_823_zj8mgt5L6GD8">Note
5 &#8211; Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Other
current assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ixv-6766"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zX8DVTzy3kmk" summary="xdx: Disclosure - Other current assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240731_zeID4xo625o9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240430_zYD437Aip8v7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zui2NmgKkI0i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid expenses</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11738">2,387,937</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11739">1,206,306</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zGhl9icFl5yg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid inventory</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11740">204,742</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11741">602,888</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zWLrkPLAqSq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract asset</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-07-31" format="ixt:zerodash" decimals="0" unitRef="USD" id="ixv-11742">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetGrossCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11743">1,477,859</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--GrantsReceivableCurrent_iI_zgjWNMUcqq64" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Grant receivable</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GrantsReceivableCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11744">675,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAssetsCurrent_iI_zRGRYMiN35V4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11745">2,592,679</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11746">3,962,053</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zQ4K2FJXZtga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>&#160;</b></span></p>

</ix:nonNumeric><p id="xdx_815_zpGICTSFnXLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="ixv-6883"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zYzrWARpNqRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_828_zrR0uon87BKh">Note
6 &#8211; Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="ixv-6893"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zsjeL5QCTHm7" summary="xdx: Disclosure - Intangible assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"/><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zC1wdR0GRknf" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQkhwGyz0tUi" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49D_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zF4SeUK4PX7f" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49B_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zWZvAphaHHi9" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zkfpwTcGZs26" style="text-align: center"/><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49A_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zyzLmWy22k54" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Gross
    Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td></tr>
  <tr id="xdx_408_ecustom--FiniteLivedProprietaryTechnologyGross_iI_zWENlT1lHKjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Proprietary technology</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11747">4,282,001</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11748">2,094,941</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11749">2,187,060</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11750">4,282,001</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right">(<ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11751">1,917,612</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedProprietaryTechnologyGross" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11752">2,364,389</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zhDKad5xG7lb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Non-compete agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11753">65,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11754">65,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11755">65,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:FiniteLivedNoncompeteAgreementsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11756">65,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0712">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zasy2FVorEwh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><span style="font-size: 10pt">Total finite-lived assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11757">4,347,001</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11758">2,159,941</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11759">2,187,060</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11760">4,347,001</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11761">1,982,612</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:FiniteLivedIntangibleAssetsGross1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11762">2,364,389</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IndefiniteLivedTradeNames_iI_zxEIZg9A2ZEl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Brand name</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11763">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0722">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11764">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11765">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0725">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11766">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zHPvJXlCl4Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"><span style="font-size: 10pt">Total indefinite-lived
    assets</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11767">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11768">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11769">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11770">1,430,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_zfACR5VZxKIc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total intangible
    assets, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11771">5,777,001</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11772">2,159,941</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11773">3,617,060</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11774">5,777,001</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11775">1,982,612</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IntangibleAssetsNetExcludingGoodwill1" contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11776">3,794,389</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zA83lKEIFBUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not
amortized but evaluated for impairment on a quarterly basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81D_zhH2xAleP8oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="ixv-7304"><p id="xdx_805_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_z9YiN0YA0b24" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82D_zN2iSw1Nvgug">Note
7 &#8211; Equity Method Investment</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; background-color: white">On
July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the &#8220;Purchasers&#8221;).
As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged
<span id="xdx_909_ecustom--ExchangeAgreementSharesExchanged_c20240501__20240731_z38JyqlzWk19"><ix:nonFraction name="RCAT:ExchangeAgreementSharesExchanged" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11777">4,250,000</ix:nonFraction></span> shares of UMAC&#8217;s common stock, par value $<span id="xdx_902_ecustom--ExchangeAgreementSharesExchangedParValue_c20240501__20240731_zEbXUfVJ8Nw1"><ix:nonFraction name="RCAT:ExchangeAgreementSharesExchangedParValue" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11778">0.001</ix:nonFraction></span> per share, for <span id="xdx_90E_ecustom--ExchangeAgreementPreferredSharesReceived_c20240501__20240731_zQDl8K4LWYU2"><ix:nonFraction name="RCAT:ExchangeAgreementPreferredSharesReceived" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11779">4,250</ix:nonFraction></span> shares of UMAC&#8217;s newly designated Series A
Convertible Preferred Stock (the &#8220;Series A&#8221;). The Company sold the Series A ownership interest ($<span id="xdx_90A_ecustom--ExchangeAgreementSharesPreferredStockValueSold_c20240501__20240731_ztxl36a9zcJh"><ix:nonFraction name="RCAT:ExchangeAgreementSharesPreferredStockValueSold" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11780">4,408,357</ix:nonFraction></span> at time of sale)
and the Note Receivable of $<span id="xdx_90E_ecustom--NoteReceivableSoldPursuantToExchangeAgreement_c20240501__20240731_zKSZWm4YDTGi"><ix:nonFraction name="RCAT:NoteReceivableSoldPursuantToExchangeAgreement" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11781">4,000,000</ix:nonFraction></span> to the Purchasers for $<span id="xdx_904_ecustom--ProceedsFromPurchaseAgreement_pin6_c20240501__20240731_zYhbVr7LHnL2"><ix:nonFraction name="RCAT:ProceedsFromPurchaseAgreement" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD" id="ixv-11782">4.4</ix:nonFraction></span> million in cash pursuant to a Purchase Agreement in a transaction that
closed on July 22, 2024.</span><span style="font-size: 8pt">&#160;&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company had owned approximately a <span id="xdx_907_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230501__20240430_zEA1zXrp3SLi"><ix:nonFraction name="us-gaap:VariableInterestEntityOwnershipPercentage" contextRef="From2023-05-012024-04-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11783">46</ix:nonFraction></span>% interest in Unusual Machines. The primary business operations included selling
first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#8217;s financial
statements are prepared in accordance with GAAP.</span> See Note 3 for additional information.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 13; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Financial
information for UMAC prior to the sale of the Company&#8217;s equity interest was derived from UMAC&#8217;s Form 10-Q for the six months
ended June 30, 2024 and was as follows:</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock" id="ixv-7340"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_ztf1asJE8Oq3" summary="xdx: Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_iE_z7ntNzm1rNGl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 25%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11784">5,116,963</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsNoncurrent_iE_zxs4ODeHzxh4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11785">20,083,390</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iE_zyWpKwK13uq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11786">931,200</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_iE_zOz7J2TYeiOe" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11787">4,297,332</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_zYXvMrsWN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11788">2,030,039</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_zJEakPFoPB5a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11789">592,607</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_z6opJzzCPFuc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11790">2,718,240</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zYTBJQxNUJ5i" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company&#8217;s investments in UMAC have been impacted by the following:</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:EquityMethodInvestmentsTextBlock" id="ixv-7394"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr id="xdx_431_c20240201__20240430_eus-gaap--EquityMethodInvestments_iS_zsLkD22pXcx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_4B2_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zKGNF3Civcdi" style="text-align: right; width: 30%">17,000,000</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_432_c20240201__20240430_eus-gaap--IncomeLossFromEquityMethodInvestments_zR1RTFfF7J3d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11791">503,625</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_43B_c20240201__20240430_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_zn7jfoOL2NU" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" contextRef="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11792">11,353,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_43C_c20240201__20240430_eus-gaap--EquityMethodInvestments_iE_zDowKCsMMHp3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11793">5,142,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_430_c20240501__20240731_eus-gaap--IncomeLossFromEquityMethodInvestments_zSBcxCyNMpXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Equity method loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11794">734,143</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SaleOfOwnershipInterestEquityMethodInvestment_zti24tbhMvKd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Sale of ownership interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="RCAT:SaleOfOwnershipInterestEquityMethodInvestment" contextRef="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD" id="ixv-11795">4,408,357</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_43A_c20240501__20240731_eus-gaap--EquityMethodInvestments_iE_zvaRO1a32IN5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Investment balance, July 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0780">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zeWKyDxOL9X6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair
market value of UMAC&#8217;s common stock. </span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><p id="xdx_814_zmkZSHkAxE9e" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-7453"><p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zUvtxMw52FH4" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_827_zjG79bpgDmda">Note
8 &#8211; Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-7464"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zU8iwyKrYQP1" summary="xdx: Disclosure - Property and equipment (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_494_20240731_zIVVfsTzYJK" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49C_20240430_z8YevSvskOS6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_zU1rZe2lsm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Equipment and related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11796">1,609,269</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11797">1,540,888</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LeaseholdImprovementsGross_iI_zN93UM6gtH3a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Leasehold improvements</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11798">1,556,139</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11799">1,547,976</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zHUpeXzvNuqi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Furniture and fixtures</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11800">186,703</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11801">163,290</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z10k40UqBvPj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Accumulated depreciation</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11802">1,208,192</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11803">911,470</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iI_zgL1ebvLX3S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Net carrying value</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11804">2,143,919</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11805">2,340,684</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zlu8YxqrJMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Depreciation
expense totaled $<span id="xdx_903_eus-gaap--Depreciation_c20240501__20240731_zQJxJVqrdVCb"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11806">296,722</ix:nonFraction> </span> and $<span id="xdx_906_eus-gaap--Depreciation_c20230501__20230731_zHrjB9UXdYla"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11807">101,001</ix:nonFraction> </span> for the three months ended July 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81D_zTGmN44fJJB" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:OtherLongTermAssetsDisclosureTextBlock" id="ixv-7582"><p id="xdx_80F_ecustom--OtherLongTermAssetsDisclosureTextBlock_zmXk6aRYGzNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_825_zvgbmdXVOP9k">Note
9 &#8211; Other Long-Term Assets</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Other
long-term assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock" id="ixv-7593"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zENx4C22DVVh" summary="xdx: Disclosure - Other long term assets (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240731_z2Zer20g4iFk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">July 31, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20240430_zE4POr3zA5zl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td></tr>
  <tr id="xdx_40F_ecustom--SAFEAgreementAssets_iI_zrYSJKSr01Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SAFEAgreementAssets" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11808">250,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:SAFEAgreementAssets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11809">250,000</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--SecurityDeposit_iI_ziM5Fzjik2Rb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11810">43,126</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11811">43,126</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NoncurrentAssets_iI_zb4QKHjYZRIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11812">293,126</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11813">293,126</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zywYwvR72358" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 14; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#8220;Firestorm&#8221;)
under which it made a payment of $<span id="xdx_908_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zDyv0sWXXzr1"><ix:nonFraction name="RCAT:PaymentForSAFEAgreement" contextRef="From2022-11-012022-11-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11814">250,000</ix:nonFraction></span> to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $<span id="xdx_905_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zeswLHl1NpN7"><ix:nonFraction name="RCAT:PaymentForSAFEAgreement" contextRef="From2022-11-012022-11-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11815">250,000</ix:nonFraction></span> into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#8217;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis.
No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;three months ended&#160;July&#160;31,&#160;2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

</ix:nonNumeric><p id="xdx_813_zyZAJYLLf3zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b></b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="ixv-7655"><p id="xdx_80A_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zLbr4wR7NhTe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82D_zhkxIP9AakOa">Note
10 &#8211; Right of Use Assets and Liabilities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of July 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#8217;s leases have remaining
lease terms of up to 6.42 years, including options to extend certain leases for up to six years. Operating lease expense totaled $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240501__20240731_zCLAO1ocURPj"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11816">90,288</ix:nonFraction></span>
and $<span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20230501__20230731_zQmFkCZaUmEj"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11817">85,252</ix:nonFraction></span> for the three months ended July 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Leases
on which the Company made rent payments during the reporting period included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfRentExpenseTableTextBlock" id="ixv-7674"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" summary="xdx: Disclosure - Operating leases (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_ziaXfkDt8teg" style="text-align: right; width: 25%"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11818">23,340</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2030</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_zPBWpmghPTEi" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11819">5,977</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zh533RUxAn4k" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation4Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11820">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zATMaDDRw507" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Supplemental
information related to operating leases for the three months ended July 31, 2024 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="ixv-7722"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zI2mqukVWKqg" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt"><ix:nonFraction name="RCAT:OperatingCashPaidToSettleLeaseLiabilities" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11821">90,951</ix:nonFraction></span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240731_z0QTAgEejtNd"><ix:nonNumeric contextRef="AsOf2024-07-31" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-11822">5.93</ix:nonNumeric></span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11823">12</ix:nonFraction>%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_8A6_zgUpGUTR1tgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_811_zo9XVb6HVMTf" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b>&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-7772"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zSzPJO103sQh" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82E_z1qA9eIlg1r2">Note
11 &#8211; Debt Obligations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>A.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Decathlon
    Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#8220;DA4&#8221;)
in the amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zAm5DKvMAIm2"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-08-31_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11824">1,670,294</ix:nonFraction></span> (the &#8220;Loan&#8221;), representing the outstanding principal amount previously due and owing by Teal
to DA4. Interest on the Loan accrues at a rate of ten (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_ztONSCjlVmR5"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-09-012023-04-30_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11825">10</ix:nonFraction></span>%) percent per annum. Principal and interest is payable in monthly installments
of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_za1MgSKb1zyi"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-08-012023-04-30_custom_DebtObligation1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11826">49,275</ix:nonFraction></span> until maturity on December 31, 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731_zZh0qSkdXCnk"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11827">230,795</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zqH8Lh9zBaRf"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11828">370,537</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>B.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Pelion
    Note</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
May 2021, Teal entered into a note agreement totaling $<span id="xdx_905_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zmtWRBOjCCD7"><ix:nonFraction name="RCAT:ConvertibleNoteAgreementAmount" contextRef="From2021-05-012022-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11829">350,000</ix:nonFraction></span>
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240501__20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_z2WBOyioFzne"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2024-05-012024-07-31_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11830">0.13</ix:nonFraction></span>% on the date of issuance. Accrued interest at July 31, 2024 and April 30, 2024
totaled $<span id="xdx_90E_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zzKXJ3mIj0rj"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-07-31_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11831">1,449</ix:nonFraction> </span>and $<span id="xdx_90C_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zSZoi2zqNVof"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-04-30_custom_DebtObligation2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11832">1,334</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>C.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Corporate
    Equity</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Beginning
in October 2021, and amended in January 2022, Teal financed a total of $<span id="xdx_901_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z6ykd1FfoSee"><ix:nonFraction name="RCAT:LeaseholdImprovementAgreementFundsReceived" contextRef="From2023-07-012024-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11833">120,000</ix:nonFraction></span>
of leasehold improvements with Corporate Equity, LLC.
The loan bears interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zlKloAID5fug"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11834">8.25</ix:nonFraction></span>% annually and requires monthly payments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zHVj8f01atXj"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11835">3,595</ix:nonFraction></span>
through December 2024. The balance outstanding at July
31, 2024 and April 30, 2024 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z8oJ6OuBx9Nf"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-07-31_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11836">17,205</ix:nonFraction> </span>
and $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zyKk8vtZDlw3"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30_custom_DebtObligation6Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11837">27,495</ix:nonFraction> </span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>D.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Ascentium
    Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $<span id="xdx_904_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zXPrPXkfuWIe"><ix:nonFraction name="RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset" contextRef="From2022-09-012022-09-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11838">24,383</ix:nonFraction></span>.
Monthly payments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zDbegMnjzO35"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-09-012023-04-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11839">656</ix:nonFraction></span>
are payable through October 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_z23c2t1VsRSg"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-07-31_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11840">1,449</ix:nonFraction> </span>
and $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zUbsfqCCpHu2"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-04-30_custom_DebtObligation8Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11841">1,334</ix:nonFraction></span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 15; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>E.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Summary
    </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Future
annual principal payments at July 31, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:ScheduleOfDebtPaymentsDueTableTextBlock" id="ixv-7878"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" summary="xdx: Disclosure - Outstanding principal payments (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_491_20240731_z2tv2nqXKtra">&#160;</td></tr>
<tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 65%">2025</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: right; width: 30%"><ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueYearOne" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11842">599,570</ix:nonFraction></td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="RCAT:OutstandingPrincipalPaymentsDueTotal" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11843">599,570</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AB_zmcWXEYcWPf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="background-color: white">&#160;&#160;&#160;</span></span></p>

</ix:nonNumeric><p id="xdx_81A_zbr6y52SKinl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-7916"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zGqdOaZwg4ig" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82A_zVlrEMmPnCfl">Note
12 &#8211; Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Our
common stock has a par value of $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240731_zDidkHuH2JSl"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11844">0.001</ix:nonFraction></span> per share. We are authorized to issue <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_z5IsRRBQvzOl"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11845">500,000,000</ix:nonFraction></span> shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="ixv-7930"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_eus-gaap--SharesOutstanding_iS_zeTvz0zbJr41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 75%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 20%"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11846">54,568,065</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_z3DfxWwJpLl2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11847">192,742</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_z9MBKNxRerb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11848">252,214</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zqtbPdkJgySj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11849">1,761</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_z7T8PLP5xf3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11850">818,334</ix:nonFraction></span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zvLE4sgzomw1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11851">53,235</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_z9lKEjNguO78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesPublicOffering" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11852">18,400,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zlxiPdB1NXxa" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11853">3,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zffjBQ61NBIf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11854">74,289,351</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zdV5XQ1QPH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    employees, net of shares withheld of 126,828 to pay taxes</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11855">231,855</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zpL6RsRdquyf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    Board of Directors</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11856">61,447</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_431_c20240501__20240731_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_zhhEcag97Bgl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Exercise of warrants</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised" contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11857">307,595</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20240501__20240731_eus-gaap--SharesOutstanding_iE_zMMqBaYlPrY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of July 31, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11858">74,890,248</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zPPZIlMCo3Jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ATM
Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
August 2023, we entered into a sales agreement (&#8220;the 2023 ATM Facility&#8221;) with ThinkEquity LLC (&#8220;ThinkEquity&#8221;),
which provides for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. </span><span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.2pt">In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $<span id="xdx_907_ecustom--ATMFacilityAggregateOfferingPrice_c20230801__20230831_zFSIY6hYrXF8"><ix:nonFraction name="RCAT:ATMFacilityAggregateOfferingPrice" contextRef="From2023-08-012023-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11859">4,375,000</ix:nonFraction></span>. </span><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
issuance and sale of these shares by us pursuant to the 2023 ATM Facility are deemed &#8220;at the market&#8221; offerings as defined
in Rule 415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are registered under the Securities
Act. We pay a commission of up to 2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Due
to the expiration of the registration statement that was used for the 2023 ATM Facility, and due to the disqualification of our prior
auditors from appearing or practicing before the SEC, no additional securities may be sold under 2023 ATM Facility.&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>Public
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#8220;Offering&#8221;)
an aggregate of <span id="xdx_90C_eus-gaap--PartnersCapitalAccountUnitsSoldInPublicOffering_c20231201__20231231_zFZKFMu862yc"><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11860">16,000,000</ix:nonFraction></span> shares of the Company&#8217;s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231211_zejWxlnkebGc"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-11" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11861">0.001</ix:nonFraction></span> per share (the &#8220;Common Stock&#8221;), at
a public offering price of $<span id="xdx_90C_ecustom--PublicOfferingPricePerShare_c20231201__20231231_zZoArySILYI6"><ix:nonFraction name="RCAT:PublicOfferingPricePerShare" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11862">0.50</ix:nonFraction></span> per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
<span id="xdx_905_ecustom--AdditionalSharesPurchaseOptionOverAllotmentCover_c20231201__20231231_zEREtP0SgDDg"><ix:nonFraction name="RCAT:AdditionalSharesPurchaseOptionOverAllotmentCover" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11863">2,400,000</ix:nonFraction></span> shares of Common Stock to cover over-allotments.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Offering closed on December 11, 2023, resulting in the issuance of <span id="xdx_907_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20231201__20231231_zPcQad0JNBP5"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingShares" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11864">18,400,000</ix:nonFraction></span> shares of Common Stock </span><span style="font-family: Times New Roman, Times, Serif">which
generated gross proceeds of $<span id="xdx_90E_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20231201__20231231_zkU9KCc7JHK4"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11865">9,200,000</ix:nonFraction></span>. <span style="background-color: white">Net proceeds to the Company from the Offering, after deducting
the underwriting discount, the underwriters&#8217; fees and expenses and the Company&#8217;s estimated Offering expenses, were approximately
$<span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20231201__20231231_zpDvrZlLYsPd"><ix:nonFraction name="RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11866">8,400,000</ix:nonFraction></span>.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white">&#160;</span></span></p>

</ix:nonNumeric><p id="xdx_811_zmTBzNnyhpk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white"></span></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b></b></span></p>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:PreferredStockTextBlock" id="ixv-8140"><p id="xdx_809_eus-gaap--PreferredStockTextBlock_zfOFDWyCbMy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zCA5ARbE0lJd">Note
13 &#8211; Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Our
preferred stock has a par value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240731_zmpsbnSarLqb"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11867">0.001</ix:nonFraction></span> per share. Series B Preferred Stock (&#8220;Series B Stock&#8221;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. <span id="xdx_90E_ecustom--PreferredStockConvertible_c20230601__20230630_zKuuSZ9cnbid"><ix:nonFraction name="RCAT:PreferredStockConvertible" contextRef="From2023-06-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11868">982,000</ix:nonFraction></span> shares of Series B Stock were converted into <span id="xdx_904_ecustom--PreferredStockConvertibleSharesIssued_c20230601__20230630_z8WVM0n5wxw6"><ix:nonFraction name="RCAT:PreferredStockConvertibleSharesIssued" contextRef="From2023-06-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11869">818,334</ix:nonFraction></span> shares of common stock in June 2023. Shares outstanding
at July 31, 2024 totaled <span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20240731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoXneuiclSbj"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11870">4,676</ix:nonFraction> </span> which are convertible into <span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20240501__20240731__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zlcsIElYcdEf"><ix:nonFraction name="RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" contextRef="From2024-05-012024-07-31_custom_SeriesAPreferredStock2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11871">3,896</ix:nonFraction> </span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_811_zWOVUvMFo0Se" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:WarrantsDisclosureTextBlock" id="ixv-8158"><p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zj0KfndLrXu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82F_zt6M9hAY1ueh">Note
14 &#8211; Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of
$</span><span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zlCkWt8DGUb7"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2022-04-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11872">1.50</ix:nonFraction></span>. The warrants were valued using the multinominal lattice The value
of the warrants was included in the determination of the initial accounting for each financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
summary of the warrants issued were:</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" id="ixv-8175"><table cellspacing="0" cellpadding="0" id="xdx_89C_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zM64ZJWssd39" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Upon
    Issuance</b></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    of Transaction</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Warrants</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
    Fair Value</b></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2020&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zyItQ0WxzUCg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RCAT:NumberOfWarrantsUponIssuance" contextRef="From2020-10-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11873">399,998</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_znz6M267FU2c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RCAT:InitialFairValueOfWarrantsUponIssuance" contextRef="From2020-10-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11874">267,999</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20210101__20210131_zTbE4gZuNo12" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RCAT:NumberOfWarrantsUponIssuance" contextRef="From2021-01-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11875">675,000</ix:nonFraction></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210101__20210131_zi0F2I3d6ZE5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="RCAT:InitialFairValueOfWarrantsUponIssuance" contextRef="From2021-01-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11876">2,870,666</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zKeT9qA7XOuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">To
date, we have received $</span><span style="font-family: Times New Roman, Times, Serif">301,248 related to the exercise of <span id="xdx_903_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_zSOisXWcjM4l"><ix:nonFraction name="RCAT:ExerciseOfWarrantsShares" contextRef="From2022-03-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11877">268,332</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
May 2021, the Company issued warrants to purchase</span>
<span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20210501__20210531_zRtkWmZKknt8"><ix:nonFraction name="RCAT:WarrantsToPurchaseSharesIssued" contextRef="From2021-05-012021-05-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11878">200,000</ix:nonFraction></span> shares of common
stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_903_ecustom--WarrantsIssuedExercisePrice_c20210501__20210531_ztFDHvpQQPYk"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2021-05-012021-05-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11879">5.00</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
July 2021, the Company issued warrants to purchase </span><span id="xdx_902_ecustom--WarrantsToPurchaseSharesIssued_c20210701__20210731_zy866tHZXLtk"><ix:nonFraction name="RCAT:WarrantsToPurchaseSharesIssued" contextRef="From2021-07-012021-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11880">533,333</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">shares of
common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_902_ecustom--WarrantsIssuedExercisePrice_c20210701__20210731_zB1Pf283Bw2b"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2021-07-012021-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11881">5.625</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
December 2023, the Company issued warrants to purchase <span id="xdx_906_ecustom--WarrantsToPurchaseSharesIssued_c20231201__20231231_zEHiJgcF4utb"><ix:nonFraction name="RCAT:WarrantsToPurchaseSharesIssued" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11882">736,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20231201__20231231_zxAZTTrGtype"><ix:nonFraction name="RCAT:WarrantsIssuedExercisePrice" contextRef="From2023-12-012023-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11883">0.625</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the changes in warrants outstanding since April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="ixv-8303"><table cellspacing="0" cellpadding="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" summary="xdx: Disclosure - Changes in warrants outstanding (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11884">1,539,999</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11885">3.38</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"><ix:nonNumeric contextRef="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-11886">2.89</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0929">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7l8cGxrduB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11887">736,000</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zKoiIywcZfRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11888">0.63</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPW0HvnKi2Xj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoUbnz544RU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2024</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoPX1vl8iK97" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11889">2,275,999</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z9rvTVjBvmvb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11890">2.49</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zevipTHxiaQg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-11891">2.77</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zm3VSq1ljz8h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_ziaEEc0CujWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zVZtrljGewfa"><span style="-sec-ix-hidden: xdx2ixbrl0939">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zqzxOXjOAyGl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11892">454,708</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zyHJ01SNfIla"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11893">0.63</ix:nonFraction></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at July 31, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmPLXm0HeVI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11894">1,821,291</ix:nonFraction></span></td>
    <td/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zGUr2ztOudKg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11895">2.96</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmn5yhaWGuv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-11896">2.05</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zZ8nCQ8hnLG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11897">389,589</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_z3WqCMANFHM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_81F_zxYmgQVffVfl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="ixv-8610"><p id="xdx_80B_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHnkXy3WHasb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82A_zgoD23Sd6pff">Note
15 &#8211; Share Based Awards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed <span id="xdx_900_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20240501__20240731_z3gxp0Bv6WY"><ix:nonFraction name="RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11898">11,750,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A.</i></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Options&#160;</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
range of assumptions used to calculate the fair value of options granted during the three months ended July 31 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="RCAT:ScheduleOfAssumptionsUsed1TableTextBlock" id="ixv-8643"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zwWKrBHKnH8b"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11899">1.15</ix:nonFraction></span>
                                       &#8211; <span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zcOyHyHyt11e"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11900">1.29</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwfKVpa6sma"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11901">1.06</ix:nonFraction></span> &#8211; <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zc86Agqdjmgd"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11902">1.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zQSYeubdsY38"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11903">1.20</ix:nonFraction></span>
                                            &#8211; <span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zytQDTqP7227"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11904">1.38</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zo79pL1riDBj"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11905">1.06</ix:nonFraction></span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zlpDkH8rMKIe"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11906">1.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zqSeJS23NFt3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11907">4.24</ix:nonFraction></span></span>
                                            &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7EtEkbAeA0f"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11908">4.44</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhXVzuPRYlOd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11909">3.47</ix:nonFraction></span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHZIPCESAVk9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11910">4.07</ix:nonFraction></span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKHNTpDho3H9"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7WApBhXuBPe"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z5RsH1tAKujb"><ix:nonNumeric contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-11911">5.24</ix:nonNumeric></span>
                                            &#8211; <span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20240501__20240731_zUkkPqnnUaM3"><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" format="ixt-sec:duryear" name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" id="ixv-11912">5.85</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zRAic9jzIjx2"><ix:nonNumeric contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-11913">6.00</ix:nonNumeric></span> &#8211;<span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zNkjWRTdD3eg"> <ix:nonNumeric contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt-sec:duryear" name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" id="ixv-11914">6.25</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKjD426i32F8" style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11915">191.28</ix:nonFraction></span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBs9oEnLmHSb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11916">199.48</ix:nonFraction></span>%</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zackZSYtBfii"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11917">257.25</ix:nonFraction></span> &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z67PDSvzOQVk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure" id="ixv-11918">260.22</ix:nonFraction></span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zXokxHCQJR8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">A
summary of options activity under the Plan since April 30, 2023 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="ixv-8752"><table cellspacing="0" cellpadding="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" summary="xdx: Disclosure - Summary of activity under the Plan (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center"/>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11919">4,784,809</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11920">1.88</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"><ix:nonNumeric contextRef="From2021-05-012022-04-30_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-11921">8.72</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-04-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11922">74,586</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z7rAkr1bfJll" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11923">2,903,542</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zAeGFu27kLl8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11924">1.02</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSXoNGEsLN28" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11925">3,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zII2A6LjHwQd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11926">0.89</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z4Eu1Ei19M1d" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11927">905,417</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpxTVULkCV4k" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11928">2.27</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zZIYNL7HUKL3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11929">6,779,934</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td/>
    <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1it06LlqCT2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11930">1.46</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zk7vSr1QQRK2" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-012023-07-31_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-11931">8.02</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zr3yRtIAuyA" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11932">2,762,242</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSqSgOyPQXvb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11933">627,500</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ztedmKcGU0Pl" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11934">1.15</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zPyTUgSssd15" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11935">4,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zdCmh0jF766f" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11936">0.72</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zq4qWyz3cta4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11937">83,446</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zqUOnW2OGdK7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11938">1.55</ix:nonFraction></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zu0ZGzckMY46" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11939">7,319,988</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"/>
    <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziYgiRtGqlGj" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11940">1.43</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zJSCAopLaHa5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-11941">7.54</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"/>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zR4wvrDYxUO2" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11942">5,658,470</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOXLhV6zDA8" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11943">4,444,723</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zjXH5OihYSKf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11944">1.65</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zExJIpuuUSvg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-05-012024-07-31_custom_Options1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-11945">6.57</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1xBWPodGjYa" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-07-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11946">3,014,807</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_z9APoiY0wBde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of July 31, 2024, there was $<span id="xdx_90D_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20230731_zG3zNaCqsrB6"><ix:nonFraction name="RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11947">2,773,793</ix:nonFraction> </span> of unrecognized stock-based compensation expense related to unvested stock
options which is expected to be recognized over the weighted average periods of 1.17.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>B.</i></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">A
summary of restricted stock activity under the Plan since April 30, 2023 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-9158"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"/><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11948">781,060</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11949">2.44</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zie7GVCpeKAa" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11950">298,643</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z2uZdheNanp6" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11951">1.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z0GJcBaAYZYf" style="text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11952">485,024</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zEG5rCLRWOb6" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11953">1.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zvu4rWDmXlr2" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares" id="ixv-11954">419,549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zv4vkLrcoawb" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11955">2.09</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z6wanxKE0xm5" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11956">175,130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zieqKXmhSHZ8" style="text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11957">2.09</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zspstRT7400a" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11958">2,447,599</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zxnJNgxejRld" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11959">1.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzfH3x7iglO2" style="text-align: right">(<ix:nonFraction name="RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11960">420,130</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zmnL8xC8W3v1" style="text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11961">1.25</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zbPtYGXtybkc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzqAoP4eTbV9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of July 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_ze5i1GuWS25i" style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" contextRef="AsOf2024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares" id="ixv-11962">2,202,599</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zFvbaVd8IXDb" style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-07-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares" id="ixv-11963">1.11</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zpESgFA0HL57" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span style="background-color: white"></span></span></p>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>C.</i></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Compensation</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Stock
compensation expense for the three months ended July 31 by functional operating expense was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" id="ixv-9292"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z1eXh3zdYvEh" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20240501__20240731_zvomcCTvv4Hh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230501__20230731_zgtio2W6FIil" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_403_ecustom--ResearchAndDevelopmentStockCompensationExpense_zvP0AFfUOoL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Research and development</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:ResearchAndDevelopmentStockCompensationExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11964">94,422</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:ResearchAndDevelopmentStockCompensationExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11965">127,417</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--SalesAndMarketingStockCompensationExpense_zD6MjHuaDdkg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SalesAndMarketingStockCompensationExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11966">116,543</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:SalesAndMarketingStockCompensationExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11967">165,309</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--GeneralAndAdministrativeStockCompensationExpense_z4KIwy9kjGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">General and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:GeneralAndAdministrativeStockCompensationExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11968">1,235,073</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:GeneralAndAdministrativeStockCompensationExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11969">618,880</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--TotalStockCompensationExpense_z14Pqh4g5ON5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:TotalStockCompensationExpense" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11970">1,446,038</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="RCAT:TotalStockCompensationExpense" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11971">911,606</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zHNDp4xHHRGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock
compensation expense pertaining to options totaled $<span id="xdx_90B_ecustom--StockCompensationExpensePertainingToOptions_c20240501__20240731_zXe7rEeodCFe"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToOptions" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11972">357,258</ix:nonFraction></span> and
$<span id="xdx_909_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20230731_zUJjBROcLm2c"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToOptions" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11973">629,426</ix:nonFraction> </span> for the three months ended July 31, 2024 and 2023, respectively.
Stock compensation expense pertaining to restricted stock totaled $<span id="xdx_903_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20240501__20240731_zBFe5bjAZgRd"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToRestrictedStockUnits" contextRef="From2024-05-01to2024-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11974">1,088,780</ix:nonFraction> </span> and $<span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20230731_zvwY64SyeDBa"><ix:nonFraction name="RCAT:StockCompensationExpensePertainingToRestrictedStockUnits" contextRef="From2023-05-012023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD" id="ixv-11975">282,180</ix:nonFraction> </span>  for the three months ended July 31, 2024 and
2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81A_zDcpgr5Wnekg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b></b></span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-9397"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zcuYH1QOt3Hi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zinB077i3fe4">Note
16 - Related-Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 7. UMAC&#8217;s
Chief Executive Officer is a direct relative of a member of the Company&#8217;s management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

</ix:nonNumeric><p id="xdx_813_zLDGgIbykFRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-9411"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zksTa3herUE6" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_82E_zQkIs6eTt0Dh">Note
17 &#8211; Commitments and Contingencies</span>&#160;</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; background-color: white">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">One pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_816_zHTj7xGFtnz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-05-01to2024-07-31" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-9439"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_z5E7tc68Xn6d" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_82B_z1NfTJxKzNTi">Note
18 &#8211; Subsequent Events</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Subsequent
events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration: underline">FlightWave
Acquisition&#160;</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
September 4, 2024, the Company, Teal, FW Acquisition, Inc. (&#8220;Buyer&#8221;), and FlightWave Aerospace Systems Corporation (&#8220;Seller&#8221;)
entered into and closed on the transactions set forth in an Asset Purchase Agreement (the &#8220;APA&#8221; and the transactions set
forth therein, the &#8220;Transactions&#8221;), pursuant to which Buyer purchased and Seller sold certain assets used in designing, developing,
manufacturing, and selling long range, AI-powered UAVs for commercial use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
a condition to the closing of the Transactions, each of the shareholders of the Seller entered into a Joinder Agreement with the Company,
Teal and Buyer pursuant to which such shareholder agreed to the terms of the APA and agreed to be bound by the provisions thereof applicable
to the Seller&#8217;s shareholders, including without limit, the indemnification provisions in the APA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
purchase price under the APA is equal to $14 million worth of shares of the Company&#8217;s common stock which are payable as follows:
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"/><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on September 30, 2024, at
                                            a price per share equal to the VWAP on such date, which shall be payable to the preferred
                                            shareholders of the Seller as set forth in the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"/><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on December 31, 2024, at a
                                            price per share equal to the VWAP on such date, of which (i) $2 million will be payable to
                                            preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders
                                            and option-holders of the Seller as set forth the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Promissory
Note</span></i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 23, 2024, we entered into a Securities
Purchase Agreement (the &#8220;SPA&#8221;) with Lind Global Asset Management X LLC (&#8220;Lind&#8221;). Under the SPA, within days of
closing, we will receive $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory
Note in the amount of $9,600,000 (the &#8220;Note&#8221;) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our
common stock at a price of $6.50 per share, exercisable for 5 years (the &#8220;Warrant&#8221;). As addition consideration to Lind, we
have agreed to pay a commitment fee in the amount of $280,000, which may be paid by deduction from the funding to be received.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Note, which does not accrue interest, shall be
repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At our
option, monthly payments can be increased up to $1,000,000 so long as our market capitalization is at least $50 million. In addition,
if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment
amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued
at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment
Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common
stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Note may be converted by Lind from time to time
at a price of $6.50 per share (the &#8220;Conversion Price&#8221;). The dollar amount of any conversions by Lind will be applied to toward
upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days&#8217; notice, but in the event of a prepayment
notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share
Price is equal to or greater than $2.00) or the Conversion Price.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81A_zaFapUAJYLUj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 20; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>ITEM
2.&#160; MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>You
should read the following discussion and analysis of our financial condition and results of operations together with our financial statements
and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion
and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially
from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified
below, and those discussed in the section titled &#8220;Risk Factors&#8221; included in our Annual Report on Form 10-K for the fiscal
year ended April 30, 2024 as may be amended, supplemented or superseded from time to time by other reports we file with the SEC. All
amounts in this report are in U.S. dollars, unless otherwise noted.</i></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
are a technology company focused on developing products, services, and solutions to the drone industry. We were originally incorporated
under the laws of the State of Colorado in 1984 under the name &#8220;Oravest International, Inc.&#8221; In November 2016, we changed
our name to &#8220;TimefireVR, Inc.&#8221; and re-incorporated in Nevada. In May 2019, we completed a share exchange agreement with Propware
which resulted in the Propware shareholders acquiring an 83% ownership interest, and management control, of the Company. In connection
with the share exchange agreement, we changed our name to &#8220;Red Cat Holdings, Inc.&#8221;, and our operating focus to the drone
industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Prior
to the share exchange agreement, Propware was focused on the research and development of software solutions that could provide secure
cloud-based analytics, storage and services for the drone industry. Following the share exchange agreement and name change, we have completed
a series of acquisitions and financings which have broadened the scope of our activities in the drone industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
September 4, 2024, the Company, Teal, FW Acquisition, Inc. (&#8220;Buyer&#8221;), and FlightWave Aerospace Systems Corporation (&#8220;Seller&#8221;)
entered into and closed on the transactions set forth in an Asset Purchase Agreement (the &#8220;APA&#8221; and the transactions set
forth therein, the &#8220;Transactions&#8221;), pursuant to which Buyer purchased and Seller sold certain assets used in designing, developing,
manufacturing, and selling long range, AI-powered UAVs for commercial use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
a condition to the closing of the Transactions, each of the shareholders of the Seller entered into a Joinder Agreement with the Company,
Teal and Buyer pursuant to which such shareholder agreed to the terms of the APA and agreed to be bound by the provisions thereof applicable
to the Seller&#8217;s shareholders, including without limit, the indemnification provisions in the APA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
purchase price under the APA is equal to $14 million worth of shares of the Company&#8217;s common stock which are payable as follows:
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on September 30, 2024, at
                                            a price per share equal to the VWAP on such date, which shall be payable to the preferred
                                            shareholders of the Seller as set forth in the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on December 31, 2024, at a
                                            price per share equal to the VWAP on such date, of which (i) $2 million will be payable to
                                            preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders
                                            and option-holders of the Seller as set forth the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 23, 2024, we entered into a Securities
Purchase Agreement (the &#8220;SPA&#8221;) with Lind Global Asset Management X LLC (&#8220;Lind&#8221;). Under the SPA, within days of
closing, we will receive $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory
Note in the amount of $9,600,000 (the &#8220;Note&#8221;) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our
common stock at a price of $6.50 per share, exercisable for 5 years (the &#8220;Warrant&#8221;). As addition consideration to Lind, we
have agreed to pay a commitment fee in the amount of $280,000, which may be paid by deduction from the funding to be received. The Note,
which does not accrue interest, shall be repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning
six months from the issuance date.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
of Operations</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since April 2016, our primary business has been to
provide products, services, and solutions to the drone industry which we presently do through our three wholly owned subsidiaries Skypersonic,
Teal, and Propware. Beginning in January 2020, we expanded the scope of our drone products and services through four acquisitions, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, we acquired
    Rotor Riot, a provider of First Person View (FPV) drones and equipment, primarily to the consumer marketplace. The purchase price
    was $1,995,114.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2020, we acquired
    Fat Shark Holdings, a provider of FPV video goggles to the drone industry. The purchase price was $8,354,076.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, we acquired
    Skypersonic which provides hardware and software solutions that enable drones to complete inspection services in locations where
    GPS is not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price
    was $2,791,012.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2021, we acquired
    Teal, a leader in commercial and government UAV technology, primarily drones, to government and commercial enterprises, most notably,
    the military. Teal manufactures drones approved by the U.S. Department of Defense for reconnaissance, public safety, and inspection
    applications. The purchase price was $10,011,279.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Following
the Teal acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established
the Enterprise segment (&#8220;Enterprise&#8221;) and the Consumer segment (&#8220;Consumer&#8221;) to focus on the unique opportunities
in each sector. Enterprise's initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous
military environments and confined industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention
on the military and other government agencies. Skypersonic's technology has been redirected to military applications and its operations
consolidated into Teal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Enterprise segment&#8217;s current business strategy is focused on providing integrated robotic hardware and software for use across
a variety of applications. Its solutions provide critical situational awareness and actionable intelligence to on-the-ground warfighters
and battlefield commanders as well as firefighters and public safety officials. Our Enterprise segment&#8217;s efforts are centered on
developing and scaling an American made family of systems. We have since completed construction of a manufacturing facility in Salt Lake
City, Utah and believe that an increased focus by the United States government and American businesses on purchasing products that are
&#8220;Made in America&#8221; provide our Enterprise segment with a competitive advantage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
February 16, 2024, we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale
reflects our decision to focus our efforts and capital on defense where we believe there are more opportunities to create long term shareholder
value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
September 4, 2024, we entered into and closed on the transactions set forth in an Asset Purchase Agreement with FlightWave pursuant to
which we purchased certain assets for designing, developing, manufacturing, and selling long range, AI-powered UAVs for commercial use.
Please refer to the Recent Developments section above for further information regarding the APA and related transactions.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Results
of Operations </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
analysis of our results of operations for the three months ended July 31, 2024 compared to the three months ended July 31, 2023 includes
only our Enterprise segment as our Consumer segment was divested in February 2024.</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Discussion
and Analysis of Three Months Ended July 31, 2024 compared to Three Months Ended July 31, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenues</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Consolidated
revenues totaled $2,776,535 during the three months ended July 31, 2024 (or the &#8220;2024 period&#8221;) compared to $1,748,129 during
the three months ended July 31, 2023 (or the &#8220;2023 period&#8221;) representing an increase of $1,028,406, or 59%. The increase
related to higher product revenue and higher contract revenue.&#160;Product revenue totaled $1,890,095 during the quarter ended July
31, 2024 compared to $1,437,248 during the quarter ended July 31, 2023 representing&#160;an increase of $452,847, or&#160;32%. Contract
revenues totaled $886,440 during the 2024 period compared to $310,881 during the 2023 period, representing&#160;an increase of $575,559,
or 185%.&#160;Contract revenues are primarily sourced through government agencies and can fluctuate from period to period based on the
timing of award deliverables and amendments.</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Gross
Profit</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Consolidated gross loss
totaled $483,391 during the 2024 period compared to a gross profit of $174,665 during the 2023 period representing a decrease of $658,056,
or 377%. On a percentage basis, gross loss was 17% during the 2024 period compared to a gross profit of 10% during the 2023 period. The
gross loss in the 2024 period was due to the delivery of final prototypes under the Short Range Reconnaissance Tranche 2 contract with
the U.S. Army and did not pertain to product sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Operating
Expenses</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research
and development expenses totaled $1,626,440 during the 2024 period compared to $1,353,551 during the 2023 period, representing an increase
of $272,889, or 20%. Professional fees totaled $483,129 in the 2024 period compared to $211,883 in the 2023 period.&#160;This increase
of $271,246, or 128%, primarily related to outsourced software development expenses and represented substantially all of the total increase
in research and development costs.</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sales
and marketing costs totaled $2,041,511 during the 2024 period compared to $1,288,760 during the 2023 period, representing an increase
of $752,751 or 58%. The increase was driven by higher payroll expenses and an increase in tradeshow attendance to support increased sales
efforts of our Teal 2 drone.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses totaled $3,483,095 during the 2024 period compared to $2,863,758 during the 2023 period, representing an
increase of $619,337 or 22%. The increase primarily related to higher stock compensation expense.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the 2024 period, we incurred stock-based compensation costs of $1,446,038 compared to $911,606 in the 2023 period, resulting in an increase
of $534,432 or 59%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other
Income</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other
expense totaled $4,688,889 during the 2024 period compared to $262,891 during the 2023 period, representing an increase of $4,425,998
or more than 16 times. During the 2024 period, we incurred a loss on the sale of our equity method investment of $4,008,357.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
Loss from Continuing Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
loss from continuing operations totaled $12,416,376 for the 2024 period compared to $5,594,295 for the 2023 period, resulting in an increase
of $6,822,081 or 122%. Total operating expenses totaled $6,407,513 for the 2024 period compared to $5,187,700 for the 2023 period. This
increase of $1,219,813 or 24%, primarily to the increase in sales and marketing expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Cash
Flows </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net cash used in operating activities was $2,348,412
during the 2024 period compared to net cash used in operating activities of $6,926,069 during the 2023 period, representing a decrease
of $4,577,657 or 66%. The decreased use of cash primarily related to timing of accounts receivable receipts for government customers.
Net cash used in operations, net of non-cash expenses, totaled $6,755,639 during the 2024 period, compared to $1,522,611 during the 2023
period, resulting in an increase of $5,233,028, or 344%. Net cash used related to changes in operating assets and liabilities totaled
$3,312,325 during the 2024 period, compared to negative $2,854,385 during the 2023 period, representing an increase of $6,166,710 or 216%.
Changes in operating assets and liabilities can fluctuate significantly from period to period depending upon the timing and level of multiple
factors, including inventory purchases, vendor payments, and customer collections.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<!-- Field: Page; Sequence: 23; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
cash provided by investing activities was $4,300,043 during the 2024 period compared to net cash provided by investing activities of
$4,883,345 during the 2023 period, resulting in a decrease of $583,302 or 12%. Proceeds of $4,400,000 from the sale of equity method
investment were used to fund operations during the 2024 period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
cash used in financing activities totaled $286,037 during the 2024 period compared to net cash used in financing activities of $146,509
during the 2023 period. Financing activities can vary from period to period depending upon market conditions, both at a macro-level and
specific to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Liquidity
and Capital Resources</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
July 31, 2024, we reported current assets totaling $21,470,151, current liabilities totaling $4,230,512 and net working capital of $17,239,639.
Cash totaled $7,732,763 at July 31, 2024.&#160;Inventory related balances, including pre-paid inventory, totaled $10,667,676.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">We
have never been profitable and have incurred net losses related to acquisitions, as well as costs incurred to pursue our long-term growth
strategy. During the three months ended July 31, 2024, we incurred a net loss </span><span style="font-family: Times New Roman, Times, Serif">of
approximately $12,000,000&#160;and used cash in operating activities of approximately $2,300,000. As of July 31, 2024, working capital
totaled approximately $17,200,000. These financial results and our financial position <span style="background-color: white">at&#160;July
31, 2024&#160;raise substantial doubt about our ability to continue as a going concern. However, we have recently taken actions to strengthen
our liquidity.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">On&#160;December
11, 2023, we completed a public offering of 18,400,000 shares of common stock which generated net proceeds of approximately $8,400,000
as further described in Note 1 and Note 12. In addition, our operating plan for the next twelve months has been updated to reflect recent
operating improvements.&#160; Revenues have accelerated and are expected to continue growing. Our manufacturing facility is scaling production
and gross profits are projected to increase.&#160;If necessary, we will seek to obtain additional debt financing for which there can
be no guarantee. As described in Note 7, we sold our equity method investment for $4,400,000 in July 2024. As described in Note 18, the
Company closed a financing with proceeds of $8 million to be received in late September 2024. Management has concluded that these recent
positive developments alleviate any substantial doubt about our ability to&#160;continue our operations, and meet our financial obligations,
for twelve months from the date these consolidated financial statements&#160;are&#160;issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Critical
Accounting Policies and Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
financial statements and accompanying notes have been prepared in accordance with GAAP applied on a consistent basis. The preparation
of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">We
regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these
policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience,
information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances.
Actual results could differ from those estimates made by management.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Significant
estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii)
the evaluation of long-term assets, including goodwill, for impairment, and (iii) the evaluation of other-than-temporary-impairment of
equity method investments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<!-- Field: Page; Sequence: 24; Value: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Goodwill
and Long-lived Assets</b> &#8211; Goodwill represents the future economic benefit arising from other assets acquired in an acquisition&#160;that
are not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of&#160;<i>ASC
350, Intangibles &#8211; Goodwill and Other,&#160;</i>(&#8220;ASC 350&#8221;). Goodwill is tested for impairment at least annually at
the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that
an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a
determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing
the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit
is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then
it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with
its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however,
the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount
that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting
unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
estimate of fair value of a reporting unit is computed using either an income approach, a market approach, or a combination of both.
Under the income approach, we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions
inherent in estimating the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross
profit, operating expenses, and capital expenditures), and a rate used to discount estimated future cash flow projections to their present
value based on estimated weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical
data, supplemented by current and anticipated market conditions, estimated growth rates, and management&#8217;s plans. Under the market
approach, fair value is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses.
The selection of comparable businesses is based on the markets in which the reporting units operate and consider risk profiles, size,
geography, and diversity of products and services.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities and Related Disclosures</b> &#8211; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, we have categorized our recurring basis financial assets and liabilities into
a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of
the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
guidance establishes three levels of the fair value hierarchy as follows:</span></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Financial
Instruments </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The carrying
amounts of cash, receivables, current assets, accounts payable, accrued expenses and current debt approximates fair value due to the
short-term nature of these instruments.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial
statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued
that might have a material impact on our financial position or results of operations.</span></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">We
are not required to provide the information required by this Item as we are a &#8220;smaller reporting company,&#8221; as defined in
Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
4. CONTROLS AND PROCEDURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Evaluation
of Disclosure Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our principal executive officer and principal financial
officer evaluated the effectiveness of our &#8220;disclosure controls and procedures&#8221; as of July 31, 2024, the end of the period
covered by this Quarterly Report on Form 10-Q. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required
to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported, within
the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange
Act is accumulated and communicated to a company&#8217;s management, including its principal executive officer and principal financial
officer, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and
procedures as of July 31, 2024, our Chief Executive Officer and our Chief Financial Officer concluded that, as of such date, our disclosure
controls and procedures were not effective, specifically pertaining to the quarter ended July 31, 2023 for which we restated items related
to the removal of the derivative liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Management's quarterly report on internal control
over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management is responsible for establishing and
maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable
assurances regarding the reliability of financial reporting and the preparation of our consolidated financial statements in accordance
with GAAP. Our accounting policies and internal controls over financial reporting, established and maintained by management, are under
the general oversight of the Board&#8217;s audit committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our internal control over financial reporting includes
those policies and procedures that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#8226;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#8226;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#8226;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the
policies or procedures may deteriorate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management assessed our internal control over financial
reporting as of July 31, 2024. The standard measures adopted by management in making its evaluation are the measures in the Internal-Control
Integrated Framework published by the Committee of Sponsoring Organizations (&#8220;COSO&#8221;) of the Treadway Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on management&#8217;s assessment using the
COSO criteria, our CEO and CFO concluded that our internal control over financial reporting was not effective, specifically pertaining
to the quarter ended July 31, 2023 for which we restated items related to the removal of the derivative liabilities. The Company is currently
in the process of formalizing narratives and processes which are expected to mitigate these weaknesses, and has hired additional personnel
to strengthen the internal control environment.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Changes In Controls Over Financial Reporting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no changes in our internal control over
financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the three months ended July 31, 2024, that
have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Limitations on Effectiveness of Controls and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b>In
designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how
well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of
controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.
In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management
is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>PART
II - OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
1. LEGAL PROCEEDINGS</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">From
time to time, we are involved in various legal proceedings, lawsuits and claims incidental to the conduct of our business, some of which
may be material. Our businesses are also subject to extensive regulation, which may result in regulatory proceedings against us.&#160;Other
than as described below, we do not believe that the outcome of any of our current legal proceedings will have a material adverse impact
on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">On&#160;May
9, 2024, Autonodyne LLC filed a complaint against wholly-owned Red Cat subsidiary Teal Drones, Inc. in the Superior Court of the State
of Delaware. The Complaint alleges a single cause of action, asserting that Teal breached a Software Licensing Agreement between it and
Autonodyne (the &#8220;SLA&#8221;) by disclosing confidential information contained in the SLA. Autonodyne alleges that it rightfully
terminated the SLA, and at that point it became entitled to $8.25 million of accelerated payments, pursuant to section 14.4(e) of the
SLA. Teal Drones has answered the Complaint, but no discovery has been served yet. As any litigation is subject to many uncertainties,
it is not possible to predict the ultimate outcome of this claim or to estimate the loss, if any, which may result. Accordingly, the
outcome of the claim is not yet determinable, and the extent to which an outflow of funds may be required to settle this possible obligation
cannot be reliably determined. The Company plans to vigorously assert defenses to the complaint.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Risk
factors that affect our business and financial results are discussed in Part I, Item 1A &#8220;Risk Factors,&#8221; in our Annual Report
on Form 10-K for the year ended April 30, 2024, as filed with the SEC on August 8, 2024 (&#8220;Annual Report&#8221;). There have been
no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks
described in our Annual Report which could materially affect our business, financial condition or future results. The risks described
in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently
deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the
risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">None.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
3. DEFAULTS UPON SENIOR SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b></b></span></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Not
applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>ITEM
5. OTHER INFORMATION</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>Rule
10b5-1 Trading Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">During
the three months ended July 31, 2024, none of our directors or officers adopted or terminated any contract, instruction or written plan
for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any
&#8220;non-Rule 10b5-1 trading arrangement.&#8221;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ITEM
6. EXHIBITS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; text-align: left; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="vertical-align: bottom; width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 87%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479522000345/rcat0922form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479522000345/rcat0922form8kexh3_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Bylaws adopted effective September 17, 2022 (incorporated by reference to Exhibit 3.1 to the Current Report on Form
    8-K filed on September 22, 2022)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000141/rcat0517form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000141/rcat0517form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Employment Agreement, between George Matus and the Company, dated May 13, 2024 (incorporated by reference to Exhibit 10.1 to the
    Current Report on Form 8-K filed on May 20, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000154/rcat0614form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2+</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000154/rcat0614form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Employment Agreement, between Leah Lunger and the Company, dated June 10, 2024 (incorporated by reference to Exhibit 10.1 to the
    Current Report on Form 8-K filed on June 14, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3+</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of 8% Promissory Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 23, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4+</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Exchange Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on July 23, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5+</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Closing Date Working Capital Agreement and Consent (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K
    filed on July 23, 2024)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6+</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/748268/000155479524000172/rcat0723form8kexh10_4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Purchase Agreement (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed on July 23, 2024)</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0923form10qexh10_7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.7**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0923form10qexh10_7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Securities
    Purchase Agreement</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0923form10qexh10_8.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.8**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0923form10qexh10_8.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Senior
    Secured Convertible Promissory Note</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0923form10qexh10_9.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.9**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0923form10qexh10_9.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Common
    Stock Purchase Warrant</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><a href="rcat0923form10qexh10_10.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.10**</span></a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><a href="rcat0923form10qexh10_10.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Security
    Agreement</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
    of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the
    Sarbanes-Oxley Act of 2002</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
    of Principal Financial and Accounting Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section
    302 of the Sarbanes-Oxley Act of 2002</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
    of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification
    of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Schema Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Calculation Linkbase Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Label Linkbase Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Presentation Linkbase Document</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Definition Linkbase Document</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File - the cover page from the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ended July
    31, 2024 is formatted in Inline XBRL</span></td></tr>
  </table>
<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">* Filed
herewith.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">**&#160;Furnished
herewith.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; background-color: white">+
</span><span style="font-family: Times New Roman, Times, Serif">Certain schedules, appendices and exhibits to this agreement have been
omitted in accordance with&#160;Item 601(b)(2) of&#160;Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished
supplementally to the SEC staff upon request.</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;<span style="background-color: white">SIGNATURES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 58%">&#160;</td><td style="font-size: 10pt; font-weight: bold; width: 1%">&#160;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RED CAT HOLDINGS, INC.</b></span></td><td style="font-size: 10pt; font-weight: bold; text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; padding-bottom: 1pt">Date: September 23, 2024</td><td style="font-size: 10pt; font-style: italic; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-style: italic; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">By: <i>/s/ Jeffrey Thompson</i></span></p></td><td style="padding-bottom: 1pt; font-size: 10pt; font-style: italic; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jeffrey Thompson</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief Executive Officer</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(Principal Executive Officer)</span></p></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; padding-bottom: 1pt">Date: September 23, 2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    <i>/s/ Leah Lunger</i></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leah Lunger</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief Financial Officer</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(Principal Financial and Accounting Officer)</span></p></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;28</span></p>














































































</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>rcat0923form10qexh10_7.htm
<DESCRIPTION>EXHIBIT 10.7
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.7</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (as amended, supplemented, restated and/or modified from time to time, this &ldquo;<B>Agreement</B>&rdquo;) is entered into
as of September 22, 2024, by and between Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and Lind Global
Asset Management X LLC, a Delaware limited liability company (the &ldquo;<B>Investor</B>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BACKGROUND</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors (the &ldquo;<B>Board of Directors</B>&rdquo;) of the Company has authorized the issuance to Investor of the Note (as
defined below) and the Warrants (as defined below).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">B&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor desires to purchase the Note and the Warrants on the terms and conditions set forth in this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently
with the execution of this Agreement, (i) the Company and the Investor will enter into a security agreement, substantially in the form
attached hereto as <B>Exhibit A</B> (the &ldquo;<B>Security Agreement</B>&rdquo;), pursuant to which the Company will grant a first priority
security interest in substantially all of the assets of the Company to secure its obligations hereunder and under the other Transaction
Documents and (ii) each Subsidiary of the Company (collectively, the &ldquo;<B>Guarantors</B>&rdquo; and each, individually, a &ldquo;<B>Guarantor</B>&rdquo;)
will enter into a joint and several guaranty substantially in the form attached hereto as <B>Exhibit E</B> (the &ldquo;<B>Guaranty</B>&rdquo;)
pursuant to which the Guarantors will guarantee, on a joint and several basis, to the Investor all of the Company&rsquo;s obligations
hereunder and under the Transaction Documents and the Guarantors and the Investor will enter into a security agreement, substantially
in the form attached hereto as <B>Exhibit F</B> (the &ldquo;<B>Guarantor Security Agreement</B>&rdquo;) pursuant to which each of the
Guarantors will grant a first priority security interest in substantially all of the assets of such Guarantor to secure such Guarantor&rsquo;s
obligations under the Guaranty and the other Transaction Documents as well as the Company&rsquo;s obligations hereunder and under the
other Transaction Documents (provided, the priority of any security interests in the Excluded Assets (as hereinafter defined) granted
to the Investor pursuant to the Security Agreement shall be subject to the provisions provided for therein, including as modified pursuant
to any Subordination Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the foregoing recitals and the covenants and agreements set forth herein, and intending hereby to be legally bound, the Company and
the Investor hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>1.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>DEFINITIONS</U></B>. As used in this Agreement, the following terms shall have the following meanings specified
or indicated below, and such meanings shall be equally applicable to the singular and plural forms of such defined terms:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>1933 Act</B>&rdquo;
means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>1934 Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquisition</B>&rdquo;
means the acquisition by the Company or any direct or indirect Subsidiary of the Company of a majority of the Equity Interests or substantially
all of the assets (tangible or intangible) and business of any Person, whether by direct purchase of Equity Interests, asset purchase,
merger, consolidation or like combination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Agreement</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>ATM Agreement</B>&rdquo;
means the ATM Sales Agreement, dated August 8, 2023 by and between the Company and ThinkEquity, LLC, and any additional agreement regarding
a registered at-the-market offering by the Company in the future.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Blue Sky Application</B>&rdquo;
has the meaning set forth in <U>Section 9.3(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board of Directors</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in New York City, as
well as July 24.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the Common Stock, the Preferred Stock and any other classes of shares in the capital stock of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means, with respect to the Company, on or after the date of this Agreement:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 12pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">a change in the composition of the Board of Directors of the Company at
a single shareholder meeting where a majority of the individuals that were directors of the Company immediately prior to the start of
such shareholder meeting are no longer directors at the conclusion of such meeting, without prior written consent of the Investor;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 12pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">a change, without prior written consent of the Investor, in the composition
of the Board of Directors of the Company prior to the termination of this Agreement where a majority of the individuals that were directors
as of the date of this Agreement cease to be directors of the Company prior to the termination of this Agreement; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 12pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">other than a shareholder that holds such a position at the date of this
Agreement, if a Person comes to have beneficial ownership, control or direction over more than forty percent (40%) of the voting rights
attached to any class of voting securities of the Company; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 12pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">the sale or other disposition by the Company or any of its Subsidiaries
in a single transaction, or in a series of transactions, of all or substantially all of their respective assets, but in no event shall
any disposition of assets having a value equal or lesser than 30% of the total value of all of the Company&rsquo;s assets as reported
on the Balance Sheet of the most recently filed Form 10-Q or Form 10-K, be considered a Change of Control.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Code&rdquo;</B>
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commitment Fee</B>&rdquo;
means an amount equal to Two Hundred Eighty Thousand Dollars ($280,000).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock</B>&rdquo;
means the common stock, par value $0.001 per share, of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock
Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any
time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common
Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Conversion Shares</B>&rdquo;
means the shares of Common Stock issuable upon the full or any partial conversion of the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Disclosure Letter</B>&rdquo;
has the meaning set forth in <U>Section 3</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Effectiveness
Period</B>&rdquo; has the meaning set forth in <U>Section 9.2(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Equity Assets</B>&rdquo;
means: (i) any Equity Interest in any Person which becomes a Subsidiary of the Company to the extent the purchase of such Equity Interest
was paid for with the proceeds of a Permitted Acquisition Arrangement; or (ii) any group of assets acquired by the Company that constitute
a &ldquo;business&rdquo; within the meaning of Rule 11-01(d) under Regulation S-X (&ldquo;<U>Business Assets</U>&rdquo;), to the extent
that: (a) the purchase of such assets was paid for with the proceeds of a Permitted Acquisition Arrangement; and (b) all of such assets
are acquired by, and held within, a newly-created and wholly-owned Subsidiary of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Equity Interests</B>&rdquo;
means and includes capital stock, membership interests and other similar equity securities, and shall also include warrants or options
to purchase capital stock, membership interests or other equity interests.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event</B>&rdquo;
means any event, change, development, effect, condition, circumstance, matter, occurrence or state of facts.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event of Default</B>&rdquo;
has the meaning set forth in <U>Section 7.1</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Excluded Assets</B>&rdquo;
means (a) PO Assets, and (b) Equity Assets.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exempted Securities</B>&rdquo;
means (a) equity securities issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock, (b)
shares of Common Stock or rights, warrants or options to purchase Common Stock issued to employees or directors of the Company or any
of its Subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors (&ldquo;<B>Equity Plans</B>&rdquo;),
(c) shares of Common Stock actually issued upon the exercise of options, warrants or shares of Common Stock actually issued upon the conversion
or exchange of any securities convertible into Common Stock, in each case issued to employees or directors of, the Company or any of its
Subsidiaries pursuant to an Equity Plan and provided that such issuance is pursuant to the terms of the applicable option, warrant or
convertible security, (d) Investor Shares, (e) shares of Common Stock sold pursuant to any ATM Agreement, and (f) shares of Common Stock
or Preferred Stock issued in connection with an Acquisition by the Company or a Subsidiary of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;FCPA&rdquo;</B>
has the meaning set forth in <U>Section 3.24</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Form 8-K&rdquo;
</B>has the meaning set forth in <U>Section 5.10</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Funding Amount&rdquo;</B>
means an amount equal to Eight Million Dollars ($8,000,000).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;GAAP&rdquo;</B>
has the meaning set forth in <U>Section 3.5(b)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental
Authority</B>&rdquo; means the government of the United States or any other nation, or of any political subdivision thereof, whether state
or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative,
judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies
such as the European Union or the European Central Bank).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Guarantor Security
Agreement</B>&rdquo; has the meaning set forth in the recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Guaranty</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSR Act</B>&rdquo;
has the meaning set forth in <U>Section 5.15</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
has the meaning set forth in the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Group</B>&rdquo;
shall mean the Investor plus any other Person with which the Investor is considered to be part of a group under Section 13 of the 1934
Act or with which the Investor otherwise files reports under Sections 13 and/or 16 of the 1934 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Party</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Shares</B>&rdquo;
means the Conversion Shares, the Warrant Shares and any other shares issued or issuable to the Investor pursuant to this Agreement, the
Note or the Warrant.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>IP Rights</B>&rdquo;
has the meaning set forth in <U>Section 3.10</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>IP Security Documents</B>&rdquo;
means any security agreement with respect to any trademarks, patents, copyrights and related rights by and between the Company or any
Subsidiary, as applicable, and the Investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Law</B>&rdquo;
means any law, rule, regulation, order, judgment or decree, including, without limitation, any federal and state securities Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Legend Removal
Date</B>&rdquo; shall have the meaning set forth in <U>Section 5.1(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Losses</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Adverse
Effect</B>&rdquo; means any material adverse effect on (i) the businesses, properties, assets, prospects, operations, results of operations
or financial condition of the Company, or the Company and the Subsidiaries, taken as a whole, or (ii) the ability of the Company to consummate
the transactions contemplated by this Agreement or to perform its obligations hereunder or under the Security Agreement, the Note or the
Warrant; <I>provided, however</I>, that none of the following shall be deemed either alone or in combination to constitute, and none of
the following shall be taken into account in determining whether there has been or would be, a Material Adverse Effect: (a)&nbsp;any adverse
effect resulting from or arising out of general economic conditions; (b) any adverse effect resulting from or arising out of general conditions
in the industries in which the Company and the Subsidiaries operate; (c) any adverse effect resulting from any changes to applicable Law;
or (d)&nbsp;any adverse effect resulting from or arising out of any natural disaster or any acts of terrorism, sabotage, military action
or war or any escalation or worsening thereof; <I>provided</I>, <I>further</I>, that any event, occurrence, fact, condition or change
referred to in clauses (a) through (d) immediately above shall be taken into account in determining whether a Material Adverse Effect
has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has a disproportionate
effect on the Company and/or the Subsidiaries compared to other participants in the industries in which the Company and the Subsidiaries
operate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Maximum Percentage</B>&rdquo;
means 4.99%.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Money Laundering
Laws</B>&rdquo; has the meaning set forth in <U>Section 3.25</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>New Securities</B>&rdquo;
means, collectively, equity securities of the Company, whether or not currently authorized, as well as rights, options, or warrants to
purchase such equity securities, or securities of any type whatsoever that are, or may become convertible or exchangeable into or exercisable
for such equity securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Note</B>&rdquo;
has the meaning set forth in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Notice Termination
Time&rdquo;</B> has the meaning set forth in <U>Section 10.2</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Obligor</B>&rdquo;
means the Company and each of its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>OFAC</B>&rdquo;
has the meaning set forth in <U>Section 3.23</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offer Notice</B>&rdquo;
has the meaning set forth in <U>Section 10.1</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Organizational
Documents&rdquo;</B> has the meaning set forth in <U>Section 3.3</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Acquisition
Arrangement</B>&rdquo; means Indebtedness incurred after the date hereof from one or more lenders in an aggregate principal amount not
to exceed $5,000,000 so long as (a) the proceeds thereof are used by the Company solely for the purchase of Equity Interests in an unaffiliated
Person which becomes a Subsidiary or Business Assets of an unaffiliated Person so long as such Business Assets are acquired by, and held
within, a newly-created and wholly-owned Subsidiary of the Company; (b) at the time of incurring such Indebtedness, no Event of Default
has occurred and is continuing under any Transaction Document; (c) the terms and conditions contained in any agreement or document relating
to such Indebtedness do not contain any covenants or defaults more onerous to the Company or any Subsidiary than those contained in the
Transaction Documents and do not contain any covenant or provision which would cause the Company to violate or otherwise contravene the
terms of any Transaction Document; (d) to the extent any security interest is granted to secure the Company&rsquo;s or any such newly-created
and wholly-owned Subsidiary&rsquo;s obligations with respect to such Indebtedness, such security interest is limited solely to a security
interest on the Equity Assets of the Person so acquired or the Business Assets so acquired, and the provider of such Indebtedness shall
have no other recourse to any other assets or recourse to the Company or any other Subsidiary (other than the Subsidiary so acquired);
and (e) the provider of such Indebtedness, the Investor and the Company (and to the extent applicable, the applicable Subsidiary) have
entered into a Subordination Agreement with respect to the security interest in the applicable Excluded Assets so acquired.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Financing
Arrangement</B>&rdquo; means a Permitted Acquisition Arrangement and a Permitted PO Financing Arrangement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted PO
Financing Arrangement</B>&rdquo; means Indebtedness incurred after the date hereof from one or more lenders in an aggregate principal
amount not to exceed $50,000,000 so long as (a) the proceeds thereof are used by the Company solely for the purchase of PO Assets; (b)
at the time of incurring such Indebtedness, no Event of Default has occurred and is continuing under any Transaction Document; (c) the
terms and conditions contained in any agreement or document relating to such Indebtedness do not contain any covenants or defaults more
onerous to the Company or any Subsidiary than those contained in the Transaction Documents and do not contain any covenant or provision
which would cause the Company to violate or otherwise contravene the terms of any Transaction Document; (d) to the extent any security
interest is granted to secure the Company&rsquo;s or any Subsidiary&rsquo;s obligations with respect to such Indebtedness, such security
interest is limited solely to a security interest on the PO Assets; and (e) the provider of such Indebtedness, the Investor and the Company
(and to the extent applicable, the applicable Subsidiary) have entered into a Subordination Agreement with respect to the security interest
in the PO Assets.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Pledge Agreements&rdquo;
</B>means, collectively, (a) that certain Pledge Agreement dated on or about the date hereof by and between the Company and the Investor;
(b) that certain Pledge Agreement dated on or about the date hereof between Red Cat Skypersonic, Inc. and the Investor; and (c) that certain
Pledge Agreement dated on or about the date hereof by and between Teal Acquisition I Corp. and the Investor.&ldquo;<B>PO Assets</B>&rdquo;
means those assets of the Company consisting of inventory (including raw material, work in process, or material used or consumed in the
Company&rsquo;s business) and accounts receivables of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Preferred Stock&rdquo;</B>
has the meaning set forth in <U>Section 3.4(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Press Release&rdquo;</B>
has the meaning set forth in <U>Section 5.10</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Principal Amount</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceedings</B>&rdquo;
has the meaning set forth in <U>Section 3.6</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prohibited Transaction</B>&rdquo;
means a transaction with a third party or third parties in which the Company issues or sells (or arranges or agrees to issue or sell):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
debt, equity or equity-linked securities (including options or warrants) that are convertible into, exchangeable or exercisable for, or
include the right to receive shares of the Company&rsquo;s Capital Stock:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
a conversion, repayment, exercise or exchange rate or other price that is based on, and/or varies with, a discount to the future trading
prices of, or quotations for, shares of Common Stock; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
a conversion, repayment, exercise or exchange rate or other price that is subject to being reset at some future date after the initial
issuance of such debt, equity or equity-linked security or upon the occurrence of specified or contingent events (other than warrants
that may be repriced by the Company); or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
securities in a capital or debt raising transaction or series of related transactions which grant to an investor the right to receive
additional securities based upon future transactions of the Company on terms more favorable than those granted to such investor in such
first transaction or series of related transactions; and are deemed to include transactions generally referred to as equity lines of credit
and stand-by equity distribution agreements, and convertible securities and loans having a similar effect; provided, that any registered
public offering of common stock by the Company, including but limited to any offering made in connection with an ATM Agreement, shall
not be considered Prohibited Transactions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus</B>&rdquo;
means the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect to
the terms of the offering of any portion of the Investor Shares covered by such Registration Statement and by all other amendments and
supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such prospectus, and
any &ldquo;free writing prospectus&rdquo; as defined in Rule 405 under the 1933 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>register</B>,&rdquo;
&ldquo;<B>registered</B>&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the 1933 Act (as defined below), and the declaration or ordering of effectiveness of
such Registration Statement or document.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration
Statement</B>&rdquo; means any registration statement of the Company filed under the 1933 Act that covers the resale of any of the Investor
Shares pursuant to the provisions of this Agreement, including the Prospectus and amendments and supplements to such Registration Statement,
and including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Reverse Split</B>&rdquo;
has the meaning set forth in <U>Section 5.20</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rule 144</B>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC Documents</B>&rdquo;
has the meaning set forth in <U>Section 3.5(a)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities</B>&rdquo;
means the Note, the Warrant and the Investor Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Agreement</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Documents</B>&rdquo;
means the Security Agreement, the Guarantor Security Agreement, the Pledge Agreements, and the IP Security Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Subordination
Agreement&rdquo;</B> means an intercreditor agreement entered into after the date hereof among the Investor, the Company and the provider
of any Permitted Financing Arrangement, which shall be entered into if and only if: (i) the Permitted Financing Agreement meets the definition
of a Permitted Acquisition Arrangement or a Permitted PO Financing Arrangement, as applicable, as set forth herein; (ii) such intercreditor
agreement does not, in the reasonable determination of the Investor, impair, impede, or otherwise materially alter the Investor&rsquo;s
rights under any of the Transaction Documents, except with respect to the first priority of the Investor&rsquo;s lien on the subject Equity
Assets or PO Assets, as applicable, (and, for the avoidance of doubt, no such agreement shall require or otherwise cause the Investor&rsquo;s
lien to rank lower than a second priority lien on the applicable Excluded Assets) or impose any additional obligations on the Investor
other than the Investor&rsquo;s obligations under the other Transaction Documents; and (iii) such intercreditor agreement shall not require
the Company, under any circumstances, to violate the terms of any Transaction Document.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Stockholder Approval</B>&rdquo;
shall mean the approval of the holders of a majority of the outstanding shares of the Company&rsquo;s voting Common Stock: (a) if and
to the extent legally required, to amend the Company&rsquo;s Articles of Incorporation to increase the number of authorized shares of
Common Stock by at least the number of shares of Common Stock equal to the number of shares of Common Stock issuable hereunder, or (b)
to ratify and approve all of the transactions contemplated by the Transaction Documents, including the issuance of all of the Investor
Shares (as such term is defined in each of such documents) issued and potentially issuable to the Investor thereunder, all as may be required
by the applicable rules and regulations of the Trading Market (or any successor entity).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsequent Financing</B>&rdquo;
has the meaning set forth in <U>Section 10</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of
the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other
than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or
the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person.
Unless otherwise specified, all references herein to a &ldquo;Subsidiary&rdquo; or to &ldquo;Subsidiaries&rdquo; shall refer to a Subsidiary
or Subsidiaries of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Trading Day&rdquo;</B>
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means whichever of the New York Stock Exchange, NYSE American, or the Nasdaq Stock Market (including the Nasdaq Capital Market), on which
the Common Stock is listed or quoted for trading on the date in question.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Documents</B>&rdquo;
means this Agreement, the Security Agreement, the Guaranty, the Guarantor Security Agreement, the Note, the Warrant, the Supplemental
Loan Documents (as such term is defined in the Security Agreement) and any other documents or agreements executed or delivered in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP&rdquo;</B>
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of one share of Common Stock trading in the ordinary course of
business at the applicable Trading Price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg
Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market and if the Common Stock is traded in the over-the-counter
market, as reported by the OTCQX or OTCQB Markets, the volume weighted average price of one share of Common Stock for such date (or the
nearest preceding date) on the OTCQX or OTCQB Markets, as reported by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed
or quoted on a Trading Market or on the OTCQX or OTCQB Markets and if prices for the Common Stock are then reported in the &ldquo;Pink
Sheets&rdquo; published by the OTC Markets Group (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price of one share of Common Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases,
the fair market value of one share of Common Stock as determined by an independent appraiser selected in good faith by the Investor and
reasonably acceptable to the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant</B>&rdquo;
has the meaning set forth in Section 2.1(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant Shares</B>&rdquo;
means the shares of Common Stock issuable upon exercise of the Warrant.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>2.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>PURCHASE AND SALE OF THE NOTE AND THE WARRANT</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Purchase and Sale of the Note and the Warrant</U>. Subject to the terms and conditions set forth herein, at the Closing,
the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company, for the Funding Amount (a) a convertible
promissory note, in the form attached hereto as <B>Exhibit B</B> (the &ldquo;<B>Note</B>&rdquo;), in the principal amount of Nine Million
Six Hundred Thousand Dollars ($9,600,000) (the &ldquo;<B>Principal Amount</B>&rdquo;) and (b) a Common Stock purchase warrant, in the
form attached hereto as <B>Exhibit C</B>, registered in the name of the Investor, pursuant to which the Investor shall have the right
to acquire 750,000 shares of Common Stock (the &ldquo;<B>Warrant</B>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Closing</U>. The closing hereunder, including payment for and delivery of the Note and the Warrant, shall take place
remotely via the exchange of documents and signatures, no later than ten (10) Business Days following the execution and delivery of this
Agreement, subject to satisfaction or waiver of the conditions set forth in <U>Section 6</U>, or at such other time and place as the Company
and the Investor agree upon, orally or in writing (the &ldquo;<B>Closing</B>,&rdquo; and the date of the Closing being the &ldquo;<B>Closing
Date</B>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Commitment Fee</U>. At the Closing, the Company shall pay to the Investor the Commitment Fee, in United States dollars
and in immediately available funds. The Commitment Fee shall be paid by being offset against the Funding Amount payable by the Investor
at Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Prepayment Right.</U> The Company will have the right to pre-pay the entire Outstanding Principal Amount (as such
term is defined in the Note) pursuant to the terms and conditions set forth in the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.5<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Senior Obligation</U>. As an inducement for the Investor to enter into this Agreement and to purchase the Note, all
obligations of the Company pursuant to this Agreement and the Note shall be (a) guaranteed by the Guarantors pursuant to the terms of
the Guaranty (and each Guarantor&rsquo;s obligations under the Guaranty shall be secured by a security interest in and lien upon all the
&ldquo;Collateral&rdquo; (as such term is defined in the Guarantor Security Agreement) of such Guarantor pursuant to the terms of the
Guarantor Security Agreement), with such security interest and lien to hold first priority except in the case of Excluded Assets, and
(b) secured by a security interest in and lien upon all assets of the Company pursuant to the terms of the Security Agreement, with such
security interest and lien to hold first priority except in the case of Excluded Assets (which, in the case of the applicable Excluded
Assets that are the subject of a Subordination Agreement, will hold second priority so long as such Subordination Agreement is in full
force and effect). Notwithstanding the foregoing, to the extent after the date hereof, (a) the Company entered into a Permitted Financing
Arrangement to be secured by PO Assets, upon the execution and delivery of the Subordination Agreement(s), the Investor&rsquo;s security
interest on the Company&rsquo;s PO Assets be subordinated to the security interest(s) granted to the creditor(s) in the transaction; and
(b) the Company enters into a transaction to acquire Equity Assets, upon the execution and delivery of the Subordination Agreement(s),
the Investor&rsquo;s security interest in the Equity Assets shall be subordinated to the security interest(s) granted to the creditor(s)
in the transaction. In addition, so long (x) as no Event of Default has occurred and is continuing or would exist as a result thereof,
and (y) the Company complies with the repayment provisions of Section 5.7 hereof, the Company may conduct a sale, exchange, or other disposition
of assets so long as the aggregate value of all assets sold, exchanged or otherwise disposed of from and after the date hereof is equal
or lesser than 30% of the contribution to revenue or the total value of all of the Company&rsquo;s assets as reported on the Balance Sheet
of the most recently filed Form 10-Q or Form 10-K (a &ldquo;Permitted Disposition&rdquo;). In the event of a Permitted Disposition, the
Lender shall promptly upon the request of the Company (but after giving effect to any required repayment pursuant to Section 5.7 hereof)
execute a release of it lien and security interest in the assets so disposed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>3.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U></B>. The Company represents and warrants to the Investor and
covenants with the Investor that, except as is set forth in the Disclosure Letter being delivered to the Investor as of the date hereof
and as of the Closing Date (the <B>&ldquo;Disclosure Letter&rdquo;</B>), the following representations and warranties are true and correct:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Organization and Qualification</U>. The Company is a corporation duly organized and validly existing in good standing
under the Laws of the State of Nevada and has the requisite corporate power and authority to own its properties and to carry on its business
as now being conducted. The Company is duly qualified to do business and is in good standing (if a good standing concept exists in such
jurisdiction) in every jurisdiction in which the ownership of its property or the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Authorization; Enforcement; Compliance with Other Instruments</U>. The Company has the requisite corporate power
and authority to execute the Transaction Documents, to issue and sell the Note and the Warrant pursuant hereto, and to perform its obligations
under the Transaction Documents, including issuing the Investor Shares on the terms set forth in this Agreement. The execution and delivery
of the Transaction Documents by the Company and the issuance and sale by the Company of the Securities pursuant hereto, including without
limitation the reservation of the Conversion Shares and the Warrant Shares for future insuance, have been duly and validly authorized
by the Company&rsquo;s Board of Directors and no further consent or authorization is required by the Company, its Board of Directors,
its stockholders or any other Person in connection therewith. The Transaction Documents have been duly and validly executed and delivered
by the Company and constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their respective
terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar Laws relating to, or affecting generally, the enforcement of creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries
(as applicable) and the issuance and sale of the Note and the Warrant hereunder will not (a) conflict with or result in a violation of
the Company&rsquo;s Articles of Incorporation, as amended, and Bylaws, or any Subsidiary&rsquo;s organizational and governing documents
(collectively, the <B>&ldquo;Organizational Documents&rdquo;</B>), (b)&nbsp;conflict with, or constitute a material default (or an event
which, with notice or lapse of time or both, would become a material default) under, or give to others any right of termination, amendment,
acceleration or cancellation of, any material agreement to which the Company or any of the Subsidiaries is a party, or (c) subject to
the making of the filings referred to in <U>Section&nbsp; 5</U>, violate in any material respect any Law or any rule or regulation of
the Trading Market applicable to the Company or any of the Subsidiaries or by which any of their properties or assets are bound or affected.
Assuming the accuracy of the Investor&rsquo;s representations in <U>Section&nbsp;4</U> and subject to the making of the filings referred
to in <U>Section&nbsp;5</U>, (i) no approval or authorization will be required from any Governmental Authority or agency, regulatory or
self-regulatory agency or other third party (including the Trading Market) in connection with the issuance of the Note and the Warrant
and the other transactions contemplated by this Agreement (including the issuance of the Conversion Shares upon conversion of the Note
and the Warrant Shares upon the exercise of the Warrant and the issuance of any other Investor Shares upon the issuance thereof) and (ii)&nbsp;the
issuance of the Note and the Warrant, and the issuance of the Conversion Shares upon the conversion of the Note and the Warrant Shares
upon exercise of the Warrant and the issuance of any other Investor Shares upon the issuance thereof will be exempt from the registration
and qualification requirements under the 1933 Act and all applicable state securities Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Capitalization and Subsidiaries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The authorized Capital Stock of the Company consists of 500,000,000 shares of Common Stock and 4,300,000 shares of preferred stock
to be designated by the Board of Directors (the <B>&ldquo;Preferred Stock&rdquo;</B>). As of the close of business on September 19, 2024,
75,409,038 shares of Common Stock and 4,676 shares of Preferred Stock were issued and outstanding; and since September 19, 2024, and through
the date of this Agreement, the Company has issued zero additional shares of Common Stock and an additional zero shares of Preferred Stock.
As of September 19, 2024, (i) an aggregate of 7,297,238 shares of Common Stock are issuable upon exercise of options granted under the
2019 Equity Incentive Plan, of which 5,404,899 shares were exercisable as of September 19, 2024 and 324,471 shares are reserved for future
issuance thereunder; and (ii) 1,567,207 shares of Common Stock are reserved for issuance upon exercise of outstanding warrants with exercise
prices ranging from $0.625 to $5.625 per share. The Company has duly reserved up to 3,067,093 shares of Common Stock for issuance upon
conversion of the Note and has duly reserved up to 750,000 shares of Common Stock for issuance upon exercise of the Warrant. <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Conversion Shares, when issued upon conversion of the Note in accordance with its terms, and the Warrant Shares, if and when issued upon
exercise of the Warrant in accordance with its terms, and any other Investor Shares, if and when issued in connection wtih the Transaction
Documents, will be validly issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issuance
thereof. </FONT>No shares of the Company&rsquo;s Capital Stock are subject to preemptive rights or any other similar rights or any liens
or encumbrances suffered or permitted by the Company. The Organizational Documents on file on the SEC&rsquo;s EDGAR website are true and
correct copies of the Organizational Documents, as in effect as of the <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Closing
Date. The Company is not in violation of any provision of its Organizational Documents.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.4(b)</U> lists each direct and indirect Subsidiary of the Company existing on the date hereof and indicates for each
Subsidiary (i) the authorized capital stock or other Equity Interests of such Subsidiary as of the date hereof, (ii) the number and kind
of shares or other ownership interests of such Subsidiary that are issued and outstanding as of the date hereof, and (iii) the owner of
such shares or other ownership interests. No Subsidiary has any outstanding stock options, warrants or other instruments pursuant to which
such Subsidiary may at any time or under any circumstances be obligated to issue any shares of its capital stock or other Equity Interests.
The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary. Each Subsidiary is duly
organized and validly existing in good standing under the laws of its jurisdiction of formation (if a good standing concept exists in
such jurisdiction) and has all requisite power and authority to own its properties and to carry on its business as now being conducted.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any Subsidiary is bound by any agreement or arrangement pursuant to which it is obligated to register the
sale of any securities under the 1933 Act. There are no outstanding securities of the Company or any of the Subsidiaries which contain
any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to redeem or purchase any security of the Company or any Subsidiary. There are no outstanding securities
or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Note, the Warrant or the Investor
Shares. Neither the Company nor any Subsidiary has any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or
any similar plan or agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The issuance and sale of any of the Securities will not obligate the Company to issue shares of Common Stock or other securities,
or to satisfy any related contractual obligations, to any other Person and will not result in the adjustment of the exercise, conversion,
exchange, or reset price of any outstanding securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the date of this Agreement, the Company has capacity under the rules and regulations of the Trading Market to issue up to
15,081,808 shares of Common Stock (or securities convertible into or exercisable for Common Stock) without obtaining Stockholder Approval.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.5<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>SEC Documents; Financial Statements</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Closing Date</FONT>, the Company has filed all reports, schedules,
forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all
of the foregoing filed prior to the <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Closing Date </FONT>and all exhibits included
therein and financial statements and schedules thereto and documents incorporated by reference therein being hereinafter referred to as
the &ldquo;<B>SEC Documents</B>&rdquo;). As of their respective filing dates, the SEC Documents complied in all material respects with
the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and
none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all
material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such
financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;),
and audited by a firm that, at time that any audit opinion was given, was member of the Public Companies Accounting Oversight Board consistently
applied, during the periods involved (except as may be otherwise indicated in such financial statements or the notes thereto, or, in the
case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present
in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its
operations and consolidated cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments). No other written information provided by or on behalf of the Company to the Investor in connection with the Investor&rsquo;s
purchase of the Note and the Warrant which is not included in the SEC Documents contains any untrue statement of a material fact or omits
to state any material fact necessary to make the statements therein, in the light of the circumstance under which they are or were made,
not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth in <U>Schedule 3.5(c)</U>, the Company and each of the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or
specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) reasonable controls to safeguard assets are in place and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.6<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Litigation and Regulatory Proceedings</U>. Except as disclosed in <U>Schedule 3.6</U> of the Disclosure Letter, there
are no material actions, causes of action, suits, claims, proceedings, inquiries or investigations (collectively, &ldquo;<B>Proceedings</B>&rdquo;)
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive
officers of Company or any of the Subsidiaries, threatened against or affecting the Company or any of the Subsidiaries, the Common Stock
or any other class of issued and outstanding shares of the Company&rsquo;s Capital Stock, or any of the Company&rsquo;s or the Subsidiaries&rsquo;
officers or directors in their capacities as such and, to the knowledge of the executive officers of the Company, there is no reason to
believe that there is any basis for any such Proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.7<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Undisclosed Events, Liabilities or Developments</U>. No event, development or circumstance has occurred or exists,
or to the knowledge of the executive officers of the Company is reasonably anticipated to occur or exist that (a) would reasonably be
anticipated to have a Material Adverse Effect or (b) would be required to be disclosed by the Company under applicable securities Laws
on a registration statement filed with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been
publicly announced.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.8<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Compliance with Law</U>. The Company and each of the Subsidiaries have conducted and are conducting their respective
businesses in compliance in all material respects with all applicable Laws and are in compliance in all material respects with the rules
and regulations of the Trading Market. The Company is not aware of any facts which could reasonably be anticipated to have the effect
of delisting the Common Stock from the Trading Market, nor has the Company received any notification that the Trading Market is currently
contemplating terminating such listing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.9<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Employee Relations</U>. Neither the Company nor any Subsidiary is involved in any union labor dispute nor, to the
knowledge of the Company, is any such dispute threatened. Neither the Company nor any Subsidiary is a party to any collective bargaining
agreement. No executive officer (as defined in Rule 501(f) of the 1933 Act) has notified the Company that such officer intends to leave
the Company&rsquo;s employ or otherwise terminate such officer&rsquo;s employment with the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.10<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Intellectual Property Rights</U>. The Company and each Subsidiary owns or possesses adequate rights or licenses to
use all trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights (collectively, &ldquo;<B>IP Rights</B>&rdquo;)
necessary to conduct their respective businesses as now conducted. None of the material IP Rights of the Company or any of the Subsidiaries
are expected to expire or terminate within three (3) years from the date of this Agreement. Neither the Company nor any Subsidiary is
infringing, misappropriating or otherwise violating any IP Rights of any other Person. No claim has been asserted, and no Proceeding is
pending, against the Company or any Subsidiary alleging that the Company or any Subsidiary is infringing, misappropriating or otherwise
violating the IP Rights of any other Person, and, to the Company&rsquo;s knowledge, no such claim or Proceeding is threatened, and the
Company is not aware of any facts or circumstances which might give rise to any such claim or Proceeding. The Company and the Subsidiaries
have taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of their material IP Rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.11<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Environmental Laws</U>. Except, in each case, as would not be reasonably anticipated to have a Material Adverse Effect,
the Company and the Subsidiaries (a) are in compliance with any and all applicable Laws relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, (b) have received and hold all permits,
licenses or other approvals required of them under all such Laws to conduct their respective businesses and (c) are in compliance with
all terms and conditions of any such permit, license or approval.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.12<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title to all personal property owned
by them which is material to their respective businesses, in each case free and clear of all liens, encumbrances and defects. Any real
property and facilities held under lease by the Company or any Subsidiary are held under valid, subsisting and enforceable leases with
such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the
Company and the Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.13<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Insurance</U>. The Company and each of the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the
businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor any of the Subsidiaries has been refused any
insurance coverage sought or applied for, and the Company has no reason to believe that it will not be able to renew all existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.14<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Regulatory Permits</U>. The Company and the Subsidiaries have in full force and effect all certificates, approvals,
authorizations and permits from all regulatory authorities and agencies necessary to own, lease or operate their respective properties
and assets and conduct their respective businesses, and neither the Company nor any Subsidiary has received any notice of Proceedings
relating to the revocation or modification of any such certificate, approval, authorization or permit, except for such certificates, approvals,
authorizations or permits with respect to which the failure to hold would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.15<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Materially Adverse Contracts, Etc</U>. Neither the Company nor any of the Subsidiaries is (a) subject to any charter,
corporate or other legal restriction, or any judgment, decree or order which in the judgment of the Company&rsquo;s officers has or is
expected in the future to have a Material Adverse Effect or (b) a party to any contract or agreement which in the judgment of the Company&rsquo;s
management has or would reasonably be anticipated to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.16<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Taxes</U>. Except as disclosed in <U>Schedule 3.16</U>, the Company and the Subsidiaries each has made or filed,
or caused to be made or filed, all United States federal and other material tax returns, reports and declarations required by any jurisdiction
to which it is subject and has paid all taxes and other governmental assessments and charges that are material in amount, required to
be paid by it, regardless of whether such amounts are shown or determined to be due on such returns, reports and declarations, except
those being contested in good faith by appropriate proceedings and for which it has set aside on its books provision reasonably adequate
for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.17<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Solvency</U>. After giving effect to the receipt by the Company of the proceeds from the transactions contemplated
by this Agreement (a) the Company&rsquo;s fair saleable value of its assets exceeds the amount that will be required to be paid on or
in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature; and (b)&nbsp;the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its debt when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.18<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Investment Company</U>. Neither the Company nor any Guarantor is, and neither the Company nor any Guarantor is, an
Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.19<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Certain Transactions</U>. There are no contracts, transactions, arrangements or understandings between the Company
or any of its Subsidiaries, on the one hand, and any director, officer or employee thereof on the other hand, that would be required to
be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC in the Company&rsquo;s Annual Report on Form 10-K or proxy
statement pertaining to an annual meeting of stockholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.20<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No General Solicitation</U>. Neither the Company, nor any of its Affiliates, nor any person acting on its behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer
or sale of the Note or the Warrant pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.21<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Acknowledgment Regarding the Investor&rsquo;s Purchase of the Note and the Warrant</U>. The Company&rsquo;s Board
of Directors has approved the execution of the Transaction Documents and the issuance and sale of the Note and the Warrant, based on its
own independent evaluation and determination that the terms of the Transaction Documents are reasonable and fair to the Company and in
the best interests of the Company and its stockholders. The Company is entering into this Agreement and the Security Agreement and is
issuing and selling the Note and the Warrant voluntarily and without economic duress. The Company has had independent legal counsel of
its own choosing review the Transaction Documents and advise the Company with respect thereto. The Company acknowledges and agrees that
the Investor is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Note and the Warrant and the transactions
contemplated hereby and that neither the Investor nor any person affiliated with the Investor is acting as a financial advisor to, or
a fiduciary of, the Company (or in any similar capacity) with respect to execution of the Transaction Documents or the issuance of the
Note and the Warrant or any other transaction contemplated hereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.22<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Brokers&rsquo;, Finders&rsquo; or Other Advisory Fees or Commissions</U>. No brokers, finders or other similar
advisory fees or commissions will be payable by the Company or any Subsidiary or by any of their respective agents with respect to the
issuance of the Note or any of the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.23<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>OFAC</U>. None of the Company nor any of the Subsidiaries nor, to the knowledge of the Company, any director, officer,
agent, employee, affiliate or person acting on behalf of the Company and/or any Subsidiary has been or is currently subject to any United
States sanctions administered by the Office of Foreign Assets Control of the United States Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;);
and the Company will not directly or indirectly use any proceeds received from the Investor, or lend, contribute or otherwise make available
such proceeds to its Subsidiaries or to any affiliated entity, joint venture partner or other person or entity, to finance any investments
in, or make any payments to, any country or person currently subject to any of the sanctions of the United States administered by OFAC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.24<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Foreign Corrupt Practices</U>. None of the Company or any of the Subsidiaries has, directly or indirectly: (a)
made or authorized any contribution, payment or gift of funds or property to any official, employee or agent of any Governmental Authority
of any jurisdiction except as otherwise permitted under applicable Law; or (b) made any contribution to any candidate for public office,
in either case, where either the payment or the purpose of such contribution, payment or gift was, is, or would be prohibited under the
Foreign Corrupt Practices Act (&ldquo;<B>FCPA</B>&rdquo;) or the rules and regulations promulgated thereunder or under any other legislation
of any relevant jurisdiction covering a similar subject matter applicable to the Company or its Subsidiaries and their respective operations
and the Company has instituted and maintained policies and procedures designed to ensure, and which are reasonably expected to continue
to ensure, continued compliance with such legislation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.25<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Anti-Money Laundering</U>. The operations of each of the Company and the Subsidiaries are and have been conducted
at all times in compliance with all applicable anti-money laundering laws, regulations, rules and guidelines in its jurisdiction of incorporation
and in each other jurisdiction in which such entity, as the case may be, conducts business (collectively, the &ldquo;<B>Money Laundering
Laws</B>&rdquo;) and no action, suit or proceeding by or before any court or Governmental Authority involving the Company or its Subsidiaries
with respect to any of the Money Laundering Laws is, to the knowledge of the Company, pending, threatened or contemplated.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.26<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Disclosure</U>. The Company confirms that neither it, nor to its knowledge, any other Person acting on its behalf
has provided the Investor or its agents or counsel with any information that the Company believes constitutes material, non-public information
other than as set forth on <U>Schedule 3.26</U>. The Company understands and confirms that the Investor will rely on the foregoing representations
and covenants in effecting transactions in securities of the Company. All disclosures provided to the Investor regarding the Company,
its business and the transactions contemplated hereby, furnished by or on behalf of the Company (including the Company&rsquo;s representations
and warranties set forth in this Agreement) are true and correct in all material respects and do not contain any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>4.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>REPRESENTATIONS AND WARRANTIES OF THE INVESTOR</U></B>. The Investor represents and warrants to the Company as
follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Organization and Qualification</U>. The Investor is a limited liability company, duly organized and validly existing
in good standing under the laws of the State of Delaware.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Authorization; Enforcement; Compliance with Other Instruments</U>. The Investor has the requisite power and authority
to enter into this Agreement and the Security Agreement, to purchase the Note and the Warrant and to perform its obligations under the
Transaction Documents. The execution and delivery of the Transaction Documents to which it is a party have been duly and validly authorized
by the Investor&rsquo;s governing body and no further consent or authorization is required. The Transaction Documents to which it is a
party have been duly and validly executed and delivered by the Investor and constitute valid and binding obligations of the Investor,
enforceable against the Investor in accordance with their terms, except as such enforceability may be limited by general principles of
equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally,
the enforcement of creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents to which it is a party by
the Investor and the purchase of the Note and the Warrant by the Investor will not (a) conflict with or result in a violation of the Investor&rsquo;s
organizational documents, (b) conflict with, or constitute a material default (or an event which, with notice or lapse of time or both,
would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material
agreement, contract, indenture mortgage, indebtedness or instrument to which the Investor is a party, or (c) violate in any material respect
any Law applicable to the Investor or by which any of the Investor&rsquo;s properties or assets are bound or affected. No approval or
authorization will be required from any Governmental Authority or agency, regulatory or self-regulatory agency or other third party in
connection with the purchase of the Note and the Warrant and the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Investment Intent; Accredited Investor</U>. The Investor is purchasing the Note and the Warrant for its own account,
for investment purposes, and not with a view towards distribution. The Investor is an &ldquo;accredited investor&rdquo; as such term is
defined in Rule 501(a) of Regulation D of the 1933 Act. The Investor has, by reason of its business and financial experience, such knowledge,
sophistication and experience in financial and business matters and in making investment decisions of this type that it is capable of
(a) evaluating the merits and risks of an investment in the Note, the Warrant and the Investor Shares and making an informed investment
decision, (b) protecting its own interests and (c) bearing the economic risk of such investment for an indefinite period of time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.5<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Other Representations.</U> Except for the representations and warranties set forth in this Agreement and in other
Transaction Documents, the Investor makes no other representations or warranties to the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>5.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>OTHER AGREEMENTS OF THE PARTIES</B>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Legends, etc.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Securities may only be disposed of pursuant to an effective registration statement under the 1933 Act, to the Company or pursuant
to an available exemption from or in a transaction not subject to the registration requirements of the 1933 Act, and in compliance with
any applicable state securities laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Certificates evidencing the Securities will contain the following legend, so long as is required by this Section 5.1:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0in">[NEITHER THESE SECURITIES
NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN REGISTERED] WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. [THESE SECURITIES
AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES] [THESE SECURITIES] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Certificates evidencing the Investor Shares shall not contain any legend (including the legend set forth in Section 5.1(b)): (i)
while a Registration Statement is effective under the 1933 Act, (ii) following any sale of such Investor Shares pursuant to Rule 144,
(iii) while such Investor Shares are eligible for sale without restriction under Rule 144, or (iv) if such legend is not required under
applicable requirements of the 1933 Act (including judicial interpretations and pronouncements issued by the Staff of the SEC). The Company
shall cause its counsel to issue any legal opinion or instruction required by the Company&rsquo;s transfer agent to comply with the requirements
set forth in this Section. At such time as a legend is no longer required for the Investor Shares under this Section 5.1(c), the Company
will, no later than three (3) Business Days following the delivery by the Investor to the Company or the Company&rsquo;s transfer agent
of a certificate representing Investor Shares containing a restrictive legend (such third Business Day, the &ldquo;<B>Legend Removal Date</B>&rdquo;),
deliver or cause to be delivered to the Investor a certificate representing such Investor Shares that is free from all restrictive and
other legends. In addition to any other remedies available to the Investor, the Company shall pay to the Investor, in cash, as partial
liquidated damages and not as a penalty, for each $1,000 of Investor Shares (based on the VWAP of the Common Stock on the date such Investor
Shares are submitted to the Company or the Company&rsquo;s transfer agent) delivered for removal of the restrictive or other legend, $5
per Trading Day for each Trading Day after the Legend Removal Date until such Investor Shares are delivered without a legend. The Company
may not make any notation on its records or give instructions to any transfer agent of the Company that enlarge the restrictions on transfer
set forth in this Section except as it may reasonably determine are necessary or appropriate to comply or to ensure compliance with those
applicable laws that are enacted or modified after the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Furnishing of Information</U>. As long as the Investor owns the Securities, the Company covenants to timely file
(or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the 1934 Act. As long as the Investor owns the Securities, if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Investor and make publicly available in accordance with Rule 144(c) such information
as is required for the Investor to sell the Investor Shares under Rule 144. The Company further covenants that it will take such further
action as any holder of the Securities may reasonably request, all to the extent required from time to time to enable such Person to sell
such Investor Shares without registration under the 1933 Act within the limitation of the exemptions provided by Rule 144 or other applicable
exemptions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Integration</U>. The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the
1933 Act) that will be integrated with the offer or sale of the Securities in a manner that would require the registration under the 1933
Act of the sale of the Securities to the Investor, or that will be integrated with the offer or sale of the Securities for purposes of
the rules and regulations of any Trading Market that would require, under the rules of the Trading Market, the Stockholder Approval.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Notification of Certain Events</U>. The Company shall give prompt written notice to the Investor of (a) the occurrence
or non-occurrence of any Event, the occurrence or non-occurrence of which would render any representation or warranty of the Company contained
in this Agreement or any other Transaction Document, if made on or immediately following the date of such Event, untrue or inaccurate
in any material respect, (b) the occurrence of any Event that, individually or in combination with any other Events, has had or could
reasonably be expected to have a Material Adverse Effect, (c) any failure of the Company to comply with or satisfy any covenant or agreement
to be complied with or satisfied by it hereunder or any Event that would otherwise result in the nonfulfillment of any of the conditions
to the Investor&rsquo;s obligations hereunder, (d) any notice or other communication from any Person alleging that the consent of such
Person is or may be required in connection with the consummation of the transactions contemplated by this Agreement or any other Transaction
Document, or (e) any Proceeding pending or, to the Company&rsquo;s knowledge, threatened against a party relating to the transactions
contemplated by this Agreement or any other Transaction Document.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.5<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Available Stock</U>. The Company shall at all times keep authorized and reserved and available for issuance, free
of preemptive rights, such number of shares of Common Stock as are issuable upon repayment or conversion in full of the Note and exercise
in full of the Warrant at any time. If the Company determines at any time that it does not have a sufficient number of authorized shares
of Common Stock to reserve and keep available for issuance as described in this <U>Section 5.5</U>, the Company shall use all commercially
reasonable efforts to increase the number of authorized shares of Common Stock by seeking Stockholder Approval for the authorization of
such additional shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.6<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Use of Proceeds</U>. The Company will use the proceeds from the sale of the Note and the Warrant hereunder for working
capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment
of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common Stock
or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.7<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Repayment of Note</U>. If the Company or any Subsidiary issues any Indebtedness (other than the Note or any Permitted
Financing Arrangement), or issues any Preferred Stock, other than Exempted Securities, or makes a Permitted Disposition, unless otherwise
waived in writing by and at the discretion of the Investor, the Company will immediately (x) utilize the proceeds of such issuance to
repay the Note and (y) utilize 50% of the proceeds of any Permitted Disposition to repay the Note. If the Company issues any Equity Interests,
other than (a) Exempted Securities, (b) shares of Common Stock issued in an Acquisition, or (c) shares of Common Stock issued by the Company
in an offering in which the sole use of proceeds is funding an Acquisition, for aggregate cumulative gross proceeds to the Company or
any Subsidiary, as applicable, of greater than Fifteen Million Dollars ($15,000,000) while the Note remains outstanding, excluding offering
costs or other expenses, unless otherwise waived in writing by and at the discretion of the Investor, the Company will direct the lower
of (y) twenty percent (20%) of the proceeds from such issuance or (z) twenty percent of the then Outstanding Principal Amount (as such
term is defined in the Note), to repay the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.8<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Intercreditor Agreement</U>. In the event that: (i) the Company or any Subsidiary incurs debt or issues convertible
debt securities to a seller as full or partial consideration paid to such seller in connection with an Acquisition; and (ii) such debt
or convertible debt securities would otherwise constitute a Prohibited Transaction as defined herein, then, unless otherwise waived in
writing by the Investor, as a condition to consummation of such Acquisition, the holder of such debt or convertible debt securities shall
enter into an intercreditor agreement with the Company and the Investor on terms reasonably satisfactory to the Investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.9<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Prohibited Transactions</U>. The Company hereby covenants and agrees not to enter into any Prohibited Transactions
or incur any Indebtedness (other than a Permitted Financing Arrangement) without the Investor&rsquo;s prior written consent, until such
time as the Note has been repaid in full, as applicable, and/or has been converted into Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.10<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Securities Laws Disclosure; Publicity</U>. The Company shall, by 9:00 a.m. (New York City time) on the Trading Day
immediately following the date hereof, issue a press release disclosing the material terms of the transactions contemplated hereby (the
<B>&ldquo;Press Release&rdquo;</B>), and shall, within four (4) days following the date hereof, file a Current Report on Form 8-K (the
<B>&ldquo;Form 8-K&rdquo;</B>) disclosing the material terms of the transactions contemplated hereby and including this Agreement as an
exhibit thereto; provided, that the Company may not issue the Press Release without the Investor&rsquo;s prior written consent. The Company
shall provide a copy of the draft Form 8-K to the Investor for review prior to release and the Company shall incorporate the Investor&rsquo;s
reasonable comments. The Company shall not issue any press release nor otherwise make any such public statement regarding the Investor
or the Transaction Documents without the prior written consent of the Investor, except if such disclosure is made in a manner consistent
with the Press Release or Form 8-K, or is required by law, in which case the Company shall (a) ensure that such disclosure is restricted
and limited in content and scope to the maximum extent permitted by Law to meet the relevant disclosure requirement and (b) provide a
copy of the proposed disclosure to the Investor for review prior to release and the Company shall incorporate the Investor&rsquo;s reasonable
comments. Following the execution of this Agreement, the Investor and its Affiliates and/or advisors may place announcements on their
respective corporate websites and in financial and other newspapers and publications (including, without limitation, customary &ldquo;tombstone&rdquo;
advertisements) describing the Investor&rsquo;s relationship with the Company under this Agreement in a manner consistent with the Press
Release or Form 8-K and including the name and corporate logo of the Company. Notwithstanding anything herein to the contrary, to comply
with United States Treasury Regulations Section 1.6011-4(b)(3)(i), each of the Company and the Investor, and each employee, representative
or other agent of the Company or the Investor, may disclose to any and all persons, without limitation of any kind, the U.S. federal and
state income tax treatment, and the U.S. federal and state income tax structure, of the transactions contemplated hereby and all materials
of any kind (including opinions or other tax analyses) that are provided to such party relating to such tax treatment and tax structure
insofar as such treatment and/or structure relates to a U.S. federal or state income tax strategy provided to such recipient.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.11<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Indemnification of the Investor</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company will indemnify and hold the Investor, its Affiliates and their respective directors, officers, managers, shareholders,
members, partners, employees and agents and permitted successors and assigns (each, an &ldquo;<B>Investor Party</B>&rdquo;) harmless from
any and all damages, losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation and defense (collectively, &ldquo;<B>Losses</B>&rdquo;)
that any such Investor Party may suffer or incur as a result of or relating to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any breach or inaccuracy of any representation, warranty, covenant or agreement made by the Company in any Transaction Document;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any misrepresentation made by the Company in any Transaction Document or in any SEC Document;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any omission to state any material fact necessary in order to make the statements made in any SEC Document, in light of the circumstances
under which they were made, not misleading;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Proceeding before or by any court, public board, government agency, self-regulatory organization or body based upon, or resulting
from the execution, delivery, performance or enforcement of any of the Transaction Documents or the consummation of the transactions contemplated
thereby, and whether or not the Investor is party thereto by claim, counterclaim, crossclaim, as a defendant or otherwise, or if such
Proceeding is based upon, or results from, any of the items set forth in clauses (i) through (iii) above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other
expenses (including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith, as
such expenses are incurred.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The provisions of this <U>Section 5.11</U> shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.12<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Non-Public Information</U>. The Company covenants and agrees that neither it nor any other Person acting on its behalf
will provide the Investor or its agents or counsel with any information that the Company believes constitutes material, non-public information.
To the extent the Company provides the Investor with material, non-public information, the Company shall publicly disclose such information
within forty eight (48) hours of providing the information to the Investor; provided, however, in the event that such material non-public
information is provided to Investor pursuant to <U>Section 9</U>, the Company shall publicly disclose such information within five (5)
Business Days of providing the information to the Investor. The Company understands and confirms that the Investor shall be relying on
the foregoing representation in effecting transactions in securities of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.13<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Stockholder Approval</U>. The Company shall hold a special meeting of stockholders (which may also be at the annual
meeting of stockholders) on or before the 90th calendar day following the date hereof for the purpose of obtaining the Stockholder Approval;
provided, however, such ninety (90) calendar days shall be increased to one hundred twenty (120) calendar days in the event the Company
receives comments to its proxy statement from the SEC, with the recommendation of the Board of Directors that such proposal be approved,
and the Company shall solicit proxies from its stockholders in connection therewith in the same manner as all other management proposals
in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. If the Company does
not obtain Stockholder Approval at the first meeting, the Company shall call a meeting every four months thereafter to seek Stockholder
Approval until the date the Stockholder Approval is obtained.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.14<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Listing of Securities</U>. The Company shall: (a) in the time and manner required by each Trading Market on which
the Common Stock is listed, prepare and file with such Trading Market a Listing of Additional Shares form covering the Investor Shares,
(b)&nbsp;take all steps necessary to cause such shares to be approved for listing on each Trading Market on which the Common Stock is
listed as soon as possible thereafter, (c) provide to the Investor evidence of such Trading Market&rsquo;s completion of review of the
Listing of Additional Shares form, and (d) maintain the listing of such shares on each such Trading Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.15<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Antitrust Notification</U>. If the Investor determines, in its sole judgment and upon the advice of counsel, that
the issuance of the Note, the Warrant or the Investor Shares pursuant to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the &ldquo;<B>HSR Act</B>&rdquo;), the Company shall file as soon as practicable after
the date on which the Company receives notice from the Investor of the applicability of the HSR Act and a request to so file with the
United States Federal Trade Commission and the United States Department of Justice the notification and report form required to be filed
by it pursuant to the HSR Act in connection with such issuance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.16<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Short Sales</U>. Except as expressly set forth below, the Investor covenants that from and after the date hereof
through and ending when the Note and Warrant no longer remain outstanding (the &ldquo;<B>Restricted Period</B>&rdquo;), neither the Investor
nor any of its officers, or any entity managed or controlled by the Investor (collectively, the &ldquo;<B>Restricted Persons</B>&rdquo;
and each of the foregoing is referred to herein as a &ldquo;<B>Restricted Person</B>&rdquo;) shall, directly or indirectly, engage in
any &ldquo;short sale&rdquo; (as such term is defined in Rule 200 of Regulation SHO of the 1934 Act) of the Common Stock, either for its
own principal account or for the principal account of any other Restricted Person. Notwithstanding the foregoing, it is expressly understood
and agreed that nothing contained herein shall (without implication that the contrary would otherwise be true) prohibit any Restricted
Person during the Restricted Period from: (1)&nbsp;selling &ldquo;long&rdquo; (as defined under Rule 200 promulgated under Regulation
SHO) Common Stock; or (2)&nbsp;selling a number of shares of Common Stock equal to the number of underlying shares of Common Stock that
such Restricted Person is entitled to receive, but has not yet received from the Company or the transfer agent, upon (A) the completion
of a pending conversion of the Note for which (a) a valid Conversion Notice (as defined in the Note) has been submitted to the Company
pursuant to Section 3.1(a) of the Note or (b) a valid Prepayment Conversion Notice (as defined in the Note) has been submitted by the
Company pursuant to Section 1.4.2 of the Note; (B) the payment by the Company of any Repayment Amount in Repayment Shares, up to the total
amount of such Repayment Shares; or (C) the completion of a pending exercise of the Warrant for which a valid Exercise Notice (as defined
in the Warrant) has been submitted to the Company pursuant to Section 2.1 of the Warrant.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.17<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Share Transfer Agent</U>. The Company has informed the Investor of the name of its share transfer agent and represents
and warrants that the transfer agent participates in the Depository Trust Company Fast Automated Securities Transfer program. The Company
shall not change its share transfer agent without the prior written consent of the Investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.18<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Set-Off</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor may set off any of its obligations to the Company (whether or not due for payment), against any of the Company&rsquo;s
obligations to the Investor (whether or not due for payment) under this Agreement and/or any other Transaction Document.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Investor may do anything necessary to effect any set-off undertaken in accordance with this <U>Section 5.18</U> (including
varying the date for payment of any amount payable by the Investor to the Company).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.19<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Ongoing Compliance with Laws</U>. The Company and each of the Subsidiaries shall (a) conduct their respective businesses
in compliance in all material respects with all applicable Laws and (b) take all steps necessary to ensure that their continued performance
of the Transaction Documents and their obligations thereunder do not violate in any material respect any Law or any rule or regulation
of the Trading Market applicable to the Company or any of the Subsidiaries or by which any of their properties or assets are bound or
affected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.20<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Reverse Stock Split</U>. The Company shall, if and to the extent required to re-establish compliance with the minimum
bid price requirements of the Trading Market, and within the time permitted (including any extension thereof) by the Trading Market therefor,
call a meeting of the stockholders of the Company for purposes of approving a reverse stock split of the shares of Common Stock such that
the trade price of the Common Stock will be at least $2.00 (a &ldquo;<B>Reverse Split</B>&rdquo;) and, subject to receipt of stockholder
approval, shall use its best efforts to promptly effect a Reverse Split.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>6.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>CLOSING CONDITIONS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Conditions Precedent to the Obligations of the Investor</U>. The obligations of the Investor to fund the Note and
acquire the Warrant are subject to the satisfaction or waiver by the Investor, at or before the Closing Date, of each of the following
conditions:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Required Documentation</U>. The Company must have delivered to the Investor copies of all resolutions duly adopted by the Board
of Directors of the Company, or any such other documentation of the Company approving the Agreement, the Transaction Documents and any
of the transactions contemplated hereby or thereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consents and Permits</U>. The Company must have obtained and delivered to the Investor copies of all necessary permits, approvals,
and registrations necessary to effect this Agreement, the Transaction Documents and any of the transactions contemplated hereby or thereby,
including pursuant to <U>Section 3.14</U> of this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Trading Market Approval</U>. The Company shall have either (i) obtained and delivered to the Investor copies of all necessary
Trading Market approvals for the issuance of the Note, the Warrant, and, upon the conversion of the Note, the Conversion Shares, and upon
exercise of the Warrant, the Warrant Shares, or (ii) submitted a Listing of Additional Shares Notification Form with the Trading Market
relating to the issuance of the Note, the Warrant, and, upon conversion of the Note, the Conversion Shares, and upon exercise of the Warrant,
the Warrant Shares;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Event(s) of Default</U>. The Investor must be of the reasonable opinion that no Event of Default has occurred and no Event
of Default would result from the execution of this Agreement or any of the Transaction Documents or the transactions contemplated hereby
or thereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The representations and warranties of (a) the Company contained herein and (b) the Company
and each Subsidiary contained in any of the Security Documents shall, in each case, be true and correct in all material respects as of
the date when made and as of the Closing Date as though made on and as of such date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance</U>. The Company and each Subsidiary shall have performed, satisfied and complied in all material respects with
all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or
prior to such Closing;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or Governmental Authority of competent jurisdiction that prohibits the consummation of any of the
transactions contemplated by the Transaction Documents;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Suspensions of Trading in Common Stock; Listing</U>. Trading in the Common Stock shall not have been suspended by the SEC
or any Trading Market (except for any suspensions of trading of not more than one day on which the Trading Market is open solely to permit
dissemination of material information regarding the Company) at any time since the date of execution of this Agreement, and the Common
Stock shall have been at all times since such date listed for trading on a Trading Market;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Limitation on Beneficial Ownership</U>. The issuance of the Note and Warrant shall not cause the Investor Group to become, directly
or indirectly, a &ldquo;beneficial owner&rdquo; (within the meaning of Section 13(d) of the 1934 Act and the rules and regulations promulgated
thereunder) of a number of Equity Interests of a class that is registered under the 1934 Act which exceeds the Maximum Percentage of the
Equity Interests of such class that are outstanding at such time;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Perfection of Security Interest</U>. The Investor shall have, to its satisfaction, perfected the security interest granted in
the assets and collateral of the Company and its Subsidiaries described in the Security Documents;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Funds Flow Request</U>. The Company shall have delivered to the Investor a flow of funds request, substantially in the form
set out in <B><U>Exhibit D</U></B>; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer Agent Instructions</U>. The Company shall have delivered to the Investor a copy of the irrevocable instructions to
the Company&rsquo;s transfer agent instructing the Company&rsquo;s transfer agent to deliver the Investor Shares to the Investor upon
conversion of the Note or exercise of the Warrant, as applicable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Conditions Precedent to the Obligations of the Company</U>. The obligations of the Company to issue the Note and
the Warrant are subject to the satisfaction or waiver by the Company, at or before the Closing Date, of each of the following conditions:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The representations and warranties of the Investor contained herein shall be true and correct
in all material respects as of the date when made and as of the Closing Date as though made on and as of such date;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance</U>. The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Investor at or prior to the Closing;
and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or Governmental Authority of competent jurisdiction that prohibits the consummation of any of the
transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>7.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>EVENTS OF DEFAULT</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Events of Default</U>. The occurrence of any of the following events shall be an &ldquo;<B>Event of Default</B>&rdquo;
under this Agreement:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>an Event of Default (as defined in the Note);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any of the representations or warranties made by the Company, any Subsidiary or any of its agents, officers, directors, employees
or representatives in any Transaction Document or public filing being inaccurate, false or misleading in any material respect, as of the
date as of which it is made or deemed to be made, including as of any Closing Date, or any certificate or financial or other written statements
furnished by or on behalf of the Company or any Subsidiary to the Investor or any of its representatives, is inaccurate, false or misleading,
in any material respect, as of the date as of which it is made or deemed to be made, including as of any Closing Date; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a failure by the Company to comply with any of its covenants or agreements set forth in this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Investor Right to Investigate an Event of Default</U>. If in the Investor&rsquo;s reasonable opinion, an Event of
Default has occurred, or is or may be continuing:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Investor may notify the Company that it wishes to investigate such purported Event of Default;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall cooperate with the Investor in such investigation;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall comply with all reasonable requests made by the Investor to the Company in connection with any investigation
by the Investor and shall (i) provide all information requested by the Investor in relation to the Event of Default to the Investor; provided
that the Investor agrees that any materially price sensitive information and/or non-public information will be subject to confidentiality,
and (ii) provide all such requested information within three (3) Business Days of such request; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall pay all reasonable costs incurred by the Investor in connection with any such investigation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>7.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Remedies Upon an Event of Default</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If an Event of Default occurs pursuant to <U>Section 7.1(a)</U>, the Investor shall have such remedies as are set forth in the
Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If an Event of Default occurs pursuant to <U>Section 7.1(b)</U> or <U>Section&nbsp;7.1(c)</U> and is not remedied within (i) ten
(10) Business Days for an Event of Default occurring by the Company&rsquo;s or any Subsidiary&rsquo;s failure to comply with <U>Section
7.1(c)</U>, or (ii) ten (10) Business Days for an Event of Default occurring pursuant to <U>Section 7.1(b)</U>, the Investor may declare,
by notice to the Company or the applicable Subsidiary, effective immediately, all outstanding obligations by the Company or the applicable
Subsidiary under the Transaction Documents to be immediately due and payable in immediately available funds and the Investor shall have
no obligation to consummate any Closing under this Agreement or to accept the conversion of any Note into Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any Event of Default occurs and is not remedied within (i) two (2) Business Days for an Event of Default occurring by the Company&rsquo;s
failure to comply with <U>Section 7.1(c)</U>, or (ii) five (5) Business Days for an Event of Default occurring pursuant to <U>Section
7.1(b)</U>, the Investor may, by written notice to the Company, terminate this Agreement effective as of the date set forth in the Investor&rsquo;s
notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>8.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>TERMINATION</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Events of Termination</U>. This Agreement:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>may be terminated:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by the Investor on the occurrence or existence of Change of Control;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by the mutual written consent of the Company and the Investor, at any time;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by either Party, by written notice to the other Party, effective immediately, if the Closing has not occurred within ten (10) Business
Days of the date specified by this Agreement or such later date as the Company and the Investor agree in writing, provided that the right
to terminate this Agreement under this <U>Section 8.1(a)(iii)</U> is not available to any party that is in material breach of or material
default under this Agreement or whose failure to fulfill any obligation under this Agreement has been the principal cause of, or has resulted
in the failure of the Closing to occur; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by the Investor, in accordance with <U>Section 7.3(c)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Automatic Termination</U>. This Agreement will automatically terminate, without further action by the parties, at
the time after the Closing Date that is sixty (60) days after the Outstanding Principal Amount under the Note and any accrued but unpaid
interest is reduced to zero (0), whether as a result of Conversion or repayment by the Company in accordance with the terms of this Agreement
and the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>8.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Effect of Termination</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to <U>Section 8.3(b)</U>, each party&rsquo;s right of termination under <U>Section 8.1</U> is in addition to any other
rights it may have under this Agreement or otherwise, and the exercise of a right of termination will not be an election of remedies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Investor terminates this Agreement under <U>Section 8.1(a)(i)</U>:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Investor may declare, by notice to the Company, all outstanding obligations by the Company under the Transaction Documents
to be due and payable (including, without limitation, the immediate repayment of any Outstanding Principal Amount under the Note plus
accrued but unpaid interest) without presentment, demand, protest or any other notice of any kind all of which are expressly waived by
the Company, anything to the contrary contained in this Agreement or in any other Transaction Document notwithstanding; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company must within five (5) Business Days of such notice being received, pay to the Investor in immediately available funds
the Outstanding Principal Amount for the Note plus all accrued interest thereon (if any), unless the Investor terminates this Agreement
as a result of an Event of Default and provided that (A) subsequent to the termination under <U>Section 8.1(a)(i)</U>, the Investor is
not prohibited by Law or otherwise from exercising its conversion rights pursuant to this Agreement or the Note, (B) the Investor actually
exercises its conversion rights under this Agreement or the Note, and (C) the Company otherwise complies in all respects with its obligation
to issue Conversion Shares in accordance with the Note (which obligation will survive termination).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon termination of this Agreement, the Investor will not be required to fund any further amount after the date of termination
of the Agreement, provided that termination will not affect any undischarged obligation under this Agreement, and any obligation of the
Company to pay or repay any amounts owing to the Investor hereunder and which have not been repaid at the time of termination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing in this Agreement will be deemed to release any party from any liability for any breach by such party of the terms and
provisions of this Agreement or to impair the right of any party to compel specific performance by any other Party of its obligations
under this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>9.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>REGISTRATION RIGHTS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Registration</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registration Statement</U>. Promptly, but in any event no later than November 15, 2024, the Company shall prepare and file with
the SEC a Registration Statement covering the resale of all of the Investor Shares. The foregoing Registration Statement shall be filed
on Form S-3, or if Form S-3 is not available to the Company, Form S-1 or any successor forms thereto. The Registration Statement (and
each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to the Investor and
its counsel at least five (5) Business Days prior to its filing or other submission and the Company shall incorporate all reasonable comments
provided by the Investor or its counsel.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expenses</U>. Except as otherwise expressly provided herein, the Company will pay all fees and expenses incident to the performance
of or compliance with this <U>Section 9</U>, including all fees and expenses associated with effecting the registration of the Investor
Shares, including all filing and printing fees, the Company&rsquo;s counsel and accounting fees and expenses, costs associated with clearing
the Investor Shares for sale under applicable state securities laws, listing fees, fees and expenses of one counsel to the Investor and
the Investor&rsquo;s reasonable expenses in connection with the registration, but excluding discounts, commissions, fees of underwriters,
selling brokers, dealer managers or similar securities industry professionals with respect to the Investor Shares being sold.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effectiveness</U>. The Company shall use its commercially reasonable efforts to have the Registration Statement declared effective
as soon as practicable after filing thereof but in no event later than the date that is one hundred twenty (120) days following the Closing
Date. The Company shall notify the Investor by e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after
the Registration Statement is declared effective and shall simultaneously provide the Investor with copies of any related Prospectus to
be used in connection with the sale or other disposition of the securities covered thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Piggyback Registration Rights</U>. If the Company at any time determines to file a registration statement under the 1933 Act
to register the offer and sale, by the Company, of shares of Common Stock (other than (y) on Form S-4 or Form S-8 under the 1933 Act or
any successor forms thereto, or (z) a registration of securities solely relating to an offering and sale to employees or directors of
the Company pursuant to any employee stock plan or other employee benefit plan arrangement), the Company shall, as soon as reasonably
practicable, give written notice to the Investor of its intention to so register the offer and sale of shares of Common Stock and, upon
the written request, given within five (5) Business Days after delivery of any such notice by the Company, of the Investor to include
in such registration the Investor Shares (which request shall specify the number of Investor Shares proposed to be included in such registration),
the Company shall cause all such Investor Shares to be included in such registration statement on the same terms and conditions as the
shares of Common Stock otherwise being sold pursuant to such registered offering.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Company Obligations</U>. The Company will use its efforts to effect the registration of the Investor Shares in accordance
with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>use its commercially reasonable efforts to cause the Registration Statement to become effective and to remain continuously effective
for a period that will terminate upon the first date on which all Investor Shares are either covered by the Registration Statement or
may be sold without restriction, including volume or manner-of-sale restrictions, pursuant to Rule 144 or have been sold by the Investor
(the &ldquo;<B>Effectiveness Period</B>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>prepare and file with the SEC such amendments and post-effective amendments and supplements to the Registration Statement and the
Prospectus as may be necessary to keep the Registration Statement effective for the Effectiveness Period and to comply with the provisions
of the 1933 Act and the 1934 Act with respect to the distribution of all of the Investor Shares covered thereby;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>provide copies to and permit counsel designated by the Investor to review all amendments and supplements to the Registration Statement
no fewer than three (3) Business Days prior to its filing with the SEC and not file any document to which such counsel reasonably objects;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to the extent not publicly available on the SEC&rsquo;s EDGAR filing system, furnish to the Investor and its legal counsel, without
charge, (i) promptly after the same is prepared and publicly distributed, filed with the SEC, or received by the Company (but not later
than two (2) Business Days after the filing date, receipt date or sending date, as the case may be) one copy of the Registration Statement
and any amendment thereto, each preliminary prospectus and Prospectus and each amendment or supplement thereto, and each letter written
by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC,
in each case relating to the Registration Statement (other than any portion of any thereof which contains information for which the Company
has sought confidential treatment), and (ii) such number of copies of a Prospectus, including a preliminary prospectus, and all amendments
and supplements thereto and such other documents as the Investor may reasonably request in order to facilitate the disposition of the
Investor Shares that are covered by the related Registration Statement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>immediately notify the Investor of any request by the SEC for the amending or supplementing of the Registration Statement or Prospectus
or for additional information;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>use its commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and,
(ii) if such order is issued, obtain the withdrawal of any such order at the earliest possible moment and notify the Company of the issuance
of any such order and the resolution thereof, or its receipt of notice of the initiation or threat of any proceeding for such purpose;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>prior to any public offering of Investor Shares, use its commercially reasonable efforts to register or qualify or cooperate with
the Investor and its counsel in connection with the registration or qualification of such Investor Shares for offer and sale under the
securities or blue sky laws of such jurisdictions requested by the Investor and do any and all other commercially reasonable acts or things
necessary or advisable to enable the distribution in such jurisdictions of the Investor covered by the Registration Statement and the
Company shall promptly notify the Investor of any notification with respect to the suspension of the registration or qualification of
any of such Investor Shares for sale under the securities or blue sky laws of such jurisdictions or its receipt of notice of the initiation
or threat of any proceeding for such purpose;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>immediately notify the Investor, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening
of any event as a result of which, the Registration Statement or Prospectus includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of the Prospectus,
in light of the circumstances in which they were made), and promptly prepare, file with the SEC and furnish to such holder a supplement
to or an amendment of such Registration Statement or Prospectus as may be necessary so that such Registration Statement or Prospectus
shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading (in the case of such Prospectus, in light of the circumstances in which they were made);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the 1933
Act and the 1934 Act;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i) disclosure
of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary
to complete the Registration Statement or to avoid or correct a misstatement or omission in the Registration Statement, (iii) the release
of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent
jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement
or any other agreement, and upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental
body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of all Investor Shares pursuant
to the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Indemnification</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification by the Company</U>. The Company will indemnify and hold harmless the Investor Parties, from and against any
Losses to which they may become subject under the 1933 Act or otherwise, arising out of, relating to or based upon: (i) any untrue statement
or alleged untrue statement of any material fact contained in any Registration Statement, any preliminary Prospectus, final Prospectus
or other document, including any Blue Sky Application (as defined below), or any amendment or supplement thereof or any omission or alleged
omission of a material fact required to be stated therein or, in the case of the Registration Statement, necessary to make the statements
therein not misleading or, in the case of any preliminary Prospectus, final Prospectus or other document, necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading; (ii) any Blue Sky Application or other document executed
by the Company specifically for that purpose or based upon written information furnished by the Company filed in any state or other jurisdiction
in order to qualify any or all of the Investor Shares under the securities laws thereof (any such application, document or information
herein called a &ldquo;<B>Blue Sky Application</B>&rdquo;); (iii) any violation or alleged violation by the Company or its agents of the
1933 Act, the 1934 Act or any similar federal or state law or any rule or regulation promulgated thereunder applicable to the Company
or its agents and relating to any action or inaction required of the Company in connection with the registration or the offer or sale
of the Investor Shares pursuant to any Registration Statement; or (iv) any failure to register or qualify the Investor Shares included
in any such Registration Statement in any state where the Company or its agents has affirmatively undertaken or agreed in writing that
the Company will undertake such registration or qualification on the Investor&rsquo;s behalf and will reimburse the Investor Parties for
any legal or other expenses reasonably incurred by them in connection with investigating, preparing or defending any such Losses; provided,
however, that the Company will not be liable in any such case if and to the extent, but only to the extent, that any such Losses arise
out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information
furnished by the Investor or any such controlling Person in writing specifically for use in such Registration Statement or Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conduct of Indemnification Proceedings</U>. Any Person entitled to indemnification hereunder shall (i) give prompt notice to
the indemnifying party of any claim, action, suit or proceeding with respect to which it seeks indemnification following such Person&rsquo;s
receipt of, or such Person otherwise become aware of, the commencement of such claim, action, suit or proceeding and (ii) permit such
indemnifying party to assume the defense of such claim, action, suit or proceeding with counsel reasonably satisfactory to the indemnified
party; provided, however, that any Person entitled to indemnification hereunder shall have the right to employ separate counsel and to
participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (A)
the indemnifying party has agreed to pay such fees or expenses, (B) the indemnifying party shall have failed to assume the defense of
such claim and employ counsel reasonably satisfactory to such Person or (C) in the reasonable judgment of any such Person, based upon
written advice of its counsel, a conflict of interest exists between such Person and the indemnifying party with respect to such claims
(in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ separate counsel at the expense
of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person);
and provided, further, that the failure or delay of any indemnified party to give notice as provided herein shall not relieve the indemnifying
party of its obligations hereunder, except to the extent that such failure or delay to give notice shall materially adversely affect the
indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection
with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for
all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, consent to entry of any judgment
or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect of such claim or litigation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 45pt; text-align: justify; text-indent: 1.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Contribution</U>. If for any reason the indemnification provided for in the preceding paragraph (a) is unavailable to an indemnified
party or insufficient to hold it harmless, other than as expressly specified therein, the indemnifying party shall contribute to the amount
paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault
of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations. No Person guilty of fraudulent
misrepresentation within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution from any Person not guilty of
such fraudulent misrepresentation. The indemnity and contribution agreements contained in this Section are in addition to any other rights
or remedies that any indemnified party may have under applicable law, by separate agreement or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>10.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>RIGHTS TO FUTURE STOCK ISSUANCES.</B> Subject to the terms and conditions of this <U>Section 10</U> and applicable
securities laws, if at any time prior to the second anniversary of the Closing, the Company or any of its Subsidiaries proposes to offer
or sell any New Securities (a <B>&ldquo;Subsequent Financing&rdquo;</B>), the Company shall first offer the Investor the opportunity to
purchase up to twenty percent (20%) of such New Securities. The Investor shall be entitled to apportion the right of first offer hereby
granted to it in such proportions as it deems appropriate among itself and&nbsp;its Affiliates.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT>The Company shall give notice (the &ldquo;<B>Offer Notice</B>&rdquo;) to the Investor, stating (a) its (or a Subsidiary&rsquo;s,
as applicable) bona fide intention to offer such New Securities, (b) the number of such New Securities to be offered, and (c) the price
and terms, if any, upon which it proposes to offer such New Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT>By notification to the Company within one (1) day after the date the Offer Notice is given (the <B>&ldquo;Notice Termination
Time&rdquo;</B>), the Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice,
up to twenty percent (20%) of such New Securities. If the Company receives no such notice from the Investor as of such Notice Termination
Time, the Investor shall be deemed to have notified the Company that it does not elect to participate in such Subsequent Financing. The
closing of any sale pursuant to this <U>Section 10</U> shall occur within three (3) days of the earlier of (a) the date that the Offer
Notice is given and (b) the date of initial sale of New Securities pursuant to <U>Section&nbsp;10.3.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT>The Company or a Subsidiary, as applicable, may, during the three (3) day period following the expiration of the period
provided in <U>Section 10.2</U>, offer and sell the remaining portion of such New Securities to any Person or Persons at a price not less
than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT>The right of first offer in this <U>Section 10</U> shall not be applicable to Exempted Securities and shall be in accordance
with all applicable federal and state securities Laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>11.<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><U>GENERAL PROVISIONS</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.1<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Fees and Expenses</U>. Prior to the date of this Agreement, the Company has paid Morgan, Lewis &amp; Bockius LLP
$25,000. At the Closing, the Company shall reimburse the Investor up to an additional $50,000 in the aggregate of due diligence costs
and fees and disbursements of Morgan, Lewis &amp; Bockius LLP in connection with the preparation of the Transaction Documents, it being
understood that Morgan, Lewis &amp; Bockius LLP has not rendered any legal advice to the Company in connection with the transactions contemplated
hereby and that the Company has relied for such matters on the advice of its own counsel. Except as specified above, each party shall
pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents. The Company shall pay all
Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the
Company and any exercise notice delivered by the Investor), stamp taxes and other taxes and duties levied in connection with the delivery
of any Securities to the Investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.2<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via email at the email address specified in this Section prior to 5:00 p.m. (New York time) on a Business Day, (b) the next
Business Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in
this Section on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New
York time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (d) upon actual receipt by the party to whom such notice is required to be given. Subject to <U>Section 11.4</U>, the address for such
notices and communications shall be as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 1.5in">Red Cat Holdings, Inc.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 1.5in">15 Ave. Munoz Rivera, Ste. 2200</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 1.5in">San Juan, PR 00901</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 1.5in">Telephone: (833) 373-3228</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">Email: leah@redcat.red<BR>
Attention: Leah Lunger</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Email: Sam.pelletier@redcat.red</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">Attention: Sam Pelletier</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">If to the Investor:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Lind Global Asset Management X LLC<BR>
c/o The Lind Partners LLC<BR>
444 Madison Avenue, Floor 41<BR>
New York, NY 10022<BR>
Telephone: (646) 395-3931<BR>
Email: jeaston@thelindpartners.com and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in; text-indent: 0.5in">notice@thelindpartners.com<BR>
Attention: Jeff Easton</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">Morgan, Lewis &amp; Bockius LLP<BR>
One Federal Street<BR>
Boston, MA 02110<BR>
Telephone: (617) 341-7269<BR>
Email: bryan.keighery@morganlewis.com<BR>
Attention: Bryan S. Keighery</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">or such other address as may be designated
in writing hereafter, in the same manner, by such Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.3<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Severability</U>. If any provision of this Agreement is held by a court of competent jurisdiction to be excessive
in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable
to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Agreement will not in any way
be affected or impaired thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.4<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of
Delaware, without reference to principles of conflict of laws or choice of laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.5<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Jurisdiction and Venue</U>. Any action, proceeding or claim arising out of, or relating in any way to this Agreement
shall be brought and enforced in the state or federal courts located in New Castle County, Delaware. The Company and the Investor irrevocably
submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection to such exclusive jurisdiction
or that such courts represent an inconvenient forum. Each party hereto agrees that it may be served with legal process in the State of
Delaware at the following address: (a) for the Investor, c/o Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware
19808 and (b) for the Company, c/o Vcorp Services, LLC, 1013 Centre Road, Suite 403-B, Wilmington, Delaware 19805. The prevailing party
in any such action shall be entitled to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating
to such action or proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.6<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>WAIVER OF RIGHT TO JURY TRIAL</U>. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER
TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.7<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Survival</U>. The representations, warranties, agreements and covenants contained herein shall survive the Closing
and the delivery of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.8<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Entire Agreement</U>. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.9<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Amendments; Waivers</U>. No provision of this Agreement may be waived or amended except in a written instrument signed
by the Company and the Investor. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise
of any such right.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.10<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Construction</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen
by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall
be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party
by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.11<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Successors and Assigns</U>. This Agreement shall be binding upon, and inure to the benefit of and be enforceable
by, the Company and the Investor and their respective successors and assigns. The Company may not assign this Agreement or any rights
or obligations hereunder without the prior written consent of the Investor. The Investor may assign any or all of its rights under this
Agreement to any Person to whom the Investor assigns or transfers any Securities, provided such transferee agrees in writing to be bound,
with respect to the transferred Securities, by the provisions hereof that apply to the &ldquo;Investor&rdquo; and such transferee is an
accredited investor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.12<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.13<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Further Assurances</U>. Each party hereto shall do and perform, or cause to be done and performed, all such further
acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party
may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.14<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Counterparts</U>. This Agreement may be executed in two identical counterparts, both of which shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.
Signature pages delivered by facsimile or e-mail shall have the same force and effect as an original signature.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>11.15<FONT STYLE="font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><U>Specific Performance</U>. The Company acknowledges that monetary damages alone would not be adequate compensation
to the Investor for a breach by the Company of this Agreement and the Investor may seek an injunction or an order for specific performance
from a court of competent jurisdiction if (a) the Company fails to comply or threatens not to comply with this Agreement or (b) the Investor
has reason to believe that the Company will not comply with this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page Follows]</I></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
undersigned have executed this Securities Purchase Agreement as of the date first set forth above.</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 12pt Times New Roman, Times, Serif">
  <TR>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: justify; width: 43%">COMPANY:</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom; width: 17%">&nbsp;</TD>
    <TD STYLE="font-weight: bold; vertical-align: middle; text-align: justify; width: 40%">INVESTOR:</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: justify">RED CAT HOLDINGS, INC.</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">Lind GLOBAL ASSET MANAGEMENT X LLC</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">By: ____________________________</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">By: __________________________</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">Name:&nbsp;</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">Name: Jeff Easton</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; text-align: justify">Title:</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; text-align: justify">Title: Authorized Person</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>FORM OF SECURITY AGREEMENT</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>FORM OF NOTE</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[See attached]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT C</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>FORM OF WARRANT</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[See attached]</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><B><U>EXHIBIT D</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>FLOW OF FUNDS REQUEST</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Red Cat Holdings, Inc. &ndash; Securities Purchase Agreement &ndash; Flow
of Funds Request</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">In connection with the Securities Purchase Agreement, dated September __,
2024 (the &ldquo;Agreement&rdquo;) between Red Cat Holdings, Inc. (the &ldquo;Company&rdquo;) and Lind Global Asset Management X LLC (the
&ldquo;Investor&rdquo;), the Company irrevocably authorizes the Investor to distribute such funds as set out below, in the manner set
out below, at the Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Capitalized terms used but not otherwise defined in this letter will have
the meaning given to such terms in the Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 71%; border: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><B><I>Item</I></B></TD>
    <TD STYLE="width: 29%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><B><I>Amount</I></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Commitment Fee</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">$[&bull;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">Total</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">$[&bull;]</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Please transfer the net amount of US $[&bull;] due at the Closing, to the
following bank account:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 20%; border-collapse: collapse; font: 11pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: middle">
    <TD COLSPAN="2"><FONT STYLE="line-height: 106%">Routing #:</FONT></TD>
    <TD STYLE="font-size: 12pt">[&bull;]</TD></TR>
  <TR STYLE="vertical-align: middle">
    <TD COLSPAN="2"><FONT STYLE="line-height: 106%">Account #</FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; width: 34%"><FONT STYLE="line-height: 106%">FBO:&nbsp;</FONT></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom; width: 33%">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; vertical-align: middle; width: 33%"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; vertical-align: middle"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; vertical-align: middle"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle"><FONT STYLE="line-height: 106%">Bank:</FONT></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; vertical-align: middle"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 12pt; vertical-align: middle"><FONT STYLE="line-height: 106%">[&bull;]</FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 12pt; vertical-align: middle">[&bull;]</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Yours sincerely,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>RED CAT HOLDINGS, INC.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">By: ______________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Name</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Title</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>rcat0923form10qexh10_8.htm
<DESCRIPTION>EXHIBIT 10.8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.8</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="letter-spacing: -0.3pt"><B>THIS
NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT
BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION..</B></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">RED CAT HOLDINGS, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-weight: normal">Form of Senior
Secured<BR>
Convertible Promissory<BR>
Note due [&bull;], 2026</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><FONT STYLE="font-weight: normal"></FONT></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left; width: 43%">Note No. [&bull;]</TD>
    <TD STYLE="font: 11pt Aptos Narrow; vertical-align: bottom; width: 17%">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: right; width: 40%">$9,600,000</TD></TR>
  <TR STYLE="vertical-align: middle">
    <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">Dated: [&bull;], 2024 (the &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; font-style: normal; font-weight: 400"><U>Issuance Date</U>&rdquo;)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><FONT STYLE="font-weight: normal"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For value received, RED CAT HOLDINGS,
INC., a Nevada corporation (the &ldquo;<U>Maker</U>&rdquo; or the &ldquo;<U>Company</U>&rdquo;), hereby promises to pay to the order of
Lind Global Asset Management X LLC, a Delaware limited liability company (together with its successors and representatives, the &ldquo;<U>Holder</U>&rdquo;),
in accordance with the terms hereinafter provided, the principal amount of NINE MILLION SIX HUNDRED THOUSAND DOLLARS ($9,600,000) (the
&ldquo;<U>Principal Amount</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">All payments under or pursuant
to this Senior Secured Convertible Promissory Note (this <FONT STYLE="letter-spacing: 0.1pt">&ldquo;<U>Note</U>&rdquo;) </FONT>shall be
made in United States Dollars in immediately available funds to the Holder at the address of the Holder set forth in the Purchase Agreement
(as hereinafter defined) or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer
of funds to the Holder&rsquo;s account, instructions for which are attached hereto as <FONT STYLE="letter-spacing: -0.25pt"><U>Exhibit
</U></FONT><U>A</U>. The Outstanding Principal Amount of this Note shall be due and payable on [&bull;], 2026 (the &ldquo;<U>Maturity
Date</U>&rdquo;) or at such earlier time as provided herein; provided, that the Holder, in its sole discretion, may extend the Maturity
Date to any date after the original Maturity Date. In the event that the Maturity Date shall fall on Saturday or Sunday, such Maturity
Date shall be the next succeeding Business Day. All calculations made pursuant to this Note shall be rounded down to two decimal places.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
1&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Purchase Agreement</U>. </FONT><FONT STYLE="letter-spacing: 0.25pt">This Note </FONT><FONT STYLE="letter-spacing: 0.2pt">has
</FONT><FONT STYLE="letter-spacing: 0.25pt">been </FONT>executed <FONT STYLE="letter-spacing: 0.2pt">and </FONT>delivered pursuant <FONT STYLE="letter-spacing: 0.15pt">to
</FONT><FONT STYLE="letter-spacing: 0.2pt">the Securities P</FONT>urchase Agreement, <FONT STYLE="letter-spacing: 0.25pt">dated </FONT><FONT STYLE="letter-spacing: 0.15pt">as
</FONT><FONT STYLE="letter-spacing: 0.35pt">of September __, 2024</FONT> (as the same may be amended from time to time, the <FONT STYLE="letter-spacing: 0.1pt">&ldquo;<U>Purchase</U></FONT><U>
Agreement</U>&rdquo;), by and between the Maker and the Holder. <FONT STYLE="letter-spacing: 0.1pt">Capitalized terms used </FONT>and
not <FONT STYLE="letter-spacing: 0.1pt">otherwise defined herein shall have </FONT>the <FONT STYLE="letter-spacing: 0.1pt">meanings </FONT>set
<FONT STYLE="letter-spacing: 0.1pt">forth </FONT>for <FONT STYLE="letter-spacing: 0.1pt">such terms </FONT>in the <FONT STYLE="letter-spacing: 0.15pt">Purchase
</FONT>Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Interest</U>. Other than as set forth in <U>Section 2.2</U> herein, this Note shall not
bear interest.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Principal Installment Payments</U>. Commencing on the date that one hundred eighty (180) days from the Issuance Date, unless
the Maker and Holder mutually consent to an earlier date, the Maker shall pay to the Holder the Outstanding Principal Amount hereunder
in eighteen (18) consecutive monthly installments, on such date and each one (1) month anniversary thereof (each, a &ldquo;<U>Payment
Date</U>&rdquo; and collectively the &ldquo;<U>Monthly Payments</U>&rdquo;), an amount equal to Five Hundred Thirty-Three Thousand Three
Hundred Thirty Four Dollars ($533,334) (the &ldquo;<U>Repayment Amount</U>&rdquo;), until the Outstanding Principal Amount has been paid
in full prior to or on the Maturity Date or, if earlier, upon acceleration, conversion or redemption of this Note in accordance with the
terms herein; provided, that, between Payment Dates, if the Company&rsquo;s Market Capitalization is at least Fifty Million Dollars ($50,000,000),
the Maker may increase the Repayment Amount, to up to One Million Dollars ($1,000,000) by providing written notice of the amount of such
increase to the Holder as described below, such payment to be due and payable by the Maker within one (1) day of the receipt of such notice,
unless the Maker&rsquo;s Market Capitalization falls below Fifty Million Dollars ($50,000,000) prior to the delivery of the Repayment
Shares to the Holder, in which case the Holder may, in its sole discretion deliver notice to the Maker one (1) day prior to the Payment
Date that the Repayment Amount shall revert to Five Hundred Thirty-Three Thousand Three Hundred Thirty Four Dollars ($533,334); provided,
further, that the Maker and Holder may mutually consent to increase the Repayment Amount in any month while this Note is outstanding.
In addition, between Payment Dates, if the Repayment Share Price (as defined below) is equal to or greater than ($2.00), the Holder may
increase the Repayment Amount, to up to One Million Three Hundred Thousand Dollars ($1,300,000) by providing written notice to the Maker
of the amount of such increase, such payment to be due and payable by the Maker within one (1) day of the receipt of such notice, for
two (2) Monthly Payments while the Note is outstanding. The Monthly Payments shall, at the Maker&rsquo;s option, be made in (i) cash,
in the amount equal to the product of Monthly Payment multiplied by 1.025, (ii) Repayment Shares (as defined below), or (iii) a combination
of cash and Repayment Shares; provided that the number of Repayment Shares shall be determined by dividing the Principal Amount being
paid in shares of Common Stock by the Repayment Share Price; provided, however, that, unless waived in writing in advance by the Holder,
no portion of the Principal Amount may be paid in Repayment Shares unless such Repayment Shares (A) may be immediately resold under Rule
144 without restriction on the number of shares to be sold or manner of sale, or (B) are registered for resale under the 1933 Act and
the registration statement is in effect and lawfully usable to effect immediate sales of such Repayment Shares by the Holder. The Company
must provide advance written notice to the Holder of whether it will elect to pay a Monthly Payment in cash, Repayment Shares or a combination
thereof, and whether it elects to increase the Repayment Amount to up to One Million Dollars ($1,000,000), provided that the Company&rsquo;s
Market Capitalization is at least Fifty Million Dollars ($50,000,000), as follows: (i) with respect to the first Monthly Payment, at least
twenty (20) days before the Payment Date, and (ii) with respect to each Monthly Payment thereafter, within three (3) Business Days of
the prior Payment Date; provided, however, that if no such notice is provided within the timeframes set forth above, such Monthly Payments
shall be made in cash.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayment.</U>&#9;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">1.4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>After the earlier to occur of (a) the date the Registration Statement is declared effective by the SEC or (b) the date that any
shares issued pursuant to this Note may be immediately resold under Rule 144 without restriction on the number of shares to be sold or
manner of sale, the Maker may repay all, but not less than all, of the then Outstanding Principal Amount upon delivering a Prepayment
Notice on any Business Day (a &ldquo;<U>Prepayment Date</U>&rdquo;), for an amount equal to the Prepayment Amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">1.4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Maker elects to prepay this Note pursuant to this <U>Section 1.4</U>, the Holder shall have the right, upon written notice
to the Maker (a &ldquo;<U>Prepayment Conversion Notice</U>&rdquo;) within five (5) Business Days of the Holder&rsquo;s receipt of a Prepayment
Notice, to convert up to twenty five percent (25%) of the Principal Amount (the &ldquo;<U>Maximum Amount</U>&rdquo;) at the lesser of
the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than Two Dollars ($2.00) or the Conversion Price
(as defined below), in accordance with the provisions of Article 3, specifying the Principal Amount (up to the Maximum Amount) that the
Holder will convert. Upon delivery of a Prepayment Notice, the Maker irrevocably and unconditionally agrees to, within five (5) Business
Days of receiving a Prepayment Conversion Notice, and if no Prepayment Conversion Notice is received, within ten (10) Business Days of
delivery of a Prepayment Notice: (i) repay the amount of the Prepayment Amount minus the Principal Amount set forth in the Prepayment
Conversion Notice and (ii) issue the applicable Conversion Shares to the Holder in accordance with Article 3, as applicable. The foregoing
notwithstanding, the Maker may not deliver a Prepayment Notice with respect to any Outstanding Principal Amount that is subject to a Conversion
Notice delivered by the Holder in accordance with Article 3.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delisting from a Trading Market.</U> If at any time the Common Stock ceases to be listed on a Trading Market, (i) the Holder
may deliver a demand for payment to the Company and, if such a demand is delivered, the Company shall, within ten (10) Business Days following
receipt of the demand for payment from the Holder, pay all of the Outstanding Principal Amount or (ii) the Holder may, at its election,
after the six-month anniversary of the Issuance Date or earlier if a Registration Statement covering the Conversion Shares has been declared
effective, upon notice to the Company in accordance with <U>Section&nbsp;5.1</U>, convert all or a portion of the Outstanding Principal
Amount and the Conversion Price shall be adjusted to the lower of (A) the then-current Conversion Price and (A) eighty-five percent (85%)
of the average of the three (3) lowest daily VWAPs during the twenty (20) Trading Days prior to delivery by the Holder of its notice of
conversion pursuant to this <U>Section 1.5</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment on Non-Business Days</U>. Whenever any payment to be made shall be due on a day which is not a Business Day, such payment
may be due on the next succeeding Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer</U>. This Note <FONT STYLE="letter-spacing: 0.1pt">may </FONT>be transferred or sold, subject to <FONT STYLE="letter-spacing: 0.1pt">the
</FONT>provisions of <U>Section 5.8</U> of this Note, or pledged, hypothecated <FONT STYLE="letter-spacing: 0.2pt">or </FONT>otherwise
granted as security by the Holder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Replacement</U>. <FONT STYLE="letter-spacing: 0.1pt">Upon receipt </FONT>of a <FONT STYLE="letter-spacing: 0.1pt">duly executed
and notarized written statement from </FONT>the <FONT STYLE="letter-spacing: 0.1pt">Holder with respect </FONT>to the <FONT STYLE="letter-spacing: 0.15pt">loss,
</FONT>theft or destruction of this Note (or any replacement hereof), or, in the case of a mutilation of this Note, upon surrender and
cancellation of such Note, the Maker shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or mutilated
Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U>. The Maker shall use the proceeds of this Note as set forth in the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: 0.2pt">1.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Status </U></FONT><U>of <FONT STYLE="letter-spacing: 0.15pt">Note</FONT> <FONT STYLE="letter-spacing: 0.2pt">and Security Interest</FONT></U><FONT STYLE="letter-spacing: 0.2pt">.
The obligations of the Maker under this Note shall be senior to all other existing Indebtedness and equity of the Company. Upon any Liquidation
Event (as hereinafter defined), the Holder will be entitled to receive, before any distribution or payment is made upon, or set apart
with respect to, any Indebtedness of the Maker, or any class of capital stock of the Maker, an amount equal to the Outstanding Principal
Amount. For purposes of this Note, &ldquo;Liquidation Event&rdquo; means a liquidation pursuant to a filing of a petition for bankruptcy
under applicable law or any other insolvency or debtor&rsquo;s relief, an assignment for the benefit of creditors, or a voluntary or involuntary
liquidation, dissolution or winding up of the affairs of the Maker. Notwithstanding the foregoing, to the extent after the date hereof
the Maker desires to enter into a Permitted Financing Arrangement, upon the execution and delivery of the applicable Subordination Agreement
relating thereto, the Holder&rsquo;s security interest in the applicable Excluded Assets shall be subordinated to the extent provided
in the relevant Subordination Agreement(s).</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Secured Note; Guarantee</U>. The full amount of this Note is (a) secured by the Collateral (as defined in the Security Agreement)
identified and described as security therefor in the Security Agreement (the &ldquo;Collateral&rdquo;); (b) guaranteed by the Guarantors;
and (c) secured by the Collateral (as defined in the Guarantor Security Agreement) identified and described as security therefor in the
Guarantor Security Agreement (the &ldquo;Guarantor Collateral&rdquo;). .</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cash Payment</U>. At the option of the Holder, if in connection with a conversion under this Note, the Repayment Share Price
is deemed to be the Floor Price, then in addition to issuing the Repayment Shares at the Floor Price, the Maker will also pay to the Holder,
within two (2) Business Days of the Payment Date, a cash amount equal to the following formula:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 85.5pt; text-align: justify; text-indent: 0in">(A &ndash; B) x C</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 85.5pt; text-align: justify; text-indent: 0in">Where:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 85.5pt; text-align: justify; text-indent: 0in">A = Number of shares
of Common Stock that would be issued to the Holder on such Payment Date determined by dividing the Repayment Amount being paid in shares
of Common Stock by ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs during the twenty (20) Trading Days
prior to the applicable Payment Date (notwithstanding the Floor Price);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 85.5pt; text-align: justify; text-indent: 0in">B = Number of Repayment
Shares issued to the Holder in connection with such Payment Date; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 85.5pt; text-align: justify; text-indent: 0in">C = the VWAP on the
Payment Date.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
2&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Events of Default</U>. An &ldquo;<U>Event of Default</U>&rdquo; under this Note shall mean the occurrence of any of the events
defined in the Purchase Agreement, and any of the additional events described below:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any <FONT STYLE="letter-spacing: 0.1pt">default </FONT>in the <FONT STYLE="letter-spacing: 0.1pt">payment </FONT>of (i) the Principal
Amount <FONT STYLE="letter-spacing: 0.1pt">or any accrued and unpaid interest hereunder when due, or any principal or interest owing under
any other Note; </FONT>or (ii)&nbsp;liquidated damages in respect of this Note or any other Note as and when the same shall become due
and payable (whether on the Maturity Date or by acceleration or otherwise), provided, to the extent the Investor demands repayment of
the entire Outstanding Principal Balance under this Note (which, for the avoidance of doubt does not include the Outstanding Principal
Balance becoming automatically due and payable as a result of any Event of Default as described in clauses (j) and (k) below), and so
long as no other creditor has taken any remedial action against the Company or any Subsidiary, the Investor shall not exercise its remedies
against the Company for ten (10) days from the date of such demand;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Reserved;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Maker&rsquo;s notice to the Holder, including by way of public announcement, at any time, of its inability to comply (including
<FONT STYLE="letter-spacing: 0.1pt">for any </FONT>of <FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">reasons
described </FONT>in <FONT STYLE="letter-spacing: 0.15pt"><U>Section 3.6(a)</U> hereof) </FONT>or <FONT STYLE="letter-spacing: 0.1pt">its
</FONT><FONT STYLE="letter-spacing: 0.15pt">intention </FONT><FONT STYLE="letter-spacing: 0.1pt">not </FONT>to <FONT STYLE="letter-spacing: 0.15pt">comply
with proper requests </FONT><FONT STYLE="letter-spacing: 0.1pt">for </FONT><FONT STYLE="letter-spacing: 0.15pt">conversion </FONT>of <FONT STYLE="letter-spacing: 0.15pt">this
Note </FONT><FONT STYLE="letter-spacing: 0.2pt">into </FONT>shares of Common Stock;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Maker shall fail to (i) timely deliver the shares of Common Stock as and when required in <U>Section 3.2</U>; or (ii) make
the payment of any fees and/or liquidated damages under this Note, the Purchase Agreement or the other Transaction Documents;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&#9;the Maker or any Subsidiary shall fail to observe or perform, or any other default shall be made in the performance or observance
of any covenant, condition or agreement contained in this Note, <FONT STYLE="letter-spacing: 0.15pt">the </FONT>Purchase Agreement or
any other Transaction Document that is not covered by any other provisions of this <U>Section 2.1</U>, which failure shall continue and
remain uncured for a period of ten (10) or more days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.1pt">at </FONT><FONT STYLE="letter-spacing: 0.15pt">any time </FONT><FONT STYLE="letter-spacing: 0.2pt">the
Maker shall </FONT><FONT STYLE="letter-spacing: 0.15pt">fail </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.15pt">have
</FONT>a <FONT STYLE="letter-spacing: 0.2pt">sufficient number </FONT><FONT STYLE="letter-spacing: 0.1pt">of </FONT><FONT STYLE="letter-spacing: 0.2pt">shares
of Common Stock</FONT> authorized, reserved and available for issuance to satisfy the potential conversion in full (disregarding for this
purpose any and all <FONT STYLE="letter-spacing: 0.25pt">limitations </FONT><FONT STYLE="letter-spacing: 0.15pt">of </FONT><FONT STYLE="letter-spacing: 0.2pt">any
kind </FONT><FONT STYLE="letter-spacing: 0.15pt">on </FONT><FONT STYLE="letter-spacing: 0.2pt">such </FONT><FONT STYLE="letter-spacing: 0.25pt">conversion)
</FONT><FONT STYLE="letter-spacing: 0.15pt">of </FONT><FONT STYLE="letter-spacing: 0.2pt">this Note or upon exercise of the Warrant, </FONT>which
failure shall continue and remain uncured for a period of ten (10) or more days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any representation or warranty made by the Maker or any of its Subsidiaries herein or in the Purchase Agreement, this Note, the
Warrant or any other Transaction Document shall prove to have been false or incorrect or breached in a material respect on the date as
of which made;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>unless otherwise approved in writing in advance by the Holder, the Maker shall, or shall announce an intention to pursue or consummate
a Change of Control, or a Change of <FONT STYLE="letter-spacing: 0.1pt">Control shall </FONT>be <FONT STYLE="letter-spacing: 0.1pt">consummated,
</FONT>or the <FONT STYLE="letter-spacing: 0.1pt">Maker shall negotiate, propose </FONT>or <FONT STYLE="letter-spacing: 0.1pt">enter into
</FONT>any <FONT STYLE="letter-spacing: 0.1pt">agreement, understanding </FONT>or <FONT STYLE="letter-spacing: 0.1pt">arrangement with
respect </FONT><FONT STYLE="letter-spacing: 0.15pt">to </FONT>any Change of Control;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Maker or any of its Subsidiaries (including, without limitation any Guarantor) shall (A) default in any payment of any amount
or amounts of principal of or interest (if any) on any <FONT STYLE="letter-spacing: 0.15pt">Indebtedness other than </FONT><FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">Indebtedness hereunder (&ldquo;<U>Other Indebtedness</U>&rdquo;), </FONT><FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">aggregate </FONT><FONT STYLE="letter-spacing: 0.2pt">principal </FONT><FONT STYLE="letter-spacing: 0.15pt">amount
</FONT>of <FONT STYLE="letter-spacing: 0.15pt">which Other Indebtedness </FONT>is in <FONT STYLE="letter-spacing: 0.15pt">excess </FONT>of
<FONT STYLE="letter-spacing: 0.15pt">$250,000 or </FONT><FONT STYLE="letter-spacing: 0.1pt">(B) </FONT><FONT STYLE="letter-spacing: 0.15pt">default
</FONT>in <FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">observance </FONT>or <FONT STYLE="letter-spacing: 0.15pt">performance
</FONT>of <FONT STYLE="letter-spacing: 0.1pt">any </FONT><FONT STYLE="letter-spacing: 0.15pt">other agreement </FONT>or <FONT STYLE="letter-spacing: 0.2pt">condition
</FONT><FONT STYLE="letter-spacing: 0.1pt">relating </FONT>to any <FONT STYLE="letter-spacing: 0.1pt">such Other Indebtedness </FONT>or
<FONT STYLE="letter-spacing: 0.1pt">contained </FONT>in any <FONT STYLE="letter-spacing: 0.1pt">instrument </FONT>or <FONT STYLE="letter-spacing: 0.1pt">agreement
evidencing, securing </FONT>or <FONT STYLE="letter-spacing: 0.1pt">relating thereto, </FONT>or any <FONT STYLE="letter-spacing: 0.1pt">other
event </FONT><FONT STYLE="letter-spacing: 0.15pt">shall </FONT><FONT STYLE="letter-spacing: 0.1pt">occur </FONT>or <FONT STYLE="letter-spacing: 0.1pt">condition
exist, </FONT>the <FONT STYLE="letter-spacing: 0.1pt">effect </FONT>of <FONT STYLE="letter-spacing: 0.1pt">which default </FONT>or <FONT STYLE="letter-spacing: 0.1pt">other
event </FONT>or <FONT STYLE="letter-spacing: 0.1pt">condition </FONT>is to <FONT STYLE="letter-spacing: 0.1pt">cause, </FONT>or to <FONT STYLE="letter-spacing: 0.1pt">permit
</FONT>the <FONT STYLE="letter-spacing: 0.1pt">holder </FONT>or <FONT STYLE="letter-spacing: 0.1pt">holders </FONT>or <FONT STYLE="letter-spacing: 0.1pt">beneficiary
</FONT><FONT STYLE="letter-spacing: 0.15pt">or </FONT>beneficiaries of such Other Indebtedness to cause with the giving of notice if required,
such Other Indebtedness to become due prior to its stated maturity, provided that such default under the Other Indebtedness shall continue
and remain uncured beyond any applicable grace or cure periods provided therein, <U>however:</U> (a) upon any maturity (whether by acceleration
or otherwise) of any obligations under any Other Indebtedness, the Holder shall have the right to declare all amounts and other obligations
due under any Transaction Document to be immediately due and payable (at which point all such amounts and obligations shall be immediately
due and payable); and (b) in the event that the holder of the Other Indebtedness has declared all or any portion of the obligations owing
thereunder due and payable and then the applicable default giving rise to such amounts becoming due and payable under the Other Indebtedness
is cured or waived in writing and the holder(s) of such Other Indebtedness have fully rescinded the acceleration of the maturity of all
or any portion of the obligations arising under the Other Indebtedness which had been accelerated such that the obligations with respect
to such Other Indebtedness are no longer due and payable and are due and payable in accordance with the terms prior to the occurrence
of any default thereunder, to the extent the Holder has declared all amounts and other obligations under any Transaction to be immediately
due solely as a result of a default occurring under this clause (i) and so long as no other Event of Default has occurred and is continuing,
the acceleration of the Maturity Date under this Note shall also be rescinded (provided, the Investor shall have no liability to the Company
or any Subsidiary for any remedial actions taken by the Investor which commenced prior to such recission);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the <FONT STYLE="letter-spacing: 0.1pt">Maker </FONT>or any of its <FONT STYLE="letter-spacing: 0.1pt">Subsidiaries </FONT>(including,
without limitation any Guarantor) <FONT STYLE="letter-spacing: 0.1pt">shall: </FONT>(i) <FONT STYLE="letter-spacing: 0.1pt">apply </FONT>for
or <FONT STYLE="letter-spacing: 0.1pt">consent </FONT>to the <FONT STYLE="letter-spacing: 0.1pt">appointment </FONT>of, or the <FONT STYLE="letter-spacing: 0.1pt">taking
</FONT>of <FONT STYLE="letter-spacing: 0.1pt">possession </FONT>by, a receiver, custodian, trustee or liquidator of itself or of <FONT STYLE="letter-spacing: 0.1pt">all
</FONT>or a substantial part of <FONT STYLE="letter-spacing: 0.1pt">its </FONT>property or assets; (ii) make a general assignment <FONT STYLE="letter-spacing: 0.1pt">for
</FONT><FONT STYLE="letter-spacing: 0.2pt">the </FONT>benefit of <FONT STYLE="letter-spacing: 0.1pt">its </FONT>creditors; (iii) commence
a voluntary case under <FONT STYLE="letter-spacing: 0.1pt">the </FONT>United States Bankruptcy Code <FONT STYLE="letter-spacing: 0.1pt">(as
now </FONT>or hereafter in effect) or under <FONT STYLE="letter-spacing: 0.2pt">the </FONT>comparable laws of any jurisdiction (foreign
or domestic); (iv) file a petition seeking to take advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar
law affecting the enforcement of creditors&rsquo; rights generally; (v) acquiesce in writing to any petition filed against it in an involuntary
case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or
domestic); (vi) issue a notice of bankruptcy or winding down of its operations or issue a press release regarding same; or (vii)&nbsp;take
any <FONT STYLE="letter-spacing: 0.1pt">action </FONT>under the laws of any jurisdiction (foreign or domestic) analogous to any of the
foregoing;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a proceeding or case shall be commenced in respect of the Maker or any of its Subsidiaries (including, without limitation any Guarantor),
without its application or consent, <FONT STYLE="letter-spacing: 0.1pt">in </FONT><FONT STYLE="letter-spacing: 0.15pt">any </FONT><FONT STYLE="letter-spacing: 0.2pt">court
</FONT><FONT STYLE="letter-spacing: 0.1pt">of </FONT><FONT STYLE="letter-spacing: 0.2pt">competent jurisdiction, seeking: </FONT><FONT STYLE="letter-spacing: 0.15pt">(i)
the </FONT><FONT STYLE="letter-spacing: 0.2pt">liquidation, reorganization, moratorium, dissolution, winding </FONT><FONT STYLE="letter-spacing: 0.15pt">up,
</FONT><FONT STYLE="letter-spacing: 0.1pt">or </FONT><FONT STYLE="letter-spacing: 0.2pt">composition </FONT><FONT STYLE="letter-spacing: 0.25pt">or
</FONT><FONT STYLE="letter-spacing: 0.1pt">readjustment </FONT>of its <FONT STYLE="letter-spacing: 0.1pt">debts; (ii) </FONT>the <FONT STYLE="letter-spacing: 0.1pt">appointment
</FONT>of a <FONT STYLE="letter-spacing: 0.1pt">trustee, receiver, custodian, liquidator </FONT>or the <FONT STYLE="letter-spacing: 0.1pt">like
</FONT>of it or of all or any <FONT STYLE="letter-spacing: 0.1pt">substantial part </FONT>of <FONT STYLE="letter-spacing: 0.15pt">its
</FONT>assets in connection with the liquidation or dissolution of the Maker or any of its Subsidiaries; or (iii) similar relief in respect
of it under any <FONT STYLE="letter-spacing: 0.1pt">law </FONT>providing for the relief of debtors, and such proceeding or case described
in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of forty-five (45) days or any order
for relief shall be entered in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable
laws of any jurisdiction (foreign or domestic) against the Maker or any of its Subsidiaries or action <FONT STYLE="letter-spacing: 0.1pt">under
</FONT>the <FONT STYLE="letter-spacing: 0.1pt">laws </FONT>of any <FONT STYLE="letter-spacing: 0.1pt">jurisdiction (foreign </FONT>or
<FONT STYLE="letter-spacing: 0.1pt">domestic) analogous </FONT>to any of the <FONT STYLE="letter-spacing: 0.1pt">foregoing shall </FONT>be
<FONT STYLE="letter-spacing: 0.1pt">taken with respect </FONT>to the <FONT STYLE="letter-spacing: 0.1pt">Maker </FONT>or any of <FONT STYLE="letter-spacing: 0.15pt">its
</FONT>Subsidiaries and shall continue undismissed, or unstayed and in effect for a period of forty-five (45) days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there is entered against the Company or any Subsidiary (i)&nbsp;a final judgment or order for the payment of money in an aggregate
amount (as to all such judgments and orders) exceeding $4,000,000 (to the extent not covered by independent third-party insurance as to
which the insurer has been notified of such judgment or order and has not denied or failed to acknowledge coverage), or (ii)&nbsp;a non-monetary
final judgment or order that, either individually or in the aggregate, has or could reasonably be expected to have a Material Adverse
Effect and, in either case, (A)&nbsp;enforcement proceedings are commenced by any creditor upon such judgment or order, or (B)&nbsp;there
is a period of 30&nbsp;consecutive days during which a stay of enforcement of such judgment, by reason of a pending appeal or otherwise,
is not in effect;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT>the failure of the Maker to instruct its transfer agent to remove any legends from shares of Common Stock and issue <FONT STYLE="letter-spacing: 0.15pt">such
</FONT><FONT STYLE="letter-spacing: 0.2pt">unlegended certificates </FONT>to <FONT STYLE="letter-spacing: 0.15pt">the </FONT><FONT STYLE="letter-spacing: 0.2pt">Holder
within two </FONT><FONT STYLE="letter-spacing: 0.15pt">(2) </FONT><FONT STYLE="letter-spacing: 0.2pt">Trading </FONT><FONT STYLE="letter-spacing: 0.15pt">Days
</FONT>of <FONT STYLE="letter-spacing: 0.15pt">the </FONT>Holder&rsquo;s <FONT STYLE="letter-spacing: 0.3pt">request </FONT><FONT STYLE="letter-spacing: 0.15pt">so
</FONT><FONT STYLE="letter-spacing: 0.25pt">long </FONT><FONT STYLE="letter-spacing: 0.15pt">as </FONT><FONT STYLE="letter-spacing: 0.2pt">the
</FONT><FONT STYLE="letter-spacing: 0.25pt">Holder </FONT><FONT STYLE="letter-spacing: 0.2pt">has </FONT><FONT STYLE="letter-spacing: 0.3pt">provided
</FONT><FONT STYLE="letter-spacing: 0.35pt">reasonable </FONT>assurances to the Maker that such shares of Common Stock can be sold pursuant
to Rule 144 or any other applicable exemption;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt">the Maker&rsquo;s shares of Common Stock are no longer publicly traded or cease to be listed
on the Trading Market or, after the six month anniversary of the Issuance Date, </FONT>any Investor Shares may not be immediately resold
under Rule 144 without restriction on the number of shares to be sold or manner of sale, unless such Investor Shares have been registered
for resale under the 1933 Act and may be sold without restriction;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.2pt">the Maker proposes to or does </FONT>consummate a <FONT STYLE="letter-spacing: 0.15pt">&ldquo;going
private&rdquo; </FONT>transaction <FONT STYLE="letter-spacing: 0.15pt">as </FONT>a result of which <FONT STYLE="letter-spacing: 0.2pt">the
</FONT>Common Stock <FONT STYLE="letter-spacing: 0.15pt">will no </FONT>longer be registered <FONT STYLE="letter-spacing: 0.3pt">under
</FONT>Sections 12(b) or 12(g) of the 1934 Act;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.2pt">there shall </FONT><FONT STYLE="letter-spacing: 0.15pt">be </FONT><FONT STYLE="letter-spacing: 0.2pt">any
SEC </FONT><FONT STYLE="letter-spacing: 0.15pt">or </FONT><FONT STYLE="letter-spacing: 0.25pt">judicial </FONT><FONT STYLE="letter-spacing: 0.2pt">stop
trade order </FONT><FONT STYLE="letter-spacing: 0.15pt">or </FONT><FONT STYLE="letter-spacing: 0.25pt">trading suspension </FONT><FONT STYLE="letter-spacing: 0.15pt">stop-order
</FONT><FONT STYLE="letter-spacing: 0.1pt">or </FONT><FONT STYLE="letter-spacing: 0.15pt">any </FONT><FONT STYLE="letter-spacing: 0.2pt">restriction
</FONT><FONT STYLE="letter-spacing: 0.1pt">in </FONT><FONT STYLE="letter-spacing: 0.2pt">place </FONT><FONT STYLE="letter-spacing: 0.15pt">with
</FONT><FONT STYLE="letter-spacing: 0.25pt">the </FONT>transfer agent for the Common Stock restricting the trading of such Common Stock,
which shall continue and remain uncured for a period of ten (10) or more days;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Depository Trust Company places any restrictions on transactions in the Common Stock or the Common Stock is no longer tradeable
through the Depository Trust Company Fast Automated Securities Transfer program;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company fails to file any report or filing required to be filed by the Securities and Exchange Commission, if such failure
results in a Material Adverse Effect;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company&rsquo;s Market Capitalization is below $50 million for twenty (20) consecutive days; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the occurrence of a Material Adverse Effect in respect of the Maker, or <FONT STYLE="letter-spacing: -0.15pt">the Maker and </FONT>its
Subsidiaries taken as a whole.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">For the avoidance of doubt,
any default pursuant to clause (s) above shall not permit the Holder to accelerate the payment of the Outstanding Principal Balance in
cash pursuant to Section 2.2(c)(1) below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Remedies Upon an Event of Default</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the occurrence of any Event of Default, the Maker shall be obligated to pay to the Holder the Mandatory Default Amount, which
Mandatory Default Amount shall be earned by the Holder on the date the Event of Default giving rise thereto occurs and shall be due and
payable on the earlier to occur of the Maturity Date, upon conversion, redemption or prepayment of this Note or the date on which all
amounts owing hereunder have been accelerated in accordance with the terms hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the occurrence of any Event of Default, the Maker shall, as promptly as possible but <FONT STYLE="letter-spacing: 0.15pt">in
</FONT>any event within one (1) Business Day of such Event of Default, notify the Holder of the occurrence of such Event of <FONT STYLE="letter-spacing: 0.15pt">Default,
</FONT>describing the event or factual situation giving rise to the Event of Default and specifying the relevant subsection or subsections
of <U>Section 2.1</U> hereof under which such Event of Default has occurred.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the occurrence and during the continuance of an Event of Default, the Holder may at any time at its option (1) declare the
Mandatory Default Amount due and payable, and thereupon, the same shall be accelerated and so due and payable, without presentment, demand,
protest or notice, all of which are hereby expressly unconditionally and irrevocably waived by the Maker and (2) exercise all other rights
and remedies available to it under the Transaction Documents; <FONT STYLE="letter-spacing: 0.15pt"><I>provided, however</I>, </FONT>that
(x) upon the occurrence of an Event of Default described above, the Holder, in its sole and absolute discretion, may: (a) from time-to-time
demand that all or a portion of the Outstanding Principal Amount be <FONT STYLE="letter-spacing: 0.2pt">converted </FONT><FONT STYLE="letter-spacing: 0.15pt">into
</FONT><FONT STYLE="letter-spacing: 0.2pt">shares of Common Stock</FONT> at the lower of (i) the then-current Conversion Price and (ii)
eighty-five percent (85%) of the average of the three (3) lowest daily VWAPs during the twenty (20) Trading Days prior to the delivery
by the Holder of the applicable notice of conversion or (b) exercise or otherwise enforce any one or more of the Holder&rsquo;s <FONT STYLE="letter-spacing: 0.25pt">rights,
powers, privileges, remedies </FONT><FONT STYLE="letter-spacing: 0.2pt">and </FONT><FONT STYLE="letter-spacing: 0.25pt">interests </FONT><FONT STYLE="letter-spacing: 0.2pt">under
this Note, the </FONT><FONT STYLE="letter-spacing: 0.25pt">Purchase Agreement, </FONT><FONT STYLE="letter-spacing: 0.2pt">the other </FONT><FONT STYLE="letter-spacing: 0.25pt">Transaction
Documents </FONT><FONT STYLE="letter-spacing: 0.3pt">or </FONT>applicable law and (y) upon the occurrence of an Event of Default described
in <U>Section 2.1(j) or 2.1(k)</U> above, the Mandatory Default Amount shall become immediately due and payable without presentment, demand,
protest or other notice of any kind, all of which are hereby waived by the Maker. No <FONT STYLE="letter-spacing: 0.15pt">course </FONT>of
<FONT STYLE="letter-spacing: 0.15pt">delay </FONT>on the <FONT STYLE="letter-spacing: 0.15pt">part </FONT>of the <FONT STYLE="letter-spacing: 0.15pt">Holder
shall operate </FONT>as a <FONT STYLE="letter-spacing: 0.15pt">waiver thereof </FONT>or <FONT STYLE="letter-spacing: 0.15pt">otherwise
prejudice </FONT>the <FONT STYLE="letter-spacing: 0.15pt">rights </FONT>of <FONT STYLE="letter-spacing: 0.2pt">the </FONT>Holder. No remedy
conferred hereby shall be exclusive of any other remedy referred to herein or now or hereafter available at law, <FONT STYLE="letter-spacing: 0.15pt">in
</FONT>equity, by statute or otherwise.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
3&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conversion</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conversion</U>. This Note shall be convertible (in whole or in part), at the option of the Holder, into such number of fully
paid and non-assessable shares of Common Stock as is determined by dividing (x) that portion of the Outstanding Principal Amount that
the Holder elects to convert (the &ldquo;<U>Conversion Amount</U>&rdquo;) by (y) the Conversion Price then in effect on the date on which
the Holder delivers a notice of conversion, in substantially the form attached hereto as <U>Exhibit B</U> (the &ldquo;<U>Conversion Notice</U>&rdquo;),
in accordance with <U>Section 5.1</U> to the Maker. Any such conversion pursuant to this Section 3.1(a) and any additional payments made
pursuant to Section 1.3 shall be applied to prepay future Monthly Payments in chronological order, (i.e. if a conversion or excess monthly
payment is increased (from $400,000 to $800,000 at the Company&rsquo;s option), those conversions would apply towards the next upcoming
payment(s)). The Holder shall deliver this Note to the Maker at the address designated in the Purchase Agreement at such time that this
Note is fully converted. With respect to partial conversions of this Note, the Maker shall keep written records of the amount of this
Note converted as of the Conversion Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conversion Price</U>. <FONT STYLE="letter-spacing: 0.5pt">The </FONT><FONT STYLE="letter-spacing: 0.1pt">&ldquo;<U>Conversion
Price</U>&rdquo; </FONT><FONT STYLE="letter-spacing: 0.2pt">means</FONT> <FONT STYLE="letter-spacing: 0.15pt">$6.50and shall be subject
to adjustment as provided herein.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delivery of Conversion Shares</U>. As soon as practicable after the occurrence of any event requiring the issuance of shares
of Common Stock issuable upon conversion of this Note (&ldquo;<U>Conversion Shares</U>&rdquo;), and in any event within two (2) Business
Day thereafter (such date, the &ldquo;<U>Share Delivery Date</U>&rdquo;), the Maker shall, at its expense, cause to be issued in the name
of and delivered to the Holder, or as the Holder may direct, the number of fully paid and nonassessable shares of Common Stock to which
the Holder shall be entitled, in such denominations as may be requested by the Holder, which certificate or certificates shall be free
of restrictive and trading legends, except for any such legends as may be required under the 1933 Act. The Company shall cause its transfer
agent to electronically transmit such shares of Common Stock issuable to the Holder (or its designee), by crediting the account of the
Holder&rsquo;s (or such designee&rsquo;s) broker with the Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) through its Deposit and
Withdrawal At Custodian (&ldquo;<U>DWAC</U>&rdquo;) system (provided that the same time periods herein as for stock certificates shall
apply) as instructed by the Holder (or its designee); provided, that such issuance shall only be made through DTC&rsquo;s DWAC system
if such Conversion Shares will be issued free of restrictive legends. If such Conversion Shares will be issued subject to legends required
under the 1933 Act, such Conversion Shares will be issued to the Holder in book entry at the Maker&rsquo;s transfer agent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Ownership Cap</U>. Notwithstanding anything to the contrary contained herein, the Holder shall not be entitled to receive shares
representing Equity Interests upon conversion of this Note to the extent (but only to the extent) that such exercise or receipt would
cause the Holder Group (as defined below) to become, directly or indirectly, a &ldquo;beneficial owner&rdquo; (within the meaning of
Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder) of a number of Equity Interests of a class that is
registered under the 1934 Act which exceeds the Maximum Percentage (as defined in the Purchase Agreement) of the Equity Interests of
such class that are outstanding at such time. Any purported delivery of Equity Interests in connection with the conversion of this Note
prior to the termination of this restriction in accordance herewith shall be void and have no effect to the extent (but only to the extent)
that such delivery would result in the Holder Group becoming the beneficial owner of more than the Maximum Percentage of the Equity Interests
of a class that is registered under the 1934 Act that is outstanding at such time. If any delivery of Equity Interests owed to the Holder
following conversion of this Note is not made, in whole or in part, as a result of this limitation, the Company&rsquo;s obligation to
make such delivery shall not be extinguished and the Company shall deliver such Equity Interests as promptly as practicable after the
Holder gives notice to the Company that such delivery would not result in such limitation being triggered or upon termination of the
restriction in accordance with the terms hereof. To the extent limitations contained in this <U>Section 3.3</U> apply, the determination
of whether this Note is convertible and of which portion of this Note is convertible shall be the sole responsibility and in the sole
determination of the Holder, and the submission of a notice of conversion shall be deemed to constitute the Holder&rsquo;s determination
that the issuance of the full number of Conversion Shares requested in the notice of conversion is permitted hereunder, and the Company
shall not have any obligation to verify or confirm the accuracy of such determination. For purposes of this <U>Section 3.3</U>, (i)&nbsp;the
term &ldquo;<U>Maximum Percentage</U>&rdquo; shall mean 4.99%; provided, that if at any time after the date hereof the Holder Group beneficially
owns in excess of 4.99% of any class of Equity Interests in the Company that is registered under the 1934 Act, then the Maximum Percentage
shall automatically increase to 9.99% so long as the Holder Group owns in excess of 4.99% of such class of Equity Interests (and shall,
for the avoidance of doubt, automatically decrease to 4.99% upon the Holder Group ceasing to own in excess of 4.99% of such class of
Equity Interests); and (ii) the term &ldquo;<U>Holder Group</U>&rdquo; shall mean the Holder plus any other Person with which the Holder
is considered to be part of a group under Section 13 of the 1934 Act or with which the Holder otherwise files reports under Sections&nbsp;13
and/or 16 of the 1934 Act. In determining the number of Equity Interests of a particular class outstanding at any point in time, the
Holder may rely on the number of outstanding Equity Interests of such class as reflected in (x) the Company&rsquo;s most recent Annual
Report on Form 10-K filed with the Securities and Exchange Commission, as the case may be, (y) a more recent public announcement by the
Company or (z) a more recent notice by the Company or its transfer agent to the Holder setting forth the number of Equity Interests of
such class then outstanding. For any reason at any time, upon written or oral request of the Holder, the Company shall, within one (1)
Business Day of such request, confirm orally and in writing to the Holder the number of Equity Interests of any class then outstanding.
The provisions of this <U>Section 3.3</U> shall be construed, corrected and implemented in a manner so as to effectuate the intended
beneficial ownership limitation herein contained.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><SUP>[1]</SUP></FONT></P>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[1]</SUP></FONT>
Note to draft: Parties to confirm blocker percentage.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustment of Conversion Price</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Until the Note has been paid in full or converted in full, the Conversion Price shall be subject to adjustment from time to time
as follows (but shall not be increased, other than pursuant to <U>Section 3.4(a)(i)</U> hereof):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustments for Stock Splits and Combinations</U>. If the Maker shall at any time or from time to time after the Closing Date
(but whether before or after the Issuance Date) effect a split or other subdivision of the outstanding Common Stock, the applicable Conversion
Price in effect immediately prior to the stock <FONT STYLE="letter-spacing: -0.35pt">or share </FONT>split shall be proportionately decreased.
If the Maker shall at any time or from time to time after the Closing Date (but whether before or after the Issuance Date), combine the
outstanding shares of Common Stock, the applicable Conversion Price in effect immediately prior to the combination shall be proportionately
increased. Any adjustments under this <U>Section 3.4(a)(i)</U> shall be effective at the close of business on the date the stock split
or combination occurs.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustments for Certain Dividends and Distributions</U>. If the Maker shall at any time or from time to time after the Closing
Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination of holders of Common Stock
entitled to receive a dividend or other distribution payable in shares of Common Stock, then, and in each event, the applicable Conversion
Price in effect immediately prior to such event shall be decreased as of the time of such issuance or, in the event such record date shall
have been fixed, as of the close of business on such record date, by multiplying the applicable Conversion Price then in effect by a fraction:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time
of such issuance or the close of business on such record date; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time
of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend
or distribution.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustment for Other Dividends and Distributions</U>. If the Maker shall at any time or from time to time after the Closing
Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination of holders of Common Stock
entitled to receive a dividend or other distribution payable in other than shares of Common Stock, then, and in each event, an appropriate
revision to the applicable Conversion Price shall be made and provision shall be made (by adjustments of the Conversion Price or otherwise)
so that the Holder of this Note shall receive upon conversions thereof, in addition to the number of shares of Common Stock receivable
thereon, the number of securities of the Maker or other issuer (as applicable) or cash or other property that it would have received had
this Note been converted into Common Stock in full (without regard to any conversion limitations herein) on the date of such event and
had thereafter, during the period from the date of such event to and including the Conversion Date, retained such securities (together
with any distributions payable thereon during such period) or assets, giving application to all adjustments called for during such period
under this <U>Section 3.4(a)(iii)</U> with respect to the rights of the holders of this Note; <FONT STYLE="letter-spacing: 0.1pt"><I>provided,
however</I>, </FONT>that if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not
fully made on the date fixed therefor, the Conversion Price shall be adjusted pursuant to this paragraph as of the time of actual payment
of such dividends or distributions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustments for Reclassification, Exchange or Substitution</U>. If the Common Stock at any time or from time to time after the
Closing Date (but whether before or after the Issuance Date) shall be changed to the same or different number of shares or other securities
of any class or classes of stock or other property, whether by reclassification, exchange, substitution or otherwise (other than by way
of a stock split or combination of shares or <FONT STYLE="letter-spacing: -0.5pt">stock </FONT>dividends provided for in <U>Sections 3.4(a)(i),
(ii) and (iii)</U> hereof, or a reorganization, merger, consolidation, or sale of assets provided for in <U>Section 3.4(a)(vii)</U> hereof),
then, and in each event, an appropriate revision to the Conversion Price shall be made and provisions shall be made (by adjustments of
the Conversion Price or otherwise) so that the Holder shall have the right thereafter to convert this Note into the kind and amount of
shares of stock or other securities or other property receivable upon reclassification, exchange, substitution or other change, by holders
of the number of shares of Common Stock into which such Note might have been converted immediately prior to such reclassification, exchange,
substitution or other change, all subject to further adjustment as provided herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustments for Issuance of Additional Shares of Common Stock</U>. Except for Exempted Securities, in the event the Maker shall
at any time or from time to time after the Closing Date (but whether before or after the Issuance Date) issue or sell any additional shares
of Common Stock (&ldquo;<U>Additional Shares of Common Stock</U>&rdquo;) at an effective price per share that is <B><I>less </I></B>than
the Conversion Price then in effect or without consideration, then the Conversion Price upon each such issuance shall be reduced to a
price equal to the consideration per share paid for such Additional Shares of Common Stock. For purposes of clarification, the amount
of consideration received for such Additional Shares of Common Stock shall not include the value of any additional securities or other
rights received in connection with such issuance of Additional Shares of Common Stock (i.e. warrants, rights of first refusal or other
similar rights).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Issuance, Amendment or Adjustment of Common Stock Equivalents</U>. <FONT STYLE="letter-spacing: -0.55pt">Except for </FONT>Exempted
Securities, if (x) the Maker, at any time after the Closing Date (but whether before or after the Issuance Date), shall issue any securities
convertible into or exercisable or exchangeable for, directly or indirectly, Common Stock (&ldquo;<U>Convertible Securities</U>&rdquo;),
or any rights or warrants or options to purchase any such Common Stock or Convertible Securities, (collectively with the Convertible Securities,
the &ldquo;<U>Common Stock Equivalents</U>&rdquo;) and the price per share for which shares of Common Stock may be issuable pursuant to
any such Common Stock Equivalent shall be <B><I>less </I></B>than the applicable Conversion Price then in effect, or (y) the price per
share for which shares of Common Stock may be issuable under any Common Stock Equivalents is amended or adjusted, pursuant to the terms
of such Common Stock Equivalents or otherwise, and such price as so amended or adjusted shall be less than the Conversion Price in effect
at the time of such amendment or adjustment, then, in each such case (x) or (y), the Conversion Price upon each such issuance or amendment
or adjustment shall be adjusted as provided in subsection (v) of this <U>Section 3.4(a)</U> as if the maximum number of shares of Common
Stock issuable upon conversion, exercise or exchange of such Common Stock Equivalents had been issued on the date of such issuance or
amendment or adjustment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consideration for Stock</U>. In case any shares of Common Stock or any Common Stock Equivalents shall be issued or sold:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in connection with any merger or consolidation in which the Maker is the surviving corporation (other than any consolidation or
merger in which the previously outstanding shares of Common Stock of the Maker shall be changed to or exchanged for the stock or other
securities of another corporation), the amount of consideration therefor shall be deemed to be the fair value, as determined reasonably
and in good faith by the Board of Directors of the Maker, of such portion of the assets and business of the nonsurviving corporation as
such Board of Directors may determine to be attributable to such shares of Common Stock, Convertible Securities, rights or warrants or
options, as the case may be; or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 2in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the event of any consolidation or merger of the Maker in which the Maker is not the surviving corporation or in which the previously
outstanding shares of Common Stock of the Maker shall be changed into or exchanged for the stock or other securities of another corporation
or other property, or in the event of any sale of all or substantially all of the assets of the Maker for stock, shares or other securities
or other property of any corporation, the Maker shall be deemed to have issued shares of its Common Stock, at a price per share equal
to the valuation of the Maker&rsquo;s Common Stock based on the actual exchange ratio on which the transaction was predicated, as applicable,
and the fair market value on the date of such transaction of all such stock or securities or other property of the other corporation.
If any such calculation results in adjustment of the applicable Conversion Price, or the number of shares of Common Stock issuable upon
conversion of the Note, the determination of the applicable Conversion Price or the number of shares of Common Stock issuable upon conversion
of the Note immediately prior to such merger, consolidation or sale, shall be made after giving effect to such adjustment of the number
of shares of Common Stock issuable upon conversion of the Note. In the event Common Stock is issued with other shares or securities or
other assets of the Maker for consideration which covers both, the consideration computed as provided in this <U>Section 3.4(a)(vii)</U>
shall be allocated among such securities and assets as determined in good faith by the Board of Directors of the Maker</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Record Date</U>. In case the Maker shall take record of the holders of its Common Stock for the purpose of entitling them to
subscribe for or purchase Common Stock or Convertible Securities, then the date of the issue or sale of the shares of Common Stock shall
be deemed to be such record date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Impairment</U>. The Maker shall not, by amendment of its <FONT STYLE="letter-spacing: -0.5pt">Organizational Documents </FONT>or
through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Maker, but
will at all times in good faith assist in the carrying out of all the provisions of this <U>Section 3.4</U> and in the taking of all such
action as may be necessary or appropriate in order to protect the conversion rights of the Holder against impairment. In the event the
Holder shall elect to convert this Note as provided herein, the Maker cannot refuse conversion based on any claim that the Holder or anyone
associated or affiliated with the Holder has been engaged in any violation of law, violation of an agreement to which the Holder is a
party or for any reason whatsoever, unless, an injunction from a court, or notice, restraining and or adjoining conversion of this Note
shall have issued and the Maker posts a surety bond for the benefit of the Holder in an amount equal to one hundred fifty percent (150%)
of the Principal Amount of the Note the Holder has elected to convert, which bond shall remain in effect until the completion of arbitration/litigation
of the dispute and the proceeds of which shall be payable to the Holder (as liquidated damages) in the event it obtains judgment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificates as to Adjustments</U>. Upon occurrence of each adjustment or readjustment of the Conversion Price or number of
shares of Common Stock issuable upon conversion of this Note pursuant to this <U>Section 3.4</U>, the Maker at its expense shall promptly
compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such
adjustment and readjustment, showing in detail the facts upon which such adjustment or readjustment is based. The Maker shall, upon written
request of the Holder, at any time, furnish or cause to be furnished to the Holder a like certificate setting forth such adjustments and
readjustments, the applicable Conversion Price in effect at the time, and the number of shares of Common Stock and the amount, if any,
of other securities or property which at the time would be received upon the conversion of this Note. Notwithstanding the foregoing, the
Maker shall not be obligated to deliver a certificate unless such certificate would reflect an increase or decrease of at least one percent
(1%) of such adjusted amount.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Issue Taxes</U>. The Maker shall pay any and all issue and other taxes, excluding federal, state or local income taxes, that
may be payable in respect of any issue or delivery of shares of Common Stock on conversion of this Note pursuant thereto; <FONT STYLE="letter-spacing: 0.1pt"><I>provided,
however</I>, </FONT>that <FONT STYLE="letter-spacing: 0.1pt">the </FONT>Maker shall not be obligated to pay any transfer taxes resulting
from any transfer requested by the Holder in connection with any such <FONT STYLE="letter-spacing: 0.15pt">conversion.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued upon conversion of this Note. In lieu of any fractional
shares to which the Holder would otherwise be entitled, the Maker shall pay cash equal such fractional shares multiplied by the Conversion
Price then in effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reservation of Common Stock</U>. The Maker shall at all times while this Note shall be outstanding, reserve and keep available
out of its authorized but unissued Common Stock, such number of shares of Common Stock as shall from time to time be sufficient to effect
the conversion of this Note (disregarding for this purpose any and all limitations of any kind on such conversion). The Maker shall, from
time to time, use all commercially reasonable efforts to increase the authorized number of shares of Common Stock or take other effective
action if at any time the unissued number of authorized shares shall not be sufficient to satisfy the Maker&rsquo;s obligations under
this <U>Section<FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT>3.4(f)</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regulatory Compliance</U>. If any shares of Common Stock to be reserved for the purpose of conversion of this Note require registration
or listing with or approval of any governmental authority, stock exchange or other regulatory body under any federal or state law or regulation
or otherwise before such shares may be validly issued or delivered upon conversion, the Maker shall, at its sole cost and expense, in
good faith and as expeditiously as possible, secure such registration, listing or approval, as the case may be.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effect of Events Prior to the Issuance Date</U>. If the Issuance Date of this Note is after the Closing Date, then, if the Conversion
Price or any other right of the Holder of this Note would have been adjusted or modified by operation of any provision of this Note had
this Note been issued on the Closing Date, such adjustment or modification shall be deemed to apply to this Note as of the Issuance Date
as if this Note had been issued on the Closing Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayment Following a Change of Control</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Mechanics of Prepayment at Option of Holder in Connection with a Change of Control</U>. No sooner than fifteen (15) days prior
to entry into an agreement for a Change of Control <FONT STYLE="letter-spacing: 0.1pt">nor </FONT><FONT STYLE="letter-spacing: 0.15pt">later
than </FONT><FONT STYLE="letter-spacing: 0.1pt">ten </FONT><FONT STYLE="letter-spacing: 0.15pt">(10) days prior </FONT>to <FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">consummation </FONT>of a <FONT STYLE="letter-spacing: 0.15pt">Change </FONT>of <FONT STYLE="letter-spacing: 0.15pt">Control,
</FONT><FONT STYLE="letter-spacing: 0.1pt">but not </FONT><FONT STYLE="letter-spacing: 0.15pt">prior </FONT>to <FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">public announcement </FONT>of <FONT STYLE="letter-spacing: 0.15pt">such Change </FONT><FONT STYLE="letter-spacing: 0.2pt">of
</FONT>Control, the Maker shall deliver written notice <FONT STYLE="letter-spacing: 0.1pt">(&ldquo;<U>Notice </U></FONT><U>of <FONT STYLE="letter-spacing: 0.1pt">Change
</FONT>of <FONT STYLE="letter-spacing: 0.1pt">Control</FONT></U><FONT STYLE="letter-spacing: 0.1pt">&rdquo;) </FONT>to <FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">Holder</FONT>. At any time after receipt of a Notice of Change of Control (or, in the event
a Notice of Change of Control is not delivered at least ten (10) days prior to a Change of Control, at any time within ten (10) days prior
to a Change of Control), <FONT STYLE="letter-spacing: 0.1pt">the Holder</FONT> <FONT STYLE="letter-spacing: 0.15pt">may </FONT><FONT STYLE="letter-spacing: 0.2pt">require
</FONT><FONT STYLE="letter-spacing: 0.15pt">the </FONT><FONT STYLE="letter-spacing: 0.2pt">Maker </FONT><FONT STYLE="letter-spacing: 0.1pt">to
</FONT><FONT STYLE="letter-spacing: 0.2pt">prepay, effective immediately prior </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.15pt">the
</FONT><FONT STYLE="letter-spacing: 0.2pt">consummation </FONT><FONT STYLE="letter-spacing: 0.1pt">of </FONT><FONT STYLE="letter-spacing: 0.15pt">such
</FONT><FONT STYLE="letter-spacing: 0.2pt">Change </FONT><FONT STYLE="letter-spacing: 0.25pt">of </FONT>Control, an amount equal to 102.5%
of the Outstanding Principal Amount (the &ldquo;<U>COC Repayment Price</U>&rdquo;), by delivering written notice thereof (&ldquo;<U>Notice
of Prepayment at <FONT STYLE="letter-spacing: 0.15pt">Option </FONT>of <FONT STYLE="letter-spacing: 0.15pt">Holder Upon Change </FONT>of
<FONT STYLE="letter-spacing: 0.15pt">Control</FONT></U><FONT STYLE="letter-spacing: 0.15pt">&rdquo;) </FONT>to <FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">Maker</FONT>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of COC Repayment Price</U>. <FONT STYLE="letter-spacing: 0.15pt">Upon the </FONT>Maker&rsquo;s receipt of a Notice(s)
of Prepayment at Option of Holder Upon Change of Control from the Holder, the Maker shall deliver the COC Repayment Price to the Holder
immediately prior to the consummation of the Change of Control; provided that the Holder&rsquo;s <FONT STYLE="letter-spacing: 0.2pt">original
</FONT><FONT STYLE="letter-spacing: 0.15pt">Note </FONT><FONT STYLE="letter-spacing: 0.2pt">shall </FONT><FONT STYLE="letter-spacing: 0.15pt">have
been </FONT><FONT STYLE="letter-spacing: 0.25pt">so </FONT>delivered to the Maker.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inability to Fully Convert</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Holder&rsquo;s Option if Maker Cannot Fully Convert</U>. If, upon the Maker&rsquo;s receipt of a Conversion Notice or as otherwise
required under this Note, including with respect to repayment of principal in shares of Common Stock as permitted under this Note, the
Maker cannot issue shares of Common Stock <FONT STYLE="letter-spacing: 0.1pt">for any </FONT><FONT STYLE="letter-spacing: 0.15pt">reason,
including, without limitation, because </FONT><FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">Maker
</FONT><FONT STYLE="letter-spacing: 0.1pt">(x) </FONT><FONT STYLE="letter-spacing: 0.15pt">does </FONT><FONT STYLE="letter-spacing: 0.1pt">not
</FONT><FONT STYLE="letter-spacing: 0.15pt">have </FONT>a <FONT STYLE="letter-spacing: 0.15pt">sufficient number </FONT>of shares of Common
Stock <FONT STYLE="letter-spacing: 0.1pt">authorized </FONT>and <FONT STYLE="letter-spacing: 0.1pt">available </FONT>or (y) is <FONT STYLE="letter-spacing: 0.1pt">otherwise
prohibited </FONT>by <FONT STYLE="letter-spacing: 0.1pt">applicable </FONT>law or by the <FONT STYLE="letter-spacing: 0.1pt">rules </FONT>or
<FONT STYLE="letter-spacing: 0.1pt">regulations </FONT>of any <FONT STYLE="letter-spacing: 0.1pt">stock </FONT><FONT STYLE="letter-spacing: 0.15pt">exchange,
</FONT><FONT STYLE="letter-spacing: 0.1pt">interdealer quotation system </FONT>or <FONT STYLE="letter-spacing: 0.1pt">other </FONT>self-regulatory
organization with jurisdiction over the Maker or any of its securities from issuing all of <FONT STYLE="letter-spacing: 0.1pt">the </FONT>Common
Stock which is to be issued to the Holder pursuant to this Note, then the Maker shall issue as many shares of Common Stock as it is <FONT STYLE="letter-spacing: 0.15pt">able
</FONT>to <FONT STYLE="letter-spacing: 0.15pt">issue and, with respect </FONT>to <FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">unconverted
portion </FONT>of <FONT STYLE="letter-spacing: 0.15pt">this Note or with respect to any </FONT>shares of Common Stock <FONT STYLE="letter-spacing: 0.15pt">not
timely issued in accordance with this Note, </FONT><FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.2pt">Holder,
</FONT>solely at Holder&rsquo;s option, can elect to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>require the Maker to prepay that portion of this Note for which the Maker is unable to issue Common Stock or for which shares of
Common Stock were not timely issued (the &ldquo;<U>Mandatory Prepayment</U>&rdquo;) at a price equal to the number of shares of Common
Stock that the Maker is unable to issue multiplied by the VWAP on the date of the Conversion Notice (the &ldquo;<U>Mandatory Prepayment
Price</U>&rdquo;);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>void its Conversion Notice and retain or have returned, as the case may be, this Note that was to be converted pursuant to the
Conversion Notice (provided that the Holder&rsquo;s voiding its Conversion Notice shall not affect the Maker&rsquo;s obligations to make
any payments which have accrued prior to the date of such notice); or</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>defer issuance of the applicable Conversion Shares until such time as the Maker can legally issue such shares; provided, that the
Principal Amount underlying such Conversion Shares shall remain outstanding until the delivery of such Conversion Shares; provided, further,
that if the Holder elects to defer the issuance of the Conversion Shares, it may exercise its rights under either clause (i) or (ii) above
at any time prior to the issuance of the Conversion Shares upon two (2) Business Days&rsquo; notice to the Maker.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Mechanics of Fulfilling Holder&rsquo;s Election</U>. The <FONT STYLE="letter-spacing: 0.1pt">Maker shall immediately send </FONT>to
the <FONT STYLE="letter-spacing: 0.1pt">Holder</FONT>, upon receipt of a Conversion Notice from the Holder, which cannot be fully satisfied
as described in <U>Section 3.6(a)</U> above, a notice of the Maker&rsquo;s inability to fully satisfy the Conversion Notice (the &ldquo;<U>Inability
to Fully Convert Notice</U>&rdquo;). Such Inability to Fully Convert Notice shall indicate (i) the reason why the Maker is unable to fully
satisfy the Holder&rsquo;s Conversion Notice; and (ii) the amount of this Note <FONT STYLE="letter-spacing: 0.1pt">which cannot </FONT>be
<FONT STYLE="letter-spacing: 0.1pt">converted. </FONT>The <FONT STYLE="letter-spacing: 0.1pt">Holder shall notify </FONT>the <FONT STYLE="letter-spacing: 0.1pt">Maker
</FONT>of its <FONT STYLE="letter-spacing: 0.1pt">election pursuant </FONT><FONT STYLE="letter-spacing: 0.15pt">to </FONT><U>Section 3.6(a)</U>
above by delivering written notice to the Maker <FONT STYLE="letter-spacing: 0.1pt">(&ldquo;<U>Notice </U></FONT><U>in <FONT STYLE="letter-spacing: 0.1pt">Response
</FONT>to <FONT STYLE="letter-spacing: 0.1pt">Inability </FONT>to Convert</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of Mandatory Prepayment Price</U>. <FONT STYLE="letter-spacing: 0.1pt">If </FONT><FONT STYLE="letter-spacing: 0.15pt">the
</FONT><FONT STYLE="letter-spacing: 0.2pt">Holder shall elect </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.15pt">have
its </FONT><FONT STYLE="letter-spacing: 0.2pt">Note prepaid pursuant </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.2pt"><U>Section
3.6(a)(i)</U> above, </FONT><FONT STYLE="letter-spacing: 0.25pt">the </FONT>Maker shall pay the Mandatory Prepayment Price to the Holder
within five (5) Business Days of the Maker&rsquo;s receipt of the Holder&rsquo;s Notice in Response to <FONT STYLE="letter-spacing: 0.1pt">Inability
</FONT>to <FONT STYLE="letter-spacing: 0.1pt">Convert; </FONT><FONT STYLE="letter-spacing: 0.2pt">provided </FONT><FONT STYLE="letter-spacing: 0.15pt">that
</FONT><FONT STYLE="letter-spacing: 0.2pt">prior </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.15pt">the
</FONT><FONT STYLE="letter-spacing: 0.1pt">Maker&rsquo;s </FONT><FONT STYLE="letter-spacing: 0.2pt">receipt </FONT><FONT STYLE="letter-spacing: 0.1pt">of
</FONT><FONT STYLE="letter-spacing: 0.15pt">the </FONT><FONT STYLE="letter-spacing: 0.1pt">Holder&rsquo;s </FONT><FONT STYLE="letter-spacing: 0.2pt">Notice
</FONT><FONT STYLE="letter-spacing: 0.1pt">in </FONT><FONT STYLE="letter-spacing: 0.2pt">Response </FONT><FONT STYLE="letter-spacing: 0.1pt">to
</FONT><FONT STYLE="letter-spacing: 0.2pt">Inability </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.2pt">Convert
</FONT><FONT STYLE="letter-spacing: 0.15pt">the </FONT><FONT STYLE="letter-spacing: 0.2pt">Maker </FONT><FONT STYLE="letter-spacing: 0.15pt">has
</FONT><FONT STYLE="letter-spacing: 0.25pt">not </FONT><FONT STYLE="letter-spacing: 0.1pt">delivered </FONT>a <FONT STYLE="letter-spacing: 0.1pt">notice
</FONT>to the <FONT STYLE="letter-spacing: 0.1pt">Holder stating, </FONT>to the <FONT STYLE="letter-spacing: 0.1pt">satisfaction </FONT>of
the <FONT STYLE="letter-spacing: 0.1pt">Holder, that </FONT>the <FONT STYLE="letter-spacing: 0.1pt">event </FONT>or <FONT STYLE="letter-spacing: 0.1pt">condition
resulting </FONT>in the <FONT STYLE="letter-spacing: 0.1pt">Mandatory Prepayment </FONT><FONT STYLE="letter-spacing: 0.15pt">has </FONT>been
cured and all Conversion Shares issuable to the Holder can and will be delivered to the Holder in accordance with the terms of this Note.
If the Maker shall fail to pay the applicable Mandatory Prepayment Price to the Holder on the date that is one (1) Business Day following
the Maker&rsquo;s receipt of the Holder&rsquo;s <FONT STYLE="letter-spacing: 0.1pt">Notice </FONT>in <FONT STYLE="letter-spacing: 0.1pt">Response
</FONT>to <FONT STYLE="letter-spacing: 0.1pt">Inability </FONT>to <FONT STYLE="letter-spacing: 0.1pt">Convert, </FONT>in <FONT STYLE="letter-spacing: 0.1pt">addition
</FONT>to any <FONT STYLE="letter-spacing: 0.1pt">remedy </FONT>the <FONT STYLE="letter-spacing: 0.1pt">Holder </FONT>may <FONT STYLE="letter-spacing: 0.1pt">have
under this Note </FONT>and the <FONT STYLE="letter-spacing: 0.1pt">Purchase Agreement, such unpaid amount </FONT><FONT STYLE="letter-spacing: 0.15pt">shall
</FONT>bear interest at the rate of two percent (2%) per month (prorated for partial months) until paid in full. Until the full Mandatory
Prepayment Price is paid in full to the Holder, the Holder may (i) void the Mandatory Prepayment with respect to that portion of the Note
for which the full Mandatory Prepayment Price has not been paid and (ii) receive back such Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Dividends and Distributions</U>. </FONT>The Holder shall be entitled to receive, on an
as-converted basis, any dividends paid or distributions on Common Stock as if this Note were converted into shares of Common Stock (without
regard to limitations on conversion) immediately prior to the record date for such dividend or distribution, at the Conversion Price.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
4&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Covenants</U>.</FONT> For so long as any Note is outstanding, without the prior written
consent of the Holder:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Transaction Documents</U>. The <FONT STYLE="letter-spacing: 0.1pt">Maker shall, </FONT>and <FONT STYLE="letter-spacing: 0.1pt">shall
cause </FONT>its <FONT STYLE="letter-spacing: 0.1pt">Subsidiaries </FONT>to, <FONT STYLE="letter-spacing: 0.1pt">comply with </FONT>its
<FONT STYLE="letter-spacing: 0.15pt">obligations </FONT>under this Note and the other Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of Taxes, Etc</U>. The Maker shall, and shall cause each of its Subsidiaries to, promptly pay and discharge, or cause
to <FONT STYLE="letter-spacing: 0.1pt">be</FONT> <FONT STYLE="letter-spacing: 0.15pt">paid and</FONT> <FONT STYLE="letter-spacing: 0.2pt">discharged,</FONT>
<FONT STYLE="letter-spacing: 0.15pt">when due and</FONT> <FONT STYLE="letter-spacing: 0.2pt">payable,</FONT> <FONT STYLE="letter-spacing: 0.15pt">all</FONT>
<FONT STYLE="letter-spacing: 0.2pt">lawful taxes, assessments</FONT> <FONT STYLE="letter-spacing: 0.15pt">and</FONT> <FONT STYLE="letter-spacing: 0.2pt">governmental
charges</FONT> <FONT STYLE="letter-spacing: 0.1pt">or</FONT> <FONT STYLE="letter-spacing: 0.2pt">levies imposed</FONT> <FONT STYLE="letter-spacing: 0.15pt">upon
the</FONT> <FONT STYLE="letter-spacing: 0.25pt">income, </FONT>profits, property or business of the Maker and the Subsidiaries, except
for such failures to pay that, individually or in the aggregate, have not <FONT STYLE="letter-spacing: 0.1pt">had </FONT>and would not
reasonably be expected to have a Material Adverse Effect; provided, however, that any such tax, assessment, charge or levy need not be
paid if the validity thereof shall currently be contested in good faith by appropriate proceedings and if the Maker or such Subsidiaries
shall <FONT STYLE="letter-spacing: 0.1pt">have </FONT>set <FONT STYLE="letter-spacing: 0.1pt">aside </FONT>on its <FONT STYLE="letter-spacing: 0.1pt">books
reserves with respect thereto in accordance with generally accepted accounting principles, </FONT>and <FONT STYLE="letter-spacing: 0.1pt">provided,
further, that </FONT>the <FONT STYLE="letter-spacing: 0.1pt">Maker </FONT>and <FONT STYLE="letter-spacing: 0.1pt">such Subsidiaries will
</FONT>pay all <FONT STYLE="letter-spacing: 0.15pt">such </FONT>taxes, assessments, charges or levies forthwith upon the commencement
of proceedings to foreclose any lien which may have attached as security therefor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Corporate Existence</U>. The Maker shall, and shall cause each of its Subsidiaries to, maintain in full force and effect its
corporate existence, rights and franchises (other than the existence, rights and franchises of the Subsidiaries of the Maker that the
board of directors of the Maker determine are no longer necessary or useful to the operation of the Maker&rsquo;s business) and all licenses
and other rights to use property owned or possessed by it and reasonably deemed to be necessary to the <FONT STYLE="letter-spacing: 0.1pt">conduct
</FONT>of its <FONT STYLE="letter-spacing: 0.15pt">business.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Investment Company </U></FONT><U>Act</U>. <FONT STYLE="letter-spacing: 0.15pt">The </FONT>Maker
and each Subsidiary shall conduct <FONT STYLE="letter-spacing: 0.15pt">its </FONT>businesses <FONT STYLE="letter-spacing: 0.1pt">in </FONT>a
manner <FONT STYLE="letter-spacing: 0.1pt">so </FONT><FONT STYLE="letter-spacing: 0.15pt">that </FONT><FONT STYLE="letter-spacing: 0.1pt">it
</FONT><FONT STYLE="letter-spacing: 0.15pt">will not </FONT>become subject <FONT STYLE="letter-spacing: 0.1pt">to, or required to be registered
under, </FONT><FONT STYLE="letter-spacing: 0.25pt">the </FONT>Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sale of Collateral; Liens</U>. From the date hereof, (i) the Maker and its Subsidiaries shall not, except in the case of a Permitted
Disposition, sell, lease, transfer or otherwise dispose of any of its assets (including the Collateral or Guarantor Collateral, as the
case may be), or attempt or contract to do so, other than sales of inventory in the ordinary course of business; and (ii) the Maker and
its Subsidiaries shall not, directly or indirectly, create, permit or suffer to exist, and shall defend their respective assets (including
the Collateral and the Guarantor Collateral) against and take such other action as is necessary to remove, any lien, security interest
or other encumbrance on any such assets (including the Collateral and the Guarantor Collateral) (except for the pledge, assignment and
security interest created under the Security Agreement or the Guarantor Security Agreement and any security interest on an Excluded Assets
to secure a Permitted Financing Arrangement and where the relevant secured parties are subject to a Subordination Agreement).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prohibited Transactions</U>. The Company hereby covenants and agrees not to enter into any Prohibited Transactions until this
Note has been converted into Conversion Shares or repaid in full, except that the Company may enter into a Prohibited Transaction if,
and only if, this Note is repaid in full directly with the proceeds of such Prohibited Transaction and concurrently with the closing thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Repayment of This Note</U>. If the Company or any Subsidiary issues any Indebtedness (other than the Note or any Permitted Financing
Arragement), or issues any Preferred Stock, other than Exempted Securities, or makes a Permitted Disposition, unless otherwise waived
in writing by and at the discretion of the Holder, the Company will immediately (x) utilize the proceeds of such issuance to repay the
Note and (y) utilize 50% of the proceeds of any Permitted Disposition to repay the Note. If the Company issues any Equity Interests, other
than (a) Exempted Securities, (b) shares of Common Stock or Preferred Stock issued in an Acquisition, or (c) shares of Common Stock or
Preferred Stock issued by the Company in an offering in which the sole use of proceeds of funding is not an Acquisition, for aggregate
cumulative gross proceeds to the Company or any Subsidiary, as applicable, of greater than Fifteen Million Dollars ($15,000,000) while
the Note remains outstanding, excluding offering costs or other expenses, unless otherwise waived in writing by and at the discretion
of the Holder, the Company will direct the lower of (y) twenty percent (20%) of the proceeds from such issuance or (z) twenty percent
of the then Outstanding Principal Amount, to repay the Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>DIP Financing</U>. Neither the Company nor any Subsidiary shall, to the extent the Company or any Subsidiary, as applicable,
seeks to obtain financing provided under Section 364 of the U.S. Bankruptcy Code or any similar provision of any other law related thereto
(such financing, a &ldquo;DIP Financing&rdquo;), enter into, or agree to enter into any DIP Financing, without providing the Holder right
of first refusal to provide all or any portion of such DIP Financing as the Holder may elect in its sole and absolute discretion.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Set-Off</U>. This Note shall be subject to the set-off provisions set forth in the Purchase Agreement.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
5&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via email at the email address specified in this Section prior to 5:00 p.m. (New York time) on a Business Day, (b) the next
Business Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in
this Section on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New
York time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses for such notices and communications
shall be as set forth in the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, without
reference to principles of conflict of laws or choice of laws.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.1pt"><U>Headings</U>. </FONT>The headings herein are for convenience only, do not constitute a part
of this Note and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Note will be deemed to
be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any
party. This Note shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any provisions of this Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.15pt"><U>Remedies, Characterizations, Other Obligations, Breaches </U></FONT><U><FONT STYLE="letter-spacing: 0.1pt">and
</FONT><FONT STYLE="letter-spacing: 0.15pt">Injunctive </FONT><FONT STYLE="letter-spacing: 0.1pt">Relief</FONT></U><FONT STYLE="letter-spacing: 0.1pt">.
</FONT><FONT STYLE="letter-spacing: 0.3pt">The </FONT><FONT STYLE="letter-spacing: 0.35pt">remedies provided </FONT><FONT STYLE="letter-spacing: 0.2pt">in
</FONT><FONT STYLE="letter-spacing: 0.3pt">this Note </FONT><FONT STYLE="letter-spacing: 0.35pt">shall </FONT><FONT STYLE="letter-spacing: 0.45pt">be
</FONT>cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation,
a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with
the provisions giving rise to such remedy and nothing herein shall limit the Holder&rsquo;s right to pursue actual damages for any failure
by the Maker to comply with the terms of this <FONT STYLE="letter-spacing: 0.2pt">Note. Amounts </FONT><FONT STYLE="letter-spacing: 0.15pt">set
</FONT><FONT STYLE="letter-spacing: 0.2pt">forth </FONT><FONT STYLE="letter-spacing: 0.1pt">or </FONT><FONT STYLE="letter-spacing: 0.2pt">provided
</FONT><FONT STYLE="letter-spacing: 0.15pt">for </FONT><FONT STYLE="letter-spacing: 0.2pt">herein </FONT><FONT STYLE="letter-spacing: 0.15pt">with
</FONT><FONT STYLE="letter-spacing: 0.2pt">respect </FONT><FONT STYLE="letter-spacing: 0.1pt">to </FONT><FONT STYLE="letter-spacing: 0.2pt">payments,
conversion </FONT><FONT STYLE="letter-spacing: 0.15pt">and the like (and the </FONT><FONT STYLE="letter-spacing: 0.2pt">computation thereof)
shall </FONT><FONT STYLE="letter-spacing: 0.1pt">be</FONT> <FONT STYLE="letter-spacing: 0.25pt">the </FONT><FONT STYLE="letter-spacing: 0.1pt">amounts
</FONT>to be <FONT STYLE="letter-spacing: 0.1pt">received </FONT>by the <FONT STYLE="letter-spacing: 0.1pt">holder thereof </FONT>and
<FONT STYLE="letter-spacing: 0.1pt">shall not, except </FONT>as <FONT STYLE="letter-spacing: 0.1pt">expressly provided herein, </FONT>be
<FONT STYLE="letter-spacing: 0.1pt">subject </FONT>to any <FONT STYLE="letter-spacing: 0.1pt">other obligation </FONT>of the <FONT STYLE="letter-spacing: 0.15pt">Maker
</FONT>(or the performance thereof). The Maker acknowledges that a breach by it of its obligations hereunder will cause irreparable and
material harm to the Holder and that the remedy at law for any such breach would be inadequate. Therefore, the Maker agrees that, in the
event of any such <FONT STYLE="letter-spacing: 0.1pt">breach </FONT>or <FONT STYLE="letter-spacing: 0.1pt">threatened breach, </FONT>the
<FONT STYLE="letter-spacing: 0.1pt">Holder shall </FONT>be <FONT STYLE="letter-spacing: 0.1pt">entitled, </FONT>in <FONT STYLE="letter-spacing: 0.1pt">addition
</FONT>to all <FONT STYLE="letter-spacing: 0.1pt">other available rights </FONT>and <FONT STYLE="letter-spacing: 0.1pt">remedies, </FONT>at
law or in <FONT STYLE="letter-spacing: 0.1pt">equity, </FONT>to <FONT STYLE="letter-spacing: 0.1pt">equitable </FONT><FONT STYLE="letter-spacing: 0.15pt">relief,
</FONT><FONT STYLE="letter-spacing: 0.1pt">including</FONT> but not <FONT STYLE="letter-spacing: 0.1pt">limited</FONT> to an <FONT STYLE="letter-spacing: 0.1pt">injunction
restraining</FONT> any <FONT STYLE="letter-spacing: 0.1pt">such breach</FONT> or <FONT STYLE="letter-spacing: 0.1pt">threatened breach,
without</FONT> the <FONT STYLE="letter-spacing: 0.1pt">necessity</FONT> of <FONT STYLE="letter-spacing: 0.1pt">showing economic loss</FONT>
<FONT STYLE="letter-spacing: 0.15pt">and </FONT>without any bond or other security being required.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Enforcement Expenses</U>. The Maker agrees to pay all costs and expenses of enforcement of this Note, including, without <FONT STYLE="letter-spacing: 0.15pt">limitation,
</FONT>reasonable attorneys&rsquo; fees and expenses.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Binding Effect</U>. <FONT STYLE="letter-spacing: 0.15pt">The</FONT> <FONT STYLE="letter-spacing: 0.2pt">obligations</FONT> <FONT STYLE="letter-spacing: 0.1pt">of</FONT>
<FONT STYLE="letter-spacing: 0.15pt">the</FONT> <FONT STYLE="letter-spacing: 0.2pt">Maker</FONT> <FONT STYLE="letter-spacing: 0.15pt">and
the</FONT> <FONT STYLE="letter-spacing: 0.2pt">Holder</FONT> <FONT STYLE="letter-spacing: 0.15pt">set</FONT> <FONT STYLE="letter-spacing: 0.2pt">forth
herein shall</FONT> <FONT STYLE="letter-spacing: 0.1pt">be</FONT> <FONT STYLE="letter-spacing: 0.2pt">binding</FONT> <FONT STYLE="letter-spacing: 0.15pt">upon
the</FONT> <FONT STYLE="letter-spacing: 0.2pt">successors</FONT> <FONT STYLE="letter-spacing: 0.15pt">and</FONT> <FONT STYLE="letter-spacing: 0.2pt">assigns</FONT>
<FONT STYLE="letter-spacing: 0.25pt">of </FONT>each such party, whether or not such successors or assigns are permitted by the terms herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments; Waivers</U>. No provision of this Note may be waived or amended except in a written instrument signed by the Company
and the Holder. No waiver of any default with respect to any provision, condition or requirement of this Note shall be deemed to be a
continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.1pt"><U>Jurisdiction; Venue</U>. </FONT>Any action, proceeding or claim arising out of, or relating
in any way to this Note shall be brought and enforced in the state or federal courts located in New Castle County, Delaware. The Company
and the Holder irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection
to such exclusive jurisdiction or that such courts represent an inconvenient forum. Each of the Company and the Holder agrees it may be
served with legal process in the State of Delaware at the address set forth in Section 11.5 of the Purchase Agreement. The prevailing
party in any such action shall be entitled to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating
to such action or proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Parties in Interest</U>. This Note shall be binding upon, inure to the benefit of and be enforceable by the Maker, the Holder
and <FONT STYLE="letter-spacing: 0.15pt">their </FONT>respective successors and permitted <FONT STYLE="letter-spacing: 0.15pt">assigns.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.1pt"><U>Failure </U></FONT><U>or <FONT STYLE="letter-spacing: 0.1pt">Indulgence </FONT>Not <FONT STYLE="letter-spacing: 0.1pt">Waiver</FONT></U><FONT STYLE="letter-spacing: 0.1pt">.
</FONT>No <FONT STYLE="letter-spacing: 0.15pt">failure </FONT>or <FONT STYLE="letter-spacing: 0.15pt">delay </FONT>on <FONT STYLE="letter-spacing: 0.1pt">the
</FONT><FONT STYLE="letter-spacing: 0.15pt">part </FONT>of <FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">Holder
</FONT>in <FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">exercise </FONT>of <FONT STYLE="letter-spacing: 0.1pt">any
</FONT><FONT STYLE="letter-spacing: 0.15pt">power, right </FONT>or <FONT STYLE="letter-spacing: 0.2pt">privilege </FONT>hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.1pt"><U>Maker Waivers</U>. Except</FONT> as <FONT STYLE="letter-spacing: 0.1pt">otherwise specifically
provided herein,</FONT> the <FONT STYLE="letter-spacing: 0.1pt">Maker</FONT> and all <FONT STYLE="letter-spacing: 0.1pt">others that</FONT>
may <FONT STYLE="letter-spacing: 0.15pt">become </FONT>liable for all or any part of the obligations evidenced by this Note, hereby waive
presentment, demand, notice of nonpayment, protest and all other <FONT STYLE="letter-spacing: 0.1pt">demands and </FONT><FONT STYLE="letter-spacing: 0.15pt">notices
</FONT>in <FONT STYLE="letter-spacing: 0.15pt">connection with </FONT><FONT STYLE="letter-spacing: 0.1pt">the </FONT><FONT STYLE="letter-spacing: 0.15pt">delivery,
acceptance, performance </FONT><FONT STYLE="letter-spacing: 0.1pt">and </FONT><FONT STYLE="letter-spacing: 0.15pt">enforcement </FONT>of
<FONT STYLE="letter-spacing: 0.15pt">this Note, </FONT><FONT STYLE="letter-spacing: 0.1pt">and </FONT>do <FONT STYLE="letter-spacing: 0.15pt">hereby
consent </FONT>to <FONT STYLE="letter-spacing: 0.2pt">any </FONT><FONT STYLE="letter-spacing: 0.1pt">number </FONT>of <FONT STYLE="letter-spacing: 0.1pt">renewals
</FONT>of <FONT STYLE="letter-spacing: 0.1pt">extensions </FONT>of the <FONT STYLE="letter-spacing: 0.1pt">time </FONT>or <FONT STYLE="letter-spacing: 0.1pt">payment
hereof </FONT>and <FONT STYLE="letter-spacing: 0.1pt">agree that </FONT>any <FONT STYLE="letter-spacing: 0.1pt">such renewals </FONT>or
<FONT STYLE="letter-spacing: 0.1pt">extensions </FONT>may be <FONT STYLE="letter-spacing: 0.1pt">made without notice </FONT><FONT STYLE="letter-spacing: 0.15pt">to
</FONT>any such persons and without affecting their liability herein and do further consent to the release of any person liable hereon,
all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL
BY JURY.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto,
shall operate as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights
on any <FONT STYLE="letter-spacing: 0.1pt">one </FONT>occasion be deemed a waiver of the same right or rights on any future occasion.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>THE MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL <FONT STYLE="letter-spacing: -0.2pt">TRANSACTION,</FONT>
<FONT STYLE="letter-spacing: -0.15pt">AND</FONT> TO <FONT STYLE="letter-spacing: -0.15pt">THE</FONT> <FONT STYLE="letter-spacing: -0.2pt">EXTENT
ALLOWED</FONT> BY <FONT STYLE="letter-spacing: -0.2pt">APPLICABLE</FONT> <FONT STYLE="letter-spacing: -0.15pt">LAW,</FONT> <FONT STYLE="letter-spacing: -0.2pt">HEREBY
WAIVES</FONT> <FONT STYLE="letter-spacing: -0.15pt">ITS</FONT> <FONT STYLE="letter-spacing: -0.2pt">RIGHT</FONT> TO <FONT STYLE="letter-spacing: -0.2pt">NOTICE</FONT>
<FONT STYLE="letter-spacing: -0.15pt">AND</FONT> <FONT STYLE="letter-spacing: -0.2pt">HEARING WITH </FONT><FONT STYLE="letter-spacing: -0.3pt">RESPECT</FONT>
<FONT STYLE="letter-spacing: -0.15pt">TO</FONT> <FONT STYLE="letter-spacing: -0.2pt">ANY</FONT> <FONT STYLE="letter-spacing: -0.3pt">PREJUDGMENT</FONT>
<FONT STYLE="letter-spacing: -0.25pt">REMEDY WHICH</FONT> <FONT STYLE="letter-spacing: -0.2pt">THE</FONT> <FONT STYLE="letter-spacing: -0.25pt">HOLDER</FONT>
<FONT STYLE="letter-spacing: -0.15pt">OR</FONT> <FONT STYLE="letter-spacing: -0.2pt">ITS</FONT> <FONT STYLE="letter-spacing: -0.3pt">SUCCESSORS</FONT>
<FONT STYLE="letter-spacing: -0.15pt">OR</FONT> <FONT STYLE="letter-spacing: -0.3pt">ASSIGNS</FONT> <FONT STYLE="letter-spacing: -0.2pt">MAY</FONT>
<FONT STYLE="letter-spacing: -0.25pt">DESIRE</FONT> <FONT STYLE="letter-spacing: -0.15pt">TO</FONT> <FONT STYLE="letter-spacing: -0.3pt">USE.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">5.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definitions</U>. <FONT STYLE="letter-spacing: 0.15pt">Capitalized terms used herein</FONT> <FONT STYLE="letter-spacing: 0.1pt">and
not</FONT> <FONT STYLE="letter-spacing: 0.15pt">defined shall have</FONT> <FONT STYLE="letter-spacing: 0.1pt">the</FONT> <FONT STYLE="letter-spacing: 0.15pt">meanings</FONT>
<FONT STYLE="letter-spacing: 0.1pt">set</FONT> <FONT STYLE="letter-spacing: 0.15pt">forth</FONT> in <FONT STYLE="letter-spacing: 0.1pt">the</FONT>
<FONT STYLE="letter-spacing: 0.15pt">Purchase Agreement. For</FONT> <FONT STYLE="letter-spacing: 0.25pt">the </FONT>purposes hereof, the
following terms shall have the following meanings:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Convertible Securities</U>&rdquo; means any securities convertible into or exercisable or exchangeable for, directly
or indirectly, shares of Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Floor Price</U>&rdquo; means $0.75.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="letter-spacing: 0.2pt"><U>&ldquo;Indebtedness</U>&rdquo; </FONT>means, with respect to the Maker or any Subsidiary:
(a) all obligations for borrowed money; (b) all obligations evidenced by bonds, debentures, notes, or other similar instruments and all
reimbursement or other obligations in respect of letters of credit, bankers acceptances, current swap agreements, interest rate hedging
agreements, interest rate swaps, or other financial products; (c) all capital lease obligations (other than capital lease obligations
where recourse is limited solely to the asset which has been leased) that exceed $5,000,000 in the aggregate in any fiscal year; (d) all
obligations or liabilities secured by a lien or encumbrance on any asset of the Maker or any Subsidiary, irrespective of whether such
obligation or liability is assumed; (e) all obligations for the deferred purchase price of assets, together with trade debt and other
accounts payable that exceed $7,500,000 in the aggregate in any fiscal year; (f) all synthetic leases; (g) any obligation guaranteeing
or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted or sold with recourse) any of the foregoing
obligations of any other person; (h) trade debt which, when taken together with the obligations described in clause (e) hereof, does not
exceed, in the aggregate, $7,500,000 in any fiscal year; and (i) endorsements for collection or deposit.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> &ldquo;<U>Mandatory Default Amount</U>&rdquo; means an amount equal to one hundred ten percent (110%) of the Outstanding Principal
Amount of this Note on the date on which the first Event of Default has occurred hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Market Capitalization</U>&rdquo; means, as of any date of determination, the product of (a) the number of issued and
outstanding shares of Common Stock as of such date (exclusive of any shares of Common Stock issuable upon the exercise of options or warrants
or conversion of any convertible securities), multiplied by (b) the closing price of the Common Stock on the Trading Market on the date
of determination.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Outstanding Principal Amount</U>&rdquo; means, at the time of determination, the Principal Amount outstanding after giving
effect to any adjustments, conversions or prepayments pursuant to the terms hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Prepayment Amount</U>&rdquo; means an amount equal to the product of the Outstanding Principal Amount multiplied by 1.05.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Repayment Shares</U>&rdquo; means shares of Common Stock issued to the Holder by the Maker as payment for the Principal
Amount, pursuant to <U>Section 1.3</U> of this Note.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 13.5pt; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Repayment Share Price</U>&rdquo; means ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs
during the twenty (20) Trading Days prior to the Payment Date; provided, that in no event shall the Repayment Share Price be less than
the Floor Price, and in the event that the calculation set forth above would result in a Repayment Share Price less than the Floor Price,
the &ldquo;Repayment Share Price&rdquo; for purposes herein shall be the Floor Price.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">[Signature Pages Follow]</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/102% Times New Roman, Times, Serif; margin: 3.95pt 1pt 24.55pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Maker
has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5in 2in; text-indent: 0.5in"><B>RED CAT HOLDINGS, INC.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: 0.5in">By:<U> ___________________________</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: 0.5in">Name: Jeffrey Thompson</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 63.4pt 2in; text-indent: 0.5in">Title: CEO</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/205% Times New Roman, Times, Serif; margin: 3.4pt 1pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><B>EXHIBIT
</B></FONT><B>A </B></P>

<P STYLE="font: 12pt/205% Times New Roman, Times, Serif; margin: 3.4pt 1pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.3pt"><B>WIRE
</B></FONT><B><FONT STYLE="letter-spacing: -0.35pt">INSTRUCTIONS</FONT></B></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/205% Times New Roman, Times, Serif; margin: 3.4pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><B>EXHIBIT
</B></FONT><B>B</B></P>

<P STYLE="font: 12pt/205% Times New Roman, Times, Serif; margin: 3.4pt 0 0; text-align: center"><FONT STYLE="letter-spacing: -0.35pt"><B>FORM
</B></FONT><B><FONT STYLE="letter-spacing: -0.45pt">OF </FONT><FONT STYLE="letter-spacing: -0.35pt">CONVERSION NOTICE</FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.3pt 0 12.5pt; text-align: center">(To be Executed by the Registered Holder
in order to Convert the Note)</P>

<P STYLE="font: 12pt/102% Times New Roman, Times, Serif; margin: 0 4.8pt 12.25pt 12.3pt; text-align: justify">The undersigned hereby irrevocably
elects to convert $ ________________ of the principal amount of the above Note No. ___ into shares of Common Stock of Red Cat Holdings,
Inc. (the &ldquo;<U>Maker</U>&rdquo;) according to the conditions hereof, as of the date written below.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12.5pt 12.3pt">Date of Conversion:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12.5pt 12.3pt">Conversion Price:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 12.3pt">Number of shares of Common Stock beneficially owned or deemed
beneficially owned by the Holder on the Conversion Date:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.25pt 0 12.5pt 12.3pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">[HOLDER]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">By: ____________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">Name:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.2pt 0 12.5pt 3.5in">Title:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">Address:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>4
<FILENAME>rcat0923form10qexh10_9.htm
<DESCRIPTION>EXHIBIT 10.9
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.9</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">The number
of shares of common stock issuable upon exercise of this warrant may be MORE OR less than the amounts set forth on the face hereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Warrant is issued pursuant to that certain Securities
Purchase Agreement dated [&bull;], 2024 by and between the Company and the Holder (as defined below) (the &ldquo;<U>Purchase Agreement</U>&rdquo;).
Receipt of this Warrant by the Holder shall constitute acceptance and agreement to all of the terms contained herein.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">No. [&bull;]&#9;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>RED CAT
HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>COMMON STOCK PURCHASE WARRANT</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Red Cat Holdings, Inc., a Nevada
corporation (together with any corporation which shall succeed to or assume the obligations of Red Cat Holdings, Inc. hereunder, the &ldquo;<U>Company</U>&rdquo;),
hereby certifies that, for value received, Lind Global Asset Management X LLC, a Delaware limited liability company (the &ldquo;<U>Holder</U>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period (as defined in
<U>Section 9</U>) up to Seven Hundred Fifty Thousand (750,000) fully paid and non-assessable shares of Common Stock, at a purchase price
per share equal to the Exercise Price (as defined in <U>Section 9</U>). The number of shares of Common Stock for which this Common Stock
Purchase Warrant (this &ldquo;<U>Warrant</U>&rdquo;) is exercisable and the Exercise Price are subject to adjustment as provided herein.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>DEFINITIONS</U>.
Certain terms are used in this Warrant as specifically defined in <U>Section 9</U>. Capitalized terms used and not otherwise defined herein
shall have the meanings set forth for such terms in the Purchase Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>EXERCISE
OF WARRANT</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise</U>.
This Warrant may be exercised prior to its expiration hereof by the Holder at any time or from time to time during the Exercise Period,
by submitting the form of subscription attached hereto (the &ldquo;<U>Exercise Notice</U>&rdquo;) duly executed by the Holder, to the
Company at its principal office, indicating whether the Holder is electing to purchase a specified number of shares by paying the Aggregate
Exercise Price as provided in <U>Section 2.2</U> or is electing to exercise this Warrant as to a specified number of shares pursuant to
the cashless exercise provisions of <U>Section 2.3</U>. On or before the first Trading Day following the date on which the Company has
received the Exercise Notice, the Company shall transmit by electronic mail an acknowledgement of confirmation of receipt of the Exercise
Notice. Subject to <U>Section 2.4</U>, this Warrant shall be deemed exercised for all purposes as of the close of business on the day
on which the Holder has delivered the Exercise Notice to the Company. The Aggregate Exercise Price, if any, shall be paid by wire transfer
to the Company within five (5) Business Days of the date of exercise and prior to the time the Company issues the certificates evidencing
the shares issuable upon such exercise. In the event this Warrant is not exercised in full, the Company may, at its expense, require the
Holder, after such partial exercise, to promptly return this Warrant to the Company and the Company will forthwith issue and deliver to
or upon the order of the Holder a new Warrant or Warrants of like tenor, in the name of the Holder or as the Holder (upon payment by the
Holder of any applicable transfer taxes) may request, calling in the aggregate on the face or faces thereof for the number of shares of
Common Stock equal (without giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant
minus the number of such shares (without giving effect to any adjustment therein) for which this Warrant shall have been exercised.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Exercise Price by Wire Transfer</U>. If the Holder elects to purchase a specified number of shares by paying the Aggregate Exercise
Price, the Holder shall pay such amount by wire transfer of immediately available funds to the account designated by the Company in its
acknowledgement of receipt of such Exercise Notice pursuant to <U>Section 2.1</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise</U>. If, after six (6) months following the Closing Date, a registration statement covering the shares of Common Stock that are
the subject of the Notice of Exercise (the &ldquo;<U>Unavailable Warrant Shares</U>&rdquo;) is not available for the resale of such Unavailable
Warrant Shares to the public or upon exercise of this Warrant in connection with a Fundamental Transaction, the Holder may elect to exercise
this Warrant by receiving shares of Common Stock equal to the number of shares determined pursuant to the following formula:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">X = <U>Y (A - B)</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">A</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 29.15pt">where,</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">X =</TD><TD>the number of shares of Common Stock to be issued to Holder;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">Y =</TD><TD>the number of shares of Common Stock as to which this Warrant is to be exercised (as indicated on the Exercise Notice);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">A =</TD><TD>VWAP for the Trading Day immediately preceding the date of exercise; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.75in">B =</TD><TD>the Exercise Price.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.75in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -0.75in">This Warrant will be exercised pursuant
to this <U>Section 2.3</U> automatically and without further</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-indent: -1.25in">action by any Person immediately prior
to the time at which it expires in accordance with <U>Section 2.5</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Antitrust
Notification</U>. If the Holder determines, in its sole judgment upon the advice of counsel, that the issuance of any Warrant Shares pursuant
to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &ldquo;<U>HSR
Act</U>&rdquo;), the Company shall file as soon as practicable after the date on which the Company receives notice from the Holder of
the applicability of the HSR Act and a request to so file with the United States Federal Trade Commission and the United States Department
of Justice the notification and report form required to be filed by it pursuant to the HSR Act in connection with such issuance.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Warrant shall terminate upon the earlier to occur of (i) exercise in full or (ii) the expiration of the Exercise Period, or (iii)
the consummation of an acquisition of substantially all outstanding equity securities the Company or substantially all assets of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REGISTRATION
RIGHTS</U>. The Holder of this Warrant has certain rights to require the Company to register its resale of the Warrant Shares under the
1933 Act and any blue sky or securities laws of any jurisdictions within the United States at the time and in the manner specified in
the Purchase Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>DELIVERY
OF STOCK CERTIFICATES ON EXERCISE</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Exercise Shares</U>. As soon as practicable after any exercise of this Warrant and in any event within three (3) Trading Day thereafter
(such date, the &ldquo;<U>Exercise Share Delivery Date</U>&rdquo;), the Company shall, at its expense (including the payment by it of
any applicable issue or stamp taxes), cause to be issued in the name of and delivered to the Holder, or as the Holder may direct, a certificate
or certificates evidencing the number of fully paid and non-assessable shares of Common Stock (which number shall be rounded down to the
nearest whole share in the event any fractional share may otherwise be issuable upon such exercise and the Company shall pay a cash adjustment
to the Holder in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price) to which the Holder
shall be entitled on such exercise, in such denominations as may be requested by the Holder, which certificate or certificates shall be
free of restrictive and trading legends (except for any such legends as may be required under the 1933 Act). In lieu of delivering physical
certificates for the shares of Common Stock issuable upon any exercise of this Warrant, provided the Warrant Shares are not restricted
securities and the Company&rsquo;s transfer agent is participating in the Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) Fast Automated
Securities Transfer program or a similar program, upon request of the Holder, the Company shall cause its transfer agent to electronically
transmit such shares of Common Stock issuable upon exercise of this Warrant to the Holder (or its designee), by crediting the account
of the Holder&rsquo;s (or such designee&rsquo;s) broker with DTC through its Deposit Withdrawal Agent Commission system (provided that
the same time periods herein as for stock certificates shall apply) as instructed by the Holder (or its designee).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Exercise Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Exercise Shares, all of which taxes and expenses shall be paid by the Company, and
such Exercise Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in the event Exercise Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto (the &ldquo;<U>Assignment Form</U>&rdquo;) duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CERTAIN
ADJUSTMENT</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (a) pays a stock dividend or otherwise makes
a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant),
(b) subdivides (including by way of share split) outstanding shares of Common Stock into a larger number of shares, (c) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (d) issues by reclassification of
shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section 5.1</U> shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder shall be notified at least ten days prior to the record date for determining shareholders entitled to participate in the
Distribution and Holder shall, at its option, exercise its warrants on or prior to such record date be entitled to participate in such
Distribution (provided, however, that, to the extent that the Holder&rsquo;s warrant exercise would result in the Holder exceeding the
beneficial ownership limitation provided for in <U>Section 10</U>, then the Holder shall not be entitled to exercise its warrants). .</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (a) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (b) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (c) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (d) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (e) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity
of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, Holder shall be notified at least ten days prior to the closing
of the transaction and Holder shall, at its option, exercise its warrants prior to the closing. In the event that Holder fails to exercise
the warrants, the warrants will be terminated upon closing.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments
to Exercise Price Upon Issuance of Common Stock</U>. In the event the Company shall at any time or from time to time after the Closing
Date (but whether before or after the Issue Date) issue or sell any additional shares of Common Stock or Common Stock Equivalents (&ldquo;<U>Additional
Shares of Common Stock</U>&rdquo;), other than Exempted Securities, at an effective price per share (or issuable, convertible or exercisable
at a price per share) that is less than the Exercise Price then in effect or without consideration (a &ldquo;<U>Dilutive Issuance</U>&rdquo;),
then automatically and without further action by any Person the Exercise Price upon each such issuance shall be reduced to a price equal
to the consideration per share paid for such Additional Shares of Common Stock (the &ldquo;<U>Base Share Price</U>&rdquo;). For purposes
of clarification, the amount of consideration received for such Additional Shares of Common Stock shall not include the value of any additional
securities or other rights received in connection with such issuance of Additional Shares of Common Stock (i.e., warrants, rights of first
refusal or other similar rights). The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Additional Shares of Common Stock subject to this Section 5.4, indicating therein the applicable issuance price,
or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;).
For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 5.4, upon the occurrence
of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of whether
the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters into a Variable Rate Transaction,
the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible price, conversion price or
exercise price at which such securities may be issued, converted or exercised.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations</U>.
All calculations under this <U>Section 5</U> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this <U>Section 5</U>, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding at the close of the Trading
Day on or, if not applicable, most recently preceding, such given date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
to Exercise Price or number of Warrant Shares</U>. Whenever the Exercise Price or number of Warrant Shares is adjusted pursuant to any
provision of this <U>Section 5</U>, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price or number
of Warrant Shares, as applicable, after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (i) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock; (ii) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock; (iii) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights; (iv) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, of any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property;
or (v) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company;
then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register
of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the
mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. Subject to applicable law,
the Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event
triggering such notice. Notwithstanding the foregoing, the delivery of the notice described in this <U>Section 5.6</U> is not intended
to and shall not bestow upon the Holder any voting rights whatsoever with respect to outstanding unexercised Warrants.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NO
IMPAIRMENT</U>. The Company will not, by amendment of the Organizational Documents or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and
in taking all such action as may be necessary or appropriate in order to protect the rights of the Holder against impairment. Without
limiting the generality of the foregoing, the Company (a) will not increase the par value of any shares of Common Stock receivable on
the exercise of this Warrant above the amount payable therefor on such exercise and (b) will take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of stock on the exercise of
this Warrant from time to time outstanding.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NOTICES
OF RECORD DATE</U>. In the event of:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are
entitled to receive any dividend or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of stock
of any class or any other securities or property, or to receive any other right;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any transfer of
all or substantially all the assets of the Company to or any consolidation or merger of the Company with or into any other Person or any
other Change of Control; or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
voluntary or involuntary dissolution, liquidation or winding-up of the Company;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">then, and in each such event, the Company will mail
or cause to be mailed to the Holder a notice specifying (i) the date on which any such record is to be taken for the purpose of such dividend,
distribution or right, and stating the amount and character of such dividend, distribution or right, or (ii) the date on which any such
reorganization, reclassification, recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up is anticipated
to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock shall be entitled to exchange their
shares of Common Stock for securities or other property deliverable on such reorganization, reclassification, recapitalization, transfer,
consolidation, merger, dissolution, liquidation or winding-up. Such notice shall be mailed at least fifteen (15) days prior to the date
specified in such notice on which any such action is to be taken.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>RESERVATION
OF STOCK ISSUABLE ON EXERCISE OF WARRANT; REGULATORY COMPLIANCE; PROHIBITED TRANSACTIONS</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation
of Stock Issuable on Exercise of Warrant</U>. The Company shall at all times while this Warrant shall be outstanding, reserve and keep
available out of its authorized but unissued Common Stock, such number of shares of Common Stock as shall from time to time be sufficient
to effect the exercise of all or any portion of the Warrant Shares (disregarding for this purpose any and all limitations of any kind
on such exercise). The Company shall, from time to time in accordance with Chapter 78 of the Nevada Revised Statutes, increase the authorized
number of shares of Common Stock or take other effective action if at any time the unissued number of authorized shares shall not be sufficient
to satisfy the Company&rsquo;s obligations under this <U>Section 8</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Compliance</U>. If any shares of Common Stock to be reserved for the purpose of exercise of the Warrant Shares require registration or
listing with or approval of any Governmental Authority, stock exchange or other regulatory body under any federal or state law or regulation
or otherwise before such shares may be validly issued or delivered upon exercise, the Company shall, at its sole cost and expense, in
good faith and as expeditiously as possible, secure such registration, listing or approval, as the case may be.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prohibited
Transactions</U>. The Company hereby covenants and agrees not to enter into any Prohibited Transactions while any balance remains due
under the Note.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>DEFINITIONS</U>.
As used herein the following terms, unless the context otherwise requires, have the following respective meanings:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="font-size: 11pt"><U>Aggregate
Exercise Price</U></FONT>&rdquo; <FONT STYLE="font-size: 11pt">means, in connection with the exercise of this Warrant at any time, an
amount equal to the product obtained by multiplying (i) the Exercise Price times (ii) the number of </FONT>shares of Common Stock <FONT STYLE="font-size: 11pt">for
which this Warrant is being exercised at such time.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Change of Control</U>&rdquo;
has the meaning set forth in the Purchase Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Convertible Securities</U>&rdquo;
means any debt, equity or other securities that are, directly or indirectly, convertible into or exchangeable for Common Stock.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exercise Period</U>&rdquo;
means the period commencing on the Issue Date and ending 11:59 P.M. (New York City time) on the date that is sixty (60) months from the
Issue Date or earlier closing of a Fundamental Transaction (other than a Fundamental Transaction of the type described in clause (d) of
the definition thereof resulting in the conversion into or exchange for another security of the Company).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exercise Price</U>&rdquo;
means $6.50 per share, as may be adjusted pursuant to the terms hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exercise Shares</U>&rdquo;
means the shares of Common Stock for which this Warrant is then being exercised.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Fair Market Value</U>&rdquo;
means, with respect to any security or other property, the fair market value of such security or other property as determined by the Board
of Directors, acting in good faith.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Governmental
Authority</U>&rdquo; means the government of the United States or any other nation, or of any political subdivision thereof, whether state
or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative,
judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies
such as the European Union or the European Central Bank).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Issue Date</U>&rdquo;
means [&bull;], 2024.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="font-size: 11pt"><U>Note</U></FONT>&rdquo;
<FONT STYLE="font-size: 11pt">means the senior secured convertible promissory note issued by the Company to the Holder pursuant to the
Purchase Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="font-size: 11pt"><U>Person</U></FONT>&rdquo;
<FONT STYLE="font-size: 11pt">means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means, as of any time of determination and with respect to any Person, any United States corporation, partnership, limited liability company
or limited liability partnership, all of the stock (or other equity interest) of every class of which, except directors&rsquo; qualifying
shares (or any equivalent), shall, at such time, be owned by such Person either directly or through Subsidiaries and of which such Person
or a Subsidiary shall have 100% control thereof, except directors&rsquo; qualifying shares. Unless the context otherwise clearly requires,
any reference to a &ldquo;Subsidiary&rdquo; is a reference to a Subsidiary of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means whichever of the New York Stock Exchange, NYSE: Amex Exchange, or the Nasdaq Stock Market (including the Nasdaq Capital Market),
on which the Common Stock is listed or quoted for trading on the date in question.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate
Transaction</U>&rdquo; means a transaction in which the Company (A) issues or sells any debt or equity securities that are convertible
into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (x) at a conversion price,
exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the Common
Stock at any time after the initial issuance of such debt or equity securities or (y) with a conversion, exercise or exchange price that
is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified
or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (B) enters into,
or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue
securities at a future determined price.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of one share of Common Stock trading in the ordinary course of
business on the applicable Trading Price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg
Financial L.P.; (b) if the Common Stock is not then listed on a Trading Market and if the Common Stock is traded in the over-the-counter
market, as reported by the OTC Bulletin Board, the volume weighted average price of one share of Common Stock for such date (or the nearest
preceding date) on the OTC Bulletin Board, as reported by Bloomberg Financial L.P.; (c) if the Common Stock is not then listed or quoted
on the OTC Bulletin Board and if prices for the Common Stock are then reported in the &ldquo;Pink Sheets&rdquo; published by the Pink
OTC Markets Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price of one
share of Common Stock so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases, the fair market value of one share
of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company
(in each case rounded to four decimal places).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="font-size: 11pt"><U>Warrant
Shares</U></FONT>&rdquo; <FONT STYLE="font-size: 11pt">means collectively the shares of Common Stock of the Company issuable upon exercise
of the Warrant in accordance with its terms, as such number may be adjusted pursuant to the provisions thereof.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>LIMITATION
ON BENEFICIAL OWNERSHIP</U>. Notwithstanding anything to the contrary contained herein, the Holder shall not be entitled to receive shares
of Common Stock or other securities (together with Common Stock, &ldquo;<U>Equity Interests</U>&rdquo;) upon exercise of this Warrant
to the extent (but only to the extent) that such exercise or receipt would cause the Holder Group to become, directly or indirectly, a
&ldquo;beneficial owner&rdquo; (within the meaning of Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder)
of a number of Equity Interests of a class that is registered under the 1934 Act which exceeds the Maximum Percentage (as defined in the
Purchase Agreement) of the Equity Interests of such class that are outstanding at such time. Any purported delivery of Equity Interests
in connection with the exercise of the Warrant prior to the termination of this restriction in accordance herewith shall be void and have
no effect to the extent (but only to the extent) that such delivery would result in the Holder Group becoming the beneficial owner of
more than the Maximum Percentage of the Equity Interests of a class that is registered under the 1934 Act that is outstanding at such
time. If any delivery of Equity Interests owed to the Holder following exercise of this Warrant is not made, in whole or in part, as a
result of this limitation, the Company&rsquo;s obligation to make such delivery shall not be extinguished and the Company shall deliver
such Equity Interests as promptly as practicable after the Holder gives notice to the Company that such delivery would not result in such
limitation being triggered or upon termination of the restriction in accordance with the terms hereof. To the extent limitations contained
in this <U>Section 10</U> apply, the determination of whether this Warrant is exercisable and of which portion of this Warrant is exercisable
shall be the sole responsibility and in the sole determination of the Holder, and the submission of an Exercise Notice shall be deemed
to constitute the Holder&rsquo;s determination that the issuance of the full number of Warrant Shares requested in the Exercise Notice
is permitted hereunder, and neither the Company nor any Warrant agent shall have any obligation to verify or confirm the accuracy of such
determination. For purposes of this <U>Section 10</U>, (i) the term &ldquo;<U>Maximum Percentage</U>&rdquo; shall have the definition
set forth in the Purchase Agreement; and (ii) the term &ldquo;<U>Holder Group</U>&rdquo; shall mean the Holder plus any other Person with
which the Holder is considered to be part of a group under Section 13 of the 1934 Act or with which the Holder otherwise files reports
under Sections 13 and/or 16 of the 1934 Act. In determining the number of Equity Interests of a particular class outstanding at any point
in time, the Holder may rely on the number of outstanding Equity Interests of such class as reflected in (x) the Company&rsquo;s most
recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as the case may be, (y) a more recent public announcement
by the Company or (z) a more recent notice by the Company or its transfer agent to the Holder setting forth the number of Equity Interests
of such class then outstanding. For any reason at any time, upon written or oral request of the Holder, the Company shall, within one
(1) Trading Day of such request, confirm orally and in writing to the Holder the number of Equity Interests of any class then outstanding.
The provisions of this <U>Section 10</U> shall be construed, corrected and implemented in a manner so as to effectuate the intended beneficial
ownership limitation herein contained.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REGISTRATION
AND TRANSFER OF WARRANT</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">11.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
of Warrant</U>. The Company shall register and record transfers, exchanges, reissuances and cancellations of this Warrant, upon the records
to be maintained by the Company for that purpose, in the name of the record holder hereof from time to time. The Company may deem and
treat the registered holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to
the Holder, and for all other purposes, absent actual notice to the contrary. The Company shall be entitled to rely, and held harmless
in acting or refraining from acting in reliance upon, any notices, instructions or documents it believes in good faith to be from an authorized
representative of the Holder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form of assignment (the &ldquo;<U>Assignment Notice</U>&rdquo;) attached hereto duly executed by the Holder
or its agent or attorney. The Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the
transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of the transferred Warrant under the 1933 Act. Upon such surrender, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified
in such Assignment Notice, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the
purchase of Exercise Shares without having a new Warrant issued.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with <U>Section 11.2</U>, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for this Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Exercise Shares issuable pursuant thereto.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>LOSS,
THEFT, DESTRUCTION OR MUTILATION OF WARRANT</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Exercise Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of this Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>REMEDIES</U>.
The Company stipulates that the remedies at law of the Holder in the event of any default or threatened default by the Company in the
performance of or compliance with any of the terms of this Warrant are not and will not be adequate, and that such terms may be specifically
enforced by a decree for the specific performance of any agreement contained herein or by an injunction against a violation of any of
the terms hereof or otherwise.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>DIVIDENDS
AND DISTRIBUTIONS</U>. With respect to the Exercise Shares, the Holder shall be entitled to receive, on the same basis as holders of Common
Stock, any dividends paid or distributions on Common Stock as if this Warrant were exercised for shares of Common Stock (without regard
to limitations on exercise) immediately prior to the record date for such dividend or distribution.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NOTICES</U>.
All notices, requests, demands and other communications that are required or may be given pursuant to the terms of this Warrant shall
be in writing and shall be deemed delivered (i) on the date of delivery when delivered by hand on a Business Day during normal business
hours or, if delivered on a day that is not a Business Day or after normal business hours, then on the next Business Day, (ii) on the
date of transmission when sent by facsimile transmission or email during normal business hours on a Business Day with telephone confirmation
of receipt or, if transmitted on a day that is not a Business Day or after normal business hours, then on the next Business Day, or (iii)
on the second Business Day after the date of dispatch when sent by a reputable courier service that maintains records of receipt. The
addresses for notice shall be as set forth in the Purchase Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>CONSENT
TO AMENDMENTS</U>. Any term of this Warrant may be amended, and the Company may take any action herein prohibited, or compliance therewith
may be waived, only if the Company shall have obtained the written consent (and not without such written consent) to such amendment, action
or waiver from the Holder. No course of dealing between the Company and the Holder nor any delay in exercising any rights hereunder shall
operate as a waiver of any rights of the Holder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>MISCELLANEOUS</U>.
In case any provision of this Warrant shall be invalid, illegal or unenforceable, or partially invalid, illegal or unenforceable, the
provision shall be enforced to the extent, if any, that it may legally be enforced and the validity, legality and enforceability of the
remaining provisions shall not in any way be affected or impaired thereby. If any provision of this Warrant is found to conflict with
the Purchase Agreement, the provisions of this Warrant shall prevail. If any provision of this Warrant is found to conflict with the Note,
the provisions of the Note shall prevail. THIS WARRANT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES
SHALL BE GOVERNED BY, THE INTERNAL LAW OF THE STATE OF DELAWARE EXCLUDING CHOICE-OF-LAW PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD
PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. Each of the Company and the Holder agrees it may be served
with legal process in the State of Delaware at the address set forth in Section 11.5 of the Purchase Agreement. The prevailing party in
any such action shall be entitled to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating to
such action or proceeding. The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any
of the terms hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Remainder of Page Intentionally Left Blank]</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its duly authorized officer.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dated as of September 22, 2024</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><B>RED CAT HOLDINGS, INC.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">By:<U>____________________________</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">Name: Jeffrey Thompson</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">Title: CEO</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM OF SUBSCRIPTION</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(To be signed only on exercise</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">of Common Stock Purchase Warrant)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">TO:&#9;Red Cat Holdings, Inc.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned Holder of the attached Warrant hereby elects to exercise its purchase right under such Warrant to purchase shares of Common
Stock of Red Cat Holdings, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), as follows (check one or more, as applicable):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&#9744;&#9;to exercise
the Warrant to purchase __________ shares of Common Stock and to pay the Aggregate Exercise Price therefor by wire transfer of United
States funds to the account of the Company, which transfer has been made prior to or as of the date of delivery of this Form of Subscription
pursuant to the instructions of the Company;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 1in; text-indent: 0in">and/or</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>to exercise the Warrant with respect to ____________ shares of Common Stock pursuant to the cashless exercise provisions specified
in Section 2.3 of the Warrant.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
exercising this Warrant, the undersigned Holder hereby confirms and acknowledges that the shares of Common Stock are being acquired solely
for the account of the undersigned and not as a nominee for any other party, and for investment, and that the undersigned shall not offer,
sell or otherwise dispose of any such shares of Common Stock except under circumstances that will not result in a violation of the 1933
Act or any state securities laws. The undersigned hereby further confirms and acknowledges that it is an &ldquo;accredited investor&rdquo;,
as that term is defined under the 1933 Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
issue a stock certificate or certificates representing the appropriate number of shares of Common Stock in the name of the undersigned
or in such other name(s) as is specified below:</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 50%; border-collapse: collapse; font-size: 11pt">
  <TR>
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: left; width: 44%">Name:</TD>
    <TD STYLE="font: bold 12pt Times New Roman, Times, Serif; text-decoration: underline; vertical-align: middle; border-bottom: Black 0.5pt solid; text-align: left; width: 56%"><U></U></TD></TR>
  <TR>
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: left">Address:</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom; border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle">
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; border-bottom: Black 0.5pt solid; text-align: justify; border-top-color: Black; border-top-width: 0.5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom; border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom; border-bottom: Black 0.5pt solid; border-top-color: Black; border-top-width: 0.5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: left">TIN:</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; border-bottom: Black 0.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>&#9; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">(Signature must conform exactly to name of Holder as specified on the face
    of the Warrant)</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt">Dated: _________________</P></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM OF ASSIGNMENT</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(To be signed only on transfer of Warrant)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For value received, the undersigned
hereby sells, assigns, and transfers unto ________________ the right represented by the within Warrant to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
shares of Common Stock of Red Cat Holdings, Inc., a Nevada corporation, to which the within Warrant relates, and appoints _________________
attorney to transfer such right on the books of Red Cat Holdings, Inc., with full power of substitution in the premises.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font: 11pt Aptos Narrow">
  <TR>
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: left; width: 40%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 55%">[insert name of Holder]</TD></TR>
  <TR>
    <TD STYLE="padding-left: 54px; font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">Dated: ________________</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">By:__________________________________</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">Title:_________________________________</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">[insert address of Holder]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">Signed in the presence of:</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: middle; text-align: justify">___________________________</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>5
<FILENAME>rcat0923form10qexh10_10.htm
<DESCRIPTION>EXHIBIT 10.10
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.10</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center">SECURITY AGREEMENT</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><B>SECURITY AGREEMENT</B>
(this &quot;<U>Agreement</U>&quot;), dated as of September __, 2024, by and between <B>RED CAT HOLDINGS, INC., </B>a Nevada corporation
(the &quot;<U>Company</U>&quot;) and <B>LIND GLOBAL ASSET MANAGEMENT X LLC</B>, a Delaware limited liability company (the &quot;<U>Secured
Party</U>&quot;).</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
(a) and the Secured Party have entered into that certain Securities Purchase Agreement dated as of the date hereof (as amended and in
effect from time to time, the &quot;<U>SPA</U>&quot;) and (b) issued to the Secured Party that certain Senior Secured Convertible Promissory
Note dated as of the date hereof (as amended and in effect from time to time, the &quot;<U>Note</U>&quot;); and</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, it is a condition
precedent to the Secured Party agreeing to make loans or otherwise extend credit to the Company under the SPA and the Note that the Company
execute and deliver to the Secured Party a security agreement in substantially the form hereof; and</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
wishes to grant security interests in favor of the Secured Party as herein provided;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Definitions</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
All capitalized terms used herein without definitions shall have the respective meanings provided therefor in the SPA. All terms defined
in the Uniform Commercial Code of the State (as hereinafter defined) and used herein shall have the same definitions herein as specified
therein, however, if a term is defined in Article 9 of the Uniform Commercial Code of the State differently than in another Article of
the Uniform Commercial Code of the State, the term has the meaning specified in Article 9, and the following terms shall have the following
meanings:</FONT></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Event of Default</U>&quot;
means the occurrence of any &quot;Event of Default&quot; under and as defined in each of the SPA, the Note or any Supplemental Loan Document,
or the failure of the Company or any Guarantor to comply with any term or covenant of any Transaction Document (including this Agreement)
to which it is a party.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Guarantor</U>&quot;
means, collectively, each Person which provides a guarantee of all or any portion of the Obligations of the Company to the Secured Party.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Lien</U>&quot; means
any mortgage, charge, pledge, hypothecation, security interest, assignment by way of security, lien (statutory or otherwise), encumbrance,
conditional sale agreement, capital lease, financing lease, deposit arrangement, title retention agreement, and any other agreement, trust
or arrangement that in substance secures payment or performance of an obligation.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Obligations</U>&quot;
means, collectively, (a) all debts, liabilities and obligations, present or future, direct or indirect, absolute or contingent, matured
or unmatured, at any time or from time to time due or accruing due and owing by or otherwise payable by the Company or any Guarantor to
the Secured Party in any currency, under, in connection with or pursuant to any Transaction Document (including, without limitation, the
SPA, the Note, any Supplemental Loan Document or this Agreement), and whether incurred by the Company or any Guarantor alone or jointly
with another or others and whether as principal, guarantor or surety and in whatever name or style and (b) all expenses, costs and charges
incurred by or on behalf of the Secured Party in connection with any Transaction Document (including, without limitation, the SPA, the
Note, any Supplemental Loan Document and this Agreement) or the Collateral, including all legal fees, court costs, receiver&rsquo;s or
agent&rsquo;s remuneration and other expenses of taking possession of, repairing, protecting, insuring, preparing for disposition, realizing,
collecting, selling, transferring, delivering or obtaining payment for the Collateral, and of taking, defending or participating in any
action or proceeding in connection with any of the foregoing matters or otherwise in connection with the Secured Party's interest in any
Collateral, directly relating to the Secured Party's rights under this Agreement or any other Transaction Document (including, without
limitation, any enforcement of this Agreement or any other Transaction Document).</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Permitted Lien</U>&quot;
means any of the following: (a) mechanics and materialman Liens and other statutory Liens (including Liens for taxes, fees, assessments
and other governmental charges or levies) arising in the ordinary course of business in respect of any amount (i) which is not at the
time overdue or (ii) which may be overdue but the validity of which is being contested at the time in good faith by appropriate proceedings
and for which the Company has maintained adequate reserves, in each case so long as the holder of such Lien has not taken any action to
foreclose or otherwise exercise any remedies with respect to such Lien; (b) Liens granted by the Company in favor of the lender in a Permitted
Financing Arrangement to secure the Company's obligations under such Permitted Financing Arrangement so long as (i) such Lien covers only
the PO Assets or Equity Assets, as applicable; (ii) a Subordination Agreement is in full force and effect among the Company, the Secured
Party and the lender under the applicable Permitted Financing Arrangement; and (iii) all other conditions for the applicable Permitted
Financing Arrangement required by the SPA have been satisfied; and (c) Liens which are permitted in writing by the Secured Party in its
sole and absolute discretion.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Person</U>&quot;
means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, governmental
authority or other entity.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>State</U>&quot; means
the State of Delaware.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Supplemental Loan
Documents</U>&quot; means any other document, agreement or instrument evidencing any debt or similar obligation owing from the Company
or any of its Subsidiaries (including, without limitation, any Guarantor) to the Secured Party.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&quot;<U>Transaction Documents</U>&quot;
means, collectively, the SPA, the Note, any guaranty from any Guarantor, any Supplemental Loan Document, this Agreement or any other &quot;Transaction
Documents&quot; as defined in the SPA, in each case as amended, supplemented, novated and/or replaced from time to time in accordance
with the applicable terms thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Grant of Security Interest</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Grant; Collateral Description</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company hereby grants to the Secured Party, to secure the payment and performance in full of all of the Obligations, a security interest
in and pledges and assigns to the Secured Party the following properties, assets and rights of the Company, wherever located, whether
now owned or hereafter acquired or arising, and all proceeds and products thereof (all of the same being hereinafter called the &quot;<U>Collateral</U>&quot;):
all personal and fixture property of every kind and nature including all goods (including inventory, equipment and any accessions thereto),
instruments (including promissory notes), documents (whether tangible or electronic), accounts (including health-care-insurance receivables),
chattel paper (whether tangible or electronic), deposit accounts, letter-of-credit rights (whether or not the letter of credit is evidenced
by a writing), commercial tort claims, securities and all other investment property, supporting obligations, any other contract rights
or rights to the payment of money, insurance claims and proceeds, and all general intangibles (including all payment intangibles). </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Commercial Tort Claims</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Secured Party acknowledges that the attachment of its security interest in any commercial tort claim as original collateral is subject
to the Company's compliance with &sect;4.7.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Authorization to File Financing Statements</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company hereby irrevocably authorizes the Secured Party at any time and from time to time to file in any filing office which the Secured
Party deems necessary in any Uniform Commercial Code jurisdiction any initial financing statements and amendments thereto that (a) indicate
the Collateral (i) as all assets of the Company or words of similar effect, regardless of whether any particular asset comprised in the
Collateral falls within the scope of Article 9 of the Uniform Commercial Code of the State or such jurisdiction, or (ii) as being of an
equal or lesser scope or with greater detail, and (b) provide any other information required by part 5 of Article 9 of the Uniform Commercial
Code of the State or such other jurisdiction for the sufficiency or filing office acceptance of any financing statement or amendment,
including whether the Company is an organization, the type of organization and any organizational identification number issued to the
Company. The Company agrees to furnish any such information to the Secured Party promptly upon the Secured Party's reasonable written
request. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Other Actions</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
Further to insure the attachment, perfection and first priority (or, to the extent applicable, second priority to the extent applicable
pursuant to the terms of a Subordination Agreement) of, and the ability of the Secured Party to enforce, the Secured Party's security
interest in the Collateral, the Company agrees, at the Company's expense, to take the following actions with respect to the following
Collateral and without limitation on the Company's other obligations contained in this Agreement (but, to the extent applicable, in all
cases subject to any applicable Subordination Agreement):</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Promissory Notes and Tangible Chattel Paper</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><I>.</I>
If the Company shall, now or at any time hereafter, hold or acquire any promissory notes or tangible chattel paper with an aggregate value
for all such promissory notes or tangible chattel paper in excess of $25,000, the Company shall forthwith endorse, assign and deliver
the same to the Secured Party, accompanied by such instruments of transfer or assignment duly executed in blank as the Secured Party may
from time to time specify.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Deposit Accounts</U>. </FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">For
each deposit account that the Company, now or at any time hereafter, opens or maintains, the Company shall, at the Secured Party's request
and option, pursuant to an agreement in form and substance reasonably satisfactory to the Secured Party, either (a) cause the depositary
bank to agree to comply without further consent of the Company, at any time with instructions from the Secured Party to such depositary
bank directing the disposition of funds from time to time credited to such deposit account, or, in the event the depository bank refuses
to so agree, (b) arrange for the Secured Party to become the customer of the depositary bank with respect to the deposit account, with
the Company being permitted, only with the consent of the Secured Party, to exercise rights to withdraw funds from such deposit account.
The Secured Party agrees with the Company that the Secured Party shall not give any such instructions or withhold any withdrawal rights
from the Company, unless an Event of Default has occurred and is continuing, or, if effect were given to any withdrawal not otherwise
permitted by the Transaction Documents, would occur. The provisions of this paragraph shall not apply to any deposit accounts specially
and exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of the Company's salaried
employees.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Investment Property</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><I>.</I>
If the Company shall, now or at any time hereafter, hold or acquire any certificated securities, the Company shall forthwith endorse,
assign and deliver the same to the Secured Party, accompanied by such instruments of transfer or assignment duly executed in blank as
the Secured Party may from time to time specify. If any securities now or hereafter acquired by the Company are uncertificated and are
issued to the Company or its nominee directly by the issuer thereof, the Company shall promptly (but in any event within two (2) Business
Days) notify the Secured Party thereof and, at the Secured Party's request and option, pursuant to an agreement in form and substance
reasonably satisfactory to the Secured Party, either (a) cause the issuer to agree to comply without further consent of the Company or
such nominee, at any time with instructions from the Secured Party as to such securities, or, in the event the issuer refuses to so agree,
(b) arrange for the Secured Party to become the registered owner of the securities. If any securities, whether certificated or uncertificated,
or other investment property now or hereafter acquired by the Company are held by the Company or its nominee through a securities intermediary
or commodity intermediary, the Company shall promptly (but in any event within two (2) Business Days) notify the Secured Party thereof
and, at the Secured Party's request and option, pursuant to an agreement in form and substance reasonably satisfactory to the Secured
Party, either (i) cause such securities intermediary or (as the case may be) commodity intermediary to agree to comply, in each case without
further consent of the Company or such nominee, at any time with entitlement orders or other instructions from the Secured Party to such
securities intermediary as to such securities or other investment property, or (as the case may be) to apply any value distributed on
account of any commodity contract as directed by the Secured Party to such commodity intermediary, or (ii) in the case of financial assets
or other investment property held through a securities intermediary, arrange for the Secured Party to become the entitlement holder with
respect to such investment property, with the Company being permitted, only with the consent of the Secured Party, to exercise rights
to withdraw or otherwise deal with such investment property. The Secured Party agrees with the Company that the Secured Party shall not
give any such entitlement orders or instructions or directions to any such issuer, securities intermediary or commodity intermediary,
and shall not withhold its consent to the exercise of any withdrawal or dealing rights by the Company, unless an Event of Default has
occurred and is continuing, or, after giving effect to any such investment and withdrawal rights not otherwise permitted by the Transaction
Documents, would occur. The provisions of this paragraph shall not apply to any financial assets credited to a securities account for
which the Secured Party is the securities intermediary.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Collateral in the Possession of a Bailee</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><I>.</I>
If any Collateral with an aggregate value in excess of $50,000 is, now or at any time hereafter, in the possession of a bailee, the Company
shall promptly notify the Secured Party thereof and, at the Secured Party's reasonable request and option, shall promptly obtain an acknowledgement
from the bailee, in form and substance reasonably satisfactory to the Secured Party, that the bailee holds such Collateral for the benefit
of the Secured Party and such bailee's agreement to comply, without further consent of the Company, at any time with instructions of the
Secured Party as to such Collateral.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Electronic Chattel Paper, Electronic Documents and Transferable
Records</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">. If the Company, now or at any time hereafter,
holds or acquires an interest in any Collateral that is electronic chattel paper, any electronic document or any &quot;transferable record,&quot;
as that term is defined in Section 201 of the federal Electronic Signatures in Global and National Commerce Act, or in &sect;16 of the
Uniform Electronic Transactions Act as in effect in any relevant jurisdiction, the Company shall promptly notify the Secured Party thereof
and, at the request and option of the Secured Party, shall take such action as the Secured Party may reasonably request to vest in the
Secured Party control, under &sect;9-105 of the Uniform Commercial Code of the State or any other relevant jurisdiction, of such electronic
chattel paper, control, under &sect;7-106 of the Uniform Commercial Code of the State or any other relevant jurisdiction, of such electronic
document or control, under Section 201 of the federal Electronic Signatures in Global and National Commerce Act or, as the case may be,
&sect;16 of the Uniform Electronic Transactions Act, as so in effect in such jurisdiction, of such transferable record. The Secured Party
agrees with the Company that the Secured Party will arrange, pursuant to procedures satisfactory to the Secured Party and so long as such
procedures will not result in the Secured Party's loss of control, for the Company to make alterations to the electronic chattel paper,
electronic document or transferable record permitted under UCC &sect;9-105, UCC &sect;7-106, or, as the case may be, Section 201 of the
federal Electronic Signatures in Global and National Commerce Act or &sect;16 of the Uniform Electronic Transactions Act for a party in
control to make without loss of control, unless an Event of Default has occurred and is continuing or would occur after taking into account
any action by the Company with respect to such electronic chattel paper, electronic document or transferable record. The provisions of
this &sect;4.5 relating to electronic documents and &quot;control&quot; under UCC &sect;7-106 apply in the event that the 2003 revisions
to Article 7, with amendments to Article 9, of the Uniform Commercial Code, in substantially the form approved by the American Law Institute
and the National Conference of Commissioners on Uniform State Laws, are now or hereafter adopted and become effective in the State or
in any other relevant jurisdiction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Letter-of-Credit Rights</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
If the Company is, now or at any time hereafter, a beneficiary under a letter of credit with a stated amount in excess of $25,000, or
if the Company is a beneficiary under letters of credit not assigned to the Secured Party with an aggregate stated amount in excess of
$50,000, the Company shall promptly notify the Secured Party thereof and, at the request and option of the Secured Party, the Company
shall, pursuant to an agreement in form and substance reasonably satisfactory to the Secured Party, either (a) arrange for the issuer
and any confirmer of such letter of credit to consent to an assignment to the Secured Party of the proceeds of the letter of credit or
(b) arrange for the Secured Party to become the transferee beneficiary of the letter of credit.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Commercial Tort Claims</U><I>.</I></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">
If the Company shall, now or at any time hereafter, hold or acquire a commercial tort claim, the Company shall promptly notify the Secured
Party in a writing signed by the Company of the particulars thereof and grant to the Secured Party in such writing a security interest
therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory
to the Secured Party.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Other Actions as to any and all Collateral</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company further agrees, upon the request of the Secured Party and at the Secured Party's option, to take any and all other actions
as the Secured Party may determine to be necessary or useful for the attachment, perfection and first priority of, and the ability of
the Secured Party to enforce, the Secured Party's security interest in any and all of the Collateral, including (a) executing, delivering
and, where appropriate, filing financing statements and amendments relating thereto under the Uniform Commercial Code of any relevant
jurisdiction, to the extent, if any, that the Company's signature thereon is required therefor, (b) causing the Secured Party's name to
be noted as secured party on any certificate of title for a titled good if such notation is a condition to attachment, perfection or priority
of, or ability of the Secured Party to enforce, the Secured Party's security interest in such Collateral, (c) complying with any provision
of any statute, regulation or treaty of the United States as to any Collateral if compliance with such provision is a condition to attachment,
perfection or priority of, or ability of the Secured Party to enforce, the Secured Party's security interest in such Collateral, (d) obtaining
governmental and other third party waivers, consents and approvals, in form and substance reasonably satisfactory to the Secured Party,
including any consent of any licensor, lessor or other Person obligated on Collateral, (e) obtaining waivers from mortgagees and landlords
of the Company's primary place of business or any other location where the aggregate value of the Collateral at such location exceeds
$50,000, in form and substance reasonably satisfactory to the Secured Party and (f) taking all actions under any earlier versions of the
Uniform Commercial Code or under any other law, as reasonably determined by the Secured Party to be applicable in any relevant Uniform
Commercial Code or other jurisdiction, including any foreign jurisdiction.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>4.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Relation to other Security Documents</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
Concurrently herewith the Company is also executing and delivering to the Secured Party a stock or equity pledge agreements pursuant to
which the Company is pledging to the Secured Party all of the shares of capital stock and other equity interests of the Company's Subsidiaries.
Such pledge(s) of capital stock and other equity interests shall be governed by the terms of the applicable pledge agreements and not
by the terms of this Agreement.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Representations and Warranties Concerning
the Company's Legal Status</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">. The Company has, on
the date hereof, delivered to the Secured Party a certificate signed by the Company and entitled &quot;Perfection Certificate&quot; (the
&quot;<U>Perfection Certificate</U>&quot;). The Company represents and warrants to the Secured Party as follows: (a) the Company's exact
legal name is that indicated on the Perfection Certificate and on the signature page hereof, (b) the Company is an organization of the
type, and is organized in the jurisdiction, set forth in the Perfection Certificate, (c) the Perfection Certificate accurately sets forth
the Company's organizational identification number or accurately states that the Company has none, (d) the Perfection Certificate accurately
sets forth the Company's place of business or, if more than one, its chief executive office, as well as the Company's mailing address,
if different, (e) all other information set forth on the Perfection Certificate pertaining to the Company is accurate and complete in
all material respects, and (f) there has been no change in any of such information since the date on which the Perfection Certificate
was signed by the Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Covenants Concerning Company's Legal Status</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company covenants with the Secured Party as follows: (a) without providing at least ten (10) days prior written notice to the Secured
Party (or such shorter period as may be agreed to in writing by the Secured Party), the Company will not change its name, its place of
business or, if more than one, chief executive office, or its mailing address or organizational identification number if it has one, (b)
if the Company does not have an organizational identification number and later obtains one, the Company will forthwith notify the Secured
Party of such organizational identification number, and (c) the Company will not change its type of organization, jurisdiction of organization
or other legal structure without the Secured Party's prior written consent.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Representations and Warranties Concerning
Collateral, Etc</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">. The Company further represents
and warrants to the Secured Party as follows: (a) the Company is the owner of or has other rights in or power to transfer the Collateral
of the Company, free from any right or claim of any Person or any adverse lien, except for the security interest created by this Agreement
and the Permitted Liens, (b) none of the account debtors or other Persons obligated on any of the Collateral is a governmental authority
covered by the Federal Assignment of Claims Act or like federal, state or local statute or rule in respect of such Collateral, (c) the
Company holds no commercial tort claim except as indicated on the Company's Perfection Certificate, (d) all other information set forth
on the Company's Perfection Certificate pertaining to the Collateral is accurate and complete in all material respects, and (e) there
has been no change in any of such information since the date on which the Company's Perfection Certificate was signed by the Company.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Covenants Concerning Collateral, Etc</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company further covenants with the Secured Party as follows (but, to the extent applicable, subject in all cases to any applicable
Subordination Agreement): (a) other than inventory sold in the ordinary course of business consistent with past practices, the Collateral,
to the extent not delivered to the Secured Party pursuant to &sect;4, will be kept at those locations listed on the Company's Perfection
Certificate and the Company will not remove the Collateral from such locations, without providing at least ten (10) Business Days prior
written notice to the Secured Party, (b) except for the security interest herein granted, the Company shall be the owner of or have other
rights in the Collateral free from any right or claim of any other Person or any Lien (other than Permitted Liens), and the Company shall
defend the same against all claims and demands of all Persons at any time claiming the same or any interests therein adverse to the Secured
Party, (c) other than in favor of the Secured Party or with respect to any Permitted Lien, the Company shall not pledge, mortgage or create,
or suffer to exist any right of any Person in or claim by any person to the Collateral, or any Lien in the Collateral in favor of any
Person, or become bound (as provided in Section 9-203(d) of the Uniform Commercial Code of the State or any other relevant jurisdiction
or otherwise) by a security agreement in favor of any Person as secured party, (d) the Company will permit the Secured Party, or its designee,
to inspect the Collateral at any reasonable time, wherever located, (e) the Company will pay promptly when due all taxes, assessments,
governmental charges and levies upon the Collateral or incurred in connection with the use or operation of the Collateral or incurred
in connection with this Agreement, and (f) the Company will not sell or otherwise dispose, or offer to sell or otherwise dispose, of the
Collateral, or any interest therein except for, so long as no Event of Default has occurred and is continuing and the Company otherwise
complies with all the conditions (including, without limitation, repayment conditions) set forth in the Transaction Documents, Permitted
Dispositions (as such term is defined in the SPA), dispositions of obsolete or worn-out property, the granting of non-exclusive licenses
in the ordinary course of business, and the sale of inventory in the ordinary course of business consistent with past practices.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Insurance</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company will maintain with financially sound and reputable insurers insurance with respect to its properties and business against
such casualties and contingencies as shall be in accordance with general practices of businesses engaged in similar activities in similar
geographic areas. Such insurance shall be in such minimum amounts that the Company will not be deemed a coinsurer under applicable insurance
laws, regulations and policies and otherwise shall be in such amounts, contain such terms, be in such forms and be for such periods as
may be reasonably satisfactory to the Secured Party. In addition, all such insurance shall be payable to the Secured Party as loss payee.
Without limiting the foregoing, the Company will (i) keep all of its physical property insured with casualty or physical hazard insurance
on an &ldquo;all risks&rdquo; basis, with broad form flood and earthquake coverages and electronic data processing coverage, with a full
replacement cost endorsement and an &ldquo;agreed amount&rdquo; clause in an amount equal to 100 percent of the full replacement cost
of such property, (ii) maintain all such workers&rsquo; compensation or similar insurance as may be required by law and (iii) maintain,
in amounts and with deductibles equal to those generally maintained by businesses engaged in similar activities in similar geographic
areas, general public liability insurance against claims of bodily injury, death or property damage occurring, on, in or about the properties
of the Company; business interruption insurance; and product liability insurance. In addition, the proceeds of any casualty insurance
in respect of any casualty loss of any of the Collateral shall, subject to the rights, if any, of other parties with a prior interest
in the property covered thereby, (i) so long as no Event of Default has occurred and is continuing, be disbursed to the Company for direct
application by the Company solely to the repair or replacement of the Company&rsquo;s property so damaged or destroyed and (ii) to the
extent the Company elects not to repair or replace the property so damaged or destroyed, or fails to repair or replace the property so
damaged or destroyed within 180 days of receipt of such proceeds, be held by the Secured Party as cash collateral for the Obligations.
To the extent the Secured Party is holding any such proceeds as cash collateral and the Company then elects to repair or replace the property
so damaged or destroyed, the Secured Party may, at its sole option, disburse from time to time all or any part of such proceeds so held
as cash collateral, upon such terms and conditions as the Secured Party may reasonably prescribe, for direct application by the Company
solely to the repair or replacement of the Company&rsquo;s property so damaged or destroyed, or, if an Event of Default has occurred and
is continuing, the Secured Party may apply all or any part of such proceeds to the Obligations. All policies of insurance shall provide
for at least thirty (30) days prior written cancellation notice to the Secured Party. In the event of failure by the Company to provide
and maintain insurance as herein provided, the Secured Party may, at its option, provide such insurance and charge the amount thereof
to the Company. The Company shall furnish the Secured Party with certificates of insurance and policies evidencing compliance with the
foregoing insurance provisions as may be reasonably requested in writing.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Collateral Protection Expenses; Preservation
of Collateral</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>10.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Expenses Incurred by Secured Party</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
In the Secured Party's discretion, the Secured Party may discharge taxes and other encumbrances at any time levied or placed on any of
the Collateral, and pay any necessary filing fees or insurance premiums, in each case if the Company fails to do so. The Company agrees
to reimburse the Secured Party on demand for all expenditures so made. The Secured Party shall have no obligation to the Company to make
any such expenditures, nor shall the making thereof be construed as a waiver or cure of any Event of Default.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>10.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Secured Party's Obligations and Duties</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
Anything herein to the contrary notwithstanding, the Company shall remain obligated and liable under each contract or agreement comprised
in the Collateral to be observed or performed by the Company thereunder. The Secured Party shall not have any obligation or liability
under any such contract or agreement by reason of or arising out of this Agreement or the receipt by the Secured Party of any payment
relating to any of the Collateral, nor shall the Secured Party be obligated in any manner to perform any of the obligations of the Company
under or pursuant to any such contract or agreement, to make inquiry as to the nature or sufficiency of any payment received by the Secured
Party in respect of the Collateral or as to the sufficiency of any performance by any party under any such contract or agreement, to present
or file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned
to the Secured Party or to which the Secured Party may be entitled at any time or times. The Secured Party's sole duty with respect to
the custody, safe keeping and physical preservation of the Collateral in its possession, under &sect;9-207 of the Uniform Commercial Code
of the State or otherwise, shall be to deal with such Collateral in the same manner as the Secured Party deals with similar property for
its own account.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Securities and Deposits</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Secured Party may at any time following and during the continuance of a payment default or an Event of Default<I>,</I> at its option,
transfer to itself or any nominee any securities constituting Collateral, receive any income thereon and hold such income as additional
Collateral or apply it to the Obligations. Whether or not any Obligations are due, the Secured Party may, following and during the continuance
of a payment default or an Event of Default demand, sue for, collect, or make any settlement or compromise which it deems desirable with
respect to the Collateral. Regardless of the adequacy of Collateral or any other security for the Obligations, any deposits or other sums
at any time credited by or due from the Secured Party to the Company may at any time be applied to or set off against any of the Obligations
then due and owing.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Notification to Account Debtors and Other
Persons Obligated on Collateral</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">. If an Event of
Default shall have occurred and be continuing (and, to the extent applicable, subject to the terms of any applicable Subordination Agreement):</FONT></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall, at the request and option of the Secured Party, notify account debtors and other Persons obligated on any of the Collateral
of the security interest of the Secured Party in any account, chattel paper, general intangible, instrument or other Collateral and that
payment thereof is to be made directly to the Secured Party or to any financial institution designated by the Secured Party as the Secured
Party's agent therefor;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Secured Party may itself, without notice to or demand upon the Company, so notify account debtors and other Persons obligated on Collateral;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
after the making of such a request or the giving of any such notification, the Company shall hold any proceeds of collection of accounts,
chattel paper, general intangibles, instruments and other Collateral received by the Company as trustee for the Secured Party, for the
benefit of the Secured Party, without commingling the same with other funds of the Company and shall turn the same over to the Secured
Party in the identical form received, together with any necessary endorsements or assignments; and</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Secured Party shall apply the proceeds of collection of accounts, chattel paper, general intangibles, instruments and other Collateral
and received by the Secured Party to the payment of the Obligations, such proceeds to be immediately credited after final payment in cash
or other immediately available funds of the items giving rise to them.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Power of Attorney</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>13.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Appointment and Powers of Secured Party</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company hereby irrevocably constitutes and appoints the Secured Party and any officer or agent thereof, with full power of substitution,
as its true and lawful attorneys-in-fact with full irrevocable power and authority in the place and stead of the Company or in the Secured
Party's own name, for the purpose of carrying out the terms of this Agreement, to take any and all appropriate action and to execute any
and all documents and instruments that may be necessary or useful to accomplish the purposes of this Agreement and, without limiting the
generality of the foregoing, hereby gives said attorneys the power and right, on behalf of the Company, without notice to or assent by
the Company, to do the following:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">upon the occurrence and during the continuance of an Event
of Default, generally to sell, transfer, pledge, make any agreement with respect to or otherwise dispose of or deal with any of the Collateral
in such manner as is consistent with the Uniform Commercial Code of the State or any other relevant jurisdiction and as fully and completely
as though the Secured Party were the absolute owner thereof for all purposes, and to do, at the Company's expense, at any time, or from
time to time, all acts and things which the Secured Party deems necessary or useful to protect, preserve or realize upon the Collateral
and the Secured Party's security interest therein, in order to effect the intent of this Agreement, all no less fully and effectively
as the Company might do, including (i) upon written notice to the Company, the exercise of voting rights with respect to voting securities,
which rights may be exercised, if the Secured Party so elects, with a view to causing the liquidation of assets of the issuer of any such
securities and (ii) the execution, delivery and recording, in connection with any sale or other disposition of any Collateral, of the
endorsements, assignments or other instruments of conveyance or transfer with respect to such Collateral; and</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">to the extent that the Company's authorization given in
&sect;3 is not sufficient, to file such financing statements with respect hereto, with or without the Company's signature, or a photocopy
of this Agreement in substitution for a financing statement, as the Secured Party may deem appropriate and to execute in the Company's
name such financing statements and amendments thereto and continuation statements which may require the Company's signature.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>13.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Ratification by Company</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
To the extent permitted by law, the Company hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof.
This power of attorney is a power coupled with an interest and is irrevocable.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.5in"><B>13.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>No Duty on Secured Party</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The powers conferred on the Secured Party hereunder are solely to protect the interests of the Secured Party in the Collateral and shall
not impose any duty upon the Secured Party to exercise any such powers. The Secured Party shall be accountable only for the amounts that
it actually receives as a result of the exercise of such powers, and neither it nor any of its officers, directors, employees or agents
shall be responsible to the Company for any act or failure to act, except for the Secured Party's own gross negligence or willful misconduct.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Rights and Remedies</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
If an Event of Default shall have occurred and be continuing, the Secured Party, without any other notice to or demand upon the Company
(but, to the extent applicable, subject to the terms of any applicable Subordination Agreement), shall have in any jurisdiction in which
enforcement hereof is sought, in addition to all other rights and remedies, the rights and remedies of a secured party under the Uniform
Commercial Code of the State or any other relevant jurisdiction and any additional rights and remedies as may be provided to a secured
party in any jurisdiction in which Collateral is located, including the right to take possession of the Collateral, and for that purpose
the Secured Party may, so far as the Company can give authority therefor, enter upon any premises on which the Collateral may be situated
and remove the same therefrom. The Secured Party may in its discretion require the Company to assemble all or any part of the Collateral
at such location or locations within the jurisdiction(s) of the Company's principal office(s) or at such other locations as the Secured
Party may reasonably designate. Unless the Collateral is perishable or threatens to decline speedily in value or is of a type customarily
sold on a recognized market, the Secured Party shall give to the Company at least ten (10) Business Days prior written notice of the time
and place of any public sale of Collateral or of the time after which any private sale or any other intended disposition is to be made.
The Company hereby acknowledges that ten (10) Business Days prior written notice of such sale or sales shall be reasonable notice. In
addition, the Company waives any and all rights that it may have to a judicial hearing in advance of the enforcement of any of the Secured
Party's rights and remedies hereunder, including its right following an Event of Default to take immediate possession of the Collateral
and to exercise its rights and remedies with respect thereto.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Standards for Exercising Rights and Remedies</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
To the extent that applicable law imposes duties on the Secured Party to exercise remedies in a commercially reasonable manner, the Company
acknowledges and agrees that it is not commercially unreasonable for the Secured Party (a) to fail to incur expenses reasonably deemed
significant by the Secured Party to prepare Collateral for disposition or otherwise to fail to complete raw material or work in process
into finished goods or other finished products for disposition, (b) to fail to obtain third party consents for access to Collateral to
be disposed of, or to obtain or, if not required by other law, to fail to obtain governmental or third party consents for the collection
or disposition of Collateral to be collected or disposed of, (c) to fail to exercise collection remedies against account debtors or other
Persons obligated on Collateral or to fail to remove Liens on or any adverse claims against Collateral, (d) to exercise collection remedies
against account debtors and other Persons obligated on the Collateral directly or through the use of collection agencies and other collection
specialists, (e) to advertise dispositions of the Collateral through publications or media of general circulation, whether or not the
Collateral is of a specialized nature, (f) to contact other Persons, whether or not in the same business as the Company, for expressions
of interest in acquiring all or any portion of the Collateral, (g) to hire one or more professional auctioneers to assist in the disposition
of the Collateral, whether or not the collateral is of a specialized nature, (h) to dispose of the Collateral by utilizing Internet sites
that provide for the auction of assets of the types included in the Collateral or that have the reasonable capability of doing so, or
that match buyers and sellers of assets, (i) to dispose of assets in wholesale rather than retail markets, (j) to disclaim disposition
warranties, (k) to purchase insurance or credit enhancements to insure the Secured Party against risks of loss, collection or disposition
of the Collateral or to provide to the Secured Party a guaranteed return from the collection or disposition of such Collateral, or (l)
to the extent deemed appropriate by the Secured Party, to obtain the services of brokers, investment bankers, consultants and other professionals
to assist the Secured Party in the collection or disposition of any of the Collateral. The Company acknowledges that the purpose of this
&sect;15 is to provide non-exhaustive indications of what actions or omissions by the Secured Party would fulfill the Secured Party's
duties under the Uniform Commercial Code of the State or any other relevant jurisdiction in the Secured Party's exercise of remedies against
the Collateral and that other actions or omissions by the Secured Party shall not be deemed to fail to fulfill such duties solely on account
of not being indicated in this &sect;15. Without limitation upon the foregoing, nothing contained in this &sect;15 shall be construed
to grant any rights to the Company or to impose any duties on the Secured Party that would not have been granted or imposed by this Agreement
or by applicable law in the absence of this &sect;15. </FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>No Waiver by Secured Party, etc</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Secured Party shall not be deemed to have waived any of its rights and remedies in respect of the Obligations or the Collateral unless
such waiver shall be in writing and signed by the Secured Party. No delay or omission on the part of the Secured Party in exercising any
right or remedy shall operate as a waiver of such right or remedy or any other right or remedy. A waiver on any one occasion shall not
be construed as a bar to or waiver of any right or remedy on any future occasion. All rights and remedies of the Secured Party with respect
to the Obligations or the Collateral, whether evidenced hereby or by any other instrument or papers, shall be cumulative and may be exercised
singularly, alternatively, successively or concurrently at such time or at such times as the Secured Party deems expedient.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Suretyship Waivers by Company</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company waives, to the maximum extent permitted by applicable law, demand, notice, protest, notice of acceptance of this Agreement,
notice of loans made, credit extended, Collateral received or delivered or other action taken in reliance hereon and all other demands
and notices of any description. With respect to both the Obligations and the Collateral, the Company assents to any extension or postponement
of the time of payment or any other indulgence, to any substitution, exchange or release of or failure to perfect any security interest
in any such Collateral, to the addition or release of any party or Person primarily or secondarily liable, to the acceptance of partial
payment thereon and the settlement, compromising or adjusting of any thereof, all in such manner and at such time or times as the Secured
Party may deem advisable. The Secured Party shall have no duty as to the collection or protection of the Collateral or any income therefrom,
the preservation of rights against prior parties, or the preservation of any rights pertaining thereto beyond the safe custody thereof
as set forth in &sect;10.2. The Company further waives any and all other suretyship defenses.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Marshaling</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Secured Party shall not be required to marshal any present or future collateral security (including but not limited to the Collateral)
for, or other assurances of payment of, the Obligations or any of them or to resort to such collateral security or other assurances of
payment in any particular order, and all of the rights and remedies of the Secured Party hereunder and of the Secured Party in respect
of such collateral security and other assurances of payment shall be cumulative and in addition to all other rights and remedies, however
existing or arising. To the extent that it lawfully may, the Company hereby agrees that it will not invoke any law relating to the marshaling
of collateral which might cause delay in or impede the enforcement of the Secured Party's rights and remedies under this Agreement or
under any other instrument creating or evidencing any of the Obligations or under which any of the Obligations is outstanding or by which
any of the Obligations is secured or payment thereof is otherwise assured, and, to the extent that it lawfully may, the Company hereby
irrevocably waives the benefits of all such laws.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Proceeds of Dispositions; Expenses</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The Company shall pay to the Secured Party upon written demand amounts equal to any and all expenses, including, without limitation, attorneys'
fees and disbursements, incurred or paid by the Secured Party in protecting or preserving the Secured Party's rights and remedies under
or in respect of any of the Obligations or any of the Collateral and any such expenses actually incurred in releasing any security interest
granted hereunder and, in addition, the Company shall pay to the Secured Party on demand amounts equal to any and all expenses, including
attorneys' fees and disbursements, incurred or paid by the Secured Party in enforcing the Secured Party's rights and remedies under or
in respect of any of the Obligations or any of the Collateral. After deducting all of said expenses, the residue of any proceeds of collection
or sale or other disposition of Collateral shall, to the extent actually received in cash, be applied to the payment of the Obligations
in such order or preference as is provided in the SPA, proper allowance and provision being made for any Obligations not then due. Upon
the final payment and satisfaction in full of all of the Obligations and after making any payments required by Sections 9-608(a)(1)(C)
or 9-615(a)(3) of the Uniform Commercial Code of the State, any excess shall be returned to the Company. In the absence of final payment
and satisfaction in full of all of the Obligations, the Company shall remain liable for any deficiency.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Overdue Amounts</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
Until paid, all amounts due and payable by the Company hereunder shall be a debt secured by the Collateral and shall bear, whether before
or after judgment, interest at the rate of interest for overdue principal set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Governing Law; Consent to Jurisdiction</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
<FONT STYLE="text-transform: uppercase"><B>This Agreement IS A contract UNDER the laws of the state of DELAWARE and shall for all purposes
be construed in accordance with and governed by the laws of SAID state of DELAWARE, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS
OR CHOICE OF LAWS. THE Company and THE SECURED PARTY EACH agree that any suit for the enforcement of this agreement or any other action
brought by SUCH PERSON arising hereunder or in any way related to this agreement </B></FONT><B>SHALL BE BROUGHT IN THE STATE OR FEDERAL
COURTS LOCATED IN NEW CASTLE COUNTY, DELAWARE, AND EACH OF THE COMPANY AND THE SECURED PARTY </B></FONT><B><FONT STYLE="font-size: 11pt; text-transform: uppercase">irrevocably
submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection to such exclusive jurisdiction
or that such courts represent an inconvenient forum<FONT STYLE="font-family: Book Antiqua, Times, Serif">. EACH PARTY HERETO AGREES IT
MAY BE SERVED WITH LEGAL PROCESS IN THE STATE OF DELAWARE AT the ADDRESS SET FORTH IN SECTION 11.5 OF THE SPA.</FONT></FONT></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Waiver of Jury Trial</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
THE COMPANY AND THE SECURED PARTY WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT TO ANY ACTION OR CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION
WITH THIS AGREEMENT, ANY RIGHTS OR OBLIGATIONS HEREUNDER OR THE PERFORMANCE OR ENFORCEMENT OF ANY SUCH RIGHTS OR OBLIGATIONS. Except as
prohibited by law, the Company waives any right which it may have to claim or recover in any litigation referred to in the preceding sentence
any special, exemplary, punitive or consequential damages or any damages other than, or in addition to, actual damages. The Company (a)
certifies that neither the Secured Party nor any representative, agent or attorney of the Secured Party has represented, expressly or
otherwise, that the Secured Party would not, in the event of litigation, seek to enforce the foregoing waivers or other waivers contained
in this Agreement and (b) acknowledges that, in entering into this Agreement and any other Transaction Document to which the Secured Party
is a party, the Secured Party is relying upon, among other things, the waivers and certifications contained in this &sect;22.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Notices</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
All notices, requests and other communications hereunder shall be made in the manner set forth in the SPA.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Miscellaneous</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
The headings of each section of this Agreement are for convenience only and shall not define or limit the provisions thereof. This Agreement
and all rights and obligations hereunder shall be binding upon the Company and its successors and assigns, and shall inure to the benefit
of the Secured Party and its successors and assigns. If any term of this Agreement shall be held to be invalid, illegal or unenforceable,
the validity of all other terms hereof shall in no way be affected thereby, and this Agreement shall be construed and be enforceable as
if such invalid, illegal or unenforceable term had not been included herein. The Company acknowledges receipt of a copy of this Agreement.
The parties agree to electronic contracting and signatures with respect to this Agreement. Delivery of an electronic signature to, or
a signed copy of, this Agreement by facsimile, email or other electronic transmission shall be fully binding on the parties to the same
extent as the delivery of the signed originals and shall be admissible into evidence for all purposes. The words &quot;execution&quot;,
&quot;execute&quot;, &quot;signed&quot;, &quot;signature&quot;, and words of like import in or related to any document to be signed in
connection with this Agreement shall be deemed to include electronic signatures, or the keeping of records in electronic form, each of
which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping
system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global
and National Commerce Act, the Delaware Uniform Electronic Transactions Act, or any other similar state laws based on the Uniform Electronic
Transactions Act. Notwithstanding the foregoing, if the Secured Party shall request manually signed counterpart signatures to this Agreement,
the Company hereby agrees to use its reasonable endeavors to provide such manually signed signature pages as soon as reasonably practicable.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt"><U>Release of Collateral; Reinstatement</U></FONT></B><FONT STYLE="font-family: Book Antiqua, Times, Serif; font-size: 11pt">.
(a)&#9;The Secured Party agrees that upon the indefeasible repayment in full, in cash, of all Obligations owing under the Transaction
Documents (other than contingent indemnification obligations for which no claims have been made) and the termination of any commitments
pursuant to the terms of the Transaction Documents, the security interests granted hereby shall, subject to the Secured Party's rights
of reinstatement set forth herein or in any other Transaction Document, automatically terminate, all rights to the Collateral shall revert
to the Company without further action from any Person and the Secured Party agrees that, at the request and sole expense of the Company,
it shall promptly execute and deliver to the Company all releases or other documents reasonably necessary for the release of the Liens
on the Collateral (including returning any possessory collateral being held by the Secured Party).</FONT></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary contained herein, the Company acknowledges and agrees its obligations and liabilities under the Transaction Documents
(and all security interests and other Liens granted hereunder) shall be deemed to have continued in existence and shall be reinstated
with full force and effect if, at any time on or after the payment of any Obligations under the Transaction Documents, all or any portion
of the Obligations or any other amounts applied by the Secured Party to any of the Obligations is voided or rescinded or must otherwise
be returned by the Secured Party to the Company or any Subsidiary upon the Company's or any Subsidiary&rsquo;s insolvency, bankruptcy
or reorganization or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><B><I>[Signature pages to follow]</I></B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
intending to be legally bound, the Company has caused this Agreement to be duly executed as of the date first above written.</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 2.5in; text-indent: 0.5in"><B>RED CAT HOLDINGS, INC.</B></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 0 3in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 0 3in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 0 3in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 0 3in">By:____________________________________&#9;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 0 240pt">Name: Jeffrey Thompson</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 0 12pt 239.75pt">Title: CEO</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 12pt 4in 0 0; text-align: justify">Accepted:</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 24pt 3.5in 0 0; text-align: justify"><B>LIND GLOBAL ASSET MANAGEMENT X LLC</B></P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 24pt 3.5in 0 0; text-align: justify">By: ____________________________&#9;</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 3.5in 0 58.3pt; text-indent: -0.5in">Name: Jeff Easton</P>

<P STYLE="font: 11pt Book Antiqua, Times, Serif; margin: 0 3.5in 0 58.3pt; text-indent: -0.5in">Title: Authorized Signatory</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>rcat0923form10qexh31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
AND RULE 13A-14(A)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF
1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Jeffrey Thompson, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly Report on Form 10-Q of Red Cat Holdings, Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt">Date: September 23, 2024</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Jeffrey Thompson</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(Principal Executive Officer)</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>rcat0923form10qexh31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
AND RULE 13A-14(A)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF
1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Leah Lunger, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly Report on Form 10-Q of Red Cat Holdings, Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt">Date: September 23, 2024</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Leah Lunger</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(Principal Financial and Accounting Officer)</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>rcat0923form10qexh32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Quarterly Report on Form 10-Q
of Red Cat Holdings, Inc. (the &ldquo;Company&rdquo;), for the quarter ended July 31, 2024, as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), I, Jeffrey Thompson, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Date: September 23, 2024</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Jeffrey Thompson</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 43%; text-align: justify"><FONT STYLE="font-size: 10pt">Jeffrey Thompson</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>rcat0923form10qexh32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Quarterly Report on Form 10-Q
of Red Cat Holdings, Inc. (the &ldquo;Company&rdquo;), for the quarter ended July 31, 2024, as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), I, Leah Lunger, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Date: September 23, 2024</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Leah Lunger</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 43%; text-align: justify"><FONT STYLE="font-size: 10pt">Leah Lunger</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>rcat-20240731.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9Ks5s7xRiXgOn8uEZ3NcOaaJmaOdwZ93+ekhvGt8ffnKjy8poiZr5So8vQhWcd4F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:RCAT="http://RCAT/20240731" elementFormDefault="qualified" targetNamespace="http://RCAT/20240731">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://RCAT/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" id="StatementsOfOperationsAndComprehensiveIncome">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfShareholdersEquity" id="StatementsOfShareholdersEquity">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note1Business" id="Note1Business">
          <link:definition>00000007 - Disclosure - Note 1 &#8211; The Business</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" id="Note2SummaryOfSignificantAccountingPolicies">
          <link:definition>00000008 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" id="Note3DivestitureOfConsumerSegment">
          <link:definition>00000009 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note4Inventories" id="Note4Inventories">
          <link:definition>00000010 - Disclosure - Note 4 &#8211; Inventories</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note5OtherCurrentAssets" id="Note5OtherCurrentAssets">
          <link:definition>00000011 - Disclosure - Note 5 &#8211; Other Current Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note6IntangibleAssets" id="Note6IntangibleAssets">
          <link:definition>00000012 - Disclosure - Note 6 &#8211; Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note7EquityMethodInvestment" id="Note7EquityMethodInvestment">
          <link:definition>00000013 - Disclosure - Note 7 &#8211; Equity Method Investment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8PropertyAndEquipment" id="Note8PropertyAndEquipment">
          <link:definition>00000014 - Disclosure - Note 8 &#8211; Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note9OtherLong-termAssets" id="Note9OtherLong-termAssets">
          <link:definition>00000015 - Disclosure - Note 9 &#8211; Other Long-Term Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" id="Note10RightOfUseAssetsAndLiabilities">
          <link:definition>00000016 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11DebtObligations" id="Note11DebtObligations">
          <link:definition>00000017 - Disclosure - Note 11 &#8211; Debt Obligations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note12CommonStock" id="Note12CommonStock">
          <link:definition>00000018 - Disclosure - Note 12 &#8211; Common Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note13PreferredStock" id="Note13PreferredStock">
          <link:definition>00000019 - Disclosure - Note 13 &#8211; Preferred Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note14Warrants" id="Note14Warrants">
          <link:definition>00000020 - Disclosure - Note 14 &#8211; Warrants</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note15ShareBasedAwards" id="Note15ShareBasedAwards">
          <link:definition>00000021 - Disclosure - Note 15 &#8211; Share Based Awards</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note16-Related-partyTransactions" id="Note16-Related-partyTransactions">
          <link:definition>00000022 - Disclosure - Note 16 - Related-Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note17CommitmentsAndContingencies" id="Note17CommitmentsAndContingencies">
          <link:definition>00000023 - Disclosure - Note 17 &#8211; Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note18SubsequentEvents" id="Note18SubsequentEvents">
          <link:definition>00000024 - Disclosure - Note 18 &#8211; Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" id="Note2SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000025 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" id="Note2SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000026 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" id="Note3DivestitureOfConsumerSegmentTables">
          <link:definition>00000027 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note4InventoriesTables" id="Note4InventoriesTables">
          <link:definition>00000028 - Disclosure - Note 4 &#8211; Inventories (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note5OtherCurrentAssetsTables" id="Note5OtherCurrentAssetsTables">
          <link:definition>00000029 - Disclosure - Note 5 &#8211; Other Current Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note6IntangibleAssetsTables" id="Note6IntangibleAssetsTables">
          <link:definition>00000030 - Disclosure - Note 6 &#8211; Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note7EquityMethodInvestmentTables" id="Note7EquityMethodInvestmentTables">
          <link:definition>00000031 - Disclosure - Note 7 &#8211; Equity Method Investment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8PropertyAndEquipmentTables" id="Note8PropertyAndEquipmentTables">
          <link:definition>00000032 - Disclosure - Note 8 &#8211; Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note9OtherLong-termAssetsTables" id="Note9OtherLong-termAssetsTables">
          <link:definition>00000033 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" id="Note10RightOfUseAssetsAndLiabilitiesTables">
          <link:definition>00000034 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11DebtObligationsTables" id="Note11DebtObligationsTables">
          <link:definition>00000035 - Disclosure - Note 11 &#8211; Debt Obligations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note12CommonStockTables" id="Note12CommonStockTables">
          <link:definition>00000036 - Disclosure - Note 12 &#8211; Common Stock (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note14WarrantsTables" id="Note14WarrantsTables">
          <link:definition>00000037 - Disclosure - Note 14 &#8211; Warrants (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note15ShareBasedAwardsTables" id="Note15ShareBasedAwardsTables">
          <link:definition>00000038 - Disclosure - Note 15 &#8211; Share Based Awards (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" id="ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails">
          <link:definition>00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" id="CustomerConcentrationRiskDetails">
          <link:definition>00000040 - Disclosure - Customer concentration risk (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" id="Note1BusinessDetailsNarrative">
          <link:definition>00000041 - Disclosure - Note 1 &#8211; The Business (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" id="CompanysRevenueDisaggregatedByRevenueTypeDetails">
          <link:definition>00000042 - Disclosure - Company's revenue disaggregated by revenue type (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" id="AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails">
          <link:definition>00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000044 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" id="DiscontinuedOperations-ResultsOfOperationsDetails">
          <link:definition>00000045 - Disclosure - Discontinued Operations - results of operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" id="Note3DivestitureOfConsumerSegmentDetailsNarrative">
          <link:definition>00000046 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/InventoriesDetails" id="InventoriesDetails">
          <link:definition>00000047 - Disclosure - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OtherCurrentAssetsDetails" id="OtherCurrentAssetsDetails">
          <link:definition>00000048 - Disclosure - Other current assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
          <link:definition>00000049 - Disclosure - Intangible assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" id="FinancialInformationForUmacDerivedFromTheirForm10-qDetails">
          <link:definition>00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" id="ImpactsOnInvestmentsIntoUmacDetails">
          <link:definition>00000051 - Disclosure - Impacts on investments into UMAC (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" id="Note7EquityMethodInvestmentDetailsNarrative">
          <link:definition>00000052 - Disclosure - Note 7 &#8211; Equity Method Investment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
          <link:definition>00000053 - Disclosure - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" id="Note8PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000054 - Disclosure - Note 8 &#8211; Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OtherLongTermAssetsDetails" id="OtherLongTermAssetsDetails">
          <link:definition>00000055 - Disclosure - Other long term assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" id="Note9OtherLong-termAssetsDetailsNarrative">
          <link:definition>00000056 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OperatingLeasesDetails" id="OperatingLeasesDetails">
          <link:definition>00000057 - Disclosure - Operating leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" id="SupplementalInformationRelatedToOperatingLeasesDetails">
          <link:definition>00000058 - Disclosure - Supplemental information related to operating leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" id="Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative">
          <link:definition>00000059 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" id="OutstandingPrincipalPaymentsDetails">
          <link:definition>00000060 - Disclosure - Outstanding principal payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note11DebtObligationsDetailsNarrative" id="Note11DebtObligationsDetailsNarrative">
          <link:definition>00000061 - Disclosure - Note 11 &#8211; Debt Obligations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" id="SummaryOfSharesOfCommonStockIssuedDetails">
          <link:definition>00000062 - Disclosure - Summary of shares of common stock issued (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note12CommonStockDetailsNarrative" id="Note12CommonStockDetailsNarrative">
          <link:definition>00000063 - Disclosure - Note 12 &#8211; Common Stock (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note13PreferredStockDetailsNarrative" id="Note13PreferredStockDetailsNarrative">
          <link:definition>00000064 - Disclosure - Note 13 &#8211; Preferred Stock (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" id="SummaryOfWarrantsIssuedAndFairValuesDetails">
          <link:definition>00000065 - Disclosure - Summary of warrants issued and fair values (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" id="ChangesInWarrantsOutstandingDetails">
          <link:definition>00000066 - Disclosure - Changes in warrants outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note14WarrantsDetailsNarrative" id="Note14WarrantsDetailsNarrative">
          <link:definition>00000067 - Disclosure - Note 14 &#8211; Warrants (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" id="AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails">
          <link:definition>00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" id="SummaryOfActivityUnderPlanDetails">
          <link:definition>00000069 - Disclosure - Summary of activity under the Plan (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" id="SummaryOfRestrictedStockActivityUnderPlanDetails">
          <link:definition>00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" id="StockCompensationExpenseByFunctionalCategoryDetails">
          <link:definition>00000071 - Disclosure - Stock compensation expense by functional category (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" id="Note15ShareBasedAwardsDetailsNarrative">
          <link:definition>00000072 - Disclosure - Note 15 &#8211; Share Based Awards (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240731_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rcat-20240731_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="RCAT_SeriesBPreferredStock1Member" name="SeriesBPreferredStock1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition1Member" name="BusinessAcquisition1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition2Member" name="BusinessAcquisition2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition3Member" name="BusinessAcquisition3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_BusinessAcquisition4Member" name="BusinessAcquisition4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactOriginallyReportedMember" name="RestatementImpactOriginallyReportedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactAsRestatedMember" name="RestatementImpactAsRestatedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactChangeMember" name="RestatementImpactChangeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk1Member" name="CustomerConcentrationRisk1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_CustomerConcentrationRisk2Member" name="CustomerConcentrationRisk2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsGrossCarryingAmountMember" name="IntangibleAssetsGrossCarryingAmountMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsAccumulatedAmortizationMember" name="IntangibleAssetsAccumulatedAmortizationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsNetCarryingValueMember" name="IntangibleAssetsNetCarryingValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation1Member" name="OperatingLeaseLocation1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation3Member" name="OperatingLeaseLocation3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingLeaseLocation4Member" name="OperatingLeaseLocation4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation1Member" name="DebtObligation1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation2Member" name="DebtObligation2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation6Member" name="DebtObligation6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DebtObligation8Member" name="DebtObligation8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SeriesAPreferredStock2Member" name="SeriesAPreferredStock2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsOutstanding1Member" name="WarrantsOutstanding1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OptionsAssumptionsUsedMember" name="OptionsAssumptionsUsedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_Options1Member" name="Options1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PreferredStockValueSeriesB" name="PreferredStockValueSeriesB" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" name="EarningsPerShareBasicAndDilutedRCATAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" name="EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" name="EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" name="WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" name="StockIssuedDuringPeriodValueStockWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" name="StockIssuedDuringPeriodSharesStockWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IncomeLossFromDiscontinuedOperations" name="IncomeLossFromDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" name="PaymentsOfTaxesRelatedToEquityTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ConversionOfPreferredStockIntoCommonStock" name="ConversionOfPreferredStockIntoCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote9OtherLongtermAssetsAbstract" name="DisclosureNote9OtherLongtermAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OtherLongTermAssetsDisclosureTextBlock" name="OtherLongTermAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisclosureNote14WarrantsAbstract" name="DisclosureNote14WarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" name="RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" name="RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" name="RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" name="EquityMethodInvestmentFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" name="ScheduleOfOtherLongTermAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" name="ScheduleOfDebtPaymentsDueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" name="ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" name="ScheduleOfAssumptionsUsed1TableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_RestatementImpactAxis" name="RestatementImpactAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_RestatementImpactDomain" name="RestatementImpactDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockholdersEquityRestatement" name="StockholdersEquityRestatement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" name="FirmCommitmentUnderwrittenPublicOfferingShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" name="FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" name="FirmCommitmentUnderwrittenPublicOfferingNetProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" name="DifferenceBetweenComprehensiveLossAndNetLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ProceedsFromPurchaseAgreement" name="ProceedsFromPurchaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" name="DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" name="DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" name="NoncashOrPartNoncashDivestitureCashConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" name="NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" name="NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" name="NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WorkingCapitalAtClosingOfDisposalGroup" name="WorkingCapitalAtClosingOfDisposalGroup" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedProprietaryTechnologyGross" name="FiniteLivedProprietaryTechnologyGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedNoncompeteAgreementsGross1" name="FiniteLivedNoncompeteAgreementsGross1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FiniteLivedIntangibleAssetsGross1" name="FiniteLivedIntangibleAssetsGross1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" name="IndefiniteLivedIntangibleAssetsExcludingGoodwill1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IntangibleAssetsNetExcludingGoodwill1" name="IntangibleAssetsNetExcludingGoodwill1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SaleOfOwnershipInterestEquityMethodInvestment" name="SaleOfOwnershipInterestEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExchangeAgreementSharesExchanged" name="ExchangeAgreementSharesExchanged" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExchangeAgreementSharesExchangedParValue" name="ExchangeAgreementSharesExchangedParValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExchangeAgreementPreferredSharesReceived" name="ExchangeAgreementPreferredSharesReceived" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExchangeAgreementSharesPreferredStockValueSold" name="ExchangeAgreementSharesPreferredStockValueSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NoteReceivableSoldPursuantToExchangeAgreement" name="NoteReceivableSoldPursuantToExchangeAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SAFEAgreementAssets" name="SAFEAgreementAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PaymentForSAFEAgreement" name="PaymentForSAFEAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OperatingCashPaidToSettleLeaseLiabilities" name="OperatingCashPaidToSettleLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueYearOne" name="OutstandingPrincipalPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueLongTerm" name="OutstandingPrincipalPaymentsDueLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_OutstandingPrincipalPaymentsDueTotal" name="OutstandingPrincipalPaymentsDueTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ConvertibleNoteAgreementAmount" name="ConvertibleNoteAgreementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_LeaseholdImprovementAgreementFundsReceived" name="LeaseholdImprovementAgreementFundsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" name="FinancingAgreementFundingOfPurchaseOfFixedAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" name="StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" name="IssuanceOfCommonStockThroughATMFacilitiesNetShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodSharesPublicOffering" name="StockIssuedDuringPeriodSharesPublicOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ATMFacilityAggregateOfferingPrice" name="ATMFacilityAggregateOfferingPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PublicOfferingPricePerShare" name="PublicOfferingPricePerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover" name="AdditionalSharesPurchaseOptionOverAllotmentCover" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PreferredStockConvertible" name="PreferredStockConvertible" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_PreferredStockConvertibleSharesIssued" name="PreferredStockConvertibleSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" name="StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfWarrantsUponIssuance" name="NumberOfWarrantsUponIssuance" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_InitialFairValueOfWarrantsUponIssuance" name="InitialFairValueOfWarrantsUponIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsIssuedExercisePrice" name="WarrantsIssuedExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ExerciseOfWarrantsShares" name="ExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_WarrantsToPurchaseSharesIssued" name="WarrantsToPurchaseSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_FairValueOfOptionsAxis" name="FairValueOfOptionsAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_FairValueOfOptionsDomain" name="FairValueOfOptionsDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" name="ShareBasedCompensationSharesRestrictedStockAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="RCAT_ShareBasedCompensationSharesRestrictedStockDomain" name="ShareBasedCompensationSharesRestrictedStockDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" name="SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" name="SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_ResearchAndDevelopmentStockCompensationExpense" name="ResearchAndDevelopmentStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_SalesAndMarketingStockCompensationExpense" name="SalesAndMarketingStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_GeneralAndAdministrativeStockCompensationExpense" name="GeneralAndAdministrativeStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_TotalStockCompensationExpense" name="TotalStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" name="NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" name="UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockCompensationExpensePertainingToOptions" name="StockCompensationExpensePertainingToOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" name="StockCompensationExpensePertainingToRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>rcat-20240731_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="rcat-20240731.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfShareholdersEquity" xlink:href="rcat-20240731.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240731.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4Inventories" xlink:href="rcat-20240731.xsd#Note4Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssets" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssets" xlink:href="rcat-20240731.xsd#Note6IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestment" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipment" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssets" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligations" xlink:href="rcat-20240731.xsd#Note11DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStock" xlink:href="rcat-20240731.xsd#Note12CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStock" xlink:href="rcat-20240731.xsd#Note13PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14Warrants" xlink:href="rcat-20240731.xsd#Note14Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwards" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16-Related-partyTransactions" xlink:href="rcat-20240731.xsd#Note16-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:href="rcat-20240731.xsd#Note17CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18SubsequentEvents" xlink:href="rcat-20240731.xsd#Note18SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4InventoriesTables" xlink:href="rcat-20240731.xsd#Note4InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssetsTables" xlink:href="rcat-20240731.xsd#Note6IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsTables" xlink:href="rcat-20240731.xsd#Note11DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockTables" xlink:href="rcat-20240731.xsd#Note12CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsTables" xlink:href="rcat-20240731.xsd#Note14WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240731.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240731.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240731.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240731.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240731.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240731.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240731.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240731.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240731.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240731.xsd#FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240731.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240731.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240731.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240731.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240731.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240731.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note11DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240731.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note12CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note13PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240731.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240731.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note14WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240731.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240731.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="loc_RCATPreferredStockValueSeriesB" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_RCATPreferredStockValueSeriesB" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaapOtherNonrecurringIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonrecurringIncomeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; Equity (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="loc_RCATIncomeLossFromDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_RCATIncomeLossFromDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:to="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000007 - Disclosure - Note 1 &#8211; The Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000009 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4Inventories" xlink:title="00000010 - Disclosure - Note 4 &#8211; Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssets" xlink:title="00000011 - Disclosure - Note 5 &#8211; Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssets" xlink:title="00000012 - Disclosure - Note 6 &#8211; Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestment" xlink:title="00000013 - Disclosure - Note 7 &#8211; Equity Method Investment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipment" xlink:title="00000014 - Disclosure - Note 8 &#8211; Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssets" xlink:title="00000015 - Disclosure - Note 9 &#8211; Other Long-Term Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:title="00000016 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligations" xlink:title="00000017 - Disclosure - Note 11 &#8211; Debt Obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStock" xlink:title="00000018 - Disclosure - Note 12 &#8211; Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStock" xlink:title="00000019 - Disclosure - Note 13 &#8211; Preferred Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14Warrants" xlink:title="00000020 - Disclosure - Note 14 &#8211; Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwards" xlink:title="00000021 - Disclosure - Note 15 &#8211; Share Based Awards" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16-Related-partyTransactions" xlink:title="00000022 - Disclosure - Note 16 - Related-Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Note 17 &#8211; Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18SubsequentEvents" xlink:title="00000024 - Disclosure - Note 18 &#8211; Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000027 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4InventoriesTables" xlink:title="00000028 - Disclosure - Note 4 &#8211; Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:title="00000029 - Disclosure - Note 5 &#8211; Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Note 6 &#8211; Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:title="00000031 - Disclosure - Note 7 &#8211; Equity Method Investment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:title="00000032 - Disclosure - Note 8 &#8211; Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:title="00000033 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000034 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsTables" xlink:title="00000035 - Disclosure - Note 11 &#8211; Debt Obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockTables" xlink:title="00000036 - Disclosure - Note 12 &#8211; Common Stock (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsTables" xlink:title="00000037 - Disclosure - Note 14 &#8211; Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:title="00000038 - Disclosure - Note 15 &#8211; Share Based Awards (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000040 - Disclosure - Customer concentration risk (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000041 - Disclosure - Note 1 &#8211; The Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000042 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000044 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000045 - Disclosure - Discontinued Operations - results of operations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000046 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000047 - Disclosure - Inventories (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000048 - Disclosure - Other current assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000049 - Disclosure - Intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000051 - Disclosure - Impacts on investments into UMAC (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 7 &#8211; Equity Method Investment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000053 - Disclosure - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:title="00000054 - Disclosure - Note 8 &#8211; Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000055 - Disclosure - Other long term assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000057 - Disclosure - Operating leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000058 - Disclosure - Supplemental information related to operating leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:title="00000059 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000060 - Disclosure - Outstanding principal payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:title="00000061 - Disclosure - Note 11 &#8211; Debt Obligations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000062 - Disclosure - Summary of shares of common stock issued (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:title="00000063 - Disclosure - Note 12 &#8211; Common Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:title="00000064 - Disclosure - Note 13 &#8211; Preferred Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000065 - Disclosure - Summary of warrants issued and fair values (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000066 - Disclosure - Changes in warrants outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:title="00000067 - Disclosure - Note 14 &#8211; Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000069 - Disclosure - Summary of activity under the Plan (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000071 - Disclosure - Stock compensation expense by functional category (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:title="00000072 - Disclosure - Note 15 &#8211; Share Based Awards (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>rcat-20240731_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="rcat-20240731.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfShareholdersEquity" xlink:href="rcat-20240731.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240731.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4Inventories" xlink:href="rcat-20240731.xsd#Note4Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssets" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssets" xlink:href="rcat-20240731.xsd#Note6IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestment" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipment" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssets" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligations" xlink:href="rcat-20240731.xsd#Note11DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStock" xlink:href="rcat-20240731.xsd#Note12CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStock" xlink:href="rcat-20240731.xsd#Note13PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14Warrants" xlink:href="rcat-20240731.xsd#Note14Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwards" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16-Related-partyTransactions" xlink:href="rcat-20240731.xsd#Note16-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:href="rcat-20240731.xsd#Note17CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18SubsequentEvents" xlink:href="rcat-20240731.xsd#Note18SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4InventoriesTables" xlink:href="rcat-20240731.xsd#Note4InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssetsTables" xlink:href="rcat-20240731.xsd#Note6IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsTables" xlink:href="rcat-20240731.xsd#Note11DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockTables" xlink:href="rcat-20240731.xsd#Note12CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsTables" xlink:href="rcat-20240731.xsd#Note14WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240731.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240731.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240731.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240731.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240731.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240731.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240731.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240731.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240731.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240731.xsd#FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240731.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240731.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240731.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240731.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240731.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240731.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note11DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240731.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note12CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note13PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240731.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240731.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note14WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240731.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240731.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; Equity (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="loc_RCATSeriesBPreferredStock1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RCATSeriesBPreferredStock1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodValueStockWarrantsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodValueStockWarrantsExercised_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000007 - Disclosure - Note 1 &#8211; The Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000009 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note4Inventories" xlink:title="00000010 - Disclosure - Note 4 &#8211; Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssets" xlink:title="00000011 - Disclosure - Note 5 &#8211; Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssets" xlink:title="00000012 - Disclosure - Note 6 &#8211; Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestment" xlink:title="00000013 - Disclosure - Note 7 &#8211; Equity Method Investment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipment" xlink:title="00000014 - Disclosure - Note 8 &#8211; Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssets" xlink:title="00000015 - Disclosure - Note 9 &#8211; Other Long-Term Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:title="00000016 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligations" xlink:title="00000017 - Disclosure - Note 11 &#8211; Debt Obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStock" xlink:title="00000018 - Disclosure - Note 12 &#8211; Common Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStock" xlink:title="00000019 - Disclosure - Note 13 &#8211; Preferred Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note14Warrants" xlink:title="00000020 - Disclosure - Note 14 &#8211; Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwards" xlink:title="00000021 - Disclosure - Note 15 &#8211; Share Based Awards" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note16-Related-partyTransactions" xlink:title="00000022 - Disclosure - Note 16 - Related-Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Note 17 &#8211; Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note18SubsequentEvents" xlink:title="00000024 - Disclosure - Note 18 &#8211; Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000027 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note4InventoriesTables" xlink:title="00000028 - Disclosure - Note 4 &#8211; Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:title="00000029 - Disclosure - Note 5 &#8211; Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Note 6 &#8211; Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:title="00000031 - Disclosure - Note 7 &#8211; Equity Method Investment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:title="00000032 - Disclosure - Note 8 &#8211; Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:title="00000033 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000034 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsTables" xlink:title="00000035 - Disclosure - Note 11 &#8211; Debt Obligations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockTables" xlink:title="00000036 - Disclosure - Note 12 &#8211; Common Stock (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsTables" xlink:title="00000037 - Disclosure - Note 14 &#8211; Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:title="00000038 - Disclosure - Note 15 &#8211; Share Based Awards (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAxis" xlink:label="loc_RCATRestatementImpactAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATRestatementImpactAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="loc_RCATRestatementImpactOriginallyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactOriginallyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="loc_RCATRestatementImpactAsRestatedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactAsRestatedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactChangeMember" xlink:label="loc_RCATRestatementImpactChangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactChangeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockholdersEquityRestatement" xlink:label="loc_RCATStockholdersEquityRestatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockholdersEquityRestatement_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000040 - Disclosure - Customer concentration risk (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="loc_RCATCustomerConcentrationRisk1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="loc_RCATCustomerConcentrationRisk2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000041 - Disclosure - Note 1 &#8211; The Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition1Member" xlink:label="loc_RCATBusinessAcquisition1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition2Member" xlink:label="loc_RCATBusinessAcquisition2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition3Member" xlink:label="loc_RCATBusinessAcquisition3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition4Member" xlink:label="loc_RCATBusinessAcquisition4Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition4Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000042 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000044 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000045 - Disclosure - Discontinued Operations - results of operations (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000046 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000047 - Disclosure - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000048 - Disclosure - Other current assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000049 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="loc_RCATIntangibleAssetsGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsGrossCarryingAmountMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="loc_RCATIntangibleAssetsAccumulatedAmortizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsAccumulatedAmortizationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="loc_RCATIntangibleAssetsNetCarryingValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsNetCarryingValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="loc_RCATFiniteLivedProprietaryTechnologyGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedProprietaryTechnologyGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="loc_RCATFiniteLivedNoncompeteAgreementsGross1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedNoncompeteAgreementsGross1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="loc_RCATFiniteLivedIntangibleAssetsGross1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedIntangibleAssetsGross1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIndefiniteLivedTradeNames_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="loc_RCATIntangibleAssetsNetExcludingGoodwill1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIntangibleAssetsNetExcludingGoodwill1_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsNoncurrent_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapRevenues_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapGrossProfit_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_30" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000051 - Disclosure - Impacts on investments into UMAC (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SaleOfOwnershipInterestEquityMethodInvestment" xlink:label="loc_RCATSaleOfOwnershipInterestEquityMethodInvestment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_RCATSaleOfOwnershipInterestEquityMethodInvestment_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 7 &#8211; Equity Method Investment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000053 - Disclosure - Property and equipment (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:title="00000054 - Disclosure - Note 8 &#8211; Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000055 - Disclosure - Other long term assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000057 - Disclosure - Operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="loc_RCATOperatingLeaseLocation1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="loc_RCATOperatingLeaseLocation3Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation3Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="loc_RCATOperatingLeaseLocation4Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation4Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000058 - Disclosure - Supplemental information related to operating leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:title="00000059 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000060 - Disclosure - Outstanding principal payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:title="00000061 - Disclosure - Note 11 &#8211; Debt Obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation1Member" xlink:label="loc_RCATDebtObligation1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation2Member" xlink:label="loc_RCATDebtObligation2Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation2Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation6Member" xlink:label="loc_RCATDebtObligation6Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation6Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation8Member" xlink:label="loc_RCATDebtObligation8Member_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation8Member_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="loc_RCATConvertibleNoteAgreementAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATConvertibleNoteAgreementAmount_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="loc_RCATLeaseholdImprovementAgreementFundsReceived_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLeaseholdImprovementAgreementFundsReceived_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset_180" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000062 - Disclosure - Summary of shares of common stock issued (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="loc_RCATStockIssuedDuringPeriodSharesPublicOffering_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesPublicOffering_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised_60" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:title="00000063 - Disclosure - Note 12 &#8211; Common Stock (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:title="00000064 - Disclosure - Note 13 &#8211; Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="loc_RCATSeriesAPreferredStock2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RCATSeriesAPreferredStock2Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertible" xlink:label="loc_RCATPreferredStockConvertible_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATPreferredStockConvertible_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertibleSharesIssued" xlink:label="loc_RCATPreferredStockConvertibleSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATPreferredStockConvertibleSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000065 - Disclosure - Summary of warrants issued and fair values (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000066 - Disclosure - Changes in warrants outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="loc_RCATWarrantsOutstanding1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantsOutstanding1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:title="00000067 - Disclosure - Note 14 &#8211; Warrants (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="loc_RCATFairValueOfOptionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFairValueOfOptionsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="loc_RCATOptionsAssumptionsUsedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATFairValueOfOptionsDomain" xlink:to="loc_RCATOptionsAssumptionsUsedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_60" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000069 - Disclosure - Summary of activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_Options1Member" xlink:label="loc_RCATOptions1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RCATOptions1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_70" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000071 - Disclosure - Stock compensation expense by functional category (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:title="00000072 - Disclosure - Note 15 &#8211; Share Based Awards (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>rcat-20240731_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="RCAT_SeriesBPreferredStock1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SeriesBPreferredStock1Member" xlink:to="RCAT_SeriesBPreferredStock1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SeriesBPreferredStock1Member_lbl" xml:lang="en-US">Series B Preferred Stock 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition1Member" xlink:label="RCAT_BusinessAcquisition1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition1Member" xlink:to="RCAT_BusinessAcquisition1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition1Member_lbl" xml:lang="en-US">Business Acquisition 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition2Member" xlink:label="RCAT_BusinessAcquisition2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition2Member" xlink:to="RCAT_BusinessAcquisition2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition2Member_lbl" xml:lang="en-US">Business Acquisition 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition3Member" xlink:label="RCAT_BusinessAcquisition3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition3Member" xlink:to="RCAT_BusinessAcquisition3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition3Member_lbl" xml:lang="en-US">Business Acquisition 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition4Member" xlink:label="RCAT_BusinessAcquisition4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_BusinessAcquisition4Member" xlink:to="RCAT_BusinessAcquisition4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_BusinessAcquisition4Member_lbl" xml:lang="en-US">Business Acquisition 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAxis" xlink:label="RCAT_RestatementImpactAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAxis" xlink:to="RCAT_RestatementImpactAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactAxis_lbl" xml:lang="en-US">Restatement Impact [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="RCAT_RestatementImpactOriginallyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactOriginallyReportedMember" xlink:to="RCAT_RestatementImpactOriginallyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactOriginallyReportedMember_lbl" xml:lang="en-US">Restatement Impact Originally Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="RCAT_RestatementImpactAsRestatedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAsRestatedMember" xlink:to="RCAT_RestatementImpactAsRestatedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactAsRestatedMember_lbl" xml:lang="en-US">Restatement Impact As Restated [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactChangeMember" xlink:label="RCAT_RestatementImpactChangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactChangeMember" xlink:to="RCAT_RestatementImpactChangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementImpactChangeMember_lbl" xml:lang="en-US">Restatement Impact Change [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="RCAT_CustomerConcentrationRisk1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk1Member" xlink:to="RCAT_CustomerConcentrationRisk1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk1Member_lbl" xml:lang="en-US">Customer Concentration Risk 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="RCAT_CustomerConcentrationRisk2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_CustomerConcentrationRisk2Member" xlink:to="RCAT_CustomerConcentrationRisk2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_CustomerConcentrationRisk2Member_lbl" xml:lang="en-US">Customer Concentration Risk 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets By Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="RCAT_IntangibleAssetsGrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:to="RCAT_IntangibleAssetsGrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsGrossCarryingAmountMember_lbl" xml:lang="en-US">Intangible Assets Gross Carrying Amount [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="RCAT_IntangibleAssetsAccumulatedAmortizationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:to="RCAT_IntangibleAssetsAccumulatedAmortizationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsAccumulatedAmortizationMember_lbl" xml:lang="en-US">Intangible Assets Accumulated Amortization [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="RCAT_IntangibleAssetsNetCarryingValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsNetCarryingValueMember" xlink:to="RCAT_IntangibleAssetsNetCarryingValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsNetCarryingValueMember_lbl" xml:lang="en-US">Intangible Assets Net Carrying Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_lbl" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="RCAT_OperatingLeaseLocation1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation1Member" xlink:to="RCAT_OperatingLeaseLocation1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation1Member_lbl" xml:lang="en-US">Operating Lease Location 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="RCAT_OperatingLeaseLocation3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation3Member" xlink:to="RCAT_OperatingLeaseLocation3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation3Member_lbl" xml:lang="en-US">Operating Lease Location 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="RCAT_OperatingLeaseLocation4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingLeaseLocation4Member" xlink:to="RCAT_OperatingLeaseLocation4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingLeaseLocation4Member_lbl" xml:lang="en-US">Operating Lease Location 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation1Member" xlink:label="RCAT_DebtObligation1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation1Member" xlink:to="RCAT_DebtObligation1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation1Member_lbl" xml:lang="en-US">Debt Obligation 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation2Member" xlink:label="RCAT_DebtObligation2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation2Member" xlink:to="RCAT_DebtObligation2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation2Member_lbl" xml:lang="en-US">Debt Obligation 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation6Member" xlink:label="RCAT_DebtObligation6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation6Member" xlink:to="RCAT_DebtObligation6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation6Member_lbl" xml:lang="en-US">Debt Obligation 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation8Member" xlink:label="RCAT_DebtObligation8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DebtObligation8Member" xlink:to="RCAT_DebtObligation8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DebtObligation8Member_lbl" xml:lang="en-US">Debt Obligation 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="RCAT_SeriesAPreferredStock2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SeriesAPreferredStock2Member" xlink:to="RCAT_SeriesAPreferredStock2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SeriesAPreferredStock2Member_lbl" xml:lang="en-US">Series A Preferred Stock 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="RCAT_WarrantsOutstanding1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsOutstanding1Member" xlink:to="RCAT_WarrantsOutstanding1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsOutstanding1Member_lbl" xml:lang="en-US">Warrants Outstanding 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="RCAT_FairValueOfOptionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfOptionsAxis" xlink:to="RCAT_FairValueOfOptionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FairValueOfOptionsAxis_lbl" xml:lang="en-US">Fair Value Of Options [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="RCAT_OptionsAssumptionsUsedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OptionsAssumptionsUsedMember" xlink:to="RCAT_OptionsAssumptionsUsedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OptionsAssumptionsUsedMember_lbl" xml:lang="en-US">Options Assumptions Used [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_Options1Member" xlink:label="RCAT_Options1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_Options1Member" xlink:to="RCAT_Options1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_Options1Member_lbl" xml:lang="en-US">Options 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:to="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_lbl" xml:lang="en-US">Share Based Compensation Shares Restricted Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US">Note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Debt obligations - short term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="RCAT_PreferredStockValueSeriesB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PreferredStockValueSeriesB" xlink:to="RCAT_PreferredStockValueSeriesB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PreferredStockValueSeriesB_lbl" xml:lang="en-US">Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock - shares authorized 500,000,000; issued and outstanding 74,890,248 and 74,289,351</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of goods sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross (loss) profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other (income) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US">Loss on sale of equity method investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_lbl" xml:lang="en-US">Equity method loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment loss, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest (income) expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="us-gaap_OtherNonrecurringIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonrecurringIncomeExpense" xlink:to="us-gaap_OtherNonrecurringIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonrecurringIncomeExpense_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Change in foreign currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTax_lbl" xml:lang="en-US">Other comprehensive loss&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedRCATAbstract_lbl" xml:lang="en-US">Loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:label="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:label="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:to="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:label="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:to="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT_lbl" xml:lang="en-US">Weighted average shares outstanding - basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Shares, Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_lbl" xml:lang="en-US">Vesting of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:to="RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Shares, Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncomeLossFromDiscontinuedOperations" xlink:to="RCAT_IncomeLossFromDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash from operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Stock based compensation - options</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Stock based compensation - restricted units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xml:lang="en-US">Realized loss from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xml:lang="en-US">Loss on sale of equity method investment and note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xml:lang="en-US">Impairment on goodwill and intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:to="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities_lbl" xml:lang="en-US">Operating lease right-of-use assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:label="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfEquityMethodInvestments_lbl" xml:lang="en-US">Proceeds from sale of equity method investment and note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by investing activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Payments under debt obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:to="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_lbl" xml:lang="en-US">Payments of taxes related to equity transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in financing activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:label="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_lbl" xml:lang="en-US">Net cash used in discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" xml:lang="en-US">Less: Cash of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash of continuing operations, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_lbl" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:label="RCAT_ConversionOfPreferredStockIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:to="RCAT_ConversionOfPreferredStockIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ConversionOfPreferredStockIntoCommonStock_lbl" xml:lang="en-US">Conversion of preferred stock into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Note 1 &#8211; The Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Note 2 &#8211; Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">Note 3 &#8211; Divestiture of Consumer Segment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Note 4 &#8211; Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Note 5 &#8211; Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 6 &#8211; Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US">Note 7 &#8211; Equity Method Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Note 8 &#8211; Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:label="RCAT_DisclosureNote9OtherLongtermAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:to="RCAT_DisclosureNote9OtherLongtermAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote9OtherLongtermAssetsAbstract_lbl" xml:lang="en-US">Note 9 Other Long-term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:label="RCAT_OtherLongTermAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:to="RCAT_OtherLongTermAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OtherLongTermAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 9 &#8211; Other Long-Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Note 10 &#8211; Right of Use Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note 11 &#8211; Debt Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Note 12 &#8211; Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Note 13 &#8211; Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="RCAT_DisclosureNote14WarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote14WarrantsAbstract" xlink:to="RCAT_DisclosureNote14WarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisclosureNote14WarrantsAbstract_lbl" xml:lang="en-US">Note 14 Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsDisclosureTextBlock" xlink:label="RCAT_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsDisclosureTextBlock" xlink:to="RCAT_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Note 14 &#8211; Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Note 15 &#8211; Share Based Awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Note 16 - Related-Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Note 17 &#8211; Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Note 18 &#8211; Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:label="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:to="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_lbl" xml:lang="en-US">Restatement of Previously Issued Consolidated Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Equity Method Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_lbl" xml:lang="en-US">Product Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RelatedPartiesPolicyTextBlock" xlink:label="RCAT_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RelatedPartiesPolicyTextBlock" xlink:to="RCAT_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Liquidity and Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:label="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:to="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:label="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:to="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_lbl" xml:lang="en-US">[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:label="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:to="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock_lbl" xml:lang="en-US">[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:to="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfRentExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfRentExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRentExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Rent Expense [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:label="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:to="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfDebtPaymentsDueTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfDebtPaymentsDueTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:label="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:to="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:label="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:to="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ScheduleOfAssumptionsUsed1TableTextBlock_lbl" xml:lang="en-US">[custom:ScheduleOfAssumptionsUsed1TableTextBlock]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_RestatementImpactAxis" xlink:to="RCAT_RestatementImpactAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_RestatementImpactAxis_2_lbl" xml:lang="en-US">RestatementImpactAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AdditionalPaidInCapital_2_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockholdersEquityRestatement" xlink:label="RCAT_StockholdersEquityRestatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockholdersEquityRestatement" xlink:to="RCAT_StockholdersEquityRestatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="RCAT_StockholdersEquityRestatement_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingShares_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:to="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds_lbl" xml:lang="en-US">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Contract related</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="us-gaap_RevenueNotFromContractWithCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueNotFromContractWithCustomer" xlink:to="us-gaap_RevenueNotFromContractWithCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueNotFromContractWithCustomer_lbl" xml:lang="en-US">Product related</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_lbl" xml:lang="en-US">Series B Preferred Stock, as converted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:to="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_lbl" xml:lang="en-US">Restricted stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Asset Impairment Charges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent_lbl" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xml:lang="en-US">Standard Product Warranty Accrual, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:label="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:to="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DifferenceBetweenComprehensiveLossAndNetLoss_lbl" xml:lang="en-US">[custom:DifferenceBetweenComprehensiveLossAndNetLoss]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_lbl" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Capital" xlink:label="us-gaap_Capital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Capital" xlink:to="us-gaap_Capital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Capital_lbl" xml:lang="en-US">Banking Regulation, Total Capital, Actual</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ProceedsFromPurchaseAgreement" xlink:label="RCAT_ProceedsFromPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ProceedsFromPurchaseAgreement" xlink:to="RCAT_ProceedsFromPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ProceedsFromPurchaseAgreement_lbl" xml:lang="en-US">[custom:ProceedsFromPurchaseAgreement]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xml:lang="en-US">Cost of goods sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expense (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:to="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:to="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_lbl" xml:lang="en-US">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:label="RCAT_WorkingCapitalAtClosingOfDisposalGroup" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:to="RCAT_WorkingCapitalAtClosingOfDisposalGroup_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WorkingCapitalAtClosingOfDisposalGroup_lbl" xml:lang="en-US">[custom:WorkingCapitalAtClosingOfDisposalGroup-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="us-gaap_ContractWithCustomerAssetGrossCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerAssetGrossCurrent_2_lbl" xml:lang="en-US">Contract asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="us-gaap_GrantsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Grant receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="RCAT_FiniteLivedProprietaryTechnologyGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedProprietaryTechnologyGross" xlink:to="RCAT_FiniteLivedProprietaryTechnologyGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedProprietaryTechnologyGross_lbl" xml:lang="en-US">Proprietary technology</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="RCAT_FiniteLivedNoncompeteAgreementsGross1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:to="RCAT_FiniteLivedNoncompeteAgreementsGross1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedNoncompeteAgreementsGross1_lbl" xml:lang="en-US">Non-compete agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="RCAT_FiniteLivedIntangibleAssetsGross1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FiniteLivedIntangibleAssetsGross1" xlink:to="RCAT_FiniteLivedIntangibleAssetsGross1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FiniteLivedIntangibleAssetsGross1_lbl" xml:lang="en-US">Total finite-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="us-gaap_IndefiniteLivedTradeNames" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTradeNames" xlink:to="us-gaap_IndefiniteLivedTradeNames_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedTradeNames_lbl" xml:lang="en-US">Brand name</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:to="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1_lbl" xml:lang="en-US">Total indefinite-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="RCAT_IntangibleAssetsNetExcludingGoodwill1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:to="RCAT_IntangibleAssetsNetExcludingGoodwill1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IntangibleAssetsNetExcludingGoodwill1_lbl" xml:lang="en-US">Total intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Long-term assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Long-term liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_EquityMethodInvestments_2_lbl" xml:lang="en-US">Initial investment, February 16, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Equity method loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xml:lang="en-US">Impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_EquityMethodInvestments_3_lbl" xml:lang="en-US">Investment balance, July 31, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SaleOfOwnershipInterestEquityMethodInvestment" xlink:label="RCAT_SaleOfOwnershipInterestEquityMethodInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SaleOfOwnershipInterestEquityMethodInvestment" xlink:to="RCAT_SaleOfOwnershipInterestEquityMethodInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SaleOfOwnershipInterestEquityMethodInvestment_lbl" xml:lang="en-US">Sale of ownership interest</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesExchanged" xlink:label="RCAT_ExchangeAgreementSharesExchanged" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExchangeAgreementSharesExchanged" xlink:to="RCAT_ExchangeAgreementSharesExchanged_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExchangeAgreementSharesExchanged_lbl" xml:lang="en-US">[custom:ExchangeAgreementSharesExchanged]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesExchangedParValue" xlink:label="RCAT_ExchangeAgreementSharesExchangedParValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExchangeAgreementSharesExchangedParValue" xlink:to="RCAT_ExchangeAgreementSharesExchangedParValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExchangeAgreementSharesExchangedParValue_lbl" xml:lang="en-US">[custom:ExchangeAgreementSharesExchangedParValue]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementPreferredSharesReceived" xlink:label="RCAT_ExchangeAgreementPreferredSharesReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExchangeAgreementPreferredSharesReceived" xlink:to="RCAT_ExchangeAgreementPreferredSharesReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExchangeAgreementPreferredSharesReceived_lbl" xml:lang="en-US">[custom:ExchangeAgreementPreferredSharesReceived]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesPreferredStockValueSold" xlink:label="RCAT_ExchangeAgreementSharesPreferredStockValueSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExchangeAgreementSharesPreferredStockValueSold" xlink:to="RCAT_ExchangeAgreementSharesPreferredStockValueSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExchangeAgreementSharesPreferredStockValueSold_lbl" xml:lang="en-US">[custom:ExchangeAgreementSharesPreferredStockValueSold]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoteReceivableSoldPursuantToExchangeAgreement" xlink:label="RCAT_NoteReceivableSoldPursuantToExchangeAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NoteReceivableSoldPursuantToExchangeAgreement" xlink:to="RCAT_NoteReceivableSoldPursuantToExchangeAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NoteReceivableSoldPursuantToExchangeAgreement_lbl" xml:lang="en-US">[custom:NoteReceivableSoldPursuantToExchangeAgreement]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Equipment and related</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US">Leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US">Furniture and fixtures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net carrying value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:to="RCAT_DisclosureNote9OtherLongtermAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisclosureNote9OtherLongtermAssetsAbstract_2_lbl" xml:lang="en-US">Other Long Term Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SAFEAgreementAssets" xlink:label="RCAT_SAFEAgreementAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SAFEAgreementAssets" xlink:to="RCAT_SAFEAgreementAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SAFEAgreementAssets_lbl" xml:lang="en-US">SAFE agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PaymentForSAFEAgreement" xlink:label="RCAT_PaymentForSAFEAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentForSAFEAgreement" xlink:to="RCAT_PaymentForSAFEAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PaymentForSAFEAgreement_lbl" xml:lang="en-US">[custom:PaymentForSAFEAgreement]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:label="RCAT_OperatingCashPaidToSettleLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:to="RCAT_OperatingCashPaidToSettleLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OperatingCashPaidToSettleLeaseLiabilities_lbl" xml:lang="en-US">Operating cash paid to settle lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:label="RCAT_OutstandingPrincipalPaymentsDueYearOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:to="RCAT_OutstandingPrincipalPaymentsDueYearOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueYearOne_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:to="RCAT_OutstandingPrincipalPaymentsDueLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:to="RCAT_OutstandingPrincipalPaymentsDueTotal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Long-Term Debt, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="RCAT_ConvertibleNoteAgreementAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ConvertibleNoteAgreementAmount" xlink:to="RCAT_ConvertibleNoteAgreementAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ConvertibleNoteAgreementAmount_lbl" xml:lang="en-US">[custom:ConvertibleNoteAgreementAmount]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accrued Liabilities, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="RCAT_LeaseholdImprovementAgreementFundsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:to="RCAT_LeaseholdImprovementAgreementFundsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_LeaseholdImprovementAgreementFundsReceived_lbl" xml:lang="en-US">[custom:LeaseholdImprovementAgreementFundsReceived]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:to="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset_lbl" xml:lang="en-US">[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_lbl" xml:lang="en-US">Vesting of restricted stock to employees, net of shares withheld of 126,828 to pay taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_lbl" xml:lang="en-US">Vesting of restricted stock to Board of Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_lbl" xml:lang="en-US">Vesting of restricted stock to consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:to="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:to="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares_lbl" xml:lang="en-US">Issuance of common stock through ATM facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="RCAT_StockIssuedDuringPeriodSharesPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:to="RCAT_StockIssuedDuringPeriodSharesPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodSharesPublicOffering_lbl" xml:lang="en-US">Issuance of common stock through public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised_2_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ATMFacilityAggregateOfferingPrice" xlink:label="RCAT_ATMFacilityAggregateOfferingPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ATMFacilityAggregateOfferingPrice" xlink:to="RCAT_ATMFacilityAggregateOfferingPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ATMFacilityAggregateOfferingPrice_lbl" xml:lang="en-US">[custom:ATMFacilityAggregateOfferingPrice]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering" xlink:label="us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering" xlink:to="us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering_lbl" xml:lang="en-US">Partners' Capital Account, Units, Sold in Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PublicOfferingPricePerShare" xlink:label="RCAT_PublicOfferingPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PublicOfferingPricePerShare" xlink:to="RCAT_PublicOfferingPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PublicOfferingPricePerShare_lbl" xml:lang="en-US">[custom:PublicOfferingPricePerShare]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover" xlink:label="RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover" xlink:to="RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover_lbl" xml:lang="en-US">[custom:AdditionalSharesPurchaseOptionOverAllotmentCover]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertible" xlink:label="RCAT_PreferredStockConvertible" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PreferredStockConvertible" xlink:to="RCAT_PreferredStockConvertible_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PreferredStockConvertible_lbl" xml:lang="en-US">[custom:PreferredStockConvertible]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertibleSharesIssued" xlink:label="RCAT_PreferredStockConvertibleSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PreferredStockConvertibleSharesIssued" xlink:to="RCAT_PreferredStockConvertibleSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PreferredStockConvertibleSharesIssued_lbl" xml:lang="en-US">[custom:PreferredStockConvertibleSharesIssued]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:to="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisclosureNote14WarrantsAbstract" xlink:to="RCAT_DisclosureNote14WarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_DisclosureNote14WarrantsAbstract_2_lbl" xml:lang="en-US">Summary Of Warrants Issued And Fair Values</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NumberOfWarrantsUponIssuance" xlink:label="RCAT_NumberOfWarrantsUponIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfWarrantsUponIssuance" xlink:to="RCAT_NumberOfWarrantsUponIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfWarrantsUponIssuance_lbl" xml:lang="en-US">[custom:NumberOfWarrantsUponIssuance]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:label="RCAT_InitialFairValueOfWarrantsUponIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:to="RCAT_InitialFairValueOfWarrantsUponIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_InitialFairValueOfWarrantsUponIssuance_lbl" xml:lang="en-US">[custom:InitialFairValueOfWarrantsUponIssuance]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsIssuedExercisePrice" xlink:label="RCAT_WarrantsIssuedExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsIssuedExercisePrice" xlink:to="RCAT_WarrantsIssuedExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsIssuedExercisePrice_lbl" xml:lang="en-US">[custom:WarrantsIssuedExercisePrice]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExerciseOfWarrantsShares" xlink:label="RCAT_ExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ExerciseOfWarrantsShares" xlink:to="RCAT_ExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ExerciseOfWarrantsShares_lbl" xml:lang="en-US">[custom:ExerciseOfWarrantsShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsToPurchaseSharesIssued" xlink:label="RCAT_WarrantsToPurchaseSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_WarrantsToPurchaseSharesIssued" xlink:to="RCAT_WarrantsToPurchaseSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_WarrantsToPurchaseSharesIssued_lbl" xml:lang="en-US">[custom:WarrantsToPurchaseSharesIssued]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_FairValueOfOptionsAxis" xlink:to="RCAT_FairValueOfOptionsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_FairValueOfOptionsAxis_2_lbl" xml:lang="en-US">FairValueOfOptionsAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:to="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_ShareBasedCompensationSharesRestrictedStockAxis_2_lbl" xml:lang="en-US">ShareBasedCompensationSharesRestrictedStockAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:to="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:to="RCAT_ResearchAndDevelopmentStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SalesAndMarketingStockCompensationExpense" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SalesAndMarketingStockCompensationExpense" xlink:to="RCAT_SalesAndMarketingStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:to="RCAT_GeneralAndAdministrativeStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_TotalStockCompensationExpense" xlink:label="RCAT_TotalStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_TotalStockCompensationExpense" xlink:to="RCAT_TotalStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RCAT_TotalStockCompensationExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:label="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:to="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_lbl" xml:lang="en-US">[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:label="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:to="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_lbl" xml:lang="en-US">[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockCompensationExpensePertainingToOptions" xlink:label="RCAT_StockCompensationExpensePertainingToOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockCompensationExpensePertainingToOptions" xlink:to="RCAT_StockCompensationExpensePertainingToOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockCompensationExpensePertainingToOptions_lbl" xml:lang="en-US">[custom:StockCompensationExpensePertainingToOptions]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:label="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:to="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockCompensationExpensePertainingToRestrictedStockUnits_lbl" xml:lang="en-US">[custom:StockCompensationExpensePertainingToRestrictedStockUnits]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">Other Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_3_lbl" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_2_lbl" xml:lang="en-US">Investment Income, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Marketable Security, Unrealized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_IncomeLossFromDiscontinuedOperations" xlink:to="RCAT_IncomeLossFromDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_IncomeLossFromDiscontinuedOperations_2_lbl" xml:lang="en-US">IncomeLossFromDiscontinuedOperations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:to="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_PaymentsOfTaxesRelatedToEquityTransactions_2_lbl" xml:lang="en-US">PaymentsOfTaxesRelatedToEquityTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:to="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInDiscontinuedOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockholdersEquityRestatement" xlink:to="RCAT_StockholdersEquityRestatement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockholdersEquityRestatement_2_lbl" xml:lang="en-US">StockholdersEquityRestatement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:to="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_2_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_2_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:to="RCAT_OutstandingPrincipalPaymentsDueLongTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueLongTerm_2_lbl" xml:lang="en-US">OutstandingPrincipalPaymentsDueLongTerm</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:to="RCAT_OutstandingPrincipalPaymentsDueTotal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_OutstandingPrincipalPaymentsDueTotal_2_lbl" xml:lang="en-US">OutstandingPrincipalPaymentsDueTotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:to="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:to="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_2_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:to="RCAT_ResearchAndDevelopmentStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_ResearchAndDevelopmentStockCompensationExpense_2_lbl" xml:lang="en-US">ResearchAndDevelopmentStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_SalesAndMarketingStockCompensationExpense" xlink:to="RCAT_SalesAndMarketingStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_SalesAndMarketingStockCompensationExpense_2_lbl" xml:lang="en-US">SalesAndMarketingStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:to="RCAT_GeneralAndAdministrativeStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_GeneralAndAdministrativeStockCompensationExpense_2_lbl" xml:lang="en-US">GeneralAndAdministrativeStockCompensationExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RCAT_TotalStockCompensationExpense" xlink:to="RCAT_TotalStockCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RCAT_TotalStockCompensationExpense_2_lbl" xml:lang="en-US">TotalStockCompensationExpense</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>rcat-20240731_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://RCAT/role/Cover" xlink:href="rcat-20240731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheets" xlink:href="rcat-20240731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/BalanceSheetsParenthetical" xlink:href="rcat-20240731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:href="rcat-20240731.xsd#StatementsOfOperationsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfShareholdersEquity" xlink:href="rcat-20240731.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StatementsOfCashFlows" xlink:href="rcat-20240731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1Business" xlink:href="rcat-20240731.xsd#Note1Business" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4Inventories" xlink:href="rcat-20240731.xsd#Note4Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssets" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssets" xlink:href="rcat-20240731.xsd#Note6IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestment" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipment" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssets" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligations" xlink:href="rcat-20240731.xsd#Note11DebtObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStock" xlink:href="rcat-20240731.xsd#Note12CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStock" xlink:href="rcat-20240731.xsd#Note13PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14Warrants" xlink:href="rcat-20240731.xsd#Note14Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwards" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwards" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note16-Related-partyTransactions" xlink:href="rcat-20240731.xsd#Note16-Related-partyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:href="rcat-20240731.xsd#Note17CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note18SubsequentEvents" xlink:href="rcat-20240731.xsd#Note18SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note4InventoriesTables" xlink:href="rcat-20240731.xsd#Note4InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:href="rcat-20240731.xsd#Note5OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note6IntangibleAssetsTables" xlink:href="rcat-20240731.xsd#Note6IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsTables" xlink:href="rcat-20240731.xsd#Note11DebtObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockTables" xlink:href="rcat-20240731.xsd#Note12CommonStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsTables" xlink:href="rcat-20240731.xsd#Note14WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:href="rcat-20240731.xsd#ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:href="rcat-20240731.xsd#CustomerConcentrationRiskDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:href="rcat-20240731.xsd#Note1BusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:href="rcat-20240731.xsd#CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="rcat-20240731.xsd#AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:href="rcat-20240731.xsd#DiscontinuedOperations-ResultsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/InventoriesDetails" xlink:href="rcat-20240731.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherCurrentAssetsDetails" xlink:href="rcat-20240731.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/IntangibleAssetsDetails" xlink:href="rcat-20240731.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:href="rcat-20240731.xsd#FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:href="rcat-20240731.xsd#ImpactsOnInvestmentsIntoUmacDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note7EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/PropertyAndEquipmentDetails" xlink:href="rcat-20240731.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:href="rcat-20240731.xsd#Note8PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OtherLongTermAssetsDetails" xlink:href="rcat-20240731.xsd#OtherLongTermAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note9OtherLong-termAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OperatingLeasesDetails" xlink:href="rcat-20240731.xsd#OperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:href="rcat-20240731.xsd#SupplementalInformationRelatedToOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:href="rcat-20240731.xsd#Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:href="rcat-20240731.xsd#OutstandingPrincipalPaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note11DebtObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:href="rcat-20240731.xsd#SummaryOfSharesOfCommonStockIssuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note12CommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:href="rcat-20240731.xsd#Note13PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:href="rcat-20240731.xsd#SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:href="rcat-20240731.xsd#ChangesInWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note14WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:href="rcat-20240731.xsd#AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:href="rcat-20240731.xsd#SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:href="rcat-20240731.xsd#StockCompensationExpenseByFunctionalCategoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:href="rcat-20240731.xsd#Note15ShareBasedAwardsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapLongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockValueSeriesB" xlink:label="loc_RCATPreferredStockValueSeriesB" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_RCATPreferredStockValueSeriesB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaapOtherNonrecurringIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonrecurringIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedRCATAbstract" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedContinuingOperationsRCAT" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedContinuingOperationsRCAT" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:label="loc_RCATEarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATEarningsPerShareBasicAndDilutedRCATAbstract" xlink:to="loc_RCATEarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:label="loc_RCATWeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_RCATWeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Shareholders&apos; Equity (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesBPreferredStock1Member" xlink:label="loc_RCATSeriesBPreferredStock1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_RCATSeriesBPreferredStock1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncomeLossFromDiscontinuedOperations" xlink:label="loc_RCATIncomeLossFromDiscontinuedOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RCATIncomeLossFromDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:label="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:label="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_RCATIncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:label="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdditionalCashFlowElementsFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PaymentsOfTaxesRelatedToEquityTransactions" xlink:label="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_RCATPaymentsOfTaxesRelatedToEquityTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInDiscontinuedOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ConversionOfPreferredStockIntoCommonStock" xlink:label="loc_RCATConversionOfPreferredStockIntoCommonStock" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_RCATConversionOfPreferredStockIntoCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1Business" xlink:title="00000007 - Disclosure - Note 1 &#8211; The Business">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegment" xlink:title="00000009 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4Inventories" xlink:title="00000010 - Disclosure - Note 4 &#8211; Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssets" xlink:title="00000011 - Disclosure - Note 5 &#8211; Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssets" xlink:title="00000012 - Disclosure - Note 6 &#8211; Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestment" xlink:title="00000013 - Disclosure - Note 7 &#8211; Equity Method Investment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipment" xlink:title="00000014 - Disclosure - Note 8 &#8211; Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssets" xlink:title="00000015 - Disclosure - Note 9 &#8211; Other Long-Term Assets">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OtherLongTermAssetsDisclosureTextBlock" xlink:label="loc_RCATOtherLongTermAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_RCATOtherLongTermAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilities" xlink:title="00000016 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligations" xlink:title="00000017 - Disclosure - Note 11 &#8211; Debt Obligations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStock" xlink:title="00000018 - Disclosure - Note 12 &#8211; Common Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStock" xlink:title="00000019 - Disclosure - Note 13 &#8211; Preferred Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14Warrants" xlink:title="00000020 - Disclosure - Note 14 &#8211; Warrants">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="loc_RCATDisclosureNote14WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsDisclosureTextBlock" xlink:label="loc_RCATWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATWarrantsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwards" xlink:title="00000021 - Disclosure - Note 15 &#8211; Share Based Awards">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note16-Related-partyTransactions" xlink:title="00000022 - Disclosure - Note 16 - Related-Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note17CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Note 17 &#8211; Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note18SubsequentEvents" xlink:title="00000024 - Disclosure - Note 18 &#8211; Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:label="loc_RCATRestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:label="loc_us-gaapGuaranteesIndemnificationsAndWarrantiesPolicies" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RelatedPartiesPolicyTextBlock" xlink:label="loc_RCATRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:label="loc_RCATRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:label="loc_RCATRevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATRevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentTables" xlink:title="00000027 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note4InventoriesTables" xlink:title="00000028 - Disclosure - Note 4 &#8211; Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note5OtherCurrentAssetsTables" xlink:title="00000029 - Disclosure - Note 5 &#8211; Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note6IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Note 6 &#8211; Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentTables" xlink:title="00000031 - Disclosure - Note 7 &#8211; Equity Method Investment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock" xlink:label="loc_RCATEquityMethodInvestmentFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATEquityMethodInvestmentFinancialInformationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentTables" xlink:title="00000032 - Disclosure - Note 8 &#8211; Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsTables" xlink:title="00000033 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock" xlink:label="loc_RCATScheduleOfOtherLongTermAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_RCATScheduleOfOtherLongTermAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables" xlink:title="00000034 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfRentExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfRentExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsTables" xlink:title="00000035 - Disclosure - Note 11 &#8211; Debt Obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfDebtPaymentsDueTableTextBlock" xlink:label="loc_RCATScheduleOfDebtPaymentsDueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATScheduleOfDebtPaymentsDueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockTables" xlink:title="00000036 - Disclosure - Note 12 &#8211; Common Stock (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsTables" xlink:title="00000037 - Disclosure - Note 14 &#8211; Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="loc_RCATDisclosureNote14WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:label="loc_RCATScheduleOfWarrantsIssuedAndFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATScheduleOfWarrantsIssuedAndFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsTables" xlink:title="00000038 - Disclosure - Note 15 &#8211; Share Based Awards (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ScheduleOfAssumptionsUsed1TableTextBlock" xlink:label="loc_RCATScheduleOfAssumptionsUsed1TableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATScheduleOfAssumptionsUsed1TableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails" xlink:title="00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAxis" xlink:label="loc_RCATRestatementImpactAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATRestatementImpactAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactDomain" xlink:label="loc_RCATRestatementImpactDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactAxis" xlink:to="loc_RCATRestatementImpactDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactOriginallyReportedMember" xlink:label="loc_RCATRestatementImpactOriginallyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactOriginallyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactAsRestatedMember" xlink:label="loc_RCATRestatementImpactAsRestatedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactAsRestatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_RestatementImpactChangeMember" xlink:label="loc_RCATRestatementImpactChangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATRestatementImpactDomain" xlink:to="loc_RCATRestatementImpactChangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockholdersEquityRestatement" xlink:label="loc_RCATStockholdersEquityRestatement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATStockholdersEquityRestatement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/CustomerConcentrationRiskDetails" xlink:title="00000040 - Disclosure - Customer concentration risk (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk1Member" xlink:label="loc_RCATCustomerConcentrationRisk1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_CustomerConcentrationRisk2Member" xlink:label="loc_RCATCustomerConcentrationRisk2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_RCATCustomerConcentrationRisk2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note1BusinessDetailsNarrative" xlink:title="00000041 - Disclosure - Note 1 &#8211; The Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition1Member" xlink:label="loc_RCATBusinessAcquisition1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition2Member" xlink:label="loc_RCATBusinessAcquisition2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition3Member" xlink:label="loc_RCATBusinessAcquisition3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_BusinessAcquisition4Member" xlink:label="loc_RCATBusinessAcquisition4Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RCATBusinessAcquisition4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails" xlink:title="00000042 - Disclosure - Company&apos;s revenue disaggregated by revenue type (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="loc_us-gaapRevenueNotFromContractWithCustomer" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueNotFromContractWithCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:label="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000044 - Disclosure - Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="loc_us-gaapStandardProductWarrantyAccrualCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyAccrualCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DifferenceBetweenComprehensiveLossAndNetLoss" xlink:label="loc_RCATDifferenceBetweenComprehensiveLossAndNetLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATDifferenceBetweenComprehensiveLossAndNetLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ProceedsFromPurchaseAgreement" xlink:label="loc_RCATProceedsFromPurchaseAgreement" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RCATProceedsFromPurchaseAgreement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails" xlink:title="00000045 - Disclosure - Discontinued Operations - results of operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:label="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract" xlink:to="loc_RCATDisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative" xlink:title="00000046 - Disclosure - Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="loc_us-gaapNoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapNoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureCashConsiderationReceived1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureCashConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:label="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATNoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WorkingCapitalAtClosingOfDisposalGroup" xlink:label="loc_RCATWorkingCapitalAtClosingOfDisposalGroup" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_RCATWorkingCapitalAtClosingOfDisposalGroup" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/InventoriesDetails" xlink:title="00000047 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherCurrentAssetsDetails" xlink:title="00000048 - Disclosure - Other current assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetGrossCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapContractWithCustomerAssetGrossCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="loc_us-gaapGrantsReceivableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapGrantsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/IntangibleAssetsDetails" xlink:title="00000049 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:label="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsGrossCarryingAmountMember" xlink:label="loc_RCATIntangibleAssetsGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsAccumulatedAmortizationMember" xlink:label="loc_RCATIntangibleAssetsAccumulatedAmortizationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsAccumulatedAmortizationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetCarryingValueMember" xlink:label="loc_RCATIntangibleAssetsNetCarryingValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain" xlink:to="loc_RCATIntangibleAssetsNetCarryingValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedProprietaryTechnologyGross" xlink:label="loc_RCATFiniteLivedProprietaryTechnologyGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedProprietaryTechnologyGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedNoncompeteAgreementsGross1" xlink:label="loc_RCATFiniteLivedNoncompeteAgreementsGross1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedNoncompeteAgreementsGross1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FiniteLivedIntangibleAssetsGross1" xlink:label="loc_RCATFiniteLivedIntangibleAssetsGross1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATFiniteLivedIntangibleAssetsGross1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIndefiniteLivedTradeNames" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:label="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIndefiniteLivedIntangibleAssetsExcludingGoodwill1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IntangibleAssetsNetExcludingGoodwill1" xlink:label="loc_RCATIntangibleAssetsNetExcludingGoodwill1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATIntangibleAssetsNetExcludingGoodwill1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails" xlink:title="00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails" xlink:title="00000051 - Disclosure - Impacts on investments into UMAC (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SaleOfOwnershipInterestEquityMethodInvestment" xlink:label="loc_RCATSaleOfOwnershipInterestEquityMethodInvestment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_RCATSaleOfOwnershipInterestEquityMethodInvestment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - Note 7 &#8211; Equity Method Investment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesExchanged" xlink:label="loc_RCATExchangeAgreementSharesExchanged" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATExchangeAgreementSharesExchanged" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesExchangedParValue" xlink:label="loc_RCATExchangeAgreementSharesExchangedParValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATExchangeAgreementSharesExchangedParValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementPreferredSharesReceived" xlink:label="loc_RCATExchangeAgreementPreferredSharesReceived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATExchangeAgreementPreferredSharesReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExchangeAgreementSharesPreferredStockValueSold" xlink:label="loc_RCATExchangeAgreementSharesPreferredStockValueSold" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATExchangeAgreementSharesPreferredStockValueSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NoteReceivableSoldPursuantToExchangeAgreement" xlink:label="loc_RCATNoteReceivableSoldPursuantToExchangeAgreement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATNoteReceivableSoldPursuantToExchangeAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ProceedsFromPurchaseAgreement" xlink:label="loc_RCATProceedsFromPurchaseAgreement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_RCATProceedsFromPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="loc_us-gaapVariableInterestEntityOwnershipPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapVariableInterestEntityOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/PropertyAndEquipmentDetails" xlink:title="00000053 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapLeaseholdImprovementsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaapFurnitureAndFixturesGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapFurnitureAndFixturesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative" xlink:title="00000054 - Disclosure - Note 8 &#8211; Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OtherLongTermAssetsDetails" xlink:title="00000055 - Disclosure - Other long term assets (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SAFEAgreementAssets" xlink:label="loc_RCATSAFEAgreementAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_RCATSAFEAgreementAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - Note 9 &#8211; Other Long-Term Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote9OtherLongtermAssetsAbstract" xlink:label="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PaymentForSAFEAgreement" xlink:label="loc_RCATPaymentForSAFEAgreement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote9OtherLongtermAssetsAbstract" xlink:to="loc_RCATPaymentForSAFEAgreement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OperatingLeasesDetails" xlink:title="00000057 - Disclosure - Operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation1Member" xlink:label="loc_RCATOperatingLeaseLocation1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation3Member" xlink:label="loc_RCATOperatingLeaseLocation3Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingLeaseLocation4Member" xlink:label="loc_RCATOperatingLeaseLocation4Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_RCATOperatingLeaseLocation4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails" xlink:title="00000058 - Disclosure - Supplemental information related to operating leases (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OperatingCashPaidToSettleLeaseLiabilities" xlink:label="loc_RCATOperatingCashPaidToSettleLeaseLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_RCATOperatingCashPaidToSettleLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative" xlink:title="00000059 - Disclosure - Note 10 &#8211; Right of Use Assets and Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/OutstandingPrincipalPaymentsDetails" xlink:title="00000060 - Disclosure - Outstanding principal payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueYearOne" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueYearOne" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueYearOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueLongTerm" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueLongTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueLongTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OutstandingPrincipalPaymentsDueTotal" xlink:label="loc_RCATOutstandingPrincipalPaymentsDueTotal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_RCATOutstandingPrincipalPaymentsDueTotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note11DebtObligationsDetailsNarrative" xlink:title="00000061 - Disclosure - Note 11 &#8211; Debt Obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation1Member" xlink:label="loc_RCATDebtObligation1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation2Member" xlink:label="loc_RCATDebtObligation2Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation6Member" xlink:label="loc_RCATDebtObligation6Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DebtObligation8Member" xlink:label="loc_RCATDebtObligation8Member" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_RCATDebtObligation8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ConvertibleNoteAgreementAmount" xlink:label="loc_RCATConvertibleNoteAgreementAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATConvertibleNoteAgreementAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_LeaseholdImprovementAgreementFundsReceived" xlink:label="loc_RCATLeaseholdImprovementAgreementFundsReceived" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATLeaseholdImprovementAgreementFundsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:label="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_RCATFinancingAgreementFundingOfPurchaseOfFixedAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails" xlink:title="00000062 - Disclosure - Summary of shares of common stock issued (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:label="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodAmountConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:label="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATIssuanceOfCommonStockThroughATMFacilitiesNetShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesPublicOffering" xlink:label="loc_RCATStockIssuedDuringPeriodSharesPublicOffering" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note12CommonStockDetailsNarrative" xlink:title="00000063 - Disclosure - Note 12 &#8211; Common Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ATMFacilityAggregateOfferingPrice" xlink:label="loc_RCATATMFacilityAggregateOfferingPrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATATMFacilityAggregateOfferingPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering" xlink:label="loc_us-gaapPartnersCapitalAccountUnitsSoldInPublicOffering" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPartnersCapitalAccountUnitsSoldInPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PublicOfferingPricePerShare" xlink:label="loc_RCATPublicOfferingPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATPublicOfferingPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover" xlink:label="loc_RCATAdditionalSharesPurchaseOptionOverAllotmentCover" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATAdditionalSharesPurchaseOptionOverAllotmentCover" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingShares" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:label="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_RCATFirmCommitmentUnderwrittenPublicOfferingNetProceeds" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note13PreferredStockDetailsNarrative" xlink:title="00000064 - Disclosure - Note 13 &#8211; Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SeriesAPreferredStock2Member" xlink:label="loc_RCATSeriesAPreferredStock2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RCATSeriesAPreferredStock2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertible" xlink:label="loc_RCATPreferredStockConvertible" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATPreferredStockConvertible" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_PreferredStockConvertibleSharesIssued" xlink:label="loc_RCATPreferredStockConvertibleSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATPreferredStockConvertibleSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:label="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RCATStockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails" xlink:title="00000065 - Disclosure - Summary of warrants issued and fair values (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="loc_RCATDisclosureNote14WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NumberOfWarrantsUponIssuance" xlink:label="loc_RCATNumberOfWarrantsUponIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATNumberOfWarrantsUponIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_InitialFairValueOfWarrantsUponIssuance" xlink:label="loc_RCATInitialFairValueOfWarrantsUponIssuance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATInitialFairValueOfWarrantsUponIssuance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/ChangesInWarrantsOutstandingDetails" xlink:title="00000066 - Disclosure - Changes in warrants outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="loc_RCATDisclosureNote14WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsOutstanding1Member" xlink:label="loc_RCATWarrantsOutstanding1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_RCATWarrantsOutstanding1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note14WarrantsDetailsNarrative" xlink:title="00000067 - Disclosure - Note 14 &#8211; Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_DisclosureNote14WarrantsAbstract" xlink:label="loc_RCATDisclosureNote14WarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsIssuedExercisePrice" xlink:label="loc_RCATWarrantsIssuedExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATWarrantsIssuedExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ExerciseOfWarrantsShares" xlink:label="loc_RCATExerciseOfWarrantsShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_WarrantsToPurchaseSharesIssued" xlink:label="loc_RCATWarrantsToPurchaseSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATDisclosureNote14WarrantsAbstract" xlink:to="loc_RCATWarrantsToPurchaseSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails" xlink:title="00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsAxis" xlink:label="loc_RCATFairValueOfOptionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATFairValueOfOptionsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_FairValueOfOptionsDomain" xlink:label="loc_RCATFairValueOfOptionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFairValueOfOptionsAxis" xlink:to="loc_RCATFairValueOfOptionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_OptionsAssumptionsUsedMember" xlink:label="loc_RCATOptionsAssumptionsUsedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATFairValueOfOptionsDomain" xlink:to="loc_RCATOptionsAssumptionsUsedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfActivityUnderPlanDetails" xlink:title="00000069 - Disclosure - Summary of activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_Options1Member" xlink:label="loc_RCATOptions1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_RCATOptions1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails" xlink:title="00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockAxis" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationSharesRestrictedStockDomain" xlink:label="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockAxis" xlink:to="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RCATShareBasedCompensationSharesRestrictedStockDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:label="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RCATSharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails" xlink:title="00000071 - Disclosure - Stock compensation expense by functional category (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_ResearchAndDevelopmentStockCompensationExpense" xlink:label="loc_RCATResearchAndDevelopmentStockCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATResearchAndDevelopmentStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_SalesAndMarketingStockCompensationExpense" xlink:label="loc_RCATSalesAndMarketingStockCompensationExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATSalesAndMarketingStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_GeneralAndAdministrativeStockCompensationExpense" xlink:label="loc_RCATGeneralAndAdministrativeStockCompensationExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATGeneralAndAdministrativeStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_TotalStockCompensationExpense" xlink:label="loc_RCATTotalStockCompensationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATTotalStockCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative" xlink:title="00000072 - Disclosure - Note 15 &#8211; Share Based Awards (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:label="loc_RCATNumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATNumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:label="loc_RCATUnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATUnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockCompensationExpensePertainingToOptions" xlink:label="loc_RCATStockCompensationExpensePertainingToOptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATStockCompensationExpensePertainingToOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcat-20240731.xsd#RCAT_StockCompensationExpensePertainingToRestrictedStockUnits" xlink:label="loc_RCATStockCompensationExpensePertainingToRestrictedStockUnits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_RCATStockCompensationExpensePertainingToRestrictedStockUnits" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774074192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Red
Cat Holdings, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0490034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15
    Ave. Munoz Rivera<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste 2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
    Juan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">373-3228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCAT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,409,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not
applicable<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769572704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 7,732,763<span></span>
</td>
<td class="nump">$ 6,067,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">681,775<span></span>
</td>
<td class="nump">4,361,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">10,462,934<span></span>
</td>
<td class="nump">8,007,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">2,592,679<span></span>
</td>
<td class="nump">3,962,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">21,470,151<span></span>
</td>
<td class="nump">22,397,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,995,500<span></span>
</td>
<td class="nump">9,088,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">3,617,060<span></span>
</td>
<td class="nump">3,794,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investee</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,142,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent', window );">Note receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,143,919<span></span>
</td>
<td class="nump">2,340,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other</a></td>
<td class="nump">293,126<span></span>
</td>
<td class="nump">293,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,435,475<span></span>
</td>
<td class="nump">1,480,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">16,485,080<span></span>
</td>
<td class="nump">26,140,063<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">37,955,231<span></span>
</td>
<td class="nump">48,537,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,081,568<span></span>
</td>
<td class="nump">1,580,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,296,931<span></span>
</td>
<td class="nump">1,069,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Debt obligations - short term</a></td>
<td class="nump">599,570<span></span>
</td>
<td class="nump">751,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Customer deposits</a></td>
<td class="nump">50,039<span></span>
</td>
<td class="nump">53,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">202,404<span></span>
</td>
<td class="nump">195,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,230,512<span></span>
</td>
<td class="nump">3,651,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">1,269,185<span></span>
</td>
<td class="nump">1,321,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,269,185<span></span>
</td>
<td class="nump">1,321,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PreferredStockValueSeriesB', window );">Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - shares authorized 500,000,000; issued and outstanding 74,890,248 and 74,289,351</a></td>
<td class="nump">74,890<span></span>
</td>
<td class="nump">74,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">125,927,705<span></span>
</td>
<td class="nump">124,616,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(93,547,108)<span></span>
</td>
<td class="num">(81,130,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">32,455,534<span></span>
</td>
<td class="nump">43,564,530<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 37,955,231<span></span>
</td>
<td class="nump">$ 48,537,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PreferredStockValueSeriesB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PreferredStockValueSeriesB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768892448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">74,890,248<span></span>
</td>
<td class="nump">74,289,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">4,676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774542608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,776,535<span></span>
</td>
<td class="nump">$ 1,748,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">3,259,926<span></span>
</td>
<td class="nump">1,573,464<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross (loss) profit</a></td>
<td class="num">(483,391)<span></span>
</td>
<td class="nump">174,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,626,440<span></span>
</td>
<td class="nump">1,353,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Sales and marketing</a></td>
<td class="nump">2,041,511<span></span>
</td>
<td class="nump">1,288,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,483,095<span></span>
</td>
<td class="nump">2,863,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment loss</a></td>
<td class="nump">93,050<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">7,244,096<span></span>
</td>
<td class="nump">5,506,069<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Operating loss</a></td>
<td class="num">(7,727,487)<span></span>
</td>
<td class="num">(5,331,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other (income) expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on sale of equity method investment</a></td>
<td class="nump">4,008,357<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Equity method loss</a></td>
<td class="nump">734,143<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment loss, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">239,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest (income) expense, net</a></td>
<td class="num">(24,554)<span></span>
</td>
<td class="nump">21,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other, net</a></td>
<td class="num">(29,057)<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="nump">4,688,889<span></span>
</td>
<td class="nump">262,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net loss from continuing operations</a></td>
<td class="num">(12,416,376)<span></span>
</td>
<td class="num">(5,594,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(242,573)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,416,376)<span></span>
</td>
<td class="num">(5,836,868)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in foreign currency translation adjustments</a></td>
<td class="num">(4,621)<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">289,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss&#160;</a></td>
<td class="num">$ (12,420,997)<span></span>
</td>
<td class="num">$ (5,545,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedRCATAbstract', window );"><strong>Loss per share - basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT', window );">Continuing operations</a></td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT', window );">Discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT', window );">Weighted average shares outstanding - basic and diluted</a></td>
<td class="nump">74,500,480<span></span>
</td>
<td class="nump">54,935,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EarningsPerShareBasicAndDilutedRCATAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EarningsPerShareBasicAndDilutedRCATAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482551/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774202032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Series B Preferred Stock 1 [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Apr. 30, 2023</a></td>
<td class="nump">$ 9,867<span></span>
</td>
<td class="nump">$ 54,568<span></span>
</td>
<td class="nump">$ 112,642,726<span></span>
</td>
<td class="num">$ (57,078,103)<span></span>
</td>
<td class="num">$ (861,117)<span></span>
</td>
<td class="nump">$ 54,767,941<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance at Apr. 30, 2023</a></td>
<td class="nump">986,676<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">911,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">911,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="num">(8,675)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock</a></td>
<td class="num">$ (9,820)<span></span>
</td>
<td class="nump">$ 818<span></span>
</td>
<td class="nump">9,002<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="num">(982,000)<span></span>
</td>
<td class="nump">818,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">289,389<span></span>
</td>
<td class="nump">289,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,836,868)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,836,868)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jul. 31, 2023</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 55,541<span></span>
</td>
<td class="nump">113,554,659<span></span>
</td>
<td class="num">(62,914,971)<span></span>
</td>
<td class="num">(570,082)<span></span>
</td>
<td class="nump">50,125,194<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Jul. 31, 2023</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">55,541,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Apr. 30, 2024</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 74,289<span></span>
</td>
<td class="nump">124,616,305<span></span>
</td>
<td class="num">(81,130,732)<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
<td class="nump">43,564,530<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance at Apr. 30, 2024</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">74,289,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,446,038<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,446,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
<td class="num">(134,330)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(134,037)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,621)<span></span>
</td>
<td class="num">(4,621)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,416,376)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,416,376)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="num">(308)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jul. 31, 2024</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 74,890<span></span>
</td>
<td class="nump">$ 125,927,705<span></span>
</td>
<td class="num">$ (93,547,108)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 32,455,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance at Jul. 31, 2024</a></td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">74,890,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770537680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,416,376)<span></span>
</td>
<td class="num">$ (5,836,868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IncomeLossFromDiscontinuedOperations', window );">Net loss from discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(242,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(12,416,376)<span></span>
</td>
<td class="num">(5,594,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash from operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Stock based compensation - options</a></td>
<td class="nump">357,258<span></span>
</td>
<td class="nump">629,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1', window );">Stock based compensation - restricted units</a></td>
<td class="nump">1,088,780<span></span>
</td>
<td class="nump">282,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">177,329<span></span>
</td>
<td class="nump">217,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Realized loss from sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">292,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">296,722<span></span>
</td>
<td class="nump">101,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on sale of equity method investment and note receivable</a></td>
<td class="nump">4,008,357<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Equity method loss</a></td>
<td class="nump">734,143<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment on goodwill and intangible assets</a></td>
<td class="nump">93,050<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">3,679,315<span></span>
</td>
<td class="num">(780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(2,455,697)<span></span>
</td>
<td class="num">(455,871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other</a></td>
<td class="nump">1,369,374<span></span>
</td>
<td class="num">(1,756,973)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities', window );">Operating lease right-of-use assets and liabilities</a></td>
<td class="num">(662)<span></span>
</td>
<td class="num">(458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Customer deposits</a></td>
<td class="num">(3,900)<span></span>
</td>
<td class="num">(110,863)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">501,146<span></span>
</td>
<td class="num">(569,876)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">222,749<span></span>
</td>
<td class="nump">40,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities of continuing operations</a></td>
<td class="num">(2,348,412)<span></span>
</td>
<td class="num">(6,926,069)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="num">(99,957)<span></span>
</td>
<td class="num">(5,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,888,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment and note receivable</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided by investing activities of continuing operations</a></td>
<td class="nump">4,300,043<span></span>
</td>
<td class="nump">4,883,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments under debt obligations</a></td>
<td class="num">(152,000)<span></span>
</td>
<td class="num">(137,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PaymentsOfTaxesRelatedToEquityTransactions', window );">Payments of taxes related to equity transactions</a></td>
<td class="num">(134,037)<span></span>
</td>
<td class="num">(8,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash used in financing activities of continuing operations</a></td>
<td class="num">(286,037)<span></span>
</td>
<td class="num">(146,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract', window );"><strong>Discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating activities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(356,109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">237,814<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations', window );">Net cash used in discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(118,295)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in Cash</a></td>
<td class="nump">1,665,594<span></span>
</td>
<td class="num">(2,307,528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash, beginning of period</a></td>
<td class="nump">6,067,169<span></span>
</td>
<td class="nump">3,260,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash, end of period</a></td>
<td class="nump">7,732,763<span></span>
</td>
<td class="nump">952,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Less: Cash of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(15,021)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash of continuing operations, end of period</a></td>
<td class="nump">7,732,763<span></span>
</td>
<td class="nump">937,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">6,295<span></span>
</td>
<td class="nump">22,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent', window );">Unrealized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">289,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,820<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ConversionOfPreferredStockIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ConversionOfPreferredStockIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IncomeLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IncomeLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PaymentsOfTaxesRelatedToEquityTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PaymentsOfTaxesRelatedToEquityTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in cash associated with the entity's discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768937216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 &#8211; The Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Note 1 &#8211; The Business</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z49jg8M1uPti" style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zPmSPEF9Nopd">Note
1 &#8211; The Business</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company was originally incorporated in February 1984. Since April 2016, the Company&#8217;s primary business has been to provide products,
services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January
2020, the Company expanded the scope of its drone products and services through four acquisitions, including:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the Company
    acquired Rotor Riot, a provider of First Person View (&#8220;FPV&#8221;) drones and equipment, primarily to consumers. The purchase
    price was $<span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zxTjophP5vu4">1,995,114</span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2020, the Company
    acquired Fat Shark Holdings, Ltd. (&#8220;Fat Shark&#8221;), a provider of FPV video goggles to the&#160;drone industry. The purchase
    price was $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_ztcvHIVe3Tyh">8,354,076</span>.</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;<span style="font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the Company
    acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations
    where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles
    away. The purchase price was $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zAcRxVPVp1q8">2,791,012</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2021, the Company
    acquired Teal Drones, Inc. (&#8220;Teal&#8221;), a leader in commercial and government Unmanned Aerial Vehicles (&#8220;UAV&#8221;)
    technology.&#160;The purchase price was $<span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_zcYUcSso4WFf">10,011,279</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#8220;Enterprise&#8221;) and the Consumer segment (&#8220;Consumer&#8221;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 16, 2024, we closed the sale of our Consumer
segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and
capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 3 and Note 7.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of <span id="xdx_90F_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zmV21Zv8E8q1">18,400,000</span> shares of common stock which generated
gross proceeds of $<span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_zrbrQy2q6oV8">9,200,000</span> and net proceeds of approximately $<span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_z7Q27q2Zfn69">8,400,000</span>.</span><span style="font-size: 8pt">&#160;</span><span style="font-size: 8pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863549632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Note 2 &#8211; Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_807_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zjz85o8K0POe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_825_zTm0e4LXiCv8" style="font-family: Times New Roman, Times, Serif; color: Black"><b>Note
2 &#8211; Summary of Significant Accounting Policies</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">&#160;</span></p>

<p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zutEcgLYyih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_865_zlvklUGo8XD6" style="font-family: Times New Roman, Times, Serif; color: Black"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; color: Black">&#8211; The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(&#8220;GAAP&#8221;) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management,
all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial
statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the
results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes
thereto for the year ended April 30, 2024, included in the Company&#8217;s Annual Report on Form 10-K.</span></p>

<p id="xdx_85F_zNIqqKUGDSVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zWM3U6GsyAFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zWCqQu6BvACa">Restatement
of Previously Issued Consolidated Financial Statements</span> </b>&#8211; The Company&#8217;s Condensed Consolidated Statement of Operations
and Stockholders&#8217; Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) on September 19, 2023, have been restated. The Company revised its financial statements to&#160;remove
derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having
a derivative component.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
impacts of these restatements are detailed in the tables below:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of derivative liability</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,810,348</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,836,868</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Shareholders&#8217; Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Additional paid-in capital</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">110,905,033</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">113,554,659</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,649,626</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Accumulated deficit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(60,397,141</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(62,914,971</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,517,830</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Total equity</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">49,993,398</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">50,125,194</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">131,796</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_ze2JTgurI8fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<p id="xdx_850_zxjGS8BOnYif" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zYX7MX8oMCjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_868_zGp4trD4Rf52">Principles
of Consolidation</span></b> &#8211; <span style="background-color: white">Our condensed consolidated financial statements include the accounts
of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February
16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for
using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions
and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>

<p id="xdx_853_zyQNzovpfQHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--UseOfEstimates_zvLQBk4nnqlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zWcAXfWWrOb9">Use
of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The preparation of financial statements in accordance with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those
used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></span></p>

<p id="xdx_85F_z1lrZVjHW9M" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white">&#160;</span></span></p>

<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_ze4wFxTi7qq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_863_zbteLT7yvvYf">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade
receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs
ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer
from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable,
net as of July&#160;31, 2024 and April 30, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>July 31, 2024</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>April 30, 2024</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%">38</td><td style="text-align: left; width: 1%">%</td>
    <td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%">53</td><td style="text-align: left; width: 1%">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right">25</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A5_z5nsI50jYiG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of July 31,
2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July
31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.</span></p>

<p id="xdx_85C_z6cWOblx5s61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>



<p id="xdx_84C_eus-gaap--EquityMethodInvestmentsPolicy_zKxQuQLqZaOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_867_zceAwNcrS64l">Equity
Method Investment</span> &#8211; </b><span style="background-color: white">The equity method of accounting is applied to investments in which
the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period
for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily
be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an
earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its
investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $<span id="xdx_908_eus-gaap--AssetImpairmentCharges_c20230501__20240430_zkbYsHH966n9">11,353,875</span> for the year ended April&#160;30,
2024. See Note 7 for additional information.</span></span></p>

<p id="xdx_854_z3fpt2Dvy0Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b></b></span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKT6sOtOpMdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zBVjhFLEIcQc">Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
guidance establishes three levels of the fair value hierarchy as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The
carrying amounts of these instruments approximates fair value due to their short-term nature.</span></p>

<p id="xdx_852_zMrN4PunMWv" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zDrocIb8lYd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span><b><span id="xdx_86D_zC2BYsAH4G68">Revenue Recognition</span> </b>&#8211;
The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting
Standards Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue
recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price,
(iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as
each obligation is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are
fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue
upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240731_zv3ruEUYdIei">50,039 </span> and $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zta0vf4KVPY1">53,939 </span> at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the
capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_90E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240731_zeehHTInjCH9">0</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zUia9GjcIxwd">1,477,859</span> at July 31, 2024 and
April 30, 2024, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table presents the Company&#8217;s revenue disaggregated by revenue type:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three
    Months Ended&#160;July 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">886,440</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">310,881</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Product related</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,890,095</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,437,248</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,776,535</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,748,129</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zyVi65qXkNFl" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_85A_zP3l9Kcd8sYg" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>



<p id="xdx_848_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zzZ20WTYGaPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zB5Fs2RckWq1">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales
data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses.&#160;Warranty
liability was approximately $<span id="xdx_90E_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240731_z2g90xAOwkf2">541,000 </span>
and $<span id="xdx_900_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zjhY2VPYHCm1">372,000 </span> as of July 31, 2024 and April 30, 2024 respectively.</span></p>

<p id="xdx_85B_zxDUjUvqiFUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIslxQr6OUV8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zBCv0DVYabr4">Recent
Accounting Pronouncements</span> </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;
<span style="background-color: white">Management does not believe that recently issued, but not yet effective accounting pronouncements,
if adopted, would have a material effect on the accompanying consolidated financial statements.</span></span></p>

<p id="xdx_854_zKiSTpicZ0Ej" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_844_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9ddSQBeNkBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_869_zGDhiRI4SNhb">Comprehensive
Loss</span> </b>&#8211; Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses
that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of
foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended
July 31, 2024 and July 31, 2023, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20240501__20240731_zk6oWTfRMTJ6">4,621</span>
higher and $<span id="xdx_90E_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20230731_z5YREAIgqlQ9">291,035</span>
lower than net loss, respectively, related to unrealized
gains on available-for-sale securities totaling $<span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20240501__20240731_z3grDvAbQi4h">0</span> and $<span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20230731_zDFVPqPEWUza">289,389</span>,  respectively, and foreign currency translation adjustments of $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dxL_c20240501__20240731_zFJ3HWWXeObe" title="::XDX::-4621"><span style="-sec-ix-hidden: xdx2ixbrl0576">4,621 </span></span>
and $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20230731_zNRVZcQe7bY1">1,646</span>.</span></p>

<p id="xdx_85C_zTbyWqSdIc61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zVUoEFBtUfU" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_860_zSU7UfLWc966">Basic and
Diluted Net Loss per Share</span></b> &#8211; Basic and diluted net loss per share has been calculated by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of
diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents
would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted
net loss per share because their effect would have been anti-dilutive include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2023</span></td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Series B Preferred Stock, as converted</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Stock options</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">7,319,988</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,884,017</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,821,291</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,539,999</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Restricted stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,202,599</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">842,701</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">11,347,774</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">9,270,613</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zKTk0JjIkx29" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p id="xdx_854_zik18tQXDauk" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zV2baH1iPfPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zPoAEykNX2k8">Related
Parties</span></b> &#8211; Parties are considered to be related to us if they have control or significant influence, directly or indirectly,
over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel
of members of the Board of Directors. Related Party transactions are disclosed in Note 16.</span></p>

<p id="xdx_857_z8Wi28svccf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAP8XuCbTS1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_86B_zRGfjLqTkQrd">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as
well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a
net loss </span><span style="font-family: Times New Roman, Times, Serif">of approximately $<span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20240501__20240731_zF35Z25bd401" title="::XDX::-12416376"><span style="-sec-ix-hidden: xdx2ixbrl0601">12,000,000 </span></span>&#160;and
used cash in operating activities of approximately $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20240501__20240731_zju8eqwXnN28" title="::XDX::-2348412"><span style="-sec-ix-hidden: xdx2ixbrl0602">2,300,000</span></span>.
As of July 31, 2024, working capital totaled approximately $<span id="xdx_903_eus-gaap--Capital_iI_c20240731_zjp5xsHPQbSj">17,200,000</span>.
These financial results and our financial position <span style="background-color: white">at&#160;July 31, 2024&#160;raise
substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen
its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of <span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zkFL43bk1sl8">18,400,000</span>
shares of common stock which generated net proceeds of approximately $<span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zz34gyeJ4D2a">8,400,000</span>
as further described in Note 1 and Note 12. In addition, the Company&#8217;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The
Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the
Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold
its equity method investment for $<span id="xdx_90C_ecustom--ProceedsFromPurchaseAgreement_c20240501__20240731_zNUW7sJPnTrg">4,400,000</span>
in July 2024.<span style="background-color: white"> As described in Note 18, the Company closed a financing with proceeds of $8
million to be received in late September 2024.</span> Management has concluded that these recent positive developments alleviate any
substantial doubt about the Company&#8217;s ability to&#160;continue its operations, and meet its financial obligations, for twelve
months from the date these consolidated financial statements&#160;are&#160;issued.</span></span></p>

<p id="xdx_855_zqov4ebKsuLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769529296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Note 3 &#8211; Divestiture of Consumer Segment</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zWAXtnQmdw4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zIqIy55O0bZ1">Note
3 &#8211; Divestiture of Consumer Segment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 16, 2024,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">the
Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement
dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#8220;SPA&#8221;). The transaction
closed concurrently with UMAC&#8217;s initial public offering and listing on the NYSE American exchange (&#8220;IPO&#8221;) under the
symbol &#8220;UMAC.&#8221; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
total consideration received by the Company was valued at $<span id="xdx_909_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_c20230501__20240430_zzAEC1rPEGPb">20</span> million and consisted of i) $<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_zILcqNPyLqqf">1
</span></span><span style="font-family: Times New Roman, Times, Serif">million in cash, ii) $<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zrPqjzZqNz2g">2
</span></span><span style="font-family: Times New Roman, Times, Serif">million in a secured promissory note (&#8220;Promissory Note&#8221;),
iii) $<span id="xdx_905_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zN7QpLusj8Ha">17
</span></span><span style="font-family: Times New Roman, Times, Serif">million in securities of Unusual Machines, and iv) a post-closing
adjustment for excess working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Secured
Promissory Note</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
Promissory Note from Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires
monthly payments of interest due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one
or more related debt or equity financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#8217;s completed
IPO), the Company may require payment of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified
Financing. During the occurrence and continuance of any event of default under the Note, the Company may, at its option, convert the
amounts due under the Note to common stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount
to the average daily volume weighted average price for UMAC&#8217;s common stock over the 10 days preceding the conversion price. Conversions
under the Note will be limited such that no conversion may be made to the extent that, after giving effect to the conversion, the Company,
together with its affiliates, would beneficially own in excess of 4.99% of UMAC&#8217;s common stock. This limit may be increased by
the Company upon 61 days written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Unusual
Machines Securities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i></i>The $<span id="xdx_90F_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20240501__20240731_ze2DW3e3BvMj">17</span> million worth of UMAC common stock was valued at the IPO price for UMAC&#8217;s common stock of $4.00
per share, resulting in
<span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20240501__20240731_zmcAOx6QeDkh">4,250,000</span> shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#8217;s
issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of
the IPO).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Working
Capital</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
purchase price was adjusted for working capital as of the closing date. </span><span style="font-family: Times New Roman, Times, Serif">Actual
working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. <span style="background-color: white">Working
capital as of closing was finalized at $<span id="xdx_90F_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zDm9R5ivZsn3">2</span> million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory
Notes due November 30, 2025 (the &#8220;New Notes&#8221;) reflecting (i) satisfaction and settlement of working capital adjustments and
(ii) a maturity date extension to November 30, 2025.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards.
Set forth below are the results of operations for the Consumer segment for:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zuKaIeWZu0c8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20240501__20240731_z4VdeuOt2Nki" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230501__20230731_zzSlhuvBqTD4" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>July
                                            31</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zj8g3sgk8Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0619">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,869,219</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zqzFk1peqQib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Cost
    of goods sold</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,385,116</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zXptTyvGvpFg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Gross Profit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">484,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zracsPLzZwCg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating Expenses</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_ziPibjoMV2if" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Research and
    development</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">46,249</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zV7ogu7xH47c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0634">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">404,104</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_z7Ru2o5k3OS2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">General
    and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">253,586</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zRJj7W3xza0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Total
    operating expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0640">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">703,939</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_zvBQO3lP0N1i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(219,836</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zaK2fMK0e4f6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Other expense
    (income)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zqIZoq6f2Xvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Interest expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">22,856</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zxpSTIawrCB8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Other,
    net</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0652">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(119</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i02_z5dvtLssGI42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><span style="font-size: 10pt">Other expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">22,737</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zsogtd9BqCLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Net
    loss from discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0658">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(242,573</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<p id="xdx_8A9_zk2MRCfa1ush" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863574256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 &#8211; Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Note 4 &#8211; Inventories</a></td>
<td class="text"><p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zzHqLTa6gtZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_828_zPEmyRPf3Feg">Note
4 &#8211; Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Inventories
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zRCtWQmDFBv7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Inventories (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_490_20240731_zvHIzK3CIl6a" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240430_zeCzF8CvuTd8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_zhWQPFnWYQk8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Raw materials</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,863,187</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,750,324</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_zw199aAvrVv4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Work-in-process</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,622,121</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,289,997</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_znaANYaOFAM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Finished goods</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,977,626</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">966,916</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryNet_iI_zvmDK7Y3Mez4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">10,462,934</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">8,007,237</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AB_zK70IRaoFp74" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774288544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 &#8211; Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Note 5 &#8211; Other Current Assets</a></td>
<td class="text"><p id="xdx_809_eus-gaap--OtherCurrentAssetsTextBlock_zOA03Ci8w8p" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_823_zj8mgt5L6GD8">Note
5 &#8211; Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Other
current assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zX8DVTzy3kmk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other current assets (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240731_zeID4xo625o9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240430_zYD437Aip8v7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zui2NmgKkI0i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid expenses</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,387,937</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,206,306</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zGhl9icFl5yg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid inventory</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">204,742</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">602,888</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zWLrkPLAqSq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract asset</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#8212;&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,477,859</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--GrantsReceivableCurrent_iI_zgjWNMUcqq64" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Grant receivable</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">675,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAssetsCurrent_iI_zRGRYMiN35V4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,592,679</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,962,053</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_zQ4K2FJXZtga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863568000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 &#8211; Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Note 6 &#8211; Intangible Assets</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zYzrWARpNqRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_828_zrR0uon87BKh">Note
6 &#8211; Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zsjeL5QCTHm7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zC1wdR0GRknf" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQkhwGyz0tUi" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49D_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zF4SeUK4PX7f" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49B_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zWZvAphaHHi9" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zkfpwTcGZs26" style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49A_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zyzLmWy22k54" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Gross
    Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td></tr>
  <tr id="xdx_408_ecustom--FiniteLivedProprietaryTechnologyGross_iI_zWENlT1lHKjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Proprietary technology</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,282,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,094,941</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,187,060</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,282,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right">(1,917,612</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,364,389</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zhDKad5xG7lb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Non-compete agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0712">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zasy2FVorEwh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><span style="font-size: 10pt">Total finite-lived assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,347,001</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,159,941</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,187,060</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,347,001</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,982,612</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,364,389</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IndefiniteLivedTradeNames_iI_zxEIZg9A2ZEl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Brand name</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0722">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0725">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zHPvJXlCl4Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"><span style="font-size: 10pt">Total indefinite-lived
    assets</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_zfACR5VZxKIc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total intangible
    assets, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,777,001</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,159,941</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,617,060</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,777,001</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,982,612</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,794,389</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_zA83lKEIFBUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not
amortized but evaluated for impairment on a quarterly basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769612896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 &#8211; Equity Method Investment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Note 7 &#8211; Equity Method Investment</a></td>
<td class="text"><p id="xdx_805_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_z9YiN0YA0b24" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82D_zN2iSw1Nvgug">Note
7 &#8211; Equity Method Investment</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt; background-color: white">On
July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the &#8220;Purchasers&#8221;).
As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged
<span id="xdx_909_ecustom--ExchangeAgreementSharesExchanged_c20240501__20240731_z38JyqlzWk19">4,250,000</span> shares of UMAC&#8217;s common stock, par value $<span id="xdx_902_ecustom--ExchangeAgreementSharesExchangedParValue_c20240501__20240731_zEbXUfVJ8Nw1">0.001</span> per share, for <span id="xdx_90E_ecustom--ExchangeAgreementPreferredSharesReceived_c20240501__20240731_zQDl8K4LWYU2">4,250</span> shares of UMAC&#8217;s newly designated Series A
Convertible Preferred Stock (the &#8220;Series A&#8221;). The Company sold the Series A ownership interest ($<span id="xdx_90A_ecustom--ExchangeAgreementSharesPreferredStockValueSold_c20240501__20240731_ztxl36a9zcJh">4,408,357</span> at time of sale)
and the Note Receivable of $<span id="xdx_90E_ecustom--NoteReceivableSoldPursuantToExchangeAgreement_c20240501__20240731_zKSZWm4YDTGi">4,000,000</span> to the Purchasers for $<span id="xdx_904_ecustom--ProceedsFromPurchaseAgreement_pin6_c20240501__20240731_zYhbVr7LHnL2">4.4</span> million in cash pursuant to a Purchase Agreement in a transaction that
closed on July 22, 2024.</span><span style="font-size: 8pt">&#160;&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">As
of April 30, 2024, the Company had owned approximately a <span id="xdx_907_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230501__20240430_zEA1zXrp3SLi">46</span>% interest in Unusual Machines. The primary business operations included selling
first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#8217;s financial
statements are prepared in accordance with GAAP.</span> See Note 3 for additional information.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>



<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Financial
information for UMAC prior to the sale of the Company&#8217;s equity interest was derived from UMAC&#8217;s Form 10-Q for the six months
ended June 30, 2024 and was as follows:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_ztf1asJE8Oq3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_iE_z7ntNzm1rNGl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 25%; font-size: 10pt; text-align: right">5,116,963</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsNoncurrent_iE_zxs4ODeHzxh4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">20,083,390</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iE_zyWpKwK13uq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">931,200</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_iE_zOz7J2TYeiOe" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,297,332</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_zYXvMrsWN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,030,039</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_zJEakPFoPB5a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">592,607</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_z6opJzzCPFuc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(2,718,240</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A6_zYTBJQxNUJ5i" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company&#8217;s investments in UMAC have been impacted by the following:</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)">
<tr id="xdx_431_c20240201__20240430_eus-gaap--EquityMethodInvestments_iS_zsLkD22pXcx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_4B2_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zKGNF3Civcdi" style="text-align: right; width: 30%">17,000,000</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_432_c20240201__20240430_eus-gaap--IncomeLossFromEquityMethodInvestments_zR1RTFfF7J3d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,625</td><td style="text-align: left">)</td></tr>
<tr id="xdx_43B_c20240201__20240430_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_zn7jfoOL2NU" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,353,875</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_43C_c20240201__20240430_eus-gaap--EquityMethodInvestments_iE_zDowKCsMMHp3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,142,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_430_c20240501__20240731_eus-gaap--IncomeLossFromEquityMethodInvestments_zSBcxCyNMpXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Equity method loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">(734,143</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SaleOfOwnershipInterestEquityMethodInvestment_zti24tbhMvKd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Sale of ownership interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(4,408,357</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_43A_c20240501__20240731_eus-gaap--EquityMethodInvestments_iE_zvaRO1a32IN5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Investment balance, July 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0780">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A4_zeWKyDxOL9X6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair
market value of UMAC&#8217;s common stock. </span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 323<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481543/323-740-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org//323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769543776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Note 8 &#8211; Property and Equipment</a></td>
<td class="text"><p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zUvtxMw52FH4" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_827_zjG79bpgDmda">Note
8 &#8211; Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zU8iwyKrYQP1" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_494_20240731_zIVVfsTzYJK" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49C_20240430_z8YevSvskOS6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_zU1rZe2lsm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Equipment and related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,609,269</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,540,888</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LeaseholdImprovementsGross_iI_zN93UM6gtH3a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Leasehold improvements</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,556,139</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,547,976</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zHUpeXzvNuqi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Furniture and fixtures</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">186,703</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">163,290</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z10k40UqBvPj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Accumulated depreciation</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,208,192</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(911,470</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iI_zgL1ebvLX3S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Net carrying value</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,143,919</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,340,684</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_zlu8YxqrJMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Depreciation
expense totaled $<span id="xdx_903_eus-gaap--Depreciation_c20240501__20240731_zQJxJVqrdVCb">296,722 </span> and $<span id="xdx_906_eus-gaap--Depreciation_c20230501__20230731_zHrjB9UXdYla">101,001 </span> for the three months ended July 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863566000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 &#8211; Other Long-Term Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract', window );"><strong>Note 9 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OtherLongTermAssetsDisclosureTextBlock', window );">Note 9 &#8211; Other Long-Term Assets</a></td>
<td class="text"><p id="xdx_80F_ecustom--OtherLongTermAssetsDisclosureTextBlock_zmXk6aRYGzNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_825_zvgbmdXVOP9k">Note
9 &#8211; Other Long-Term Assets</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Other
long-term assets included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zENx4C22DVVh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other long term assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240731_z2Zer20g4iFk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">July 31, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20240430_zE4POr3zA5zl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td></tr>
  <tr id="xdx_40F_ecustom--SAFEAgreementAssets_iI_zrYSJKSr01Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--SecurityDeposit_iI_ziM5Fzjik2Rb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NoncurrentAssets_iI_zb4QKHjYZRIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zywYwvR72358" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#8220;Firestorm&#8221;)
under which it made a payment of $<span id="xdx_908_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zDyv0sWXXzr1">250,000</span> to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $<span id="xdx_905_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zeswLHl1NpN7">250,000</span> into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#8217;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis.
No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;three months ended&#160;July&#160;31,&#160;2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote9OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OtherLongTermAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OtherLongTermAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863588352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Right of Use Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Note 10 &#8211; Right of Use Assets and Liabilities</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zLbr4wR7NhTe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82D_zhkxIP9AakOa">Note
10 &#8211; Right of Use Assets and Liabilities</span></b></span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of July 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#8217;s leases have remaining
lease terms of up to 6.42 years, including options to extend certain leases for up to six years. Operating lease expense totaled $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240501__20240731_zCLAO1ocURPj">90,288</span>
and $<span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20230501__20230731_zQmFkCZaUmEj">85,252</span> for the three months ended July 31, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Leases
on which the Company made rent payments during the reporting period included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_ziaXfkDt8teg" style="text-align: right; width: 25%">23,340</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2030</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_zPBWpmghPTEi" style="text-align: right">5,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zh533RUxAn4k" style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AE_zATMaDDRw507" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Supplemental
information related to operating leases for the three months ended July 31, 2024 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zI2mqukVWKqg" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt">90,951</span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240731_z0QTAgEejtNd">5.93</span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">12%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_8A6_zgUpGUTR1tgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//840/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863542016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Debt Obligations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note 11 &#8211; Debt Obligations</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zSzPJO103sQh" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82E_z1qA9eIlg1r2">Note
11 &#8211; Debt Obligations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>A.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Decathlon
    Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#8220;DA4&#8221;)
in the amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zAm5DKvMAIm2">1,670,294</span> (the &#8220;Loan&#8221;), representing the outstanding principal amount previously due and owing by Teal
to DA4. Interest on the Loan accrues at a rate of ten (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_ztONSCjlVmR5">10</span>%) percent per annum. Principal and interest is payable in monthly installments
of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_za1MgSKb1zyi">49,275</span> until maturity on December 31, 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731_zZh0qSkdXCnk">230,795</span> and $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zqH8Lh9zBaRf">370,537</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>B.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Pelion
    Note</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
May 2021, Teal entered into a note agreement totaling $<span id="xdx_905_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zmtWRBOjCCD7">350,000</span>
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240501__20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_z2WBOyioFzne">0.13</span>% on the date of issuance. Accrued interest at July 31, 2024 and April 30, 2024
totaled $<span id="xdx_90E_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zzKXJ3mIj0rj">1,449 </span>and $<span id="xdx_90C_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zSZoi2zqNVof">1,334</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>C.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Corporate
    Equity</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Beginning
in October 2021, and amended in January 2022, Teal financed a total of $<span id="xdx_901_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z6ykd1FfoSee">120,000</span>
of leasehold improvements with Corporate Equity, LLC.
The loan bears interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zlKloAID5fug">8.25</span>% annually and requires monthly payments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zHVj8f01atXj">3,595</span>
through December 2024. The balance outstanding at July
31, 2024 and April 30, 2024 totaled $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z8oJ6OuBx9Nf">17,205 </span>
and $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zyKk8vtZDlw3">27,495 </span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>D.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Ascentium
    Capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $<span id="xdx_904_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zXPrPXkfuWIe">24,383</span>.
Monthly payments of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zDbegMnjzO35">656</span>
are payable through October 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_z23c2t1VsRSg">1,449 </span>
and $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zUbsfqCCpHu2">1,334</span>
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>E.</b></span></td>
    <td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"><b>&#160;Summary
    </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Future
annual principal payments at July 31, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_491_20240731_z2tv2nqXKtra">&#160;</td></tr>
<tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 65%">2025</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: right; width: 30%">599,570</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">599,570</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AB_zmcWXEYcWPf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="background-color: white">&#160;&#160;&#160;</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863558704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 &#8211; Common Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Note 12 &#8211; Common Stock</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zGqdOaZwg4ig" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82A_zVlrEMmPnCfl">Note
12 &#8211; Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Our
common stock has a par value of $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240731_zDidkHuH2JSl">0.001</span> per share. We are authorized to issue <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_z5IsRRBQvzOl">500,000,000</span> shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_eus-gaap--SharesOutstanding_iS_zeTvz0zbJr41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 75%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 20%"><span style="font-size: 10pt">54,568,065</span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_z3DfxWwJpLl2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">192,742</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_z9MBKNxRerb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">252,214</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zqtbPdkJgySj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">1,761</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_z7T8PLP5xf3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">818,334</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zvLE4sgzomw1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">53,235</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_z9lKEjNguO78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">18,400,000</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zlxiPdB1NXxa" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">3,000</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zffjBQ61NBIf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,289,351</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zdV5XQ1QPH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    employees, net of shares withheld of 126,828 to pay taxes</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">231,855</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zpL6RsRdquyf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    Board of Directors</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">61,447</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_431_c20240501__20240731_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_zhhEcag97Bgl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Exercise of warrants</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">307,595</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20240501__20240731_eus-gaap--SharesOutstanding_iE_zMMqBaYlPrY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of July 31, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,890,248</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8AF_zPPZIlMCo3Jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>ATM
Facility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
August 2023, we entered into a sales agreement (&#8220;the 2023 ATM Facility&#8221;) with ThinkEquity LLC (&#8220;ThinkEquity&#8221;),
which provides for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. </span><span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.2pt">In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $<span id="xdx_907_ecustom--ATMFacilityAggregateOfferingPrice_c20230801__20230831_zFSIY6hYrXF8">4,375,000</span>. </span><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
issuance and sale of these shares by us pursuant to the 2023 ATM Facility are deemed &#8220;at the market&#8221; offerings as defined
in Rule 415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are registered under the Securities
Act. We pay a commission of up to 2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Due
to the expiration of the registration statement that was used for the 2023 ATM Facility, and due to the disqualification of our prior
auditors from appearing or practicing before the SEC, no additional securities may be sold under 2023 ATM Facility.&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>Public
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#8220;Offering&#8221;)
an aggregate of <span id="xdx_90C_eus-gaap--PartnersCapitalAccountUnitsSoldInPublicOffering_c20231201__20231231_zFZKFMu862yc">16,000,000</span> shares of the Company&#8217;s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231211_zejWxlnkebGc">0.001</span> per share (the &#8220;Common Stock&#8221;), at
a public offering price of $<span id="xdx_90C_ecustom--PublicOfferingPricePerShare_c20231201__20231231_zZoArySILYI6">0.50</span> per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
<span id="xdx_905_ecustom--AdditionalSharesPurchaseOptionOverAllotmentCover_c20231201__20231231_zEREtP0SgDDg">2,400,000</span> shares of Common Stock to cover over-allotments.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Offering closed on December 11, 2023, resulting in the issuance of <span id="xdx_907_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20231201__20231231_zPcQad0JNBP5">18,400,000</span> shares of Common Stock </span><span style="font-family: Times New Roman, Times, Serif">which
generated gross proceeds of $<span id="xdx_90E_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20231201__20231231_zkU9KCc7JHK4">9,200,000</span>. <span style="background-color: white">Net proceeds to the Company from the Offering, after deducting
the underwriting discount, the underwriters&#8217; fees and expenses and the Company&#8217;s estimated Offering expenses, were approximately
$<span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20231201__20231231_zpDvrZlLYsPd">8,400,000</span>.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="background-color: white">&#160;</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629867467152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 &#8211; Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Note 13 &#8211; Preferred Stock</a></td>
<td class="text"><p id="xdx_809_eus-gaap--PreferredStockTextBlock_zfOFDWyCbMy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zCA5ARbE0lJd">Note
13 &#8211; Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Our
preferred stock has a par value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240731_zmpsbnSarLqb">0.001</span> per share. Series B Preferred Stock (&#8220;Series B Stock&#8221;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. <span id="xdx_90E_ecustom--PreferredStockConvertible_c20230601__20230630_zKuuSZ9cnbid">982,000</span> shares of Series B Stock were converted into <span id="xdx_904_ecustom--PreferredStockConvertibleSharesIssued_c20230601__20230630_z8WVM0n5wxw6">818,334</span> shares of common stock in June 2023. Shares outstanding
at July 31, 2024 totaled <span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20240731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoXneuiclSbj">4,676 </span> which are convertible into <span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20240501__20240731__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zlcsIElYcdEf">3,896 </span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863624448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 &#8211; Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote14WarrantsAbstract', window );"><strong>Note 14 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsDisclosureTextBlock', window );">Note 14 &#8211; Warrants</a></td>
<td class="text"><p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zj0KfndLrXu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82F_zt6M9hAY1ueh">Note
14 &#8211; Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of
$</span><span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zlCkWt8DGUb7">1.50</span>. The warrants were valued using the multinominal lattice The value
of the warrants was included in the determination of the initial accounting for each financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
summary of the warrants issued were:</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zM64ZJWssd39" style="font: 12pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Upon
    Issuance</b></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    of Transaction</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Warrants</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
    Fair Value</b></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2020&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zyItQ0WxzUCg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,998</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_znz6M267FU2c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20210101__20210131_zTbE4gZuNo12" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">675,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210101__20210131_zi0F2I3d6ZE5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,870,666</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  </table>
<p id="xdx_8A4_zKeT9qA7XOuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">To
date, we have received $</span><span style="font-family: Times New Roman, Times, Serif">301,248 related to the exercise of <span id="xdx_903_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_zSOisXWcjM4l">268,332
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
May 2021, the Company issued warrants to purchase</span>
<span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20210501__20210531_zRtkWmZKknt8">200,000</span> shares of common
stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_903_ecustom--WarrantsIssuedExercisePrice_c20210501__20210531_ztFDHvpQQPYk">5.00</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
July 2021, the Company issued warrants to purchase </span><span id="xdx_902_ecustom--WarrantsToPurchaseSharesIssued_c20210701__20210731_zy866tHZXLtk">533,333
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">shares of
common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_902_ecustom--WarrantsIssuedExercisePrice_c20210701__20210731_zB1Pf283Bw2b">5.625</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
December 2023, the Company issued warrants to purchase <span id="xdx_906_ecustom--WarrantsToPurchaseSharesIssued_c20231201__20231231_zEHiJgcF4utb">736,000</span></span> <span style="font-family: Times New Roman, Times, Serif">shares
of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $<span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20231201__20231231_zxAZTTrGtype">0.625</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the changes in warrants outstanding since April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt">2.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0929">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7l8cGxrduB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">736,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zKoiIywcZfRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.63</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPW0HvnKi2Xj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoUbnz544RU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2024</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoPX1vl8iK97" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,275,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z9rvTVjBvmvb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zevipTHxiaQg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zm3VSq1ljz8h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_ziaEEc0CujWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zVZtrljGewfa"><span style="-sec-ix-hidden: xdx2ixbrl0939">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zqzxOXjOAyGl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(454,708</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zyHJ01SNfIla">0.63</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at July 31, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmPLXm0HeVI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,821,291</span></td>
    <td></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zGUr2ztOudKg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.96</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmn5yhaWGuv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.05</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zZ8nCQ8hnLG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A5_z3WqCMANFHM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote14WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote14WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863544848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 &#8211; Share Based Awards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Note 15 &#8211; Share Based Awards</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHnkXy3WHasb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82A_zgoD23Sd6pff">Note
15 &#8211; Share Based Awards</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed <span id="xdx_900_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20240501__20240731_z3gxp0Bv6WY">11,750,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A.</i></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Options&#160;</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
range of assumptions used to calculate the fair value of options granted during the three months ended July 31 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zwWKrBHKnH8b">1.15</span>
                                       &#8211; <span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zcOyHyHyt11e">1.29</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwfKVpa6sma">1.06</span> &#8211; <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zc86Agqdjmgd">1.12</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zQSYeubdsY38">1.20</span>
                                            &#8211; <span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zytQDTqP7227">1.38</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zo79pL1riDBj">1.06</span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zlpDkH8rMKIe">1.12</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zqSeJS23NFt3">4.24</span></span>
                                            &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7EtEkbAeA0f">4.44</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhXVzuPRYlOd">3.47</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHZIPCESAVk9">4.07</span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKHNTpDho3H9"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7WApBhXuBPe"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z5RsH1tAKujb">5.24</span>
                                            &#8211; <span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20240501__20240731_zUkkPqnnUaM3">5.85</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zRAic9jzIjx2">6.00</span> &#8211;<span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zNkjWRTdD3eg"> 6.25</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKjD426i32F8" style="font-size: 10pt">191.28</span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBs9oEnLmHSb">199.48</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zackZSYtBfii">257.25</span> &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z67PDSvzOQVk">260.22</span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zXokxHCQJR8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">A
summary of options activity under the Plan since April 30, 2023 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: center"></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,784,809</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.88</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt">8.72</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt">74,586<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z7rAkr1bfJll" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,903,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zAeGFu27kLl8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSXoNGEsLN28" style="text-align: right"><span style="font-size: 10pt">(3,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zII2A6LjHwQd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z4Eu1Ei19M1d" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,417</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpxTVULkCV4k" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zZIYNL7HUKL3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,779,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1it06LlqCT2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zk7vSr1QQRK2" style="font-size: 10pt">8.02</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zr3yRtIAuyA" style="text-align: right"><span style="font-size: 10pt">2,762,242<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSqSgOyPQXvb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">627,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ztedmKcGU0Pl" style="text-align: right"><span style="font-size: 10pt">1.15</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zPyTUgSssd15" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zdCmh0jF766f" style="text-align: right"><span style="font-size: 10pt">0.72</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zq4qWyz3cta4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(83,446</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zqUOnW2OGdK7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">1.55</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zu0ZGzckMY46" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,319,988</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziYgiRtGqlGj" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.43</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zJSCAopLaHa5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.54</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zR4wvrDYxUO2" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,658,470</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOXLhV6zDA8" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,444,723</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zjXH5OihYSKf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.65</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zExJIpuuUSvg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.57</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1xBWPodGjYa" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014,807</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p id="xdx_8A4_z9APoiY0wBde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span style="background-color: white">&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of July 31, 2024, there was $<span id="xdx_90D_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20230731_zG3zNaCqsrB6">2,773,793 </span> of unrecognized stock-based compensation expense related to unvested stock
options which is expected to be recognized over the weighted average periods of 1.17.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>B.</i></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">A
summary of restricted stock activity under the Plan since April 30, 2023 was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%">781,060</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%">2.44</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zie7GVCpeKAa" style="text-align: right">298,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z2uZdheNanp6" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z0GJcBaAYZYf" style="text-align: right">(485,024</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zEG5rCLRWOb6" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zvu4rWDmXlr2" style="border-bottom: Black 1pt solid; text-align: right">(419,549</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zv4vkLrcoawb" style="border-bottom: Black 1pt solid; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z6wanxKE0xm5" style="text-align: right">175,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zieqKXmhSHZ8" style="text-align: right">2.09</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zspstRT7400a" style="text-align: right">2,447,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zxnJNgxejRld" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzfH3x7iglO2" style="text-align: right">(420,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zmnL8xC8W3v1" style="text-align: right">1.25</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zbPtYGXtybkc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzqAoP4eTbV9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of July 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_ze5i1GuWS25i" style="border-bottom: Black 3pt double; text-align: right">2,202,599</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zFvbaVd8IXDb" style="border-bottom: Black 3pt double; text-align: right">1.11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zpESgFA0HL57" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span style="background-color: white"></span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>C.</i></b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Compensation</i></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Stock
compensation expense for the three months ended July 31 by functional operating expense was:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z1eXh3zdYvEh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20240501__20240731_zvomcCTvv4Hh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230501__20230731_zgtio2W6FIil" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_403_ecustom--ResearchAndDevelopmentStockCompensationExpense_zvP0AFfUOoL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Research and development</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">94,422</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">127,417</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--SalesAndMarketingStockCompensationExpense_zD6MjHuaDdkg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">116,543</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">165,309</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--GeneralAndAdministrativeStockCompensationExpense_z4KIwy9kjGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">General and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,235,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">618,880</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--TotalStockCompensationExpense_z14Pqh4g5ON5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,446,038</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">911,606</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_zHNDp4xHHRGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock
compensation expense pertaining to options totaled $<span id="xdx_90B_ecustom--StockCompensationExpensePertainingToOptions_c20240501__20240731_zXe7rEeodCFe">357,258</span> and
$<span id="xdx_909_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20230731_zUJjBROcLm2c">629,426 </span> for the three months ended July 31, 2024 and 2023, respectively.
Stock compensation expense pertaining to restricted stock totaled $<span id="xdx_903_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20240501__20240731_zBFe5bjAZgRd">1,088,780 </span> and $<span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20230731_zvwY64SyeDBa">282,180 </span>  for the three months ended July 31, 2024 and
2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629867407648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 - Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Note 16 - Related-Party Transactions</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zcuYH1QOt3Hi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_82C_zinB077i3fe4">Note
16 - Related-Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 7. UMAC&#8217;s
Chief Executive Officer is a direct relative of a member of the Company&#8217;s management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629864421552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 17 &#8211; Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Note 17 &#8211; Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zksTa3herUE6" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_82E_zQkIs6eTt0Dh">Note
17 &#8211; Commitments and Contingencies</span>&#160;</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; background-color: white">&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">One pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863600912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 18 &#8211; Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Note 18 &#8211; Subsequent Events</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_z5E7tc68Xn6d" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_82B_z1NfTJxKzNTi">Note
18 &#8211; Subsequent Events</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Subsequent
events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration: underline">FlightWave
Acquisition&#160;</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On
September 4, 2024, the Company, Teal, FW Acquisition, Inc. (&#8220;Buyer&#8221;), and FlightWave Aerospace Systems Corporation (&#8220;Seller&#8221;)
entered into and closed on the transactions set forth in an Asset Purchase Agreement (the &#8220;APA&#8221; and the transactions set
forth therein, the &#8220;Transactions&#8221;), pursuant to which Buyer purchased and Seller sold certain assets used in designing, developing,
manufacturing, and selling long range, AI-powered UAVs for commercial use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
a condition to the closing of the Transactions, each of the shareholders of the Seller entered into a Joinder Agreement with the Company,
Teal and Buyer pursuant to which such shareholder agreed to the terms of the APA and agreed to be bound by the provisions thereof applicable
to the Seller&#8217;s shareholders, including without limit, the indemnification provisions in the APA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
purchase price under the APA is equal to $14 million worth of shares of the Company&#8217;s common stock which are payable as follows:
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on September 30, 2024, at
                                            a price per share equal to the VWAP on such date, which shall be payable to the preferred
                                            shareholders of the Seller as set forth in the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#149;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$7
                                            million worth of the Company&#8217;s common stock to be issued on December 31, 2024, at a
                                            price per share equal to the VWAP on such date, of which (i) $2 million will be payable to
                                            preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders
                                            and option-holders of the Seller as set forth the APA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Promissory
Note</span></i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 23, 2024, we entered into a Securities
Purchase Agreement (the &#8220;SPA&#8221;) with Lind Global Asset Management X LLC (&#8220;Lind&#8221;). Under the SPA, within days of
closing, we will receive $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory
Note in the amount of $9,600,000 (the &#8220;Note&#8221;) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our
common stock at a price of $6.50 per share, exercisable for 5 years (the &#8220;Warrant&#8221;). As addition consideration to Lind, we
have agreed to pay a commitment fee in the amount of $280,000, which may be paid by deduction from the funding to be received.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Note, which does not accrue interest, shall be
repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At our
option, monthly payments can be increased up to $1,000,000 so long as our market capitalization is at least $50 million. In addition,
if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment
amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued
at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment
Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common
stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Note may be converted by Lind from time to time
at a price of $6.50 per share (the &#8220;Conversion Price&#8221;). The dollar amount of any conversions by Lind will be applied to toward
upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days&#8217; notice, but in the event of a prepayment
notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share
Price is equal to or greater than $2.00) or the Conversion Price.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769201280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zutEcgLYyih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span id="xdx_865_zlvklUGo8XD6" style="font-family: Times New Roman, Times, Serif; color: Black"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; color: Black">&#8211; The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(&#8220;GAAP&#8221;) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management,
all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial
statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the
results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes
thereto for the year ended April 30, 2024, included in the Company&#8217;s Annual Report on Form 10-K.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock', window );">Restatement of Previously Issued Consolidated Financial Statements</a></td>
<td class="text"><p id="xdx_844_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zWM3U6GsyAFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zWCqQu6BvACa">Restatement
of Previously Issued Consolidated Financial Statements</span> </b>&#8211; The Company&#8217;s Condensed Consolidated Statement of Operations
and Stockholders&#8217; Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) on September 19, 2023, have been restated. The Company revised its financial statements to&#160;remove
derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having
a derivative component.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
impacts of these restatements are detailed in the tables below:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of derivative liability</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,810,348</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,836,868</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Shareholders&#8217; Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Additional paid-in capital</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">110,905,033</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">113,554,659</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,649,626</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Accumulated deficit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(60,397,141</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(62,914,971</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,517,830</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Total equity</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">49,993,398</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">50,125,194</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">131,796</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_ze2JTgurI8fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zYX7MX8oMCjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_868_zGp4trD4Rf52">Principles
of Consolidation</span></b> &#8211; <span style="background-color: white">Our condensed consolidated financial statements include the accounts
of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February
16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for
using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions
and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. </span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--UseOfEstimates_zvLQBk4nnqlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zWcAXfWWrOb9">Use
of Estimates</span></b> &#8211;<span style="background-color: white">&#160;The preparation of financial statements in accordance with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those
used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.</span></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_ze4wFxTi7qq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_863_zbteLT7yvvYf">Concentration
of Credit Risk</span> </b>&#8211; Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade
receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs
ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer
from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable,
net as of July&#160;31, 2024 and April 30, 2024 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>July 31, 2024</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>April 30, 2024</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%">38</td><td style="text-align: left; width: 1%">%</td>
    <td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%">53</td><td style="text-align: left; width: 1%">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right">25</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A5_z5nsI50jYiG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of July 31,
2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July
31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investment</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--EquityMethodInvestmentsPolicy_zKxQuQLqZaOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_867_zceAwNcrS64l">Equity
Method Investment</span> &#8211; </b><span style="background-color: white">The equity method of accounting is applied to investments in which
the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period
for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily
be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an
earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its
investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $<span id="xdx_908_eus-gaap--AssetImpairmentCharges_c20230501__20240430_zkbYsHH966n9">11,353,875</span> for the year ended April&#160;30,
2024. See Note 7 for additional information.</span></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKT6sOtOpMdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86F_zBVjhFLEIcQc">Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></b> &#8211; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
guidance establishes three levels of the fair value hierarchy as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i>Level
3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The
carrying amounts of these instruments approximates fair value due to their short-term nature.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zDrocIb8lYd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span><b><span id="xdx_86D_zC2BYsAH4G68">Revenue Recognition</span> </b>&#8211;
The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting
Standards Board (&#8220;FASB&#8221;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue
recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price,
(iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as
each obligation is satisfied.&#160;The Company&#8217;s revenue transactions include the shipment of goods to customers as orders are
fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue
upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240731_zv3ruEUYdIei">50,039 </span> and $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zta0vf4KVPY1">53,939 </span> at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the
capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $<span id="xdx_90E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240731_zeehHTInjCH9">0</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zUia9GjcIxwd">1,477,859</span> at July 31, 2024 and
April 30, 2024, respectively.</p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table presents the Company&#8217;s revenue disaggregated by revenue type:</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three
    Months Ended&#160;July 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">886,440</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">310,881</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Product related</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,890,095</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,437,248</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,776,535</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,748,129</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_zyVi65qXkNFl" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Product Warranty</a></td>
<td class="text"><p id="xdx_848_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zzZ20WTYGaPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zB5Fs2RckWq1">Product
Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales
data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses.&#160;Warranty
liability was approximately $<span id="xdx_90E_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240731_z2g90xAOwkf2">541,000 </span>
and $<span id="xdx_900_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zjhY2VPYHCm1">372,000 </span> as of July 31, 2024 and April 30, 2024 respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIslxQr6OUV8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zBCv0DVYabr4">Recent
Accounting Pronouncements</span> </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;
<span style="background-color: white">Management does not believe that recently issued, but not yet effective accounting pronouncements,
if adopted, would have a material effect on the accompanying consolidated financial statements.</span></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9ddSQBeNkBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_869_zGDhiRI4SNhb">Comprehensive
Loss</span> </b>&#8211; Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses
that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of
foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended
July 31, 2024 and July 31, 2023, comprehensive loss was $<span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20240501__20240731_zk6oWTfRMTJ6">4,621</span>
higher and $<span id="xdx_90E_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20230731_z5YREAIgqlQ9">291,035</span>
lower than net loss, respectively, related to unrealized
gains on available-for-sale securities totaling $<span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20240501__20240731_z3grDvAbQi4h">0</span> and $<span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20230731_zDFVPqPEWUza">289,389</span>,  respectively, and foreign currency translation adjustments of $<span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dxL_c20240501__20240731_zFJ3HWWXeObe" title="::XDX::-4621"><span style="-sec-ix-hidden: xdx2ixbrl0576">4,621 </span></span>
and $<span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20230731_zNRVZcQe7bY1">1,646</span>.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zVUoEFBtUfU" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_860_zSU7UfLWc966">Basic and
Diluted Net Loss per Share</span></b> &#8211; Basic and diluted net loss per share has been calculated by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of
diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents
would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted
net loss per share because their effect would have been anti-dilutive include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2023</span></td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Series B Preferred Stock, as converted</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Stock options</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">7,319,988</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,884,017</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,821,291</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,539,999</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Restricted stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,202,599</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">842,701</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">11,347,774</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">9,270,613</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zKTk0JjIkx29" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 5pt">&#160;</span></p>

<p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RelatedPartiesPolicyTextBlock', window );">Related Parties</a></td>
<td class="text"><p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zV2baH1iPfPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_86A_zPoAEykNX2k8">Related
Parties</span></b> &#8211; Parties are considered to be related to us if they have control or significant influence, directly or indirectly,
over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel
of members of the Board of Directors. Related Party transactions are disclosed in Note 16.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Liquidity and Going Concern</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAP8XuCbTS1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; background-color: white"><b><span id="xdx_86B_zRGfjLqTkQrd">Liquidity
and Going Concern</span> </b>&#8211; The Company has never been profitable and has incurred net losses related to acquisitions, as
well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a
net loss </span><span style="font-family: Times New Roman, Times, Serif">of approximately $<span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20240501__20240731_zF35Z25bd401" title="::XDX::-12416376"><span style="-sec-ix-hidden: xdx2ixbrl0601">12,000,000 </span></span>&#160;and
used cash in operating activities of approximately $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20240501__20240731_zju8eqwXnN28" title="::XDX::-2348412"><span style="-sec-ix-hidden: xdx2ixbrl0602">2,300,000</span></span>.
As of July 31, 2024, working capital totaled approximately $<span id="xdx_903_eus-gaap--Capital_iI_c20240731_zjp5xsHPQbSj">17,200,000</span>.
These financial results and our financial position <span style="background-color: white">at&#160;July 31, 2024&#160;raise
substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen
its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of <span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zkFL43bk1sl8">18,400,000</span>
shares of common stock which generated net proceeds of approximately $<span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zz34gyeJ4D2a">8,400,000</span>
as further described in Note 1 and Note 12. In addition, the Company&#8217;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The
Company&#8217;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the
Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold
its equity method investment for $<span id="xdx_90C_ecustom--ProceedsFromPurchaseAgreement_c20240501__20240731_zNUW7sJPnTrg">4,400,000</span>
in July 2024.<span style="background-color: white"> As described in Note 18, the Company closed a financing with proceeds of $8
million to be received in late September 2024.</span> Management has concluded that these recent positive developments alleviate any
substantial doubt about the Company&#8217;s ability to&#160;continue its operations, and meet its financial obligations, for twelve
months from the date these consolidated financial statements&#160;are&#160;issued.</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//460/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629775164064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock', window );">[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Change in fair value of derivative liability</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Net loss</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,810,348</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(5,836,868</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-size: 10pt">(26,520</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic">&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
                                            Consolidated Statement of Shareholders&#8217; Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
                                            the three months ended July 31, 2023</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Originally</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restated</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Change</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Additional paid-in capital</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">110,905,033</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">113,554,659</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,649,626</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Accumulated deficit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(60,397,141</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(62,914,971</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,517,830</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Total equity</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">49,993,398</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">50,125,194</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">131,796</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>July 31, 2024</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>April 30, 2024</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%">38</td><td style="text-align: left; width: 1%">%</td>
    <td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%">53</td><td style="text-align: left; width: 1%">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right">25</td><td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right">24</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock', window );">[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three
    Months Ended&#160;July 31,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">886,440</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">310,881</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Product related</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,890,095</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,437,248</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,776,535</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,748,129</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2023</span></td></tr>
  <tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Series B Preferred Stock, as converted</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,896</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Stock options</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">7,319,988</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,884,017</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,821,291</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,539,999</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Restricted stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,202,599</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">842,701</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">11,347,774</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">9,270,613</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769542480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zuKaIeWZu0c8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_496_20240501__20240731_z4VdeuOt2Nki" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20230501__20230731_zzSlhuvBqTD4" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
                                            months ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>July
                                            31</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zj8g3sgk8Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0619">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 15%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,869,219</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zqzFk1peqQib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Cost
    of goods sold</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,385,116</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zXptTyvGvpFg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Gross Profit</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">484,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zracsPLzZwCg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating Expenses</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_ziPibjoMV2if" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Research and
    development</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0631">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">46,249</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zV7ogu7xH47c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0634">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">404,104</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_z7Ru2o5k3OS2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">General
    and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">253,586</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zRJj7W3xza0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"><span style="font-size: 10pt">Total
    operating expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0640">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">703,939</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_zvBQO3lP0N1i" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(219,836</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zaK2fMK0e4f6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Other expense
    (income)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zqIZoq6f2Xvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Interest expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">22,856</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zxpSTIawrCB8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">Other,
    net</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0652">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(119</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i02_z5dvtLssGI42" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><span style="font-size: 10pt">Other expense</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">&#8212;</span>&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">22,737</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zsogtd9BqCLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"><span style="font-size: 10pt">Net
    loss from discontinued operations</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0658">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt">(242,573</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768878528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 &#8211; Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zRCtWQmDFBv7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Inventories (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_490_20240731_zvHIzK3CIl6a" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240430_zeCzF8CvuTd8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_zhWQPFnWYQk8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Raw materials</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,863,187</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,750,324</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_zw199aAvrVv4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Work-in-process</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,622,121</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,289,997</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_znaANYaOFAM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Finished goods</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,977,626</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">966,916</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryNet_iI_zvmDK7Y3Mez4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">10,462,934</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">8,007,237</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863621312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 &#8211; Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zX8DVTzy3kmk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other current assets (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_498_20240731_zeID4xo625o9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240430_zYD437Aip8v7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zui2NmgKkI0i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid expenses</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,387,937</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,206,306</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zGhl9icFl5yg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid inventory</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">204,742</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">602,888</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zWLrkPLAqSq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Contract asset</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#8212;&#160;&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,477,859</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--GrantsReceivableCurrent_iI_zgjWNMUcqq64" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Grant receivable</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">675,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAssetsCurrent_iI_zRGRYMiN35V4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,592,679</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,962,053</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769080384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 &#8211; Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zsjeL5QCTHm7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_493_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zC1wdR0GRknf" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQkhwGyz0tUi" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49D_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zF4SeUK4PX7f" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49B_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zWZvAphaHHi9" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_494_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zkfpwTcGZs26" style="text-align: center"></td><td style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_49A_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zyzLmWy22k54" style="text-align: center"><span style="font-size: 10pt"></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Gross
    Value</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Accumulated
    Amortization</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Net
    Value</span></td></tr>
  <tr id="xdx_408_ecustom--FiniteLivedProprietaryTechnologyGross_iI_zWENlT1lHKjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Proprietary technology</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,282,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,094,941</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,187,060</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,282,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right">(1,917,612</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 6%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,364,389</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zhDKad5xG7lb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Non-compete agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0709">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(65,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0712">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zasy2FVorEwh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><span style="font-size: 10pt">Total finite-lived assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,347,001</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,159,941</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,187,060</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">4,347,001</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,982,612</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,364,389</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IndefiniteLivedTradeNames_iI_zxEIZg9A2ZEl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Brand name</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0722">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0725">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zHPvJXlCl4Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"><span style="font-size: 10pt">Total indefinite-lived
    assets</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,430,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_zfACR5VZxKIc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total intangible
    assets, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,777,001</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(2,159,941</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,617,060</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">5,777,001</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,982,612</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">3,794,389</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769539248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 &#8211; Equity Method Investment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock', window );">[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_ztf1asJE8Oq3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_iE_z7ntNzm1rNGl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; font-size: 10pt; text-align: left">Current assets</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 25%; font-size: 10pt; text-align: right">5,116,963</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsNoncurrent_iE_zxs4ODeHzxh4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">20,083,390</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iE_zyWpKwK13uq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">931,200</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_iE_zOz7J2TYeiOe" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,297,332</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Revenues_zYXvMrsWN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,030,039</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_zJEakPFoPB5a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">592,607</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_z6opJzzCPFuc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(2,718,240</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)">
<tr id="xdx_431_c20240201__20240430_eus-gaap--EquityMethodInvestments_iS_zsLkD22pXcx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"><td style="width: 67%">Initial investment, February 16, 2024</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_4B2_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zKGNF3Civcdi" style="text-align: right; width: 30%">17,000,000</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_432_c20240201__20240430_eus-gaap--IncomeLossFromEquityMethodInvestments_zR1RTFfF7J3d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity method loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,625</td><td style="text-align: left">)</td></tr>
<tr id="xdx_43B_c20240201__20240430_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_zn7jfoOL2NU" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Impairment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(11,353,875</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_43C_c20240201__20240430_eus-gaap--EquityMethodInvestments_iE_zDowKCsMMHp3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Investment balance, April 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,142,500</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_430_c20240501__20240731_eus-gaap--IncomeLossFromEquityMethodInvestments_zSBcxCyNMpXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Equity method loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">(734,143</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SaleOfOwnershipInterestEquityMethodInvestment_zti24tbhMvKd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Sale of ownership interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(4,408,357</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_43A_c20240501__20240731_eus-gaap--EquityMethodInvestments_iE_zvaRO1a32IN5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Investment balance, July 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0780">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863630864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zU8iwyKrYQP1" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_494_20240731_zIVVfsTzYJK" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">July
    31, 2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49C_20240430_z8YevSvskOS6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">April
    30, 2024</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_zU1rZe2lsm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Equipment and related</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,609,269</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,540,888</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LeaseholdImprovementsGross_iI_zN93UM6gtH3a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Leasehold improvements</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,556,139</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,547,976</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zHUpeXzvNuqi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Furniture and fixtures</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">186,703</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">163,290</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z10k40UqBvPj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Accumulated depreciation</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(1,208,192</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(911,470</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iI_zgL1ebvLX3S" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Net carrying value</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,143,919</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">2,340,684</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769532944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 &#8211; Other Long-Term Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract', window );"><strong>Note 9 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock', window );">[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zENx4C22DVVh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other long term assets (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_495_20240731_z2Zer20g4iFk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">July 31, 2024</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49F_20240430_zE4POr3zA5zl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">April 30, 2024</td></tr>
  <tr id="xdx_40F_ecustom--SAFEAgreementAssets_iI_zrYSJKSr01Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">SAFE agreement</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 3%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">250,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--SecurityDeposit_iI_ziM5Fzjik2Rb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Security deposits</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">43,126</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NoncurrentAssets_iI_zb4QKHjYZRIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">293,126</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote9OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863638960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Right of Use Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRentExpenseTableTextBlock', window );">Schedule of Rent Expense [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Monthly Rent</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 42%">South Salt Lake, Utah</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_ziaXfkDt8teg" style="text-align: right; width: 25%">23,340</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 25%"><span style="font-size: 10pt">December 2030</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">San Juan, Puerto Rico</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_zPBWpmghPTEi" style="text-align: right">5,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">June 2027</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Grantsville, Utah</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zh533RUxAn4k" style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">December 2026</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Lessee, Operating Lease, Disclosure [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)">
<tr style="vertical-align: bottom">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 12pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49E_20240501__20240731_zI2mqukVWKqg" style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"><span style="font-size: 10pt">Operating cash
    paid to settle lease liabilities</span></td><td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 10pt"></span></td><td style="text-align: center; width: 20%">$<span style="font-size: 10pt">90,951</span></td><td style="text-align: center; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0pt"><span style="font-size: 10pt">Weighted average remaining lease term (in years)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240731_z0QTAgEejtNd">5.93</span></span></td><td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Weighted average discount rate</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-size: 10pt">12%</span></td><td style="text-align: center"><span style="font-size: 10pt"></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481440/840-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481418/840-10-55-40<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRentExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRentExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863624192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Debt Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfDebtPaymentsDueTableTextBlock', window );">[custom:ScheduleOfDebtPaymentsDueTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt">&#160;</td>
    <td colspan="2" style="text-align: left; font-size: 10pt">Fiscal Year Ended:</td><td>&#160;</td>
    <td colspan="3" id="xdx_491_20240731_z2tv2nqXKtra">&#160;</td></tr>
<tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 65%">2025</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; text-align: right; width: 30%">599,570</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td></tr>
<tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">599,570</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfDebtPaymentsDueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfDebtPaymentsDueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863467216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 &#8211; Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt; color: Black">Description
    of Shares</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt; color: Black">&#160;</span></td>
    <td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt; color: Black">Shares
    Issued</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_eus-gaap--SharesOutstanding_iS_zeTvz0zbJr41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; width: 75%"><span style="font-size: 10pt">Shares outstanding as of April 30, 2023</span></td><td style="font-size: 9pt; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right; width: 20%"><span style="font-size: 10pt">54,568,065</span></td><td style="font-size: 9pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_z3DfxWwJpLl2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">192,742</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_z9MBKNxRerb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to Board
    of Directors</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">252,214</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zqtbPdkJgySj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Vesting of restricted stock to consultants</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">1,761</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_z7T8PLP5xf3j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-left: 9pt"><span style="font-size: 10pt">Conversion of preferred stock</span></td><td style="font-size: 9pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">818,334</span></td><td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zvLE4sgzomw1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through ATM facilities</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">53,235</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43A_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_z9lKEjNguO78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Issuance of common
    stock through public offering</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">18,400,000</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zlxiPdB1NXxa" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"><span style="font-size: 10pt">Exercise of stock
    options</span></td><td style="font-size: 9pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">3,000</span></td><td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_439_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zffjBQ61NBIf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of April 30, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,289,351</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_430_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zdV5XQ1QPH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    employees, net of shares withheld of 126,828 to pay taxes</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">231,855</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_435_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zpL6RsRdquyf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vesting of restricted stock to
    Board of Directors</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 9pt; text-align: right"><span style="font-size: 10pt">61,447</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_431_c20240501__20240731_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_zhhEcag97Bgl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Exercise of warrants</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"><span style="font-size: 10pt">307,595</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_43C_c20240501__20240731_eus-gaap--SharesOutstanding_iE_zMMqBaYlPrY1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">Shares outstanding as of July 31, 2024</span></td><td style="font-size: 9pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"><span style="font-size: 10pt">74,890,248</span></td><td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769070496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 &#8211; Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote14WarrantsAbstract', window );"><strong>Note 14 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock', window );">[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zM64ZJWssd39" style="font: 12pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Upon
    Issuance</b></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    of Transaction</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Warrants</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
    Fair Value</b></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2020&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zyItQ0WxzUCg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,998</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_znz6M267FU2c" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20210101__20210131_zTbE4gZuNo12" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">675,000</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210101__20210131_zi0F2I3d6ZE5" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,870,666</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average
    Exercise Price per Share</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;Weighted-average
                                            Remaining Contractual Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
    years)&#160;</b></span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value&#160;</b></span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of April 30, 2023</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,539,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt">3.38</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt">2.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0929">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7l8cGxrduB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">736,000</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right; width: 12%"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zKoiIywcZfRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.63</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPW0HvnKi2Xj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0932">&#8212;</span></span></td>
    <td style="border-bottom: black 1pt solid"></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoUbnz544RU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0933">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April 30, 2024</span></td>
    <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoPX1vl8iK97" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,275,999</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z9rvTVjBvmvb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zevipTHxiaQg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.77</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zm3VSq1ljz8h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0937">&#8212;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted&#160;</span></td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_ziaEEc0CujWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0938">&#8212;</span></span><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zVZtrljGewfa"><span style="-sec-ix-hidden: xdx2ixbrl0939">&#8212;</span></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zqzxOXjOAyGl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(454,708</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zyHJ01SNfIla">0.63</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at July 31, 2024</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmPLXm0HeVI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,821,291</span></td>
    <td></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zGUr2ztOudKg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.96</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmn5yhaWGuv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.05</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zZ8nCQ8hnLG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">389,589</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote14WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote14WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769095984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 &#8211; Share Based Awards (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ScheduleOfAssumptionsUsed1TableTextBlock', window );">[custom:ScheduleOfAssumptionsUsed1TableTextBlock]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%">2025</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Exercise Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zwWKrBHKnH8b">1.15</span>
                                       &#8211; <span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zcOyHyHyt11e">1.29</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwfKVpa6sma">1.06</span> &#8211; <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zc86Agqdjmgd">1.12</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Stock price on date of grant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zQSYeubdsY38">1.20</span>
                                            &#8211; <span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zytQDTqP7227">1.38</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zo79pL1riDBj">1.06</span> &#8211; <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zlpDkH8rMKIe">1.12</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"> <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zqSeJS23NFt3">4.24</span></span>
                                            &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7EtEkbAeA0f">4.44</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhXVzuPRYlOd">3.47</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHZIPCESAVk9">4.07</span>%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKHNTpDho3H9"><span style="-sec-ix-hidden: xdx2ixbrl0963">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7WApBhXuBPe"><span style="-sec-ix-hidden: xdx2ixbrl0964">&#8212;</span></span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z5RsH1tAKujb">5.24</span>
                                            &#8211; <span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20240501__20240731_zUkkPqnnUaM3">5.85</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zRAic9jzIjx2">6.00</span> &#8211;<span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zNkjWRTdD3eg"> 6.25</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKjD426i32F8" style="font-size: 10pt">191.28</span>
                                            &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBs9oEnLmHSb">199.48</span>%</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zackZSYtBfii">257.25</span> &#8211; <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z67PDSvzOQVk">260.22</span>%</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: center"></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Exercise Price</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average
    Remaining Contractual Term</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate
    Intrinsic Value</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    as of April 30, 2023</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,784,809</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.88</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right; width: 10%"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt">8.72</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"><span style="font-size: 10pt">74,586<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z7rAkr1bfJll" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,903,542</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zAeGFu27kLl8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSXoNGEsLN28" style="text-align: right"><span style="font-size: 10pt">(3,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zII2A6LjHwQd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.89</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z4Eu1Ei19M1d" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(905,417</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpxTVULkCV4k" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of April
    30, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zZIYNL7HUKL3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,779,934</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td></td>
    <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1it06LlqCT2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zk7vSr1QQRK2" style="font-size: 10pt">8.02</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zr3yRtIAuyA" style="text-align: right"><span style="font-size: 10pt">2,762,242<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSqSgOyPQXvb" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">627,500</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ztedmKcGU0Pl" style="text-align: right"><span style="font-size: 10pt">1.15</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zPyTUgSssd15" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zdCmh0jF766f" style="text-align: right"><span style="font-size: 10pt">0.72</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or expired</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zq4qWyz3cta4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(83,446</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zqUOnW2OGdK7" style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 10pt">1.55</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zu0ZGzckMY46" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,319,988</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziYgiRtGqlGj" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.43</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zJSCAopLaHa5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.54</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zR4wvrDYxUO2" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,658,470</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of July 31, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOXLhV6zDA8" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,444,723</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zjXH5OihYSKf" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.65</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zExJIpuuUSvg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.57</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 3pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1xBWPodGjYa" style="border-bottom: Black 3pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014,807</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)">
<tr style="vertical-align: bottom">
    <td style="padding-left: -10pt; text-align: center"></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Shares</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Weighted Average Grant-Date Fair Value Per Share</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt; width: 52%">Unvested and outstanding as of April 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%">781,060</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%">2.44</td><td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zie7GVCpeKAa" style="text-align: right">298,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z2uZdheNanp6" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z0GJcBaAYZYf" style="text-align: right">(485,024</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zEG5rCLRWOb6" style="text-align: right">1.92</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zvu4rWDmXlr2" style="border-bottom: Black 1pt solid; text-align: right">(419,549</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zv4vkLrcoawb" style="border-bottom: Black 1pt solid; text-align: right">2.09</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Unvested and outstanding as of April 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z6wanxKE0xm5" style="text-align: right">175,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zieqKXmhSHZ8" style="text-align: right">2.09</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zspstRT7400a" style="text-align: right">2,447,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zxnJNgxejRld" style="text-align: right">1.06</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzfH3x7iglO2" style="text-align: right">(420,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zmnL8xC8W3v1" style="text-align: right">1.25</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zbPtYGXtybkc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzqAoP4eTbV9" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Unvested and outstanding as of July 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_ze5i1GuWS25i" style="border-bottom: Black 3pt double; text-align: right">2,202,599</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zFvbaVd8IXDb" style="border-bottom: Black 3pt double; text-align: right">1.11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock', window );">Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z1eXh3zdYvEh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_497_20240501__20240731_zvomcCTvv4Hh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="3" id="xdx_49A_20230501__20230731_zgtio2W6FIil" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr>
  <tr id="xdx_403_ecustom--ResearchAndDevelopmentStockCompensationExpense_zvP0AFfUOoL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Research and development</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">94,422</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 20%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">127,417</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--SalesAndMarketingStockCompensationExpense_zD6MjHuaDdkg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Sales and marketing</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">116,543</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">165,309</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--GeneralAndAdministrativeStockCompensationExpense_z4KIwy9kjGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">General and administrative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,235,073</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">618,880</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--TotalStockCompensationExpense_z14Pqh4g5ON5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"><span style="font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">1,446,038</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">911,606</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ScheduleOfAssumptionsUsed1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ScheduleOfAssumptionsUsed1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483043/710-10-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482943/710-10-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770623392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of restatements of previously issued consolidated financial statements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,416,376)<span></span>
</td>
<td class="num">$ (5,836,868)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">125,927,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (93,547,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember', window );">Restatement Impact Originally Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,810,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,905,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,397,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,993,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember', window );">Restatement Impact As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,836,868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,554,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,914,971)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,125,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember', window );">Restatement Impact Change [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,649,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,517,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockholdersEquityRestatement', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockholdersEquityRestatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockholdersEquityRestatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactOriginallyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactAsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_RestatementImpactAxis=RCAT_RestatementImpactChangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629870321872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Customer concentration risk (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member', window );">Customer Concentration Risk 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member', window );">Customer Concentration Risk 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=RCAT_CustomerConcentrationRisk2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774034224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 &#8211; The Business (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]</a></td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</a></td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member', window );">Business Acquisition 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,995,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member', window );">Business Acquisition 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,354,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member', window );">Business Acquisition 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,791,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member', window );">Business Acquisition 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,011,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RCAT_BusinessAcquisition4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863547248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company's revenue disaggregated by revenue type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Contract related</a></td>
<td class="nump">$ 886,440<span></span>
</td>
<td class="nump">$ 310,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Product related</a></td>
<td class="nump">1,890,095<span></span>
</td>
<td class="nump">1,437,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="nump">$ 2,776,535<span></span>
</td>
<td class="nump">$ 1,748,129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769603312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Antidilutive securities excluded from computation of diluted net loss per share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount', window );">Series B Preferred Stock, as converted</a></td>
<td class="nump">3,896<span></span>
</td>
<td class="nump">3,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount', window );">Stock options</a></td>
<td class="nump">7,319,988<span></span>
</td>
<td class="nump">6,884,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount', window );">Warrants</a></td>
<td class="nump">1,821,291<span></span>
</td>
<td class="nump">1,539,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount', window );">Restricted stock</a></td>
<td class="nump">2,202,599<span></span>
</td>
<td class="nump">842,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">11,347,774<span></span>
</td>
<td class="nump">9,270,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770585184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,353,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract with Customer, Liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Contract with Customer, Asset, before Allowance for Credit Loss, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,477,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Standard Product Warranty Accrual, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 372,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DifferenceBetweenComprehensiveLossAndNetLoss', window );">[custom:DifferenceBetweenComprehensiveLossAndNetLoss]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
<td class="nump">$ 291,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">289,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,621)<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,416,376)<span></span>
</td>
<td class="num">(5,594,295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,348,412)<span></span>
</td>
<td class="num">$ (6,926,069)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Capital', window );">Banking Regulation, Total Capital, Actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</a></td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ProceedsFromPurchaseAgreement', window );">[custom:ProceedsFromPurchaseAgreement]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DifferenceBetweenComprehensiveLossAndNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DifferenceBetweenComprehensiveLossAndNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ProceedsFromPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ProceedsFromPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480696/942-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769130400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - results of operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,869,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of goods sold</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,385,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross Profit</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">484,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">46,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">404,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">253,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total operating expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">703,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating loss</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(219,836)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract', window );"><strong>Other expense (income)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">22,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome', window );">Other, net</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense', window );">Other expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">22,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net loss from discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (242,573)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480781/205-20-S99-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482551/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770331216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 &#8211; Divestiture of Consumer Segment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Feb. 16, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Noncash or Part Noncash Divestiture, Amount of Consideration Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1', window );">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares', window );">[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]</a></td>
<td class="nump">4,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WorkingCapitalAtClosingOfDisposalGroup', window );">[custom:WorkingCapitalAtClosingOfDisposalGroup-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WorkingCapitalAtClosingOfDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WorkingCapitalAtClosingOfDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769192768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 6,863,187<span></span>
</td>
<td class="nump">$ 5,750,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">1,622,121<span></span>
</td>
<td class="nump">1,289,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,977,626<span></span>
</td>
<td class="nump">966,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 10,462,934<span></span>
</td>
<td class="nump">$ 8,007,237<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769734096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 2,387,937<span></span>
</td>
<td class="nump">$ 1,206,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid inventory</a></td>
<td class="nump">204,742<span></span>
</td>
<td class="nump">602,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Contract asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,477,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grant receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">675,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 2,592,679<span></span>
</td>
<td class="nump">$ 3,962,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769803792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember', window );">Intangible Assets Gross Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="nump">$ 4,282,001<span></span>
</td>
<td class="nump">$ 4,282,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="nump">4,347,001<span></span>
</td>
<td class="nump">4,347,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">1,430,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">1,430,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="nump">5,777,001<span></span>
</td>
<td class="nump">5,777,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember', window );">Intangible Assets Accumulated Amortization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="num">(2,094,941)<span></span>
</td>
<td class="num">(1,917,612)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="num">(65,000)<span></span>
</td>
<td class="num">(65,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="num">(2,159,941)<span></span>
</td>
<td class="num">(1,982,612)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="num">(2,159,941)<span></span>
</td>
<td class="num">(1,982,612)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember', window );">Intangible Assets Net Carrying Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedProprietaryTechnologyGross', window );">Proprietary technology</a></td>
<td class="nump">2,187,060<span></span>
</td>
<td class="nump">2,364,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedNoncompeteAgreementsGross1', window );">Non-compete agreements</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FiniteLivedIntangibleAssetsGross1', window );">Total finite-lived assets</a></td>
<td class="nump">2,187,060<span></span>
</td>
<td class="nump">2,364,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand name</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">1,430,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1', window );">Total indefinite-lived assets</a></td>
<td class="nump">1,430,000<span></span>
</td>
<td class="nump">1,430,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IntangibleAssetsNetExcludingGoodwill1', window );">Total intangible assets, net</a></td>
<td class="nump">$ 3,617,060<span></span>
</td>
<td class="nump">$ 3,794,389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedIntangibleAssetsGross1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedIntangibleAssetsGross1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedNoncompeteAgreementsGross1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedNoncompeteAgreementsGross1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedProprietaryTechnologyGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedProprietaryTechnologyGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IntangibleAssetsNetExcludingGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IntangibleAssetsNetExcludingGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsGrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsAccumulatedAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis=RCAT_IntangibleAssetsNetCarryingValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769171648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial information for UMAC derived from their Form 10-Q (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 21,470,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="nump">16,485,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">4,230,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="nump">1,269,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,776,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,748,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="num">(483,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,416,376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,836,868)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity Method Investment, Nonconsolidated Investee, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,116,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,083,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,297,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,030,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">592,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,718,240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769461168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impacts on investments into UMAC (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Initial investment, February 16, 2024</a></td>
<td class="nump">$ 5,142,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment balance, July 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,142,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity Method Investment, Nonconsolidated Investee, Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Initial investment, February 16, 2024</a></td>
<td class="nump">5,142,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method loss</a></td>
<td class="num">(734,143)<span></span>
</td>
<td class="num">(503,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,353,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment balance, July 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,142,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SaleOfOwnershipInterestEquityMethodInvestment', window );">Sale of ownership interest</a></td>
<td class="num">$ (4,408,357)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SaleOfOwnershipInterestEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SaleOfOwnershipInterestEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769087840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 &#8211; Equity Method Investment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExchangeAgreementSharesExchanged', window );">[custom:ExchangeAgreementSharesExchanged]</a></td>
<td class="nump">4,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExchangeAgreementSharesExchangedParValue', window );">[custom:ExchangeAgreementSharesExchangedParValue]</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExchangeAgreementPreferredSharesReceived', window );">[custom:ExchangeAgreementPreferredSharesReceived]</a></td>
<td class="nump">4,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExchangeAgreementSharesPreferredStockValueSold', window );">[custom:ExchangeAgreementSharesPreferredStockValueSold]</a></td>
<td class="nump">$ 4,408,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NoteReceivableSoldPursuantToExchangeAgreement', window );">[custom:NoteReceivableSoldPursuantToExchangeAgreement]</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ProceedsFromPurchaseAgreement', window );">[custom:ProceedsFromPurchaseAgreement]</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExchangeAgreementPreferredSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExchangeAgreementPreferredSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExchangeAgreementSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExchangeAgreementSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExchangeAgreementSharesExchangedParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExchangeAgreementSharesExchangedParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExchangeAgreementSharesPreferredStockValueSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExchangeAgreementSharesPreferredStockValueSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NoteReceivableSoldPursuantToExchangeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NoteReceivableSoldPursuantToExchangeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ProceedsFromPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ProceedsFromPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768946720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment and related</a></td>
<td class="nump">$ 1,609,269<span></span>
</td>
<td class="nump">$ 1,540,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">1,556,139<span></span>
</td>
<td class="nump">1,547,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">186,703<span></span>
</td>
<td class="nump">163,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(1,208,192)<span></span>
</td>
<td class="num">(911,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net carrying value</a></td>
<td class="nump">$ 2,143,919<span></span>
</td>
<td class="nump">$ 2,340,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769001424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 &#8211; Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 296,722<span></span>
</td>
<td class="nump">$ 101,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863566000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other long term assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract', window );"><strong>Note 9 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SAFEAgreementAssets', window );">SAFE agreement</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposits</a></td>
<td class="nump">43,126<span></span>
</td>
<td class="nump">43,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total</a></td>
<td class="nump">$ 293,126<span></span>
</td>
<td class="nump">$ 293,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote9OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SAFEAgreementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SAFEAgreementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863502992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 &#8211; Other Long-Term Assets (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract', window );"><strong>Note 9 Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PaymentForSAFEAgreement', window );">[custom:PaymentForSAFEAgreement]</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote9OtherLongtermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote9OtherLongtermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PaymentForSAFEAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PaymentForSAFEAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629763555808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 90,288<span></span>
</td>
<td class="nump">$ 85,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member', window );">Operating Lease Location 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">23,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member', window );">Operating Lease Location 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">5,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member', window );">Operating Lease Location 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=RCAT_OperatingLeaseLocation4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629864462080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental information related to operating leases (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jul. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OperatingCashPaidToSettleLeaseLiabilities', window );">Operating cash paid to settle lease liabilities</a></td>
<td class="nump">$ 90,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OperatingCashPaidToSettleLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OperatingCashPaidToSettleLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768946720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 &#8211; Right of Use Assets and Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 90,288<span></span>
</td>
<td class="nump">$ 85,252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769162720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Outstanding principal payments (Details)<br></strong></div></th>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueYearOne', window );">&#160;</a></td>
<td class="nump">$ 599,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueLongTerm', window );">&#160;</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_OutstandingPrincipalPaymentsDueTotal', window );">&#160;</a></td>
<td class="nump">$ 599,570<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_OutstandingPrincipalPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_OutstandingPrincipalPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770653904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 &#8211; Debt Obligations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,296,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,069,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member', window );">Debt Obligation 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,670,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member', window );">Debt Obligation 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ConvertibleNoteAgreementAmount', window );">[custom:ConvertibleNoteAgreementAmount]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member', window );">Debt Obligation 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_LeaseholdImprovementAgreementFundsReceived', window );">[custom:LeaseholdImprovementAgreementFundsReceived]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member', window );">Debt Obligation 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-Term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset', window );">[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]</a></td>
<td class="nump">$ 24,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ConvertibleNoteAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ConvertibleNoteAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_LeaseholdImprovementAgreementFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_LeaseholdImprovementAgreementFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=RCAT_DebtObligation8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629772075328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of shares of common stock issued (Details) - Common Stock [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Beginning Balance</a></td>
<td class="nump">74,289,351<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
<td class="nump">54,568,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1', window );">Vesting of restricted stock to employees, net of shares withheld of 126,828 to pay taxes</a></td>
<td class="nump">231,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2', window );">Vesting of restricted stock to Board of Directors</a></td>
<td class="nump">61,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3', window );">Vesting of restricted stock to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities', window );">Conversion of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">818,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares', window );">Issuance of common stock through ATM facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesPublicOffering', window );">Issuance of common stock through public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding, Ending Balance</a></td>
<td class="nump">74,890,248<span></span>
</td>
<td class="nump">55,541,875<span></span>
</td>
<td class="nump">74,289,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="nump">307,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769734800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 &#8211; Common Stock (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Dec. 11, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ATMFacilityAggregateOfferingPrice', window );">[custom:ATMFacilityAggregateOfferingPrice]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering', window );">Partners' Capital Account, Units, Sold in Public Offering</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PublicOfferingPricePerShare', window );">[custom:PublicOfferingPricePerShare]</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover', window );">[custom:AdditionalSharesPurchaseOptionOverAllotmentCover]</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingShares]</a></td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]</a></td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds', window );">[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]</a></td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ATMFacilityAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ATMFacilityAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FirmCommitmentUnderwrittenPublicOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FirmCommitmentUnderwrittenPublicOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PublicOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PublicOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units sold in a public offering of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769227392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 &#8211; Preferred Stock (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PreferredStockConvertible', window );">[custom:PreferredStockConvertible]</a></td>
<td class="nump">982,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_PreferredStockConvertibleSharesIssued', window );">[custom:PreferredStockConvertibleSharesIssued]</a></td>
<td class="nump">818,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">4,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member', window );">Series A Preferred Stock 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock', window );">[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PreferredStockConvertible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PreferredStockConvertible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_PreferredStockConvertibleSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_PreferredStockConvertibleSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RCAT_SeriesAPreferredStock2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768810752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of warrants issued and fair values (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote14WarrantsAbstract', window );"><strong>Note 14 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfWarrantsUponIssuance', window );">[custom:NumberOfWarrantsUponIssuance]</a></td>
<td class="nump">675,000<span></span>
</td>
<td class="nump">399,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_InitialFairValueOfWarrantsUponIssuance', window );">[custom:InitialFairValueOfWarrantsUponIssuance]</a></td>
<td class="nump">$ 2,870,666<span></span>
</td>
<td class="nump">$ 267,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote14WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote14WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_InitialFairValueOfWarrantsUponIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_InitialFairValueOfWarrantsUponIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfWarrantsUponIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfWarrantsUponIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629770003584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in warrants outstanding (Details) - Warrants Outstanding 1 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">1,821,291<span></span>
</td>
<td class="nump">2,275,999<span></span>
</td>
<td class="nump">1,539,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.96<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">2 years 18 days<span></span>
</td>
<td class="text">2 years 9 months 7 days<span></span>
</td>
<td class="text">2 years 10 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 389,589<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(454,708)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantsOutstanding1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=RCAT_WarrantsOutstanding1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629920939504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 &#8211; Warrants (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_DisclosureNote14WarrantsAbstract', window );"><strong>Note 14 Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsIssuedExercisePrice', window );">[custom:WarrantsIssuedExercisePrice]</a></td>
<td class="nump">$ 0.625<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 5.625<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ExerciseOfWarrantsShares', window );">[custom:ExerciseOfWarrantsShares]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_WarrantsToPurchaseSharesIssued', window );">[custom:WarrantsToPurchaseSharesIssued]</a></td>
<td class="nump">736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533,333<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_DisclosureNote14WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_DisclosureNote14WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsIssuedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsIssuedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_WarrantsToPurchaseSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_WarrantsToPurchaseSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629768619120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assumptions used to calculate fair value of options granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember', window );">Options Assumptions Used [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</a></td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]</a></td>
<td class="nump">1.12<span></span>
</td>
<td class="nump">1.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]</a></td>
<td class="nump">1.06<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]</a></td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="nump">3.47%<span></span>
</td>
<td class="nump">4.24%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="nump">4.07%<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years 2 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="nump">257.25%<span></span>
</td>
<td class="nump">191.28%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="nump">260.22%<span></span>
</td>
<td class="nump">199.48%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_FairValueOfOptionsAxis=RCAT_OptionsAssumptionsUsedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769447408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of activity under the Plan (Details) - Options 1 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">7,319,988<span></span>
</td>
<td class="nump">6,779,934<span></span>
</td>
<td class="nump">4,784,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 6 months 14 days<span></span>
</td>
<td class="text">8 years 7 days<span></span>
</td>
<td class="text">8 years 8 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 5,658,470<span></span>
</td>
<td class="nump">$ 2,762,242<span></span>
</td>
<td class="nump">$ 74,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">627,500<span></span>
</td>
<td class="nump">2,903,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</a></td>
<td class="num">(83,446)<span></span>
</td>
<td class="num">(905,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">4,444,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 6 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 3,014,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RCAT_Options1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=RCAT_Options1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629769192176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of restricted stock activity under the Plan (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]</a></td>
<td class="nump">2,202,599<span></span>
</td>
<td class="nump">175,130<span></span>
</td>
<td class="nump">781,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice', window );">[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]</a></td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]</a></td>
<td class="nump">2,447,599<span></span>
</td>
<td class="nump">298,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]</a></td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]</a></td>
<td class="num">(420,130)<span></span>
</td>
<td class="num">(485,024)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(419,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares', window );">[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">419,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ShareBasedCompensationSharesRestrictedStockAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ShareBasedCompensationSharesRestrictedStockAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629863508352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock compensation expense by functional category (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_ResearchAndDevelopmentStockCompensationExpense', window );">Research and development</a></td>
<td class="nump">$ 94,422<span></span>
</td>
<td class="nump">$ 127,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_SalesAndMarketingStockCompensationExpense', window );">Sales and marketing</a></td>
<td class="nump">116,543<span></span>
</td>
<td class="nump">165,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_GeneralAndAdministrativeStockCompensationExpense', window );">General and administrative</a></td>
<td class="nump">1,235,073<span></span>
</td>
<td class="nump">618,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_TotalStockCompensationExpense', window );">Total</a></td>
<td class="nump">$ 1,446,038<span></span>
</td>
<td class="nump">$ 911,606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_GeneralAndAdministrativeStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_GeneralAndAdministrativeStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_ResearchAndDevelopmentStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_ResearchAndDevelopmentStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_SalesAndMarketingStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_SalesAndMarketingStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_TotalStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_TotalStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45629774149584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 &#8211; Share Based Awards (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum', window );">[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]</a></td>
<td class="nump">11,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions', window );">[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,773,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockCompensationExpensePertainingToOptions', window );">[custom:StockCompensationExpensePertainingToOptions]</a></td>
<td class="nump">$ 357,258<span></span>
</td>
<td class="nump">629,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RCAT_StockCompensationExpensePertainingToRestrictedStockUnits', window );">[custom:StockCompensationExpensePertainingToRestrictedStockUnits]</a></td>
<td class="nump">$ 1,088,780<span></span>
</td>
<td class="nump">$ 282,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockCompensationExpensePertainingToOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockCompensationExpensePertainingToOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_StockCompensationExpensePertainingToRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_StockCompensationExpensePertainingToRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RCAT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MLR0)0XQ;W+JX!,<Q -W4DBVUY,#",Z)X4+ S-@/8NT&2[B1R$F'>)NK 14G
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M AR?&Z.3=DRCN'_]:/VGRGEPYIXI/A?Y7UFJUU>3>()2OF3;7'\4#[_PQJ'
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MT-(64-P##586/W*#2%8^$EM-IN<T.23Q(!)ALTH4M^*%1B+ZYZYXAUQ\6KC
MJKCBR0J1QL:'+3&6%M?>;!"@V 7#P)<J5*PQG09DCKUYB.7IUYCZH>-$1,X/
MU=!W,/'QW#LQO0>="+]!*.KG_$@E>GVR5?W'4T4BC54[W9%\9%R:NSUV/V,5
M+;&*EMI"&P; 02K"9JWH7!76T[+NG9%BJDWH$7EE7V)50<'$"W#@.K*<H#&=
M1I"/3N@2.<544R\@6,XOC97K!Y[OGM $\$' P68%YVU"K'ZR5=E"EV*J53O=
MKJ\4M3?(*884LXF66$5+;:$-8^ @#&&S,C1&CC5#C=F76 ):8HUJY'F!XT9R
M6EIJ,;$%E)[1]2&E!_D&F_6;-PFS9LPQW*HZ#YF[<GJK0L\4NY[K.C)OML0>
M6T#IB:X[;GB"MX.>@\V"SO]'I#4W.E:EQ:KB ^RZLD:WM-IJ;!4ML8J6VD(;
M!LU!]L%FW>=-XH MP<<6T-(64&P+*,&JFC/5[<Y>,QO>/CAH/L2L^9CD ;/K
M"/IL 2UM <5$%5NFL-.&C;:\ETQLM9F>U>:0QH/*0\PJ3_R-U:N<LZ9N/],:
M4E2?D6:8,91B9?5U'>52B4814:QB6WU*; &E%H"&/![=!C(+/;]WU]G>M^MR
MMQQW_W'I_N'2+<GMCU]ZEE^8SW27F&[,S8U=E(DJP<!YTY_+NH755F.K:(E5
MM-06VC!<#L(5,0M79^F"VG-T#VP4+30VH1?-'9EMU0P3?T["4!$M-*93.)1[
M(9:K0F(>^9AD5MMTB>?[OGM"-R0'V8B\<L5HO&ZH)T,GT"BBAL:JI8-X2MU]
MPX4>0_[91$NLHJ6VT+H F!W=$6XNF?],Z\>\Y*A@#P#OO MA[NONWG;W(JIM
M>VWXOA)0M=O'-:,9JQL#^/VAJL3+2W,3>7][_OI_4$L#!!0    ( &N"-UF^
M6#$X;P@  $ I   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5IM;]LX
M$OXK@N]P:(%U+;[H+9<82-,M+H?=;="@=Y\5B;9YE44O12?-_OH;2K9H2R03
MI_X22\IP- ^'G.<AJ<LG(;\W*\94\&-=U<W59*74YF(V:XH56^?-![%A-?QG
M(>0Z5W KE[-F(UE>MHW6U0R'83Q;Y[R>S"_;9W=R?BFVJN(UNY-!LUVO<_G\
MD57BZ6J")OL'7_ERI?2#V?QRDR_9/5/?-G<2[F:]EY*O6=UP40>2+:XFU^CB
MAJ:Z06OQ'\Z>FH/K0$-Y$.*[OKDMKR:ACHA5K%#:10X_C^R&597V!''\N7,Z
MZ=^I&QY>[[U_;L$#F(>\83>B^B\OU>IJDDZ"DBWR;:6^BJ=_L1V@2/LK1-6T
M?X.GSC8))T&Q;918[QI#!&M>=[_YCUU''#0 /_8&>-< #QM01P.R:T!:H%UD
M+:Q/N<KGEU(\!5);@S=]T?9-VQK0\%JG\5Y)^"^'=FI^(^H2DL+* *X:4?$R
M5W!SK^ 'LJ6:0"R"F[Q9!9\AXTWP[EN=;TL.-N^#:?#M_E/P[N_O+V<*0M$.
M9\7NM1^[UV+':TGPNZC5J@E^A=>7Q^UG *''@?<X/F*OPW]OJP\!0;\$.,34
M$L_-ZYL33SBD[U;2^B.N;C4]MI!B'7S9,)DK7B^#:SUNN>*LL?5:YY7:O>HI
M?=%L\H)=36#.-DP^LLG\'W]#<?A/&^0S.3OJ -IW /5YG_\!%:@2C15DUS)N
M6^HR\SB?(DQ13)+X<O9XB,!B&:4D3N.T-SR*+NJCBUX579><DC<%C$9>;V'D
MBRY3,!ELH7O=VKLTL*6F\Q,= L,41PFQXXI[7/$)N':@]*CSHXK'T3@28K&,
MHHSB++('GO2!)][Y<EW^#VI=5W"4 'Z V M>L:#>(X*G^KK0$ZM%9R!=V# E
MYYQ)9W)VU#5IWS6I-Z?W2A3?6ZHJ(:-KX.^FA0WE5VR<*4U'B2)1@J-TD,^Q
M68PAG;$]FUD?<O;6D*%_E.2%YIAMS94U]FP4% K3-$G#0?!C.YQB=&!V%#P*
M#26&WO"OUT(J_E<7,M ?KU5>+_D##,>\:9@]Z)W/HZB3A.!L$+3%#J.$N"H:
M.B!RY(WZ*\LK_A?TJRD 30XA P 0:-^9RC6 AA5;Z:0?_RM.J&\[1T<H,QP3
MQ\!"V*#$7I2?&+RYX&UNK BPY<5Q@O$P#6,[%*(P1(X #?$C+ZW.?].]#^-F
MW_?LSRU7S\&:J94H82@]LJ[.!7E=!K503!<[QA]U=JR R"A0&H8IS.8AHC?0
M?>"I3\A0/?)S_:]'$%VLOW-R""0A%%$RQ.%]V1MP&%& _*K@=KW)N6R3 PE<
M"E$^\:IJ$_6Z$C!F]8R$T;!L^:-X T"C#E#L5Z4K ,$:0+-G3Y &'9X69<7S
M!UZYJX-7?)S*J>?R=MP71G @+VG/KXM";+7<>&'Z)6,BC9.,H&B8U;'A-'%R
MD2%_Y&?_6R@8M1+RV1K<F+Y!1D91G(V*@\42#-/$5>\,U2,_UW]1*R:MP5EH
MG,092>@PMK'A%"4:A$,-8\/DV,_D9ME5,5 C@=2+^JE83+<-.V'@XS%G3^-X
M2"DV*QHY>!T;7L=^7K]I-P&8#$JV$8U#,N$QWTY)%@Y+C\T,@;B*73UM>!G[
M>;F?3IO\V367\)ASHQ A.EQD6.RF,!S2Q*$>L"%G["=GB%+J11[[H36I(]EC
MPL48)W0HY"QV-*0NA8,-F^*75\[M*F>KY?-QJ>[W#K2R>/7R#H^9=XH)32D:
M#6&+90RZ+8PS!RQ#KC@Z:4?DME5"+^^(X#>PI9MTSN7MN!,, 6/_^OQN*XL5
M%*(V?QNITP;"25<@+1,W6GI8^\"R[,ZR;"0!;791&%%'[@Q78C]7WDE1,%:^
M=57A]W["J@*/.9:F:4HRU^@T-(O]-&M'^+/:'8]9EX)X#\=UV1O=Z9(0&_K&
M?OKNJPV,QD=>0L5Y>-XA_9F*,Z9T2@#V2.S;#"&AA#KVDXBA?A*>5&\^\SJO
MBU?LP'H5Q<E;L&?R=MP)1CL0OW:XRY^[/;5M7;8*X@&6-@\57[I31VP2(<+C
M,6LU)$F6.B8C,5J"^+5$'S4,.97_8%JC5^VQA!+[.:ED7C=YX89AT1"(T) ,
M:Z;-, 6\#A '!P!^J3&B\44_ -\XJ<A8<$QQ&EL@60Q!946A*S-&FQ#JG52?
M7K]33MZPC/?,HS-Y.\9MQ OQ[PQ\L4@P*^ASG0\0RP$!B6+D3*&1(,0O06XM
MM=T*Y0W+<SN4GW=T#-7(%N*7+9\M,\X*]5SZA(SU"29)BAP"C!AY0OSR9%1,
M3CBR\KL^!9UE#P&AU'GV0XP((2^+$%X7LEVCORM9=_5> ]4T;D5EV5V(8WT6
M-2R&EMT%3,(DPHZ5.342@_IW%W1LOP0/;,GKNBW?H.F9Y**T!4S'NP.PK$I0
M/%Q76@P)K,!(Z.AF:M0 ?6$GH8V7@7;U1SHF=GV0D<1#\68QS"*<)(DC4",
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M)WI-T.X.=Y]S]4_[SP"OVX_?!L\_HHN;[F,^XZ;[MO#W7 +E-D'%%N R_)!
MO\ON<[WN1HE-^\7;@U!*K-O+%<MA!:P-X/\+(=3^1K^@_VAR_G]02P,$%
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MV1A3W.BRC#VI1G)J&Q@FK :!MTHT1',>(2AJR*U@14#;H\-D&G*,*P-D&Q'
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MO=J$FW=X<;KVM]V%=K@[^\>U1$,V9(#QI489MR^T0/_OC\O_ 5!+ P04
M" !K@C=9%>E3?IH"  "@!0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6R55%%OVC 0?L^OL-*I3VF3."$!"DC0;EHG=:K:;7V8]F"2@UAU[,PVI?WW
M.R>0,8DB[87<V=]]]QWGN\E6Z6=3 5CR6@MIIGYE;3,.0U-44#-SJ1J0>+-2
MNF867;T.3:.!E6U0+4(:15E8,R[]V:0]N]>SB=I8P27<:V(V=<WTVP*$VD[]
MV-\?//!U9=U!.)LT; V/8+\W]QJ]L&<I>0W2<"6)AM74G\?C1>KP+> 'AZTY
ML(FK9*G4LW-NRZD?.4$@H+".@>'G!:Y!"$>$,G[O./T^I0L\M/?LG]K:L98E
M,W"MQ!,O;37UASXI8<4VPCZH[6?8U3-P?(42IOTEVPZ;4)\4&V-5O0M&!367
MW9>][OZ'@X!A]$X W0705G>7J%5YPRR;3;3:$NW0R.:,MM0V&L5QZ9KR:#7>
M<HRSLZ_* DG)^=F0QO$5N94O(*W2',PDM,CO4&&QXUIT7/0=KH3<*6DK0S[*
M$LI_XT/4U8NC>W$+>I+PRT9<DB0."(UH>H(OZ8M-6K[D';Y]=6_DAIM"*+/1
M0'[.E\9J?!V_CE7<$:;'"=W$C$W#"ICZ.!(&] OXL_.S.(NN3LA->[GI*?;_
M[,U)KN-*70+O:()#VRL4SJ"Q4!*U(K8"LE("AYG+]=C#%KUY^Q:1>:.Y\)*H
M<[T'ML6W:D%S)@SY0+)@F"5!/,S1'@3Y( H21#WAV%YP>=%H58 Q) XR2H.8
MQFC1X2@8C7+O$Y<<'WE)UDJ5#C+*<X1E9)1EP2C.O&_*,H&T<12D&0U&28K.
M,(BB/*!)3HYU(SR8FAKTNMT-AA1J(VTW0/UIOW[FW=3]A7>[ZX[I-9>&"%AA
M:'29#WRBNWW0.58U[0PNE<6);LT*5RAH!\#[E<)6[!R7H%_*LS]02P,$%
M  @ :X(W6<<#\X>^ @    8  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&ULG51+;]LP#+[[5PCNT)-1.W9B.VD2($GW!+H%[1Z'80?%9F)ALN5)<M+N
MUX^R'"\#TAQVL4F*_/A1%#D]"/E3%0":/)6\4C.WT+J>^+[*"BBINA$U5'BR
M%;*D&E6Y\U4M@>9M4,G], ABOZ2L<N?3UK:6\ZEH-&<5K"5135E2^;P$+@XS
M=^ >#0]L5VAC\.?3FN[@$?27>BU1\WN4G)50*28J(F$[<Q>#R7)H_%N'KPP.
MZD0FII*-$#^-\CZ?N8$A!!PR;1 H_O:P LX-$-+XU6&Z?4H3>"H?T=^TM6,M
M&ZI@)?@WENMBYJ8NR6%+&ZX?Q.$==/6,#%XFN&J_Y&!]D\0E6:.T*+M@9%"R
MRO[I4W</)P%I\$) V 6$+6^;J&5Y1S6=3Z4X$&F\$<T(;:EM-))CE6G*HY9X
MRC!.SS\*#61$KJ_2<#"X)9]T 9*L&BFATF2A%&@U]34F,NY^UH$N+6CX FA$
M[D6E"T5>5SGD_\;[2+!G&1Y9+L.+@!\:?D.B@4?"(!Q>P(OZJJ,6+WH![PZV
M@"7F9"645AY9T9IIRMEOR#VREE!3A@*M\NY"[$60.Z8R+E0C@7Q?;)26^*9^
MG+L>FWUX/KN9LXFJ:08S%P=)@=R#.[^^&L3![87:AGUMPTOH_]O1BZ#G*9M,
MSN5,UNADG9%:(ZLRWN#+F#C8V&?GV%BRJ"7C3A18U>D:0> )5Y "15Z1T(O2
MQ!M'"<H#+PQB+PKBWI%5>\PBY#/&#[UD&)(X"+TT39T5OD?3+<O 4@YO$6*8
M)%XZ&CMO)45^$C)@>[KAT+O$R<@+@L#Y+/"!M Q&X]"+DS'*D3>.0R\81>1<
MW_R3J2Q![MK=HT@FFDK; >VM_7I;V*G^ZVYWXSV5.U8IPF&+H<%-,G*)M/O&
M*EK4[8QOA,:-T8H%KFB0Q@'/MP)[U2DF0;_TYW\ 4$L#!!0    ( &N"-UEA
MLO&XP ,  ,\(   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*56VV[;
M1A!]YU<,&"-( ,:\B+K9D@#92=,4B&$D;?I0]&%%CJ1%EKOR[M*R^O6=75(2
MG<I"T;Z(>YDY<V;GILE6Z>]FC6CAJ1+23,.UM9NK.#;%&BMF+M4&)=TLE:Z8
MI:U>Q6:CD95>J1)QEB2#N&)<AK.)/[O7LXFJK> 2[S68NJJ8WMV@4-MIF(;[
M@R]\M;;N()Y--FR%7]'^MKG7M(L/*"6O4!JN)&A<3L-Y>G63.WDO\(WCUG36
MX#Q9*/7=;3Z5TS!QA%!@81T"H\\CWJ(0#HAH/+28X<&D4^RN]^@_>=_)EP4S
M>*O$[[RTZVDX"J'$):N%_:*V/V/K3]_A%4H8_PO;1K;?"Z&HC555JTP,*BZ;
M+WMJWZ&C,$I>4,A:A<SS;@QYEN^99;.)5EO03IK0W,*[ZK6)')<N*%^MIEM.
M>G9VIRS" %Z_&F5I>@V?I&5RQ1<"86X,6C.)+5EQLG'1(MXTB-D+B#WXK*1=
M&_@@2RR?Z\?$[D QVU.\R<X"_E*+2^BE$61)EI_!ZQU<[GF\W@MX'Y4JMUP(
M8++\I\/PGIM"*%-KA#_F"V,U)<Z?IYZAL9*?MN**Z<IL6('3D*K%H'[$</;Z
M53I(KL_XD!]\R,^A_Z>PG44\S=>9"<Z8Z9P$K#G1*!AQLXH*[J'FAKOB,U"H
M:B/08@F+'=@UPBT=,+F+@,M"U"67*SI6!JFD3*'Y@B2Y!.\GA=Z%:HL4$F9@
MJ02U$G,54&+L@GUBP'RCN0AZ2;,-/FIE3/"-B9K(%D5=U8Y7&<PKI2W_B_F>
M<(>V%?'B\&_%@WNMR!Q:ZF-@L5A+)=1J!Q>01]DHBY(DI?4;6HSS:)RG\):V
M692.AE$R2'X42Z-Q.HP&:=:*]09YU!N-@SLEW[EWHV<#MM*(U SIA0=]4DS@
M3?M]VX0GNW[Q(OA5629@R26W^$Y0%RRAC189RH>>!Y%-^^.6[)%J1X!H$N>&
MYI'DC7:QD:QR<<KI^9WI/:/CR9F[EAZG=M&EN$^H_XOZ0X)&(&G474 _&@Z'
MQT =?;^ 'CFY#]0SL>X+.+'AV+\!=+(AZ&2#?YC3,624R@MT2<^:!*.0J$>D
M:<F?8(=,&Z]MUZ31[".J++-!/\3$[A*>=;%.$!RR5#8XXBYJ"_A(:>L2FJI'
M Z?2X]HQ 3<8X:%FVJ(6.S?@N+F$4QTJ[@R9"O7*CU)7V+6TS;PYG!ZF];P9
M4D?Q9M1_9GK%J2D(7))J<CGLAZ";\=ELK-KXD;50E@:@7Z[I'P=J)T#W2T5]
MH=TX X?_,+._ 5!+ P04    " !K@C=9C%=.F),$   3"@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6RE5EEOXS80?M>O&&B#10(HMBY?.0PX:;+-
MHMFF27?[4/2!EL86$8G4DE2<_/L.*=EQ+O>A@"'SF/GF^CCDR4JJ>UT@&GBL
M2J%/_<*8^JC?UUF!%=,]6:.@G854%3,T5<N^KA6RW"E593\.PV&_8ESXTQ.W
M=J.F)[(Q)1=XHT W5<74TQF6<G7J1_YZX98O"V,7^M.3FBWQ#LWW^D;1K+]!
MR7F%0G,I0.'BU)]%1V>IE7<"/SBN]-88;"1S*>_MY"H_]4/K$):8&8O Z.\!
MS[$L+1"Y\;/#]#<FK>+V>(U^Z6*G6.9,X[DL_^*Y*4[]L0\Y+EA3FENY^A6[
M> 86+Y.E=E]8M;*#H0]9HXVL.F7RH.*B_6>/71ZV%,;A!PIQIQ [OUM#SLM?
MF&'3$R57H*PTH=F!"]5IDW-<V*+<&46[G/3,])LT""/X_&D<1]$Q7/QLN'F"
M:S2%S.%*/* V5 )STC=DS*KTLP[XK 6./P!.X%H*4VBX$#GF+_7[Y.3&TWCM
MZ5F\$_!K4_8@B0*(PSC=@9=L(D\<7O(!WD>A:F BAZ^2"P,_:-XHU/#W;*Z-
M(@K]\UXF6D/I^X;LL3K2-<OPU*=SHU$]H#_]_"D:AL<[PD@W8:2[T/]/ 7<"
MO^^VM>;]MS7X77A4KR>(X[9> 9@"X5Q6-1-/H&69 RM+D O@E'"-6:.XX91H
M+N#[]>P<C 2SDM (MECPDC.#.4%PE1_63)')NE%90:=1:=BWT-:C.#R^V2R[
MA>CXH.?--%@=:\Q*4AF%9JXG!$!]88>?% DJ,DQ4D,0*N'@D<+%$F"T5H@MT
MQ4W1>DP>Z8;1$LFN"IX5+Z$ZU=Q+@W@0!F$80M@+PPC<G+YI. Z2P8A&M.?V
MTUX*,^V1W[-:\1*2\#TG"Y:#7 ERD]6UDH^<6A522 S2(5QRP43&6>EQT79P
MVPIIU/FL. UMK@E0LQ+72>K 79U'QQJP+31W"=$4-M/4^Q0UU!P62E8.;B-M
M^R5$X>$?SI+#YH]0N7[@H>T'E'6!FX#<B;.0]%O(DBX*?>2=-TK9##.MD3BR
M!X,@BH;!9)AXOTFQ/"1/JO5F3 D;)T$R"3=JQ)DY$<>1:D)M@VZI+;WM72K
M9!0D2>S=X@.*AI;B("3?PF3B?5%2$W^47' #@TD<#,.1]XTNR]*N[\%^'(RB
M<1"G(1S GP5ZKS/'MQK+FMP%>T"8(PK@))Q9;L^?7)[:Z+E8'GE7@MQCY19
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M=L_>3:OV1_/VS?S"](9+-_5K<DUZXV$(NGV'VH55M=?^E;+TDOC/DIYNU,Z
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MLV! V? *A>92@,+MS%U$I\O4VK<&WSGN]8LQ6"5K*7_8R?5FYH:6$):8&XO
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M5ZSA^D7L/F-7S[7E2P57[@N[-C88$4@;I479@8V"LJC:E;UU?3@ Q/0$(.@
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M'.<^=8!&M49_\>95/(J.7^ W[/D-7T+_K52\B'28IX7W#L##=8G>F:P;)AZ
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MI#L=*FM _Y>2MO#MAPW0WQ(7?P-02P,$%     @ :X(W62F+2C-K!@  0 X
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M/'Q[GI'OAFNWB*Y) VWI(L9C>JSP/<)>#N!]Z="=^H4XV'WA+/X!4$L#!!0
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M][&7NRG-AC^P6IBR-!E?KI4$M:87\#L=]#<W-$'[R=W9?P!02P,$%     @
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MH+IKNMW$JL8WNHVRV#;]L,)W"K0SP/VMPF;73UR X>5;_0=02P,$%     @
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MW@G67.@EC,($Z/L9UY.\=4R"_5H?_@502P,$%     @ :X(W60M9-QEN @
M7 4  !D   !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL?51M3]LP$/[.K[#,
MA#:)D;>606DCM0RT36,@VFT?IGUPDVMBX<3!OE#X]_-+2#NI]$M\9]_SW',7
MG\=KJ1YT"8#DN1*UGM 2L1D%@<Y*J)@^D0W4YF0E5<70N*H(=*. Y0Y4B2 .
MP].@8KRFZ=CMW:ET+%L4O(8[171;54R]S$#(]81&]'7CGA<EVHT@'3>L@#G@
MS^9.&2_H67)>0:VYK(F"U81.H]%L8.-=P"\.:[UE$UO)4LH'ZWS-)S2T@D!
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M&N#Y4F+OWBVL@_U#/OT/4$L#!!0    ( &N"-UF%]X#?@P,  -,'   9
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;(55VV[;.!!]]U<,U$4W ;36S9:L
MQ#9@I^EN"K0)XK1Y*/:!EL:V$$I422I._KY#RE;2KN-]D7B9.7/FRO%6R >U
M0=3P5/)*39R-UO69YZEL@R53?5%C13<K(4NF:2O7GJHELMPJE=P+?3_V2E94
MSG1LSV[D="P:S8L*;R2HIBR9?)XC%]N)$SC[@]MBO='FP)N.:[;&!>JO]8VD
MG=>AY$6)E2I$!1)7$V<6G,V'1MX*?"MPJUZMP7BR%.+!;*[RB>,;0L@QTP:!
MT>\1+Y!S T0T?NPPG<ZD47R]WJ-_M+Z3+TNF\$+P^R+7FXDS<B#'%6NXOA7;
M?W#GCR68":[L%[:M;)(XD#5*BW*G3 S*HFK_[&D7AU<*(_\-A7"G$%K>K2'+
M\@/3;#J68@O22!.:65A7K3:1*RJ3E(66=%N0GIY^$1HA&,#[=Z,P",[AGDG)
M*JW@Y(XM.:K3L:?)C!'VLAWDO(4,WX",X+.H]$;!995C_JN^1_0ZCN&>XSP\
M"OBIX7V( A="/QP<P8LZGR.+%_V/SWM?#[G8(@P.(YA..5,URW#B4"LHE(_H
M3-^_"V+__ B_0<=O< Q]^KW-^]F".C!O.%ZO]DROE&HPGU7Y1U;(;XPW:+-T
MAT]ZSD7V\.\A5XX:.^S*UUI4/6.,51GVJ+"P)U9P1QP4:[OI2U,N49K3KF*N
MJD(7C/<,-[#D>M>9%B1F$N=#E*9NFH[@#PCCA%9I[Q.K&IH$YCJ .!FZON^;
M:W>4^&X<QW DF,,NF,.CP=P'$8CJ0E.,-H+G*-6?</FC*?0SF&IP7[P0$NQD
M4O#=QA9,<.'MZ!ZU?CBZ+[%;;!B=PKV='9C_Q1Y1TBCL73ZAS J%<".+#*&F
M$%K1_TK>HIF\1;6&"VHZ2=EI&"?.LH23HNH](Y/J%&;KM<2U2>,5"14T4K-=
MAN:,FQP#4R9 LUH6'"+?MEH$@3N,3,Y2B/K1",+^**7TV%$1GO?^-@'#')(H
MWB7.[\=1QSW?"W8*UXU6FE6Y87O WH 2'U(1&'MA?V ^27+ WN^P+P9/!L.!
MF_@C.&VI_&)0 \V1YVZ.D'.D[H9I8"JNG\;T\8>TCD:I.R1'#]6>]VK0EBC7
M]CE1D(FFTNW,[4Z[%VO6#NH7\?:Y^\SDFA(!'%>DZO<3*B39/B'M1HO:CNVE
MT#0,[')#KRY*(T#W*T&%N]L8 ]T[/OT)4$L#!!0    ( &N"-UF.:Y-"3 4
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M!(W5QTL)FEZ[+MJ11W,\$=IA'3J7 >TVXT>UT0X_NAAO0 .V.G1^!MH-C4U
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MUADS0+]?<JZ>&F:"]I9W_C]02P,$%     @ :X(W63/=J/JE @  =0D  !D
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M5, DX0P)6$V<J7\UCTV\#?A.8"L/QL@X67+^8"9?BHGC&4% (5>& >O7!N9
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M+W-H965T-#8N>&ULO9=K;YLP%(;_BL6FJI6V<LFU71(I#;M*6Z-&6S],^^#
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MMA1T#V._PMAO ^-<\(1)R<6C7OJ/ -H8_5B@_6= O5J@+07= SJH@ [: +J
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MK]"P:[O'9J(ATCX3:XN&=H_NZO1G_3%7+52_XW1'K IMQQ\JT>=":W>C7A-
M^Z)@@$9W;1[!<>2%'=4S!/IAX(_C(T-7+PB@?44P0*&M0$->KI<#M8NMEQ/0
MOIX8IO%QW\$Q!-H&!]5NC^QN;U=XU/5M\V*R1V";8.WOR.[O@Q4:=>W[".?3
M@6W.C<_J/D;?7V%+N.:7HA]"PSPP!4:Q81ZXC:V/?-_I$Q9KRB1(R4IG>I>1
MKEH<MG(.)XIOB]V0!5>*9\7AAN E$7F OK_B7#V=Y!LLU8;:[']02P,$%
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ML- %P!#;'>.9ZLOG(=>6S\[O;FG<6-7\6+F>=4+O47WHT38F@"W!^V];*G^
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M@+(;<'TEI=D/K('F"R?Y%U!+ P04    " !K@C=9!NS#IGL#  #-"P  &0
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M-DBS )^O!'XQ]< X:#KXZ%]02P,$%     @ :X(W65IK-UW' @  I0<  !D
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M=LZ1W5G_:>>BP05,'/4K"> ;</)W;_S$>V^+_9_,G@U". Q">,@]_Q-8Q^=
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M0C)>$ '+J7%M7T6VJPWJ$=\9;.16F^A0'CE_TA>WR=2P](P@@UAI"8H_:UA
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M7AR!% W)MOD._".3RF3YY0:P\I:^0;V_8DP^-W2 ZB!J^C]02P,$%     @
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MA?XJ@# !^GW.]<EN)R9!]YU)?@%02P,$%     @ :X(W61V@PTPQ!   :Q$
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MS^@8X..<K")Q2S>_XRZ@IN*;T8CK7]CL;"T#9BLN:+P#2P_B,$G_R>-.B!S
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M;\[Z<8'$1Z8,Y/LYI6+?4 -DWU?Z_P)02P,$%     @ :X(W6=(Z<I0: P
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M%,$"KU)^0S9?H,S'DWPA29GZ1QMMZSD&"E>,DZP$BPBR)-=/_%C6H080/,T
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M Y4&XON"B'NL'$@'57\?_ 502P,$%     @ :X(W61!R-R$I!   .1(  !D
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MAF^ @$QQ&HD'NOJ=% XYRMZ$1CS[#U:%K&F 2<H%C0MEN8(X3/)?_%R V%%
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MI@3D]2FE8G.B)B@_P?3^!5!+ P04    " !K@C=9(5@,%?L#  "P$   &0
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MO3[9!KB;33)5.F>Z3=,E&]=X*%@!<C2?+^!N5!4#:(PJ[2#G=*XD=1HV$<W
MTLZ8$+?P,'TO]KA7Q4[=.E UV0ZMH&;H:;P!_+MLGGN7MO<BWJCB#\I\6MKE
M2&=#J[$;S0J^<O:J: 5@[%V<G5:56'\4?"Y+YA?_[(3C(=W$10NE^2^;#5IE
M9AU,D^B!:<-GNYZ?FE9W;&4V[;0J<,V]5ZCY[^[SG$FFJ=@5;7O_F'?YQ8J3
MRW\EV?U7.10<U-B\(8]=9/\UB$Q?@\A7T9.#XQ>99$>I,6[>WSN'A+TC0NN-
MX"@V(M_@8">V2:/ID@O#96,M>)XS^>BD8.D-G=K#_!Z_G9^S@BZ%N6O!$=F.
MO[*<+\NLG74#&]',VHZ_P/*Z:7L.M+FXS-F*Y9/&U/.I&T9V8+,V%P0<(M?N
M"B-8C,?""&!8'DP!%N.CL#S_TWH&Z'H\AFD;!)$!&C- 8WQ4")FX#Y8G')/9
M*[S2+$N2-,5V=#()*IA@^Y:F\ VS8=H@ LL#F?YLK_%JXQWR=!]@-7VJ0["5
MXIV(K13?:T#"^P8161:N-I8'(K J8+T#^<-YH*?",4D"5<6T84\PCF09AD O
MAGLT39'=2>$3K@_VE"1)EH41P,(*D@1#X&G$$4P!:,"0)''OP8/W4;QY3\7;
M7[C&OP%02P,$%     @ :X(W69>*NQS     $P(   L   !?<F5L<R\N<F5L
M<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\
M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
M+AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*
M(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC
M)8QQ8K3^-8+)#^Q^ %!+ P04    " !K@C=9\92Q?#X&   %,   #P   'AL
M+W=O<FMB;V]K+GAM;,6:6W/3.!2 _XHF+\L^=!-?4QC*3&E@MS- .Z2PCXQB
M*XD&6S*2W%)^_1[)"97;Y,R^2'U*?,T7W;YS)+V^D^K[2LKOY&?;"'TVV1K3
MO9I.=;5E+=5_R8X)N+*6JJ4&#M5FJCO%:*VWC)FVF::S63EM*1>3-Z_W[[I6
M4_] &E89+@6<M">^<G:G'Z[;0W++-5_QAIO[LXG[WK ):;G@+?_%ZK/);$+T
M5M[](Q7_)86AS;)2LFG.)LEPX2M3AE=/3B\MY U=:7?&T-5G"B!GDW(&+UQS
MI8V[P[V? N,M@YN'H][(][PQ3"VH87\KV7=<;.QKX%],O;_ARF'_.13B*_5_
MBE&NU[QB"UGU+1-F*$?%&@LH])9W>D($;=G9Y$+>,F7_#_S 93W\-P-07DFI
M5QPNJ,O:X85$$343FM4$OFG9\!HX:O*6-E14C'B0*0*9/B/DM]2#S!#([%D@
MEQ8''O4@<P0R?T;(44D6"&3QG)"9!UDBD&58R$\P!I*$?",W6T;>]IH+IK6'
M-D?0YA'04D!;]FU+U3V1:[+D&\'A>2J,!WF*0)Y&@,P <@%CM#;<](I94%OE
M\*P'^1*!?!D!,@?(2W$+=X*KF%_'R0P;N&<1V I@NS);ILA%KQ0\0,ZU!GOY
MD*A= NO%09:N  T5&_OK!P@QM22!W>((YT#X[D</P0KYR,Q6UJ["M1FUPP23
M2Q+8+@[S%# A^.H@-+HG5-2.N;-/^IB87I+ ?G&8+W\WR@]2;$YNF&H/5#HF
MF"2P88;!>P:<G_EF:^RX\T7O6R:A/B:FF"2*8ZQD%FQER-6JX9OA+I\0,TT2
M0S6)=<V%;%LI0-*R^N[388I)8C@FR5RO86L& V3]%!#32Q+#+XD5S+]4*7"S
M7[$I9I<TAET2JY?EEH*9WU(;CYW?456/&#&YI#'DDI3DA'RVEUE]<DWMR'@#
M):EIY6.BR4L,PR3S71_AQMZNW? -L8[A/B9FF#2&89)3%S:N-/O1VVCBG0U[
M1A6.V26-89=C@>TH>TDQNZ0Q['(4T\]?4LPN:0R['(O QZ6)*2:-H9A',3AY
M<4.!0O_I0V*F26.8YE@P3E[XF)AOTAB^.1B.NQ+U)U(P^60QY',L)A_/]V#^
MR6+XYUA,/L;$_)/%\,^QF'R,B4Z?1?'/D9A\C(DY*(OAH(,Q^9,NA#DHBY+A
M/ [,#XV;&>:@+$J&XP? !Q$Q_V114IS#D3# ^IB8@;+ !KIL.UJY7J.8WLTY
M0VG"<:?8K1]E9IB!LL &NNBUD2T,0Y44%=RJW"U$<0V-<^%/M^28@?(HZ<^C
MV5T+:"AOM+\LDF,&RH.OWD"MB_L_-%0Z!$<](S77=+-1;&/S(1\3,U >V$#G
MD.;4O.GM<AS1K.H5-S:*8S^KIJ]'E8X9*(]AH*-Q>^YCHDLX@0VTX+JRB2-4
M=TVN(/#8Z>?$]OR^\3$Q ^4Q#'0TO?"SH!PS4![80*.L8M>_???DF'ORP.X9
M(K9JETW07:1^B!)33QY:/0_)!(:(:2</K)WW7%!1<=H0+H876.O -_+EX_F%
M/YX7F':*P-H9) [6%L Y+$!8B7-HH!;4Q\2T4\1(?([F9W[7+C#M%(&U,TK+
MV'ZIY'?C]#$Q[13/N;0S+DU,.T5@[0QC40/9(S$V>WS4U7U,=.] #.T<S79'
MI8EIIPBLG9VWH3 ;!@G%X2&SP-Q3!';/LN^ZQF41CT9-=[<?M!68?(HH:SS'
MI@U&]8T)J @LH*O>P&^+VM9XISBXJ(-B[>C],,+[>UHP 951\I[#LQO00'U,
M3$!E8 %Y ;JV2;G+<ZMAH@/R2Q\3$U 99>7GZ23,TR&SQ 141IEY.[!,.I#Z
MF)B RL "\BK];C]9Q+6V69 5IH^)":@,O7MM"\$PLT'; Z9\Z/T^)KI][1EF
MWO;3&Y^HOSNUQ"Q4!K80C.-]VPTC4&\GWB 2KFA3]=9!9.UC8A8J UO(:YMN
MU[&-BGM10P "40BY]C$Q"Y6!+>1AVEE"Q2N[L5*[O@[<_O9%S$+SP!8:!A\8
MS^$=>@@ZV$_[G9'5_:C2YYB%YE'V'QR;&5[XF)B%YLY"4W>S?O.Z9FLN6/T)
M?D+#>=O8KY5K\\->N;RP6U;6?=-<P+DK\4'2>K^+?;\#_\U_4$L#!!0    (
M &N"-UFL;5!7/ (  *\J   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'/-VLUJHU 8QO%;"5Y S7F_;(>FJ]ET6WH#DIY\T"2*QZ'MW4](%\DCLYA-
M\5G)47S]@_!#U,>7?&C'?7<JNWU?%I_'PZFLJMTX]K_JNJQW^=B6NZ[/I_.1
M33<<V_&\'+9UWZ[?VVVN9;F,>KB=43T]WLY<O'[U^7\F=IO-?IU_=^L_QWP:
M_S&X_NB&][++>:P6K^VPS>.JJC\/U]VEOFS2W7ERM7A^6U7#\UNJZKF#!()D
M_B"%()T_R"#(Y@]R"/+Y@P*"8OZ@!H*:^8/N(>A^_J '"'J8/R@M4<8E0=($
M:P*M$W*="+Q."'8B$#LAV8G [(1H)P*U$[*="-Q."'<BD#LAW8G [H1X)P*]
M!?46 KT%]18"O67RL$V@MZ#>0J"WH-Y"H+>@WD*@MZ#>0J"WH-Y"H+>@WD*@
MMZ#>0J"WHMY*H+>BWDJ@MZ+>2J"W3EZ6$.BMJ+<2Z*VHMQ+HK:BW$NBMJ+<2
MZ*VHMQ+HK:BW$NAMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z&V3E]T$>AOJ;01Z&^IM
M!'H;ZFT$>AOJ;01Z&^IM!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z^^1C
M)8'>CGH[@=Z.>CN!WHYZ.X'>CGH[@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z
M!X'>@7H'@=XQ^=F$0.] O8- [T"]@T#O0+V#0.\&]6X(]&Y0[X9 [P;U;GY2
M[S)^'7*Y]GRO\?H_2?5X/C=?+W]9?N^<W)<+SO5M17GZ"U!+ P04    " !K
M@C=90&L7N@ "  #&*0  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VDU.PS 0
M!>"K5-FBQO5O 5$VP!98< &33-NH26S9!LKM<5)  D$%*A)OTZBU/6_BD;Y5
MS^Z>/<7)MFO[N"C6*?E3QF*UIL[&TGGJ\\K2A<ZF_#6LF+?5QJZ(B=G,L,KU
MB?HT34.-XOSLDI;VH4V3JVW^.3:N7Q2!VEA,+G8;AZQ%8;UOF\JFO,X>^_I3
MRO0UH<PGQSUQW?AXE#<4[,N$8>7[@-=S-X\40E/3Y-:&=&V[O(MM6Q;3<TNQ
MW%_BBQ[=<ME45+OJH<M'RN@#V3JNB5+7EKNB1_N34[YAVGWR@_/',OL"\\[;
MX'S,$POT^[BWD0RGISX7HI":_:_XGIA+'_Q^-$R[IOJ'V?EZGUS8C/.(;'P<
M?L<?9_Q>_Y=]") ^)$@?"J0/#=*' >EC#M+',4@?)R!]\!E*(RBB<A12.8JI
M' 55CJ(J1V&5H[C*46#E*+(*%%D%BJP"15:!(JM D56@R"I09!4HL@H4606*
MK!)%5HDBJT215:+(*E%DE2BR2A19)8JL$D56B2*K0I%5H<BJ4&15*+(J%%D5
MBJP*15:%(JM"D56AR*I19-4HLFH4636*K!I%5HTBJT:15:/(JE%DU2BR&A19
M#8JL!D56@R*K09'5H,AJ4&0U*+(:%%D-BJQS%%GG*++._U/6>^<V?QP_/LO.
M-OU;/AO_OGG^ E!+ 0(4 Q0    ( &N"-UD'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ :X(W610:
M%<GO    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ :X(W69E<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !K@C=9M_]3IQD&  "W
M(   &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ :X(W66>X -R-!@  BQH  !@              ("!70X
M 'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( &N"-UGR%5CA
MC0(  &L'   8              " @2 5  !X;"]W;W)K<VAE971S+W-H965T
M,RYX;6Q02P$"% ,4    " !K@C=9,\EG?ST&  "#&@  &
M@('C%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ :X(W
M65_VL1:*!P  22\  !@              ("!5AX  'AL+W=O<FMS:&5E=',O
M<VAE970U+GAM;%!+ 0(4 Q0    ( &N"-UF^6#$X;P@  $ I   8
M      " @18F  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M" !K@C=9\Q(A)IL&  "+#@  &               @(&[+@  >&PO=V]R:W-H
M965T<R]S:&5E=#<N>&UL4$L! A0#%     @ :X(W61&9X^LR#0  SA\  !@
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M970Q,BYX;6Q02P$"% ,4    " !K@C=9C%=.F),$   3"@  &0
M    @(&75   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (
M &N"-UE![**G0 ,   4'   9              " @6%9  !X;"]W;W)K<VAE
M971S+W-H965T,30N>&UL4$L! A0#%     @ :X(W6:$Z9L[' @  4P8  !D
M             ("!V%P  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"
M% ,4    " !K@C=93+6!]ZP#   8"   &0              @('67P  >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( &N"-UF@N6("M@,
M .$'   9              " @;EC  !X;"]W;W)K<VAE971S+W-H965T,3<N
M>&UL4$L! A0#%     @ :X(W64>1X,1'!@  _PX  !D              ("!
MIF<  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !K@C=9
MO"K P4("   =!0  &0              @($D;@  >&PO=V]R:W-H965T<R]S
M:&5E=#$Y+GAM;%!+ 0(4 Q0    ( &N"-UE/G(?Y4@0  #$*   9
M      " @9UP  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%
M  @ :X(W62F+2C-K!@  0 X  !D              ("!)G4  'AL+W=O<FMS
M:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !K@C=9TJ>@(9X"  #:!0
M&0              @('(>P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+
M 0(4 Q0    ( &N"-UE<H52-&P0  .T(   9              " @9U^  !X
M;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ :X(W6<XT2/-9
M"   JA0  !D              ("![X(  'AL+W=O<FMS:&5E=',O<VAE970R
M-"YX;6Q02P$"% ,4    " !K@C=9OAO;%SP.  !^)P  &0
M@(%_BP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( &N"
M-UGF%D'XX00  '0+   9              " @?*9  !X;"]W;W)K<VAE971S
M+W-H965T,C8N>&UL4$L! A0#%     @ :X(W6:@KV?U. P  !0<  !D
M         ("!"I\  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
M    " !K@C=9?&6UW*,"  !]!0  &0              @(&/H@  >&PO=V]R
M:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( &N"-UD%B;<2QP(  -8%
M   9              " @6FE  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL
M4$L! A0#%     @ :X(W6= ]_]4Y P  A@<  !D              ("!9Z@
M 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " !K@C=9)#,%
M:TP#  !I!P  &0              @('7JP  >&PO=V]R:W-H965T<R]S:&5E
M=#,Q+GAM;%!+ 0(4 Q0    ( &N"-UEEFU[SQ (  .(%   9
M  " @5JO  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @
M:X(W60M9-QEN @  7 4  !D              ("!5;(  'AL+W=O<FMS:&5E
M=',O<VAE970S,RYX;6Q02P$"% ,4    " !K@C=94G,$E@4#  #+!@  &0
M            @('ZM   >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4
M Q0    ( &N"-UD 5%GX7P(  !D%   9              " @3:X  !X;"]W
M;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ :X(W6?[T5>)K P
MU <  !D              ("!S+H  'AL+W=O<FMS:&5E=',O<VAE970S-BYX
M;6Q02P$"% ,4    " !K@C=9A?> WX,#  #3!P  &0              @(%N
MO@  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( &N"-UF.
M:Y-"3 4  ,\,   9              " @2C"  !X;"]W;W)K<VAE971S+W-H
M965T,S@N>&UL4$L! A0#%     @ :X(W65H3+K1Q!   \14  !D
M     ("!J\<  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
M" !K@C=9,]VH^J4"  !U"0  &0              @(%3S   >&PO=V]R:W-H
M965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( &N"-UF[,60KI@0  &PC   9
M              " @2_/  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L!
M A0#%     @ :X(W62_(S5ZF @  Z@8  !D              ("!#-0  'AL
M+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !K@C=9]?*Q$P<#
M  !7"   &0              @('IU@  >&PO=V]R:W-H965T<R]S:&5E=#0S
M+GAM;%!+ 0(4 Q0    ( &N"-UGV84>(Q 4  / 9   9              "
M@2?:  !X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ :X(W
M63FBA@< !   7A   !D              ("!(N   'AL+W=O<FMS:&5E=',O
M<VAE970T-2YX;6Q02P$"% ,4    " !K@C=9L4<40WL#  "E#0  &0
M        @(%9Y   >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0
M   ( &N"-UF2/#Z2B (  ,,&   9              " @0OH  !X;"]W;W)K
M<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ :X(W6?TT\!K) @  N <
M !D              ("!RNH  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q0
M2P$"% ,4    " !K@C=946ZO8@4$  !<$P  &0              @('*[0
M>&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( &N"-UGH_?(6
M?P0  (87   9              " @0;R  !X;"]W;W)K<VAE971S+W-H965T
M-3 N>&UL4$L! A0#%     @ :X(W6;B]J EM P  [0P  !D
M ("!O/8  'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " !K
M@C=9!NS#IGL#  #-"P  &0              @(%@^@  >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( &N"-UE::S==QP(  *4'   9
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M970U-RYX;6Q02P$"% ,4    " !K@C=9\S[]@)("   1!@  &0
M    @(&,"P$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    (
M &N"-UG-$?)Q;@(  +<%   9              " @54. 0!X;"]W;W)K<VAE
M971S+W-H965T-3DN>&UL4$L! A0#%     @ :X(W6=$^9.41 @  1P4  !D
M             ("!^A ! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"
M% ,4    " !K@C=9!:KZRP<'  #%2   &0              @(%"$P$ >&PO
M=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( &N"-UG0#Q09200
M #\1   9              " @8 : 0!X;"]W;W)K<VAE971S+W-H965T-C(N
M>&UL4$L! A0#%     @ :X(W65/LIBV+!   E!H  !D              ("!
M !\! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " !K@C=9
MCS%?^* #  #_$   &0              @('"(P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8T+GAM;%!+ 0(4 Q0    ( &N"-UE;@@-<D0(  ',&   9
M      " @9DG 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%
M  @ :X(W61V@PTPQ!   :Q$  !D              ("!82H! 'AL+W=O<FMS
M:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " !K@C=9TCIRE!H#  #K"P
M&0              @(')+@$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+
M 0(4 Q0    ( &N"-UD0<C<A*00  #D2   9              " @1HR 0!X
M;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ :X(W6?J-Z%<3
M!0  CAD  !D              ("!>C8! 'AL+W=O<FMS:&5E=',O<VAE970V
M.2YX;6Q02P$"% ,4    " !K@C=9(5@,%?L#  "P$   &0
M@('$.P$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( &N"
M-UE0DL>+Y (  *P'   9              " @?8_ 0!X;"]W;W)K<VAE971S
M+W-H965T-S$N>&UL4$L! A0#%     @ :X(W65#=Z7DG P  M0@  !D
M         ("!$4,! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4
M    " !K@C=9 @.:@2\#  #N$@  #0              @ %O1@$ >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( &N"-UF7BKL<P    !,"   +
M  "  <E) 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( &N"-UGQE+%\/@8   4P
M   /              "  ;)* 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !K@C=9K&U05SP"  "O*@  &@              @ $=40$ >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !K@C=90&L7N@ "  #&*0
M$P              @ &14P$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..4 !0 .<5  #"50$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>119</ContextCount>
  <ElementCount>329</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Note 1 ??? The Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note1Business</Role>
      <ShortName>Note 1 ??? The Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Note 3 ??? Divestiture of Consumer Segment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegment</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Note 4 ??? Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note4Inventories</Role>
      <ShortName>Note 4 ??? Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Note 5 ??? Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note5OtherCurrentAssets</Role>
      <ShortName>Note 5 ??? Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note 6 ??? Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note6IntangibleAssets</Role>
      <ShortName>Note 6 ??? Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Note 7 ??? Equity Method Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note7EquityMethodInvestment</Role>
      <ShortName>Note 7 ??? Equity Method Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Note 8 ??? Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8PropertyAndEquipment</Role>
      <ShortName>Note 8 ??? Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note 9 ??? Other Long-Term Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note9OtherLong-termAssets</Role>
      <ShortName>Note 9 ??? Other Long-Term Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Note 10 ??? Right of Use Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10RightOfUseAssetsAndLiabilities</Role>
      <ShortName>Note 10 ??? Right of Use Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Note 11 ??? Debt Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11DebtObligations</Role>
      <ShortName>Note 11 ??? Debt Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Note 12 ??? Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note12CommonStock</Role>
      <ShortName>Note 12 ??? Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Note 13 ??? Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note13PreferredStock</Role>
      <ShortName>Note 13 ??? Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Note 14 ??? Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note14Warrants</Role>
      <ShortName>Note 14 ??? Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Note 15 ??? Share Based Awards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note15ShareBasedAwards</Role>
      <ShortName>Note 15 ??? Share Based Awards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Note 16 - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note16-Related-partyTransactions</Role>
      <ShortName>Note 16 - Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Note 17 ??? Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note17CommitmentsAndContingencies</Role>
      <ShortName>Note 17 ??? Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Note 18 ??? Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note18SubsequentEvents</Role>
      <ShortName>Note 18 ??? Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Note 3 ??? Divestiture of Consumer Segment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegmentTables</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note3DivestitureOfConsumerSegment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Note 4 ??? Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note4InventoriesTables</Role>
      <ShortName>Note 4 ??? Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note4Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Note 5 ??? Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note5OtherCurrentAssetsTables</Role>
      <ShortName>Note 5 ??? Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note5OtherCurrentAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Note 6 ??? Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note6IntangibleAssetsTables</Role>
      <ShortName>Note 6 ??? Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note6IntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Note 7 ??? Equity Method Investment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note7EquityMethodInvestmentTables</Role>
      <ShortName>Note 7 ??? Equity Method Investment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note7EquityMethodInvestment</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Note 8 ??? Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8PropertyAndEquipmentTables</Role>
      <ShortName>Note 8 ??? Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note8PropertyAndEquipment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Note 9 ??? Other Long-Term Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note9OtherLong-termAssetsTables</Role>
      <ShortName>Note 9 ??? Other Long-Term Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note9OtherLong-termAssets</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Note 10 ??? Right of Use Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables</Role>
      <ShortName>Note 10 ??? Right of Use Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note10RightOfUseAssetsAndLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Note 11 ??? Debt Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11DebtObligationsTables</Role>
      <ShortName>Note 11 ??? Debt Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note11DebtObligations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Note 12 ??? Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note12CommonStockTables</Role>
      <ShortName>Note 12 ??? Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note12CommonStock</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Note 14 ??? Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note14WarrantsTables</Role>
      <ShortName>Note 14 ??? Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note14Warrants</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Note 15 ??? Share Based Awards (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note15ShareBasedAwardsTables</Role>
      <ShortName>Note 15 ??? Share Based Awards (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://RCAT/role/Note15ShareBasedAwards</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails</Role>
      <ShortName>Impact of restatements of previously issued consolidated financial statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Customer concentration risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/CustomerConcentrationRiskDetails</Role>
      <ShortName>Customer concentration risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Note 1 ??? The Business (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note1BusinessDetailsNarrative</Role>
      <ShortName>Note 1 ??? The Business (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note1Business</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Company's revenue disaggregated by revenue type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails</Role>
      <ShortName>Company's revenue disaggregated by revenue type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Antidilutive securities excluded from computation of diluted net loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Note 2 ??? Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Note 2 ??? Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Discontinued Operations - results of operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails</Role>
      <ShortName>Discontinued Operations - results of operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Note 3 ??? Divestiture of Consumer Segment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative</Role>
      <ShortName>Note 3 ??? Divestiture of Consumer Segment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note3DivestitureOfConsumerSegmentTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OtherCurrentAssetsDetails</Role>
      <ShortName>Other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails</Role>
      <ShortName>Financial information for UMAC derived from their Form 10-Q (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Impacts on investments into UMAC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails</Role>
      <ShortName>Impacts on investments into UMAC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Note 7 ??? Equity Method Investment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative</Role>
      <ShortName>Note 7 ??? Equity Method Investment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note7EquityMethodInvestmentTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Note 8 ??? Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Note 8 ??? Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note8PropertyAndEquipmentTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Other long term assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OtherLongTermAssetsDetails</Role>
      <ShortName>Other long term assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Note 9 ??? Other Long-Term Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative</Role>
      <ShortName>Note 9 ??? Other Long-Term Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note9OtherLong-termAssetsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Operating leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OperatingLeasesDetails</Role>
      <ShortName>Operating leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Supplemental information related to operating leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails</Role>
      <ShortName>Supplemental information related to operating leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Note 10 ??? Right of Use Assets and Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative</Role>
      <ShortName>Note 10 ??? Right of Use Assets and Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Outstanding principal payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/OutstandingPrincipalPaymentsDetails</Role>
      <ShortName>Outstanding principal payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Note 11 ??? Debt Obligations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note11DebtObligationsDetailsNarrative</Role>
      <ShortName>Note 11 ??? Debt Obligations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note11DebtObligationsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Summary of shares of common stock issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails</Role>
      <ShortName>Summary of shares of common stock issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Note 12 ??? Common Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note12CommonStockDetailsNarrative</Role>
      <ShortName>Note 12 ??? Common Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note12CommonStockTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Note 13 ??? Preferred Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note13PreferredStockDetailsNarrative</Role>
      <ShortName>Note 13 ??? Preferred Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note13PreferredStock</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Summary of warrants issued and fair values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails</Role>
      <ShortName>Summary of warrants issued and fair values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Changes in warrants outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/ChangesInWarrantsOutstandingDetails</Role>
      <ShortName>Changes in warrants outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Note 14 ??? Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note14WarrantsDetailsNarrative</Role>
      <ShortName>Note 14 ??? Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note14WarrantsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails</Role>
      <ShortName>Assumptions used to calculate fair value of options granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Summary of activity under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfActivityUnderPlanDetails</Role>
      <ShortName>Summary of activity under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails</Role>
      <ShortName>Summary of restricted stock activity under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Stock compensation expense by functional category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails</Role>
      <ShortName>Stock compensation expense by functional category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="rcat0923form10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Note 15 ??? Share Based Awards (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative</Role>
      <ShortName>Note 15 ??? Share Based Awards (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://RCAT/role/Note15ShareBasedAwardsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>rcat-20240731.xsd</File>
    <File>rcat-20240731_cal.xml</File>
    <File>rcat-20240731_def.xml</File>
    <File>rcat-20240731_lab.xml</File>
    <File>rcat-20240731_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="rcat0923form10q.htm">rcat0923form10q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="519">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rcat0923form10q.htm": {
   "nsprefix": "RCAT",
   "nsuri": "http://RCAT/20240731",
   "dts": {
    "schema": {
     "local": [
      "rcat-20240731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rcat-20240731_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rcat-20240731_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rcat-20240731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rcat-20240731_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "rcat0923form10q.htm"
     ]
    }
   },
   "keyStandard": 232,
   "keyCustom": 97,
   "axisStandard": 9,
   "axisCustom": 4,
   "memberStandard": 7,
   "memberCustom": 24,
   "hidden": {
    "total": 112,
    "http://fasb.org/us-gaap/2023": 87,
    "http://RCAT/20240731": 18,
    "http://xbrl.sec.gov/dei/2023": 7
   },
   "contextCount": 119,
   "entityCount": 1,
   "segmentCount": 31,
   "elementCount": 472,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 519,
    "http://xbrl.sec.gov/dei/2023": 31
   },
   "report": {
    "R1": {
     "role": "http://RCAT/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://RCAT/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://RCAT/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://RCAT/role/StatementsOfShareholdersEquity",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30_custom_SeriesBPreferredStock1Member",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30_custom_SeriesBPreferredStock1Member",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://RCAT/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012023-07-31",
      "name": "RCAT:IncomeLossFromDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://RCAT/role/Note1Business",
     "longName": "00000007 - Disclosure - Note 1 \u2013 The Business",
     "shortName": "Note 1 \u2013 The Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies",
     "longName": "00000008 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegment",
     "longName": "00000009 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://RCAT/role/Note4Inventories",
     "longName": "00000010 - Disclosure - Note 4 \u2013 Inventories",
     "shortName": "Note 4 \u2013 Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://RCAT/role/Note5OtherCurrentAssets",
     "longName": "00000011 - Disclosure - Note 5 \u2013 Other Current Assets",
     "shortName": "Note 5 \u2013 Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://RCAT/role/Note6IntangibleAssets",
     "longName": "00000012 - Disclosure - Note 6 \u2013 Intangible Assets",
     "shortName": "Note 6 \u2013 Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://RCAT/role/Note7EquityMethodInvestment",
     "longName": "00000013 - Disclosure - Note 7 \u2013 Equity Method Investment",
     "shortName": "Note 7 \u2013 Equity Method Investment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://RCAT/role/Note8PropertyAndEquipment",
     "longName": "00000014 - Disclosure - Note 8 \u2013 Property and Equipment",
     "shortName": "Note 8 \u2013 Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://RCAT/role/Note9OtherLong-termAssets",
     "longName": "00000015 - Disclosure - Note 9 \u2013 Other Long-Term Assets",
     "shortName": "Note 9 \u2013 Other Long-Term Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:OtherLongTermAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:OtherLongTermAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://RCAT/role/Note10RightOfUseAssetsAndLiabilities",
     "longName": "00000016 - Disclosure - Note 10 \u2013 Right of Use Assets and Liabilities",
     "shortName": "Note 10 \u2013 Right of Use Assets and Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://RCAT/role/Note11DebtObligations",
     "longName": "00000017 - Disclosure - Note 11 \u2013 Debt Obligations",
     "shortName": "Note 11 \u2013 Debt Obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://RCAT/role/Note12CommonStock",
     "longName": "00000018 - Disclosure - Note 12 \u2013 Common Stock",
     "shortName": "Note 12 \u2013 Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://RCAT/role/Note13PreferredStock",
     "longName": "00000019 - Disclosure - Note 13 \u2013 Preferred Stock",
     "shortName": "Note 13 \u2013 Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://RCAT/role/Note14Warrants",
     "longName": "00000020 - Disclosure - Note 14 \u2013 Warrants",
     "shortName": "Note 14 \u2013 Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://RCAT/role/Note15ShareBasedAwards",
     "longName": "00000021 - Disclosure - Note 15 \u2013 Share Based Awards",
     "shortName": "Note 15 \u2013 Share Based Awards",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://RCAT/role/Note16-Related-partyTransactions",
     "longName": "00000022 - Disclosure - Note 16 - Related-Party Transactions",
     "shortName": "Note 16 - Related-Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://RCAT/role/Note17CommitmentsAndContingencies",
     "longName": "00000023 - Disclosure - Note 17 \u2013 Commitments and Contingencies",
     "shortName": "Note 17 \u2013 Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://RCAT/role/Note18SubsequentEvents",
     "longName": "00000024 - Disclosure - Note 18 \u2013 Subsequent Events",
     "shortName": "Note 18 \u2013 Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000025 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Policies)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000026 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Tables)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegmentTables",
     "longName": "00000027 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment (Tables)",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://RCAT/role/Note4InventoriesTables",
     "longName": "00000028 - Disclosure - Note 4 \u2013 Inventories (Tables)",
     "shortName": "Note 4 \u2013 Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://RCAT/role/Note5OtherCurrentAssetsTables",
     "longName": "00000029 - Disclosure - Note 5 \u2013 Other Current Assets (Tables)",
     "shortName": "Note 5 \u2013 Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://RCAT/role/Note6IntangibleAssetsTables",
     "longName": "00000030 - Disclosure - Note 6 \u2013 Intangible Assets (Tables)",
     "shortName": "Note 6 \u2013 Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://RCAT/role/Note7EquityMethodInvestmentTables",
     "longName": "00000031 - Disclosure - Note 7 \u2013 Equity Method Investment (Tables)",
     "shortName": "Note 7 \u2013 Equity Method Investment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://RCAT/role/Note8PropertyAndEquipmentTables",
     "longName": "00000032 - Disclosure - Note 8 \u2013 Property and Equipment (Tables)",
     "shortName": "Note 8 \u2013 Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://RCAT/role/Note9OtherLong-termAssetsTables",
     "longName": "00000033 - Disclosure - Note 9 \u2013 Other Long-Term Assets (Tables)",
     "shortName": "Note 9 \u2013 Other Long-Term Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables",
     "longName": "00000034 - Disclosure - Note 10 \u2013 Right of Use Assets and Liabilities (Tables)",
     "shortName": "Note 10 \u2013 Right of Use Assets and Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfRentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfRentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://RCAT/role/Note11DebtObligationsTables",
     "longName": "00000035 - Disclosure - Note 11 \u2013 Debt Obligations (Tables)",
     "shortName": "Note 11 \u2013 Debt Obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://RCAT/role/Note12CommonStockTables",
     "longName": "00000036 - Disclosure - Note 12 \u2013 Common Stock (Tables)",
     "shortName": "Note 12 \u2013 Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://RCAT/role/Note14WarrantsTables",
     "longName": "00000037 - Disclosure - Note 14 \u2013 Warrants (Tables)",
     "shortName": "Note 14 \u2013 Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://RCAT/role/Note15ShareBasedAwardsTables",
     "longName": "00000038 - Disclosure - Note 15 \u2013 Share Based Awards (Tables)",
     "shortName": "Note 15 \u2013 Share Based Awards (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
     "longName": "00000039 - Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)",
     "shortName": "Impact of restatements of previously issued consolidated financial statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember",
      "name": "us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
       "RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://RCAT/role/CustomerConcentrationRiskDetails",
     "longName": "00000040 - Disclosure - Customer concentration risk (Details)",
     "shortName": "Customer concentration risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://RCAT/role/Note1BusinessDetailsNarrative",
     "longName": "00000041 - Disclosure - Note 1 \u2013 The Business (Details Narrative)",
     "shortName": "Note 1 \u2013 The Business (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-12-012023-12-31",
      "name": "RCAT:FirmCommitmentUnderwrittenPublicOfferingShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2019-05-012020-04-30_custom_BusinessAcquisition1Member",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails",
     "longName": "00000042 - Disclosure - Company's revenue disaggregated by revenue type (Details)",
     "shortName": "Company's revenue disaggregated by revenue type (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
     "longName": "00000043 - Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)",
     "shortName": "Antidilutive securities excluded from computation of diluted net loss per share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000044 - Disclosure - Note 2 \u2013 Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Note 2 \u2013 Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-05-012024-04-30",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails",
     "longName": "00000045 - Disclosure - Discontinued Operations - results of operations (Details)",
     "shortName": "Discontinued Operations - results of operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-05-012023-07-31",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012023-07-31",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative",
     "longName": "00000046 - Disclosure - Note 3 \u2013 Divestiture of Consumer Segment (Details Narrative)",
     "shortName": "Note 3 \u2013 Divestiture of Consumer Segment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-05-012024-04-30",
      "name": "us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012024-04-30",
      "name": "us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://RCAT/role/InventoriesDetails",
     "longName": "00000047 - Disclosure - Inventories (Details)",
     "shortName": "Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://RCAT/role/OtherCurrentAssetsDetails",
     "longName": "00000048 - Disclosure - Other current assets (Details)",
     "shortName": "Other current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://RCAT/role/IntangibleAssetsDetails",
     "longName": "00000049 - Disclosure - Intangible assets (Details)",
     "shortName": "Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember",
      "name": "RCAT:FiniteLivedProprietaryTechnologyGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember",
      "name": "RCAT:FiniteLivedProprietaryTechnologyGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
     "longName": "00000050 - Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)",
     "shortName": "Financial information for UMAC derived from their Form 10-Q (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails",
     "longName": "00000051 - Disclosure - Impacts on investments into UMAC (Details)",
     "shortName": "Impacts on investments into UMAC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative",
     "longName": "00000052 - Disclosure - Note 7 \u2013 Equity Method Investment (Details Narrative)",
     "shortName": "Note 7 \u2013 Equity Method Investment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ExchangeAgreementSharesExchanged",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ExchangeAgreementSharesExchanged",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://RCAT/role/PropertyAndEquipmentDetails",
     "longName": "00000053 - Disclosure - Property and equipment (Details)",
     "shortName": "Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative",
     "longName": "00000054 - Disclosure - Note 8 \u2013 Property and Equipment (Details Narrative)",
     "shortName": "Note 8 \u2013 Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R55": {
     "role": "http://RCAT/role/OtherLongTermAssetsDetails",
     "longName": "00000055 - Disclosure - Other long term assets (Details)",
     "shortName": "Other long term assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "RCAT:SAFEAgreementAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "RCAT:SAFEAgreementAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative",
     "longName": "00000056 - Disclosure - Note 9 \u2013 Other Long-Term Assets (Details Narrative)",
     "shortName": "Note 9 \u2013 Other Long-Term Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2022-11-012022-11-30",
      "name": "RCAT:PaymentForSAFEAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-11-012022-11-30",
      "name": "RCAT:PaymentForSAFEAgreement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:OtherLongTermAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://RCAT/role/OperatingLeasesDetails",
     "longName": "00000057 - Disclosure - Operating leases (Details)",
     "shortName": "Operating leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-012024-07-31_custom_OperatingLeaseLocation1Member",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRentExpenseTableTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails",
     "longName": "00000058 - Disclosure - Supplemental information related to operating leases (Details)",
     "shortName": "Supplemental information related to operating leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:OperatingCashPaidToSettleLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:OperatingCashPaidToSettleLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative",
     "longName": "00000059 - Disclosure - Note 10 \u2013 Right of Use Assets and Liabilities (Details Narrative)",
     "shortName": "Note 10 \u2013 Right of Use Assets and Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R60": {
     "role": "http://RCAT/role/OutstandingPrincipalPaymentsDetails",
     "longName": "00000060 - Disclosure - Outstanding principal payments (Details)",
     "shortName": "Outstanding principal payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "RCAT:OutstandingPrincipalPaymentsDueYearOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "RCAT:OutstandingPrincipalPaymentsDueYearOne",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfDebtPaymentsDueTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://RCAT/role/Note11DebtObligationsDetailsNarrative",
     "longName": "00000061 - Disclosure - Note 11 \u2013 Debt Obligations (Details Narrative)",
     "shortName": "Note 11 \u2013 Debt Obligations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails",
     "longName": "00000062 - Disclosure - Summary of shares of common stock issued (Details)",
     "shortName": "Summary of shares of common stock issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-30_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-012024-07-31_us-gaap_CommonStockMember",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://RCAT/role/Note12CommonStockDetailsNarrative",
     "longName": "00000063 - Disclosure - Note 12 \u2013 Common Stock (Details Narrative)",
     "shortName": "Note 12 \u2013 Common Stock (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://RCAT/role/Note13PreferredStockDetailsNarrative",
     "longName": "00000064 - Disclosure - Note 13 \u2013 Preferred Stock (Details Narrative)",
     "shortName": "Note 13 \u2013 Preferred Stock (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails",
     "longName": "00000065 - Disclosure - Summary of warrants issued and fair values (Details)",
     "shortName": "Summary of warrants issued and fair values (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2021-01-012021-01-31",
      "name": "RCAT:NumberOfWarrantsUponIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-01-012021-01-31",
      "name": "RCAT:NumberOfWarrantsUponIssuance",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
     "longName": "00000066 - Disclosure - Changes in warrants outstanding (Details)",
     "shortName": "Changes in warrants outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31_custom_WarrantsOutstanding1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31_custom_WarrantsOutstanding1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://RCAT/role/Note14WarrantsDetailsNarrative",
     "longName": "00000067 - Disclosure - Note 14 \u2013 Warrants (Details Narrative)",
     "shortName": "Note 14 \u2013 Warrants (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2023-12-012023-12-31",
      "name": "RCAT:WarrantsIssuedExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-012023-12-31",
      "name": "RCAT:WarrantsIssuedExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "RCAT:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
     "longName": "00000068 - Disclosure - Assumptions used to calculate fair value of options granted (Details)",
     "shortName": "Assumptions used to calculate fair value of options granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "RCAT:ScheduleOfAssumptionsUsed1TableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://RCAT/role/SummaryOfActivityUnderPlanDetails",
     "longName": "00000069 - Disclosure - Summary of activity under the Plan (Details)",
     "shortName": "Summary of activity under the Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31_custom_Options1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31_custom_Options1Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails",
     "longName": "00000070 - Disclosure - Summary of restricted stock activity under the Plan (Details)",
     "shortName": "Summary of restricted stock activity under the Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-31_us-gaap_RestrictedStockMember",
      "name": "RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-31_us-gaap_RestrictedStockMember",
      "name": "RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails",
     "longName": "00000071 - Disclosure - Stock compensation expense by functional category (Details)",
     "shortName": "Stock compensation expense by functional category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ResearchAndDevelopmentStockCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:ResearchAndDevelopmentStockCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative",
     "longName": "00000072 - Disclosure - Note 15 \u2013 Share Based Awards (Details Narrative)",
     "shortName": "Note 15 \u2013 Share Based Awards (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-05-01to2024-07-31",
      "name": "RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rcat0923form10q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "RCAT_ATMFacilityAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ATMFacilityAggregateOfferingPrice",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ATMFacilityAggregateOfferingPrice]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r538"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "verboseLabel": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r191",
      "r422"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income (loss)",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r127",
      "r198",
      "r419",
      "r432",
      "r433"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14",
      "r35",
      "r377",
      "r380",
      "r399",
      "r428",
      "r429",
      "r584",
      "r585",
      "r586",
      "r596",
      "r597",
      "r598"
     ]
    },
    "us-gaap_AdditionalCashFlowElementsFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalCashFlowElementsFinancingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "periodEndLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r538",
      "r628"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r443",
      "r596",
      "r597",
      "r598",
      "r619",
      "r630"
     ]
    },
    "RCAT_AdditionalSharesPurchaseOptionOverAllotmentCover": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "AdditionalSharesPurchaseOptionOverAllotmentCover",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AdditionalSharesPurchaseOptionOverAllotmentCover]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash from operations:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of intangible assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r53",
      "r55"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock, as converted"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount",
     "presentation": [
      "http://RCAT/role/AntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r194",
      "r219",
      "r243",
      "r251",
      "r255",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r372",
      "r374",
      "r385",
      "r415",
      "r476",
      "r538",
      "r548",
      "r610",
      "r611",
      "r622"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total current assets",
        "periodEndLabel": "Current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r202",
      "r219",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r372",
      "r374",
      "r385",
      "r538",
      "r610",
      "r611",
      "r622"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long-term assets",
        "periodEndLabel": "Long-term assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r372",
      "r374",
      "r385",
      "r610",
      "r611",
      "r622"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 2 \u2013 Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "RCAT_BusinessAcquisition1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "BusinessAcquisition1Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "BusinessAcquisition2Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "BusinessAcquisition3Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_BusinessAcquisition4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "BusinessAcquisition4Member",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r534",
      "r535"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r371",
      "r534",
      "r535"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r12"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://RCAT/role/Note1Business"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 1 \u2013 The Business",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r142",
      "r143"
     ]
    },
    "us-gaap_Capital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Capital",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Banking Regulation, Total Capital, Actual",
        "documentation": "Amount of total capital as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r417",
      "r454",
      "r471",
      "r538",
      "r548",
      "r574"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, beginning of period",
        "periodEndLabel": "Cash, end of period",
        "label": "Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations",
        "documentation": "For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash of continuing operations, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r139",
      "r216"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in Cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r139"
     ]
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing activities",
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing activities",
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r139"
     ]
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating activities",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r139"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r195",
      "r196",
      "r197",
      "r219",
      "r234",
      "r235",
      "r237",
      "r238",
      "r241",
      "r242",
      "r270",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r326",
      "r327",
      "r330",
      "r333",
      "r340",
      "r385",
      "r435",
      "r436",
      "r437",
      "r438",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r463",
      "r485",
      "r506",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r569",
      "r593",
      "r599"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r241",
      "r326",
      "r327",
      "r328",
      "r330",
      "r333",
      "r338",
      "r340",
      "r435",
      "r436",
      "r437",
      "r438",
      "r533",
      "r569",
      "r593"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 17)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r86",
      "r416",
      "r462"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note17CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 17 \u2013 Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r286",
      "r287",
      "r520",
      "r607"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r540",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r596",
      "r597",
      "r619",
      "r627",
      "r630"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r463"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r118",
      "r463",
      "r482",
      "r630",
      "r631"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock - shares authorized 500,000,000; issued and outstanding 74,890,248 and 74,289,351",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r418",
      "r538"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r80",
      "r81",
      "r260",
      "r519",
      "r571"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r178"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r80",
      "r81",
      "r260"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r80",
      "r81",
      "r260",
      "r519"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r524"
     ]
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "verboseLabel": "Contract asset",
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r614"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits",
        "verboseLabel": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r346"
     ]
    },
    "RCAT_ConversionOfPreferredStockIntoCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ConversionOfPreferredStockIntoCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock into common stock"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ConvertibleNoteAgreementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ConvertibleNoteAgreementAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConvertibleNoteAgreementAmount]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of goods sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r408"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "CustomerConcentrationRisk1Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_CustomerConcentrationRisk2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "CustomerConcentrationRisk2Member",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note11DebtObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 11 \u2013 Debt Obligations",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r217",
      "r298",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r314",
      "r321",
      "r322",
      "r323"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r114",
      "r115",
      "r161",
      "r162",
      "r221",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r394",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r594"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r162",
      "r324"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r85",
      "r299",
      "r394",
      "r529",
      "r530"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r83",
      "r317"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r221",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r394",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r594"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r87"
     ]
    },
    "RCAT_DebtObligation1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DebtObligation1Member",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DebtObligation2Member",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation6Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DebtObligation6Member",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 6 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DebtObligation8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DebtObligation8Member",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Obligation 8 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r601"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note8PropertyAndEquipmentDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57"
     ]
    },
    "RCAT_DifferenceBetweenComprehensiveLossAndNetLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DifferenceBetweenComprehensiveLossAndNetLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DifferenceBetweenComprehensiveLossAndNetLoss]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote14WarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisclosureNote14WarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 Warrants",
        "verboseLabel": "Summary Of Warrants Issued And Fair Values"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisclosureNote9OtherLongtermAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisclosureNote9OtherLongtermAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 Other Long-term Assets",
        "verboseLabel": "Other Long Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwards"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 15 \u2013 Share Based Awards",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r360",
      "r361",
      "r362",
      "r536"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r68"
     ]
    },
    "us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationAdditionalDisclosuresAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Less: Cash of discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of goods sold",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r187"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r187"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r23",
      "r103"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total operating expenses",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss",
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Disposal Group, Including Discontinued Operation, Other Income",
        "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expense"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expense (income)"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r187"
     ]
    },
    "RCAT_DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 3 \u2013 Divestiture of Consumer Segment",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r146"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r562",
      "r563"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "RCAT_EarningsPerShareBasicAndDilutedContinuingOperationsRCAT": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "EarningsPerShareBasicAndDilutedContinuingOperationsRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_EarningsPerShareBasicAndDilutedRCATAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "EarningsPerShareBasicAndDilutedRCATAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r186",
      "r207",
      "r208",
      "r209",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r240",
      "r272",
      "r273",
      "r341",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r399",
      "r428",
      "r429",
      "r430",
      "r443",
      "r506"
     ]
    },
    "RCAT_EquityMethodInvestmentFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "EquityMethodInvestmentFinancialInformationTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r219",
      "r270",
      "r385"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r219",
      "r270",
      "r385"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Nonconsolidated Investee, Other [Member]",
        "documentation": "Nonconsolidated equity method investee classified as other. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r595",
      "r604",
      "r620"
     ]
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment",
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on sale of equity method investment",
        "negatedTerseLabel": "Loss on sale of equity method investment and note receivable",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r592"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity method investee",
        "periodStartLabel": "Initial investment, February 16, 2024",
        "periodEndLabel": "Investment balance, July 31, 2024",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r264",
      "r575",
      "r603"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 7 \u2013 Equity Method Investment",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r268",
      "r271",
      "r570"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r82",
      "r267"
     ]
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "RCAT_ExchangeAgreementPreferredSharesReceived": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ExchangeAgreementPreferredSharesReceived",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExchangeAgreementPreferredSharesReceived]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ExchangeAgreementSharesExchanged": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ExchangeAgreementSharesExchanged",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExchangeAgreementSharesExchanged]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ExchangeAgreementSharesExchangedParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ExchangeAgreementSharesExchangedParValue",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExchangeAgreementSharesExchangedParValue]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ExchangeAgreementSharesPreferredStockValueSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ExchangeAgreementSharesPreferredStockValueSold",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExchangeAgreementSharesPreferredStockValueSold]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ExerciseOfWarrantsShares",
     "presentation": [
      "http://RCAT/role/Note14WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ExerciseOfWarrantsShares]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r18"
     ]
    },
    "RCAT_FairValueOfOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FairValueOfOptionsAxis",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Options [Axis]",
        "verboseLabel": "FairValueOfOptionsAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FairValueOfOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FairValueOfOptionsDomain",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "auth_ref": []
    },
    "RCAT_FinancingAgreementFundingOfPurchaseOfFixedAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FinancingAgreementFundingOfPurchaseOfFixedAsset",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Axis]",
        "verboseLabel": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassDomain",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "auth_ref": []
    },
    "RCAT_FiniteLivedIntangibleAssetsGross1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FiniteLivedIntangibleAssetsGross1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finite-lived assets"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedNoncompeteAgreementsGross1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FiniteLivedNoncompeteAgreementsGross1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-compete agreements"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FiniteLivedProprietaryTechnologyGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FiniteLivedProprietaryTechnologyGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proprietary technology"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingGrossProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingGrossProceeds",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative",
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingNetProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingNetProceeds",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative",
      "http://RCAT/role/Note1BusinessDetailsNarrative",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_FirmCommitmentUnderwrittenPublicOfferingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "FirmCommitmentUnderwrittenPublicOfferingShares",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative",
      "http://RCAT/role/Note1BusinessDetailsNarrative",
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:FirmCommitmentUnderwrittenPublicOfferingShares]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and fixtures",
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Equity method loss",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r587",
      "r588",
      "r592",
      "r626"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r487"
     ]
    },
    "RCAT_GeneralAndAdministrativeStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "GeneralAndAdministrativeStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "GeneralAndAdministrativeStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r277",
      "r409",
      "r527",
      "r538",
      "r605",
      "r606"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross (loss) profit",
        "label": "Gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r219",
      "r243",
      "r250",
      "r254",
      "r256",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r385",
      "r526",
      "r610"
     ]
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranty",
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "verboseLabel": "Impairment on goodwill and intangible assets",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss from continuing operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r132",
      "r141",
      "r227",
      "r228",
      "r229",
      "r230",
      "r236",
      "r238"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r369"
     ]
    },
    "RCAT_IncomeLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IncomeLossFromDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss from discontinued operations",
        "label": "IncomeLossFromDiscontinuedOperations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/DiscontinuedOperations-ResultsOfOperationsDetails",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from discontinued operations",
        "verboseLabel": "Net loss from discontinued operations",
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r96",
      "r97",
      "r106",
      "r187",
      "r370",
      "r425"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity method loss",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r128",
      "r164",
      "r247",
      "r264",
      "r424"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Customer deposits",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r591"
     ]
    },
    "us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDerivativeAssetsAndLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of derivative liability",
        "documentation": "The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "RCAT_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Increase (Decrease) in Other Current Assets",
        "documentation": "Amount of increase (decrease) in current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IndefiniteLivedIntangibleAssetsExcludingGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total indefinite-lived assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedTradeNames": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedTradeNames",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand name",
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "RCAT_InitialFairValueOfWarrantsUponIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "InitialFairValueOfWarrantsUponIssuance",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:InitialFairValueOfWarrantsUponIssuance]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IntangibleAssetsAccumulatedAmortizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IntangibleAssetsAccumulatedAmortizationMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Accumulated Amortization [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note6IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 6 \u2013 Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "RCAT_IntangibleAssetsGrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IntangibleAssetsGrossCarryingAmountMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Gross Carrying Amount [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_IntangibleAssetsNetCarryingValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IntangibleAssetsNetCarryingValueMember",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Net Carrying Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54"
     ]
    },
    "RCAT_IntangibleAssetsNetExcludingGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IntangibleAssetsNetExcludingGoodwill1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total intangible assets, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest (income) expense, net",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r166",
      "r210",
      "r246",
      "r393",
      "r491",
      "r547",
      "r629"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r215"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note4Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 4 \u2013 Inventories",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "verboseLabel": "Total",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r522",
      "r538"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment loss, net",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "RCAT_IssuanceOfCommonStockThroughATMFacilitiesNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "IssuanceOfCommonStockThroughATMFacilitiesNetShares",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock through ATM facilities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_LeaseholdImprovementAgreementFundsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "LeaseholdImprovementAgreementFundsReceived",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LeaseholdImprovementAgreementFundsReceived]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note10RightOfUseAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 10 \u2013 Right of Use Assets and Liabilities",
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r163",
      "r421",
      "r538",
      "r595",
      "r604",
      "r620"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total current liabilities",
        "periodEndLabel": "Current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r189",
      "r219",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r373",
      "r374",
      "r375",
      "r385",
      "r538",
      "r610",
      "r622",
      "r623"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long-term liabilities",
        "periodEndLabel": "Long-term liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r110",
      "r111",
      "r112",
      "r116",
      "r219",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r373",
      "r374",
      "r375",
      "r385",
      "r610",
      "r622",
      "r623"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermAccountsNotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable",
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "us-gaap_MarketableSecuritiesGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized loss from sale of marketable securities",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized gain on marketable securities",
        "label": "Marketable Security, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in discontinued operations",
        "label": "Net Cash Provided by (Used in) Discontinued Operations",
        "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash used in financing activities of continuing operations",
        "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities of continuing operations",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash used in operating activities of continuing operations",
        "verboseLabel": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r141"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/StatementsOfCashFlows",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome",
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r141",
      "r165",
      "r187",
      "r205",
      "r206",
      "r209",
      "r219",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r236",
      "r243",
      "r250",
      "r254",
      "r256",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r384",
      "r385",
      "r426",
      "r484",
      "r504",
      "r505",
      "r526",
      "r547",
      "r610"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received",
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ]
    },
    "RCAT_NoncashOrPartNoncashDivestitureCashConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NoncashOrPartNoncashDivestitureCashConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "RCAT_NoteReceivableSoldPursuantToExchangeAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NoteReceivableSoldPursuantToExchangeAgreement",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NoteReceivableSoldPursuantToExchangeAgreement]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_NumberOfWarrantsUponIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "NumberOfWarrantsUponIssuance",
     "presentation": [
      "http://RCAT/role/SummaryOfWarrantsIssuedAndFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NumberOfWarrantsUponIssuance]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingCashPaidToSettleLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OperatingCashPaidToSettleLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash paid to settle lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses [Default Label]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss from continuing operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r250",
      "r254",
      "r256",
      "r526"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesDetailsNarrative",
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "RCAT_OperatingLeaseLocation1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OperatingLeaseLocation1Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingLeaseLocation3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OperatingLeaseLocation3Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OperatingLeaseLocation4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OperatingLeaseLocation4Member",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Location 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r537"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://RCAT/role/SupplementalInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r537"
     ]
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r169",
      "r170",
      "r171",
      "r172"
     ]
    },
    "RCAT_Options1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "Options1Member",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OptionsAssumptionsUsedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OptionsAssumptionsUsedMember",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Assumptions Used [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "verboseLabel": "Total",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r538"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unrealized gain on marketable securities",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r13",
      "r158"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in foreign currency translation adjustments",
        "verboseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r13",
      "r158"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency translation adjustments",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r13",
      "r158"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss",
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r386",
      "r387",
      "r392",
      "r411",
      "r427",
      "r584",
      "r585"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized gain on marketable securities",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r263"
     ]
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentAssetsTextBlock",
     "presentation": [
      "http://RCAT/role/Note5OtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 5 \u2013 Other Current Assets",
        "documentation": "The entire disclosure for other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OtherLongTermAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OtherLongTermAssetsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note9OtherLong-termAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 9 \u2013 Other Long-Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Other expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (income) expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonrecurringIncomeExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other, net",
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "RCAT_OutstandingPrincipalPaymentsDueLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OutstandingPrincipalPaymentsDueLongTerm",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "OutstandingPrincipalPaymentsDueLongTerm"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OutstandingPrincipalPaymentsDueTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OutstandingPrincipalPaymentsDueTotal",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "",
        "label": "OutstandingPrincipalPaymentsDueTotal"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_OutstandingPrincipalPaymentsDueYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "OutstandingPrincipalPaymentsDueYearOne",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/OutstandingPrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": ""
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PartnersCapitalAccountUnitsSoldInPublicOffering",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partners' Capital Account, Units, Sold in Public Offering",
        "documentation": "The number of units sold in a public offering of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155"
     ]
    },
    "RCAT_PaymentForSAFEAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PaymentForSAFEAgreement",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note9OtherLong-termAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PaymentForSAFEAgreement]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_PaymentsOfTaxesRelatedToEquityTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PaymentsOfTaxesRelatedToEquityTransactions",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of taxes related to equity transactions",
        "label": "PaymentsOfTaxesRelatedToEquityTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r616",
      "r617",
      "r618"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "RCAT_PreferredStockConvertible": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PreferredStockConvertible",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PreferredStockConvertible]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_PreferredStockConvertibleSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PreferredStockConvertibleSharesIssued",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PreferredStockConvertibleSharesIssued]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r326"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r463"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r463",
      "r482",
      "r630",
      "r631"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://RCAT/role/Note13PreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 13 \u2013 Preferred Stock",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "RCAT_PreferredStockValueSeriesB": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PreferredStockValueSeriesB",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid inventory",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r275",
      "r276",
      "r523"
     ]
    },
    "RCAT_ProceedsFromPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ProceedsFromPurchaseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ProceedsFromPurchaseAgreement]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of equity method investment and note receivable",
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note8PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 8 \u2013 Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r179",
      "r182",
      "r183"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment and related",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r190",
      "r423"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "verboseLabel": "Net carrying value",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r413",
      "r423",
      "r538"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://RCAT/role/Note8PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Subject to or Available for Operating Lease [Axis]",
        "documentation": "Information by property that could be leased or is available for lease."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "presentation": [
      "http://RCAT/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "RCAT_PublicOfferingPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "PublicOfferingPricePerShare",
     "presentation": [
      "http://RCAT/role/Note12CommonStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PublicOfferingPricePerShare]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RelatedPartiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RelatedPartiesPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note16-Related-partyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 16 - Related-Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r440",
      "r441",
      "r442",
      "r488",
      "r489",
      "r490",
      "r510",
      "r512"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments under debt obligations",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r366",
      "r624"
     ]
    },
    "RCAT_ResearchAndDevelopmentStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ResearchAndDevelopmentStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "ResearchAndDevelopmentStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactAsRestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementImpactAsRestatedMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact As Restated [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementImpactAxis",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact [Axis]",
        "verboseLabel": "RestatementImpactAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactChangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementImpactChangeMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact Change [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementImpactDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementImpactDomain",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "auth_ref": []
    },
    "RCAT_RestatementImpactOriginallyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementImpactOriginallyReportedMember",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Impact Originally Reported [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement of Previously Issued Consolidated Financial Statements"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock units",
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "periodEndLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r154",
      "r420",
      "r431",
      "r433",
      "r439",
      "r464",
      "r538"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r272",
      "r273",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r376",
      "r378",
      "r379",
      "r381",
      "r383",
      "r428",
      "r430",
      "r443",
      "r630"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract related",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r249",
      "r252",
      "r253",
      "r257",
      "r258",
      "r260",
      "r344",
      "r345",
      "r408"
     ]
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueNotFromContractWithCustomer",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product related",
        "documentation": "Amount of revenue that is not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r521",
      "r525"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://RCAT/role/CompanysRevenueDisaggregatedByRevenueTypeDetails",
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "verboseLabel": "Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r219",
      "r244",
      "r245",
      "r249",
      "r252",
      "r253",
      "r257",
      "r258",
      "r260",
      "r270",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r385",
      "r412",
      "r610"
     ]
    },
    "RCAT_SAFEAgreementAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SAFEAgreementAssets",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SAFE agreement"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SaleOfOwnershipInterestEquityMethodInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SaleOfOwnershipInterestEquityMethodInvestment",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of ownership interest"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SalesAndMarketingStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SalesAndMarketingStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "SalesAndMarketingStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "RCAT_ScheduleOfAssumptionsUsed1TableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ScheduleOfAssumptionsUsed1TableTextBlock",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfAssumptionsUsed1TableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note12CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ScheduleOfDebtPaymentsDueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ScheduleOfDebtPaymentsDueTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfDebtPaymentsDueTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]",
        "documentation": "Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r66",
      "r68",
      "r156"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r16",
      "r22",
      "r92",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r105",
      "r107",
      "r108",
      "r148"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r266",
      "r267",
      "r269",
      "r270",
      "r385"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://RCAT/role/FinancialInformationForUmacDerivedFromTheirForm10-qDetails",
      "http://RCAT/role/ImpactsOnInvestmentsIntoUmacDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r219",
      "r266",
      "r267",
      "r269",
      "r270",
      "r385"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note6IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note4InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r124",
      "r125",
      "r126"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note5OtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ScheduleOfOtherLongTermAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ScheduleOfOtherLongTermAssetsTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note9OtherLong-termAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://RCAT/role/CustomerConcentrationRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRentExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRentExpenseTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note10RightOfUseAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Rent Expense [Table Text Block]",
        "documentation": "Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://RCAT/role/Note1BusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r152",
      "r153",
      "r154",
      "r195",
      "r196",
      "r197",
      "r241",
      "r326",
      "r327",
      "r328",
      "r330",
      "r333",
      "r338",
      "r340",
      "r435",
      "r436",
      "r437",
      "r438",
      "r533",
      "r569",
      "r593"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://RCAT/role/Note14WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "RCAT_ScheduleOfWarrantsIssuedAndFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ScheduleOfWarrantsIssuedAndFairValueTableTextBlock",
     "presentation": [
      "http://RCAT/role/Note14WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r47",
      "r80",
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/OtherLongTermAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposits",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "RCAT_SeriesAPreferredStock2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SeriesAPreferredStock2Member",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SeriesBPreferredStock1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SeriesBPreferredStock1Member",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r578",
      "r612"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationSharesRestrictedStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationSharesRestrictedStockAxis",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Shares Restricted Stock [Axis]",
        "verboseLabel": "ShareBasedCompensationSharesRestrictedStockAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_ShareBasedCompensationSharesRestrictedStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "ShareBasedCompensationSharesRestrictedStockDomain",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation - options",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to employees, net of shares withheld of 126,828 to pay taxes"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to Board of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock to consultants"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation - restricted units"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]",
        "negatedLabel": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "RCAT_SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares, Outstanding, Beginning Balance",
        "periodEndLabel": "Shares, Outstanding, Ending Balance",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt obligations - short term",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r161",
      "r538",
      "r625"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://RCAT/role/Note11DebtObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrualCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyAccrualCurrent",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard Product Warranty Accrual, Current",
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r609"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r195",
      "r196",
      "r197",
      "r219",
      "r234",
      "r235",
      "r237",
      "r238",
      "r241",
      "r242",
      "r270",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r326",
      "r327",
      "r330",
      "r333",
      "r340",
      "r385",
      "r435",
      "r436",
      "r437",
      "r438",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r463",
      "r485",
      "r506",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r569",
      "r593",
      "r599"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r33",
      "r186",
      "r207",
      "r208",
      "r209",
      "r222",
      "r223",
      "r224",
      "r226",
      "r231",
      "r233",
      "r240",
      "r272",
      "r273",
      "r341",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r399",
      "r428",
      "r429",
      "r430",
      "r443",
      "r506"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/IntangibleAssetsDetails",
      "http://RCAT/role/OperatingLeasesDetails",
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r240",
      "r408",
      "r434",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r483",
      "r486",
      "r487",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r542"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://RCAT/role/AssumptionsUsedToCalculateFairValueOfOptionsGrantedDetails",
      "http://RCAT/role/BalanceSheetsParenthetical",
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails",
      "http://RCAT/role/IntangibleAssetsDetails",
      "http://RCAT/role/OperatingLeasesDetails",
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfRestrictedStockActivityUnderPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r240",
      "r408",
      "r434",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r483",
      "r486",
      "r487",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r542"
     ]
    },
    "RCAT_StockCompensationExpensePertainingToOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockCompensationExpensePertainingToOptions",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockCompensationExpensePertainingToOptions]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockCompensationExpensePertainingToRestrictedStockUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockCompensationExpensePertainingToRestrictedStockUnits",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockCompensationExpensePertainingToRestrictedStockUnits]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversion of preferred stock",
        "label": "StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock",
     "presentation": [
      "http://RCAT/role/Note13PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r32",
      "r62",
      "r154",
      "r315"
     ]
    },
    "RCAT_StockIssuedDuringPeriodSharesPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockIssuedDuringPeriodSharesPublicOffering",
     "presentation": [
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock through public offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails",
      "http://RCAT/role/SummaryOfActivityUnderPlanDetails",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of stock options",
        "negatedLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r117",
      "r118",
      "r154",
      "r353"
     ]
    },
    "RCAT_StockIssuedDuringPeriodSharesStockWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantsExercised",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity",
      "http://RCAT/role/SummaryOfSharesOfCommonStockIssuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]",
        "verboseLabel": "Exercise of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r33",
      "r154"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r117",
      "r118",
      "r154"
     ]
    },
    "RCAT_StockIssuedDuringPeriodValueStockWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockIssuedDuringPeriodValueStockWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://RCAT/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://RCAT/role/BalanceSheets",
      "http://RCAT/role/StatementsOfShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r121",
      "r122",
      "r144",
      "r465",
      "r482",
      "r507",
      "r508",
      "r538",
      "r548",
      "r595",
      "r604",
      "r620",
      "r630"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://RCAT/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note12CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 12 \u2013 Common Stock",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r218",
      "r325",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r341",
      "r382",
      "r509",
      "r511",
      "r518"
     ]
    },
    "RCAT_StockholdersEquityRestatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "StockholdersEquityRestatement",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/ImpactOfRestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Total equity",
        "label": "StockholdersEquityRestatement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://RCAT/role/Note18SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 18 \u2013 Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406"
     ]
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity and Going Concern",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "RCAT_TotalStockCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "TotalStockCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/StockCompensationExpenseByFunctionalCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "TotalStockCompensationExpense"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://RCAT/role/Note15ShareBasedAwardsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://RCAT/role/Note2SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r176",
      "r177",
      "r180",
      "r181"
     ]
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://RCAT/role/Note7EquityMethodInvestmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "RCAT_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://RCAT/role/Note14Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note 14 \u2013 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsIssuedExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WarrantsIssuedExercisePrice",
     "presentation": [
      "http://RCAT/role/Note14WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantsIssuedExercisePrice]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsOutstanding1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WarrantsOutstanding1Member",
     "presentation": [
      "http://RCAT/role/ChangesInWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Outstanding 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WarrantsToPurchaseSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WarrantsToPurchaseSharesIssued",
     "presentation": [
      "http://RCAT/role/Note14WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantsToPurchaseSharesIssued]"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT",
     "presentation": [
      "http://RCAT/role/StatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "RCAT_WorkingCapitalAtClosingOfDisposalGroup": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://RCAT/20240731",
     "localname": "WorkingCapitalAtClosingOfDisposalGroup",
     "crdr": "credit",
     "presentation": [
      "http://RCAT/role/Note3DivestitureOfConsumerSegmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WorkingCapitalAtClosingOfDisposalGroup-0]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://RCAT/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-6"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-7"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480781/205-20-S99-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-8"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-40/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.13)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//840/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//323/tableOfContent"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//460/tableOfContent"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480696/942-505-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "323",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0001554795-24-000238-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001554795-24-000238-xbrl.zip
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M2%R6%#+H7>,_R=]K"AEGEZ9\Y@\B_HBDGM<%OAOZG5C3\M5Q1L_C"NQ2LV?
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M%+2JA0K^UZ^2]P?,7<(5X#__!5!+ P04    " !K@C=9L;O26!X6  "2  $
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MHQOJ$IM@+>P:@NJ.^]$EJ+ ?D"!D&(0#^AVN,+O#2RXN'8RU '3'\_C:>P:
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M!H\>3;>1H()LLZ038 :(UOJ6TL#10^)V4I&2:Z3W9_PU<-;<^U?-&_M0MI7
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M/HVL,C+QC23^'_ZU,?C)_P!02P,$%     @ :X(W6;V!^LZS(0  < 0" !4
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M!B='H$A5(,D!QQ3=%)- 7OH,=OU@1JY_PVC'R3LJ2V5))8B2/?SI7O[-'I.
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M9)Y-JW#!7NB;#F&:N6CYFEJ%(<[JW^I,IIN]AA?8*ORP-P""(YIN\()GVBK
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MKE4LHG5,3I=U3#+:3D;<65$?IH )20D"*%F,(Y\ F9?X8K-3JSY44'#<R'=
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MN"B'%?FEB]%RSI5:A=SL"<[]I7>%=D+*)^-N"M<*<7N5>AK(U9(F<8)[)@7
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M:<BF@C*;;HA67@?\&8S5Q&5$<9F<ZD>&2N/HG!;JUQ6W9724I"A:4T9GV .
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M:X_<=^M#EN;Y>9!E^RAY6FS275+( ZJ%LC-66SM4,]A8$P9;;>'VF3GD';.
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MY2Z/Z-R@1,[55U;"K+ZX4 C$UU<A&R0)Y;*H*^R8%O=I'*TB6J/E9S+YS*)
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M8 NO.?2%P804'4+Y?89+*)>2[W".R=M[)B'Q@O29<<I2Z97PI'VO4L?MF,4
M?G<@HU  0RP3E,,A#]=AQ^S"1LL[Q7X.LM\Q93WQ9A&^X*R(\J;-2-Z 3LDE
MR<P<:+-,K0&&9D8P!WLI08SYI8=-I>Z=8A]P0B)KS-S81$E$HW 1O6 UQ[1:
M3L=/9BYTQE1J%3 T,\,Y&'9Q+<:TH*/GG6[7FVT09;QN8C]EO'&&?SL;3I>,
MQKC764BR,0"&IF-0#Q:=:AN(SA>\,W4P0C4=R7J>%QC-!V!-)&7PQ&?JTGHJ
M "8_47.L](I\''X+<D<0EHZE27Z&UVE6'C]]"%YQ?D'^D1?12KE@.]*B^T7R
M@UP?+J2/,@>+TX<[HKC2#R(^TE/1'].D;H[<D[()ZQ95#)6=YW,W=FB0X%VK
M"::WMH(KS/V.ON;GW[^I0K!W-HK+Q=SA(*:;[!^"**%-<9E<1/DVS:57U>S-
M^"_OHW=27_=';L,-:W_DK$WP$[UQH8JK(_$/DOC2A6EZ0Y-,R>E.!184$ *Q
M!-1X1%</EFNVQ7^=W.\>\RB,@FR_S(:O!$OG[6.M.9W/'^9R9YX_SA0TTA_F
MAKI8%HC!1-.2>5^DK@,\D'1=#E@"M5\5N"<&C55RB*)2P5R2T05&N:#KI,#D
MS6AV7 92CBL_BB#VBCRV1< ,$L6X!*4;F=1@0 B#(M5(-\,TWU5_I*L9'LN4
M?,Q)U Z(YB)B#3#T,H(IG'O 8I9X#C5JX@5IMFL_R_71N3UH%Q9-((MGN% F
MMLLN=#H*U*VBMB6]+$4/H0H7HQLQ.&%)BFU0G1/SL1"B[Z!,8D?7]ZKEZ32!
M,*INKT&2&7$)$X?-*J0FRX6="7\+SV;.R5>:U?I@^#D"M'#E@Y$V;*E#HBUQ
M0!OL>C(NB2>$UV961P ,=42H9$'-.P5,,K?<XBQ*P_-GXH#1=L,H<\Z'9 <X
M/1BLC; %AJX'.B >U$'.X2-S^"K-</24\&SSJ_U#%B0Y\9-$ZD42LO^*6=Q>
MA'_;\34:OK%(WT^:L5^*(HL>=P7-\?"0W@:ZLLH.04!H7O.^8)-&.0\"\$UY
M5K<'5U)8E"!M'JWY8\O:#*L]*II'H:!^%MQ.\%.2E=M=_Y'&[&15LSU EU-X
MRJ",'4B]V-'%%1XH-4/]^1X'H95/]=),VO.ASP+?<B=RL-]&&[/HB1BD^[/\
MH#1MWRBO+8-MF?05U#%JQ,"FI0NAS0C=,1UEUHK@V2Q":S)^I./&?_G#V^_?
M_'FFY/)5ME72>-B5_K,@CU;T8DL4[PH<4AG)Q,=>W5GZ^1%.U?GH+72]LVXD
M8.%RS99PC^401Z?HD9K@-Y6X$3_D$YUHI'HCWH+<%!12ZIPU):C,SE&050-^
M> =\AB7Q<5P5KY..9*O*&!2^ZATV9:S<TE%P5@M_4-%VGC5Q"6]_)1/19P)S
M\4(>](0_[C:/.%NNF2>MY#V"7D/T+@ZQYHRYA[M<4W>\*1C</1A_G[R5011P
MBU7=D791$<L!Q(RSCM&YP-\Y_7Q;-G.]+X*L4!TU4.#L?Z8S_!0E-&J13T%^
M6.$3]$)KR7B?UIKF?_.<],THTYO?]&ZFI#%,[R9(Z':"&AJ=<1KYYP\[ELR*
M&;57?7A=KK)WIN/(#3U:PSI656.R-.2\C,$H1P>AS<J*]W[K8.C"4GVT2\(A
M6UVIQ+US^0Z3:7FT*CJUY5@SY&Y72YFT5/TS7P25YZ0;8\IQ+IC1SO92Q%C;
M </I \#W6?T+O<=))[YKE-56RVIPNR0"L+?4<W;@)__#59J-HKB%.8\TMW9:
M075C6U#I;NN ((=2Q?-NJF-N$M&C1:0YE']<IQDB=E';L/<VH>K4SM.$S*ER
MTC,MU_S?!4UQT>QVC>@H#6Q"&=08NV\ZOM$:!--.IO!"L#9:ZM$VT:M%"[4=
M\*8[<4,P-@J@)5B^ (.F8&@1VL7!2;P1SP3*WH*;1=QND]"\VVY:UM$]G,,!
M/]='%AI0S<F&ZJ2$Y-6:*KM/XF?JT#"9GT[3::@GC'E,<ZRBMQ7J+^X,B_VI
MO/HXKL?CID88()RIF?7USG/8U   F-&:#Z\'H[N9#Y9*-A.5:W+TMU^#C "B
M&?EPMHKR0?V@T5:<;1Z.=['>-+0WX9W;A^$>9/\H?Z<CJ,^ECEM&\M'<P914
MF_'-21,G=:14V0#-2@/@?5K^MB+A,=W\-,*BLB@-Q WL]Q[V(B\3_91.C'(0
M0/A! O.]:WA;P3Y.$.@^@!2DT69P^5'@[ 27I:.6Z_,@?[Z*T\^Z.AMJ%2_%
M?17@A65^!?+>P[0%2'GI7[K80I00TX)4#8P,TBFPVRQ]B4(<GNT_D?[@.JG3
M."S($/^%WT91LV^,(<>7SD<ZVKN9;FD%#']'0Q_,SAHBLRP(35K=QL1,XV&3
M[ VB49:9GK,1KXT;]1#71 G*.K<M8'5N&*AI-O09JB5-T4015@IR42S4:T%;
MES9&?(RYBIJ%M_PAO</TLT<Q[B0M>4BGZ>OG>91+QL_YLMIM9([G@!E1S.A<
MOP&V'H6*%&75PV@J0]XRR5_IOU=T<,)::=,T?_+>-MF,\[%_HG-!EV&>V 3A
M;-^(W 9[5F+X<Y"1GI)Y0(_#T1?'EW*N@BACRY9O55/A61[G_)3ZC"]ML,(Q
MP[/ M-69'30]E8Q.2;N<\T+8:#_KXW>?Z/%2PP;GYI'N5N+=O+QFU7[>YWEO
M? Z=M&B K0/5,(Y2+S9TA_@?#-^P_)EL\*%1<CJ:-'*@,RY4:G@GKA7,P5BM
MI407/J-:#05,SSOA1.>31APK@W.8S/8(F9>#8RJB&8 <GI<O3XDU$_.J%@W,
M\V(7>$OF+9'JVEY7Q"6K1.#:+&K_#H8U E"#= 0M$4];K%Z*3CG:H.VED\>9
M>@%NM!MCJT^Q6_I)6F"Z9("C%QH3/-' <65;MSOT)HNOH^ KBMR2S_]4BK//
M#&^<<9VL,DR&X!>8_]_KA)VN;):_&,Q%$MY$P6,4LV[J(RXTJZ\'6W6\M3#%
M*^CM.QQB$DSO-8T?XC2M.<W3VM3YY>V!M9*X,0:P?2Q6JW27%/E=':V-7YY(
MU2_3Y<ZHZ3S4 \Q9*=C!M+ 4-.R)/1&0CDH2\B#Y/3R-CE_*">"KN=92 #=@
M,  KJK-')?8 J<5O5K"K#85R:<M,%4 O+G3&H*ONZ,&GG12S,,?M?$>?^K"J
M[OV&_O<=S5RV7'_*L6C<(#F?<Y!%E\>E)G"]?9#J '/>N^+I?!C0MQXOQM0&
MRJB1TW1]NLOQ\0PAZ;$>.CZFF3'.V94(G%6^[XW;O,:*W^!KY*(Z#BM-P _)
M)O"'MPJY' KQ-LTA;'S)1].WP7[4Y*?6@S'SZ;EA-NTIE>"34 Q8.N_9<C&8
MK,MV6#%>L%/USCV),UKZ]?2.@H%BS (24L&J**O_T&=^&\'B7/6A1F'>1S$]
MCWV81>_CVDG=$!W@9D=#=_1 3'=MM+9'-Y*@GNT.(XHDB*NK9Y<Q.SN47T5)
MD*SL#F^/LN7V=/8![G:/7X\P!*8E'()>=VF+[[Y.>VGK8)J7I]_RAW2Q^OLN
MRC ) N&.XE.?!3/0<TE?8S?:5-4J0;G;90NXS\1;@N69C%YRGKF/1MEBS]85
MZ";^EMKT3\0L76$<LFM"]T&,%TGX<U#0@T3[Y5IT5DGVCNSM."7J6#<[Q+4U
M B:^CD4^8'1IYQ@.H?5]7J[%9W),&:W0]\EDK5LJ!DN5P3)7A]B,L5,=HO(Y
M@:S'-5-.((V- IA 6KX @PFDH46GC:-(BR!6C4XF\44ZB]R69M'COFPGQS*3
M-'\OX_)]* W!;!XC\GTHK(#I(T9#UTT=Z\DGI*GC'=Z6\Y'E^@(_RE@[%'-;
M/D$,LEL6H2L#;=HGP3<8891":)>$;,OML4#I8QP]S5H.\+:&]A"\XOP.Q^Q8
M>LI'1ZV<I<(#$3;:S@X_V+M4'W0P5X5"LG&PI=PCO7!!39!Q*[-!DP24@]RB
M9<9[\)*$:L$JW^%C66.C #IKRQ=@T'$;6H3>B=NYH=T,6=<]^C$,8869I)JU
M<OISG.:[3#N$'6/(Z9V\T8YV;NY96X&V[SW: T>UB0]FM.%^IU&^NXELNN3Y
M).ZW*7^003"Q?PHOY$<\ SAS-\-IZL'TM[#IF_[6[NOH;VP0-/UMO1!=#^FO
MU8&DOV" =S#]+6SZIK^U^SKZ&QL$37];+_KTOQ*,\[W37S+%L:*[I0T 4UMS
M.EL9.(I-&.M4P)W)*M1LP-13^O_I,M5+$&-V)[;*M$5_6"1A]P\M29[5:WC
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MG.;J65, Z8S^2-OF+4VSGR:+@@P&'G?LIME#>AO0+&62ESG_8UVV!%<OL=V
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M&"1$LK;BDJ C76R3U=($&.*.P]TG,;>"N!G4LL-"+K.$*E.0@JS$>_-8:V,
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M(*J!N HP-E5'W^F4]6*7T1Z=38.-7H1<V1_3= [)>2?3!,I"#5PM)^M+#]0
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MRHQ[!P&"-<+Q_!;FC%$M?%4*WPJAPWQ(WH-7Z0Y=]9FU!)3@.<<49*2O:<K
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M+0EQ"4QY_6F0\D;%%8LC[Q6_CY%Q)XG]F+<L&"A9".-)[:LAO[<0[UP4*.^
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MV0J*,<JF4R44"K9EI"%*>0$@';Z[+:$8H^PU=<*AX'PFTNG#RVA*GOZ3K'5
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M*S4P&JMBXTX'1'XGU:0OF*61KTW%K $C3!TT-73IK(YA<_APTG;"KJ@!5A%
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M?$K]2+&5/Y9G71QMTRXVW0?;O6]9M-JSR[KUN5,OJ<.WY]H>[NS)U7A7=^(
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M_.@WN):R.#FQ_4:"^8(_*?C(?CLGMX3/VN4?>5Q3]G",=-* 4,+V]D !B[8
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MYP$+&CQ;<WN7ZAP;4"ZG-R9X\\#$NDHE0.VV7-X^*K&+G;K2]N[\#4Z93_L
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M(>0'+M8:<WBWPJ;LVI_)PZ>=QV$G@2\"K.,&UFP<EMT@A,:G&H?%8:A0');
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M;57^LP )%&Y=0Z&MV\"A;F\K*44/,QX5.#3RMO=PJH:*"KC 26<,/4@ ,3!
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MU.,M"K]"G"ANJ-Q?QF@48[+=9$M4!L%;$2,R!:>(,@"%+WCV56=,Z?(+3;U
MG)LX]CLR5#0S3^ $Q=MU"#?4I'GH2H'?;1F#(1*O 7RA2 CHHF[/<Y%R;^U'
M4^>%E:-S!RAD'DP=3-,NF@5G"X6!%<1VS"?\^A4TN;#&8;NNX_4>CB7@)PAV
M-,[YH;[6WE%_,\,Q9PG#KKWF4(H.9,N5TH@H?%#(L53BB>B@S ?4?&] =5.=
M+K1/@J.Q0D"'DSE"S2UTW7QQEYB5<N1F-*! =,=>ML!U(\>^""_FY8F7HO;#
M_2O?A4?60<=,@8$K0M,7VZ,APKSJ':*X1E873TR"O5HS5'RPA[(#M#QYBM6/
M@*OHK#^D5?Q*!,U0(2G0VI[\@GPXN-HA47!K$5[<7)+9<4L7T.J&/%++D"=-
MO4\@9I^!F\C&[X$(AD*B]&FDS)!@H1*&R44N^)%.?)8U'1O1 :FAI^J\2_7@
MBF9A'P M5#VXAOFJ>4*Y^S0O;WDB(^M7]Z[QWHB6<>_B&1K\;.<\E6%>4/#-
M4/>BY1W#>7H085#<)T+DMH>&W)H<%^IR#^5_L74 5P&D4KRLO'_@H@7_1-QP
MZP/0TV6DXF1E[,X9:IL/'&!XF0LL7<'W0\D*)5[5TY.??72P(YQ"[U4!Z\)V
MH/'J,2K(#6PR34EY0?4FSVY*%Q5J#@&NUH2<>$9(1/G(0'HEC"<\6"CQ4.<,
MX<1 G+@#/Z5N-*1\W;SB3&X/*DK43BJFF8:(5>01HGQZ#@%<AQ3T7'7DC02;
M/D;DBG(23&-"HPPK85ES\[8F9$O/9>YTY9RNEU-K"+UT@FK#,$>N)><GO''"
M%^>!_8H=%.A;J)E/PD4&'G0\3 66XKGB%16EE\VA.YKL*J^L*U?D6F [%N"5
M/]Z2Z)F1GF58"1UR2$_J4L#L-R-[\@V<0.]+*";^M[AL")V[BOH20=G]8NIX
MOR^-&@^>HL,B:^!95F5D\4.B/!4Z]4TU7%1F(M5EOB 8*<%V1BC_KJF:C(M
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MX"TTF"0[6'4777%'!'UW@CZ/S[3C+ZB# $<+HDB+/.D@1- 7#WU)K20EN))
MSU,2(/IBYU3VNYPP:QR(%3CE%*\J/RY&XO.7VM=[)\V:4?Q%1DXY#1R:%??
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MC+J7>U"Y-L&?$3 4*.K2)PJ?B7!&\50^[ZT:JO;L$QA\K804R\R+):Q8L3Z
M;]5U3SUAS8?^AJ-6_+_#RE\Q=5T>VO#-_J=/U(NF.GW$#^:OD$I##$*O65@C
M"NF+5'!3O>D]FN?_FDY)6+/Z5PA_+6!F@(T^ S]1K?$0$EBVY(ZF?*)J<$EQ
MF5PS$3_%X$T?_;O0+XO>SO\5N; %249JV-?!GS_"R9J?MHX%Y*=\!\!%"M(S
MQ),>;RJ'X9F'T HN!L/0"X-C0V/&"-HANC<5R<^=\\;5Y4FEW**^U&\OJ[6;
M)DU5:Q6HP3KG>Y+4+<92\77T226HHR=A=ALI]HIL]ZEKW7RQ#W.0'Q[\->GO
M^0'$TS]^ H-GBFV6Y=IOK8=O#6X\^L/7-:B=1@,XBC&^Y&S*/"I/3?A+Q>(O
M%2 U-\-9;C5GXZG'7*RB^?G2C7C3$M2ZZ^W#7W3/A XX&O3M/SE^.B%"J=R.
MR!B]];\-'LL#:WS7[.8R/@ 6D<U/!L"[ [":5O%U\*S]*H-D!Q!WUT2,ODE+
MF+3@ZEA>Z](:LOA,+BQ/\P6*O.(0N3[O6WT+ $S6 /[4MRD =8'J4NY7*;W/
MF>'W/#/Q2L/>(5?XE76%S&6X!0A:N^XM\UF#T+X8/\"5KFK4A\"2'<BALN)H
MSYJC ;O<L1T4G6AK%^VWX7.K__C][K'52[U-NLN>^.$+EQ.!!;EKF0-J,B!J
M.J+$%H4(W1Z'QJ3ZRZSYM(U)(PR*NRI/98U;V&Y'@\;"0*Z\-6K7[3>V\"]S
M^3 &S2ZW@3PMV GI&8Q2<=Z=GA<H[QL-&;M0 ^4Y)IBS0%= ]Y19K2;A(#$=
M2SKU^(9LI)>_)<06/WM]';(H?NV_@UOUDEBPS/HNX1*_R2[A).=A48+-#YH0
M'"6"(W[21H)/ 45"[ERDB[Q$%Z78*=ST0!2IJPO3,[VGK$+,N=1LQ"_-& '5
M,R1, VOP6EO5IEI<NA2_ODB-,E_I[L<JBC1LT]#LKE&E!OA"F1/&Q+7+DS7"
M-S6\$S5*MGI[+#&/FQ*7-NGH$XF>=#E&4)&B\L>'8<?194DO"(O7 1%ZJ0)'
MBP5^TYQW,J",L1[P =L]S,2*RT%(57@Y: \<=RD8V)4W,)#:;_7'$=L:U!Y+
MY=_)&?:[-.:GZAY3H4Q&OK;"WUZ*=ZR)DC;!5F-H+_:]M&47H&2->@*:1$"3
MKC%?0,8\M.EIKA2["'D7&OLZH+&GAW+8+;,!((\430<A-ZAEKAW[9-B+]MN+
MT=6^U&]*K=][BGXFI=\#/*(<$Y-A^9RB#%_Y.R;^K*"0*K;[IYK_C(0(20PU
M[1CJQ>R&PXX,!15M' 2&[1[ 8UFRT</I^(OQ]))[>8R^*K_(%K1U,6!_ -M!
M0GX/+,U4KV7-P@50+)1L;FJU/8U>FXI\?3.X$#-FM0DQI!K7LE*8 Y02X!(F
M* ^EEQAMP?&MWLJ9 MZ2M_06K];%W#DO%N!:$SOPMM,Y(Q#;(<12\>E+N7.)
M*]$"MSOW(>[:$8CI;LSG!F2PI2D.>( <B+F"L-]$KO0,5/L^]28\>UU,+)\W
M*L8'6566BCR.QZ6,P]VM+!*#MJ/23+%(%XJQMUZ3M>68@9;"^B(Q;.Z<*W(T
MNU^0+5I?IA&' 3KU\PUSN=ZM&@[DL];10=FV@6.[ZX/LK0_JS=?&U^&36>X_
M':"'$1PI)L+LHLU$WG@I&0^82&@<ZV\Y:':IS#FHS L%FN=*1)4?!U!24<8\
M5,8LA$G\,HZ]*.,[V7H">&=($WH %@[CWLB:X=7>!4SUR_KHN78OEJ5:[[!-
M]0: #WV#ECB*VF(J<+36EJ%*A@IZ,.$(94]8$FNC>J*BM^:F^O4D;]TN ^O5
M5!1W>[P;T9'KZLAE0K\[#2E #5GB:(G/7CA$"FC(2S"TX(#P@A(V3J\Y=B#7
M?DAOH).V<;JUT@N.@@A)'"$)<FR7]B6J_"E)=('CB'UYB+!(15>BXA.&I1F&
MS9RN#%J3;DN8.^#T3;5J/ ,W:>X;7/X24S<N-7MH0H,+Z5.W-MBW,E\UZX'_
M5VT]?LMPS4 <A8L&2D'T(+/2]_T!9@\UP/RAM F#*-E0<<L15%8 M&>T,A-I
MC".-ZP)N#Y5C$H-:.4/1+=*\&+NC,]'IR:(HKNM2V,YUV9U9.L5V$VJ8>A<G
MH*I&<]2Q-563K7'=FA<. .8U;NU7WV*J7\8O5_H!AEBO@BIUU8ZZ]P?[I<IS
M0PCM18>BWMR\0+-"['IXHD'WHD%+6P9_TM6@3'"OPF H:Q:R%^;CQ%?_/WM?
MVIRVDC7\G5^AUS6I2:ID7VUL-_.X"N\D7HC7.%\H 0TH%A*6!#;\^O><;FV
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M.#!GUN!=J5&Q0 !N'&?6:2?@*-BLM(B+*(W+;A-:K$3GEP$IY#Q?+&Q!MF;
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MZ"BF@QV#S!C>I9N>NVGVNO^WO\^=:41O_,M5U!8PSCORVB-&'0@Z_Y6C-3=
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M&EY@-M6(KH'5Y)IS#OT8[;R.:8V3(1*119 J=!/9"N*E#1LG;5-'7:&/.7V
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M/*?6;'])>"UK#XX0M4C=[!,V5+&N6A8=*<R"SJ/)3BP0:KF?>"N,Y4/1C"I
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MAV;0SZEY[*5,NF*=0W4"=</1,-4D161Z +>1O0,6-'IUYI:T3,=T!EUXO&>
MZ'$C5&^ ))[Y[5=@!G64])A4072))R@3 AG4-6V-NNT<%8X_&:LZ'DW"HPL\
M >UY2WC>XL$QDX)5K>SF:F*&YK O6[W3A^=&F6@Q$N/FKA[9:L?G[A\.6Q4$
MVH%)D"=[,'L5\/1Z)Z D+ TE&MAS5*'?5+X_5I[%54(IH>!>0<3L9;XX$TK.
MR'B;J,*Q\:RQ,UIO#.*(LASXEY].?3XNV]1MJ!E]4^]3NL^XC?JUH<^<P]\+
M2 @(6 >-C=$,>M'=%5TU[L"7-9[F/I5$3N=</HVMG%NF;4?3""'MB_NR\?OX
M8FY8-];RJR82:>]P:L?(:/+(+0\A2A\/FEH\_UTOO[\U5@JAI A$WCL4>26?
MYPO3N[E'DDAF)HE,-Z+^$87LIZW2S[=NDS2&0AV=5->AMCWH<S:UK9P9&D9#
ML]56"Q4YARF8ONJ!R7>KLDIHV[E)0^(DO!GWSRR9_1Y/%&FKX!3=A2L_CX,V
MK,OOHCJ4'V_$BF;>%WXIL^L_?4,\%MBGUX0F,O2RL,3,RR6:+"8S.RB8]"A6
M(XIDA@_#,_O][D=1NVDMU0HRZ5V>1,VC'%X.!Z9]7NNT-.UC8P16>%]3.R?2
M#]8R*^H#,R@C-KGXK*A[#"O1;5V9=)3A*69ML9U[TFRK;R:)2Q@M1TD>R*P8
M^L\^H#R_$WAATJ6&4C1*PSM]=QTI)1H0)XU[]1UXRL/MO7B7/[^^#Y+[5C"(
M+#MWKDR<;JJ^N>&&7/[L26-21(U%XK-XED":606:HTK;QZT$9>^P4,CQBA*[
M_WXZ\>D/QK(@#UM.#L>P=X$H\(5"[%DAFQCXE)WD]->F,PVBP-@MX.OM$\&^
M;V]DVM,"2EW%==_.YNH3[TY6?5Q694R4IWSH[<G1Z0S$6B?SQ^F2?*$H\$)Q
M:GU$C$8]J[ZT%#&W%C%7(B_RU',IYWE)B3W!9&UH&2D[3B=EAUT='O]P1$EZ
M^B&<:"M1_>?2A720C3D(:%G*B_6&)6F/KLTUS%Y-)RM4TS[Z[N2(+[HT;D6\
MG\[AS.=S?%9>FO=3*&V<^Z<XN'(<7 F;Q_),/J\4>%&*/6YXC1BXV!B90G4X
M>-1RV=>?+]=G^EA ()M4W"DRK)78ZDF&WF;E^)6JPXJL%[_7&P7[>7P$RU:>
M9IM21I=J<B(*:9>3\2>2[')23+N<))X+>]Y3+166(7;9:) .2WBG.78EH_&D
M6OA'C;"2:6UDRD41A]E/'0ZUX+K5X?"7)#S=/Y^KE>3G125;C V<]2A[9DNW
M]9>G5]%W_&3<4WF#/KE]FA\;S@)DV>&T+8DW4<%K/T[>NRQ"[IC<F[L0YBUI
M'=LM-J3Y@H!>[2 -W6AP;0T,1XN6GWCY@SB8R<[0V@]\(EC-M-E@!OQZXX#S
M'%;^ Y@C8?7="3>8L6@U6):A]\)P/0,845@N/9;O[N9Q>J#(!,74V&8CE-BN
M#V:G5WDIO.XFO05+^#Y5CTZODEI%X;UT\_;2E.8I8K&67W%Z51%S$!61%X3)
ML("77I>9FX2X(*!HEM7O]K/T6'F^..[,S4+\$* 2RK(JPB[EO#034*%&]K-2
M$9=M&G=4';Z?//Q^Z+]J9P_U;6)0ZRF9@-<'^?6 "P;\6">A;AK3*RB*V -W
MZD2.11>N#LNV_O[#RMT\/!:62 E:T3U$*5B3DB,'DN.X+YP\/JLU2\'2"E2'
M,@$ N%$(A.LLO!M.8'^%0 D9Q9[$SNX5A<1K_'45S&OR!V[4B*Z1OMLIRZ)P
MPH9,M/:#-;O"IP;$X0B=W825&J%>8=T1./(9K<FI#;-+JVM99Q ZAD_E4!99
M6#["EO%*^G$I*K/=%.390QF7:DCT7;N[[VKU7\+I1/>9[<+C6'<X8Q30B@9O
MK&C(4*CTIVP $I"Y_*TPWO]O=.)0O 6KPV*C<??CB%R_'&W['+AB=7A^TM9N
MR\K==;N&"2VA,V8N37N$<7E=@T:>8KWLW&I+*KEQ& W]$(4VJX*N3WSC@+N9
M\A<<3$98759+U0RW]8V)D?B,7WKKZ[2L-2#1_4I>.S3V^;]>NS_D,O@UUP!K
ML,HT;Z.PEYXU=:=8W40_I75=9A-+Q0E<B:M+U]W^03JK76#EY6[U)VR\9X#)
MJ=,^/^PT6$Q,#X,,2NVKFHX&ZSXLND_GL-I8.T$5\P/N)%0+1GM#=%@"'VV[
MEIG4D,*?R'S465!WCTKU]_*&3]P6+G5RQ!HAC=PU(@08?=?$P9\B^[L/7W+F
MTWWS]NK^6VZ:1DKSI!=YTQH=_44P.!0^)TW-O<C0KCU6=-'$Z0<@.9%>FWV^
M/2V56Z_ZCZDU)LE <A7NZJ*\=R@5P22:'B[)8+<=MV>F1XJCU1.\W\N -BSR
M*"GC4M(<^@DZ3D_<4S[$UT](S;GSOU3R5CPSK3M8[\%_ZSF\=#K:RRWKI%^J
M_="4]CQ#;-$7KA/[E87KA.2/@G("[T_.'BNOE=.GAZ&Z%E"N!/VS@/Z%(B\7
MIL9J>&X,UQ&\L65+5(_2<,D6E:X1*LL9>\&QN_Y]4(H+3.(^>%G)?]<1]9;>
MJ^\5[(P+?W$<2P.!2JM&S(I*O1*-]\MHNCC[)E\\/?TD-S70T!S-0:7EWW]_
MGOS\]]]]!=CLF#ZS#^2[K[WOM[5&@X#6 P>3M/>:I0M9-#XI9^9&==-HQXJX
M.5A$(O7U[>.O^@^2K\TO%UWO=M='$C1]*J?DIA'$8IW_[VN#I]>[1KF^C9W_
M5^W$.75[,%>(==>&:YQJT^0$01JS:<)<8LXZU>'C@WEZ=N0\-!^V"<@1EHQ0
M'=X]Y!^:ET_U8@XP[4BU =98GGFBZ3U4(4 #XE &8%L$CIXVJB.J_SVNX7[/
M-V?P>S9^CW;PI'T$ZZJ.7?K<:K>&UM=H9PC_*VYK"U9[ 8J+VB<6!H2 @&IL
MG"==D U>-3L=[". ]@MG]AS:SP)7"TV#]F9 'X>?11NG#^(.Q0(=[#EJY=!6
MW,!-@.S=ZNK,C*.-;Z1&ZFK/IF7: W=LJ.%H^W0%X$RL-P*@-!S,IJM;\'IB
MU36;!"UQZE.VZ[9V9=OA_,;BP6ZT)KP3]P#LCPUB==P&3V[K*]HN!\RW %HA
M_0_]2IK7.-S]RB@DO$O.1$ B='+-\IQ*(8\318 18'@OV[%QJJL;>WK3+ %\
M// $BMJIBZ L=]*_D)OF.#^*YFC%)6IC2Q%349/;7G5XI3WWKW)GI^<#,K-H
M-OS&,*Z.TFPTED;1ZQ]15+L%19HCY:ZGD46Y%:<KEN3O]Z9>W'!%)QW3A$<(
M1L1N-3RCRX>=MT)'/1':VH]-5\B.PS-&H6,^\/1\D(D@,1+[J$+=GA9IW*&4
M+-&N<M6A??RSV\Y^M[X]+5,UL^9R2'82[HCSS\+1P_!NKQ;<^,X72<:IP5MI
M#1OU^:T.YQ+V-M%)A;Y-2%]NCYJ%^;U#F2\4IYJ%:4%EBI')>2CFXV-AN_!Q
M6IE]4M('X7S39?E\KM"Y*)QTRUGQM:/DUEBJ.5>Z,,.8;36>PO-Q.EUSK<8V
M$>0$8JQ=,H"=E^=EL<@7"[$+V]9Z82E^K1R_5L7G\X*P=YCC"P6%%\3\)K%K
M6H5D0@S>S?/TF7LQ5R[\[IX>/3^0=519S@.(M[V4X%9-<*.(L&9FGA=$6CPO
MB;Q4C-W7(F7F?PYNK8Z12XA961G4A&+LPL@=U-1OB>U86MT9]Q"]7-P5._;[
MS6U^V_NJ!"=@H:"T?\7:^U<D0>R1B+AV>8+Y93RLRV?C4WW:C"5%YJ61>74"
M3-D[+"@2#SK2UB%RI$P+%ZU]$/R>%+O[?MI[N"\^U<E:K)*T]TO"U+[>YAN)
M(-W:)5:6S5=7\GP^KVQA!X\4E_\L7%Z=P,KM'19Y*2_P.5'>0D1>K!7-&8Z/
M?Q&^_2Z_O$O%R?8JR>=JL>UG(W8_I5_--I009MU*6&_'01UKK!I)[44L.#]^
MGJB]EW6 ./GS[>:M)#[<@B:[5G \M=OR(S+K6)3&*RGE\&R*&8M4AX]23;T0
MM4IS%]J'5,S2Z>#E^J?T0N?KT8-EW)-%I1>[?Z+%B*&1<VP&7;C8R9O2-F#)
MIG32D>D.I@V&F6I&4Z>M<WBNH5FDCI75.,C6\'[C,R:HT; <'QI<]P*K=H)*
M[2ZQ;-,PB$[3GCL$4Y/]^=-L[![\<D)7Q(%Y\ +</GL%VS0=:0\/35L9)YW/
M7?B <P%(H308'1/'WD@3*5DR[[7I$$[,+5 TD*\."T^:5+#[]7I3V2;<6E-6
M;C Z^ 24&Z=4,WO.N0D8<6P""EE&)"7+V3%*'LFDC;UD=5BJ%'[VCFOW=V(C
M<=@G/V%XUHJ3G."H.KP];_Z^?+U_^6$U]@XOM=<>:'7.@!8G48!P+D2B"JK#
MG86PML @2+0TP3R4]$Z;!*E!WQ\_'9B.(O19AUJ'=]N:.U=2M3-O1-=9!EZX
M:Q ^VNU9-D[TA(]U$W0S.H,6SOSFM %B.(ZZ-9A3A3S:IX4/3V4*7J4&^?4?
M:U"Q=P@,8T[OH?#T0U8XA54?7IM>S>C!86Z ,[$>5C,JU^3L+RE;:RB".%&Y
M)DJ*F)-I.Y3P0:97K^5H_(LVOL'_C96P,?K'8I4><C><5XPLSF2[Q"'#6"3(
M$L7G R [TI3%.8;5*I;9!U'3.!H\P O*QHVW<LE?>#'@_.X5R.O;3^,:!/TX
M<"19*2BBM !L)/3ER@PTHY YR)0FNP%AXP_KA?;S8(,#_3E_<R 3KE4]9E\=
M:SSUNYM]MR\J/VIWO^<9;NX"JVTME1>PNW.>ESS@3"F=PZ&]-@FU- &;K:>[
M/0C,GA7Z"YT>BL>)UPY$=48G!=$;8!]9JF:33&@B/36:'4Y%*4#?ZK4,PS&N
M#+\([=C M4RW'0NRQ /NPGQ#EC?*/I#7^?UB'/4%RVU<;0#6 _Y$C!8\;V0H
M__(XKMNW[,9@_Y[  K362O3;(KP1;PXL8@PPP1IHH(!D339N$K MHIC44U[/
M- L-\HY&"RP?L'7:&YCL#C$J=)T;=QEF-H_5@KI-NU[.+A6Y]B+:>F&F:WNQ
M=\WQ 2S6Q&N^#P"V+A9X939>9J:4MP%NU=M<BQC(:5Q)!I1;)Z01A\,=+7X?
MP @K[@NB+V4H*ZT!^::<2%.KSA>ZE- +$[V9F<RBN'<X_TZ K)H]BW8[:8"^
M:&FUL$9-.0;[43K@REAUWJ#\@H^<N!C(J*X.=P1'H(\9<%K. <VC[ZL+7M%D
MIM=M>+J*19HZ,R+JM'V+OYC6 03HNSV9&"5[4\5MM^%3O4YT%WUPRZR]"Y;3
MLZ5]?H/Z#"Q)*Q4SX]L'#:.'@\"9B@,_,7Z% ZWKK'>$VXN1UM_#:UH6K;^B
M6AFS2N#GW_Y;0>6QB&H3=\]E[(93)[:M6@,*/V\#W)L&2IE-R M^RZPYJA9
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MIY&C;89W>KO7/WJ]/U$2W7^H'=L*[SAV&ZB$9@5]8/Q/9!PZ.7$V?7S0<DG
M-%7['HOH*13B_B=<<#^6XLUM^VG]V4IQ_R.+8T?<"M2G'X3G3"6!^/)>_/<M
M,]?J0Z/!=N2 ,69UG4XKHIFM1KCUIM7A[T)+MELOA?)J>E.Z CPW?0:7!H2/
MM+T_RH8QAR=>[W*O=';'9V_]9\[^L\D,.0K_=4;;"K&XQSJX2!X &#3BS&-*
MIU>M^4YGCY%?F"FL:VIV7BS0N0FY(B^)L?M<KV\DU<+L<$K#^6387,(:?X3B
M_F&R3,:*271K*8 6;X%=7$ZE.,867#?-<]-LV'>@\U2'K\.S%[%+7G]HM?4T
MOHXUR2$IO0//2W=D-KD6'IHVH$A;Y:^R57Y,[462EM!>T@$*NXH52>D_XQQL
M?8I0$14AN9#E13'V;,Y-S$E(5:)=E_@I@)91B8Z64XG.L:%6A?;3PCZ=U>'/
MKG,_Z)_WNV>M36E$R9 >/1G'CA9/N'U<CJU9%J]..\DNH9VL]?!_P5TEI3.,
MD?C:5 8)^[@5%%X48D^I2'6#5/2E $I<-PCUCUR ;_A=JD_?N\2P2:F&3<GK
M3E4[J@[A![MR.?SU=KSC:H)_2LX]YGB4)D6XE"(3ITAI*8J\)391K7J[9#1.
M@J:@+MY6-4&L#K6*5OMM7CU*6G.M\VCG$Z,4*U#*#DCS/W$3H=ZGJ5ZXF X/
M.ERJPV_ZKJ:GFR=%]NM3YP&?E!PO*=LWY?MT*6YZI^K$!IA>J=8+">DYC)$^
MYLU6+_]^H>3KVZO@Q.&I])BLJ;-WT)0\%V2E2LI*-WY7B;#2:32_/BXJ 1<5
MT"D2>P;MVMCHLBYD.D=$IZG]'<W0Z.@JK4]&V&G^MB>9V1?YYDY:JUZZ9'0]
M#F-USTTW14=@C)P^C:=N091=SJ=1]K\(*Q+SF,_F:.L3%MBO-"OSV<)6A]P#
M"2(L)T'&/8U,9-Q^^YU_DM^'JK",*V.3N5ER#.EQCTVU67*6[X$DT1[(E$ML
M0G8H0BH[_B*L2$IVC/.R]0D+,%+S@LP7Y=@.FLT*BZG#=6(".)@N6QWVCW[<
MR'I%N!:U+7-[+Q:#PB&]J<6_(*.64^_,IN_J<_+\,R#OI%FH#><"C)K%2[.@
M>(M%OB#'5KP_?$-?$LM:F:_ZI@DL:;A\2P&48(#G!GO4,C82E<*B?I>:5]\%
MHC1SNZ@ST :\KL5(=_%9HT?]DN);2I"K)LC<<KI[V6WP/N+G>2W_,E]S3>EG
MO[';D5;O=!Y5ILKA@HK\,A7]J2*_G5GG8Z2^/C=(#E1WB2]DUZ>YQV6:RI(.
MCT"-089Y76UHU>%[]^Z^K+Y9QT>%/R6>2L_)TST9)&:Z7^KM7"E'SJ95RG\1
M5B3HQ E8UOH8?W[O4(S?I&4U6#K5B3/2NR(16Q9D@50=9AM]Y]*VS\O*,GDU
MB09)%^3TJ9:\)$].:S,W?U>))"-.TO3ZF&6!:LEY>>K@DC^V-#,.@TK]1"F
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MY@OY^;@^O:=[3 (X7E9,GU:')^;;]V/[ZNJB*R?'8Z?4[ ?OAJ5TS,'CQU)
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M&03/=(VINFA#L,FN.(E-+V*[<XFQC3H35CK2,*K(_5!EBSLTV)2#E#Z6\2W
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MJ/5_6-^/&JFJ\-3EDX):#;]W?R.;%CO5YM9NA9?JU;3(U=O1)Y$Z;_IJR9N
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MK-LF?TU!Z5 9C<O2?4?-/,AMO-;.Q%K]Z%;LK!RY9[M'IFB>EH9?KVSM F@
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M?KEG37'Z"(?RW^0X3_&[.^9@TK?N?E^L#%YBP9,=%&)4T-PVC]-CVD#:NWN
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MTU/>EX,M.:3'Y3"R)C^5Y'?+O*RH-^UOS:5@CY -]A1 $T[AC;.XLL=:_.7
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M65&]"(3_&I0S%^)*F)0 1JWL)$.$9PFP+/SHGM@'A[!3%JLL*9A6<%,2%.^
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M:MV^ G2YX"R:D=PCM&/:&PW]K>>[1F9<8HU\L:P$<9( &W8DE"L"7Q5FDK>
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M[= 0F!%):A19=\%@CDDM#PSM<AV,#6F6LPF-.E]W!QO'N,<TNS06-11!K6O
MVJC65?Z.*;(/&PUD"G!1T\@[\$8LOR6Q8U^V^Z4C;&U<\-RKY$+G(IT2(/H_
M+>0=;/D#0]A8L")#& [N@7?:!+,"F-;YG>R<IL[;?7_R0L D0_-?W/)@J=(
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MU, J/H#.,UZAV<A7AQ9+NB".U O9]>-1=\83&8MQ"[$2P1T^3\D]#WXI:..
M@VR\Q+Z0OXY]B60B^=_^^"2Z/)K"W&'SD]Y0ERT0PRJV4'3%AI=60_ /,ZT
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M')OH7O_#O4Q_, -9'TY&[B__#U!+ P04    " !K@C=9)QA@%>9#  !_/ $
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MJ?@8QSV35'1:\GZ352J><EBC6'+\2O@CZ]+6,%.PK>TV4%B4+48WJIK"(QS
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MZ#>1&[3&"S1B^A1W"J':ZCS X&1L9:(!.\.5Z?EA6H63N!'<M1XRJ@'_LAX
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M%&B+G/E46-NYJCHPEV==,<M#J <8)A7E<."E^NR<GSP,?N.ZXOLBNX]48RJ
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MT"F1+%#@"9 <?8E#,?4AWSZ<'/P234X/S@Z.WD7(^8$:\9&]@[.3#T#10*S
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MHB) :X((30I+ 5->T,5B0(QX Y__#:@1B$?*^2U>VQ& $T&:LK*I] 6J0A"
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MXH>QB>FH.LEA25UI>(7":@6SJ8G(6=3.,Z-)^;*@9#5YV$YR;0R3 *]H#6$
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M,GEFR1@<HZT$/JB+YT.]WV@V0S(N)Q.&B3=C])=K##72O2=W%%Z=509OM0G
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MTHD1%&K_[G'N\E9K?0ASA A&\A'?9 33WA:L& #QN_<,PH!:#J;/"GCZ70V
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ME6?UDUR7+)9Y5X.X(9(+4<N0^ R9WXJY]RMK07)<Y<RM/,K/LW(:#TV<SSH
MC.P6Q'+.LE5H/%</@T-\JZ48'<+-;<_@AJ!!#(\+P+]TT:V.6/+:#QVSG5.6
M''[(L^#.6BZP;@[;K^[R@6-QS^?3Q&R!/DSY$KM (.-@+RLC4I\K>@8K"%<1
M$DY<@8B=T2Y&*4;I 4XF$_P$R[)P3+X8%P)KEVUC"^]EH!+5@M_)6HY=6LAO
M5N<^GZGG^/(58ERD7M.#"-3,Q5K&(6RZT?AE_*8ZQZ?S81\L;L83R$'JPNB]
M1P'O<905Z+%A?1[/2@T)^5%LB.N.ATVRG5*)9)H1<F-)_L!ICLQ7$XMOAT<)
MN2,%0B\VQ1;4K@0O(!-4[RY8O2'5P DC%WW35[2V-33=%UDI%:G1D0/J 8F'
ML2;)(?'FO ,CH5(.Q52KY3Q&W\\W]^/[>0_'[IE'UAY[C/Y170DOOF1!^:T_
M8>8#WC7AUB>N4-WA'8:$E*4VG(<<<O$9*F/9.V,NJX&GQE@H=98%A9;*K$#W
MQL(W"T4_ZKVNE!2>="ZK,,H<LHS#IF->QUQ?&^7HL) L$$;$+NLV945ZG(Q0
M!TPE38DIY"3;(4YOB"L-4!$L)-AG@A^GBGV<5Y=<J]9[R3')#/,7*Q1N4HKP
M^E >#BSL)- E<%=*SF200GBSD*"3V,[?ZLI\2^6!,FM8P^K'4=P"KY5&[8@O
M%K4LK&/5:&$U'9W:U!]C3:"HU:E-P7+)_,SFDQN,>V*'W31*%BXK1%J0#/W=
MHQQL@ LY8=PUV*M1!K:"D MKX2^W\AZCA/KVWM(Q/\R]Q"$^+6C9>ZF*)YO_
M#4Q"62T, P#<1YE[F*_I?J-<.:L;!FQ<%'I Y(8+DGW>:N%L;E\1 S079"P5
MIQ.]SKU+=)-L4W(&S7TCRA0*[EU-,2'U-%WV8>S(\J,8):-V''=1N@H,QYPH
MFWQVC%'QNYXYF\JLSJGKV #0;=L!L;/23MXN4-#1X8#V"XIC&M<Y:!_C>R""
MNH/=]-V]<3D']!DPNUW"C)6:.BU!S[Q"JEKMOI&C)DK&5W12+BJL:\-*7W6<
M245)\OJ^VSS'>;/9C71M5+,7YYI=2CD=_ Y-5(^?Z>S;>,L[DF/&Y5* !+/(
M&WLT&SR\IJ/%A<$0WZ%L)IYF:YP7%^("Q\1DEZSF2&VBF"VJYBCPV(WE$Q^I
M+9IQK*4XI9&/<8M]?S];; \&L[K*<U"F997)@71CI)GS'DI:])+<F&4VJIAU
M$?/5YUZ/7%_K'%&>.Z3QZH?>ZE7%VS1*\L#5W/+:-6@Z]1E'XF%_>4J9@ZI[
M4A(#L2$=IAC%R^VG&]--$X<BL-NFBGWAJ;*NKW-7B$ >BZ;C?$)V;)EG%WD_
M@T%.,Q.23.J"SX,'1K?0,>=$R7W5L[H+?K;M.]T3 SL  <&T.A!'=*1<7L0"
MWT//Y$X;BUJ_9,S9HJ(T$]3C)TCPV=I<#C@7T#G=D"*^;+A@.%7XPW)H:,O@
MWU37!>/B>7V!R"+YS7X,%!OSF]R)8IQT3OY#6H#1Q\65_HW&YYQO1Y8B;ECJ
MLNL;:S>BO1NYC+BEH'75>1"W+^Q(.E8T&8)!"W?_R VVM6\#KY,2O'8B7.:L
M%BRQX9([,%%;=]BZU]T<>LH>@/S3@BO,$>'6HF#CV^](W'%DTV%RT<;S37*K
M-_YX[,<XW4*H8;!BBL$;(I>>%8UW.@D7KQ<4DN1"L,^KL,\Q-(YD'SDL2(9Q
MB!8Y:5LE2 $CTAN#U!!Q#Z2]C$?=ML-2S\]8><BNNY9.E!MV<WW-]Y/"!ZOZ
MF096=2QMW:%$M6Y(NO*8P/N"SIL#R<&+,5GO.O4KLN54'YM1(.",\[Z:7 ^L
MH09TA5%WL;+^1JY'A#@C.HTBFL9YZ5#',_@.*_R(4[J5D"IO;O06H0>W0(D.
MS\ ;)#TAIAVFJH[Q#GN49\[=DH(.:5WSBZ*N5+ZBJ6"]EA0EHD,&(WB4)>=Y
M&T?Y"FM]M<4=E83K6SU<N*UCL;"!(_?T&3K6A*;P)*\E"0^<+V&XD_,\*^DQ
M$\PBF.:M(PAS@Y&0R?#OK)Y42_:I59^*,>)$=-=@)"QK"-:P@ -EV6KV$07V
M4!33X8>.!1H,8W!,N!8 L4I3%,.>?AY][$Y![Y#@-3Y3SP,\@/8G]?RFIQ.&
M),9#8PLG#&H#?45>--4"7\C-3E67$(JW1XL@?7JWC)T#>^VT:!G<Q23[_2I=
MO^. \J7P9ZY8RR@Q?9RLHX9R1#T'[.7<,PS.?&3:24?>($/K)-SZG*A,"P(,
MA5I%+J7]IF'.+S,<XBYOMI(=LK218-ZUB[$/8W5"GN>E$ADPL7GLXNJ>X75N
M[Z(4-:K<UFB4##5C0X9(SU4<'_,9DG3C&&,CB2RM":L0BE%B^/ =!LB\'8,J
M,X:_Z3+L%KD&V55(WVL>9=#ET;(H.:.'.^A/ZKY9?Y2;Z&Z)!P>-)(E.W]+_
ME@EAJ601\9^UU*H>5V><\^C#Q[@I$+>D,5K5+]F[4SE1"KK21^%_%C02U_IL
M&+NDH?!8QP_\7A0+:60)+>KE1 LMC6&N*D(/*68I= EV,\%Z10@9#?,S:,HU
MKHM^QZ6HXG4^73;L,$,#0$$"2$%/5=L;I&=I'=LGDW=XDH< @VF"04D0"RI:
MGQR##D&!P]:@Y5X*5MEEHDH+F 6?FI )0SQ"D5AQU5_83I*37'(@7!Z6NXI,
M)/U6E\BCW(MWRSHUL!=MV)OUF-N<:5+/*(G+&=$TCS&Y9<HY]=8? !LQ\ $D
M0B8ZHPKT2J1A.?,D*U@S@"GXC!\"LQX.RU3.'U2_" &7=X]'GTVL%0\:=3S<
M0/42&_;F"8@='S5G>)E(/)91#?7=.K^HQBZ$/JLFWK%M%3@SOGYXTXC*T+%V
M.$+@*0$:P_M7SX][1I?%Q$LO0Q]/FK$W,L+X@/5\X!I*"0QZ44R6IBPJ/M"Q
M+F&#_I.HY9_>;;+3</!8QPR&54=MUV<L[[7CZ[WS?:=)P8:=P=N35_P\JQ'G
M0KPM0C'OS* 2)I+.X[8N!-PB+_AM.3F;2:QZC HJWE-[U*(L!KUL$#&AX6B*
M:M?D5W(K36N#,^7YC6/)';<_#UV0[7NK5B*TW2D3TM">T/?M[/!'N0/N%O(U
M9*LA%=,M %Q/O^E';G8V "FHYZ0;3FC!$@R D1.$X@I-"?V=CK6PX.\TGQ"H
MTKN]O6F7?8)E 2L6K3/)>A/#;%QFBNZVS/F\G3S=!H&,+1&#[EAEX6!6*R6M
M,HT('?84A_ )%DIHY7AE7),Q9D>*<VKA%X@4<@6)"_KM+*LG9<YH*E#TZ)VA
MWHU\5N=( ()QOYS]XA[,L20N*;KCVB'2<P_=54B6Z.A!8/Q%.)!E#N<7'&TX
MC 9]:2!W;/16M1_1<X$"9PVB;Y6-I*H^-H8%RKK7)([#8%%R;$GM,#'%>1JF
M?-P2(!\M8JQ0YI,1'51?I[9_%&C8S#I!=3YB?<!2&S0M_-J8AYJG@MW&P<B+
M<0]WD:'N.9"GG17X*&73W8*]AA*/I6:"% GNKS0G@..\@,'JKR$BZ],$A@:9
MG<6-%%([A^5"W6F*>2T$5B+;S7GHB]95 ,0]E4^DSB&OE(#N(X)?T3HC;922
M9%2!'#C,G7TXR4=!3+ TR#=#2XWAEKE4DCS#?IGK-J4:(ZUL./Z%Q7)D^9\%
M$N(S8[H0R.J,I93S(+F1M[.BASFI_*FPI=)4:O&+7,,<?BQ3+C0(\HDYS;G(
M*,/+V3UNU &%"+><D6/X]N.D@.R*;Q:)RJ9 ./;8!AQB8VS+Y1RD[)G$T#"<
M5'GC7&QS8;Q'B!]/W"B_JJ36@Y8=D98Q*(-G-YB>9*-G%#C2T!8S]0RZ3DUY
MSK1]7,1^55<W>Y))JQ#G.!QEDTH(:&1.9%Y['1]$=C@E6H\8#VV+H/C,5%]/
M)>G>I9Q<_Q'"]6ZQ?X/^183#DX23B;[>T/$5NXL;&/GQU>MK.U/,4N>H/'ZC
MF(3"MV6L8H[9A5R(/\? Z=R4,^BVG[+3X=>GW[_8MC5''N4:N%MPVA#:,Z_)
M/VCX7KUGJY?!RYZ<:4C8I3R"GM)KE+>7Z% UB\.G"TP[Y6U2)9U$$,DY00>4
MT58Q_*E#="$^6H%TK61]ZNVT(OD!?-[VX)U)X?9VCJ6SV,?TLA?;+["-Q[Z2
MR,F3OP64!J)L()RYZ"_%O3.?(R[GF-1-;)TOY%L1"=@G& ^/DU[P;'A8=,;W
MS_*\E85OJWD]QF7][(O@RPZJY)TDXH$*"<<]%T\9E&^I]>3@JG1RJO$_+835
M:JSTJ&3(4.IMB@B01B,/:B10NCX\4',"&],4*NPCWV<3(C@BTI*-?GEG5N&;
MP1(G%>:WT?[J%( 22ZI3;I#4YP ;]1C7U!?!C^R,5?^AO7I,YGE<5]'M_*,;
MY%!W0@AAG4 "@?O2!^=<^0M,9@&[^FJ,'J/>4U:L4Q'%<LH--2W%["0N6\Z9
M\D@R"C.&(#3L?8[6CL\*5-]#!"MG<,7JUM5A1J[0!<0UF3CJR!KNB&M^&\[7
MSI51V<,.7#\G]@/5GR-SSSFS%+ 5_D2@0"FI24.9EZ4N@]Y,^8NJQ!38NI!*
MB4I/EL,>KF;%&.DA\J;IJMSGV208='8/HZX/[R2682H+BD;=><6<1W5^4<!>
M6;T:0-X0[,V:9+W\'D%TRRU_%UZ"46'_%L^+)QIH5$B"Q,M+#>EZ)CE2TV'J
M9V[!ER ZH07*/%#W\L#WCJY^MGJ)S5F 18S=&:F3,FL#E=4U.I;R>@!,NDP)
MIH.X)TTHG4:6 J\I4V#";Y/E6'BV0Y_I!EM?F6')U ':['3_AGM=Q'Q$&KJ^
MUCMR0=JF&;ZD9_ >Y;'P1:!.H&J\KJN/N2NNF2(_WL1_QG'F&L0[O#JNDK<Y
MQ^<QIP?FRF2 @*G,#TMQ56G)UJ > 7*%R'.F\IRQ?XYS+:F9?RW(R&<S]]$9
M81"Y)Z#9#A8$"R-BMZZC]B@7VA>! QV^W=G553*/\WA61B+GJS+*G0;<:V5A
M4/F,XHYJ:Z5>-$K$.U2*^[EH0/;\M3_R3X ;EJDNYRP.FG(T:'U-PD$-+#KQ
MUT] Z2"B;&^.'5++L0%@;.4P\P)"Y*!NY3CEPQ#3&^36" AI3VO":5]9VBF>
M Y\R\<I7ZO,GJ6!Z^FGM"5-'YXQZ1AWTP3FG]9RAZ"^<C!/FL:N+T=)$BRGG
M@'AOLHL,! -L=L'\>:=KU3&Q!19$<^*/.,2:(S3XMZI A04^HI,11V3.EC;O
M8YELM+SE!B0EH]./.^7=.)0YD3)3U$?I,8=QFH3KFQ-[ O3JRBRCP14@<^)G
MOG<2X^6 T_4H!<H7P33!8:,[9+>JT;&:'*&3!XM(#0N:U?BYH6H./V 0!0/[
M'.DUU4$<9@!7-T$>7+@/8SU3VH_3)>;N5;4'FKIU@<Y\Q/,X7U#%149;=0;W
MUR(EXRKV%9MBX'Z+^6H^G23X]]GE*X5!"$XV[(P#1:!#C.(:%+9DNA 6L2F%
M>D0CY=R#2W*]&275C A]7-8+*6@GT+]5PW>)LU)PK67G!X-Q)"+4L+3:X')@
MYE8O!]_N'NU8.:@MZ^<1'* !K6S9$0> *1J^S4U0G9=@;4*'@IDB("-IX$Y[
M5I$QRY!)9G6!WXY8%#$>*C^>'ZXKYZGFGA:'5L1ZH6RC"W+UR'-)'I.1)T4.
M):&-4)=IXFD, F/X*L" <=ANF1-:0>_4+R>=O!'&[OK1?)12\(L P':P1,,O
M(.BPCC2M1UA5WC-C* *K:8"YOA:'S/@1I<%T.9*PE#A@V=(8]"7]A,D^5$1B
M1BTL70L3KI]NMEEJ=M_9LD#V@#D_OZ],36'KL_/JUBP(WHK!#0Z S3D%<O@+
MSP!E33 ?9*K=-/5F>@JT>T$2#_SZ&B=F&=$BV9"6[4E. DT09!Y$(6?*E)8)
MOQNH0\WI\SVD1[%86%_K(Q*3!1"WG7.3BN8&NK;+Y32D3))/I:;1H]RQ7P2P
MYDG#NAAL2IU$IV/@Z"F$&4/T89-W&B>L]GKWV;GO:#<#5Y L&C&3:0[9/>?2
M]RQU9R<7UV5$(/<HGR4^;RFE.HJB+9C'P-$HJ@%ZT2S18A6#]9Y]TQTC'Z-S
M>&XS9D'OR)BIT84GD35/V!Z5I6<1@J<R90/Z$H.TRZS]C]D(0[6(MI(=>.'$
M3; =]8C-M [\[[JSV"7J:UWU. ?[W%M8P+*>,Q?R-:RJ49WWV'/?.RQ2L0W[
M&Y!BAJZ/S:"P8Z)U'0>9:TSNEC"L)CR]/02KAB[:,JPZBO,0U!;QJQ*E.2F)
M_42KI/JV-R(T1S1=Q+4Z3&C^I27@-M.K?C:W*CV,EAINU1^2Y0*4!SP=23R^
MV/J#V69N*$!?4S[+WM'QWLG>P>G.Z?[AP4FR<_ F^>?.\?'.P>G^W@D8SLGI
MSWO)_L$_]DY.#X]1AN C6(Z8+2AK77*1M"YA'+MI$,I9(I7R#X_N4'NQ=;?!
MQ9N[^RRX"8?W[TOHJ6:X>*D>!"5@Y\W(J%-HWY7":5(NN[RZYB&9HM<5/21=
MMQ5BC3=Y2;P+CT];>;%UM^&!FQL<-FOH5;+'Z;LH25\E,?D:QPWV?7&YGGE7
MNJ^5A2+%;&R9,>86(4]29ATA^.HH'#$5<XV"MK'EP:R/H3=PQ5WR02Z.*9=@
M,O@"M?T1KPB[K\DHWNZB96\7N_<]:<IX-WK/R'ZR+9"954P0T!'82P-=$@]+
MF$56^$P#[M'-VKR^=FVC'0NU&1GO\G9K05GL69/DN^G+42'<LF92 AA=A:Y^
MFTIN668LA7S,@<U.$ZD_[OUG8BC*\U@42<T E5'0>$7 F"(/&-:6NJY5X,3Q
MZ$_4,1I!AJ<1#C1-9FC4PIPL9VF (ZU\]<4RHL](0R9<5Y!"R#MROT4)2PLC
M7R D0P-\PK;$;J\9_/@8L]I?;-UM%.LV;NA=L$!@FJUX<[(@]8) $F#)#C)A
MQUL)AM%5!%9027:CH@?Q?G/!'DP1&$LO>%^0?J0E#[.P GJ?S''UB#,I@3[Q
M]8[0OQP\/15O@6YT4T!ADD\S?.L&]8T9;GDD4FZ89M?B-EA(?PNN CT"NQ+6
MO'J)J9AJ]]%2+"AE#_,%N5?)(&4FP=HS?7E,4,I07#Y1L,Q+F==N6XYQ-DLW
M/&E@C!C&P-3A4"D;5J)4L-];A-WQ=R.0+&3Z5;8H:YB#&ZI,M"ZH,\@5P_.4
M=_)\Q.KBJJ;OL\L>][+U";C:M<9?U#EE3,7FJK:D^ES ULDDYE5SJ<>,+ D.
MGDX^">>'#T8_-$C"\M/0DG>8RODJ'P($Q:&>R%Y"0%8?#O%&6TD__W^ $'BQ
M=;?QO,]!^"/C(FJ8.V,^OF!D=3WVVQ(RB2N1;5/Q?B$$39)0N,R@"01KM$K3
M!2J1CR@2$:E6@?DPH813%\/J,6Q<HD#FVU^X_<29 JIUH-@AE%X?C6BV&<-I
M8UK1KGJ=<D4_8O$0?'#@8?+X+XS8U 66F$BY+=[5N+[65(MSM+/&WJ;SUQ-'
MA,>1$8V.O(+C68YY9::9/VZ$)_E8:DDKU6%[M?#)-@77<*6<'U"N< @4OBF3
M.X-&J )#)"\,T#.O$ 3?0:?ZM"X)-UY<?5KB81\9)"G.2S=G^$B<'FXVGV_*
M7H9=DR7E,9[*Y#7*,U=)R\$GL<DN%FK:S,SZ="K R))A1%FA>N(]1D%R3P5@
MX?1A4_0X=&]N43&//<^8P89H<(WU#5WC =4E3F?"@*F8ALL-_9&4G,;G2/QN
MU-'\JT/'U'^8?_'E@_$O'I[^O'><[+P[WMO[9>_@U+D3CW:.T;M(GL1'M_=>
MWI<C\'U^ALS58%RWXRWVQ'ZMLMP[;J9R*;H:JCGSA""K.:5X@=RWB2^9"U$1
M9V5OY0KO_E3U(&:SI5BT/)6\;!B34T >FK$SHM]CC5Q<* ':&C4B@W9C"6H:
M,U"*5QHC$K/+;3F_"LIUD,/6Q-W0!?*UMNO02MHUG$^@+"$9[UCU#K/*R.S2
MV!N'1S',0? ,VK6@!59)67&B0!'RD-#1=R*V$TB7.XV-H+R[T9&$4_%_#O;V
M263#?T[V,)_QP_$^2NKUM8-#^M9\E^R?G'S8>?U^+_EP='B0[/WOWO'N/MS%
M,CZX/?EYYQ][R>N]O8/D>._=_LGIWO'>F_^;_)_^ZPX.3[O7_A,:AL]=7S.7
M8[!J[W]W?]XY>+>7[![^\@LT:1_:TFVK_?$MW/<KC.S.*0:VX"WO]W<.=J4;
M.]237XXP&I:\/3[\15IQ3/&QY,/!&QZ>L!V[I_A8W(QIL@.?X;1[L_<FV<!6
MB+T27N[*U6(?X#^[NX?';_8/WKW_-4U^V?E5Q@ >^A:[CQTZ.7Q/G=T[.DV.
M/AS#T,.6.3U<7\,6PV6[I_LP=D%CJ8MX\/IF)W&KC^W#L/<[_]C9?T_3&HY#
MBM?"<.TD\/B#$[@9?\%VGGQX_3_P>E#3#E-Z1]"(X[V_?]@_#L__J!$XC?AD
M&@2:"IKMG:.C]_N[U!2>+'/;^YU_GN!([_UC_\T>W/$F>?TK-.W]WKN=]^MK
MAT?[!S+5NX<?#D[VWF/G\,W4=AA37"&'T/+=GV7PN.70%7@5M@!N_>?/^_#S
MR<\[[]_C7!SO[9P<'D!S?L66PC10R^2YL+Z.8%5M==<T3M";S]\Z/;OD_](*
M@18=O=][\VZ/QF[W\.!@CZ>$QRYY#6U-WL+HP-7'[_8/H!V[.!BG_"0>,1H
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MTZ7C<K3#X+J)K5_%:KQ8T0BQ[@;Y*YOQW1?C)XV$J0+883)#RQ-V#VIEH:M
M1!@==M)!R7\B1TN&W2(N\0$\'V-/XC$Q T:[J+?X!M@"(V4\<\E^W"F>X]21
M>'%:8#G!&B:KBGRL*"/(A>R(<Y<+B,2&4^@9(K'2%LWT*K'Z;5"4@:*5(S5J
M5#2Y.PLI']4F0<I^.#*R2+ST]YA7;!TLK>FRA+.F=)EH'@_I"^Y12WHADA:O
M[IH!@S'95 -4L*R5:&JSV7*NN\Z!(#6WLU,2U2'Y>0FMK\F51</,)5<!J'*
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M,U_*CKS=A,:BW'RF;7%:JK%<F"&5<%Q:%,Q?S,1X<-7]KKOIPUMWW=5WY+W
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ML7 >"8(@]9?]Z"7PUHIOG;1I7TWUSOV@7V@)WY/3?X^)Y'KLD:_VQ\  GOC
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MBM"<7^-B%A[V8N_XX!,Z9"]^/'W?>?O_4$L#!!0    ( &N"-UF^\H&9EF<
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MX4^I/>3"WFY2L^Y9-^N1ZB[;?H!&[A> Z;@LF@^HGJ%D79GZ.K1R2:*,!U^
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M=4F(&'5L0DLBE[O!.$@J.M#4[5@1N_5*Y3Z%JC?& 7]ZI!Q0^5-(UJ9/'=[
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MJ!@B516AB9:,EZ6DW"G],I&:'61[I!C@%0@780[Z8L6G,J /.2NS=XK>QB?
MG.,_33BPBAP-K'?WV16>_;4&V5;PELL-%UD1%Q6^+>Y::Q\#VD:5P8FI[7 4
MP''- [8A$P;39$:)M2@>%G&9<#X:UM&%Z:=\N2@G=YC.1E+!^,1FX:U:.--
MDH(Z!R-/[EADC<O,]EX#QY_R\@LLZF-)*S[<,1@ TX3\ A-0#1-XL^!M#6ZR
M&>P V>0XA/ZQV[$6-,!CAM'U*=\FO)7+A4X6G$[#)'=/;@NWT':^<<A:^>8&
MZG"H=*VT:M,H"L9RUDZ Q')%<0Y2-17F?N,&GV&22XEJXEN@:4YC'N:@.5Y)
M=0K)7AZ)4G[I;D2UM#YK]R^6")P@^05VT25L=%C*4K!.T;XT^C2TJJJ2TQ7;
MMT88?9[,EAC,IO)H*VFGT$,;^U]V2 7 =>H2S":^04);,=]>T=]X7OS.YNK*
M' $B1<-XJU\&ORY#LBQB(] I!SELJ A-"@KU%O(!,3\.,%P"IPL\Q@Z(R,%H
MZ:&/H@^'ACN33#%SC,E/9<W:U@W1U90NXXHO.6$D,PT5.WI)P>0KM4 ]85DR
M7/V7K*/W)BT7I;_0M+S@2U;7[:S[IK-0\V!]R5O!YA37G<W5YMCD?8"Y@^(+
M8IH><@@Q6]B.29V@/*7$ERQ-Q: GF1S:^?,5!66P.K0(E(VT F<6B5\)'WT[
MRS#=)U?QMI23_3BT1BE98-(HH5#+\9( :/4C.N\4[^JLR.I5(0/6+Y"^),NT
M,?I;R7V2W,L&S4&[UU%PS9>S\,5#DEKP\_[6OB?%(;WUAL%?T@CF^C)XTP\^
M!P>;G,Q'O,P;W8YA\+?@I)*[0KYM)[Y#(;G;;#F+*%&&DVDJZ8E2ZV.3Q;KT
MV5H&(:7/!F[V;'TF\)D4O@=,3KOC?]DV"0,5;[P.--NU2E_FF.]VG*H!2P]Q
M5MQ+&Q0VZP[V'S0%K.UIOW%.NUZ$T7BR#6RN=M)4A[7)E1W RG#.>)[B0^]V
M[!D^;N2"799'&Y+!NX\4N>##:S(42>0<QM-P.5.2.;62@-@F=Q]1MF6SCP M
M3A;M$XX <LD668K,. B\H\!T$$=_JSN=. _%>E/)9Y!__)%J;=?#LON=/=]K
M0HEQH(9_]9/6YX>[XN7]YG-K66J.;RH18OSM*L&@'C/V*MQG=T$XF>1+T<*7
MJ8@DL4-U12QFR:<8LM/N%0-NE9FJZH!5'RFB-<X(MJ+4Q#DO@/=/N0T0B"6<
M@S2CT@3E[7$,*\>]H5REDL'/NTA0#<HRGF1S"C*R]:+JD7HJW7]%R2C!+%@U
MHE1=J@),5CY_U1M!^0F@#!<E>5LPDZ((3'J0\DR@S9.ORIMX$\XHF:!ZCWL4
M7!UH_TQXDR6<=@#[$V7+,<CW+.;0*WP+_03KO%AJ&-HB2CY;EG %"%\0E(1J
M!1=N,AX($JWPC2H3<HLZ483.PB7ZQGI_]#F[X%-?Y_[AST76[<PR'!IG+4>J
M?$V4DU&"XIY*,(4RE4&!9YD<7H58>.TD8PAI7"S'!2A=87XW< ]$HP"@2R>?
M(%@%YA7PIU'S:OHH;;=*HG&KU\GCI.(E?-H/J^JTY73C;\CISN,BSF_B#:]X
M\@U7K"U)[;)K*EH:R.7#*X689US=N%B.07?&="9@S!,E1DU^V4 EN22I C.D
MU.'Y NYB3W_1&_^$/FQ$A&<(OQ7,#E9&@8F!"H.Z\T::^<)\J-2 O:V?4$XK
M](YLVK?DA,_LD](;]8<'1V&5TMB>;^%+R#M,!-EK'#Y#B5^ W !U&3C./Y?
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M80_S[,!2U\T6]7:F68I@]#';NJLVEUL6QDG)J'N$^\*-2DW>KM[A ?O"T0I
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MF?8J9_W"U";YPH-IOH0G%E-@S@17?%<B)9;>R5K56E3>"3IAXE985IFETYC
M$H0DC#V,;8 +E L*"H:5#WH1_B6O80*IQHZM%0\8K00$%5P]3R1XR\;A-N*4
MI(E0/,O29?./N_W<WD;;S^T]VO9S1B'YOCQA]:4'EQ6,$2H?)<62W (]+)M&
M1[6D>",3[ ^4VK>BA6ZJ\#],OA1!ZZ#W*6'+!Q/.0\),H-NYNCL(-= MF[J-
MHM)/2G8;W9KM!4O5 WML4C*4%R_;Z:WL;)A\P\;_Q FA).?H347++:6UKQ2"
MV+X\Y0QSIB+::.&4<]M.-^R?:JKK9BPUD4? >90,6"TNP) :2XP^7R=CL,7>
M,![7RG6=T&@.KBFI&56?FZ5V[(OSPL[1Q/Z-=WSPEI)L>_!)!S1]77;0@E)]
M%JT&B^)++ A/FT#W:S& G:T]RZQ&]4K<L^2)!'(K,67\/>8.PCZ=J0]B_=QU
MGJ79++O")G JY;^7;,5;&*@,*_J]H)+.^4/D/B4W)P&;3C!]%5%XR K\X;G4
MA< T?OA9_CMT:EJTNL\7IX\J&L([FS$+:<?+V"EE=AOF4<&YA\ Z0!0P4):>
M2*_H][E+NX-]9CKOJ-OM)-/*K&#+J>@?E$M@4\K3BG]IZ'^BTF_)92)(5+J'
M$HS"X%G:*-T*/MIE7.0YSROM%DP7%&,7V+[W3W&\(-"&DM(DD1AUFVJW'[U,
MPYC$H7[0HO.U_6+_U_F)W3M.+(E9_CTJ$%L_WB;:CI41Z0S9[>@Q*[F1/FHC
M]G(ME)?!2VG[X:>M_6TGZ ',\@^%BF:5>X<6>B'KCEMJ8IM2E!YK)/%0'"2"
MNJZ(B7.8I6<O^LJRE'<5[66V<TT2=SU,P=YW3BM1#AO=IB5;W:Z<GL&/5\)1
M;M"IURCCS)0-=K<4:M;"&%@F@[Y/%<8 ^S^\8\N+E]5CV,U0,2TS(@T3Z&U#
MCN..60_(L/<9*^)2K&QC1%'!L>.^W<*4TW"NH/4BQ>&K7;VY\4%1=7='24ZU
MWFX2.[-L6R>[7R6#T>J:BUT$GI2S.!)=A;!)4Y18"@:Q4 GL4H13C7BJYE=6
MC107$%@E4WJT*<@FVA"=;'8C.)3B\9/"KP&)\46IP>UH9JHJS)T3)3K5<^]9
MQJJD*<D:I).RJ\^PNZJ4GY%>"9J&M)JE)S!'8ET)BZ9O-\#<0]6[5&(ZQO+-
ML:IE5-<'534M#V%3*N[%'H6BZ#CX&^HOH,'F&5*C#JJNS*>S[M7AY8&C!:M\
M/)REO,_19M0!HCR\104<OJ2@*IQO?1RZ'RON@"SF!MHPT+"7%$PA_4.AT(KI
M#T>(1UMP(5"-5N!84)WJDSTA58.U4'MMEU_:'9!U]9'F4^+.2;F@E9K=J&V
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M]K$OO9FNS7.Z;2K']R2EB6.ILCK\*;(*H5FGL7TGL#"7,XF+I6>0GK$MHVJ
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M\HVJ[34O0J9D[Y)UW%&>IBJ7U-IR<^@#=W.K*"U4AXF@.\H^"@SE*LXE&/U
M!]6C@TRN#\J1/V4F'V1SXPJ#\)5<)&L;H@8PU4Z'"1$C]9M$D4Q1+D&CBMJ,
MQ%4F: >F-+IO1^QA+X3=FTN)4./7T18T.<*M85Z@"5%X=>(_@X8!W0/5/D$E
M\VO0@XV )$OF5QC"+.Y"Z_'0>JA01OJLZR]#FZ+DVQQ-P#LHB*"P^7W8$".S
M+=)J'M?C*Y]RF/TY7W"H-.9<I.3T+:]-'I?VIE3:S:(L 4AC!\6-[\^3R/JP
MU#)&^'ZILE#+!-2:]R =@B#JG@Y!WSE3G3<@J? Z)!%-&,)(81_AX=6ARS-R
MNMH((1=HY:ME<GT/D9;V<U,., J4F5I#6)CT0>W?Q' *\3D,.TQ] -N);3&U
MS_!W#7>@:YDP9[YFIC: %LF*X*D=<\F>N>DIDG$3MDP#*4T])NT^4:>%3=X!
MIA'3G6JCI+[!^MH^>#QQ9;B.+P(^$]\RL& JB9@[/5RO@G!+A #E<KQ8#ZIP
M;P_]8OZ=+V**KWD#SIO>X+![<M(Y[9Y=:#'78T.4@VL:%R<WJCRG.=4[!5:7
MT;U%7-M!M%Y&GS%@"R-YQ-=QY_.LQ9NN'?5-5&DOGE;7OH^$J?)9TW<HN:_I
M+:5OZ8OX*1W=9\:0.I=6H3MP)AY))U+#M92)4C=ROLF_P"*>K\C2L=RC6Q,5
MNYRJ*3+)13YAL"^?9NFXEIBO=L:H\_X:(20A9)Y@M>U/&0%UA-58!!<,^^0?
MP_Z&Q[V!1G'4X+AS<J(.N@HYZ+!_T3U2J.%W3U^=]0_A0^]4=0[Q&B8LZJ[>
M]H;'$3TP/.ZJ?N_U\7" F!!^.N_TASV\N<DT^?KL]V[_%!HY>!?1([W3(7S1
M.5$GG;?ZM<&P,Z1Z\D==^+;3[ZKNWP]/+HYZIZ_5X?$9Z'J[9Z]V\87S?N_T
ML'=^TC5=2C.#B\-C:6=XW!FJMV<7)T>;&^?=_IO>D![LG)^?] X-A"7O4CL=
M];>+?F]PU!.X"W[K8S.G3K-[JHOY1X'S,>"&4CXV-7*%2R\+0,GG"A8(KR+3
M0I6J>F"S1\!!;^@&:<''Y7Y;3PP[L/(S/986L:PX@(D6FTX(WF;,F&UPU\$R
M&PS3%\D1:> K 9?%A4^5+QD*-U4PIHFNMK&H=XOI[AS,I*3619(K%V_359P,
M?D=423C@# =_E5 D6&4NFW0A@&D0:FI+8:!\=?U@)B\YN#N*W8U<&L4%'!ZR
MGMV7EC9C2NC>VG_9V_]'GYBC>-7/,<L @]]RKBD [/<$(<R#+,[?__/ES[W/
MFH;ESQ?Z^#^[N^I5FF23YS2R%] 0V&RP>M"?VMV%QQ3\]_*H][L>#'>Q.RI@
MQ\V>JU\ICVY(%U*@F#SO'"&K^.O6HRWZ/#CO'.K/TL)-.JFOGE-5%WRU#_\_
MTK\U:?A"><_K&0R/@%#X[L_4-_P-8VP9[@C.S/M=+D3^',X>SE&F4!?S;W3\
MSJK\3!N&5N++^2M!R(!D.>T.0"X!^^V>O?(@9ZY:2XEC$Y\AR!W33C@%A8-@
MC(5SAP'[&+]W/?+(P<H'R;Q.R*?UY G7C/N^Y_;P/>@=]@ONKY<'^WU00T !
M4,=G)WC>!A$H(X>P(PZ^(/_[M^^!_@<KLJ2G@]OG8/_\SXK_.%WZ1YCK*9CH
MS]7?DNFT3&Y!ZP%.1Z7_/G_/0U3UGH.P.?M6)/^3_TC^'UCR:]44#,HW;*T=
M# [[O7,TMQYD!WX!M7I[2(J&A D1D.>X>#YCQZ'CR=A[H@'M?'L4! YS]ORG
M__KM11_O" .#%NUC-.<BJJWR[0UX_6(?Z^1?$-Y.\*?LGF,GK2"Q\<%:I942
M6120RSE"VHN*JJV)=>2Z<0*KNK$1&/JK'PJ]E[H8&WS1OCA@/NM+R9Q2HV'$
MLZCE;IPSA;AQIGBEMF%"=.TY1<!B6EL0_+JS_%Z6SUREY;]^^_/3IR]P=SJ4
M9?"LC8!6\UAZH1W#<O.8XQ[,=2N-JTKT3?8C=%8Y0?+8(A=YQ=6AX(SI GV7
M.H!W3$6DP@A)G1&J6T$+:81X/2;A6S<S12#K=QON1@TTOI(@]P'?O3UGCT'H
M ?4S.A[^?EX0D+"B^.=CH[QXKF).9#5=W4^4ONT=#8__ND4R\6/'9@2X^2)0
M2OJZ92H'.8XSO1OAQ:U]'.M1(--E0[)X7O:K;%?]T+[+#=PM&Q81=E7F91LW
M7-UQ7%U1U5JG=*2%UKT0= U$/MDS"<LRDKVFNO$5V/,ZL8^]W!3+Y&!B-_8.
M9];"NLWM8>1DELO#QN_SXB9+)I=N=-4RIE$F4NQ!+K*?4/T"#$W244C!L7='
MH5V!Y#ZC:.=$WT:B,],)\[4I9&E^G52U^ -UD%38K 5-BRE?XXNU4'WL%#W2
M3EJ;>]%>.$<)PF4)-4[+\6+&B2-"'A/"90MB!&%2.GMC<T,RX3F&#9F84_TH
MBV\JAHW=R<@231>E1'^L7*JTYHN=M8P#XE/%2HIU1M(5NL00%FO6ZXLNY=26
MXVE).?E*ZLDZ$8/G>)LRU9; 0.NX+6JS=#]2I0$.[#<W?N--A2!Q\.$[[R=M
M29=QUHU3H"0&7E^D,4NV,;&LHMN%S(7.HP1TC>>!,#@XZQ]U^T8.W-_$>O;H
M3R_4J"AA)+M87"V>5V#$Z7^]4(TZ;&@_H44F=I3EX'.LWYM?[F;)%%;DV=/Y
M!WE[&L_2[/;Y7>L>2I!9.IEDB;_ZV+:Q]IX^_9/ "<1\&P/B+3<"UG4O[8KZ
MF6#@"!W$Y[P\6,EU^=B$<%HH'F1PQ' SSC%[*$LG*T;_[-<_45T\1G:T\/CJ
MU-W:[[ +;@5139^=>5U GR UBIMF%TR5^Q!)G@"= ?=@4<I#W@]60<!=&-KX
M0K=EV@C/=NOAR=HDGS.R)3OR/IMQO8UEF.*#$?)3QGZ?K=: R[Z_O?8?$GT$
MB;X<&QOV3E?*A4]9IH\ZG4NHY%H+UK!S!78HT)L8Z0H)OG47:Q1#+:"1JQWH
M-2/D!;[;>XI*6;"2^*5IY^$0KA^^.=  $)11]U=<__/GM_RG==0]P.;8'E!U
M![P+8 9,A*PY1*R2#S'5B:T+8T_H6"S74I"8ZVF,-?1P.#YF01!Z.XO\>L>?
M@; '/F:?M5$*3WBN0H_M_QCJMO#ZK^UX_.4_CL<?RO'X!3R!VHO9&0QZKT\Q
MR^"+NQU=S\&#N@%_A!"3-6"R5W2[$5Y\('F'DP;BN[DA0")="Q5)U1+)#K?E
M#!9Y +H3\$XI?N2F,Y"9K3$AU0_;G$ZH"SV@&#:W[H50W)I>0*K78^N0!A/@
M&XJ$,O&<*H!636FPN:$CA\GOH'<R%WLD6HFT'A7%^VK5$,GG015UZ;)9SA$?
M<9%>J8K,(?')+*V2ZDL&_WTB%GF'*<.6H@S<M76_*5 R$ 2-$2TSR[7*=<?K
MGS+XL"OLZQ]I7L%C@1[YSV_*E%^?G \%PWTL3O/-X43?*YD><C/Y <5-C?UA
M*?=91GYP^WQ5E*@SC_N@XGHJ9ORMD[KSR]6K^#'T^Z9HSF&C_Z'ZEZ6ZEDLZ
M(6R%:/J"A/XQN_J"RSHPM0]%1ZWD@M E6/UGVL=?:?8/??K^,].O/].[1,*7
MG_Y#Q9]]"<QB%(_?7]+-AMK5"(9VG31Z^?G@[.@= J<_'P_?G.S_?U!+ 0(4
M Q0    ( &N"-UG;(-4%OA8  *T- 0 1              "  0    !R8V%T
M+3(P,C0P-S,Q+GAS9%!+ 0(4 Q0    ( &N"-UFQN])8'A8  )(  0 5
M          "  >T6  !R8V%T+3(P,C0P-S,Q7V-A;"YX;6Q02P$"% ,4
M" !K@C=9O8'ZSK,A  !P! ( %0              @ $^+0  <F-A="TR,#(T
M,#<S,5]D968N>&UL4$L! A0#%     @ :X(W65B^;9_=6P  NF$% !4
M         ( !)$\  ')C870M,C R-# W,S%?;&%B+GAM;%!+ 0(4 Q0    (
M &N"-UFCOL_2P44  -]V!  5              "  32K  !R8V%T+3(P,C0P
M-S,Q7W!R92YX;6Q02P$"% ,4    " !K@C=9108M.@1* 0"XBPX $P
M        @ $H\0  <F-A=# Y,C-F;W)M,3!Q+FAT;5!+ 0(4 Q0    ( &N"
M-UDG&& 5YD,  '\\ 0 ;              "  5T[ @!R8V%T,#DR,V9O<FTQ
M,'%E>&@Q,%\Q,"YH=&U02P$"% ,4    " !K@C=9>JO2](29  "#'@, &@
M            @ %\?P( <F-A=# Y,C-F;W)M,3!Q97AH,3!?-RYH=&U02P$"
M% ,4    " !K@C=9OO*!F99G  !U"0( &@              @ $X&0, <F-A
M=# Y,C-F;W)M,3!Q97AH,3!?."YH=&U02P$"% ,4    " !K@C=9J9/('/H]
M  !A'P$ &@              @ $&@0, <F-A=# Y,C-F;W)M,3!Q97AH,3!?
;.2YH=&U02P4&      H "@"M @  .+\#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>rcat0923form10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:RCAT="http://RCAT/20240731"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rcat-20240731.xsd" xlink:type="simple"/>
    <context id="From2024-05-01to2024-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_SeriesBPreferredStock1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RCAT:SeriesBPreferredStock1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="From2019-05-012020-04-30_custom_BusinessAcquisition1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="From2020-05-012021-04-30_custom_BusinessAcquisition2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_BusinessAcquisition3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_BusinessAcquisition4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RCAT:BusinessAcquisition4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_RestatementImpactChangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactOriginallyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactAsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_RestatementImpactChangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:RestatementImpactAxis">RCAT:RestatementImpactChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_CustomerConcentrationRisk2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">RCAT:CustomerConcentrationRisk2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2024-02-16</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsGrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsAccumulatedAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis">RCAT:IntangibleAssetsNetCarryingValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="From2022-11-012022-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_OperatingLeaseLocation4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">RCAT:OperatingLeaseLocation4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-08-31_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="From2022-09-012023-04-30_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-08-012023-04-30_custom_DebtObligation1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012023-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2022-09-012022-09-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-09-012023-04-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-04-30_custom_DebtObligation8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">RCAT:DebtObligation8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2023-08-012023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <instant>2023-12-11</instant>
        </period>
    </context>
    <context id="From2023-05-012024-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_SeriesAPreferredStock2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RCAT:SeriesAPreferredStock2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-03-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012021-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="From2020-10-012020-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_WarrantsOutstanding1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">RCAT:WarrantsOutstanding1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:FairValueOfOptionsAxis">RCAT:OptionsAssumptionsUsedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">RCAT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-07-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748268</identifier>
            <segment>
                <xbrldi:explicitMember dimension="RCAT:ShareBasedCompensationSharesRestrictedStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-05-01to2024-07-31" id="ixv-10427">0000748268</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-05-01to2024-07-31" id="ixv-10428">false</dei:AmendmentFlag>
    <dei:DocumentQuarterlyReport contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0011">true</dei:DocumentQuarterlyReport>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0012">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0013">2025</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0014">--04-30</dei:CurrentFiscalYearEndDate>
    <dei:EntitySmallBusiness contextRef="From2024-05-01to2024-07-31" id="xdx2ixbrl0035">true</dei:EntitySmallBusiness>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0188"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0217"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0229"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <RCAT:EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0230"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0250"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0320"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-012024-07-31_custom_SeriesBPreferredStock1Member"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0342"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:IncomeLossFromDiscontinuedOperations
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-05-012023-07-31"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:ConversionOfPreferredStockIntoCommonStock
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="xdx2ixbrl0576"
      unitRef="USD">-4621</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="xdx2ixbrl0601"
      unitRef="USD">-12416376</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="xdx2ixbrl0602"
      unitRef="USD">-2348412</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0625"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0631"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0655"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-05-01to2024-07-31"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0690"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0722"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0725"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0729"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      id="xdx2ixbrl0732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      id="xdx2ixbrl0780"
      unitRef="USD"
      xsi:nil="true"/>
    <RCAT:OutstandingPrincipalPaymentsDueLongTerm
      contextRef="AsOf2024-07-31"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0929"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0932"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0933"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0937"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0938"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member"
      id="xdx2ixbrl0939"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      id="xdx2ixbrl0963"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      id="xdx2ixbrl0964"
      unitRef="Pure"
      xsi:nil="true"/>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      id="xdx2ixbrl1020"
      unitRef="Shares"
      xsi:nil="true"/>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      id="xdx2ixbrl1021"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-05-01to2024-07-31" id="ixv-11407">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-05-01to2024-07-31" id="ixv-11408">2024-07-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-05-01to2024-07-31" id="ixv-11409">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-05-01to2024-07-31" id="ixv-11410">001-40202</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-05-01to2024-07-31" id="ixv-11411">Red Cat Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-05-01to2024-07-31" id="ixv-11412">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-05-01to2024-07-31" id="ixv-11413">88-0490034</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-05-01to2024-07-31" id="ixv-11414">15     Ave. Munoz Rivera</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-05-01to2024-07-31" id="ixv-11415">Ste 2200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-05-01to2024-07-31" id="ixv-11416">San     Juan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2024-05-01to2024-07-31" id="ixv-11417">PR</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2024-05-01to2024-07-31" id="ixv-11418">00901</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-05-01to2024-07-31" id="ixv-11419">(833)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-05-01to2024-07-31" id="ixv-11420">373-3228</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2024-05-01to2024-07-31" id="ixv-11421">Not applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:Security12bTitle contextRef="From2024-05-01to2024-07-31" id="ixv-11422">Common     stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-05-01to2024-07-31" id="ixv-11423">RCAT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-05-01to2024-07-31" id="ixv-11424">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2024-05-01to2024-07-31" id="ixv-11425">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-05-01to2024-07-31" id="ixv-11426">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-05-01to2024-07-31" id="ixv-11427">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-05-01to2024-07-31" id="ixv-11428">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2024-05-01to2024-07-31" id="ixv-11429">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="ixv-11430"
      unitRef="Shares">75409038</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11431"
      unitRef="USD">7732763</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11432"
      unitRef="USD">6067169</us-gaap:Cash>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11433"
      unitRef="USD">681775</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11434"
      unitRef="USD">4361090</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11435"
      unitRef="USD">10462934</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11436"
      unitRef="USD">8007237</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11437"
      unitRef="USD">2592679</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11438"
      unitRef="USD">3962053</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11439"
      unitRef="USD">21470151</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11440"
      unitRef="USD">22397549</us-gaap:AssetsCurrent>
    <us-gaap:Goodwill
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11441"
      unitRef="USD">8995500</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11442"
      unitRef="USD">9088550</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11443"
      unitRef="USD">3617060</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11444"
      unitRef="USD">3794389</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11445"
      unitRef="USD">5142500</us-gaap:EquityMethodInvestments>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11446"
      unitRef="USD">4000000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11447"
      unitRef="USD">2143919</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11448"
      unitRef="USD">2340684</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11449"
      unitRef="USD">293126</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11450"
      unitRef="USD">293126</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11451"
      unitRef="USD">1435475</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11452"
      unitRef="USD">1480814</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11453"
      unitRef="USD">16485080</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11454"
      unitRef="USD">26140063</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11455"
      unitRef="USD">37955231</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11456"
      unitRef="USD">48537612</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11457"
      unitRef="USD">2081568</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11458"
      unitRef="USD">1580422</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11459"
      unitRef="USD">1296931</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11460"
      unitRef="USD">1069561</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11461"
      unitRef="USD">599570</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11462"
      unitRef="USD">751570</us-gaap:ShortTermBorrowings>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11463"
      unitRef="USD">50039</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11464"
      unitRef="USD">53939</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11465"
      unitRef="USD">202404</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11466"
      unitRef="USD">195638</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11467"
      unitRef="USD">4230512</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11468"
      unitRef="USD">3651130</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11469"
      unitRef="USD">1269185</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11470"
      unitRef="USD">1321952</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11471"
      unitRef="USD">1269185</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11472"
      unitRef="USD">1321952</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-11473"
      unitRef="Shares">4300000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-11474"
      unitRef="Shares">4676</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-07-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-11475"
      unitRef="Shares">4676</us-gaap:PreferredStockSharesOutstanding>
    <RCAT:PreferredStockValueSeriesB
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11476"
      unitRef="USD">47</RCAT:PreferredStockValueSeriesB>
    <RCAT:PreferredStockValueSeriesB
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11477"
      unitRef="USD">47</RCAT:PreferredStockValueSeriesB>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-07-31"
      decimals="INF"
      id="ixv-11478"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="ixv-11479"
      unitRef="Shares">74890248</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-07-31"
      decimals="INF"
      id="ixv-11480"
      unitRef="Shares">74289351</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11481"
      unitRef="USD">74890</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11482"
      unitRef="USD">74289</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11483"
      unitRef="USD">125927705</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11484"
      unitRef="USD">124616305</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11485"
      unitRef="USD">-93547108</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11486"
      unitRef="USD">-81130732</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11487"
      unitRef="USD">4621</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11488"
      unitRef="USD">32455534</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11489"
      unitRef="USD">43564530</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11490"
      unitRef="USD">37955231</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11491"
      unitRef="USD">48537612</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11492"
      unitRef="USD">2776535</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11493"
      unitRef="USD">1748129</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11494"
      unitRef="USD">3259926</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11495"
      unitRef="USD">1573464</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11496"
      unitRef="USD">-483391</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11497"
      unitRef="USD">174665</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11498"
      unitRef="USD">1626440</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11499"
      unitRef="USD">1353551</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11500"
      unitRef="USD">2041511</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11501"
      unitRef="USD">1288760</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11502"
      unitRef="USD">3483095</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11503"
      unitRef="USD">2863758</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11504"
      unitRef="USD">93050</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:OperatingExpenses
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11505"
      unitRef="USD">7244096</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11506"
      unitRef="USD">5506069</us-gaap:OperatingExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11507"
      unitRef="USD">-7727487</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11508"
      unitRef="USD">-5331404</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11509"
      unitRef="USD">-4008357</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11510"
      unitRef="USD">-734143</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11511"
      unitRef="USD">-239490</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11512"
      unitRef="USD">-24554</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11513"
      unitRef="USD">21857</us-gaap:InterestExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11514"
      unitRef="USD">-29057</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11515"
      unitRef="USD">1544</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11516"
      unitRef="USD">-4688889</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11517"
      unitRef="USD">-262891</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11518"
      unitRef="USD">-12416376</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11519"
      unitRef="USD">-5594295</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11520"
      unitRef="USD">-242573</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11521"
      unitRef="USD">-12416376</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11522"
      unitRef="USD">-5836868</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11523"
      unitRef="USD">-4621</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11524"
      unitRef="USD">1646</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11525"
      unitRef="USD">289389</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11526"
      unitRef="USD">-12420997</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11527"
      unitRef="USD">-5545833</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11528"
      unitRef="USDPShares">-0.17</RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT>
    <RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11529"
      unitRef="USDPShares">-0.11</RCAT:EarningsPerShareBasicAndDilutedContinuingOperationsRCAT>
    <RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11530"
      unitRef="Shares">74500480</RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT>
    <RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11531"
      unitRef="Shares">54935339</RCAT:WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-11532"
      unitRef="Shares">986676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-11533"
      unitRef="USD">9867</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11534"
      unitRef="Shares">54568065</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11535"
      unitRef="USD">54568</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11536"
      unitRef="USD">112642726</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11537"
      unitRef="USD">-57078103</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11538"
      unitRef="USD">-861117</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-11539"
      unitRef="USD">54767941</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11540"
      unitRef="USD">911606</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11541"
      unitRef="USD">911606</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11542"
      unitRef="Shares">155476</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11543"
      unitRef="USD">155</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11544"
      unitRef="USD">-8675</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11545"
      unitRef="USD">-8520</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-11546"
      unitRef="Shares">982000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-11547"
      unitRef="USD">-9820</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11548"
      unitRef="Shares">-818334</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11549"
      unitRef="USD">818</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11550"
      unitRef="USD">9002</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11551"
      unitRef="USD">289389</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11552"
      unitRef="USD">289389</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11553"
      unitRef="USD">1646</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11554"
      unitRef="USD">1646</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11555"
      unitRef="USD">-5836868</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11556"
      unitRef="USD">-5836868</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-07-31_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-11557"
      unitRef="Shares">4676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-11558"
      unitRef="USD">47</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11559"
      unitRef="Shares">55541875</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11560"
      unitRef="USD">55541</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11561"
      unitRef="USD">113554659</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11562"
      unitRef="USD">-62914971</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11563"
      unitRef="USD">-570082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31"
      decimals="0"
      id="ixv-11564"
      unitRef="USD">50125194</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-11565"
      unitRef="Shares">4676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-11566"
      unitRef="USD">47</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11567"
      unitRef="Shares">74289351</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11568"
      unitRef="USD">74289</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11569"
      unitRef="USD">124616305</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11570"
      unitRef="USD">-81130732</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11571"
      unitRef="USD">4621</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11572"
      unitRef="USD">43564530</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11573"
      unitRef="USD">1446038</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11574"
      unitRef="USD">1446038</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11575"
      unitRef="Shares">293302</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11576"
      unitRef="USD">293</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11577"
      unitRef="USD">-134330</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11578"
      unitRef="USD">-134037</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11579"
      unitRef="Shares">307595</RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11580"
      unitRef="USD">308</RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11581"
      unitRef="USD">-308</RCAT:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-012024-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="ixv-11582"
      unitRef="USD">-4621</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11583"
      unitRef="USD">-4621</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-012024-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11584"
      unitRef="USD">-12416376</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11585"
      unitRef="USD">-12416376</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-07-31_custom_SeriesBPreferredStock1Member"
      decimals="INF"
      id="ixv-11586"
      unitRef="Shares">4676</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31_custom_SeriesBPreferredStock1Member"
      decimals="0"
      id="ixv-11587"
      unitRef="USD">47</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11588"
      unitRef="Shares">74890248</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31_us-gaap_CommonStockMember"
      decimals="0"
      id="ixv-11589"
      unitRef="USD">74890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="ixv-11590"
      unitRef="USD">125927705</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="ixv-11591"
      unitRef="USD">-93547108</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11592"
      unitRef="USD">32455534</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11593"
      unitRef="USD">-12416376</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11594"
      unitRef="USD">-5836868</us-gaap:NetIncomeLoss>
    <RCAT:IncomeLossFromDiscontinuedOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11595"
      unitRef="USD">242573</RCAT:IncomeLossFromDiscontinuedOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11596"
      unitRef="USD">-12416376</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11597"
      unitRef="USD">-5594295</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11598"
      unitRef="USD">357258</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11599"
      unitRef="USD">629426</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11600"
      unitRef="USD">1088780</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11601"
      unitRef="USD">282180</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11602"
      unitRef="USD">177329</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11603"
      unitRef="USD">217368</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11604"
      unitRef="USD">292636</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:Depreciation
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11605"
      unitRef="USD">296722</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11606"
      unitRef="USD">101001</us-gaap:Depreciation>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11607"
      unitRef="USD">-4008357</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11608"
      unitRef="USD">-734143</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11609"
      unitRef="USD">93050</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11610"
      unitRef="USD">3679315</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11611"
      unitRef="USD">-780</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11612"
      unitRef="USD">-2455697</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11613"
      unitRef="USD">-455871</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11614"
      unitRef="USD">1369374</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11615"
      unitRef="USD">-1756973</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11616"
      unitRef="USD">-662</RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11617"
      unitRef="USD">-458</RCAT:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11618"
      unitRef="USD">-3900</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11619"
      unitRef="USD">-110863</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11620"
      unitRef="USD">501146</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11621"
      unitRef="USD">-569876</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11622"
      unitRef="USD">222749</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11623"
      unitRef="USD">40436</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11624"
      unitRef="USD">-2348412</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11625"
      unitRef="USD">-6926069</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11626"
      unitRef="USD">99957</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11627"
      unitRef="USD">5054</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11628"
      unitRef="USD">4888399</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11629"
      unitRef="USD">4400000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11630"
      unitRef="USD">4300043</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11631"
      unitRef="USD">4883345</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11632"
      unitRef="USD">152000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11633"
      unitRef="USD">137989</us-gaap:RepaymentsOfDebt>
    <RCAT:PaymentsOfTaxesRelatedToEquityTransactions
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11634"
      unitRef="USD">134037</RCAT:PaymentsOfTaxesRelatedToEquityTransactions>
    <RCAT:PaymentsOfTaxesRelatedToEquityTransactions
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11635"
      unitRef="USD">8520</RCAT:PaymentsOfTaxesRelatedToEquityTransactions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11636"
      unitRef="USD">-286037</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11637"
      unitRef="USD">-146509</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11638"
      unitRef="USD">-356109</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11639"
      unitRef="USD">237814</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11640"
      unitRef="USD">-118295</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11641"
      unitRef="USD">1665594</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11642"
      unitRef="USD">-2307528</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11643"
      unitRef="USD">6067169</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2023-04-30"
      decimals="0"
      id="ixv-11644"
      unitRef="USD">3260305</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11645"
      unitRef="USD">7732763</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="AsOf2023-07-31"
      decimals="0"
      id="ixv-11646"
      unitRef="USD">952777</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="AsOf2023-07-31"
      decimals="0"
      id="ixv-11647"
      unitRef="USD">15021</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11648"
      unitRef="USD">7732763</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-07-31"
      decimals="0"
      id="ixv-11649"
      unitRef="USD">937756</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11650"
      unitRef="USD">6295</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11651"
      unitRef="USD">22590</us-gaap:InterestPaidNet>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11652"
      unitRef="USD">289389</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent>
    <RCAT:ConversionOfPreferredStockIntoCommonStock
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11653"
      unitRef="USD">9820</RCAT:ConversionOfPreferredStockIntoCommonStock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5381">&lt;p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z49jg8M1uPti" style="font: 12pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82C_zPmSPEF9Nopd"&gt;Note
1 &#x2013; The Business&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company was originally incorporated in February 1984. Since April 2016, the Company&#x2019;s primary business has been to provide products,
services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January
2020, the Company expanded the scope of its drone products and services through four acquisitions, including:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In January 2020, the Company
    acquired Rotor Riot, a provider of First Person View (&#x201c;FPV&#x201d;) drones and equipment, primarily to consumers. The purchase
    price was $&lt;span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20190501__20200430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition1Member_zxTjophP5vu4"&gt;1,995,114&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;B.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In November 2020, the Company
    acquired Fat Shark Holdings, Ltd. (&#x201c;Fat Shark&#x201d;), a provider of FPV video goggles to the&#160;drone industry. The purchase
    price was $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20200501__20210430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition2Member_ztcvHIVe3Tyh"&gt;8,354,076&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;C.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In May 2021, the Company
    acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations
    where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles
    away. The purchase price was $&lt;span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition3Member_zAcRxVPVp1q8"&gt;2,791,012&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;D.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In August 2021, the Company
    acquired Teal Drones, Inc. (&#x201c;Teal&#x201d;), a leader in commercial and government Unmanned Aerial Vehicles (&#x201c;UAV&#x201d;)
    technology.&#160;The purchase price was $&lt;span id="xdx_909_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--BusinessAcquisitionAxis__custom--BusinessAcquisition4Member_zcYUcSso4WFf"&gt;10,011,279&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Following the Teal acquisition
in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment
(&#x201c;Enterprise&#x201d;) and the Consumer segment (&#x201c;Consumer&#x201d;) to focus on the unique opportunities in each sector. Enterprise's
initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined
industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government
agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 16, 2024, we closed the sale of our Consumer
segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and
capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 3 and Note 7.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;On December 11, 2023,
the Company completed a firm commitment underwritten public offering with ThinkEquity of &lt;span id="xdx_90F_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zmV21Zv8E8q1"&gt;18,400,000&lt;/span&gt; shares of common stock which generated
gross proceeds of $&lt;span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20230501__20240430_zrbrQy2q6oV8"&gt;9,200,000&lt;/span&gt; and net proceeds of approximately $&lt;span id="xdx_902_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_z7Q27q2Zfn69"&gt;8,400,000&lt;/span&gt;.&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2019-05-012020-04-30_custom_BusinessAcquisition1Member"
      decimals="0"
      id="ixv-11654"
      unitRef="USD">1995114</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2020-05-012021-04-30_custom_BusinessAcquisition2Member"
      decimals="0"
      id="ixv-11655"
      unitRef="USD">8354076</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition3Member"
      decimals="0"
      id="ixv-11656"
      unitRef="USD">2791012</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2021-05-012022-04-30_custom_BusinessAcquisition4Member"
      decimals="0"
      id="ixv-11657"
      unitRef="USD">10011279</us-gaap:BusinessCombinationConsiderationTransferred1>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingShares
      contextRef="From2023-05-012024-04-30"
      decimals="INF"
      id="ixv-11658"
      unitRef="Shares">18400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingShares>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds
      contextRef="From2023-05-012024-04-30"
      decimals="0"
      id="ixv-11659"
      unitRef="USD">9200000</RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds
      contextRef="From2023-05-012024-04-30"
      decimals="0"
      id="ixv-11660"
      unitRef="USD">8400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5454">&lt;p id="xdx_807_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zjz85o8K0POe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_825_zTm0e4LXiCv8" style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Note
2 &#x2013; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zutEcgLYyih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_865_zlvklUGo8XD6" style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&#x2013; The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(&#x201c;GAAP&#x201d;) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management,
all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial
statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the
results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes
thereto for the year ended April 30, 2024, included in the Company&#x2019;s Annual Report on Form 10-K.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zNIqqKUGDSVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zWM3U6GsyAFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zWCqQu6BvACa"&gt;Restatement
of Previously Issued Consolidated Financial Statements&lt;/span&gt; &lt;/b&gt;&#x2013; The Company&#x2019;s Condensed Consolidated Statement of Operations
and Stockholders&#x2019; Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange
Commission (the &#x201c;SEC&#x201d;) on September 19, 2023, have been restated. The Company revised its financial statements to&#160;remove
derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having
a derivative component.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
impacts of these restatements are detailed in the tables below:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Operations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0512"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,810,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,836,868&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Shareholders&#x2019; Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;110,905,033&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;113,554,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,649,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(60,397,141&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(62,914,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,517,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;49,993,398&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,125,194&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;131,796&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_ze2JTgurI8fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_850_zxjGS8BOnYif" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zYX7MX8oMCjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_868_zGp4trD4Rf52"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/b&gt; &#x2013; &lt;span style="background-color: white"&gt;Our condensed consolidated financial statements include the accounts
of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February
16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for
using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions
and balances have been eliminated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. &lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zyQNzovpfQHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zvLQBk4nnqlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWcAXfWWrOb9"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt; &#x2013;&lt;span style="background-color: white"&gt;&#160;The preparation of financial statements in accordance with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those
used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_z1lrZVjHW9M" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_ze4wFxTi7qq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_863_zbteLT7yvvYf"&gt;Concentration
of Credit Risk&lt;/span&gt; &lt;/b&gt;&#x2013; Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade
receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs
ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer
from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable,
net as of July&#160;31, 2024 and April 30, 2024 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;July 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;April 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%"&gt;38&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%"&gt;53&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_z5nsI50jYiG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of July 31,
2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July
31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_z6cWOblx5s61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_84C_eus-gaap--EquityMethodInvestmentsPolicy_zKxQuQLqZaOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_867_zceAwNcrS64l"&gt;Equity
Method Investment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;The equity method of accounting is applied to investments in which
the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period
for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily
be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an
earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its
investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $&lt;span id="xdx_908_eus-gaap--AssetImpairmentCharges_c20230501__20240430_zkbYsHH966n9"&gt;11,353,875&lt;/span&gt; for the year ended April&#160;30,
2024. See Note 7 for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_z3fpt2Dvy0Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKT6sOtOpMdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86F_zBVjhFLEIcQc"&gt;Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures&lt;/span&gt;&lt;/b&gt; &#x2013; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
guidance establishes three levels of the fair value hierarchy as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
1&lt;/i&gt;: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
2&lt;/i&gt;: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
3&lt;/i&gt;: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The
carrying amounts of these instruments approximates fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zMrN4PunMWv" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zDrocIb8lYd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;b&gt;&lt;span id="xdx_86D_zC2BYsAH4G68"&gt;Revenue Recognition&lt;/span&gt; &lt;/b&gt;&#x2013;
The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting
Standards Board (&#x201c;FASB&#x201d;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue
recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price,
(iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as
each obligation is satisfied.&#160;The Company&#x2019;s revenue transactions include the shipment of goods to customers as orders are
fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue
upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240731_zv3ruEUYdIei"&gt;50,039 &lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zta0vf4KVPY1"&gt;53,939 &lt;/span&gt; at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the
capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240731_zeehHTInjCH9"&gt;0&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zUia9GjcIxwd"&gt;1,477,859&lt;/span&gt; at July 31, 2024 and
April 30, 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table presents the Company&#x2019;s revenue disaggregated by revenue type:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Three
    Months Ended&#160;July 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Contract related&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;886,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;310,881&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Product related&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,890,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,437,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,776,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,748,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zyVi65qXkNFl" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zP3l9Kcd8sYg" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_848_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zzZ20WTYGaPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zB5Fs2RckWq1"&gt;Product
Warranty&lt;/span&gt; - &lt;/b&gt;The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales
data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses.&#160;Warranty
liability was approximately $&lt;span id="xdx_90E_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240731_z2g90xAOwkf2"&gt;541,000 &lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zjhY2VPYHCm1"&gt;372,000 &lt;/span&gt; as of July 31, 2024 and April 30, 2024 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zxDUjUvqiFUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIslxQr6OUV8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zBCv0DVYabr4"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;
&lt;span style="background-color: white"&gt;Management does not believe that recently issued, but not yet effective accounting pronouncements,
if adopted, would have a material effect on the accompanying consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zKiSTpicZ0Ej" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9ddSQBeNkBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zGDhiRI4SNhb"&gt;Comprehensive
Loss&lt;/span&gt; &lt;/b&gt;&#x2013; Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses
that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of
foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended
July 31, 2024 and July 31, 2023, comprehensive loss was $&lt;span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20240501__20240731_zk6oWTfRMTJ6"&gt;4,621&lt;/span&gt;
higher and $&lt;span id="xdx_90E_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20230731_z5YREAIgqlQ9"&gt;291,035&lt;/span&gt;
lower than net loss, respectively, related to unrealized
gains on available-for-sale securities totaling $&lt;span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20240501__20240731_z3grDvAbQi4h"&gt;0&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20230731_zDFVPqPEWUza"&gt;289,389&lt;/span&gt;,  respectively, and foreign currency translation adjustments of $&lt;span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dxL_c20240501__20240731_zFJ3HWWXeObe" title="::XDX::-4621"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0576"&gt;4,621 &lt;/span&gt;&lt;/span&gt;
and $&lt;span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20230731_zNRVZcQe7bY1"&gt;1,646&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zTbyWqSdIc61" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zVUoEFBtUfU" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_860_zSU7UfLWc966"&gt;Basic and
Diluted Net Loss per Share&lt;/span&gt;&lt;/b&gt; &#x2013; Basic and diluted net loss per share has been calculated by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of
diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents
would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted
net loss per share because their effect would have been anti-dilutive include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Series B Preferred Stock, as converted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7,319,988&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6,884,017&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,821,291&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,202,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;842,701&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;11,347,774&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9,270,613&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zKTk0JjIkx29" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zik18tQXDauk" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zV2baH1iPfPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zPoAEykNX2k8"&gt;Related
Parties&lt;/span&gt;&lt;/b&gt; &#x2013; Parties are considered to be related to us if they have control or significant influence, directly or indirectly,
over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel
of members of the Board of Directors. Related Party transactions are disclosed in Note 16.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_z8Wi28svccf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAP8XuCbTS1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_86B_zRGfjLqTkQrd"&gt;Liquidity
and Going Concern&lt;/span&gt; &lt;/b&gt;&#x2013; The Company has never been profitable and has incurred net losses related to acquisitions, as
well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a
net loss &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;of approximately $&lt;span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20240501__20240731_zF35Z25bd401" title="::XDX::-12416376"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0601"&gt;12,000,000 &lt;/span&gt;&lt;/span&gt;&#160;and
used cash in operating activities of approximately $&lt;span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20240501__20240731_zju8eqwXnN28" title="::XDX::-2348412"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0602"&gt;2,300,000&lt;/span&gt;&lt;/span&gt;.
As of July 31, 2024, working capital totaled approximately $&lt;span id="xdx_903_eus-gaap--Capital_iI_c20240731_zjp5xsHPQbSj"&gt;17,200,000&lt;/span&gt;.
These financial results and our financial position &lt;span style="background-color: white"&gt;at&#160;July 31, 2024&#160;raise
substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen
its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of &lt;span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zkFL43bk1sl8"&gt;18,400,000&lt;/span&gt;
shares of common stock which generated net proceeds of approximately $&lt;span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zz34gyeJ4D2a"&gt;8,400,000&lt;/span&gt;
as further described in Note 1 and Note 12. In addition, the Company&#x2019;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The
Company&#x2019;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the
Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold
its equity method investment for $&lt;span id="xdx_90C_ecustom--ProceedsFromPurchaseAgreement_c20240501__20240731_zNUW7sJPnTrg"&gt;4,400,000&lt;/span&gt;
in July 2024.&lt;span style="background-color: white"&gt; As described in Note 18, the Company closed a financing with proceeds of $8
million to be received in late September 2024.&lt;/span&gt; Management has concluded that these recent positive developments alleviate any
substantial doubt about the Company&#x2019;s ability to&#160;continue its operations, and meet its financial obligations, for twelve
months from the date these consolidated financial statements&#160;are&#160;issued.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_855_zqov4ebKsuLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5460">&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zutEcgLYyih8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span id="xdx_865_zlvklUGo8XD6" style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; color: Black"&gt;&#x2013; The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(&#x201c;GAAP&#x201d;) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management,
all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial
statements have been included. The results of operations for the three months ended July 31, 2024 are not necessarily indicative of the
results for the full year ending April 30, 2025. For further information, refer to the consolidated financial statements and footnotes
thereto for the year ended April 30, 2024, included in the Company&#x2019;s Annual Report on Form 10-K.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5467">&lt;p id="xdx_844_ecustom--RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock_zWM3U6GsyAFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zWCqQu6BvACa"&gt;Restatement
of Previously Issued Consolidated Financial Statements&lt;/span&gt; &lt;/b&gt;&#x2013; The Company&#x2019;s Condensed Consolidated Statement of Operations
and Stockholders&#x2019; Equity for the three months ended July 31, 2023, which were originally filed with the U.S. Securities and Exchange
Commission (the &#x201c;SEC&#x201d;) on September 19, 2023, have been restated. The Company revised its financial statements to&#160;remove
derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 14, as having
a derivative component.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
impacts of these restatements are detailed in the tables below:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Operations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0512"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,810,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,836,868&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Shareholders&#x2019; Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;110,905,033&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;113,554,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,649,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(60,397,141&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(62,914,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,517,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;49,993,398&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,125,194&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;131,796&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_ze2JTgurI8fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

</RCAT:RestatementPreviouslyIssuedFinancialStatementsPolicyTextBlock>
    <RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5487">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock_zZXPp7inSHUi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Impact of restatements of previously issued consolidated financial statements (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_zRnsDc490zte"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zk7HPWG478D5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zRVqVONDv2Ne"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Operations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDerivativeAssetsAndLiabilities_zSqUqKuYk6J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Change in fair value of derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0512"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_z9PoOqGoZmWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,810,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(5,836,868&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(26,520&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactOriginallyReportedMember_ztDL1NhTolx7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_493_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactAsRestatedMember_zJf3pZhVg6Ic"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20230731__custom--RestatementImpactAxis__custom--RestatementImpactChangeMember_zSkZ1lcbNEMf"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Condensed
                                            Consolidated Statement of Shareholders&#x2019; Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the three months ended July 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Originally&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restated&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_iE_zTnGXZRqPKd6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;110,905,033&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;113,554,659&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,649,626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_iE_zo2uMiVPuOF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(60,397,141&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(62,914,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,517,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockholdersEquityRestatement_iE_z0Yu2l5VqJu8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Total equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;49,993,398&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,125,194&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;131,796&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-11661"
      unitRef="USD">-26520</us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-11662"
      unitRef="USD">-26520</us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-11663"
      unitRef="USD">-5810348</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-11664"
      unitRef="USD">-5836868</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-11665"
      unitRef="USD">-26520</us-gaap:NetIncomeLoss>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-11666"
      unitRef="USD">110905033</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-11667"
      unitRef="USD">113554659</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-11668"
      unitRef="USD">2649626</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-11669"
      unitRef="USD">-60397141</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-11670"
      unitRef="USD">-62914971</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-11671"
      unitRef="USD">-2517830</us-gaap:RetainedEarningsAccumulatedDeficit>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-07-31_custom_RestatementImpactOriginallyReportedMember"
      decimals="0"
      id="ixv-11672"
      unitRef="USD">49993398</RCAT:StockholdersEquityRestatement>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-07-31_custom_RestatementImpactAsRestatedMember"
      decimals="0"
      id="ixv-11673"
      unitRef="USD">50125194</RCAT:StockholdersEquityRestatement>
    <RCAT:StockholdersEquityRestatement
      contextRef="AsOf2023-07-31_custom_RestatementImpactChangeMember"
      decimals="0"
      id="ixv-11674"
      unitRef="USD">131796</RCAT:StockholdersEquityRestatement>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5729">&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zYX7MX8oMCjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_868_zGp4trD4Rf52"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/b&gt; &#x2013; &lt;span style="background-color: white"&gt;Our condensed consolidated financial statements include the accounts
of our wholly owned subsidiaries which include Teal and Skypersonic as well as Rotor Riot and Fat Shark through the sale date of February
16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for
using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions
and balances have been eliminated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Consumer segment businesses are characterized as discontinued operations in these financial statements.&#160; The operating results and
cash flows of discontinued operations are separately stated in those respective financial statements. See Note 3. &lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-05-01to2024-07-31" id="ixv-5741">&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zvLQBk4nnqlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86F_zWcAXfWWrOb9"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt; &#x2013;&lt;span style="background-color: white"&gt;&#160;The preparation of financial statements in accordance with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those
used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment,
and (iii) the evaluation of other-than-temporary-impairment of equity method investments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-05-01to2024-07-31" id="ixv-5750">&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_ze4wFxTi7qq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_863_zbteLT7yvvYf"&gt;Concentration
of Credit Risk&lt;/span&gt; &lt;/b&gt;&#x2013; Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade
receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs
ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer
from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable,
net as of July&#160;31, 2024 and April 30, 2024 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;July 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;April 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%"&gt;38&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%"&gt;53&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_z5nsI50jYiG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As of July 31,
2024, three customers accounted for equal to or greater than 10% of total revenue, totaling 32%, 20% and 12%, respectively. As of July
31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5758">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;July 31, 2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;April 30, 2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zdifqskIWQdi" style="text-align: right; width: 25%"&gt;38&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right; width: 25%"&gt;53&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20240731__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zYpAPnUmhTW1" style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right"&gt;24&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-05-012024-07-31_custom_CustomerConcentrationRisk1Member"
      decimals="INF"
      id="ixv-11675"
      unitRef="Pure">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk1Member"
      decimals="INF"
      id="ixv-11676"
      unitRef="Pure">0.53</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-05-012024-07-31_custom_CustomerConcentrationRisk2Member"
      decimals="INF"
      id="ixv-11677"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012024-04-30_custom_CustomerConcentrationRisk2Member"
      decimals="INF"
      id="ixv-11678"
      unitRef="Pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2024-05-01to2024-07-31" id="ixv-5808">&lt;p id="xdx_84C_eus-gaap--EquityMethodInvestmentsPolicy_zKxQuQLqZaOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_867_zceAwNcrS64l"&gt;Equity
Method Investment&lt;/span&gt; &#x2013; &lt;/b&gt;&lt;span style="background-color: white"&gt;The equity method of accounting is applied to investments in which
the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period
for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily
be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an
earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its
investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $&lt;span id="xdx_908_eus-gaap--AssetImpairmentCharges_c20230501__20240430_zkbYsHH966n9"&gt;11,353,875&lt;/span&gt; for the year ended April&#160;30,
2024. See Note 7 for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-05-012024-04-30"
      decimals="0"
      id="ixv-11679"
      unitRef="USD">11353875</us-gaap:AssetImpairmentCharges>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-05-01to2024-07-31" id="ixv-5820">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zKT6sOtOpMdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86F_zBVjhFLEIcQc"&gt;Fair
Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures&lt;/span&gt;&lt;/b&gt; &#x2013; The fair value measurements
and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that
would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities
into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and
the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair
value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has
been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment
of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific
to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
guidance establishes three levels of the fair value hierarchy as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
1&lt;/i&gt;: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
2&lt;/i&gt;: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the related assets or liabilities; and&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Level
3&lt;/i&gt;: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported
by little or no market data.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company's financial instruments mainly consist of cash, receivables, current assets, accounts payable, accrued expenses and debt. The
carrying amounts of these instruments approximates fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5850">&lt;p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zDrocIb8lYd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;b&gt;&lt;span id="xdx_86D_zC2BYsAH4G68"&gt;Revenue Recognition&lt;/span&gt; &lt;/b&gt;&#x2013;
The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting
Standards Board (&#x201c;FASB&#x201d;). This standard includes a comprehensive evaluation of factors to be considered regarding revenue
recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price,
(iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as
each obligation is satisfied.&#160;The Company&#x2019;s revenue transactions include the shipment of goods to customers as orders are
fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue
upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240731_zv3ruEUYdIei"&gt;50,039 &lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240430_zta0vf4KVPY1"&gt;53,939 &lt;/span&gt; at July 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the
capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $&lt;span id="xdx_90E_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240731_zeehHTInjCH9"&gt;0&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_c20240430_zUia9GjcIxwd"&gt;1,477,859&lt;/span&gt; at July 31, 2024 and
April 30, 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table presents the Company&#x2019;s revenue disaggregated by revenue type:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Three
    Months Ended&#160;July 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Contract related&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;886,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;310,881&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Product related&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,890,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,437,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,776,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,748,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zyVi65qXkNFl" style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 5pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11680"
      unitRef="USD">50039</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11681"
      unitRef="USD">53939</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11682"
      unitRef="USD">0</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11683"
      unitRef="USD">1477859</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5863">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock_z3VO1PioT8Z4" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Company's revenue disaggregated by revenue type (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240501__20240731_zUzFsxSQ9iOg"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_zLzyosGbmgii"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Three
    Months Ended&#160;July 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zLURT1S7GNTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Contract related&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;886,440&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;310,881&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RevenueNotFromContractWithCustomer_zLrT1ShD0sTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Product related&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,890,095&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,437,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Revenues_zCQt122WQ0Di" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,776,535&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,748,129&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11684"
      unitRef="USD">886440</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11685"
      unitRef="USD">310881</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11686"
      unitRef="USD">1890095</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11687"
      unitRef="USD">1437248</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11688"
      unitRef="USD">2776535</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11689"
      unitRef="USD">1748129</us-gaap:Revenues>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies contextRef="From2024-05-01to2024-07-31" id="ixv-5967">&lt;p id="xdx_848_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zzZ20WTYGaPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zB5Fs2RckWq1"&gt;Product
Warranty&lt;/span&gt; - &lt;/b&gt;The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales
data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses.&#160;Warranty
liability was approximately $&lt;span id="xdx_90E_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240731_z2g90xAOwkf2"&gt;541,000 &lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zjhY2VPYHCm1"&gt;372,000 &lt;/span&gt; as of July 31, 2024 and April 30, 2024 respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11690"
      unitRef="USD">541000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11691"
      unitRef="USD">372000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5976">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIslxQr6OUV8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zBCv0DVYabr4"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;
&lt;span style="background-color: white"&gt;Management does not believe that recently issued, but not yet effective accounting pronouncements,
if adopted, would have a material effect on the accompanying consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-5988">&lt;p id="xdx_844_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9ddSQBeNkBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zGDhiRI4SNhb"&gt;Comprehensive
Loss&lt;/span&gt; &lt;/b&gt;&#x2013; Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses
that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of
foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the three months ended
July 31, 2024 and July 31, 2023, comprehensive loss was $&lt;span id="xdx_906_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20240501__20240731_zk6oWTfRMTJ6"&gt;4,621&lt;/span&gt;
higher and $&lt;span id="xdx_90E_ecustom--DifferenceBetweenComprehensiveLossAndNetLoss_c20230501__20230731_z5YREAIgqlQ9"&gt;291,035&lt;/span&gt;
lower than net loss, respectively, related to unrealized
gains on available-for-sale securities totaling $&lt;span id="xdx_907_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20240501__20240731_z3grDvAbQi4h"&gt;0&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--DebtSecuritiesAvailableForSaleUnrealizedGainLoss_c20230501__20230731_zDFVPqPEWUza"&gt;289,389&lt;/span&gt;,  respectively, and foreign currency translation adjustments of $&lt;span id="xdx_906_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dxL_c20240501__20240731_zFJ3HWWXeObe" title="::XDX::-4621"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0576"&gt;4,621 &lt;/span&gt;&lt;/span&gt;
and $&lt;span id="xdx_901_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c20230501__20230731_zNRVZcQe7bY1"&gt;1,646&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <RCAT:DifferenceBetweenComprehensiveLossAndNetLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11692"
      unitRef="USD">4621</RCAT:DifferenceBetweenComprehensiveLossAndNetLoss>
    <RCAT:DifferenceBetweenComprehensiveLossAndNetLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11693"
      unitRef="USD">291035</RCAT:DifferenceBetweenComprehensiveLossAndNetLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11694"
      unitRef="USD">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11695"
      unitRef="USD">289389</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11696"
      unitRef="USD">1646</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6002">&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zVUoEFBtUfU" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_860_zSU7UfLWc966"&gt;Basic and
Diluted Net Loss per Share&lt;/span&gt;&lt;/b&gt; &#x2013; Basic and diluted net loss per share has been calculated by dividing net loss by the weighted
average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of
diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents
would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted
net loss per share because their effect would have been anti-dilutive include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Series B Preferred Stock, as converted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7,319,988&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6,884,017&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,821,291&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,202,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;842,701&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;11,347,774&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9,270,613&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zKTk0JjIkx29" style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6009">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zMiYvM6FEGye" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Antidilutive securities excluded from computation of diluted net loss per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240501__20240731_zPtp1A3KTol9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49D_20230501__20230731_ztw8maD0hiQ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount_zsCXph5KrJWh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Series B Preferred Stock, as converted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount_zH8DpI51qm46" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;7,319,988&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6,884,017&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount_z96I8jpEBYUe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,821,291&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount_zskHS9msxOR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,202,599&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;842,701&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zSKEuUT9Wcee" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;11,347,774&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9,270,613&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11697"
      unitRef="Shares">3896</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11698"
      unitRef="Shares">3896</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11699"
      unitRef="Shares">7319988</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11700"
      unitRef="Shares">6884017</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11701"
      unitRef="Shares">1821291</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11702"
      unitRef="Shares">1539999</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11703"
      unitRef="Shares">2202599</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount>
    <RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11704"
      unitRef="Shares">842701</RCAT:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11705"
      unitRef="Shares">11347774</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-05-012023-07-31"
      decimals="INF"
      id="ixv-11706"
      unitRef="Shares">9270613</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <RCAT:RelatedPartiesPolicyTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6128">&lt;p id="xdx_843_ecustom--RelatedPartiesPolicyTextBlock_zV2baH1iPfPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span id="xdx_86A_zPoAEykNX2k8"&gt;Related
Parties&lt;/span&gt;&lt;/b&gt; &#x2013; Parties are considered to be related to us if they have control or significant influence, directly or indirectly,
over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel
of members of the Board of Directors. Related Party transactions are disclosed in Note 16.&lt;/span&gt;&lt;/p&gt;

</RCAT:RelatedPartiesPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6135">&lt;p id="xdx_84A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zAP8XuCbTS1d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_86B_zRGfjLqTkQrd"&gt;Liquidity
and Going Concern&lt;/span&gt; &lt;/b&gt;&#x2013; The Company has never been profitable and has incurred net losses related to acquisitions, as
well as costs incurred to pursue its long-term growth strategy. During the three months ended July 31, 2024, the Company incurred a
net loss &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;of approximately $&lt;span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperations_dxL_c20240501__20240731_zF35Z25bd401" title="::XDX::-12416376"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0601"&gt;12,000,000 &lt;/span&gt;&lt;/span&gt;&#160;and
used cash in operating activities of approximately $&lt;span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_dxL_c20240501__20240731_zju8eqwXnN28" title="::XDX::-2348412"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0602"&gt;2,300,000&lt;/span&gt;&lt;/span&gt;.
As of July 31, 2024, working capital totaled approximately $&lt;span id="xdx_903_eus-gaap--Capital_iI_c20240731_zjp5xsHPQbSj"&gt;17,200,000&lt;/span&gt;.
These financial results and our financial position &lt;span style="background-color: white"&gt;at&#160;July 31, 2024&#160;raise
substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen
its liquidity.&#160;On&#160;December 11, 2023, we completed a public offering of &lt;span id="xdx_901_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20230501__20240430_zkFL43bk1sl8"&gt;18,400,000&lt;/span&gt;
shares of common stock which generated net proceeds of approximately $&lt;span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20230501__20240430_zz34gyeJ4D2a"&gt;8,400,000&lt;/span&gt;
as further described in Note 1 and Note 12. In addition, the Company&#x2019;s operating plan for the next twelve months has been
updated to reflect recent operating improvements.&#160; Revenues have accelerated and are expected to continue growing. The
Company&#x2019;s manufacturing facility is scaling production and gross profits are projected to increase.&#160;If necessary, the
Company will seek to obtain additional debt financing for which there can be no guarantee. As described in Note 7, the Company sold
its equity method investment for $&lt;span id="xdx_90C_ecustom--ProceedsFromPurchaseAgreement_c20240501__20240731_zNUW7sJPnTrg"&gt;4,400,000&lt;/span&gt;
in July 2024.&lt;span style="background-color: white"&gt; As described in Note 18, the Company closed a financing with proceeds of $8
million to be received in late September 2024.&lt;/span&gt; Management has concluded that these recent positive developments alleviate any
substantial doubt about the Company&#x2019;s ability to&#160;continue its operations, and meet its financial obligations, for twelve
months from the date these consolidated financial statements&#160;are&#160;issued.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:Capital
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11707"
      unitRef="USD">17200000</us-gaap:Capital>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingShares
      contextRef="From2023-05-012024-04-30"
      decimals="INF"
      id="ixv-11708"
      unitRef="Shares">18400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingShares>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds
      contextRef="From2023-05-012024-04-30"
      decimals="0"
      id="ixv-11709"
      unitRef="USD">8400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds>
    <RCAT:ProceedsFromPurchaseAgreement
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11710"
      unitRef="USD">4400000</RCAT:ProceedsFromPurchaseAgreement>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6155">&lt;p id="xdx_80C_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zWAXtnQmdw4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82C_zIqIy55O0bZ1"&gt;Note
3 &#x2013; Divestiture of Consumer Segment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
February 16, 2024,&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;the
Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement
dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the &#x201c;SPA&#x201d;). The transaction
closed concurrently with UMAC&#x2019;s initial public offering and listing on the NYSE American exchange (&#x201c;IPO&#x201d;) under the
symbol &#x201c;UMAC.&#x201d; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
total consideration received by the Company was valued at $&lt;span id="xdx_909_eus-gaap--NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_c20230501__20240430_zzAEC1rPEGPb"&gt;20&lt;/span&gt; million and consisted of i) $&lt;span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureCashConsiderationReceived1_pn6n6_c20230501__20240430_zILcqNPyLqqf"&gt;1
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;million in cash, ii) $&lt;span id="xdx_900_ecustom--NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1_pn6n6_c20230501__20240430_zrPqjzZqNz2g"&gt;2
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;million in a secured promissory note (&#x201c;Promissory Note&#x201d;),
iii) $&lt;span id="xdx_905_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20230501__20240430_zN7QpLusj8Ha"&gt;17
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;million in securities of Unusual Machines, and iv) a post-closing
adjustment for excess working capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Secured
Promissory Note&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Promissory Note from Unusual Machines bears interest at a rate of 8% per year, is due 18 months from the date of issue, and requires
monthly payments of interest due in arrears on the 15th&#160;day of each month. In the event of a Qualified Financing (defined as one
or more related debt or equity financings by UMAC resulting in net proceeds of at least $5 million, other than UMAC&#x2019;s completed
IPO), the Company may require payment of this Promissory Note in whole or in part upon written notice given within 10 days of the Qualified
Financing. During the occurrence and continuance of any event of default under the Note, the Company may, at its option, convert the
amounts due under the Note to common stock of UMAC in whole or in part from time to time. The conversion price will be a 10% discount
to the average daily volume weighted average price for UMAC&#x2019;s common stock over the 10 days preceding the conversion price. Conversions
under the Note will be limited such that no conversion may be made to the extent that, after giving effect to the conversion, the Company,
together with its affiliates, would beneficially own in excess of 4.99% of UMAC&#x2019;s common stock. This limit may be increased by
the Company upon 61 days written notice.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Unusual
Machines Securities&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;/i&gt;The $&lt;span id="xdx_90F_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1_pn6n6_c20240501__20240731_ze2DW3e3BvMj"&gt;17&lt;/span&gt; million worth of UMAC common stock was valued at the IPO price for UMAC&#x2019;s common stock of $4.00
per share, resulting in
&lt;span id="xdx_900_ecustom--NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares_c20240501__20240731_zmcAOx6QeDkh"&gt;4,250,000&lt;/span&gt; shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC&#x2019;s
issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of
the IPO).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Working
Capital&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
purchase price was adjusted for working capital as of the closing date. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Actual
working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. &lt;span style="background-color: white"&gt;Working
capital as of closing was finalized at $&lt;span id="xdx_90F_ecustom--WorkingCapitalAtClosingOfDisposalGroup_iI_pn6n6_c20240216_zDm9R5ivZsn3"&gt;2&lt;/span&gt; million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory
Notes due November 30, 2025 (the &#x201c;New Notes&#x201d;) reflecting (i) satisfaction and settlement of working capital adjustments and
(ii) a maturity date extension to November 30, 2025.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards.
Set forth below are the results of operations for the Consumer segment for:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zuKaIeWZu0c8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240501__20240731_z4VdeuOt2Nki" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230501__20230731_zzSlhuvBqTD4" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three
                                            months ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;July
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zj8g3sgk8Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0619"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,869,219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zqzFk1peqQib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Cost
    of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,385,116&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zXptTyvGvpFg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Gross Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;484,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zracsPLzZwCg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Operating Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_ziPibjoMV2if" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Research and
    development&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0631"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;46,249&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zV7ogu7xH47c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0634"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;404,104&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_z7Ru2o5k3OS2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;General
    and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0637"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;253,586&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zRJj7W3xza0f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"&gt;&lt;span style="font-size: 10pt"&gt;Total
    operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0640"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;703,939&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_zvBQO3lP0N1i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0643"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(219,836&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zaK2fMK0e4f6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expense
    (income)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zqIZoq6f2Xvd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0649"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;22,856&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zxpSTIawrCB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Other,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(119&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i02_z5dvtLssGI42" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0655"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;22,737&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zsogtd9BqCLk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Net
    loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(242,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zk2MRCfa1ush" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="From2023-05-012024-04-30"
      decimals="0"
      id="ixv-11711"
      unitRef="USD">20</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1
      contextRef="From2023-05-012024-04-30"
      decimals="-6"
      id="ixv-11712"
      unitRef="USD">1000000</RCAT:NoncashOrPartNoncashDivestitureCashConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1
      contextRef="From2023-05-012024-04-30"
      decimals="-6"
      id="ixv-11713"
      unitRef="USD">2000000</RCAT:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2023-05-012024-04-30"
      decimals="-6"
      id="ixv-11714"
      unitRef="USD">17000000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
      contextRef="From2024-05-01to2024-07-31"
      decimals="-6"
      id="ixv-11715"
      unitRef="USD">17000000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1>
    <RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11716"
      unitRef="Shares">4250000</RCAT:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares>
    <RCAT:WorkingCapitalAtClosingOfDisposalGroup
      contextRef="AsOf2024-02-16"
      decimals="-6"
      id="ixv-11717"
      unitRef="USD">2000000</RCAT:WorkingCapitalAtClosingOfDisposalGroup>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6229">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zuKaIeWZu0c8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Discontinued Operations - results of operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20240501__20240731_z4VdeuOt2Nki" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20230501__20230731_zzSlhuvBqTD4" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three
                                            months ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;July
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_zj8g3sgk8Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 62%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0619"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,869,219&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_zqzFk1peqQib" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Cost
    of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,385,116&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_zXptTyvGvpFg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Gross Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;484,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationOperatingExpenseAbstract_iB_zracsPLzZwCg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Operating Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense_i01_ziPibjoMV2if" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Research and
    development&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0631"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;46,249&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense_i01_zV7ogu7xH47c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0634"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;404,104&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_i01_z7Ru2o5k3OS2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;General
    and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0637"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;253,586&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_i01_zRJj7W3xza0f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt"&gt;&lt;span style="font-size: 10pt"&gt;Total
    operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0640"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;703,939&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_zvBQO3lP0N1i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0643"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(219,836&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseAbstract_iB_zaK2fMK0e4f6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expense
    (income)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInterestExpense_i01_zqIZoq6f2Xvd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0649"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;22,856&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherIncome_i01N_di_zxpSTIawrCB8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Other,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(119&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense_i02_z5dvtLssGI42" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0655"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;22,737&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_zsogtd9BqCLk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 20pt"&gt;&lt;span style="font-size: 10pt"&gt;Net
    loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(242,573&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11718"
      unitRef="USD">1869219</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11719"
      unitRef="USD">1385116</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11720"
      unitRef="USD">484103</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11721"
      unitRef="USD">46249</RCAT:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11722"
      unitRef="USD">404104</RCAT:DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11723"
      unitRef="USD">253586</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11724"
      unitRef="USD">703939</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11725"
      unitRef="USD">-219836</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11726"
      unitRef="USD">22856</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11727"
      unitRef="USD">119</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome>
    <RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11728"
      unitRef="USD">22737</RCAT:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11729"
      unitRef="USD">-242573</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6652">&lt;p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zzHqLTa6gtZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_828_zPEmyRPf3Feg"&gt;Note
4 &#x2013; Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Inventories
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zRCtWQmDFBv7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20240731_zvHIzK3CIl6a" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240430_zeCzF8CvuTd8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_zhWQPFnWYQk8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6,863,187&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,750,324&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_zw199aAvrVv4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,622,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,289,997&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_znaANYaOFAM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,977,626&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;966,916&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryNet_iI_zvmDK7Y3Mez4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;10,462,934&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;8,007,237&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zK70IRaoFp74" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6663">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zRCtWQmDFBv7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_490_20240731_zvHIzK3CIl6a" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240430_zeCzF8CvuTd8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_zhWQPFnWYQk8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6,863,187&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,750,324&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_zw199aAvrVv4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,622,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,289,997&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_znaANYaOFAM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,977,626&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;966,916&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryNet_iI_zvmDK7Y3Mez4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;10,462,934&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;8,007,237&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11730"
      unitRef="USD">6863187</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11731"
      unitRef="USD">5750324</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11732"
      unitRef="USD">1622121</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11733"
      unitRef="USD">1289997</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11734"
      unitRef="USD">1977626</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11735"
      unitRef="USD">966916</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11736"
      unitRef="USD">10462934</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11737"
      unitRef="USD">8007237</us-gaap:InventoryNet>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6755">&lt;p id="xdx_809_eus-gaap--OtherCurrentAssetsTextBlock_zOA03Ci8w8p" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_823_zj8mgt5L6GD8"&gt;Note
5 &#x2013; Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Other
current assets included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zX8DVTzy3kmk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other current assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240731_zeID4xo625o9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240430_zYD437Aip8v7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zui2NmgKkI0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,387,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,206,306&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zGhl9icFl5yg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;204,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;602,888&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zWLrkPLAqSq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Contract asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,477,859&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--GrantsReceivableCurrent_iI_zgjWNMUcqq64" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Grant receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0690"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;675,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherAssetsCurrent_iI_zRGRYMiN35V4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,592,679&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,962,053&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zQ4K2FJXZtga" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6766">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zX8DVTzy3kmk" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other current assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240731_zeID4xo625o9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240430_zYD437Aip8v7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zui2NmgKkI0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,387,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,206,306&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_zGhl9icFl5yg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;204,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;602,888&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ContractWithCustomerAssetGrossCurrent_iI_d0_zWLrkPLAqSq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Contract asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,477,859&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--GrantsReceivableCurrent_iI_zgjWNMUcqq64" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Grant receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0690"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;675,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherAssetsCurrent_iI_zRGRYMiN35V4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,592,679&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,962,053&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11738"
      unitRef="USD">2387937</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11739"
      unitRef="USD">1206306</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11740"
      unitRef="USD">204742</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11741"
      unitRef="USD">602888</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11742"
      unitRef="USD">0</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11743"
      unitRef="USD">1477859</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:GrantsReceivableCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11744"
      unitRef="USD">675000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11745"
      unitRef="USD">2592679</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11746"
      unitRef="USD">3962053</us-gaap:OtherAssetsCurrent>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6883">&lt;p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zYzrWARpNqRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_828_zrR0uon87BKh"&gt;Note
6 &#x2013; Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Intangible
assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zsjeL5QCTHm7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zC1wdR0GRknf" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQkhwGyz0tUi" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zF4SeUK4PX7f" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zWZvAphaHHi9" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zkfpwTcGZs26" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zyzLmWy22k54" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Gross
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated
    Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Net
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated
    Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Net
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FiniteLivedProprietaryTechnologyGross_iI_zWENlT1lHKjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,282,001&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,094,941&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,187,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,282,001&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,917,612&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,364,389&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zhDKad5xG7lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0712"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zasy2FVorEwh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total finite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,347,001&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,159,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,187,060&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,347,001&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,982,612&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,364,389&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IndefiniteLivedTradeNames_iI_zxEIZg9A2ZEl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Brand name&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0725"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zHPvJXlCl4Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total indefinite-lived
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0729"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0732"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_zfACR5VZxKIc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,777,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,159,941&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,617,060&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,777,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,982,612&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,794,389&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zA83lKEIFBUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Proprietary
technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not
amortized but evaluated for impairment on a quarterly basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-6893">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zsjeL5QCTHm7" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zC1wdR0GRknf" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zQkhwGyz0tUi" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20240731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zF4SeUK4PX7f" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49B_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsGrossCarryingAmountMember_zWZvAphaHHi9" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsAccumulatedAmortizationMember_zkfpwTcGZs26" style="text-align: center"&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49A_20230731__custom--FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsNetCarryingValueMember_zyzLmWy22k54" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Gross
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated
    Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Net
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.85pt 0 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated
    Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Net
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FiniteLivedProprietaryTechnologyGross_iI_zWENlT1lHKjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,282,001&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,094,941&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,187,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,282,001&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;(1,917,612&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,364,389&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FiniteLivedNoncompeteAgreementsGross1_iI_zhDKad5xG7lb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0709"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(65,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0712"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FiniteLivedIntangibleAssetsGross1_iI_zasy2FVorEwh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total finite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,347,001&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,159,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,187,060&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4,347,001&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,982,612&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,364,389&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IndefiniteLivedTradeNames_iI_zxEIZg9A2ZEl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Brand name&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0725"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IndefiniteLivedIntangibleAssetsExcludingGoodwill1_iI_zHPvJXlCl4Fa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total indefinite-lived
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0729"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0732"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,430,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--IntangibleAssetsNetExcludingGoodwill1_iI_zfACR5VZxKIc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,777,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,159,941&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,617,060&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,777,001&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,982,612&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,794,389&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11747"
      unitRef="USD">4282001</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11748"
      unitRef="USD">-2094941</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11749"
      unitRef="USD">2187060</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11750"
      unitRef="USD">4282001</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11751"
      unitRef="USD">-1917612</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedProprietaryTechnologyGross
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11752"
      unitRef="USD">2364389</RCAT:FiniteLivedProprietaryTechnologyGross>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11753"
      unitRef="USD">65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11754"
      unitRef="USD">-65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11755"
      unitRef="USD">65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedNoncompeteAgreementsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11756"
      unitRef="USD">-65000</RCAT:FiniteLivedNoncompeteAgreementsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11757"
      unitRef="USD">4347001</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11758"
      unitRef="USD">-2159941</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11759"
      unitRef="USD">2187060</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11760"
      unitRef="USD">4347001</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11761"
      unitRef="USD">-1982612</RCAT:FiniteLivedIntangibleAssetsGross1>
    <RCAT:FiniteLivedIntangibleAssetsGross1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11762"
      unitRef="USD">2364389</RCAT:FiniteLivedIntangibleAssetsGross1>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11763"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11764"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11765"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11766"
      unitRef="USD">1430000</us-gaap:IndefiniteLivedTradeNames>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11767"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11768"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11769"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11770"
      unitRef="USD">1430000</RCAT:IndefiniteLivedIntangibleAssetsExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11771"
      unitRef="USD">5777001</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11772"
      unitRef="USD">-2159941</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2024-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11773"
      unitRef="USD">3617060</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsGrossCarryingAmountMember"
      decimals="0"
      id="ixv-11774"
      unitRef="USD">5777001</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsAccumulatedAmortizationMember"
      decimals="0"
      id="ixv-11775"
      unitRef="USD">-1982612</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <RCAT:IntangibleAssetsNetExcludingGoodwill1
      contextRef="AsOf2023-07-31_custom_IntangibleAssetsNetCarryingValueMember"
      decimals="0"
      id="ixv-11776"
      unitRef="USD">3794389</RCAT:IntangibleAssetsNetExcludingGoodwill1>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7304">&lt;p id="xdx_805_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_z9YiN0YA0b24" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82D_zN2iSw1Nvgug"&gt;Note
7 &#x2013; Equity Method Investment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt; background-color: white"&gt;On
July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the &#x201c;Purchasers&#x201d;).
As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged
&lt;span id="xdx_909_ecustom--ExchangeAgreementSharesExchanged_c20240501__20240731_z38JyqlzWk19"&gt;4,250,000&lt;/span&gt; shares of UMAC&#x2019;s common stock, par value $&lt;span id="xdx_902_ecustom--ExchangeAgreementSharesExchangedParValue_c20240501__20240731_zEbXUfVJ8Nw1"&gt;0.001&lt;/span&gt; per share, for &lt;span id="xdx_90E_ecustom--ExchangeAgreementPreferredSharesReceived_c20240501__20240731_zQDl8K4LWYU2"&gt;4,250&lt;/span&gt; shares of UMAC&#x2019;s newly designated Series A
Convertible Preferred Stock (the &#x201c;Series A&#x201d;). The Company sold the Series A ownership interest ($&lt;span id="xdx_90A_ecustom--ExchangeAgreementSharesPreferredStockValueSold_c20240501__20240731_ztxl36a9zcJh"&gt;4,408,357&lt;/span&gt; at time of sale)
and the Note Receivable of $&lt;span id="xdx_90E_ecustom--NoteReceivableSoldPursuantToExchangeAgreement_c20240501__20240731_zKSZWm4YDTGi"&gt;4,000,000&lt;/span&gt; to the Purchasers for $&lt;span id="xdx_904_ecustom--ProceedsFromPurchaseAgreement_pin6_c20240501__20240731_zYhbVr7LHnL2"&gt;4.4&lt;/span&gt; million in cash pursuant to a Purchase Agreement in a transaction that
closed on July 22, 2024.&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="background-color: white"&gt;As
of April 30, 2024, the Company had owned approximately a &lt;span id="xdx_907_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230501__20240430_zEA1zXrp3SLi"&gt;46&lt;/span&gt;% interest in Unusual Machines. The primary business operations included selling
first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC&#x2019;s financial
statements are prepared in accordance with GAAP.&lt;/span&gt; See Note 3 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Financial
information for UMAC prior to the sale of the Company&#x2019;s equity interest was derived from UMAC&#x2019;s Form 10-Q for the six months
ended June 30, 2024 and was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_ztf1asJE8Oq3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AssetsCurrent_iE_z7ntNzm1rNGl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 72%; font-size: 10pt; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 25%; font-size: 10pt; text-align: right"&gt;5,116,963&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AssetsNoncurrent_iE_zxs4ODeHzxh4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;20,083,390&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iE_zyWpKwK13uq4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;931,200&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_iE_zOz7J2TYeiOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,297,332&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_zYXvMrsWN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,030,039&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--GrossProfit_zJEakPFoPB5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;592,607&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_z6opJzzCPFuc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,718,240&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zYTBJQxNUJ5i" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Company&#x2019;s investments in UMAC have been impacted by the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)"&gt;
&lt;tr id="xdx_431_c20240201__20240430_eus-gaap--EquityMethodInvestments_iS_zsLkD22pXcx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 67%"&gt;Initial investment, February 16, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_4B2_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zKGNF3Civcdi" style="text-align: right; width: 30%"&gt;17,000,000&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20240201__20240430_eus-gaap--IncomeLossFromEquityMethodInvestments_zR1RTFfF7J3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity method loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,625&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43B_c20240201__20240430_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_zn7jfoOL2NU" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(11,353,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20240201__20240430_eus-gaap--EquityMethodInvestments_iE_zDowKCsMMHp3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,142,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20240501__20240731_eus-gaap--IncomeLossFromEquityMethodInvestments_zSBcxCyNMpXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Equity method loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(734,143&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20240501__20240731_ecustom--SaleOfOwnershipInterestEquityMethodInvestment_zti24tbhMvKd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Sale of ownership interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(4,408,357&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20240501__20240731_eus-gaap--EquityMethodInvestments_iE_zvaRO1a32IN5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, July 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0780"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zeWKyDxOL9X6" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair
market value of UMAC&#x2019;s common stock. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <RCAT:ExchangeAgreementSharesExchanged
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11777"
      unitRef="Shares">4250000</RCAT:ExchangeAgreementSharesExchanged>
    <RCAT:ExchangeAgreementSharesExchangedParValue
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11778"
      unitRef="USDPShares">0.001</RCAT:ExchangeAgreementSharesExchangedParValue>
    <RCAT:ExchangeAgreementPreferredSharesReceived
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11779"
      unitRef="Shares">4250</RCAT:ExchangeAgreementPreferredSharesReceived>
    <RCAT:ExchangeAgreementSharesPreferredStockValueSold
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11780"
      unitRef="USD">4408357</RCAT:ExchangeAgreementSharesPreferredStockValueSold>
    <RCAT:NoteReceivableSoldPursuantToExchangeAgreement
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11781"
      unitRef="USD">4000000</RCAT:NoteReceivableSoldPursuantToExchangeAgreement>
    <RCAT:ProceedsFromPurchaseAgreement
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11782"
      unitRef="USD">4400000</RCAT:ProceedsFromPurchaseAgreement>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="From2023-05-012024-04-30"
      decimals="INF"
      id="ixv-11783"
      unitRef="Pure">0.46</us-gaap:VariableInterestEntityOwnershipPercentage>
    <RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7340">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--EquityMethodInvestmentFinancialInformationTableTextBlock_ztf1asJE8Oq3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%" summary="xdx: Disclosure - Financial information for UMAC derived from their Form 10-Q (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_498_20240101__20240331__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zYeBfmK7l2wj"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AssetsCurrent_iE_z7ntNzm1rNGl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 72%; font-size: 10pt; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 25%; font-size: 10pt; text-align: right"&gt;5,116,963&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AssetsNoncurrent_iE_zxs4ODeHzxh4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;20,083,390&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesCurrent_iE_zyWpKwK13uq4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;931,200&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_iE_zOz7J2TYeiOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Long-term liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,297,332&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--Revenues_zYXvMrsWN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Revenues&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,030,039&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--GrossProfit_zJEakPFoPB5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;592,607&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_z6opJzzCPFuc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,718,240&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:EquityMethodInvestmentFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11784"
      unitRef="USD">5116963</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11785"
      unitRef="USD">20083390</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11786"
      unitRef="USD">931200</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11787"
      unitRef="USD">4297332</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11788"
      unitRef="USD">2030039</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11789"
      unitRef="USD">592607</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11790"
      unitRef="USD">-2718240</us-gaap:NetIncomeLoss>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7394">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--EquityMethodInvestmentsTextBlock_zLOji0k794G2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Impacts on investments into UMAC (Details)"&gt;
&lt;tr id="xdx_431_c20240201__20240430_eus-gaap--EquityMethodInvestments_iS_zsLkD22pXcx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 67%"&gt;Initial investment, February 16, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_4B2_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis_us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_zKGNF3Civcdi" style="text-align: right; width: 30%"&gt;17,000,000&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_432_c20240201__20240430_eus-gaap--IncomeLossFromEquityMethodInvestments_zR1RTFfF7J3d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity method loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,625&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43B_c20240201__20240430_eus-gaap--EquityMethodInvestmentOtherThanTemporaryImpairment_zn7jfoOL2NU" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(11,353,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20240201__20240430_eus-gaap--EquityMethodInvestments_iE_zDowKCsMMHp3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, April 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,142,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20240501__20240731_eus-gaap--IncomeLossFromEquityMethodInvestments_zSBcxCyNMpXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Equity method loss&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(734,143&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20240501__20240731_ecustom--SaleOfOwnershipInterestEquityMethodInvestment_zti24tbhMvKd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Sale of ownership interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(4,408,357&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20240501__20240731_eus-gaap--EquityMethodInvestments_iE_zvaRO1a32IN5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Investment balance, July 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0780"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11791"
      unitRef="USD">-503625</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="From2024-02-012024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11792"
      unitRef="USD">-11353875</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-04-30_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11793"
      unitRef="USD">5142500</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11794"
      unitRef="USD">-734143</us-gaap:IncomeLossFromEquityMethodInvestments>
    <RCAT:SaleOfOwnershipInterestEquityMethodInvestment
      contextRef="From2024-05-012024-07-31_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"
      decimals="0"
      id="ixv-11795"
      unitRef="USD">-4408357</RCAT:SaleOfOwnershipInterestEquityMethodInvestment>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7453">&lt;p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zUvtxMw52FH4" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_827_zjG79bpgDmda"&gt;Note
8 &#x2013; Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Property
and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation.
The reported values are periodically assessed for impairment, and were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zU8iwyKrYQP1" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20240731_zIVVfsTzYJK" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20240430_z8YevSvskOS6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_zU1rZe2lsm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Equipment and related&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,609,269&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,540,888&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LeaseholdImprovementsGross_iI_zN93UM6gtH3a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,556,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,547,976&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zHUpeXzvNuqi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;186,703&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;163,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z10k40UqBvPj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,208,192&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(911,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iI_zgL1ebvLX3S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,143,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,340,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zlu8YxqrJMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Depreciation
expense totaled $&lt;span id="xdx_903_eus-gaap--Depreciation_c20240501__20240731_zQJxJVqrdVCb"&gt;296,722 &lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--Depreciation_c20230501__20230731_zHrjB9UXdYla"&gt;101,001 &lt;/span&gt; for the three months ended July 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7464">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zU8iwyKrYQP1" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_494_20240731_zIVVfsTzYJK" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;July
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49C_20240430_z8YevSvskOS6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;April
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_zU1rZe2lsm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Equipment and related&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,609,269&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,540,888&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LeaseholdImprovementsGross_iI_zN93UM6gtH3a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,556,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,547,976&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FurnitureAndFixturesGross_iI_zHUpeXzvNuqi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;186,703&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;163,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_z10k40UqBvPj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(1,208,192&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(911,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentNet_iI_zgL1ebvLX3S" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,143,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,340,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11796"
      unitRef="USD">1609269</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11797"
      unitRef="USD">1540888</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11798"
      unitRef="USD">1556139</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11799"
      unitRef="USD">1547976</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11800"
      unitRef="USD">186703</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11801"
      unitRef="USD">163290</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11802"
      unitRef="USD">1208192</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11803"
      unitRef="USD">911470</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11804"
      unitRef="USD">2143919</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11805"
      unitRef="USD">2340684</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11806"
      unitRef="USD">296722</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11807"
      unitRef="USD">101001</us-gaap:Depreciation>
    <RCAT:OtherLongTermAssetsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7582">&lt;p id="xdx_80F_ecustom--OtherLongTermAssetsDisclosureTextBlock_zmXk6aRYGzNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_825_zvgbmdXVOP9k"&gt;Note
9 &#x2013; Other Long-Term Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Other
long-term assets included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zENx4C22DVVh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other long term assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20240731_z2Zer20g4iFk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;July 31, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240430_zE4POr3zA5zl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SAFEAgreementAssets_iI_zrYSJKSr01Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;SAFE agreement&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--SecurityDeposit_iI_ziM5Fzjik2Rb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Security deposits&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NoncurrentAssets_iI_zb4QKHjYZRIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zywYwvR72358" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (&#x201c;Firestorm&#x201d;)
under which it made a payment of $&lt;span id="xdx_908_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zDyv0sWXXzr1"&gt;250,000&lt;/span&gt; to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits
the Company to participate in a future equity financing of Firestorm by converting the $&lt;span id="xdx_905_ecustom--PaymentForSAFEAgreement_c20221101__20221130_zeswLHl1NpN7"&gt;250,000&lt;/span&gt; into shares of Preferred Stock of Firestorm.
If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive
cash payments, or shares of stock, whichever has greater value. The Company&#x2019;s investment in the SAFE agreement has been recorded
on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis.
No&#160;factors indicative of impairment were identified&#160;during&#160;the&#160;three months ended&#160;July&#160;31,&#160;2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RCAT:OtherLongTermAssetsDisclosureTextBlock>
    <RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7593">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfOtherLongTermAssetsTableTextBlock_zENx4C22DVVh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Other long term assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20240731_z2Zer20g4iFk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;July 31, 2024&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49F_20240430_zE4POr3zA5zl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;April 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SAFEAgreementAssets_iI_zrYSJKSr01Cd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;SAFE agreement&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--SecurityDeposit_iI_ziM5Fzjik2Rb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Security deposits&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;43,126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NoncurrentAssets_iI_zb4QKHjYZRIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;293,126&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RCAT:ScheduleOfOtherLongTermAssetsTableTextBlock>
    <RCAT:SAFEAgreementAssets
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11808"
      unitRef="USD">250000</RCAT:SAFEAgreementAssets>
    <RCAT:SAFEAgreementAssets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11809"
      unitRef="USD">250000</RCAT:SAFEAgreementAssets>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11810"
      unitRef="USD">43126</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11811"
      unitRef="USD">43126</us-gaap:SecurityDeposit>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11812"
      unitRef="USD">293126</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11813"
      unitRef="USD">293126</us-gaap:NoncurrentAssets>
    <RCAT:PaymentForSAFEAgreement
      contextRef="From2022-11-012022-11-30"
      decimals="0"
      id="ixv-11814"
      unitRef="USD">250000</RCAT:PaymentForSAFEAgreement>
    <RCAT:PaymentForSAFEAgreement
      contextRef="From2022-11-012022-11-30"
      decimals="0"
      id="ixv-11815"
      unitRef="USD">250000</RCAT:PaymentForSAFEAgreement>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7655">&lt;p id="xdx_80A_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zLbr4wR7NhTe" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82D_zhkxIP9AakOa"&gt;Note
10 &#x2013; Right of Use Assets and Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;As
of July 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company&#x2019;s leases have remaining
lease terms of up to 6.42 years, including options to extend certain leases for up to six years. Operating lease expense totaled $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240501__20240731_zCLAO1ocURPj"&gt;90,288&lt;/span&gt;
and $&lt;span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20230501__20230731_zQmFkCZaUmEj"&gt;85,252&lt;/span&gt; for the three months ended July 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Leases
on which the Company made rent payments during the reporting period included:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Monthly Rent&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;South Salt Lake, Utah&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_ziaXfkDt8teg" style="text-align: right; width: 25%"&gt;23,340&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;December 2030&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;San Juan, Puerto Rico&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_zPBWpmghPTEi" style="text-align: right"&gt;5,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Grantsville, Utah&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zh533RUxAn4k" style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;December 2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zATMaDDRw507" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Supplemental
information related to operating leases for the three months ended July 31, 2024 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240501__20240731_zI2mqukVWKqg" style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"&gt;&lt;span style="font-size: 10pt"&gt;Operating cash
    paid to settle lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 20%"&gt;$&lt;span style="font-size: 10pt"&gt;90,951&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240731_z0QTAgEejtNd"&gt;5.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A6_zgUpGUTR1tgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11816"
      unitRef="USD">90288</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11817"
      unitRef="USD">85252</us-gaap:OperatingLeaseExpense>
    <us-gaap:ScheduleOfRentExpenseTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7674">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfRentExpenseTableTextBlock_zQ1JIeepMl5k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Location&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Monthly Rent&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 42%"&gt;South Salt Lake, Utah&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation1Member_ziaXfkDt8teg" style="text-align: right; width: 25%"&gt;23,340&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 25%"&gt;&lt;span style="font-size: 10pt"&gt;December 2030&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;San Juan, Puerto Rico&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation3Member_zPBWpmghPTEi" style="text-align: right"&gt;5,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Grantsville, Utah&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseExpense_c20240501__20240731__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--OperatingLeaseLocation4Member_zh533RUxAn4k" style="text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;December 2026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRentExpenseTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation1Member"
      decimals="0"
      id="ixv-11818"
      unitRef="USD">23340</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation3Member"
      decimals="0"
      id="ixv-11819"
      unitRef="USD">5977</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-05-012024-07-31_custom_OperatingLeaseLocation4Member"
      decimals="0"
      id="ixv-11820"
      unitRef="USD">1000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7722">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_z7efdYCP0wsl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Supplemental information related to operating leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 12pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49E_20240501__20240731_zI2mqukVWKqg" style="font-size: 12pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--OperatingCashPaidToSettleLeaseLiabilities_zOf4I3cCkeX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt; width: 77%"&gt;&lt;span style="font-size: 10pt"&gt;Operating cash
    paid to settle lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 20%"&gt;$&lt;span style="font-size: 10pt"&gt;90,951&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_pip0_dtY_c20240731_z0QTAgEejtNd"&gt;5.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iE_zY85bVC2Kdmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <RCAT:OperatingCashPaidToSettleLeaseLiabilities
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11821"
      unitRef="USD">90951</RCAT:OperatingCashPaidToSettleLeaseLiabilities>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-07-31" id="ixv-11822">P5Y11M4D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="ixv-11823"
      unitRef="Pure">0.12</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7772">&lt;p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zSzPJO103sQh" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82E_z1qA9eIlg1r2"&gt;Note
11 &#x2013; Debt Obligations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Decathlon
    Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;On
August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (&#x201c;DA4&#x201d;)
in the amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_zAm5DKvMAIm2"&gt;1,670,294&lt;/span&gt; (the &#x201c;Loan&#x201d;), representing the outstanding principal amount previously due and owing by Teal
to DA4. Interest on the Loan accrues at a rate of ten (&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_ztONSCjlVmR5"&gt;10&lt;/span&gt;%) percent per annum. Principal and interest is payable in monthly installments
of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation1Member_za1MgSKb1zyi"&gt;49,275&lt;/span&gt; until maturity on December 31, 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $&lt;span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731_zZh0qSkdXCnk"&gt;230,795&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430_zqH8Lh9zBaRf"&gt;370,537&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Pelion
    Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
May 2021, Teal entered into a note agreement totaling $&lt;span id="xdx_905_ecustom--ConvertibleNoteAgreementAmount_c20210501__20220430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zmtWRBOjCCD7"&gt;350,000&lt;/span&gt;
which is payable upon demand. The Note bears interest at the applicable
Federal Rate as of the date of the Note which was &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240501__20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_z2WBOyioFzne"&gt;0.13&lt;/span&gt;% on the date of issuance. Accrued interest at July 31, 2024 and April 30, 2024
totaled $&lt;span id="xdx_90E_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zzKXJ3mIj0rj"&gt;1,449 &lt;/span&gt;and $&lt;span id="xdx_90C_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation2Member_zSZoi2zqNVof"&gt;1,334&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Corporate
    Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Beginning
in October 2021, and amended in January 2022, Teal financed a total of $&lt;span id="xdx_901_ecustom--LeaseholdImprovementAgreementFundsReceived_c20230701__20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z6ykd1FfoSee"&gt;120,000&lt;/span&gt;
of leasehold improvements with Corporate Equity, LLC.
The loan bears interest at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zlKloAID5fug"&gt;8.25&lt;/span&gt;% annually and requires monthly payments of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20221001__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zHVj8f01atXj"&gt;3,595&lt;/span&gt;
through December 2024. The balance outstanding at July
31, 2024 and April 30, 2024 totaled $&lt;span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_z8oJ6OuBx9Nf"&gt;17,205 &lt;/span&gt;
and $&lt;span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation6Member_zyKk8vtZDlw3"&gt;27,495 &lt;/span&gt;
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; padding-left: 9pt; text-align: justify; line-height: 105%; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Ascentium
    Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $&lt;span id="xdx_904_ecustom--FinancingAgreementFundingOfPurchaseOfFixedAsset_c20220901__20220930__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zXPrPXkfuWIe"&gt;24,383&lt;/span&gt;.
Monthly payments of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20230430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zDbegMnjzO35"&gt;656&lt;/span&gt;
are payable through October 2024. The balance outstanding at July 31, 2024 and April 30, 2024 totaled $&lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240731__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_z23c2t1VsRSg"&gt;1,449 &lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240430__us-gaap--DebtInstrumentAxis__custom--DebtObligation8Member_zUbsfqCCpHu2"&gt;1,334&lt;/span&gt;
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 98%; padding-bottom: 8pt; text-align: justify; line-height: 105%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%"&gt;&lt;b&gt;&#160;Summary
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Future
annual principal payments at July 31, 2024 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240731_z2tv2nqXKtra"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 65%"&gt;2025&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 30%"&gt;599,570&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;599,570&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AB_zmcWXEYcWPf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-08-31_custom_DebtObligation1Member"
      decimals="0"
      id="ixv-11824"
      unitRef="USD">1670294</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-09-012023-04-30_custom_DebtObligation1Member"
      decimals="INF"
      id="ixv-11825"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-08-012023-04-30_custom_DebtObligation1Member"
      decimals="0"
      id="ixv-11826"
      unitRef="USD">49275</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11827"
      unitRef="USD">230795</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30"
      decimals="0"
      id="ixv-11828"
      unitRef="USD">370537</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:ConvertibleNoteAgreementAmount
      contextRef="From2021-05-012022-04-30_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-11829"
      unitRef="USD">350000</RCAT:ConvertibleNoteAgreementAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2024-05-012024-07-31_custom_DebtObligation2Member"
      decimals="INF"
      id="ixv-11830"
      unitRef="Pure">0.0013</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-07-31_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-11831"
      unitRef="USD">1449</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-04-30_custom_DebtObligation2Member"
      decimals="0"
      id="ixv-11832"
      unitRef="USD">1334</us-gaap:AccruedLiabilitiesCurrent>
    <RCAT:LeaseholdImprovementAgreementFundsReceived
      contextRef="From2023-07-012024-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-11833"
      unitRef="USD">120000</RCAT:LeaseholdImprovementAgreementFundsReceived>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member"
      decimals="INF"
      id="ixv-11834"
      unitRef="Pure">0.0825</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-10-012023-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-11835"
      unitRef="USD">3595</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-07-31_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-11836"
      unitRef="USD">17205</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30_custom_DebtObligation6Member"
      decimals="0"
      id="ixv-11837"
      unitRef="USD">27495</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset
      contextRef="From2022-09-012022-09-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-11838"
      unitRef="USD">24383</RCAT:FinancingAgreementFundingOfPurchaseOfFixedAsset>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-09-012023-04-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-11839"
      unitRef="USD">656</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-07-31_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-11840"
      unitRef="USD">1449</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-04-30_custom_DebtObligation8Member"
      decimals="0"
      id="ixv-11841"
      unitRef="USD">1334</us-gaap:DebtInstrumentCarryingAmount>
    <RCAT:ScheduleOfDebtPaymentsDueTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7878">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfDebtPaymentsDueTableTextBlock_z3uP9BcDMky8" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Outstanding principal payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; font-size: 10pt"&gt;Fiscal Year Ended:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_491_20240731_z2tv2nqXKtra"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--OutstandingPrincipalPaymentsDueYearOne_iI_zbmEsNFx6o97" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 65%"&gt;2025&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; width: 30%"&gt;599,570&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--OutstandingPrincipalPaymentsDueLongTerm_iI_zaRHrANgX5L5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--OutstandingPrincipalPaymentsDueTotal_iI_zhiLvdsDxxG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;599,570&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</RCAT:ScheduleOfDebtPaymentsDueTableTextBlock>
    <RCAT:OutstandingPrincipalPaymentsDueYearOne
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11842"
      unitRef="USD">599570</RCAT:OutstandingPrincipalPaymentsDueYearOne>
    <RCAT:OutstandingPrincipalPaymentsDueTotal
      contextRef="AsOf2024-07-31"
      decimals="0"
      id="ixv-11843"
      unitRef="USD">599570</RCAT:OutstandingPrincipalPaymentsDueTotal>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7916">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zGqdOaZwg4ig" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82A_zVlrEMmPnCfl"&gt;Note
12 &#x2013; Common Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Our
common stock has a par value of $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240731_zDidkHuH2JSl"&gt;0.001&lt;/span&gt; per share. We are authorized to issue &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_z5IsRRBQvzOl"&gt;500,000,000&lt;/span&gt; shares of common stock. Each share of common
stock is entitled to one vote.&#160;A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Description
    of Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Shares
    Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_eus-gaap--SharesOutstanding_iS_zeTvz0zbJr41" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; width: 75%"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right; width: 20%"&gt;&lt;span style="font-size: 10pt"&gt;54,568,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_z3DfxWwJpLl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;192,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_z9MBKNxRerb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;252,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zqtbPdkJgySj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,761&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_z7T8PLP5xf3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;818,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zvLE4sgzomw1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through ATM facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;53,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_z9lKEjNguO78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through public offering&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;18,400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zlxiPdB1NXxa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_439_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zffjBQ61NBIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,289,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zdV5XQ1QPH2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to
    employees, net of shares withheld of 126,828 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;231,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zpL6RsRdquyf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to
    Board of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;61,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_431_c20240501__20240731_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_zhhEcag97Bgl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;307,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20240501__20240731_eus-gaap--SharesOutstanding_iE_zMMqBaYlPrY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of July 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,890,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zPPZIlMCo3Jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;ATM
Facility&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
August 2023, we entered into a sales agreement (&#x201c;the 2023 ATM Facility&#x201d;) with ThinkEquity LLC (&#x201c;ThinkEquity&#x201d;),
which provides for the sale, in our sole discretion, of shares of our common stock through ThinkEquity, as our sales agent. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; letter-spacing: 0.2pt"&gt;In
accordance with the terms of the ATM Sales Agreement, the Company may offer and sell shares of our common stock, par value $0.001 per
share, having an aggregate offering price of up to $&lt;span id="xdx_907_ecustom--ATMFacilityAggregateOfferingPrice_c20230801__20230831_zFSIY6hYrXF8"&gt;4,375,000&lt;/span&gt;. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
issuance and sale of these shares by us pursuant to the 2023 ATM Facility are deemed &#x201c;at the market&#x201d; offerings as defined
in Rule 415 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), and are registered under the Securities
Act. We pay a commission of up to 2.5% of gross sales proceeds of any common stock sold under the 2023 ATM Facility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Due
to the expiration of the registration statement that was used for the 2023 ATM Facility, and due to the disqualification of our prior
auditors from appearing or practicing before the SEC, no additional securities may be sold under 2023 ATM Facility.&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;Public
Offering&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant
to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the &#x201c;Offering&#x201d;)
an aggregate of &lt;span id="xdx_90C_eus-gaap--PartnersCapitalAccountUnitsSoldInPublicOffering_c20231201__20231231_zFZKFMu862yc"&gt;16,000,000&lt;/span&gt; shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231211_zejWxlnkebGc"&gt;0.001&lt;/span&gt; per share (the &#x201c;Common Stock&#x201d;), at
a public offering price of $&lt;span id="xdx_90C_ecustom--PublicOfferingPricePerShare_c20231201__20231231_zZoArySILYI6"&gt;0.50&lt;/span&gt; per share. The Company&#160;also granted the underwriters a 45-day option to purchase up to an additional
&lt;span id="xdx_905_ecustom--AdditionalSharesPurchaseOptionOverAllotmentCover_c20231201__20231231_zEREtP0SgDDg"&gt;2,400,000&lt;/span&gt; shares of Common Stock to cover over-allotments.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Offering closed on December 11, 2023, resulting in the issuance of &lt;span id="xdx_907_ecustom--FirmCommitmentUnderwrittenPublicOfferingShares_c20231201__20231231_zPcQad0JNBP5"&gt;18,400,000&lt;/span&gt; shares of Common Stock &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;which
generated gross proceeds of $&lt;span id="xdx_90E_ecustom--FirmCommitmentUnderwrittenPublicOfferingGrossProceeds_c20231201__20231231_zkU9KCc7JHK4"&gt;9,200,000&lt;/span&gt;. &lt;span style="background-color: white"&gt;Net proceeds to the Company from the Offering, after deducting
the underwriting discount, the underwriters&#x2019; fees and expenses and the Company&#x2019;s estimated Offering expenses, were approximately
$&lt;span id="xdx_90B_ecustom--FirmCommitmentUnderwrittenPublicOfferingNetProceeds_c20231201__20231231_zpDvrZlLYsPd"&gt;8,400,000&lt;/span&gt;.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="ixv-11844"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="ixv-11845"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-7930">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zZwEuTZUFlwi" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of shares of common stock issued (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Description
    of Shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zRc8LXBmCtQ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt; color: Black"&gt;Shares
    Issued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_eus-gaap--SharesOutstanding_iS_zeTvz0zbJr41" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; width: 75%"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; width: 3%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right; width: 20%"&gt;&lt;span style="font-size: 10pt"&gt;54,568,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43D_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_z3DfxWwJpLl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to employees,
    net of shares withheld of 27,189 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;192,742&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_z9MBKNxRerb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to Board
    of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;252,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20230501__20240430_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3_zqtbPdkJgySj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to consultants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,761&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20230501__20240430_ecustom--StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities_z7T8PLP5xf3j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Conversion of preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;818,334&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_ecustom--IssuanceOfCommonStockThroughATMFacilitiesNetShares_zvLE4sgzomw1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through ATM facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;53,235&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43A_c20230501__20240430_ecustom--StockIssuedDuringPeriodSharesPublicOffering_z9lKEjNguO78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Issuance of common
    stock through public offering&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;18,400,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20230501__20240430_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_zlxiPdB1NXxa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 9pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_439_c20230501__20240430_eus-gaap--SharesOutstanding_iE_zffjBQ61NBIf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,289,351&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_430_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_zdV5XQ1QPH2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to
    employees, net of shares withheld of 126,828 to pay taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;231,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_435_c20240501__20240731_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2_zpL6RsRdquyf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Vesting of restricted stock to
    Board of Directors&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;61,447&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_431_c20240501__20240731_ecustom--StockIssuedDuringPeriodSharesStockWarrantsExercised_zhhEcag97Bgl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;307,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_43C_c20240501__20240731_eus-gaap--SharesOutstanding_iE_zMMqBaYlPrY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Shares outstanding as of July 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 9pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 9pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;74,890,248&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 9pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11846"
      unitRef="Shares">54568065</us-gaap:SharesOutstanding>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11847"
      unitRef="Shares">192742</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11848"
      unitRef="Shares">252214</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11849"
      unitRef="Shares">1761</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares3>
    <RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11850"
      unitRef="Shares">818334</RCAT:StockIssuedDuringPeriodAmountConversionOfConvertibleSecurities>
    <RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11851"
      unitRef="Shares">53235</RCAT:IssuanceOfCommonStockThroughATMFacilitiesNetShares>
    <RCAT:StockIssuedDuringPeriodSharesPublicOffering
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11852"
      unitRef="Shares">18400000</RCAT:StockIssuedDuringPeriodSharesPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11853"
      unitRef="Shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11854"
      unitRef="Shares">74289351</us-gaap:SharesOutstanding>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11855"
      unitRef="Shares">231855</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11856"
      unitRef="Shares">61447</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares2>
    <RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised
      contextRef="From2024-05-012024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11857"
      unitRef="Shares">307595</RCAT:StockIssuedDuringPeriodSharesStockWarrantsExercised>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="ixv-11858"
      unitRef="Shares">74890248</us-gaap:SharesOutstanding>
    <RCAT:ATMFacilityAggregateOfferingPrice
      contextRef="From2023-08-012023-08-31"
      decimals="0"
      id="ixv-11859"
      unitRef="USD">4375000</RCAT:ATMFacilityAggregateOfferingPrice>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11860"
      unitRef="Shares">16000000</us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-11"
      decimals="INF"
      id="ixv-11861"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <RCAT:PublicOfferingPricePerShare
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11862"
      unitRef="USDPShares">0.50</RCAT:PublicOfferingPricePerShare>
    <RCAT:AdditionalSharesPurchaseOptionOverAllotmentCover
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11863"
      unitRef="Shares">2400000</RCAT:AdditionalSharesPurchaseOptionOverAllotmentCover>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingShares
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11864"
      unitRef="Shares">18400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingShares>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds
      contextRef="From2023-12-012023-12-31"
      decimals="0"
      id="ixv-11865"
      unitRef="USD">9200000</RCAT:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds>
    <RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds
      contextRef="From2023-12-012023-12-31"
      decimals="0"
      id="ixv-11866"
      unitRef="USD">8400000</RCAT:FirmCommitmentUnderwrittenPublicOfferingNetProceeds>
    <us-gaap:PreferredStockTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8140">&lt;p id="xdx_809_eus-gaap--PreferredStockTextBlock_zfOFDWyCbMy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82C_zCA5ARbE0lJd"&gt;Note
13 &#x2013; Preferred Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Our
preferred stock has a par value of $&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240731_zmpsbnSarLqb"&gt;0.001&lt;/span&gt; per share. Series B Preferred Stock (&#x201c;Series B Stock&#x201d;) is convertible into common
stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an
as-if-converted basis. &lt;span id="xdx_90E_ecustom--PreferredStockConvertible_c20230601__20230630_zKuuSZ9cnbid"&gt;982,000&lt;/span&gt; shares of Series B Stock were converted into &lt;span id="xdx_904_ecustom--PreferredStockConvertibleSharesIssued_c20230601__20230630_z8WVM0n5wxw6"&gt;818,334&lt;/span&gt; shares of common stock in June 2023. Shares outstanding
at July 31, 2024 totaled &lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20240731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoXneuiclSbj"&gt;4,676 &lt;/span&gt; which are convertible into &lt;span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock_c20240501__20240731__us-gaap--StatementClassOfStockAxis__custom--SeriesAPreferredStock2Member_zlcsIElYcdEf"&gt;3,896 &lt;/span&gt;
shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="ixv-11867"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <RCAT:PreferredStockConvertible
      contextRef="From2023-06-012023-06-30"
      decimals="INF"
      id="ixv-11868"
      unitRef="Shares">982000</RCAT:PreferredStockConvertible>
    <RCAT:PreferredStockConvertibleSharesIssued
      contextRef="From2023-06-012023-06-30"
      decimals="INF"
      id="ixv-11869"
      unitRef="Shares">818334</RCAT:PreferredStockConvertibleSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-07-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="ixv-11870"
      unitRef="Shares">4676</us-gaap:PreferredStockSharesOutstanding>
    <RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock
      contextRef="From2024-05-012024-07-31_custom_SeriesAPreferredStock2Member"
      decimals="INF"
      id="ixv-11871"
      unitRef="Shares">3896</RCAT:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock>
    <RCAT:WarrantsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8158">&lt;p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zj0KfndLrXu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82F_zt6M9hAY1ueh"&gt;Note
14 &#x2013; Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of
$&lt;/span&gt;&lt;span id="xdx_90B_ecustom--WarrantsIssuedExercisePrice_c20220401__20220430_zlCkWt8DGUb7"&gt;1.50&lt;/span&gt;. The warrants were valued using the multinominal lattice The value
of the warrants was included in the determination of the initial accounting for each financing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;A
summary of the warrants issued were:&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zM64ZJWssd39" style="font: 12pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Upon
    Issuance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Date
    of Transaction&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Initial
    Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October 2020&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zyItQ0WxzUCg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;399,998&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_znz6M267FU2c" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;267,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20210101__20210131_zTbE4gZuNo12" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;675,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210101__20210131_zi0F2I3d6ZE5" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,870,666&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zKeT9qA7XOuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;To
date, we have received $&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;301,248 related to the exercise of &lt;span id="xdx_903_ecustom--ExerciseOfWarrantsShares_c20220301__20220430_zSOisXWcjM4l"&gt;268,332
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
May 2021, the Company issued warrants to purchase&lt;/span&gt;
&lt;span id="xdx_90A_ecustom--WarrantsToPurchaseSharesIssued_c20210501__20210531_zRtkWmZKknt8"&gt;200,000&lt;/span&gt; shares of common
stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $&lt;span id="xdx_903_ecustom--WarrantsIssuedExercisePrice_c20210501__20210531_ztFDHvpQQPYk"&gt;5.00&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
July 2021, the Company issued warrants to purchase &lt;/span&gt;&lt;span id="xdx_902_ecustom--WarrantsToPurchaseSharesIssued_c20210701__20210731_zy866tHZXLtk"&gt;533,333
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;shares of
common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $&lt;span id="xdx_902_ecustom--WarrantsIssuedExercisePrice_c20210701__20210731_zB1Pf283Bw2b"&gt;5.625&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
December 2023, the Company issued warrants to purchase &lt;span id="xdx_906_ecustom--WarrantsToPurchaseSharesIssued_c20231201__20231231_zEHiJgcF4utb"&gt;736,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif"&gt;shares
of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $&lt;span id="xdx_900_ecustom--WarrantsIssuedExercisePrice_c20231201__20231231_zxAZTTrGtype"&gt;0.625&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table summarizes the changes in warrants outstanding since April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Shares&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average
    Exercise Price per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;Weighted-average
                                            Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(in
    years)&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"&gt;2.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7l8cGxrduB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;736,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zKoiIywcZfRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPW0HvnKi2Xj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0932"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoUbnz544RU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoPX1vl8iK97" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,275,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z9rvTVjBvmvb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zevipTHxiaQg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zm3VSq1ljz8h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0937"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_ziaEEc0CujWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zVZtrljGewfa"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zqzxOXjOAyGl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(454,708&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zyHJ01SNfIla"&gt;0.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmPLXm0HeVI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,821,291&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zGUr2ztOudKg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.96&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmn5yhaWGuv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.05&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zZ8nCQ8hnLG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;389,589&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_z3WqCMANFHM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</RCAT:WarrantsDisclosureTextBlock>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2022-04-012022-04-30"
      decimals="INF"
      id="ixv-11872"
      unitRef="USDPShares">1.50</RCAT:WarrantsIssuedExercisePrice>
    <RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8175">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfWarrantsIssuedAndFairValueTableTextBlock_zM64ZJWssd39" style="font: 12pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse" summary="xdx: Disclosure - Summary of warrants issued and fair values (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 27%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Upon
    Issuance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Date
    of Transaction&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Initial
    Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October 2020&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20201001__20201031_zyItQ0WxzUCg" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;399,998&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InitialFairValueOfWarrantsUponIssuance_c20201001__20201031_znz6M267FU2c" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;267,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfWarrantsUponIssuance_c20210101__20210131_zTbE4gZuNo12" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;675,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InitialFairValueOfWarrantsUponIssuance_c20210101__20210131_zi0F2I3d6ZE5" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,870,666&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
</RCAT:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock>
    <RCAT:NumberOfWarrantsUponIssuance
      contextRef="From2020-10-012020-10-31"
      decimals="INF"
      id="ixv-11873"
      unitRef="Shares">399998</RCAT:NumberOfWarrantsUponIssuance>
    <RCAT:InitialFairValueOfWarrantsUponIssuance
      contextRef="From2020-10-012020-10-31"
      decimals="0"
      id="ixv-11874"
      unitRef="USD">267999</RCAT:InitialFairValueOfWarrantsUponIssuance>
    <RCAT:NumberOfWarrantsUponIssuance
      contextRef="From2021-01-012021-01-31"
      decimals="INF"
      id="ixv-11875"
      unitRef="Shares">675000</RCAT:NumberOfWarrantsUponIssuance>
    <RCAT:InitialFairValueOfWarrantsUponIssuance
      contextRef="From2021-01-012021-01-31"
      decimals="0"
      id="ixv-11876"
      unitRef="USD">2870666</RCAT:InitialFairValueOfWarrantsUponIssuance>
    <RCAT:ExerciseOfWarrantsShares
      contextRef="From2022-03-012022-04-30"
      decimals="INF"
      id="ixv-11877"
      unitRef="Shares">268332</RCAT:ExerciseOfWarrantsShares>
    <RCAT:WarrantsToPurchaseSharesIssued
      contextRef="From2021-05-012021-05-31"
      decimals="INF"
      id="ixv-11878"
      unitRef="Shares">200000</RCAT:WarrantsToPurchaseSharesIssued>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2021-05-012021-05-31"
      decimals="INF"
      id="ixv-11879"
      unitRef="USDPShares">5.00</RCAT:WarrantsIssuedExercisePrice>
    <RCAT:WarrantsToPurchaseSharesIssued
      contextRef="From2021-07-012021-07-31"
      decimals="INF"
      id="ixv-11880"
      unitRef="Shares">533333</RCAT:WarrantsToPurchaseSharesIssued>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2021-07-012021-07-31"
      decimals="INF"
      id="ixv-11881"
      unitRef="USDPShares">5.625</RCAT:WarrantsIssuedExercisePrice>
    <RCAT:WarrantsToPurchaseSharesIssued
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11882"
      unitRef="Shares">736000</RCAT:WarrantsToPurchaseSharesIssued>
    <RCAT:WarrantsIssuedExercisePrice
      contextRef="From2023-12-012023-12-31"
      decimals="INF"
      id="ixv-11883"
      unitRef="USDPShares">0.625</RCAT:WarrantsIssuedExercisePrice>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8303">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsdFJDMohnN8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Changes in warrants outstanding (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
    of Shares&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average
    Exercise Price per Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;Weighted-average
                                            Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(in
    years)&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zTW3ZBJWhzde" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,539,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zo1SLf91aMLl" style="font-size: 10pt"&gt;3.38&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20210501__20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7rVNAKJOWTi" style="font-size: 10pt"&gt;2.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zH26NEBRYuvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0929"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; width: 35%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z7l8cGxrduB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;736,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 12%"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zKoiIywcZfRa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zPW0HvnKi2Xj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0932"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoUbnz544RU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zoPX1vl8iK97" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,275,999&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_z9rvTVjBvmvb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20230501__20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zevipTHxiaQg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.77&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zm3VSq1ljz8h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0937"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_ziaEEc0CujWe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zVZtrljGewfa"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zqzxOXjOAyGl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(454,708&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zyHJ01SNfIla"&gt;0.63&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmPLXm0HeVI2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,821,291&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zGUr2ztOudKg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.96&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zmn5yhaWGuv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.05&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOutstanding1Member_zZ8nCQ8hnLG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;389,589&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11884"
      unitRef="Shares">1539999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2022-04-30_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11885"
      unitRef="USDPShares">3.38</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2021-05-012022-04-30_custom_WarrantsOutstanding1Member"
      id="ixv-11886">P2Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11887"
      unitRef="Shares">736000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11888"
      unitRef="USDPShares">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11889"
      unitRef="Shares">2275999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2023-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11890"
      unitRef="USDPShares">2.49</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2023-05-012023-07-31_custom_WarrantsOutstanding1Member"
      id="ixv-11891">P2Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11892"
      unitRef="Shares">454708</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11893"
      unitRef="USDPShares">0.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11894"
      unitRef="Shares">1821291</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member"
      decimals="INF"
      id="ixv-11895"
      unitRef="USDPShares">2.96</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2024-05-012024-07-31_custom_WarrantsOutstanding1Member"
      id="ixv-11896">P2Y18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-07-31_custom_WarrantsOutstanding1Member"
      decimals="0"
      id="ixv-11897"
      unitRef="USD">389589</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8610">&lt;p id="xdx_80B_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHnkXy3WHasb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82A_zgoD23Sd6pff"&gt;Note
15 &#x2013; Share Based Awards&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
2019 Equity Incentive Plan (the "Plan") allows us to incentivize key employees, consultants, and directors with long term compensation
awards such as stock options, restricted stock, and restricted stock units (collectively, the "Awards"). The number of shares
issuable in connection with Awards under the Plan may not exceed &lt;span id="xdx_900_ecustom--NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum_c20240501__20240731_z3gxp0Bv6WY"&gt;11,750,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;A.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Options&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
range of assumptions used to calculate the fair value of options granted during the three months ended July 31 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zwWKrBHKnH8b"&gt;1.15&lt;/span&gt;
                                       &#x2013; &lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zcOyHyHyt11e"&gt;1.29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwfKVpa6sma"&gt;1.06&lt;/span&gt; &#x2013; &lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zc86Agqdjmgd"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Stock price on date of grant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zQSYeubdsY38"&gt;1.20&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zytQDTqP7227"&gt;1.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zo79pL1riDBj"&gt;1.06&lt;/span&gt; &#x2013; &lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zlpDkH8rMKIe"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt; &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zqSeJS23NFt3"&gt;4.24&lt;/span&gt;&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7EtEkbAeA0f"&gt;4.44&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhXVzuPRYlOd"&gt;3.47&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHZIPCESAVk9"&gt;4.07&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKHNTpDho3H9"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7WApBhXuBPe"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0964"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z5RsH1tAKujb"&gt;5.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20240501__20240731_zUkkPqnnUaM3"&gt;5.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zRAic9jzIjx2"&gt;6.00&lt;/span&gt; &#x2013;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zNkjWRTdD3eg"&gt; 6.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKjD426i32F8" style="font-size: 10pt"&gt;191.28&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBs9oEnLmHSb"&gt;199.48&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zackZSYtBfii"&gt;257.25&lt;/span&gt; &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z67PDSvzOQVk"&gt;260.22&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zXokxHCQJR8a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;A
summary of options activity under the Plan since April 30, 2023 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,784,809&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.88&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 10%"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"&gt;8.72&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;74,586&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z7rAkr1bfJll" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,903,542&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zAeGFu27kLl8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSXoNGEsLN28" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zII2A6LjHwQd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z4Eu1Ei19M1d" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpxTVULkCV4k" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zZIYNL7HUKL3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,779,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1it06LlqCT2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.46&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zk7vSr1QQRK2" style="font-size: 10pt"&gt;8.02&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zr3yRtIAuyA" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,762,242&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSqSgOyPQXvb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;627,500&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ztedmKcGU0Pl" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.15&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zPyTUgSssd15" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zdCmh0jF766f" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.72&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zq4qWyz3cta4" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(83,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zqUOnW2OGdK7" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zu0ZGzckMY46" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,319,988&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziYgiRtGqlGj" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.43&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zJSCAopLaHa5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.54&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zR4wvrDYxUO2" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,658,470&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable as of July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOXLhV6zDA8" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,444,723&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zjXH5OihYSKf" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.65&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zExJIpuuUSvg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.57&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1xBWPodGjYa" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,014,807&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_z9APoiY0wBde" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;span style="background-color: white"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price
of each option. As of July 31, 2024, there was $&lt;span id="xdx_90D_ecustom--UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions_c20230501__20230731_zG3zNaCqsrB6"&gt;2,773,793 &lt;/span&gt; of unrecognized stock-based compensation expense related to unvested stock
options which is expected to be recognized over the weighted average periods of 1.17.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;B.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Restricted Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;A
summary of restricted stock activity under the Plan since April 30, 2023 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: -10pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value Per Share&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt; width: 52%"&gt;Unvested and outstanding as of April 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"&gt;781,060&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"&gt;2.44&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zie7GVCpeKAa" style="text-align: right"&gt;298,643&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z2uZdheNanp6" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z0GJcBaAYZYf" style="text-align: right"&gt;(485,024&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zEG5rCLRWOb6" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zvu4rWDmXlr2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(419,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zv4vkLrcoawb" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z6wanxKE0xm5" style="text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zieqKXmhSHZ8" style="text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zspstRT7400a" style="text-align: right"&gt;2,447,599&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zxnJNgxejRld" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzfH3x7iglO2" style="text-align: right"&gt;(420,130&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zmnL8xC8W3v1" style="text-align: right"&gt;1.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zbPtYGXtybkc" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzqAoP4eTbV9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Unvested and outstanding as of July 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_ze5i1GuWS25i" style="border-bottom: Black 3pt double; text-align: right"&gt;2,202,599&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zFvbaVd8IXDb" style="border-bottom: Black 3pt double; text-align: right"&gt;1.11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zpESgFA0HL57" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;C.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Stock
compensation expense for the three months ended July 31 by functional operating expense was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z1eXh3zdYvEh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20240501__20240731_zvomcCTvv4Hh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20230731_zgtio2W6FIil" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ResearchAndDevelopmentStockCompensationExpense_zvP0AFfUOoL5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;94,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;127,417&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--SalesAndMarketingStockCompensationExpense_zD6MjHuaDdkg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;116,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;165,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--GeneralAndAdministrativeStockCompensationExpense_z4KIwy9kjGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,235,073&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;618,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--TotalStockCompensationExpense_z14Pqh4g5ON5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,446,038&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;911,606&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zHNDp4xHHRGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock
compensation expense pertaining to options totaled $&lt;span id="xdx_90B_ecustom--StockCompensationExpensePertainingToOptions_c20240501__20240731_zXe7rEeodCFe"&gt;357,258&lt;/span&gt; and
$&lt;span id="xdx_909_ecustom--StockCompensationExpensePertainingToOptions_c20230501__20230731_zUJjBROcLm2c"&gt;629,426 &lt;/span&gt; for the three months ended July 31, 2024 and 2023, respectively.
Stock compensation expense pertaining to restricted stock totaled $&lt;span id="xdx_903_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20240501__20240731_zBFe5bjAZgRd"&gt;1,088,780 &lt;/span&gt; and $&lt;span id="xdx_901_ecustom--StockCompensationExpensePertainingToRestrictedStockUnits_c20230501__20230731_zvwY64SyeDBa"&gt;282,180 &lt;/span&gt;  for the three months ended July 31, 2024 and
2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum
      contextRef="From2024-05-01to2024-07-31"
      decimals="INF"
      id="ixv-11898"
      unitRef="Shares">11750000</RCAT:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum>
    <RCAT:ScheduleOfAssumptionsUsed1TableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8643">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfAssumptionsUsed1TableTextBlock_zlJsdOqFLd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Assumptions used to calculate fair value of options granted (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; font-size: 12pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 51%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; width: 20%"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zwWKrBHKnH8b"&gt;1.15&lt;/span&gt;
                                       &#x2013; &lt;span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zcOyHyHyt11e"&gt;1.29&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zpwfKVpa6sma"&gt;1.06&lt;/span&gt; &#x2013; &lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zc86Agqdjmgd"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Stock price on date of grant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zQSYeubdsY38"&gt;1.20&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zytQDTqP7227"&gt;1.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zo79pL1riDBj"&gt;1.06&lt;/span&gt; &#x2013; &lt;span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1_iI_c20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zlpDkH8rMKIe"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt; &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zqSeJS23NFt3"&gt;4.24&lt;/span&gt;&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7EtEkbAeA0f"&gt;4.44&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zhXVzuPRYlOd"&gt;3.47&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zHZIPCESAVk9"&gt;4.07&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKHNTpDho3H9"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z7WApBhXuBPe"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0964"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z5RsH1tAKujb"&gt;5.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dtY_c20240501__20240731_zUkkPqnnUaM3"&gt;5.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zRAic9jzIjx2"&gt;6.00&lt;/span&gt; &#x2013;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_pip0_dtY_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zNkjWRTdD3eg"&gt; 6.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zKjD426i32F8" style="font-size: 10pt"&gt;191.28&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20240501__20240731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zBs9oEnLmHSb"&gt;199.48&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_zackZSYtBfii"&gt;257.25&lt;/span&gt; &#x2013; &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pip0_dp_c20250501__20250731__custom--FairValueOfOptionsAxis__custom--OptionsAssumptionsUsedMember_z67PDSvzOQVk"&gt;260.22&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</RCAT:ScheduleOfAssumptionsUsed1TableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11899"
      unitRef="USDPShares">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1
      contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11900"
      unitRef="USDPShares">1.29</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11901"
      unitRef="USDPShares">1.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1
      contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11902"
      unitRef="USDPShares">1.12</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate
      contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11903"
      unitRef="USDPShares">1.20</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1
      contextRef="AsOf2024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11904"
      unitRef="USDPShares">1.38</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate
      contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11905"
      unitRef="USDPShares">1.06</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1
      contextRef="AsOf2025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11906"
      unitRef="USDPShares">1.12</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11907"
      unitRef="Pure">0.0424</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11908"
      unitRef="Pure">0.0444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11909"
      unitRef="Pure">0.0347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11910"
      unitRef="Pure">0.0407</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      id="ixv-11911">P5Y2M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2 contextRef="From2024-05-01to2024-07-31" id="ixv-11912">P5Y10M6D</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      id="ixv-11913">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      id="ixv-11914">P6Y3M</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11915"
      unitRef="Pure">1.9128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-05-012024-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11916"
      unitRef="Pure">1.9948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11917"
      unitRef="Pure">2.5725</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2025-05-012025-07-31_custom_OptionsAssumptionsUsedMember"
      decimals="INF"
      id="ixv-11918"
      unitRef="Pure">2.6022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-8752">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_z5BxiEb8u2p4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Exercise Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-Average
    Remaining Contractual Term&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    as of April 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z9JddxlLgW45" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,784,809&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zDfQygnCPCS3" style="text-align: right; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.88&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; width: 10%"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20210501__20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zGwlEPulhxN" style="font-size: 10pt"&gt;8.72&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20220430__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zbymHYYhCbFf" style="text-align: right; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;74,586&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z7rAkr1bfJll" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,903,542&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zAeGFu27kLl8" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.02&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSXoNGEsLN28" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zII2A6LjHwQd" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.89&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z4Eu1Ei19M1d" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(905,417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zpxTVULkCV4k" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of April
    30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zZIYNL7HUKL3" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,779,934&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1it06LlqCT2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.46&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20230501__20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zk7vSr1QQRK2" style="font-size: 10pt"&gt;8.02&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zr3yRtIAuyA" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2,762,242&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zSqSgOyPQXvb" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;627,500&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ztedmKcGU0Pl" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.15&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zPyTUgSssd15" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zdCmh0jF766f" style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.72&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zq4qWyz3cta4" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(83,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zqUOnW2OGdK7" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zu0ZGzckMY46" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,319,988&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_ziYgiRtGqlGj" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.43&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zJSCAopLaHa5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.54&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zR4wvrDYxUO2" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,658,470&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable as of July 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zOXLhV6zDA8" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,444,723&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zjXH5OihYSKf" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.65&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pip0_dtY_c20240501__20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_zExJIpuuUSvg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.57&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20240731__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Options1Member_z1xBWPodGjYa" style="border-bottom: Black 3pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,014,807&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-11919"
      unitRef="Shares">4784809</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="INF"
      id="ixv-11920"
      unitRef="USDPShares">1.88</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-05-012022-04-30_custom_Options1Member"
      id="ixv-11921">P8Y8M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2022-04-30_custom_Options1Member"
      decimals="0"
      id="ixv-11922"
      unitRef="USD">74586</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11923"
      unitRef="Shares">2903542</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11924"
      unitRef="USDPShares">1.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11925"
      unitRef="Shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11926"
      unitRef="USDPShares">0.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11927"
      unitRef="Shares">905417</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11928"
      unitRef="USDPShares">2.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11929"
      unitRef="Shares">6779934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2023-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11930"
      unitRef="USDPShares">1.46</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-05-012023-07-31_custom_Options1Member"
      id="ixv-11931">P8Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-07-31_custom_Options1Member"
      decimals="0"
      id="ixv-11932"
      unitRef="USD">2762242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11933"
      unitRef="Shares">627500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11934"
      unitRef="USDPShares">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11935"
      unitRef="Shares">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11936"
      unitRef="USDPShares">0.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11937"
      unitRef="Shares">83446</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11938"
      unitRef="USDPShares">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11939"
      unitRef="Shares">7319988</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11940"
      unitRef="USDPShares">1.43</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      id="ixv-11941">P7Y6M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="0"
      id="ixv-11942"
      unitRef="USD">5658470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11943"
      unitRef="Shares">4444723</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="INF"
      id="ixv-11944"
      unitRef="USDPShares">1.65</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-05-012024-07-31_custom_Options1Member"
      id="ixv-11945">P6Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-07-31_custom_Options1Member"
      decimals="0"
      id="ixv-11946"
      unitRef="USD">3014807</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11947"
      unitRef="USD">2773793</RCAT:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-9158">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z84tdguiL5Rl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Summary of restricted stock activity under the Plan (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: -10pt; text-align: center"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value Per Share&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt; width: 52%"&gt;Unvested and outstanding as of April 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zV8dAXgikZgj" style="text-align: right; width: 20%"&gt;781,060&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20210430__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zhXB56LbIqZ3" style="text-align: right; width: 20%"&gt;2.44&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zie7GVCpeKAa" style="text-align: right"&gt;298,643&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z2uZdheNanp6" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z0GJcBaAYZYf" style="text-align: right"&gt;(485,024&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zEG5rCLRWOb6" style="text-align: right"&gt;1.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zvu4rWDmXlr2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(419,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230501__20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zv4vkLrcoawb" style="border-bottom: Black 1pt solid; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Unvested and outstanding as of April 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_z6wanxKE0xm5" style="text-align: right"&gt;175,130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20230731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zieqKXmhSHZ8" style="text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zspstRT7400a" style="text-align: right"&gt;2,447,599&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zxnJNgxejRld" style="text-align: right"&gt;1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzfH3x7iglO2" style="text-align: right"&gt;(420,130&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zmnL8xC8W3v1" style="text-align: right"&gt;1.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zbPtYGXtybkc" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20240501__20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zzqAoP4eTbV9" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Unvested and outstanding as of July 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_ze5i1GuWS25i" style="border-bottom: Black 3pt double; text-align: right"&gt;2,202,599&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice_iI_c20240731__custom--ShareBasedCompensationSharesRestrictedStockAxis__us-gaap--RestrictedStockMember_zFvbaVd8IXDb" style="border-bottom: Black 3pt double; text-align: right"&gt;1.11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11948"
      unitRef="Shares">781060</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-04-30_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11949"
      unitRef="USDPShares">2.44</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11950"
      unitRef="Shares">298643</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11951"
      unitRef="USDPShares">1.06</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11952"
      unitRef="Shares">485024</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11953"
      unitRef="USDPShares">1.92</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11954"
      unitRef="Shares">-419549</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-05-012023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11955"
      unitRef="USDPShares">2.09</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11956"
      unitRef="Shares">175130</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11957"
      unitRef="USDPShares">2.09</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11958"
      unitRef="Shares">2447599</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11959"
      unitRef="USDPShares">1.06</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11960"
      unitRef="Shares">420130</RCAT:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-05-012024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11961"
      unitRef="USDPShares">1.25</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue>
    <RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber
      contextRef="AsOf2024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11962"
      unitRef="Shares">2202599</RCAT:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber>
    <RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-07-31_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ixv-11963"
      unitRef="USDPShares">1.11</RCAT:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-9292">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z1eXh3zdYvEh" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Stock compensation expense by functional category (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20240501__20240731_zvomcCTvv4Hh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_49A_20230501__20230731_zgtio2W6FIil" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ResearchAndDevelopmentStockCompensationExpense_zvP0AFfUOoL5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;94,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;127,417&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--SalesAndMarketingStockCompensationExpense_zD6MjHuaDdkg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;116,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;165,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--GeneralAndAdministrativeStockCompensationExpense_z4KIwy9kjGr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,235,073&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;618,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--TotalStockCompensationExpense_z14Pqh4g5ON5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,446,038&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;911,606&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock>
    <RCAT:ResearchAndDevelopmentStockCompensationExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11964"
      unitRef="USD">94422</RCAT:ResearchAndDevelopmentStockCompensationExpense>
    <RCAT:ResearchAndDevelopmentStockCompensationExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11965"
      unitRef="USD">127417</RCAT:ResearchAndDevelopmentStockCompensationExpense>
    <RCAT:SalesAndMarketingStockCompensationExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11966"
      unitRef="USD">116543</RCAT:SalesAndMarketingStockCompensationExpense>
    <RCAT:SalesAndMarketingStockCompensationExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11967"
      unitRef="USD">165309</RCAT:SalesAndMarketingStockCompensationExpense>
    <RCAT:GeneralAndAdministrativeStockCompensationExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11968"
      unitRef="USD">1235073</RCAT:GeneralAndAdministrativeStockCompensationExpense>
    <RCAT:GeneralAndAdministrativeStockCompensationExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11969"
      unitRef="USD">618880</RCAT:GeneralAndAdministrativeStockCompensationExpense>
    <RCAT:TotalStockCompensationExpense
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11970"
      unitRef="USD">1446038</RCAT:TotalStockCompensationExpense>
    <RCAT:TotalStockCompensationExpense
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11971"
      unitRef="USD">911606</RCAT:TotalStockCompensationExpense>
    <RCAT:StockCompensationExpensePertainingToOptions
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11972"
      unitRef="USD">357258</RCAT:StockCompensationExpensePertainingToOptions>
    <RCAT:StockCompensationExpensePertainingToOptions
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11973"
      unitRef="USD">629426</RCAT:StockCompensationExpensePertainingToOptions>
    <RCAT:StockCompensationExpensePertainingToRestrictedStockUnits
      contextRef="From2024-05-01to2024-07-31"
      decimals="0"
      id="ixv-11974"
      unitRef="USD">1088780</RCAT:StockCompensationExpensePertainingToRestrictedStockUnits>
    <RCAT:StockCompensationExpensePertainingToRestrictedStockUnits
      contextRef="From2023-05-012023-07-31"
      decimals="0"
      id="ixv-11975"
      unitRef="USD">282180</RCAT:StockCompensationExpensePertainingToRestrictedStockUnits>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-9397">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zcuYH1QOt3Hi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82C_zinB077i3fe4"&gt;Note
16 - Related-Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 3 and Note 7. UMAC&#x2019;s
Chief Executive Officer is a direct relative of a member of the Company&#x2019;s management.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-9411">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zksTa3herUE6" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82E_zQkIs6eTt0Dh"&gt;Note
17 &#x2013; Commitments and Contingencies&lt;/span&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt; background-color: white"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/11.75pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;&lt;b&gt;Legal
Proceedings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;In
the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not
believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position,
results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant
uncertainties. We have not recorded any litigation reserves as of&#160;July 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;One pending legal matter is an action filed against
Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting
vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with
Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the Lawsuit have occurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-05-01to2024-07-31" id="ixv-9439">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_z5E7tc68Xn6d" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;&lt;span id="xdx_82B_z1NfTJxKzNTi"&gt;Note
18 &#x2013; Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Subsequent
events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;FlightWave
Acquisition&#160;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;On
September 4, 2024, the Company, Teal, FW Acquisition, Inc. (&#x201c;Buyer&#x201d;), and FlightWave Aerospace Systems Corporation (&#x201c;Seller&#x201d;)
entered into and closed on the transactions set forth in an Asset Purchase Agreement (the &#x201c;APA&#x201d; and the transactions set
forth therein, the &#x201c;Transactions&#x201d;), pursuant to which Buyer purchased and Seller sold certain assets used in designing, developing,
manufacturing, and selling long range, AI-powered UAVs for commercial use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;As
a condition to the closing of the Transactions, each of the shareholders of the Seller entered into a Joinder Agreement with the Company,
Teal and Buyer pursuant to which such shareholder agreed to the terms of the APA and agreed to be bound by the provisions thereof applicable
to the Seller&#x2019;s shareholders, including without limit, the indemnification provisions in the APA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
purchase price under the APA is equal to $14 million worth of shares of the Company&#x2019;s common stock which are payable as follows:
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x95;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;$7
                                            million worth of the Company&#x2019;s common stock to be issued on September 30, 2024, at
                                            a price per share equal to the VWAP on such date, which shall be payable to the preferred
                                            shareholders of the Seller as set forth in the APA.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x95;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;$7
                                            million worth of the Company&#x2019;s common stock to be issued on December 31, 2024, at a
                                            price per share equal to the VWAP on such date, of which (i) $2 million will be payable to
                                            preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders
                                            and option-holders of the Seller as set forth the APA.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Promissory
Note&lt;/span&gt;&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 23, 2024, we entered into a Securities
Purchase Agreement (the &#x201c;SPA&#x201d;) with Lind Global Asset Management X LLC (&#x201c;Lind&#x201d;). Under the SPA, within days of
closing, we will receive $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory
Note in the amount of $9,600,000 (the &#x201c;Note&#x201d;) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our
common stock at a price of $6.50 per share, exercisable for 5 years (the &#x201c;Warrant&#x201d;). As addition consideration to Lind, we
have agreed to pay a commitment fee in the amount of $280,000, which may be paid by deduction from the funding to be received.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Note, which does not accrue interest, shall be
repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At our
option, monthly payments can be increased up to $1,000,000 so long as our market capitalization is at least $50 million. In addition,
if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment
amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued
at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment
Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common
stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Note may be converted by Lind from time to time
at a price of $6.50 per share (the &#x201c;Conversion Price&#x201d;). The dollar amount of any conversions by Lind will be applied to toward
upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days&#x2019; notice, but in the event of a prepayment
notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share
Price is equal to or greater than $2.00) or the Conversion Price.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
